<HTML><HEAD><TITLE>Gene Ontology Results</TITLE></HEAD><BODY>
<H1>Gene Ontology Enrichment Results</H1>
<A HREF="homerResults.html">Homer <i>de novo</i> Motif Enrichment Results</A><BR/>
<A HREF="knownResults.html">Known Motif Enrichment Results</A><BR/>
<H4>Text file version of complete results (i.e. open with Excel)
<UL>
<LI><A HREF="biological_process.txt">biological process</A>: Functional groupings of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="molecular_function.txt">molecular function</A>: Mechanistic actions of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="cellular_component.txt">cellular component</A>: Protein localization (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="chromosome.txt">chromosome location</A>: Genes with similar chromosome localization (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="kegg.txt">KEGG pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.genome.jp/kegg/pathway.html">KEGG</A>)</LI>
<LI><A HREF="interactions.txt">protein interactions</A>: "Proteins interacting with a common protein (BIND, EcoCyc, HPRD)" (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="interpro.txt">interpro domains</A>: Proteins with similar domains and features (<A HREF="http://www.ebi.ac.uk/interpro/">Interpro</A>)</LI>
<LI><A HREF="pfam.txt">pfam domains</A>: Proteins with similar domains and features (<A HREF="http://www.sanger.ac.uk/Software/Pfam/">Pfam</A>)</LI>
<LI><A HREF="smart.txt">smart domains</A>: Proteins with similar domains and features (<A HREF="http://smart.embl-heidelberg.de/">SMART</A>)</LI>
<LI><A HREF="gene3d.txt">gene3d domains</A>: Proteins with similar domains and features (<A HREF="http://cathwww.biochem.ucl.ac.uk:8080/Gene3D">Gene3D</A>)</LI>
<LI><A HREF="prosite.txt">prosite domains</A>: Proteins with similar domains and features (<A HREF="http://ca.expasy.org/prosite/">Prosite</A>)</LI>
<LI><A HREF="prints.txt">prints domains</A>: Proteins with similar domains and features (<A HREF="http://www.bioinf.manchester.ac.uk/dbbrowser/PRINTS/">PRINTS</A>)</LI>
<LI><A HREF="msigdb.txt">MSigDB lists</A>: "Genes sets for pathways, factor/miRNA target predictions, expression patterns, etc." (<A HREF="http://www.broadinstitute.org/gsea/msigdb/index.jsp">MSigDB</A>)</LI>
<LI><A HREF="biocyc.txt">BIOCYC pathways</A>: Groups of proteins in the same pathways (<A HREF="http://biocyc.org/">BIOCYC</A>)</LI>
<LI><A HREF="cosmic.txt">COSMIC cancer mutations</A>: Genes mutated in similar cancers (<A HREF="http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/">COSMIC</A>)</LI>
<LI><A HREF="gwas.txt">GWAS genes</A>: Genes mutated in similar diseases (<A HREF="http://www.genome.gov/26525384">GWAS Catalog</A>)</LI>
<LI><A HREF="lipidmaps.txt">Lipid Maps pathways</A>: Groups of proteins in the same lipid pathways (<A HREF="http://www.ncbi.nlm.nih.gov/biosystems/">Lipid Maps/Biosystems</A>)</LI>
<LI><A HREF="pathwayInteractionDB.txt">Pathway Interaction DB</A>: Groups of proteins in the same pathways (<A HREF="http://pid.nci.nih.gov/">Pathway Interaction Database</A>)</LI>
<LI><A HREF="reactome.txt">REACTOME pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.reactome.org/PathwayBrowser/">REACTOME</A>)</LI>
<LI><A HREF="smpdb.txt">SMPDB pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.smpdb.ca/">SMPDB</A>)</LI>
<LI><A HREF="wikipathways.txt">WikiPathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.wikipathways.org/index.php/Special:BrowsePathwaysPage">Wikipathways</A>)</LI>
</UL>
<H2>Enriched Categories</H2>
<TABLE border="1" cellpading="0" cellspacing="0">
<TR><TH>P-value</TH><TD>ln(P)</TD><TD>Term</TD><TD>GO Tree</TD><TD>GO ID</TD><TD># of Genes in Term</TD><TD># of Target Genes in Term</TD><TD># of Total Genes</TD><TD># of Target Genes</TD><TD>Common Genes</TD></TR>
<TR><TD>7.340e-21</TD><TD>-46.36</TD><TD>Burkitt_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>Burkitt_lymphoma</TD><TD>2125</TD><TD>75</TD><TD>16984</TD><TD>192</TD>
<TD>CPXM2,MAP2,PI15,PRKCE,PHLPP1,NOVA1,CNTNAP2,CNTN1,NAALADL2,DSCAM,KCNK9,SLIT2,NCKAP5,NOL4,DAOA,SKAP2,CASK,NBEA,TMEFF2,FIGN,SYT1,SGCD,DNER,GMDS,EPYC,EFNA5,EDIL3,UBR4,ACVR1C,KAZN,LMX1A,WRN,IL1RAPL2,MEGF10,CTSO,BCHE,ADAMTS3,UTRN,PAX6,RBM20,ACVR2A,EPHA3,ZFPM2,IQGAP2,STXBP6,GAP43,ADAMTS12,NTRK2,CD96,THSD7A,ZPLD1,PCDH9,VAV3,SPATA16,SGCG,ADAMTS5,RYR2,ROBO2,UNC5C,PTPRD,NRG1,SERGEF,PWWP2A,EPS8,SLC7A8,CRTC3,MRPL13,SEMA3C,KLF12,FMNL2,FBN2,ZNF521,ATG10,THSD7B,FGF14</TD></TR>
<TR><TD>7.340e-21</TD><TD>-46.36</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma</TD><TD>2125</TD><TD>75</TD><TD>16984</TD><TD>192</TD>
<TD>BCHE,ADAMTS3,CTSO,MEGF10,IL1RAPL2,WRN,UBR4,LMX1A,ACVR1C,KAZN,EFNA5,EDIL3,EPYC,DNER,GMDS,NBEA,CASK,TMEFF2,FIGN,SYT1,SGCD,NCKAP5,DAOA,NOL4,SKAP2,DSCAM,KCNK9,SLIT2,CNTNAP2,CNTN1,NAALADL2,NOVA1,PRKCE,PHLPP1,CPXM2,MAP2,PI15,THSD7B,FGF14,ATG10,FMNL2,FBN2,ZNF521,KLF12,CRTC3,MRPL13,SEMA3C,SLC7A8,SERGEF,PWWP2A,EPS8,UNC5C,PTPRD,NRG1,RYR2,ROBO2,SGCG,SPATA16,ADAMTS5,VAV3,THSD7A,ZPLD1,PCDH9,NTRK2,CD96,STXBP6,IQGAP2,GAP43,ADAMTS12,EPHA3,ZFPM2,UTRN,PAX6,ACVR2A,RBM20</TD></TR>
<TR><TD>5.051e-13</TD><TD>-28.31</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma</TD><TD>7233</TD><TD>131</TD><TD>16984</TD><TD>192</TD>
<TD>RBM20,EPHA3,ARX,ADAMTS12,CD96,NTRK2,HNF4G,THSD7A,PCDH9,ZPLD1,AOAH,SGCG,PHF14,ADAMTS5,ROBO2,CDH5,RPH3A,RYR2,NRG1,PTPRD,LHCGR,ADAM28,CALN1,SEMA3C,CRTC3,DAAM1,MRPL13,KLF12,ZNF521,PTPRK,FMNL2,EFR3A,NAV3,ATG10,LMBRD1,FGF14,THSD7B,PI15,CPXM2,FAT4,PRKCE,CNTNAP2,KCNK9,DSCAM,XPO4,DAOA,DCDC2C,SKAP2,BANK1,TMEFF2,SGCD,FANCB,SYT1,CASK,DNER,EPHA4,GMDS,SPHKAP,EDIL3,ACVR1C,PXDNL,LRRN2,AGA,SLC25A46,KIF6,PAQR3,MEGF10,CXCL13,BACH2,TCF20,CTSO,SEZ6L,PAX6,ACVR2A,UTRN,FGD3,ZFPM2,GAP43,RASGEF1B,CELF2,STXBP6,IQGAP2,PLEK,SLC39A10,VAV3,LRIG3,SPATA16,IPO8,AFM,PTPRZ1,UNC5C,GPR83,B3GAT2,SERGEF,PWWP2A,CD226,RGS6,TRPS1,DEPTOR,FBN2,WWOX,MUC7,MAP2,PHLPP1,SS18,NOVA1,AKAP9,CNTN1,NAALADL2,JMJD1C,PARP8,SLIT2,NOL4,EFR3B,NCKAP5,FIGN,FGF20,EPYC,EFNA5,PRLHR,LMX1A,KAZN,UBR4,SLC10A2,LGI1,GCNT1,WRN,IL1RAPL2,FGFR2,BCHE,ADAMTS3</TD></TR>
<TR><TD>1.129e-12</TD><TD>-27.51</TD><TD>chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma</TD><TD>3513</TD><TD>83</TD><TD>16984</TD><TD>192</TD>
<TD>TMEFF2,FIGN,FANCB,SYT1,NBEA,DNER,MPEG1,EPHA4,GMDS,SLIT2,DSCAM,CHRM3,NOL4,SKAP2,NCKAP5,NOVA1,NAALADL2,CNTNAP2,MAP2,CPXM2,IRX1,PHLPP1,FAT4,ZNF133,CTSO,SEZ6L,ADAMTS3,LRFN5,MRPL3,IL1RAPL2,MEGF10,BACH2,FGFR2,KAZN,PXDNL,NOBOX,UBR4,KIF6,PAQR3,SPHKAP,FNIP2,EFNA5,EDIL3,RAI2,NRSN1,SPATA16,SGCG,ADAMTS5,AFM,ROBO2,FUT9,CDH5,RYR2,THSD7A,PCDH9,AOAH,VAV3,LRIG3,REG1B,ADAMTS12,IQGAP2,NTRK2,HNF4G,ACVR2A,UHMK1,UTRN,FGD3,EPHA3,ZFPM2,EFR3A,EFEMP1,THSD7B,ZNF521,PTPRK,FMNL2,FBN2,SEMA3C,NRCAM,NRG1,PTPRZ1,UNC5C,PTPRD,B3GAT2</TD></TR>
<TR><TD>1.129e-12</TD><TD>-27.51</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma</TD><TD>3513</TD><TD>83</TD><TD>16984</TD><TD>192</TD>
<TD>AFM,ADAMTS5,SGCG,SPATA16,NRSN1,RYR2,CDH5,FUT9,ROBO2,PCDH9,THSD7A,REG1B,VAV3,LRIG3,AOAH,IQGAP2,ADAMTS12,NTRK2,HNF4G,UTRN,UHMK1,ACVR2A,ZFPM2,EPHA3,FGD3,EFR3A,THSD7B,EFEMP1,FBN2,FMNL2,PTPRK,ZNF521,NRCAM,SEMA3C,PTPRD,UNC5C,PTPRZ1,NRG1,B3GAT2,NBEA,SYT1,FANCB,TMEFF2,FIGN,GMDS,EPHA4,DNER,MPEG1,DSCAM,CHRM3,SLIT2,NCKAP5,SKAP2,NOL4,NOVA1,CNTNAP2,NAALADL2,CPXM2,MAP2,ZNF133,FAT4,PHLPP1,IRX1,CTSO,LRFN5,ADAMTS3,SEZ6L,MRPL3,FGFR2,BACH2,IL1RAPL2,MEGF10,NOBOX,UBR4,KAZN,PXDNL,PAQR3,KIF6,FNIP2,SPHKAP,RAI2,EDIL3,EFNA5</TD></TR>
<TR><TD>1.356e-12</TD><TD>-27.33</TD><TD>diffuse_large_B_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>diffuse_large_B_cell_lymphoma</TD><TD>4162</TD><TD>92</TD><TD>16984</TD><TD>192</TD>
<TD>CNTNAP2,FAT4,PRKCE,CPXM2,DNER,MPEG1,GMDS,EPHA4,BANK1,TMEFF2,SGCD,SYT1,CASK,XPO4,DAOA,SKAP2,DSCAM,CHRM3,KIF6,EDIL3,SEZ6L,CTSO,MEGF10,CXCL13,FGF5,CD96,NTRK2,ADAMTS12,EPHA3,ARX,ROBO2,RPH3A,RYR2,REXO2,SGCG,ADAMTS5,THSD7A,ZPLD1,PCDH9,SEMA3C,CRTC3,DAAM1,EPS8,LHCGR,NRG1,PTPRD,FGF14,THSD7B,NAV3,ATG10,FZD6,ZNF521,PTPRK,FMNL2,KLF12,AKAP9,CNTN1,NAALADL2,NOVA1,PHLPP1,MAP2,FGF20,FIGN,NOL4,ASPN,NCKAP5,SLIT2,LGI1,KAZN,LMX1A,EFNA5,EPYC,BCHE,ADAMTS3,IL1RAPL2,STXBP6,FGD3,ZFPM2,UTRN,NRSN1,SPATA16,VAV3,LRIG3,CD226,SERGEF,B3GAT2,UNC5C,LINC01387,EFEMP1,DEPTOR,FBN2,TRPS1</TD></TR>
<TR><TD>1.457e-12</TD><TD>-27.25</TD><TD>central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV</TD><TD>2542</TD><TD>68</TD><TD>16984</TD><TD>192</TD>
<TD>CD96,STXBP6,IQGAP2,ADAMTS12,ZFPM2,EPHA3,UTRN,RBM20,RYR2,CDH5,ROBO2,AFM,ADAMTS5,SPATA16,VAV3,SLC39A10,PCDH9,THSD7A,SEMA3C,CD226,SERGEF,LHCGR,EPS8,UNC5C,PRSS12,TGFBR2,PTPRZ1,NRG1,FGF14,THSD7B,FZD6,EFR3A,FMNL2,PTPRK,ZNF521,KLF12,PARP8,CNTNAP2,NAALADL2,PRKCE,PHLPP1,PI15,EPHA4,GMDS,DNER,CASK,NBEA,SGCD,SYT1,TMEFF2,FIGN,BANK1,NCKAP5,NOL4,DSCAM,SLIT2,KIF6,UBR4,KAZN,LMX1A,EDIL3,EFNA5,LRFN5,ADAMTS3,SEZ6L,ACP6,BACH2,IL1RAPL2</TD></TR>
<TR><TD>1.575e-12</TD><TD>-27.18</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm</TD><TD>7328</TD><TD>131</TD><TD>16984</TD><TD>192</TD>
<TD>CNTNAP2,PI15,CPXM2,IRX1,FAT4,PRKCE,BANK1,TMEFF2,SGCD,SYT1,FANCB,CASK,NBEA,DNER,GMDS,EPHA4,COQ2,KCNK9,DSCAM,CHRM3,XPO4,DAOA,DCDC2C,SKAP2,PXDNL,ACVR1C,SLC25A46,KIF6,SPHKAP,EDIL3,SLC7A14,TCF20,CTSO,SEZ6L,LRFN5,MEGF10,CXCL13,FGF5,ADAMTS12,CD96,NTRK2,RBM20,EPHA3,REXO2,PHF14,SGCG,ADAMTS5,ROBO2,RPH3A,CDH5,RYR2,THSD7A,ZPLD1,PCDH9,AOAH,CALN1,SLC7A8,SEMA3C,DAAM1,CRTC3,MRPL13,NRG1,TGFBR2,PRSS12,PTPRD,EPS8,LHCGR,ADAM28,EFR3A,NAV3,ATG10,FZD6,LMBRD1,FGF14,THSD7B,KLF12,ZNF521,FMNL2,SS18,NOVA1,CNTN1,AKAP9,NAALADL2,JMJD1C,PARP8,MAP2,PHLPP1,FIGN,FGF20,SLIT2,NOL4,EFR3B,NCKAP5,LMX1A,KAZN,LGI1,PSKH2,EPYC,EFNA5,DNAJC12,BCHE,ADAMTS3,LINC00583,WRN,MRPL3,IL1RAPL2,RUNX1T1,GAP43,STXBP6,IQGAP2,PAX6,ACVR2A,UTRN,ZFPM2,NRSN1,SPATA16,IPO8,PLEK,SLC39A10,LRIG3,VAV3,CD226,PTPRZ1,UNC5C,SERGEF,B3GAT2,LINC01387,MUC7,EFEMP1,DEPTOR,FBN2</TD></TR>
<TR><TD>1.923e-12</TD><TD>-26.98</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>3616</TD><TD>84</TD><TD>16984</TD><TD>192</TD>
<TD>LINC01387,FGF14,THSD7B,EFEMP1,NAV3,FZD6,ATG10,ZNF521,FMNL2,FBN2,DEPTOR,KLF12,SEMA3C,DAAM1,CRTC3,CD226,EPS8,LHCGR,B3GAT2,SERGEF,NRG1,UNC5C,ROBO2,RYR2,RPH3A,NRSN1,REXO2,ADAMTS5,SGCG,SPATA16,VAV3,LRIG3,ZPLD1,PCDH9,THSD7A,CD96,ADAMTS12,STXBP6,FGD3,ARX,ZFPM2,EPHA3,UTRN,ADAMTS3,SEZ6L,BCHE,CTSO,CXCL13,MEGF10,IL1RAPL2,FGF5,LGI1,LMX1A,KAZN,EDIL3,EFNA5,EPYC,GMDS,EPHA4,MPEG1,DNER,SGCD,SYT1,TMEFF2,BANK1,FIGN,CASK,ASPN,SKAP2,XPO4,DAOA,NOL4,NCKAP5,SLIT2,DSCAM,NAALADL2,AKAP9,CNTN1,CNTNAP2,NOVA1,FAT4,PHLPP1,PRKCE,CPXM2</TD></TR>
<TR><TD>5.862e-12</TD><TD>-25.86</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma</TD><TD>2746</TD><TD>70</TD><TD>16984</TD><TD>192</TD>
<TD>NOVA1,CNTN1,NAALADL2,JMJD1C,CNTNAP2,MAP2,CPXM2,PHLPP1,FAT4,ZNF133,PRKCE,TMEFF2,FIGN,SYT1,NBEA,DNER,GMDS,SLIT2,DSCAM,DAOA,NOL4,NCKAP5,KAZN,FABP7,DNAJC12,EFNA5,EDIL3,TCF20,BCHE,SEZ6L,ADAMTS3,MEGF10,IL1RAPL2,ADAMTS12,STXBP6,IQGAP2,NTRK2,RBM20,UTRN,EPHA3,ZFPM2,SGCG,ADAMTS5,ROBO2,INSM1,RPH3A,RYR2,SHISA3,THSD7A,PLEK,PCDH9,LRIG3,SEMA3C,NRG1,UNC5C,PRSS12,GPR83,LHCGR,NAV3,ATG10,LMBRD1,EFEMP1,THSD7B,FGF14,TRPS1,KLF12,ZNF521,DEPTOR,FBN2,FMNL2</TD></TR>
<TR><TD>1.312e-11</TD><TD>-25.06</TD><TD>mantle_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>mantle_cell_lymphoma</TD><TD>2858</TD><TD>71</TD><TD>16984</TD><TD>192</TD>
<TD>PHLPP1,FAT4,PRKCE,ZNF133,CPXM2,MAP2,NAALADL2,CNTN1,CNTNAP2,JMJD1C,NOVA1,DAOA,NOL4,NCKAP5,SLIT2,DSCAM,GMDS,DNER,SYT1,TMEFF2,FIGN,CASK,NBEA,EDIL3,DNAJC12,EFNA5,FABP7,KAZN,IL1RAPL2,MEGF10,ADAMTS3,BCHE,SEZ6L,TCF20,ZFPM2,EPHA3,RBM20,UTRN,NTRK2,ADAMTS12,IQGAP2,STXBP6,LRIG3,SHISA3,PLEK,PCDH9,THSD7A,ROBO2,INSM1,RYR2,RPH3A,ADAMTS5,SGCG,GPR83,LHCGR,NRG1,UNC5C,PRSS12,SEMA3C,ZNF521,FMNL2,FBN2,DEPTOR,KLF12,TRPS1,LMBRD1,FGF14,THSD7B,EFEMP1,NAV3,ATG10</TD></TR>
<TR><TD>3.286e-11</TD><TD>-24.14</TD><TD>Ig_I-set</TD><TD>interpro domains</TD><TD>IPR013098</TD><TD>132</TD><TD>15</TD><TD>18605</TD><TD>214</TD>
<TD>PXDNL,UNC5C,NTRK2,CNTN1,SEMA3C,PTPRD,PTPRK,LRIG3,IL1RAPL2,ROBO2,DSCAM,FGFR2,NRG1,NRCAM,LRRN2</TD></TR>
<TR><TD>3.335e-11</TD><TD>-24.12</TD><TD>I-set</TD><TD>pfam domains</TD><TD>PF07679</TD><TD>132</TD><TD>15</TD><TD>17869</TD><TD>206</TD>
<TD>PTPRK,LRIG3,SEMA3C,LRRN2,PTPRD,IL1RAPL2,NRG1,NRCAM,PXDNL,CNTN1,UNC5C,ROBO2,NTRK2,FGFR2,DSCAM</TD></TR>
<TR><TD>5.366e-11</TD><TD>-23.65</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia</TD><TD>3841</TD><TD>84</TD><TD>16984</TD><TD>192</TD>
<TD>EDIL3,EFNA5,KIF6,LGI1,PSKH2,PAQR3,ACVR1C,UBR4,NOBOX,BACH2,IL1RAPL2,MEGF10,FGFR2,LINC00583,MRPL3,ADAMTS3,BCHE,FAT4,PHLPP1,PRKCE,MAP2,CPXM2,NAALADL2,AKAP9,CNTN1,PARP8,CNTNAP2,JMJD1C,SKAP2,NOL4,EFR3B,NCKAP5,SLIT2,CHRM3,DSCAM,EPHA4,GMDS,DNER,SGCD,SYT1,FIGN,TMEFF2,BANK1,NBEA,SERGEF,LHCGR,PTPRZ1,NRG1,UNC5C,NRCAM,CRTC3,CD226,SLC7A8,CALN1,ZNF521,FBN2,FMNL2,KLF12,MUC7,LMBRD1,FGF14,THSD7B,NAV3,EFR3A,ATG10,EPHA3,ACVR2A,RBM20,UTRN,CD96,NTRK2,ADAMTS12,IQGAP2,STXBP6,LRIG3,PCDH9,THSD7A,ROBO2,RYR2,RPH3A,NRSN1,ADAMTS5,SPATA16,SGCG</TD></TR>
<TR><TD>5.366e-11</TD><TD>-23.65</TD><TD>acute_lymphoblastic_B_cell_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>acute_lymphoblastic_B_cell_leukaemia</TD><TD>3841</TD><TD>84</TD><TD>16984</TD><TD>192</TD>
<TD>UNC5C,PTPRZ1,NRG1,LHCGR,SERGEF,SLC7A8,CALN1,CD226,CRTC3,NRCAM,KLF12,FMNL2,FBN2,ZNF521,ATG10,NAV3,EFR3A,THSD7B,FGF14,MUC7,LMBRD1,UTRN,ACVR2A,RBM20,EPHA3,STXBP6,IQGAP2,ADAMTS12,NTRK2,CD96,PCDH9,THSD7A,LRIG3,ADAMTS5,SPATA16,SGCG,NRSN1,RYR2,RPH3A,ROBO2,EDIL3,EFNA5,UBR4,NOBOX,ACVR1C,PSKH2,PAQR3,LGI1,KIF6,MRPL3,LINC00583,FGFR2,BACH2,MEGF10,IL1RAPL2,ADAMTS3,BCHE,CPXM2,MAP2,PRKCE,PHLPP1,FAT4,PARP8,CNTNAP2,JMJD1C,NAALADL2,CNTN1,AKAP9,DSCAM,CHRM3,SLIT2,NCKAP5,SKAP2,EFR3B,NOL4,NBEA,SYT1,SGCD,BANK1,TMEFF2,FIGN,GMDS,EPHA4,DNER</TD></TR>
<TR><TD>9.717e-11</TD><TD>-23.05</TD><TD>brainstem</TD><TD>COSMIC cancer mutations</TD><TD>brainstem</TD><TD>3116</TD><TD>73</TD><TD>16984</TD><TD>192</TD>
<TD>SEMA3C,CD226,EPS8,LHCGR,SERGEF,NRG1,PTPRZ1,TGFBR2,PRSS12,UNC5C,PTPRD,THSD7B,FGF14,EFR3A,WWOX,FZD6,ZNF521,PTPRK,FMNL2,KLF12,CD96,ADAMTS12,IQGAP2,STXBP6,EPHA3,ZFPM2,RBM20,UTRN,ROBO2,RPH3A,CDH5,RYR2,SPATA16,AFM,ADAMTS5,SLC39A10,VAV3,THSD7A,PCDH9,KIF6,LMX1A,KAZN,UBR4,EFNA5,EDIL3,SEZ6L,ADAMTS3,LRFN5,IGFL4,IL1RAPL2,BACH2,FGFR2,ACP6,NAALADL2,CNTNAP2,PARP8,PHLPP1,PRKCE,PI15,DNER,GMDS,EPHA4,FIGN,BANK1,TMEFF2,SGCD,SYT1,CASK,NBEA,NOL4,NCKAP5,SLIT2,DSCAM</TD></TR>
<TR><TD>1.204e-10</TD><TD>-22.84</TD><TD>oesophagus-lower_third-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-lower_third-carcinoma-adenocarcinoma</TD><TD>6317</TD><TD>115</TD><TD>16984</TD><TD>192</TD>
<TD>PHLPP1,MAP2,SERINC5,JMJD1C,PARP8,AKAP9,CNTN1,NAALADL2,TWIST1,SS18,NCKAP5,NOL4,LRRC3B,SLIT2,RAI2,EFNA5,PRLHR,PSKH2,SLC10A2,UBR4,KAZN,LMX1A,IL1RAPL2,RUNX1T1,GCNT1,WRN,BCHE,ADAMTS3,FERD3L,ZFPM2,FGD3,UTRN,PAX6,ACVR2A,CELF2,RASGEF1B,IQGAP2,SLC39A10,VAV3,LRIG3,REG1B,IPO8,NAT2,SERGEF,UNC5C,PTPRZ1,CD226,FBN2,TRPS1,RGS6,EFEMP1,SPAG9,MUC7,ZNF133,PRKCE,IRX1,FAT4,CPXM2,PI15,CNTNAP2,XPO4,SKAP2,DSCAM,CHRM3,KCNK9,COQ2,MPEG1,EPHA4,GMDS,NBEA,ZNF518B,TMEFF2,SGCD,SLC7A14,SPHKAP,PAQR3,SLC25A46,AGA,PXDNL,MEGF10,CXCL13,BACH2,LRFN5,PCGF5,EPHA3,NTRK2,ADAMTS12,AOAH,THSD7A,PCDH9,ZPLD1,RPH3A,CDH5,RYR2,ROBO2,PHF14,ADAMTS5,LHCGR,ADAM28,EPS8,PRSS12,PTPRD,NRG1,TGFBR2,DAAM1,CRTC3,SLC7A8,ZNF521,PTPRK,KLF12,THSD7B,FZD6,EFR3A,NAV3,NUP35</TD></TR>
<TR><TD>1.355e-10</TD><TD>-22.72</TD><TD>acute_myeloid_leukaemia_therapy_related</TD><TD>COSMIC cancer mutations</TD><TD>acute_myeloid_leukaemia_therapy_related</TD><TD>1526</TD><TD>47</TD><TD>16984</TD><TD>192</TD>
<TD>UTRN,ACVR2A,RBM20,PAX6,ZFPM2,CD96,NTRK2,PCDH9,THSD7A,VAV3,LRIG3,SPATA16,SGCG,RYR2,RPH3A,ROBO2,UNC5C,NRG1,B3GAT2,SLC7A8,CRTC3,FMNL2,ZNF521,THSD7B,FGF14,MAP2,NOVA1,CNTNAP2,NAALADL2,DSCAM,SLIT2,KCNK9,NCKAP5,DAOA,CASK,SYT1,SGCD,BANK1,FIGN,DNER,SLC7A14,EDIL3,EFNA5,LMX1A,IL1RAPL2,MEGF10,ADAMTS3</TD></TR>
<TR><TD>1.355e-10</TD><TD>-22.72</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related</TD><TD>1526</TD><TD>47</TD><TD>16984</TD><TD>192</TD>
<TD>B3GAT2,NRG1,UNC5C,CRTC3,SLC7A8,ZNF521,FMNL2,THSD7B,FGF14,ZFPM2,RBM20,ACVR2A,PAX6,UTRN,NTRK2,CD96,LRIG3,VAV3,PCDH9,THSD7A,ROBO2,RYR2,RPH3A,SGCG,SPATA16,EDIL3,SLC7A14,EFNA5,LMX1A,MEGF10,IL1RAPL2,ADAMTS3,MAP2,NAALADL2,CNTNAP2,NOVA1,DAOA,NCKAP5,SLIT2,KCNK9,DSCAM,DNER,SGCD,SYT1,FIGN,BANK1,CASK</TD></TR>
<TR><TD>2.691e-10</TD><TD>-22.04</TD><TD>prostate-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>prostate-carcinoma</TD><TD>9014</TD><TD>144</TD><TD>16984</TD><TD>192</TD>
<TD>UBR4,KAZN,LMX1A,PSKH2,LGI1,SLC10A2,EPYC,RAI2,PBX1,EFNA5,DNAJC12,FERD3L,ADAMTS3,WRN,GCNT1,CETN3,FGFR2,RUNX1T1,IL1RAPL2,NOVA1,TWIST1,SS18,PARP8,JMJD1C,NAALADL2,CNTN1,AKAP9,MAP2,PHLPP1,FGF20,SLIT2,NCKAP5,ASPN,NOL4,CD226,OR2AG1,UCHL1,UNC5C,PTPRZ1,GHITM,SERGEF,GPR83,SPAG9,EFEMP1,TRPS1,RGS6,DEPTOR,FBN2,STXBP6,IQGAP2,RASGEF1B,CELF2,GAP43,UTRN,ACVR2A,PAX6,ZFPM2,SPATA16,NAT2,FUT9,VAV3,LRIG3,REG1B,SLC39A10,NOBOX,AGA,ERCC6L2,LRRN2,PXDNL,ACVR1C,KIF6,FNIP2,SPHKAP,SLC7A14,EDIL3,CTSO,LRFN5,SEZ6L,FGF5,ACP6,BACH2,MEGF10,CNTNAP2,CPXM2,PRKCE,ZNF133,FAT4,IRX1,NBEA,CASK,SGCD,SYT1,FANCB,BANK1,TMEFF2,COQ2,EPHA4,GMDS,DNER,CHRM3,DSCAM,KCNK9,SKAP2,XPO4,CALN1,MRPL13,DAAM1,CRTC3,SEMA3C,NRCAM,PTPRD,PRSS12,TGFBR2,NRG1,LHCGR,EPS8,FZD6,ATG10,NAV3,THSD7B,FGF14,LMBRD1,KLF12,FMNL2,PTPRK,ZNF521,ADAMTS12,NTRK2,HNF4G,CD96,UHMK1,RBM20,EPHA3,ADAMTS5,PHF14,SGCG,RYR2,CDH5,RPH3A,INSM1,ROBO2,PCDH9,THSD7A,AOAH</TD></TR>
<TR><TD>3.856e-10</TD><TD>-21.68</TD><TD>system development</TD><TD>biological process</TD><TD>GO:0048731</TD><TD>3545</TD><TD>80</TD><TD>18905</TD><TD>219</TD>
<TD>IRX1,IL1RAPL2,PECAM1,ARX,ZNF521,CNTN1,SLC25A46,LHCGR,FABP7,PLAAT1,PAX6,FERD3L,ADAMTS5,ADAMTS12,WWOX,FUT9,FGF20,ZFAND5,ACVR1C,SGCD,ROBO2,PTPRZ1,SGCG,SLIT2,LGI1,FGF14,VAV3,RBM20,GCNT1,INSM1,AFG2A,PBX1,EFEMP1,AMELX,CNTNAP2,SEMA3C,BCHE,CHRM3,FGFR2,PTPRD,MAP2,THSD7A,CDH5,UCHL1,DSCAM,EPHA3,RYR2,NRCAM,ACVR2A,FZD6,GAP43,ADGRL3,TGFBR2,PPP1R17,CYTL1,DNER,FBN2,PCDH9,NOVA1,NRG1,BRINP3,EPYC,SEZ6L,EFNA5,SHTN1,PHF14,FAT4,UHMK1,EPHA4,ZFPM2,SERINC5,DAW1,NTRK2,FGF5,NRSN1,UNC5C,TWIST1,TRPS1,LMX1A,NAV3</TD></TR>
<TR><TD>9.475e-10</TD><TD>-20.78</TD><TD>blood_vessel</TD><TD>COSMIC cancer mutations</TD><TD>blood_vessel</TD><TD>2217</TD><TD>57</TD><TD>16984</TD><TD>192</TD>
<TD>SLC10A2,LMX1A,KAZN,EDIL3,EFNA5,FGF5,FGFR2,IL1RAPL2,CNTNAP2,PARP8,NAALADL2,SPANXN1,NOVA1,PRKCE,PHLPP1,CPXM2,MAP2,DNER,NBEA,SGCD,BANK1,NCKAP5,SKAP2,NOL4,DSCAM,SLIT2,SEMA3C,ADAM28,SERGEF,B3GAT2,EPS8,UNC5C,PTPRZ1,FGF14,THSD7B,LMBRD1,FZD6,FMNL2,FBN2,ZNF521,NTRK2,ARX,EPHA3,UTRN,UHMK1,RBM20,RYR2,RPH3A,ROBO2,SPATA16,SGCG,VAV3,AOAH,PCDH9,PLEK,ZPLD1,THSD7A</TD></TR>
<TR><TD>1.176e-09</TD><TD>-20.56</TD><TD>multicellular organism development</TD><TD>biological process</TD><TD>GO:0007275</TD><TD>3972</TD><TD>85</TD><TD>18905</TD><TD>219</TD>
<TD>EFNA5,SHTN1,PHF14,LMBRD1,EPYC,SEZ6L,DAW1,NTRK2,FAT4,UHMK1,ZFPM2,EPHA4,SERINC5,UNC5C,TWIST1,LRIG3,FGF5,NRSN1,NAV3,LMX1A,TRPS1,ADGRL3,ACVR2A,FZD6,GAP43,CYTL1,TGFBR2,PPP1R17,NOVA1,DNER,FBN2,PCDH9,RAI2,BRINP3,NRG1,VAV3,GCNT1,RBM20,INSM1,EFEMP1,AFG2A,PBX1,SLIT2,LGI1,FGF14,CNTNAP2,SEMA3C,BCHE,CHRM3,FGFR2,AMELX,MAP2,THSD7A,CDH5,PTPRD,NRCAM,DSCAM,EPHA3,UCHL1,RYR2,SLC25A46,LHCGR,IL1RAPL2,IRX1,PECAM1,ZNF521,ARX,CNTN1,ADAMTS3,FERD3L,PAX6,FABP7,PLAAT1,ADAMTS5,ADAMTS12,TMEFF2,SGCG,ROBO2,PTPRZ1,WWOX,FGF20,FUT9,ZFAND5,SGCD,ACVR1C</TD></TR>
<TR><TD>1.983e-09</TD><TD>-20.04</TD><TD>soft_tissue-blood_vessel-angiosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-blood_vessel-angiosarcoma</TD><TD>2198</TD><TD>56</TD><TD>16984</TD><TD>192</TD>
<TD>SLC10A2,KAZN,LMX1A,EFNA5,EDIL3,IL1RAPL2,FGF5,NAALADL2,PARP8,CNTNAP2,NOVA1,SPANXN1,PHLPP1,PRKCE,CPXM2,MAP2,DNER,BANK1,SGCD,NBEA,NOL4,SKAP2,NCKAP5,SLIT2,DSCAM,SEMA3C,EPS8,SERGEF,B3GAT2,ADAM28,PTPRZ1,UNC5C,LMBRD1,FGF14,THSD7B,FZD6,ZNF521,FMNL2,FBN2,NTRK2,EPHA3,ARX,RBM20,UHMK1,UTRN,ROBO2,RPH3A,RYR2,SPATA16,SGCG,VAV3,AOAH,THSD7A,PCDH9,ZPLD1,PLEK</TD></TR>
<TR><TD>1.983e-09</TD><TD>-20.04</TD><TD>angiosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>angiosarcoma</TD><TD>2198</TD><TD>56</TD><TD>16984</TD><TD>192</TD>
<TD>RPH3A,RYR2,ROBO2,SGCG,SPATA16,AOAH,VAV3,THSD7A,ZPLD1,PLEK,PCDH9,NTRK2,EPHA3,ARX,UHMK1,UTRN,RBM20,FGF14,THSD7B,LMBRD1,FZD6,FMNL2,FBN2,ZNF521,SEMA3C,SERGEF,B3GAT2,ADAM28,EPS8,UNC5C,PTPRZ1,DNER,NBEA,BANK1,SGCD,NCKAP5,NOL4,SKAP2,DSCAM,SLIT2,PARP8,CNTNAP2,NAALADL2,SPANXN1,NOVA1,PRKCE,PHLPP1,CPXM2,MAP2,FGF5,IL1RAPL2,SLC10A2,KAZN,LMX1A,EFNA5,EDIL3</TD></TR>
<TR><TD>8.872e-09</TD><TD>-18.54</TD><TD>anatomical structure development</TD><TD>biological process</TD><TD>GO:0048856</TD><TD>5236</TD><TD>100</TD><TD>18905</TD><TD>219</TD>
<TD>PLEK,TRPS1,LRIG3,TWIST1,UNC5C,CXCL13,FGF5,SPATA16,NTRK2,ZFPM2,FAT4,LMBRD1,SHTN1,EPYC,NOVA1,MEGF10,HNF4G,PCDH9,DNER,CYTL1,TGFBR2,ACVR2A,DSCAM,ACP6,EPHA3,THSD7A,MAP2,PTPRD,FGFR2,CHRM3,KAZN,AFG2A,PBX1,INSM1,GCNT1,SLIT2,PTPRZ1,ROBO2,ACVR1C,SGCD,FUT9,FGF20,LRATD1,ADAMTS12,ADAMTS5,PAX6,FERD3L,ADAMTS3,PLAAT1,LHCGR,CPQ,CNTN1,ZNF521,IRX1,SLC39A10,NAV3,LMX1A,NRSN1,DAW1,UTRN,SERINC5,EPHA4,UHMK1,PHF14,EFNA5,SEZ6L,ASPN,BRINP3,RAI2,NRG1,FBN2,PPP1R17,ADGRL3,GAP43,FZD6,NRCAM,RYR2,UCHL1,CDH5,SPAG9,BCHE,SEMA3C,CNTNAP2,AMELX,EFEMP1,RBM20,VAV3,FGF14,LGI1,SGCG,ZFAND5,WWOX,SS18,NOBOX,TMEFF2,FABP7,SLC25A46,ARX,PECAM1,IL1RAPL2</TD></TR>
<TR><TD>9.292e-09</TD><TD>-18.49</TD><TD>chondroblastoma</TD><TD>COSMIC cancer mutations</TD><TD>chondroblastoma</TD><TD>536</TD><TD>24</TD><TD>16984</TD><TD>192</TD>
<TD>ZFPM2,CNTNAP2,NAALADL2,IQGAP2,NCKAP5,VAV3,NOL4,DCDC2C,THSD7A,DSCAM,PCDH9,SLIT2,GMDS,TMEFF2,SYT1,SGCD,EDIL3,FMNL2,ZNF521,IL1RAPL2,FGF14,SEZ6L,ATG10,EFR3A</TD></TR>
<TR><TD>1.059e-08</TD><TD>-18.36</TD><TD>axonogenesis</TD><TD>biological process</TD><TD>GO:0007409</TD><TD>366</TD><TD>20</TD><TD>18905</TD><TD>219</TD>
<TD>UCHL1,DSCAM,EPHA3,LMX1A,NRCAM,ROBO2,PTPRZ1,UNC5C,EPHA4,FGFR2,PAX6,SEMA3C,ARX,CNTN1,GAP43,SLIT2,LGI1,SLC25A46,SHTN1,EFNA5</TD></TR>
<TR><TD>1.852e-08</TD><TD>-17.80</TD><TD>nervous system development</TD><TD>biological process</TD><TD>GO:0007399</TD><TD>2193</TD><TD>55</TD><TD>18905</TD><TD>219</TD>
<TD>PPP1R17,TGFBR2,FZD6,GAP43,ADGRL3,NRG1,BRINP3,DNER,PCDH9,NOVA1,UHMK1,FAT4,SERINC5,EPHA4,NTRK2,SEZ6L,EFNA5,SHTN1,LMX1A,NAV3,FGF5,NRSN1,TWIST1,UNC5C,FABP7,PAX6,FERD3L,IRX1,IL1RAPL2,CNTN1,ARX,ZNF521,SLC25A46,ACVR1C,FUT9,FGF20,ROBO2,PTPRZ1,BCHE,SEMA3C,CNTNAP2,FGFR2,CHRM3,SLIT2,LGI1,FGF14,AFG2A,PBX1,INSM1,DSCAM,EPHA3,UCHL1,NRCAM,PTPRD,MAP2</TD></TR>
<TR><TD>4.351e-08</TD><TD>-16.95</TD><TD>cerebellum</TD><TD>COSMIC cancer mutations</TD><TD>cerebellum</TD><TD>769</TD><TD>28</TD><TD>16984</TD><TD>192</TD>
<TD>TCF20,FGF14,THSD7B,BCHE,RGS6,FBN2,IL1RAPL2,DAAM1,NRCAM,SEMA3C,PTPRD,PTPRZ1,NRG1,SPATA16,FIGN,RYR2,ROBO2,DSCAM,PCDH9,SLIT2,NOL4,CELF2,CNTNAP2,NTRK2,NAALADL2,UTRN,ZFPM2,EPHA3</TD></TR>
<TR><TD>4.808e-08</TD><TD>-16.85</TD><TD>carcinoid-endocrine_tumour</TD><TD>COSMIC cancer mutations</TD><TD>carcinoid-endocrine_tumour</TD><TD>7779</TD><TD>125</TD><TD>16984</TD><TD>192</TD>
<TD>PHLPP1,MAP2,NAALADL2,CNTN1,PARP8,JMJD1C,NOVA1,SS18,SPANXN1,NOL4,EFR3B,NCKAP5,SLIT2,FIGN,PRLHR,EFNA5,EPYC,PSKH2,KAZN,LMX1A,UBR4,RUNX1T1,IL1RAPL2,FGFR2,LINC00583,WRN,MRPL3,ADAMTS3,BCHE,FERD3L,ZFPM2,ACVR2A,UTRN,GAP43,STXBP6,IQGAP2,RASGEF1B,VAV3,LRIG3,REG1B,SLC39A10,PLEK,AFM,IPO8,SPATA16,GPR83,B3GAT2,SERGEF,PTPRZ1,UNC5C,UCHL1,CD226,DEPTOR,TRPS1,LINC01387,EFEMP1,FAT4,PRKCE,ZNF133,PI15,CPXM2,CNTNAP2,SKAP2,DCDC2C,KCNK9,DSCAM,GMDS,EPHA4,DNER,COQ2,SGCD,SYT1,TMEFF2,BANK1,CASK,EDIL3,SLC7A14,SPHKAP,KIF6,PAQR3,ACVR1C,BACH2,MEGF10,FGF5,ACP6,ZFAND5,SEZ6L,LRFN5,EPHA3,RBM20,UHMK1,CD96,HNF4G,NTRK2,ADAMTS12,AOAH,PCDH9,THSD7A,INSM1,ROBO2,RYR2,RPH3A,CDH5,SGCG,PHF14,EPS8,ADAM28,LHCGR,TGFBR2,NRG1,PRSS12,SEMA3C,NRCAM,MRPL13,DAAM1,CRTC3,SLC7A8,ZNF521,FMNL2,KLF12,LMBRD1,THSD7B,FGF14,EFR3A,ATG10</TD></TR>
<TR><TD>5.236e-08</TD><TD>-16.77</TD><TD>cell morphogenesis involved in neuron differentiation</TD><TD>biological process</TD><TD>GO:0048667</TD><TD>443</TD><TD>21</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4,SEMA3C,FGFR2,PAX6,SLIT2,LGI1,GAP43,ARX,CNTN1,EFNA5,SLC25A46,SHTN1,LMX1A,EPHA3,UCHL1,DSCAM,PTPRZ1,ROBO2,NRCAM,MAP2,UNC5C</TD></TR>
<TR><TD>5.593e-08</TD><TD>-16.70</TD><TD>neuron projection morphogenesis</TD><TD>biological process</TD><TD>GO:0048812</TD><TD>486</TD><TD>22</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4,FGFR2,PAX6,SEMA3C,CNTNAP2,CNTN1,ARX,GAP43,SLIT2,LGI1,SLC25A46,SHTN1,EFNA5,DSCAM,UCHL1,EPHA3,LMX1A,NRCAM,ROBO2,PTPRZ1,MAP2,UNC5C</TD></TR>
<TR><TD>5.622e-08</TD><TD>-16.69</TD><TD>generation of neurons</TD><TD>biological process</TD><TD>GO:0048699</TD><TD>1159</TD><TD>36</TD><TD>18905</TD><TD>219</TD>
<TD>UCHL1,EPHA3,DSCAM,LMX1A,NRCAM,PTPRD,UNC5C,MAP2,TWIST1,EPHA4,UHMK1,FGFR2,CNTNAP2,SEMA3C,NTRK2,BCHE,SLIT2,LGI1,SHTN1,INSM1,PBX1,EFNA5,FUT9,FGF20,BRINP3,PTPRZ1,ROBO2,DNER,PAX6,GAP43,CNTN1,ZNF521,ARX,IRX1,SLC25A46,ADGRL3</TD></TR>
<TR><TD>5.654e-08</TD><TD>-16.69</TD><TD>neuron projection guidance</TD><TD>biological process</TD><TD>GO:0097485</TD><TD>224</TD><TD>15</TD><TD>18905</TD><TD>219</TD>
<TD>UNC5C,NRCAM,ROBO2,EPHA3,DSCAM,LMX1A,EFNA5,GAP43,ARX,CNTN1,LGI1,SLIT2,PAX6,SEMA3C,EPHA4</TD></TR>
<TR><TD>5.654e-08</TD><TD>-16.69</TD><TD>axon guidance</TD><TD>biological process</TD><TD>GO:0007411</TD><TD>224</TD><TD>15</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4,PAX6,SEMA3C,GAP43,CNTN1,ARX,LGI1,SLIT2,EFNA5,EPHA3,DSCAM,LMX1A,NRCAM,ROBO2,UNC5C</TD></TR>
<TR><TD>6.116e-08</TD><TD>-16.61</TD><TD>bone-humerus-other-chondroblastoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-humerus-other-chondroblastoma</TD><TD>302</TD><TD>17</TD><TD>16984</TD><TD>192</TD>
<TD>SGCD,EFR3A,ATG10,GMDS,FGF14,SLIT2,DSCAM,THSD7A,ZNF521,IL1RAPL2,FMNL2,NCKAP5,IQGAP2,NAALADL2,CNTNAP2,EDIL3,ZFPM2</TD></TR>
<TR><TD>6.692e-08</TD><TD>-16.52</TD><TD>plasma membrane bounded cell projection morphogenesis</TD><TD>biological process</TD><TD>GO:0120039</TD><TD>491</TD><TD>22</TD><TD>18905</TD><TD>219</TD>
<TD>PTPRZ1,ROBO2,PAX6,SLC25A46,GAP43,ARX,CNTN1,NRCAM,LMX1A,UCHL1,DSCAM,EPHA3,MAP2,UNC5C,CNTNAP2,SEMA3C,FGFR2,EPHA4,EFNA5,SHTN1,SLIT2,LGI1</TD></TR>
<TR><TD>7.376e-08</TD><TD>-16.42</TD><TD>neurogenesis</TD><TD>biological process</TD><TD>GO:0022008</TD><TD>1335</TD><TD>39</TD><TD>18905</TD><TD>219</TD>
<TD>DSCAM,UCHL1,EPHA3,LMX1A,NRCAM,NAV3,PTPRD,FGF5,TWIST1,UNC5C,MAP2,EPHA4,UHMK1,FAT4,FGFR2,BCHE,NTRK2,SEMA3C,CNTNAP2,LGI1,SLIT2,PBX1,INSM1,SHTN1,EFNA5,FGF20,FUT9,ROBO2,BRINP3,PTPRZ1,DNER,PAX6,CNTN1,ARX,ZNF521,GAP43,IRX1,SLC25A46,ADGRL3</TD></TR>
<TR><TD>7.703e-08</TD><TD>-16.38</TD><TD>follicular_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>follicular_lymphoma</TD><TD>1212</TD><TD>36</TD><TD>16984</TD><TD>192</TD>
<TD>RYR2,ROBO2,DNER,PHF14,SPATA16,ADAMTS5,AFM,SYT1,NCKAP5,LRIG3,NOL4,DSCAM,PCDH9,SLIT2,JMJD1C,CNTNAP2,NAALADL2,RASGEF1B,ADAMTS12,ZFPM2,CPXM2,MAP2,EFEMP1,FGF14,SEZ6L,AMELX,ADAMTS3,WWOX,FBN2,ZNF521,IL1RAPL2,MEGF10,KIF6,EDIL3,UNC5C,NRG1</TD></TR>
<TR><TD>7.988e-08</TD><TD>-16.34</TD><TD>cell projection morphogenesis</TD><TD>biological process</TD><TD>GO:0048858</TD><TD>496</TD><TD>22</TD><TD>18905</TD><TD>219</TD>
<TD>UNC5C,MAP2,LMX1A,UCHL1,DSCAM,EPHA3,NRCAM,LGI1,SLIT2,EFNA5,SHTN1,EPHA4,CNTNAP2,SEMA3C,FGFR2,ROBO2,PTPRZ1,GAP43,CNTN1,ARX,SLC25A46,PAX6</TD></TR>
<TR><TD>9.589e-08</TD><TD>-16.16</TD><TD>stomach-carcinoma-intestinal_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>stomach-carcinoma-intestinal_adenocarcinoma</TD><TD>7235</TD><TD>118</TD><TD>16984</TD><TD>192</TD>
<TD>TRPS1,FBN2,SPAG9,MUC7,UNC5C,PTPRZ1,B3GAT2,GPR83,PLEK,SLC39A10,LRIG3,SPATA16,IPO8,NAT2,NRSN1,UTRN,PAX6,ACVR2A,ZFPM2,FGD3,IQGAP2,GCNT1,CETN3,WRN,FGFR2,IL1RAPL2,RUNX1T1,FERD3L,BCHE,ADAMTS3,EPYC,PRLHR,UBR4,KAZN,LMX1A,SLC10A2,LRRC3B,SLIT2,NCKAP5,EFR3B,ASPN,FIGN,MAP2,SS18,OR52K2,JMJD1C,PARP8,CNTN1,AKAP9,NAALADL2,KLF12,FMNL2,ZNF521,PTPRK,FZD6,NAV3,FGF14,THSD7B,PTPRD,NRG1,TGFBR2,LHCGR,ADAM28,CALN1,TSN,NRCAM,THSD7A,PCDH9,AOAH,PHF14,SGCG,ADAMTS5,CDH5,RPH3A,RYR2,ROBO2,UHMK1,RBM20,EPHA3,ADAMTS12,NTRK2,ZFAND5,ACP6,FGF5,MEGF10,BACH2,CTSO,TCF20,LRFN5,IGFL4,SEZ6L,SPHKAP,FNIP2,EDIL3,ERCC6L2,AGA,PXDNL,LRRN2,PAQR3,KIF6,CHRM3,DSCAM,KCNK9,XPO4,NBEA,ZNF518B,SYT1,MPEG1,DNER,GMDS,EPHA4,CPXM2,PI15,ZNF133,PRKCE,IRX1,FAT4,CNTNAP2</TD></TR>
<TR><TD>9.589e-08</TD><TD>-16.16</TD><TD>intestinal_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>intestinal_adenocarcinoma</TD><TD>7235</TD><TD>118</TD><TD>16984</TD><TD>192</TD>
<TD>BCHE,ADAMTS3,FERD3L,FGFR2,IL1RAPL2,RUNX1T1,GCNT1,CETN3,WRN,SLC10A2,UBR4,LMX1A,KAZN,PRLHR,EPYC,FIGN,NCKAP5,EFR3B,ASPN,LRRC3B,SLIT2,JMJD1C,PARP8,AKAP9,CNTN1,NAALADL2,OR52K2,SS18,MAP2,SPAG9,MUC7,FBN2,TRPS1,B3GAT2,GPR83,UNC5C,PTPRZ1,SPATA16,IPO8,NAT2,NRSN1,SLC39A10,LRIG3,PLEK,IQGAP2,ZFPM2,FGD3,UTRN,PAX6,ACVR2A,LRFN5,IGFL4,SEZ6L,CTSO,TCF20,ACP6,FGF5,MEGF10,BACH2,ZFAND5,PAQR3,KIF6,ERCC6L2,AGA,PXDNL,LRRN2,EDIL3,SPHKAP,FNIP2,DNER,MPEG1,GMDS,EPHA4,NBEA,ZNF518B,SYT1,XPO4,DSCAM,CHRM3,KCNK9,CNTNAP2,ZNF133,PRKCE,IRX1,FAT4,CPXM2,PI15,FGF14,THSD7B,FZD6,NAV3,FMNL2,ZNF521,PTPRK,KLF12,NRCAM,CALN1,TSN,LHCGR,ADAM28,PTPRD,NRG1,TGFBR2,RPH3A,CDH5,RYR2,ROBO2,PHF14,SGCG,ADAMTS5,AOAH,THSD7A,PCDH9,NTRK2,ADAMTS12,EPHA3,UHMK1,RBM20</TD></TR>
<TR><TD>9.596e-08</TD><TD>-16.16</TD><TD>central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype</TD><TD>653</TD><TD>25</TD><TD>16984</TD><TD>192</TD>
<TD>NAALADL2,CNTNAP2,NTRK2,CELF2,EPHA3,UTRN,ROBO2,RYR2,FIGN,SLIT2,PCDH9,DSCAM,NRCAM,SEMA3C,DAAM1,NRG1,PTPRZ1,PTPRD,BCHE,FGF14,THSD7B,TCF20,IL1RAPL2,FBN2,RGS6</TD></TR>
<TR><TD>9.881e-08</TD><TD>-16.13</TD><TD>SHH_subtype</TD><TD>COSMIC cancer mutations</TD><TD>SHH_subtype</TD><TD>654</TD><TD>25</TD><TD>16984</TD><TD>192</TD>
<TD>THSD7B,FGF14,BCHE,TCF20,FBN2,IL1RAPL2,RGS6,DAAM1,SEMA3C,NRCAM,PTPRD,NRG1,PTPRZ1,RYR2,ROBO2,FIGN,PCDH9,DSCAM,SLIT2,NTRK2,CNTNAP2,NAALADL2,CELF2,EPHA3,UTRN</TD></TR>
<TR><TD>1.068e-07</TD><TD>-16.05</TD><TD>axon development</TD><TD>biological process</TD><TD>GO:0061564</TD><TD>421</TD><TD>20</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,PAX6,SEMA3C,EPHA4,SHTN1,SLC25A46,EFNA5,CNTN1,ARX,GAP43,SLIT2,LGI1,NRCAM,ROBO2,PTPRZ1,UCHL1,DSCAM,EPHA3,LMX1A,UNC5C</TD></TR>
<TR><TD>1.397e-07</TD><TD>-15.78</TD><TD>pancreas-carcinoid-endocrine_tumour</TD><TD>COSMIC cancer mutations</TD><TD>pancreas-carcinoid-endocrine_tumour</TD><TD>7277</TD><TD>118</TD><TD>16984</TD><TD>192</TD>
<TD>CNTNAP2,PI15,CPXM2,FAT4,PRKCE,ZNF133,SYT1,SGCD,BANK1,TMEFF2,CASK,GMDS,EPHA4,DNER,COQ2,KCNK9,DSCAM,DCDC2C,SKAP2,ACVR1C,KIF6,PAQR3,SPHKAP,SLC7A14,EDIL3,SEZ6L,LRFN5,ZFAND5,BACH2,MEGF10,FGF5,ACP6,ADAMTS12,NTRK2,HNF4G,CD96,RBM20,EPHA3,SGCG,PHF14,INSM1,ROBO2,RYR2,RPH3A,CDH5,PCDH9,THSD7A,AOAH,SLC7A8,NRCAM,SEMA3C,MRPL13,CRTC3,DAAM1,NRG1,PRSS12,EPS8,ADAM28,LHCGR,EFR3A,ATG10,LMBRD1,FGF14,THSD7B,KLF12,ZNF521,FMNL2,NOVA1,SS18,SPANXN1,NAALADL2,CNTN1,PARP8,MAP2,PHLPP1,FIGN,SLIT2,EFR3B,NOL4,NCKAP5,KAZN,LMX1A,UBR4,EPYC,EFNA5,FERD3L,ADAMTS3,BCHE,LINC00583,WRN,MRPL3,RUNX1T1,IL1RAPL2,FGFR2,GAP43,STXBP6,IQGAP2,RASGEF1B,ACVR2A,UTRN,ZFPM2,AFM,IPO8,SPATA16,PLEK,LRIG3,REG1B,VAV3,SLC39A10,CD226,UCHL1,UNC5C,GPR83,B3GAT2,SERGEF,LINC01387,EFEMP1,DEPTOR</TD></TR>
<TR><TD>1.411e-07</TD><TD>-15.77</TD><TD>Ig_sub2</TD><TD>interpro domains</TD><TD>IPR003598</TD><TD>242</TD><TD>15</TD><TD>18605</TD><TD>214</TD>
<TD>PECAM1,LRFN5,PXDNL,UNC5C,NTRK2,CNTN1,PTPRD,LRIG3,ROBO2,DSCAM,NRG1,FGFR2,CD226,NRCAM,LRRN2</TD></TR>
<TR><TD>1.493e-07</TD><TD>-15.72</TD><TD>developmental process</TD><TD>biological process</TD><TD>GO:0032502</TD><TD>5746</TD><TD>103</TD><TD>18905</TD><TD>219</TD>
<TD>TRPS1,PLEK,FGF5,CXCL13,UNC5C,TWIST1,LRIG3,FAT4,ZFPM2,NTRK2,SPATA16,EPYC,SHTN1,LMBRD1,SYT1,DNER,PCDH9,HNF4G,MEGF10,NOVA1,TGFBR2,CYTL1,ACVR2A,ACP6,EPHA3,DSCAM,PTPRD,MAP2,THSD7A,CHRM3,KAZN,FGFR2,SLIT2,GCNT1,INSM1,AFG2A,PBX1,FGF20,FUT9,ACVR1C,SGCD,ROBO2,PTPRZ1,COX7B2,ADAMTS5,ADAMTS12,ADAM28,LRATD1,PLAAT1,ADAMTS3,FERD3L,PAX6,IRX1,ZNF521,CNTN1,CPQ,LHCGR,LMX1A,NAV3,SLC39A10,NRSN1,UHMK1,EPHA4,SERINC5,UTRN,DAW1,ASPN,SEZ6L,EFNA5,PHF14,NRG1,RAI2,BRINP3,FBN2,PPP1R17,FZD6,GAP43,ADGRL3,UCHL1,RYR2,NRCAM,SPAG9,CDH5,AMELX,CNTNAP2,BCHE,SEMA3C,LGI1,FGF14,VAV3,RBM20,EFEMP1,WWOX,ZFAND5,SGCG,TMEFF2,SS18,NOBOX,FABP7,IL1RAPL2,PECAM1,ARX,SLC25A46</TD></TR>
<TR><TD>1.539e-07</TD><TD>-15.69</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm</TD><TD>767</TD><TD>27</TD><TD>16984</TD><TD>192</TD>
<TD>CNTNAP2,PARP8,NTRK2,ZFPM2,PRKCE,EPHA3,UTRN,RYR2,GMDS,DNER,SYT1,NCKAP5,SLC39A10,NOL4,DSCAM,PCDH9,THSD7A,SLIT2,SLC7A8,KAZN,SERGEF,EFNA5,UNC5C,THSD7B,LMBRD1,IL1RAPL2,MEGF10</TD></TR>
<TR><TD>1.642e-07</TD><TD>-15.62</TD><TD>bone-femur-other-chondroblastoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-femur-other-chondroblastoma</TD><TD>183</TD><TD>13</TD><TD>16984</TD><TD>192</TD>
<TD>SLIT2,DSCAM,PCDH9,DCDC2C,NOL4,NCKAP5,SYT1,TMEFF2,ATG10,SEZ6L,FGF14,IQGAP2,CNTNAP2</TD></TR>
<TR><TD>1.704e-07</TD><TD>-15.59</TD><TD>central_nervous_system-brain-glioma-astrocytoma_Grade_III</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brain-glioma-astrocytoma_Grade_III</TD><TD>1424</TD><TD>39</TD><TD>16984</TD><TD>192</TD>
<TD>DNER,ROBO2,GMDS,FUT9,RYR2,DCDC2C,NCKAP5,AOAH,VAV3,PLEK,DSCAM,NAALADL2,CNTNAP2,PARP8,IQGAP2,FAT4,EPHA3,PRKCE,ZFPM2,PAX6,UTRN,ADAMTS3,THSD7B,ATG10,IL1RAPL2,DEPTOR,FBN2,GCNT1,SEMA3C,LGI1,LMX1A,AGA,UBR4,EFNA5,EDIL3,ADAM28,SPHKAP,UNC5C,PRSS12</TD></TR>
<TR><TD>1.776e-07</TD><TD>-15.54</TD><TD>pharynx</TD><TD>COSMIC cancer mutations</TD><TD>pharynx</TD><TD>2697</TD><TD>59</TD><TD>16984</TD><TD>192</TD>
<TD>FGF5,FGFR2,TCF20,LRFN5,ADAMTS3,BCHE,SPHKAP,PBX1,SLC7A14,DNAJC12,UBR4,PAQR3,SLC10A2,DSCAM,SLIT2,NCKAP5,XPO4,NBEA,FANCB,TMEFF2,MPEG1,MAP2,PRKCE,FAT4,TWIST1,CNTNAP2,JMJD1C,NAALADL2,AKAP9,FBN2,FMNL2,DEPTOR,ZNF521,EFEMP1,MUC7,LMBRD1,UNC5C,TGFBR2,PTPRZ1,B3GAT2,EPS8,CALN1,DAAM1,CRTC3,NRCAM,PCDH9,THSD7A,REG1B,ADAMTS5,SPATA16,RYR2,FUT9,ROBO2,UTRN,ZFPM2,EPHA3,STXBP6,GAP43,NTRK2</TD></TR>
<TR><TD>1.930e-07</TD><TD>-15.46</TD><TD>Ig_sub</TD><TD>interpro domains</TD><TD>IPR003599</TD><TD>399</TD><TD>19</TD><TD>18605</TD><TD>214</TD>
<TD>LRRN2,CD96,NRCAM,CD226,NRG1,FGFR2,DSCAM,PTPRD,ROBO2,IL1RAPL2,PTPRK,LRIG3,SEMA3C,UNC5C,NTRK2,PXDNL,CNTN1,PECAM1,LRFN5</TD></TR>
<TR><TD>1.993e-07</TD><TD>-15.43</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma</TD><TD>984</TD><TD>31</TD><TD>16984</TD><TD>192</TD>
<TD>MEGF10,IL1RAPL2,WWOX,EFEMP1,FGF14,SEZ6L,ADAMTS3,UNC5C,NRG1,EDIL3,DSCAM,PCDH9,SLIT2,NCKAP5,LRIG3,NOL4,SPATA16,PHF14,AFM,SYT1,RYR2,DNER,ROBO2,MAP2,CPXM2,ZFPM2,RASGEF1B,ADAMTS12,JMJD1C,CNTNAP2,NAALADL2</TD></TR>
<TR><TD>1.999e-07</TD><TD>-15.43</TD><TD>scalp</TD><TD>COSMIC cancer mutations</TD><TD>scalp</TD><TD>2110</TD><TD>50</TD><TD>16984</TD><TD>192</TD>
<TD>NAV3,ZNF521,TRPS1,SEMA3C,NRCAM,DAAM1,LHCGR,PWWP2A,ADAM28,NRG1,PTPRZ1,UNC5C,PTPRD,ROBO2,RPH3A,NRSN1,ADAMTS5,IPO8,VAV3,AOAH,DEFB115,GAP43,UTRN,AMELX,SEZ6L,ADAMTS3,LRFN5,FERD3L,MEGF10,BACH2,FGFR2,WRN,LMX1A,ACVR1C,UBR4,PRLHR,SLC7A14,SPHKAP,EPHA4,SYT1,NOL4,SLIT2,DSCAM,CHRM3,LRRC3B,CNTN1,FAT4,ZNF133,CPXM2,MAP2</TD></TR>
<TR><TD>2.587e-07</TD><TD>-15.17</TD><TD>lymphoid_neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>lymphoid_neoplasm</TD><TD>12270</TD><TD>168</TD><TD>16984</TD><TD>192</TD>
<TD>DNAJC12,EFNA5,PRLHR,RAI2,EPYC,SLC10A2,LGI1,PSKH2,LMX1A,KAZN,UBR4,IL1RAPL2,RUNX1T1,FGFR2,LINC00583,WRN,MRPL3,AMELX,BCHE,ADAMTS3,PHLPP1,MAP2,CNTN1,AKAP9,NAALADL2,JMJD1C,PARP8,SS18,NOVA1,EFR3B,NOL4,ASPN,NCKAP5,SLIT2,LRRC3B,FGF20,FIGN,GPR83,SERGEF,B3GAT2,PWWP2A,PTPRZ1,UNC5C,CD226,FBN2,DEPTOR,RGS6,TRPS1,LINC01387,MUC7,EFEMP1,SPAG9,WWOX,FGD3,ZFPM2,PAX6,ACVR2A,UTRN,DEFB115,GAP43,RASGEF1B,IQGAP2,STXBP6,SLC39A10,VAV3,LRIG3,REG1B,PLEK,FUT9,NAT2,NRSN1,SPATA16,IPO8,AFM,SLC7A14,EDIL3,SPHKAP,FNIP2,SLC25A46,FABP7,KIF6,PAQR3,ACVR1C,PXDNL,LRRN2,NOBOX,MEGF10,CXCL13,BACH2,FGF5,PCGF5,SEZ6L,LRFN5,TCF20,CTSO,IRX1,FAT4,ZNF133,PRKCE,PI15,CPXM2,CNTNAP2,XPO4,DAOA,DCDC2C,SKAP2,KCNK9,DSCAM,CHRM3,DNER,MPEG1,GMDS,EPHA4,COQ2,TMEFF2,BANK1,FANCB,SGCD,SYT1,NBEA,CASK,EPS8,LHCGR,ADAM28,NRG1,TGFBR2,PRSS12,PTPRD,SEMA3C,NRCAM,CRTC3,DAAM1,MRPL13,CALN1,SLC7A8,ZNF521,PTPRK,FMNL2,KLF12,LMBRD1,FGF14,THSD7B,EFR3A,NAV3,ATG10,FZD6,EPHA3,ARX,RBM20,UHMK1,NTRK2,HNF4G,CD96,ADAMTS12,AOAH,SHISA3,THSD7A,ZPLD1,PCDH9,INSM1,ROBO2,CDH5,RPH3A,RYR2,REXO2,PHF14,SGCG,ADAMTS5</TD></TR>
<TR><TD>2.792e-07</TD><TD>-15.09</TD><TD>lower_third</TD><TD>COSMIC cancer mutations</TD><TD>lower_third</TD><TD>7979</TD><TD>125</TD><TD>16984</TD><TD>192</TD>
<TD>SEZ6L,PCGF5,LRFN5,TCF20,MEGF10,BACH2,CXCL13,ACP6,SLC25A46,PAQR3,PXDNL,AGA,SLC7A14,SPHKAP,DNER,MPEG1,EPHA4,GMDS,COQ2,ZNF518B,TMEFF2,SGCD,NBEA,CASK,XPO4,SKAP2,KCNK9,CHRM3,DSCAM,CNTNAP2,IRX1,FAT4,ZNF133,PRKCE,PI15,CPXM2,THSD7B,EFR3A,NAV3,NUP35,FZD6,ZNF521,PTPRK,KLF12,DAAM1,CRTC3,SLC7A8,EPS8,LHCGR,ADAM28,NRG1,TGFBR2,PRSS12,PTPRD,ROBO2,CDH5,RPH3A,RYR2,PHF14,ADAMTS5,AOAH,THSD7A,ZPLD1,PCDH9,NTRK2,ADAMTS12,EPHA3,ARL14,BCHE,ADAMTS3,FERD3L,IL1RAPL2,RUNX1T1,GCNT1,WRN,SLC10A2,PSKH2,KAZN,LMX1A,UBR4,EFNA5,PRLHR,RAI2,EFR3B,NOL4,NCKAP5,SLIT2,LRRC3B,CNTN1,AKAP9,NAALADL2,JMJD1C,PARP8,TWIST1,SS18,NOVA1,PHLPP1,SERINC5,MAP2,MUC7,EFEMP1,SPAG9,FBN2,DEPTOR,RGS6,TRPS1,CD226,SERGEF,B3GAT2,PTPRZ1,UNC5C,NAT2,IPO8,SLC39A10,VAV3,REG1B,LRIG3,RASGEF1B,CELF2,IQGAP2,FGD3,ZFPM2,PAX6,ACVR2A,UTRN</TD></TR>
<TR><TD>2.983e-07</TD><TD>-15.03</TD><TD>skin-mucosal-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-mucosal-malignant_melanoma</TD><TD>2009</TD><TD>48</TD><TD>16984</TD><TD>192</TD>
<TD>UNC5C,PTPRD,NRG1,SERGEF,LHCGR,ADAM28,EPS8,CALN1,SLC7A8,RGS6,FBN2,PTPRK,EFEMP1,PCDH9,VAV3,SGCG,SPATA16,CDH5,SPHKAP,SLC7A14,EDIL3,ACVR1C,LRRN2,SLC10A2,KIF6,MRPL3,GCNT1,CETN3,WRN,FGFR2,IL1RAPL2,BACH2,LRFN5,IGFL4,SEZ6L,FAT4,OR52K2,CNTNAP2,PARP8,CHRM3,LRRC3B,SLIT2,SKAP2,ASPN,BANK1,SYT1,DNER,EPHA4</TD></TR>
<TR><TD>2.983e-07</TD><TD>-15.03</TD><TD>mucosal</TD><TD>COSMIC cancer mutations</TD><TD>mucosal</TD><TD>2009</TD><TD>48</TD><TD>16984</TD><TD>192</TD>
<TD>CDH5,SGCG,SPATA16,VAV3,PCDH9,CALN1,SLC7A8,EPS8,LHCGR,SERGEF,ADAM28,NRG1,UNC5C,PTPRD,EFEMP1,PTPRK,FBN2,RGS6,PARP8,CNTNAP2,OR52K2,FAT4,DNER,EPHA4,BANK1,SYT1,SKAP2,ASPN,SLIT2,LRRC3B,CHRM3,SLC10A2,KIF6,ACVR1C,LRRN2,EDIL3,SLC7A14,SPHKAP,SEZ6L,LRFN5,IGFL4,IL1RAPL2,BACH2,FGFR2,CETN3,GCNT1,WRN,MRPL3</TD></TR>
<TR><TD>4.484e-07</TD><TD>-14.62</TD><TD>cell morphogenesis</TD><TD>biological process</TD><TD>GO:0000902</TD><TD>688</TD><TD>25</TD><TD>18905</TD><TD>219</TD>
<TD>SHTN1,EFNA5,LGI1,SLIT2,FGFR2,SEMA3C,CNTNAP2,EPHA4,CDH5,MAP2,UNC5C,NRCAM,DSCAM,UCHL1,EPHA3,LMX1A,SLC25A46,ARX,CNTN1,GAP43,PAX6,LRATD1,SS18,ROBO2,PTPRZ1</TD></TR>
<TR><TD>5.800e-07</TD><TD>-14.36</TD><TD>anatomical structure morphogenesis</TD><TD>biological process</TD><TD>GO:0009653</TD><TD>2238</TD><TD>52</TD><TD>18905</TD><TD>219</TD>
<TD>LMX1A,UNC5C,TWIST1,LRIG3,FGF5,CXCL13,NTRK2,EPHA4,ZFPM2,EFNA5,SHTN1,LMBRD1,NRG1,FBN2,TGFBR2,ACVR2A,FZD6,GAP43,NRCAM,DSCAM,UCHL1,EPHA3,RYR2,MAP2,THSD7A,CDH5,CNTNAP2,SEMA3C,FGFR2,AMELX,VAV3,GCNT1,RBM20,EFEMP1,PBX1,SLIT2,LGI1,PTPRZ1,ROBO2,WWOX,FGF20,ZFAND5,SGCD,SS18,LRATD1,ADAMTS5,TMEFF2,PAX6,SLC25A46,IRX1,CNTN1,ARX</TD></TR>
<TR><TD>7.229e-07</TD><TD>-14.14</TD><TD>human chr20p11.23</TD><TD>chromosome location</TD><TD>human chr20p11.23</TD><TD>78</TD><TD>5</TD><TD>193383</TD><TD>404</TD>
<TD>KIZ-AS1,INSM1,SCP2D1-AS1,SLC24A3-AS1,ZNF133</TD></TR>
<TR><TD>7.695e-07</TD><TD>-14.08</TD><TD>Ig-like_dom</TD><TD>interpro domains</TD><TD>IPR007110</TD><TD>437</TD><TD>19</TD><TD>18605</TD><TD>214</TD>
<TD>CNTN1,UNC5C,NTRK2,PXDNL,LRFN5,PECAM1,IL1RAPL2,ROBO2,LRIG3,PTPRK,PTPRD,SEMA3C,CD226,NRG1,FGFR2,DSCAM,LRRN2,NRCAM,CD96</TD></TR>
<TR><TD>8.012e-07</TD><TD>-14.04</TD><TD>LRR_8</TD><TD>pfam domains</TD><TD>PF13855</TD><TD>173</TD><TD>12</TD><TD>17869</TD><TD>206</TD>
<TD>PHLPP1,NTRK2,ASPN,LRRN2,LRRC70,LGI1,PXDNL,SLIT2,LRRC3B,LRFN5,LRIG3,EPYC</TD></TR>
<TR><TD>9.275e-07</TD><TD>-13.89</TD><TD>neuron recognition</TD><TD>biological process</TD><TD>GO:0008038</TD><TD>46</TD><TD>7</TD><TD>18905</TD><TD>219</TD>
<TD>GAP43,NRCAM,CNTNAP2,ROBO2,EPHA4,DSCAM,EPHA3</TD></TR>
<TR><TD>9.935e-07</TD><TD>-13.82</TD><TD>neuron differentiation</TD><TD>biological process</TD><TD>GO:0030182</TD><TD>1082</TD><TD>32</TD><TD>18905</TD><TD>219</TD>
<TD>UNC5C,MAP2,PTPRD,NRCAM,DSCAM,UCHL1,EPHA3,LMX1A,INSM1,SHTN1,PBX1,EFNA5,SLIT2,LGI1,FGFR2,CNTNAP2,NTRK2,SEMA3C,EPHA4,UHMK1,ROBO2,PTPRZ1,BRINP3,FGF20,FUT9,SLC25A46,GAP43,ZNF521,CNTN1,ARX,IRX1,PAX6</TD></TR>
<TR><TD>1.246e-06</TD><TD>-13.60</TD><TD>oesophagus</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus</TD><TD>15043</TD><TD>188</TD><TD>16984</TD><TD>192</TD>
<TD>CTSO,IGFL4,BACH2,FGF5,PXDNL,AGA,SLC25A46,FABP7,SLC7A14,EDIL3,BANK1,ZNF518B,SYT1,FANCB,NBEA,MPEG1,GMDS,KCNK9,CHRM3,DAOA,FAT4,NAV3,FZD6,LMBRD1,FGF14,THSD7B,SLC7A8,CRTC3,MRPL13,NRG1,PRSS12,EPS8,LHCGR,INSM1,CDH5,SHISA3,PCDH9,RBM20,UHMK1,ARL14,ARX,FERD3L,AMELX,GCNT1,LINC00583,RUNX1T1,FGFR2,LMX1A,KAZN,SLC10A2,LGI1,PSKH2,EPYC,EFNA5,PRLHR,FGF20,SLIT2,NOL4,NCKAP5,SS18,TWIST1,NOVA1,SPANXN1,CNTN1,AKAP9,NAALADL2,PARP8,SERINC5,MAP2,WWOX,EFEMP1,TRPS1,CD226,OR2AG1,GHITM,PTPRZ1,UNC5C,GPR83,SERGEF,B3GAT2,NAT2,SPATA16,AFM,PLEK,SLC39A10,VAV3,GAP43,RASGEF1B,CELF2,DEFB115,ACVR2A,UTRN,ZFPM2,TCF20,PCGF5,SEZ6L,LRFN5,ZFAND5,MEGF10,CXCL13,ACP6,ACVR1C,LRRN2,ERCC6L2,NOBOX,KIF6,PAQR3,SPHKAP,TMEFF2,SGCD,CASK,DNER,EPHA4,COQ2,DSCAM,XPO4,DCDC2C,SKAP2,CNTNAP2,PI15,CPXM2,IRX1,ZNF133,PRKCE,EFR3A,NUP35,ATG10,CYTL1,KLF12,ZNF521,PTPRK,FMNL2,TSN,CALN1,NRCAM,SEMA3C,DAAM1,TGFBR2,PTPRD,ADAM28,REXO2,SGCG,PHF14,ADAMTS5,ROBO2,RPH3A,RYR2,THSD7A,ZPLD1,AOAH,ADAMTS12,HNF4G,CD96,NTRK2,EPHA3,BCHE,ADAMTS3,CETN3,WRN,MRPL3,IL1RAPL2,UBR4,DNAJC12,RAI2,FIGN,LRRC3B,EFR3B,ASPN,OR52K2,JMJD1C,LRRC70,PHLPP1,LINC01387,MUC7,SPAG9,RGS6,DEPTOR,FBN2,UCHL1,NRSN1,IPO8,FUT9,LRIG3,REG1B,STXBP6,IQGAP2,PAX6,FGD3</TD></TR>
<TR><TD>1.487e-06</TD><TD>-13.42</TD><TD>astrocytoma_Grade_III</TD><TD>COSMIC cancer mutations</TD><TD>astrocytoma_Grade_III</TD><TD>1551</TD><TD>39</TD><TD>16984</TD><TD>192</TD>
<TD>RYR2,FUT9,GMDS,ROBO2,DNER,AOAH,VAV3,NCKAP5,DCDC2C,DSCAM,PLEK,PARP8,CNTNAP2,NAALADL2,IQGAP2,ZFPM2,PRKCE,EPHA3,FAT4,UTRN,PAX6,THSD7B,ADAMTS3,ATG10,DEPTOR,FBN2,IL1RAPL2,GCNT1,LGI1,SEMA3C,AGA,UBR4,LMX1A,ADAM28,EDIL3,EFNA5,SPHKAP,UNC5C,PRSS12</TD></TR>
<TR><TD>1.524e-06</TD><TD>-13.39</TD><TD>EGF-like_CS</TD><TD>interpro domains</TD><TD>IPR013032</TD><TD>32</TD><TD>6</TD><TD>18605</TD><TD>214</TD>
<TD>FAT4,MEGF10,EDIL3,SLIT2,DNER,FBN2</TD></TR>
<TR><TD>1.540e-06</TD><TD>-13.38</TD><TD>hEGF</TD><TD>pfam domains</TD><TD>PF12661</TD><TD>32</TD><TD>6</TD><TD>17869</TD><TD>206</TD>
<TD>DNER,EDIL3,FAT4,SLIT2,MEGF10,FBN2</TD></TR>
<TR><TD>1.550e-06</TD><TD>-13.38</TD><TD>soft_tissue</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue</TD><TD>5855</TD><TD>98</TD><TD>16984</TD><TD>192</TD>
<TD>SKAP2,DSCAM,KCNK9,COQ2,MPEG1,DNER,NBEA,BANK1,ZNF518B,FANCB,SGCD,PRKCE,IRX1,FAT4,CPXM2,CNTNAP2,FGF5,SEZ6L,TCF20,EDIL3,KIF6,NOBOX,PXDNL,ACVR1C,AOAH,THSD7A,PCDH9,ZPLD1,SHISA3,RPH3A,RYR2,ROBO2,INSM1,SGCG,ADAMTS5,EPHA3,ARX,UHMK1,RBM20,NTRK2,FMNL2,ZNF521,FGF14,THSD7B,LMBRD1,FZD6,LHCGR,ADAM28,EPS8,PRSS12,NRG1,SEMA3C,NCKAP5,NOL4,ASPN,SLIT2,PHLPP1,MAP2,JMJD1C,PARP8,AKAP9,NAALADL2,SPANXN1,SS18,NOVA1,FGFR2,IL1RAPL2,MRPL3,GCNT1,WRN,BCHE,ADAMTS3,EFNA5,SLC10A2,UBR4,KAZN,LMX1A,SLC39A10,VAV3,PLEK,SPATA16,AFM,ZFPM2,FGD3,UTRN,RASGEF1B,IQGAP2,GAP43,FBN2,TRPS1,RGS6,SPAG9,SERGEF,B3GAT2,UNC5C,PTPRZ1,UCHL1,CD226</TD></TR>
<TR><TD>1.606e-06</TD><TD>-13.34</TD><TD>adenoma</TD><TD>COSMIC cancer mutations</TD><TD>adenoma</TD><TD>2876</TD><TD>59</TD><TD>16984</TD><TD>192</TD>
<TD>FAT4,MAP2,AKAP9,CNTNAP2,NCKAP5,SLIT2,KCNK9,DNER,COQ2,ZNF518B,SYT1,CASK,EDIL3,SPHKAP,SLC25A46,LGI1,PAQR3,PXDNL,KAZN,UBR4,MEGF10,RUNX1T1,GCNT1,SEZ6L,BCHE,ADAMTS3,FGD3,EPHA3,HNF4G,NTRK2,ADAMTS12,IQGAP2,AOAH,LRIG3,PCDH9,ZPLD1,ROBO2,RPH3A,SPATA16,LHCGR,PWWP2A,NRG1,PTPRZ1,UNC5C,PTPRD,UCHL1,CRTC3,CD226,CALN1,ZNF521,PTPRK,FBN2,RGS6,KLF12,FGF14,THSD7B,SPAG9,EFR3A,NAV3</TD></TR>
<TR><TD>1.649e-06</TD><TD>-13.32</TD><TD>lung-right_lower_lobe-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-right_lower_lobe-carcinoma-adenocarcinoma</TD><TD>5698</TD><TD>96</TD><TD>16984</TD><TD>192</TD>
<TD>TRPS1,RGS6,FBN2,MUC7,UNC5C,PTPRZ1,GPR83,OR2AG1,PLEK,SLC39A10,LRIG3,REG1B,VAV3,AFM,IPO8,FUT9,UTRN,PAX6,ZFPM2,IQGAP2,GCNT1,WRN,FGFR2,IL1RAPL2,RUNX1T1,BCHE,AMELX,RAI2,PRLHR,UBR4,LMX1A,PSKH2,SLC10A2,LGI1,SLIT2,NCKAP5,NOL4,ASPN,MAP2,SERINC5,PHLPP1,NOVA1,JMJD1C,CNTN1,AKAP9,ZNF521,EFR3A,NAV3,THSD7B,LMBRD1,PTPRD,ADAM28,SLC7A8,CRTC3,SEMA3C,NRCAM,THSD7A,ZPLD1,PHF14,SGCG,ADAMTS5,RYR2,ROBO2,INSM1,EPHA3,ADAMTS12,HNF4G,NTRK2,FGF5,MEGF10,TCF20,LRFN5,SEZ6L,SPHKAP,FNIP2,EDIL3,NOBOX,AGA,PXDNL,ACVR1C,CHRM3,DSCAM,KCNK9,NBEA,ZNF518B,TMEFF2,FANCB,MPEG1,DNER,EPHA4,GMDS,CPXM2,PI15,ZNF133,FAT4,CNTNAP2</TD></TR>
<TR><TD>1.649e-06</TD><TD>-13.32</TD><TD>right_lower_lobe</TD><TD>COSMIC cancer mutations</TD><TD>right_lower_lobe</TD><TD>5698</TD><TD>96</TD><TD>16984</TD><TD>192</TD>
<TD>PTPRZ1,UNC5C,GPR83,OR2AG1,RGS6,TRPS1,FBN2,MUC7,PAX6,UTRN,ZFPM2,IQGAP2,PLEK,REG1B,VAV3,LRIG3,SLC39A10,IPO8,AFM,FUT9,PRLHR,RAI2,LMX1A,UBR4,LGI1,SLC10A2,PSKH2,WRN,GCNT1,RUNX1T1,IL1RAPL2,FGFR2,AMELX,BCHE,SERINC5,MAP2,PHLPP1,NOVA1,AKAP9,CNTN1,JMJD1C,SLIT2,ASPN,NOL4,NCKAP5,PTPRD,ADAM28,SLC7A8,SEMA3C,NRCAM,CRTC3,ZNF521,NAV3,EFR3A,LMBRD1,THSD7B,EPHA3,ADAMTS12,NTRK2,HNF4G,ZPLD1,THSD7A,ADAMTS5,PHF14,SGCG,ROBO2,INSM1,RYR2,FNIP2,SPHKAP,EDIL3,PXDNL,ACVR1C,AGA,NOBOX,MEGF10,FGF5,TCF20,SEZ6L,LRFN5,PI15,CPXM2,FAT4,ZNF133,CNTNAP2,KCNK9,CHRM3,DSCAM,FANCB,ZNF518B,TMEFF2,NBEA,EPHA4,GMDS,DNER,MPEG1</TD></TR>
<TR><TD>1.670e-06</TD><TD>-13.30</TD><TD>cell adhesion</TD><TD>biological process</TD><TD>GO:0007155</TD><TD>946</TD><TD>29</TD><TD>18905</TD><TD>219</TD>
<TD>ROBO2,PTPRK,PRKCE,PCDH9,ADAMTS12,MEGF10,TGFBR2,CD96,CNTN1,PECAM1,STXBP6,ADGRL3,LRFN5,CASK,EPHA3,DSCAM,EDIL3,PLEK,NRCAM,LRRN2,PTPRD,CD226,CDH5,FAT4,EPHA4,AMELX,CNTNAP2,GCNT1,EFNA5</TD></TR>
<TR><TD>1.759e-06</TD><TD>-13.25</TD><TD>multicellular organismal process</TD><TD>biological process</TD><TD>GO:0032501</TD><TD>6260</TD><TD>106</TD><TD>18905</TD><TD>219</TD>
<TD>SLC25A46,ARX,PECAM1,IL1RAPL2,FABP7,SS18,TMEFF2,EPS8,SGCG,JMJD1C,ZFAND5,WWOX,EFEMP1,RBM20,VAV3,FGF14,LGI1,BCHE,SEMA3C,CNTNAP2,AMELX,OR2AG1,CDH5,CD226,CRTC3,NRCAM,RYR2,UCHL1,ADGRL3,GAP43,FZD6,PPP1R17,FBN2,BRINP3,RAI2,NRG1,PHF14,EFNA5,SEZ6L,ASPN,WRN,DAW1,UTRN,SERINC5,EPHA4,UHMK1,NRSN1,NAV3,LMX1A,LHCGR,CNTN1,ZNF521,IRX1,PAX6,FERD3L,ADAMTS3,PLAAT1,OR52K2,ADAMTS12,ADAMTS5,ROBO2,PTPRZ1,ACVR1C,SGCD,FUT9,FGF20,PBX1,AFG2A,INSM1,GCNT1,SLIT2,FGFR2,KAZN,CHRM3,THSD7A,PRLHR,MAP2,PTPRD,DSCAM,EPHA3,ACVR2A,CYTL1,TGFBR2,SEPTIN5,NOVA1,MEGF10,PCDH9,PRKCE,DNER,SKAP2,BANK1,LMBRD1,SHTN1,EPYC,SLC7A8,NTRK2,ZFPM2,FAT4,LRIG3,TWIST1,UNC5C,GPR83,CXCL13,FGF5,PLEK,TRPS1</TD></TR>
<TR><TD>1.928e-06</TD><TD>-13.16</TD><TD>upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma</TD><TD>1946</TD><TD>45</TD><TD>16984</TD><TD>192</TD>
<TD>MAP2,FAT4,PARP8,CNTNAP2,JMJD1C,NAALADL2,CNTN1,DSCAM,NCKAP5,NOL4,NBEA,EPHA4,DNER,SPHKAP,SLC7A14,UBR4,LRRN2,LMX1A,PXDNL,WRN,RUNX1T1,MEGF10,LRFN5,ADAMTS3,EPHA3,IQGAP2,ADAMTS12,HNF4G,PCDH9,THSD7A,SHISA3,REG1B,ADAMTS5,PHF14,NRSN1,RYR2,ROBO2,PTPRD,ADAM28,SEMA3C,FBN2,FMNL2,PTPRK,NAV3,THSD7B</TD></TR>
<TR><TD>1.982e-06</TD><TD>-13.13</TD><TD>larynx</TD><TD>COSMIC cancer mutations</TD><TD>larynx</TD><TD>1948</TD><TD>45</TD><TD>16984</TD><TD>192</TD>
<TD>UBR4,LRRN2,LMX1A,PXDNL,SPHKAP,SLC7A14,LRFN5,ADAMTS3,WRN,RUNX1T1,MEGF10,PARP8,CNTNAP2,JMJD1C,NAALADL2,CNTN1,MAP2,FAT4,NBEA,EPHA4,DNER,DSCAM,NCKAP5,NOL4,SEMA3C,PTPRD,ADAM28,NAV3,THSD7B,FMNL2,FBN2,PTPRK,IQGAP2,ADAMTS12,HNF4G,EPHA3,ADAMTS5,PHF14,NRSN1,RYR2,ROBO2,PCDH9,THSD7A,SHISA3,REG1B</TD></TR>
<TR><TD>2.389e-06</TD><TD>-12.94</TD><TD>lymph_node</TD><TD>COSMIC cancer mutations</TD><TD>lymph_node</TD><TD>1706</TD><TD>41</TD><TD>16984</TD><TD>192</TD>
<TD>ADAMTS3,LMBRD1,AMELX,ATG10,WWOX,NAV3,FBN2,FGFR2,PTPRK,IL1RAPL2,MEGF10,ZNF521,TRPS1,KIF6,SEMA3C,B3GAT2,EPS8,PTPRD,TGFBR2,RYR2,FGF20,ROBO2,CASK,LRIG3,XPO4,DSCAM,CHRM3,PCDH9,SLIT2,CNTNAP2,NTRK2,NAALADL2,AKAP9,ADAMTS12,ZFPM2,PRKCE,EPHA3,FAT4,UTRN,UHMK1,ACVR2A</TD></TR>
<TR><TD>2.690e-06</TD><TD>-12.83</TD><TD>lung-carcinoma-small_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-small_cell_carcinoma</TD><TD>9947</TD><TD>143</TD><TD>16984</TD><TD>192</TD>
<TD>GAP43,RASGEF1B,CELF2,FGD3,ZFPM2,ACVR2A,PAX6,UTRN,NRSN1,NAT2,AFM,IPO8,SPATA16,VAV3,REG1B,LRIG3,SLC39A10,UCHL1,OR2AG1,CD226,SERGEF,PTPRZ1,MUC7,SPAG9,FBN2,DEPTOR,RGS6,TRPS1,NAALADL2,AKAP9,CNTN1,PARP8,JMJD1C,NOVA1,SS18,TWIST1,SPANXN1,MAP2,FGF20,FIGN,NOL4,SLIT2,LGI1,SLC10A2,PSKH2,LMX1A,UBR4,PRLHR,DNAJC12,RAI2,PBX1,EPYC,ADAMTS3,AMELX,BCHE,FERD3L,RUNX1T1,IL1RAPL2,FGFR2,WRN,MRPL3,NTRK2,HNF4G,CD96,ADAMTS12,ARX,EPHA3,ARL14,UHMK1,ROBO2,INSM1,RYR2,RPH3A,CDH5,ADAMTS5,PHF14,AOAH,PCDH9,ZPLD1,THSD7A,NRCAM,MRPL13,CRTC3,DAAM1,TSN,CALN1,EPS8,ADAM28,LHCGR,TGFBR2,NRG1,PTPRD,PRSS12,LMBRD1,THSD7B,FGF14,NAV3,NUP35,FZD6,PTPRK,ZNF521,COX7B2,FMNL2,CNTNAP2,FAT4,IRX1,PRKCE,CPXM2,EPHA4,GMDS,MPEG1,DNER,SYT1,FANCB,ZNF518B,TMEFF2,BANK1,CASK,SKAP2,XPO4,DAOA,KCNK9,DSCAM,CHRM3,KIF6,FABP7,SLC25A46,LRRN2,ACVR1C,PXDNL,AGA,NOBOX,EDIL3,SPHKAP,PCGF5,SEZ6L,LRFN5,TCF20,BACH2,CXCL13,MEGF10,FGF5,ZFAND5</TD></TR>
<TR><TD>2.796e-06</TD><TD>-12.79</TD><TD>small_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>small_cell_carcinoma</TD><TD>9952</TD><TD>143</TD><TD>16984</TD><TD>192</TD>
<TD>ADAMTS5,PHF14,INSM1,ROBO2,RYR2,CDH5,RPH3A,ZPLD1,PCDH9,THSD7A,AOAH,ADAMTS12,CD96,HNF4G,NTRK2,ARL14,UHMK1,ARX,EPHA3,NAV3,NUP35,FZD6,LMBRD1,FGF14,THSD7B,PTPRK,ZNF521,COX7B2,FMNL2,TSN,CALN1,NRCAM,MRPL13,DAAM1,CRTC3,TGFBR2,NRG1,PTPRD,PRSS12,EPS8,ADAM28,LHCGR,SYT1,FANCB,BANK1,TMEFF2,ZNF518B,CASK,EPHA4,GMDS,DNER,MPEG1,KCNK9,CHRM3,DSCAM,SKAP2,XPO4,DAOA,CNTNAP2,CPXM2,FAT4,IRX1,PRKCE,TCF20,PCGF5,SEZ6L,LRFN5,ZFAND5,CXCL13,BACH2,MEGF10,FGF5,LRRN2,PXDNL,ACVR1C,NOBOX,AGA,KIF6,FABP7,SLC25A46,SPHKAP,EDIL3,NRSN1,NAT2,IPO8,AFM,SPATA16,REG1B,LRIG3,VAV3,SLC39A10,GAP43,CELF2,RASGEF1B,ACVR2A,PAX6,UTRN,FGD3,ZFPM2,MUC7,SPAG9,RGS6,TRPS1,DEPTOR,FBN2,CD226,UCHL1,OR2AG1,PTPRZ1,SERGEF,FIGN,FGF20,SLIT2,NOL4,NOVA1,TWIST1,SS18,SPANXN1,NAALADL2,CNTN1,AKAP9,PARP8,JMJD1C,MAP2,FERD3L,ADAMTS3,AMELX,BCHE,WRN,MRPL3,RUNX1T1,IL1RAPL2,FGFR2,LMX1A,UBR4,LGI1,SLC10A2,PSKH2,EPYC,PRLHR,DNAJC12,RAI2,PBX1</TD></TR>
<TR><TD>3.025e-06</TD><TD>-12.71</TD><TD>mouth</TD><TD>COSMIC cancer mutations</TD><TD>mouth</TD><TD>9009</TD><TD>133</TD><TD>16984</TD><TD>192</TD>
<TD>PTPRZ1,UNC5C,GPR83,PWWP2A,B3GAT2,OR2AG1,RGS6,TRPS1,DEPTOR,FBN2,WWOX,MUC7,EFEMP1,ACVR2A,UTRN,ZFPM2,STXBP6,CELF2,RASGEF1B,DEFB115,PLEK,LRIG3,VAV3,REG1B,NRSN1,NAT2,IPO8,AFM,SPATA16,FUT9,EPYC,PRLHR,KAZN,LMX1A,UBR4,LGI1,PSKH2,WRN,GCNT1,RUNX1T1,IL1RAPL2,FGFR2,FERD3L,AMELX,SERINC5,MAP2,PHLPP1,NOVA1,OR52K2,SS18,NAALADL2,AKAP9,CNTN1,PARP8,JMJD1C,SLIT2,NOL4,NCKAP5,FIGN,TGFBR2,PTPRD,PRSS12,EPS8,ADAM28,LHCGR,SLC7A8,SEMA3C,NRCAM,CRTC3,DAAM1,PTPRK,ZNF521,FMNL2,NAV3,ATG10,LMBRD1,THSD7B,CYTL1,RBM20,ARL14,UHMK1,EPHA3,ADAMTS12,NTRK2,CD96,HNF4G,PCDH9,THSD7A,AOAH,ADAMTS5,PHF14,SGCG,ROBO2,RYR2,RPH3A,CDH5,SPHKAP,EDIL3,SLC7A14,LRRN2,PXDNL,ACVR1C,NOBOX,AGA,KIF6,SLC25A46,PAQR3,BACH2,MEGF10,FGF5,TCF20,CTSO,SEZ6L,PCGF5,LRFN5,PI15,CPXM2,FAT4,IRX1,PRKCE,CNTNAP2,DSCAM,CHRM3,XPO4,SYT1,FANCB,TMEFF2,BANK1,ZNF518B,CASK,NBEA,MPEG1,COQ2</TD></TR>
<TR><TD>3.210e-06</TD><TD>-12.65</TD><TD>IGc2</TD><TD>smart domains</TD><TD>SM00408</TD><TD>242</TD><TD>15</TD><TD>9743</TD><TD>146</TD>
<TD>PXDNL,UNC5C,LRFN5,FGFR2,PECAM1,LRIG3,LRRN2,CD226,ROBO2,PTPRD,NRG1,DSCAM,NTRK2,CNTN1,NRCAM</TD></TR>
<TR><TD>3.258e-06</TD><TD>-12.63</TD><TD>stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable</TD><TD>COSMIC cancer mutations</TD><TD>stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable</TD><TD>953</TD><TD>28</TD><TD>16984</TD><TD>192</TD>
<TD>ROBO2,NBEA,IPO8,ADAMTS5,FIGN,LRIG3,NCKAP5,CHRM3,DSCAM,THSD7A,CNTN1,SPANXN1,CELF2,ZFPM2,UTRN,MAP2,ACVR2A,RBM20,SEZ6L,TCF20,FBN2,RUNX1T1,BACH2,ZNF521,PSKH2,UBR4,DNAJC12,PTPRD</TD></TR>
<TR><TD>3.258e-06</TD><TD>-12.63</TD><TD>mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable</TD><TD>COSMIC cancer mutations</TD><TD>mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable</TD><TD>953</TD><TD>28</TD><TD>16984</TD><TD>192</TD>
<TD>ROBO2,FIGN,NBEA,ADAMTS5,IPO8,LRIG3,NCKAP5,CHRM3,DSCAM,THSD7A,CNTN1,SPANXN1,CELF2,ZFPM2,RBM20,ACVR2A,UTRN,MAP2,SEZ6L,TCF20,RUNX1T1,BACH2,ZNF521,FBN2,PSKH2,UBR4,DNAJC12,PTPRD</TD></TR>
<TR><TD>3.268e-06</TD><TD>-12.63</TD><TD>transmembrane receptor protein kinase activity</TD><TD>molecular function</TD><TD>GO:0019199</TD><TD>81</TD><TD>8</TD><TD>18530</TD><TD>206</TD>
<TD>ACVR2A,ACVR1C,EFEMP1,NTRK2,EPHA3,TGFBR2,EPHA4,FGFR2</TD></TR>
<TR><TD>3.395e-06</TD><TD>-12.59</TD><TD>human chr4q28.1</TD><TD>chromosome location</TD><TD>human chr4q28.1</TD><TD>48</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>LINC02516,MIR2054,AFG2A,FAT4</TD></TR>
<TR><TD>3.419e-06</TD><TD>-12.59</TD><TD>oesophagus-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-carcinoma</TD><TD>4273</TD><TD>77</TD><TD>16984</TD><TD>192</TD>
<TD>SPHKAP,PRLHR,RAI2,UBR4,NOBOX,KIF6,FABP7,SLC10A2,WRN,GCNT1,RUNX1T1,CXCL13,MEGF10,FGFR2,CTSO,BCHE,LRFN5,PI15,MAP2,CPXM2,FAT4,SS18,CNTN1,AKAP9,CNTNAP2,JMJD1C,SLIT2,KCNK9,DSCAM,NOL4,EFR3B,NCKAP5,FANCB,SGCD,BANK1,FIGN,CASK,NBEA,DNER,PTPRZ1,TGFBR2,GHITM,PTPRD,UNC5C,ADAM28,CD226,NRCAM,RGS6,TRPS1,PTPRK,ZNF521,FBN2,NUP35,NAV3,EFR3A,FZD6,MUC7,SPAG9,RBM20,UTRN,FGD3,EPHA3,ADAMTS12,IQGAP2,DEFB115,HNF4G,NTRK2,CD96,PCDH9,ZPLD1,THSD7A,REG1B,VAV3,ADAMTS5,SPATA16,ROBO2,RYR2</TD></TR>
<TR><TD>3.691e-06</TD><TD>-12.51</TD><TD>human chr4q21.21</TD><TD>chromosome location</TD><TD>human chr4q21.21</TD><TD>49</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>RASGEF1B,PCAT4,FGF5,PAQR3</TD></TR>
<TR><TD>3.904e-06</TD><TD>-12.45</TD><TD>Ig-like_dom_sf</TD><TD>interpro domains</TD><TD>IPR036179</TD><TD>488</TD><TD>19</TD><TD>18605</TD><TD>214</TD>
<TD>DSCAM,NRG1,FGFR2,CD226,CD96,NRCAM,LRRN2,LRFN5,PECAM1,CNTN1,PXDNL,UNC5C,NTRK2,SEMA3C,LRIG3,PTPRK,ROBO2,IL1RAPL2,PTPRD</TD></TR>
<TR><TD>4.051e-06</TD><TD>-12.42</TD><TD>humerus</TD><TD>COSMIC cancer mutations</TD><TD>humerus</TD><TD>547</TD><TD>20</TD><TD>16984</TD><TD>192</TD>
<TD>EDIL3,ZFPM2,NAALADL2,CNTNAP2,IQGAP2,UBR4,IL1RAPL2,ZNF521,FMNL2,NCKAP5,SLIT2,DSCAM,THSD7A,GMDS,ADAMTS3,RYR2,FGF14,SGCD,EFR3A,ATG10</TD></TR>
<TR><TD>4.331e-06</TD><TD>-12.35</TD><TD>oesophagus-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-carcinoma-adenocarcinoma</TD><TD>13175</TD><TD>173</TD><TD>16984</TD><TD>192</TD>
<TD>FERD3L,AMELX,LINC00583,GCNT1,RUNX1T1,FGFR2,KAZN,LMX1A,LGI1,SLC10A2,PSKH2,EPYC,PRLHR,EFNA5,FGF20,SLIT2,NOL4,NCKAP5,NOVA1,SS18,TWIST1,SPANXN1,NAALADL2,AKAP9,CNTN1,PARP8,MAP2,EFEMP1,TRPS1,CD226,OR2AG1,PTPRZ1,GHITM,UNC5C,GPR83,B3GAT2,SERGEF,AFM,SPATA16,PLEK,VAV3,SLC39A10,GAP43,CELF2,RASGEF1B,DEFB115,ACVR2A,UTRN,ZFPM2,CTSO,BACH2,PXDNL,SLC25A46,EDIL3,SLC7A14,SYT1,ZNF518B,BANK1,NBEA,GMDS,KCNK9,DAOA,FAT4,NAV3,FZD6,LMBRD1,FGF14,THSD7B,SLC7A8,MRPL13,CRTC3,NRG1,PRSS12,EPS8,LHCGR,CDH5,SHISA3,PCDH9,RBM20,UHMK1,ARX,ADAMTS3,BCHE,WRN,CETN3,MRPL3,IL1RAPL2,UBR4,DNAJC12,RAI2,FIGN,LRRC3B,ASPN,EFR3B,OR52K2,LRRC70,JMJD1C,PHLPP1,MUC7,LINC01387,SPAG9,RGS6,FBN2,DEPTOR,UCHL1,NRSN1,IPO8,FUT9,REG1B,LRIG3,STXBP6,IQGAP2,PAX6,TCF20,PCGF5,SEZ6L,LRFN5,CXCL13,MEGF10,ACP6,LRRN2,ACVR1C,NOBOX,ERCC6L2,KIF6,PAQR3,SPHKAP,SGCD,TMEFF2,CASK,EPHA4,DNER,COQ2,DSCAM,SKAP2,DCDC2C,XPO4,CNTNAP2,PI15,CPXM2,IRX1,PRKCE,ZNF133,NUP35,EFR3A,ATG10,CYTL1,KLF12,PTPRK,ZNF521,FMNL2,TSN,CALN1,SEMA3C,NRCAM,DAAM1,TGFBR2,PTPRD,ADAM28,REXO2,ADAMTS5,PHF14,SGCG,ROBO2,RYR2,RPH3A,ZPLD1,THSD7A,AOAH,ADAMTS12,NTRK2,CD96,EPHA3</TD></TR>
<TR><TD>4.372e-06</TD><TD>-12.34</TD><TD>IG_LIKE</TD><TD>prosite domains</TD><TD>PS50835</TD><TD>435</TD><TD>19</TD><TD>12232</TD><TD>161</TD>
<TD>UNC5C,CD226,NRG1,IL1RAPL2,SEMA3C,PTPRK,DSCAM,PXDNL,ROBO2,PECAM1,CD96,NTRK2,FGFR2,PTPRD,LRFN5,LRRN2,NRCAM,LRIG3,CNTN1</TD></TR>
<TR><TD>4.514e-06</TD><TD>-12.31</TD><TD>cell recognition</TD><TD>biological process</TD><TD>GO:0008037</TD><TD>137</TD><TD>10</TD><TD>18905</TD><TD>219</TD>
<TD>CD226,PECAM1,GAP43,MEGF10,EPHA3,EPHA4,DSCAM,NRCAM,ROBO2,CNTNAP2</TD></TR>
<TR><TD>5.546e-06</TD><TD>-12.10</TD><TD>Ig_3</TD><TD>pfam domains</TD><TD>PF13927</TD><TD>141</TD><TD>10</TD><TD>17869</TD><TD>206</TD>
<TD>PXDNL,CNTN1,LRIG3,LRFN5,PECAM1,PTPRD,FGFR2,ROBO2,NRCAM,DSCAM</TD></TR>
<TR><TD>5.774e-06</TD><TD>-12.06</TD><TD>ovary-carcinoma-serous_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>ovary-carcinoma-serous_carcinoma</TD><TD>10739</TD><TD>150</TD><TD>16984</TD><TD>192</TD>
<TD>PAQR3,FABP7,KIF6,NOBOX,AGA,ACVR1C,PXDNL,LRRN2,SLC7A14,EDIL3,SPHKAP,FNIP2,LRFN5,SEZ6L,PCGF5,CTSO,TCF20,ACP6,FGF5,MEGF10,CXCL13,BACH2,CNTNAP2,ZNF133,PRKCE,IRX1,FAT4,CPXM2,PI15,COQ2,MPEG1,DNER,GMDS,EPHA4,CASK,NBEA,TMEFF2,ZNF518B,BANK1,SYT1,SGCD,XPO4,SKAP2,DSCAM,CHRM3,KCNK9,CRTC3,DAAM1,MRPL13,SEMA3C,NRCAM,CALN1,SLC7A8,LHCGR,ADAM28,EPS8,PTPRD,NRG1,TGFBR2,CYTL1,FGF14,THSD7B,LMBRD1,EFR3A,NUP35,NAV3,FMNL2,ZNF521,PTPRK,KLF12,NTRK2,HNF4G,CD96,ADAMTS12,EPHA3,UHMK1,RBM20,RPH3A,CDH5,RYR2,ROBO2,INSM1,PHF14,ADAMTS5,THSD7A,PCDH9,ZPLD1,SHISA3,PSKH2,SLC10A2,LGI1,UBR4,LMX1A,KAZN,DNAJC12,PRLHR,BCHE,ADAMTS3,FERD3L,FGFR2,IL1RAPL2,RUNX1T1,MRPL3,WRN,JMJD1C,PARP8,CNTN1,AKAP9,SPANXN1,SS18,OR52K2,NOVA1,PHLPP1,MAP2,SERINC5,FIGN,NCKAP5,NOL4,ASPN,LRRC3B,SLIT2,OR2AG1,CD226,B3GAT2,GPR83,UNC5C,PTPRZ1,EFEMP1,SPAG9,MUC7,FBN2,DEPTOR,TRPS1,RGS6,DEFB115,IQGAP2,GAP43,ZFPM2,FGD3,UTRN,PAX6,ACVR2A,FUT9,SPATA16,AFM,NAT2,NRSN1,VAV3,LRIG3,PLEK</TD></TR>
<TR><TD>5.951e-06</TD><TD>-12.03</TD><TD>Leu-rich_rpt_typical-subtyp</TD><TD>interpro domains</TD><TD>IPR003591</TD><TD>175</TD><TD>11</TD><TD>18605</TD><TD>214</TD>
<TD>LRRC3B,LRIG3,LRRC70,LRFN5,ASPN,PHLPP1,PXDNL,EPYC,SLIT2,LRRN2,LGI1</TD></TR>
<TR><TD>6.184e-06</TD><TD>-11.99</TD><TD>neuron projection development</TD><TD>biological process</TD><TD>GO:0031175</TD><TD>694</TD><TD>23</TD><TD>18905</TD><TD>219</TD>
<TD>LGI1,SLIT2,EFNA5,SHTN1,UHMK1,EPHA4,CNTNAP2,SEMA3C,FGFR2,UNC5C,MAP2,LMX1A,EPHA3,DSCAM,UCHL1,NRCAM,GAP43,ARX,CNTN1,SLC25A46,PAX6,ROBO2,PTPRZ1</TD></TR>
<TR><TD>6.513e-06</TD><TD>-11.94</TD><TD>ovary-other-neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>ovary-other-neoplasm</TD><TD>12765</TD><TD>169</TD><TD>16984</TD><TD>192</TD>
<TD>SPANXN1,SS18,TWIST1,NOVA1,JMJD1C,PARP8,LRRC70,CNTN1,AKAP9,NAALADL2,MAP2,PHLPP1,FIGN,FGF20,SLIT2,NCKAP5,EFR3B,NOL4,ASPN,UBR4,LMX1A,KAZN,PSKH2,SLC10A2,LGI1,EPYC,RAI2,PBX1,EFNA5,DNAJC12,FERD3L,BCHE,ADAMTS3,MRPL3,CETN3,LINC00583,WRN,FGFR2,IL1RAPL2,RUNX1T1,RASGEF1B,STXBP6,IQGAP2,GAP43,DEFB115,UTRN,PAX6,ACVR2A,ZFPM2,FGD3,SPATA16,AFM,IPO8,NRSN1,FUT9,PLEK,SLC39A10,LRIG3,VAV3,REG1B,CD226,UCHL1,UNC5C,GHITM,B3GAT2,SERGEF,PWWP2A,GPR83,EFEMP1,SPAG9,LINC01387,MUC7,TRPS1,FBN2,DEPTOR,CNTNAP2,CPXM2,PI15,ZNF133,PRKCE,IRX1,FAT4,CASK,NBEA,BANK1,TMEFF2,SYT1,SGCD,FANCB,COQ2,DNER,MPEG1,EPHA4,GMDS,CHRM3,DSCAM,KCNK9,DAOA,SKAP2,DCDC2C,AGA,PXDNL,ACVR1C,LRRN2,PAQR3,SLC25A46,FABP7,KIF6,SPHKAP,FNIP2,EDIL3,SLC7A14,CTSO,TCF20,LRFN5,PCGF5,SEZ6L,ZFAND5,ACP6,FGF5,MEGF10,BACH2,CXCL13,ADAMTS12,CD96,HNF4G,NTRK2,RBM20,EPHA3,ARX,SGCG,PHF14,ADAMTS5,REXO2,RPH3A,CDH5,RYR2,ROBO2,INSM1,THSD7A,ZPLD1,PCDH9,SHISA3,AOAH,SLC7A8,CRTC3,DAAM1,MRPL13,SEMA3C,PRSS12,PTPRD,NRG1,TGFBR2,LHCGR,ADAM28,EPS8,ATG10,FZD6,EFR3A,NUP35,NAV3,CYTL1,FGF14,THSD7B,LMBRD1,KLF12,FMNL2,ZNF521,PTPRK</TD></TR>
<TR><TD>7.473e-06</TD><TD>-11.80</TD><TD>IG</TD><TD>smart domains</TD><TD>SM00409</TD><TD>399</TD><TD>19</TD><TD>9743</TD><TD>146</TD>
<TD>PTPRD,NRCAM,CNTN1,DSCAM,NTRK2,NRG1,FGFR2,SEMA3C,IL1RAPL2,PECAM1,LRFN5,PXDNL,UNC5C,PTPRK,CD96,ROBO2,CD226,LRIG3,LRRN2</TD></TR>
<TR><TD>7.725e-06</TD><TD>-11.77</TD><TD>neuron development</TD><TD>biological process</TD><TD>GO:0048666</TD><TD>860</TD><TD>26</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,SLC25A46,CNTN1,ARX,GAP43,PTPRZ1,ROBO2,SEMA3C,NTRK2,CNTNAP2,FGFR2,UHMK1,EPHA4,EFNA5,PBX1,INSM1,SHTN1,SLIT2,LGI1,NRCAM,LMX1A,DSCAM,EPHA3,UCHL1,UNC5C,MAP2</TD></TR>
<TR><TD>7.799e-06</TD><TD>-11.76</TD><TD>human chr3q26.2</TD><TD>chromosome location</TD><TD>human chr3q26.2</TD><TD>59</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>SLC7A14,MIR551B,MIR569,SLC7A14-AS1</TD></TR>
<TR><TD>8.224e-06</TD><TD>-11.71</TD><TD>right_upper_lobe</TD><TD>COSMIC cancer mutations</TD><TD>right_upper_lobe</TD><TD>10389</TD><TD>146</TD><TD>16984</TD><TD>192</TD>
<TD>ZFPM2,PAX6,ACVR2A,UTRN,DEFB115,GAP43,RASGEF1B,IQGAP2,SLC39A10,REG1B,VAV3,PLEK,FUT9,NAT2,NRSN1,SPATA16,IPO8,AFM,GPR83,SERGEF,B3GAT2,GHITM,PTPRZ1,UNC5C,UCHL1,OR2AG1,CD226,FBN2,DEPTOR,RGS6,TRPS1,MUC7,EFEMP1,SPAG9,SERINC5,MAP2,CNTN1,AKAP9,NAALADL2,JMJD1C,PARP8,OR52K2,SS18,NOVA1,SPANXN1,NOL4,NCKAP5,SLIT2,FIGN,DNAJC12,EFNA5,PRLHR,RAI2,EPYC,SLC10A2,LGI1,PSKH2,LMX1A,UBR4,RUNX1T1,FGFR2,GCNT1,WRN,MRPL3,BCHE,ADAMTS3,FERD3L,EPHA3,ARX,UHMK1,NTRK2,HNF4G,CD96,ADAMTS12,AOAH,SHISA3,THSD7A,PCDH9,ZPLD1,INSM1,ROBO2,CDH5,RPH3A,RYR2,PHF14,ADAMTS5,EPS8,LHCGR,ADAM28,NRG1,TGFBR2,PRSS12,PTPRD,SEMA3C,NRCAM,DAAM1,TSN,CALN1,SLC7A8,ZNF521,PTPRK,COX7B2,KLF12,LMBRD1,CYTL1,THSD7B,EFR3A,NUP35,NAV3,FZD6,IRX1,FAT4,PRKCE,PI15,CPXM2,CNTNAP2,DAOA,XPO4,SKAP2,KCNK9,DSCAM,CHRM3,DNER,GMDS,EPHA4,COQ2,TMEFF2,ZNF518B,FANCB,SGCD,NBEA,CASK,EDIL3,SLC7A14,SPHKAP,KIF6,PAQR3,PXDNL,ACVR1C,LRRN2,NOBOX,MEGF10,BACH2,SEZ6L,LRFN5,TCF20</TD></TR>
<TR><TD>8.224e-06</TD><TD>-11.71</TD><TD>lung-right_upper_lobe-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-right_upper_lobe-carcinoma-adenocarcinoma</TD><TD>10389</TD><TD>146</TD><TD>16984</TD><TD>192</TD>
<TD>UNC5C,GHITM,PTPRZ1,B3GAT2,SERGEF,GPR83,CD226,OR2AG1,UCHL1,TRPS1,RGS6,DEPTOR,FBN2,EFEMP1,SPAG9,MUC7,UTRN,PAX6,ACVR2A,ZFPM2,RASGEF1B,IQGAP2,GAP43,DEFB115,PLEK,SLC39A10,VAV3,REG1B,SPATA16,AFM,IPO8,NAT2,NRSN1,FUT9,EPYC,RAI2,EFNA5,DNAJC12,PRLHR,UBR4,LMX1A,PSKH2,SLC10A2,LGI1,MRPL3,GCNT1,WRN,FGFR2,RUNX1T1,FERD3L,BCHE,ADAMTS3,MAP2,SERINC5,SPANXN1,SS18,OR52K2,NOVA1,JMJD1C,PARP8,CNTN1,AKAP9,NAALADL2,SLIT2,NCKAP5,NOL4,FIGN,PRSS12,PTPRD,NRG1,TGFBR2,LHCGR,ADAM28,EPS8,CALN1,SLC7A8,TSN,DAAM1,NRCAM,SEMA3C,KLF12,COX7B2,ZNF521,PTPRK,FZD6,EFR3A,NAV3,NUP35,CYTL1,THSD7B,LMBRD1,UHMK1,EPHA3,ARX,ADAMTS12,CD96,NTRK2,HNF4G,THSD7A,PCDH9,ZPLD1,SHISA3,AOAH,PHF14,ADAMTS5,RPH3A,CDH5,RYR2,ROBO2,INSM1,SPHKAP,EDIL3,SLC7A14,NOBOX,PXDNL,ACVR1C,LRRN2,PAQR3,KIF6,MEGF10,BACH2,TCF20,LRFN5,SEZ6L,CPXM2,PI15,PRKCE,IRX1,FAT4,CNTNAP2,DSCAM,CHRM3,KCNK9,XPO4,DAOA,SKAP2,NBEA,CASK,TMEFF2,ZNF518B,SGCD,FANCB,COQ2,DNER,GMDS,EPHA4</TD></TR>
<TR><TD>8.456e-06</TD><TD>-11.68</TD><TD>oesophagus-middle_third-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-middle_third-carcinoma-squamous_cell_carcinoma</TD><TD>3538</TD><TD>66</TD><TD>16984</TD><TD>192</TD>
<TD>IQGAP2,RASGEF1B,CELF2,ADAMTS12,HNF4G,UTRN,EPHA3,ADAMTS5,IPO8,SGCG,RYR2,CDH5,PCDH9,ZPLD1,THSD7A,SHISA3,VAV3,LRIG3,MRPL13,DAAM1,SEMA3C,UNC5C,PRSS12,PTPRZ1,B3GAT2,GPR83,EPS8,NAV3,THSD7B,SPAG9,CYTL1,MUC7,LMBRD1,KLF12,RGS6,FMNL2,FBN2,ZNF521,SS18,CNTNAP2,JMJD1C,AKAP9,IRX1,NBEA,SGCD,FIGN,EPHA4,MPEG1,LRRC3B,DSCAM,SLIT2,NOL4,UBR4,NOBOX,LRRN2,LMX1A,PXDNL,KIF6,SLC10A2,SPHKAP,LRFN5,ADAMTS3,FGF5,FGFR2,RUNX1T1,MEGF10</TD></TR>
<TR><TD>8.622e-06</TD><TD>-11.66</TD><TD>middle_third</TD><TD>COSMIC cancer mutations</TD><TD>middle_third</TD><TD>3540</TD><TD>66</TD><TD>16984</TD><TD>192</TD>
<TD>ZPLD1,PCDH9,THSD7A,SHISA3,LRIG3,VAV3,IPO8,ADAMTS5,SGCG,RYR2,CDH5,UTRN,EPHA3,IQGAP2,CELF2,RASGEF1B,ADAMTS12,HNF4G,KLF12,RGS6,FMNL2,FBN2,ZNF521,NAV3,THSD7B,SPAG9,CYTL1,MUC7,LMBRD1,PRSS12,UNC5C,PTPRZ1,B3GAT2,GPR83,EPS8,MRPL13,DAAM1,SEMA3C,LRRC3B,DSCAM,SLIT2,NOL4,NBEA,SGCD,FIGN,EPHA4,MPEG1,IRX1,SS18,CNTNAP2,JMJD1C,AKAP9,FGF5,FGFR2,RUNX1T1,MEGF10,LRFN5,ADAMTS3,SPHKAP,UBR4,NOBOX,LRRN2,LMX1A,PXDNL,KIF6,SLC10A2</TD></TR>
<TR><TD>8.720e-06</TD><TD>-11.65</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome</TD><TD>1178</TD><TD>31</TD><TD>16984</TD><TD>192</TD>
<TD>PTPRD,UNC5C,TGFBR2,EFNA5,SLC7A8,UBR4,ACVR1C,PSKH2,FGFR2,RUNX1T1,MEGF10,IL1RAPL2,THSD7B,UHMK1,ACVR2A,ZFPM2,PRKCE,EPHA3,CNTNAP2,PARP8,NTRK2,DSCAM,SLIT2,SLC39A10,NCKAP5,SKAP2,NOL4,CASK,GMDS,EPHA4,DNER</TD></TR>
<TR><TD>8.720e-06</TD><TD>-11.65</TD><TD>myelodysplastic_syndrome</TD><TD>COSMIC cancer mutations</TD><TD>myelodysplastic_syndrome</TD><TD>1178</TD><TD>31</TD><TD>16984</TD><TD>192</TD>
<TD>TGFBR2,PTPRD,UNC5C,EFNA5,ACVR1C,SLC7A8,UBR4,PSKH2,RUNX1T1,MEGF10,IL1RAPL2,FGFR2,THSD7B,ACVR2A,UHMK1,ZFPM2,PRKCE,EPHA3,NTRK2,PARP8,CNTNAP2,SLIT2,DSCAM,SKAP2,NOL4,SLC39A10,NCKAP5,CASK,GMDS,EPHA4,DNER</TD></TR>
<TR><TD>8.976e-06</TD><TD>-11.62</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell</TD><TD>1121</TD><TD>30</TD><TD>16984</TD><TD>192</TD>
<TD>NAALADL2,CNTNAP2,SS18,ADAMTS12,IQGAP2,FAT4,EPHA3,ZFPM2,RBM20,UTRN,GMDS,RYR2,COQ2,BANK1,SPATA16,CASK,NBEA,NCKAP5,AOAH,DSCAM,KIF6,KAZN,EDIL3,B3GAT2,UNC5C,THSD7B,FGF14,IL1RAPL2,PTPRK,RGS6</TD></TR>
<TR><TD>9.171e-06</TD><TD>-11.60</TD><TD>oesophagus-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-carcinoma-squamous_cell_carcinoma</TD><TD>6490</TD><TD>103</TD><TD>16984</TD><TD>192</TD>
<TD>PTPRD,NRG1,TGFBR2,LHCGR,ADAM28,EPS8,DAAM1,CRTC3,SEMA3C,ZNF521,NAV3,FGF14,THSD7B,LMBRD1,RBM20,EPHA3,ADAMTS12,CD96,HNF4G,THSD7A,ZPLD1,PCDH9,PHF14,ADAMTS5,CDH5,RPH3A,RYR2,INSM1,SPHKAP,SLC7A14,EDIL3,PXDNL,LRRN2,PAQR3,SLC25A46,ZFAND5,BACH2,CTSO,LRFN5,SEZ6L,PCGF5,CPXM2,PI15,PRKCE,IRX1,FAT4,CNTNAP2,CHRM3,DSCAM,KCNK9,XPO4,NBEA,CASK,BANK1,TMEFF2,FANCB,MPEG1,UNC5C,PTPRZ1,TRPS1,FBN2,WWOX,SPAG9,MUC7,UTRN,ZFPM2,FGD3,CELF2,IQGAP2,GAP43,DEFB115,LRIG3,VAV3,SPATA16,IPO8,EPYC,DNAJC12,UBR4,LMX1A,KAZN,WRN,FGFR2,RUNX1T1,BCHE,AMELX,ADAMTS3,MAP2,PHLPP1,SPANXN1,SS18,NOVA1,JMJD1C,PARP8,AKAP9,CNTN1,NAALADL2,SLIT2,NCKAP5,EFR3B,NOL4,ASPN,FIGN,FGF20</TD></TR>
<TR><TD>9.288e-06</TD><TD>-11.59</TD><TD>upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma</TD><TD>1485</TD><TD>36</TD><TD>16984</TD><TD>192</TD>
<TD>UTRN,MAP2,FAT4,EPHA3,ZFPM2,TWIST1,GAP43,NAALADL2,JMJD1C,CNTNAP2,SLIT2,THSD7A,PCDH9,XPO4,REG1B,FANCB,SPATA16,FUT9,RYR2,TGFBR2,PTPRZ1,DNAJC12,EPS8,SLC7A14,PBX1,NRCAM,SLC10A2,DAAM1,PAQR3,FGFR2,DEPTOR,FBN2,LMBRD1,MUC7,LRFN5,EFEMP1</TD></TR>
<TR><TD>1.014e-05</TD><TD>-11.50</TD><TD>serous_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>serous_carcinoma</TD><TD>11016</TD><TD>152</TD><TD>16984</TD><TD>192</TD>
<TD>HNF4G,NTRK2,CD96,ADAMTS12,EPHA3,UHMK1,RBM20,CDH5,RPH3A,RYR2,INSM1,ROBO2,PHF14,ADAMTS5,THSD7A,PCDH9,ZPLD1,SHISA3,CRTC3,DAAM1,MRPL13,NRCAM,SEMA3C,CALN1,SLC7A8,LHCGR,ADAM28,EPS8,PTPRD,NRG1,TGFBR2,CYTL1,FGF14,THSD7B,LMBRD1,EFR3A,NUP35,NAV3,FMNL2,ZNF521,PTPRK,KLF12,CNTNAP2,ZNF133,PRKCE,IRX1,FAT4,CPXM2,PI15,COQ2,DNER,MPEG1,EPHA4,GMDS,NBEA,CASK,TMEFF2,BANK1,ZNF518B,SGCD,SYT1,XPO4,SKAP2,CHRM3,DSCAM,KCNK9,PAQR3,FABP7,KIF6,AGA,NOBOX,PXDNL,ACVR1C,LRRN2,EDIL3,SLC7A14,SPHKAP,FNIP2,LRFN5,PCGF5,SEZ6L,CTSO,TCF20,ACP6,FGF5,MEGF10,BACH2,CXCL13,DEFB115,RASGEF1B,IQGAP2,GAP43,ZFPM2,FGD3,UTRN,PAX6,ACVR2A,FUT9,SPATA16,AFM,NAT2,NRSN1,LRIG3,VAV3,PLEK,OR2AG1,CD226,B3GAT2,GPR83,UNC5C,PTPRZ1,EFEMP1,SPAG9,MUC7,WWOX,DEPTOR,FBN2,TRPS1,RGS6,JMJD1C,PARP8,CNTN1,AKAP9,SPANXN1,OR52K2,SS18,NOVA1,PHLPP1,MAP2,SERINC5,FIGN,NCKAP5,NOL4,ASPN,LRRC3B,SLIT2,PSKH2,SLC10A2,LGI1,UBR4,LMX1A,KAZN,DNAJC12,PRLHR,BCHE,ADAMTS3,FERD3L,FGFR2,IL1RAPL2,RUNX1T1,MRPL3,WRN</TD></TR>
<TR><TD>1.048e-05</TD><TD>-11.47</TD><TD>TSP1_ADAMTS</TD><TD>pfam domains</TD><TD>PF19030</TD><TD>26</TD><TD>5</TD><TD>17869</TD><TD>206</TD>
<TD>THSD7A,ADAMTS5,ADAMTS12,THSD7B,ADAMTS3</TD></TR>
<TR><TD>1.075e-05</TD><TD>-11.44</TD><TD>outflow tract septum morphogenesis</TD><TD>biological process</TD><TD>GO:0003148</TD><TD>26</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,ZFPM2,SEMA3C,ROBO2,FGFR2</TD></TR>
<TR><TD>1.100e-05</TD><TD>-11.42</TD><TD>upper_aerodigestive_tract-mouth-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-mouth-carcinoma</TD><TD>6429</TD><TD>102</TD><TD>16984</TD><TD>192</TD>
<TD>UNC5C,GPR83,TRPS1,RGS6,DEPTOR,FBN2,EFEMP1,MUC7,UTRN,ACVR2A,ZFPM2,RASGEF1B,STXBP6,DEFB115,PLEK,REG1B,LRIG3,AFM,IPO8,NAT2,NRSN1,FUT9,PRLHR,UBR4,KAZN,GCNT1,FGFR2,RUNX1T1,FERD3L,SERINC5,PHLPP1,SS18,OR52K2,NOVA1,JMJD1C,CNTN1,AKAP9,NAALADL2,SLIT2,NCKAP5,NOL4,FIGN,PRSS12,PTPRD,TGFBR2,LHCGR,EPS8,SLC7A8,CRTC3,NRCAM,SEMA3C,ZNF521,NAV3,THSD7B,LMBRD1,ARL14,RBM20,EPHA3,ADAMTS12,HNF4G,CD96,THSD7A,AOAH,SGCG,PHF14,ADAMTS5,RPH3A,CDH5,RYR2,ROBO2,SPHKAP,SLC7A14,EDIL3,AGA,NOBOX,PXDNL,ACVR1C,LRRN2,PAQR3,SLC25A46,KIF6,MEGF10,BACH2,CTSO,TCF20,LRFN5,PCGF5,CPXM2,PI15,IRX1,FAT4,CNTNAP2,DSCAM,CHRM3,XPO4,NBEA,CASK,BANK1,ZNF518B,FANCB,SYT1,COQ2</TD></TR>
<TR><TD>1.136e-05</TD><TD>-11.39</TD><TD>large_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>large_cell_carcinoma</TD><TD>850</TD><TD>25</TD><TD>16984</TD><TD>192</TD>
<TD>MRPL3,FGF5,FGFR2,UBR4,ACVR1C,PSKH2,SEMA3C,TGFBR2,PTPRZ1,NRG1,CASK,FANCB,SYT1,TMEFF2,EPHA4,ROBO2,ZPLD1,NOL4,NTRK2,CNTNAP2,UHMK1,ACVR2A,PRKCE,EPHA3,FAT4</TD></TR>
<TR><TD>1.136e-05</TD><TD>-11.39</TD><TD>lung-carcinoma-large_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-large_cell_carcinoma</TD><TD>850</TD><TD>25</TD><TD>16984</TD><TD>192</TD>
<TD>CNTNAP2,NTRK2,EPHA3,PRKCE,FAT4,UHMK1,ACVR2A,ROBO2,EPHA4,CASK,TMEFF2,SYT1,FANCB,NOL4,ZPLD1,PSKH2,SEMA3C,UBR4,ACVR1C,NRG1,PTPRZ1,TGFBR2,FGFR2,FGF5,MRPL3</TD></TR>
<TR><TD>1.188e-05</TD><TD>-11.34</TD><TD>NS-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>NS-malignant_melanoma</TD><TD>3425</TD><TD>64</TD><TD>16984</TD><TD>192</TD>
<TD>UTRN,EPHA3,ZFPM2,ADAMTS12,IQGAP2,THSD7A,ZPLD1,PCDH9,VAV3,SPATA16,SGCG,PHF14,FUT9,RYR2,PTPRZ1,EPS8,GPR83,LHCGR,ADAM28,TSN,SEMA3C,ZNF521,PTPRK,DEPTOR,FBN2,EFEMP1,SPAG9,FGF14,THSD7B,CPXM2,FAT4,SS18,OR52K2,JMJD1C,CNTNAP2,PARP8,KCNK9,DSCAM,CHRM3,NOL4,SKAP2,NCKAP5,FANCB,SYT1,NBEA,DNER,EPHA4,EPYC,SPHKAP,EDIL3,RAI2,PXDNL,LMX1A,LRRN2,UBR4,NOBOX,PSKH2,WRN,MEGF10,RUNX1T1,FGFR2,TCF20,BCHE,LRFN5</TD></TR>
<TR><TD>1.226e-05</TD><TD>-11.31</TD><TD>upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma</TD><TD>6955</TD><TD>108</TD><TD>16984</TD><TD>192</TD>
<TD>FIGN,SLIT2,NCKAP5,NOL4,OR52K2,NOVA1,JMJD1C,PARP8,AKAP9,CNTN1,NAALADL2,MAP2,PHLPP1,FERD3L,AMELX,GCNT1,WRN,FGFR2,IL1RAPL2,RUNX1T1,UBR4,LMX1A,KAZN,PSKH2,LGI1,EPYC,PRLHR,SPATA16,IPO8,AFM,NAT2,FUT9,LRIG3,VAV3,CELF2,DEFB115,UTRN,ACVR2A,ZFPM2,WWOX,MUC7,TRPS1,RGS6,DEPTOR,FBN2,OR2AG1,PTPRZ1,B3GAT2,PWWP2A,GPR83,CASK,NBEA,ZNF518B,TMEFF2,FANCB,MPEG1,DSCAM,CHRM3,XPO4,CNTNAP2,CPXM2,PRKCE,IRX1,FAT4,CTSO,TCF20,LRFN5,SEZ6L,FGF5,MEGF10,NOBOX,AGA,PXDNL,ACVR1C,KIF6,SPHKAP,SLC7A14,SGCG,PHF14,ADAMTS5,CDH5,RYR2,ROBO2,THSD7A,PCDH9,ADAMTS12,HNF4G,CD96,ARL14,RBM20,EPHA3,ATG10,NAV3,CYTL1,THSD7B,LMBRD1,FMNL2,ZNF521,PTPRK,CRTC3,DAAM1,NRCAM,SEMA3C,PTPRD,TGFBR2,LHCGR,ADAM28,EPS8</TD></TR>
<TR><TD>1.274e-05</TD><TD>-11.27</TD><TD>LRRNT</TD><TD>pfam domains</TD><TD>PF01462</TD><TD>27</TD><TD>5</TD><TD>17869</TD><TD>206</TD>
<TD>SLIT2,NTRK2,ASPN,LRRC3B,EPYC</TD></TR>
<TR><TD>1.375e-05</TD><TD>-11.19</TD><TD>human chr7q21.11</TD><TD>chromosome location</TD><TD>human chr7q21.11</TD><TD>68</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>LINC03017,SEMA3C,LINC00972,MAGI2-AS2</TD></TR>
<TR><TD>1.375e-05</TD><TD>-11.19</TD><TD>human chr2q36.3</TD><TD>chromosome location</TD><TD>human chr2q36.3</TD><TD>68</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>DAW1,DNER,LOC646736,SPHKAP</TD></TR>
<TR><TD>1.627e-05</TD><TD>-11.03</TD><TD>prostate</TD><TD>COSMIC cancer mutations</TD><TD>prostate</TD><TD>13932</TD><TD>178</TD><TD>16984</TD><TD>192</TD>
<TD>ADAMTS5,SGCG,PHF14,REXO2,RYR2,RPH3A,ROBO2,ZPLD1,THSD7A,AOAH,ADAMTS12,HNF4G,NTRK2,CD96,EPHA3,ATG10,NUP35,EFR3A,CYTL1,KLF12,FMNL2,PTPRK,ZNF521,CALN1,DAAM1,SEMA3C,NRCAM,PTPRD,TGFBR2,ADAM28,CASK,SGCD,TMEFF2,COQ2,EPHA4,DNER,DSCAM,SKAP2,DCDC2C,XPO4,CNTNAP2,CPXM2,PI15,PRKCE,ZNF133,IRX1,TCF20,LRFN5,SEZ6L,PCGF5,ZFAND5,ACP6,MEGF10,NOBOX,ERCC6L2,LRRN2,ACVR1C,PAQR3,KIF6,SPHKAP,IPO8,NRSN1,FUT9,REG1B,LRIG3,STXBP6,IQGAP2,PAX6,FGD3,SPAG9,MUC7,LINC01387,RGS6,DEPTOR,FBN2,UCHL1,FIGN,LRRC3B,ASPN,EFR3B,JMJD1C,PHLPP1,ADAMTS3,BCHE,MRPL3,WRN,CETN3,IL1RAPL2,UBR4,RAI2,PBX1,DNAJC12,CDH5,INSM1,PCDH9,UHMK1,RBM20,ARX,FZD6,NAV3,FGF14,THSD7B,LMBRD1,SLC7A8,MRPL13,CRTC3,PRSS12,NRG1,LHCGR,EPS8,NBEA,FANCB,SYT1,BANK1,ZNF518B,GMDS,MPEG1,CHRM3,KCNK9,DAOA,FAT4,CTSO,FGF5,BACH2,AGA,PXDNL,SLC25A46,FNIP2,SLC7A14,EDIL3,AFM,SPATA16,NAT2,PLEK,VAV3,SLC39A10,CELF2,RASGEF1B,GAP43,UTRN,ACVR2A,ZFPM2,EFEMP1,TRPS1,CD226,OR2AG1,UNC5C,PTPRZ1,GHITM,B3GAT2,SERGEF,GPR83,FGF20,SLIT2,NCKAP5,NOL4,SPANXN1,NOVA1,TWIST1,SS18,PARP8,NAALADL2,CNTN1,AKAP9,MAP2,FERD3L,AMELX,LINC00583,GCNT1,FGFR2,RUNX1T1,KAZN,LMX1A,PSKH2,LGI1,SLC10A2,EPYC,EFNA5</TD></TR>
<TR><TD>1.823e-05</TD><TD>-10.91</TD><TD>human chr8q21.3</TD><TD>chromosome location</TD><TD>human chr8q21.3</TD><TD>73</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>RUNX1T1,PARAIL,PSKH2,C8orf88</TD></TR>
<TR><TD>1.846e-05</TD><TD>-10.90</TD><TD>lung-left_upper_lobe-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-left_upper_lobe-carcinoma-adenocarcinoma</TD><TD>556</TD><TD>19</TD><TD>16984</TD><TD>192</TD>
<TD>RGS6,DSCAM,TRPS1,MEGF10,DAOA,FBN2,LRIG3,NAV3,ZNF518B,BCHE,RYR2,LRFN5,PTPRD,MAP2,FAT4,ZFPM2,CALN1,NTRK2,CNTNAP2</TD></TR>
<TR><TD>1.940e-05</TD><TD>-10.85</TD><TD>left_upper_lobe</TD><TD>COSMIC cancer mutations</TD><TD>left_upper_lobe</TD><TD>558</TD><TD>19</TD><TD>16984</TD><TD>192</TD>
<TD>CALN1,NTRK2,CNTNAP2,MAP2,PTPRD,FAT4,ZFPM2,ZNF518B,NAV3,BCHE,LRFN5,RYR2,RGS6,TRPS1,DSCAM,MEGF10,DAOA,LRIG3,FBN2</TD></TR>
<TR><TD>1.978e-05</TD><TD>-10.83</TD><TD>diffuse_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>diffuse_adenocarcinoma</TD><TD>4392</TD><TD>76</TD><TD>16984</TD><TD>192</TD>
<TD>NCKAP5,EFR3B,XPO4,NOL4,LRRC3B,DSCAM,SLIT2,GMDS,DNER,CASK,NBEA,BANK1,ZNF133,FAT4,MAP2,CPXM2,CNTNAP2,JMJD1C,CNTN1,OR52K2,FGF5,FGFR2,BACH2,IL1RAPL2,LRFN5,ADAMTS3,BCHE,SEZ6L,FERD3L,SLC7A14,PRLHR,SPHKAP,LGI1,SLC10A2,AGA,NOBOX,UBR4,LMX1A,KAZN,LRIG3,AOAH,REG1B,PCDH9,THSD7A,RYR2,ROBO2,IPO8,ADAMTS5,SPATA16,ZFPM2,EPHA3,UTRN,RBM20,ACVR2A,DEFB115,IQGAP2,GAP43,ADAMTS12,DEPTOR,ZNF521,TRPS1,FGF14,THSD7B,EFR3A,ADAM28,B3GAT2,GPR83,EPS8,PTPRD,TGFBR2,PTPRZ1,NRG1,MRPL13,SLC7A8,CALN1,CD226</TD></TR>
<TR><TD>1.978e-05</TD><TD>-10.83</TD><TD>stomach-carcinoma-diffuse_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>stomach-carcinoma-diffuse_adenocarcinoma</TD><TD>4392</TD><TD>76</TD><TD>16984</TD><TD>192</TD>
<TD>JMJD1C,CNTNAP2,CNTN1,OR52K2,ZNF133,FAT4,MAP2,CPXM2,DNER,GMDS,NBEA,CASK,BANK1,NCKAP5,EFR3B,NOL4,XPO4,LRRC3B,DSCAM,SLIT2,SLC10A2,LGI1,NOBOX,AGA,UBR4,KAZN,LMX1A,PRLHR,SLC7A14,SPHKAP,LRFN5,BCHE,SEZ6L,ADAMTS3,FERD3L,FGFR2,FGF5,IL1RAPL2,BACH2,DEFB115,IQGAP2,ADAMTS12,GAP43,EPHA3,ZFPM2,UTRN,ACVR2A,RBM20,RYR2,ROBO2,SPATA16,ADAMTS5,IPO8,REG1B,AOAH,LRIG3,THSD7A,PCDH9,MRPL13,CALN1,SLC7A8,CD226,B3GAT2,ADAM28,EPS8,GPR83,PTPRD,NRG1,TGFBR2,PTPRZ1,FGF14,THSD7B,EFR3A,DEPTOR,ZNF521,TRPS1</TD></TR>
<TR><TD>2.036e-05</TD><TD>-10.80</TD><TD>trunk</TD><TD>COSMIC cancer mutations</TD><TD>trunk</TD><TD>3556</TD><TD>65</TD><TD>16984</TD><TD>192</TD>
<TD>FGF5,FGFR2,CXCL13,WRN,LRFN5,ADAMTS3,SEZ6L,EDIL3,SPHKAP,KIF6,UBR4,AGA,LMX1A,NCKAP5,SKAP2,DAOA,DSCAM,CHRM3,SLIT2,KCNK9,NBEA,BANK1,ZNF133,FAT4,CPXM2,PI15,PARP8,JMJD1C,NAALADL2,AKAP9,OR52K2,FMNL2,FBN2,PTPRK,TRPS1,RGS6,THSD7B,SPAG9,MUC7,ADAM28,LHCGR,EPS8,PTPRD,PRSS12,PTPRZ1,NRCAM,UCHL1,TSN,PLEK,PCDH9,THSD7A,RYR2,RPH3A,ROBO2,AFM,ZFPM2,EPHA3,UTRN,RBM20,PAX6,CD96,HNF4G,NTRK2,IQGAP2,ADAMTS12</TD></TR>
<TR><TD>2.168e-05</TD><TD>-10.74</TD><TD>Developmental Biology</TD><TD>REACTOME pathways</TD><TD>R-HSA-1266738</TD><TD>1078</TD><TD>26</TD><TD>10391</TD><TD>106</TD>
<TD>EFNA5,SHTN1,PAX6,GAP43,ACVR1C,FGFR2,ROBO2,PAQR3,SLIT2,VAV3,EPHA4,AKAP9,KAZN,FGF20,NRG1,EPHA3,NRCAM,UNC5C,FGF5,SPAG9,INSM1,LGI1,ACVR2A,PBX1,HNF4G,CNTN1</TD></TR>
<TR><TD>2.289e-05</TD><TD>-10.68</TD><TD>lung-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-squamous_cell_carcinoma</TD><TD>14744</TD><TD>184</TD><TD>16984</TD><TD>192</TD>
<TD>RASGEF1B,CELF2,GAP43,DEFB115,UTRN,ACVR2A,ZFPM2,AFM,SPATA16,NAT2,PLEK,VAV3,SLC39A10,CD226,OR2AG1,UNC5C,PTPRZ1,GHITM,SERGEF,B3GAT2,GPR83,WWOX,EFEMP1,TRPS1,SPANXN1,NOVA1,TWIST1,SS18,PARP8,NAALADL2,AKAP9,CNTN1,MAP2,SERINC5,FGF20,SLIT2,NCKAP5,NOL4,KAZN,LMX1A,PSKH2,LGI1,SLC10A2,EPYC,PRLHR,EFNA5,FERD3L,AMELX,GCNT1,FGFR2,RUNX1T1,ARL14,UHMK1,RBM20,CDH5,PCDH9,SHISA3,SLC7A8,MRPL13,CRTC3,PRSS12,NRG1,LHCGR,EPS8,FZD6,NAV3,THSD7B,FGF14,LMBRD1,COX7B2,FAT4,NBEA,FANCB,SYT1,ZNF518B,BANK1,GMDS,MPEG1,CHRM3,KCNK9,DAOA,AGA,PXDNL,FABP7,SLC25A46,FNIP2,EDIL3,SLC7A14,CTSO,FGF5,BACH2,IQGAP2,PAX6,FGD3,IPO8,NRSN1,FUT9,REG1B,LRIG3,UCHL1,PWWP2A,SPAG9,MUC7,RGS6,DEPTOR,FBN2,OR52K2,JMJD1C,PHLPP1,FIGN,LRRC3B,ASPN,EFR3B,UBR4,RAI2,PBX1,DNAJC12,ADAMTS3,BCHE,MRPL3,WRN,CETN3,IL1RAPL2,ADAMTS12,NTRK2,CD96,HNF4G,EPHA3,ADAMTS5,SGCG,PHF14,REXO2,RYR2,RPH3A,ROBO2,ZPLD1,THSD7A,AOAH,CALN1,TSN,DAAM1,SEMA3C,NRCAM,PTPRD,TGFBR2,ADAM28,ATG10,NUP35,EFR3A,CYTL1,KLF12,FMNL2,PTPRK,ZNF521,CNTNAP2,CPXM2,PI15,PRKCE,ZNF133,IRX1,CASK,SGCD,TMEFF2,EPHA4,DNER,DSCAM,SKAP2,DCDC2C,XPO4,NOBOX,ERCC6L2,LRRN2,ACVR1C,PAQR3,KIF6,SPHKAP,TCF20,LRFN5,PCGF5,SEZ6L,ZFAND5,ACP6,CXCL13,MEGF10</TD></TR>
<TR><TD>2.297e-05</TD><TD>-10.68</TD><TD>O-linked glycosylation</TD><TD>REACTOME pathways</TD><TD>R-HSA-5173105</TD><TD>116</TD><TD>8</TD><TD>10391</TD><TD>106</TD>
<TD>ADAMTS12,THSD7B,GCNT1,ADAMTS3,MUC7,GALNT15,ADAMTS5,THSD7A</TD></TR>
<TR><TD>2.353e-05</TD><TD>-10.66</TD><TD>breast-carcinoma-basal_(triple-negative)_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>breast-carcinoma-basal_(triple-negative)_carcinoma</TD><TD>2983</TD><TD>57</TD><TD>16984</TD><TD>192</TD>
<TD>ACVR1C,SPHKAP,DNAJC12,PBX1,BCHE,WRN,RUNX1T1,FGF5,FGFR2,TWIST1,SS18,AKAP9,CNTN1,CNTNAP2,PARP8,JMJD1C,CPXM2,FAT4,PRKCE,ZNF133,FANCB,TMEFF2,EPHA4,GMDS,DNER,FGF20,CHRM3,DCDC2C,NRCAM,UCHL1,TGFBR2,NRG1,PTPRD,GPR83,EPS8,LHCGR,EFR3A,FZD6,SPAG9,THSD7B,FGF14,CYTL1,ZNF521,ADAMTS12,CELF2,HNF4G,NTRK2,ACVR2A,PAX6,UTRN,EPHA3,IPO8,SPATA16,PHF14,ROBO2,CDH5,VAV3</TD></TR>
<TR><TD>2.353e-05</TD><TD>-10.66</TD><TD>basal_(triple-negative)_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>basal_(triple-negative)_carcinoma</TD><TD>2983</TD><TD>57</TD><TD>16984</TD><TD>192</TD>
<TD>ACVR1C,SPHKAP,DNAJC12,PBX1,BCHE,WRN,RUNX1T1,FGFR2,FGF5,TWIST1,SS18,AKAP9,CNTN1,JMJD1C,CNTNAP2,PARP8,CPXM2,FAT4,ZNF133,PRKCE,TMEFF2,FANCB,DNER,EPHA4,GMDS,FGF20,CHRM3,DCDC2C,NRCAM,UCHL1,NRG1,TGFBR2,PTPRD,EPS8,GPR83,LHCGR,EFR3A,FZD6,CYTL1,FGF14,THSD7B,SPAG9,ZNF521,ADAMTS12,CELF2,NTRK2,HNF4G,PAX6,ACVR2A,UTRN,EPHA3,SPATA16,PHF14,IPO8,ROBO2,CDH5,VAV3</TD></TR>
<TR><TD>2.369e-05</TD><TD>-10.65</TD><TD>human chr5q23.2</TD><TD>chromosome location</TD><TD>human chr5q23.2</TD><TD>78</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>MARCHF3,MEGF10,LINC01170,LINC02240</TD></TR>
<TR><TD>2.768e-05</TD><TD>-10.49</TD><TD>chondrosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>chondrosarcoma</TD><TD>1189</TD><TD>30</TD><TD>16984</TD><TD>192</TD>
<TD>CNTNAP2,CNTN1,AKAP9,IQGAP2,SS18,EPHA3,PHLPP1,FGD3,UTRN,MAP2,PI15,ACVR2A,RBM20,RYR2,SPATA16,SGCD,FIGN,LRIG3,DAAM1,NOBOX,UBR4,LHCGR,UNC5C,SPHKAP,THSD7B,ADAMTS3,NAV3,FMNL2,CXCL13,MEGF10</TD></TR>
<TR><TD>2.857e-05</TD><TD>-10.46</TD><TD>TSP_1</TD><TD>pfam domains</TD><TD>PF00090</TD><TD>52</TD><TD>6</TD><TD>17869</TD><TD>206</TD>
<TD>UNC5C,ADAMTS3,THSD7B,THSD7A,ADAMTS12,ADAMTS5</TD></TR>
<TR><TD>2.859e-05</TD><TD>-10.46</TD><TD>fn3</TD><TD>pfam domains</TD><TD>PF00041</TD><TD>136</TD><TD>9</TD><TD>17869</TD><TD>206</TD>
<TD>PTPRD,ROBO2,EPHA4,EPHA3,NRCAM,DSCAM,CNTN1,PTPRZ1,PTPRK</TD></TR>
<TR><TD>2.984e-05</TD><TD>-10.42</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma</TD><TD>476</TD><TD>17</TD><TD>16984</TD><TD>192</TD>
<TD>EPHA3,ZFPM2,PRKCE,FAT4,UTRN,CNTNAP2,SEMA3C,NAALADL2,IL1RAPL2,PCDH9,DSCAM,SLIT2,ROBO2,LMBRD1,ADAMTS3,ATG10,CASK</TD></TR>
<TR><TD>3.131e-05</TD><TD>-10.37</TD><TD>Diseases associated with O-glycosylation of proteins</TD><TD>REACTOME pathways</TD><TD>R-HSA-3906995</TD><TD>60</TD><TD>6</TD><TD>10391</TD><TD>106</TD>
<TD>ADAMTS3,THSD7B,ADAMTS12,THSD7A,ADAMTS5,MUC7</TD></TR>
<TR><TD>3.139e-05</TD><TD>-10.37</TD><TD>animal organ morphogenesis</TD><TD>biological process</TD><TD>GO:0009887</TD><TD>989</TD><TD>27</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,SEMA3C,NTRK2,AMELX,ZFPM2,EFEMP1,PBX1,GCNT1,RBM20,SLIT2,RYR2,DSCAM,LRIG3,TWIST1,FGF5,PAX6,TGFBR2,FZD6,IRX1,ACVR2A,ROBO2,ZFAND5,NRG1,FGF20,WWOX,ADAMTS5,FBN2</TD></TR>
<TR><TD>3.378e-05</TD><TD>-10.30</TD><TD>Defective B3GALTL causes Peters-plus syndrome (PpS)</TD><TD>REACTOME pathways</TD><TD>R-HSA-5083635</TD><TD>37</TD><TD>5</TD><TD>10391</TD><TD>106</TD>
<TD>ADAMTS12,THSD7B,ADAMTS3,THSD7A,ADAMTS5</TD></TR>
<TR><TD>3.393e-05</TD><TD>-10.29</TD><TD>femur</TD><TD>COSMIC cancer mutations</TD><TD>femur</TD><TD>1202</TD><TD>30</TD><TD>16984</TD><TD>192</TD>
<TD>CNTNAP2,HNF4G,JMJD1C,IQGAP2,ADAMTS12,FAT4,PHLPP1,PI15,FGF20,SYT1,TMEFF2,LRIG3,NCKAP5,DCDC2C,NOL4,DSCAM,PCDH9,SLIT2,UBR4,LHCGR,SPHKAP,UNC5C,PTPRZ1,FGF14,THSD7B,SEZ6L,ATG10,FMNL2,CXCL13,ZNF521</TD></TR>
<TR><TD>3.475e-05</TD><TD>-10.27</TD><TD>Ig-like_fold</TD><TD>interpro domains</TD><TD>IPR013783</TD><TD>726</TD><TD>22</TD><TD>18605</TD><TD>214</TD>
<TD>LRRN2,NRCAM,CD96,PTPRZ1,NRG1,FGFR2,EPHA3,CD226,DSCAM,PTPRD,LRIG3,PTPRK,IL1RAPL2,ROBO2,SEMA3C,PXDNL,UNC5C,NTRK2,CNTN1,PECAM1,LRFN5,EPHA4</TD></TR>
<TR><TD>3.727e-05</TD><TD>-10.20</TD><TD>animal organ development</TD><TD>biological process</TD><TD>GO:0048513</TD><TD>2860</TD><TD>56</TD><TD>18905</TD><TD>219</TD>
<TD>LMX1A,SLC39A10,FGF5,UNC5C,TWIST1,LRIG3,FAT4,ZFPM2,EPHA4,UTRN,NTRK2,DAW1,EPYC,ASPN,PHF14,NRG1,RAI2,DNER,FBN2,PCDH9,MEGF10,TGFBR2,CYTL1,ACVR2A,FZD6,DSCAM,RYR2,NRCAM,AMELX,CNTNAP2,SEMA3C,KAZN,FGFR2,SLIT2,GCNT1,RBM20,INSM1,EFEMP1,AFG2A,PBX1,WWOX,FGF20,SGCD,ZFAND5,ROBO2,SGCG,ADAMTS5,ADAMTS12,PLAAT1,PAX6,IRX1,PECAM1,CNTN1,ARX,SLC25A46,LHCGR</TD></TR>
<TR><TD>3.858e-05</TD><TD>-10.16</TD><TD>Axon guidance</TD><TD>REACTOME pathways</TD><TD>R-HSA-422475</TD><TD>551</TD><TD>17</TD><TD>10391</TD><TD>106</TD>
<TD>CNTN1,SLIT2,VAV3,PAQR3,FGFR2,FGF5,ROBO2,NRCAM,UNC5C,EPHA3,GAP43,FGF20,NRG1,SHTN1,AKAP9,EPHA4,EFNA5</TD></TR>
<TR><TD>3.895e-05</TD><TD>-10.15</TD><TD>human chr4q21.23</TD><TD>chromosome location</TD><TD>human chr4q21.23</TD><TD>31</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>WDFY3-AS2,MIR4451,COQ2</TD></TR>
<TR><TD>3.932e-05</TD><TD>-10.14</TD><TD>central nervous system development</TD><TD>biological process</TD><TD>GO:0007417</TD><TD>1002</TD><TD>27</TD><TD>18905</TD><TD>219</TD>
<TD>SLC25A46,FZD6,IL1RAPL2,CNTN1,ARX,GAP43,PAX6,PPP1R17,TGFBR2,DNER,PCDH9,PTPRZ1,ROBO2,BRINP3,AFG2A,PBX1,SLIT2,NTRK2,CNTNAP2,FGFR2,FAT4,EPHA4,UNC5C,MAP2,NRCAM,LMX1A,DSCAM</TD></TR>
<TR><TD>4.032e-05</TD><TD>-10.12</TD><TD>central nervous system neuron differentiation</TD><TD>biological process</TD><TD>GO:0021953</TD><TD>176</TD><TD>10</TD><TD>18905</TD><TD>219</TD>
<TD>MAP2,SLC25A46,SLIT2,ARX,BRINP3,NTRK2,PAX6,FGFR2,LMX1A,EPHA4</TD></TR>
<TR><TD>4.130e-05</TD><TD>-10.09</TD><TD>upper_aerodigestive_tract</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract</TD><TD>13226</TD><TD>171</TD><TD>16984</TD><TD>192</TD>
<TD>CDH5,PCDH9,SHISA3,ARX,UHMK1,ARL14,RBM20,THSD7B,LMBRD1,FZD6,NAV3,COX7B2,CRTC3,MRPL13,SLC7A8,LHCGR,EPS8,PRSS12,MPEG1,GMDS,NBEA,ZNF518B,BANK1,FANCB,SYT1,DAOA,CHRM3,KCNK9,FAT4,CTSO,FGF5,BACH2,SLC25A46,AGA,PXDNL,EDIL3,SLC7A14,SPATA16,AFM,NAT2,SLC39A10,VAV3,PLEK,DEFB115,RASGEF1B,CELF2,GAP43,ZFPM2,UTRN,ACVR2A,EFEMP1,WWOX,TRPS1,OR2AG1,CD226,B3GAT2,SERGEF,GPR83,UNC5C,PTPRZ1,FGF20,NCKAP5,NOL4,SLIT2,PARP8,AKAP9,CNTN1,NAALADL2,SPANXN1,SS18,TWIST1,NOVA1,MAP2,SERINC5,AMELX,FERD3L,FGFR2,RUNX1T1,GCNT1,PSKH2,SLC10A2,LGI1,KAZN,LMX1A,EFNA5,PRLHR,EPYC,RPH3A,RYR2,ROBO2,PHF14,SGCG,ADAMTS5,AOAH,THSD7A,ZPLD1,CD96,HNF4G,NTRK2,ADAMTS12,EPHA3,CYTL1,ATG10,NUP35,FMNL2,ZNF521,PTPRK,DAAM1,SEMA3C,NRCAM,CALN1,TSN,ADAM28,PTPRD,TGFBR2,COQ2,DNER,EPHA4,CASK,TMEFF2,XPO4,SKAP2,DSCAM,CNTNAP2,PRKCE,IRX1,CPXM2,PI15,LRFN5,SEZ6L,PCGF5,TCF20,ACP6,MEGF10,CXCL13,ZFAND5,PAQR3,KIF6,NOBOX,ACVR1C,LRRN2,SPHKAP,FUT9,IPO8,NRSN1,LRIG3,REG1B,STXBP6,IQGAP2,FGD3,PAX6,SPAG9,MUC7,FBN2,DEPTOR,RGS6,PWWP2A,FIGN,JMJD1C,LRRC70,OR52K2,PHLPP1,BCHE,ADAMTS3,IL1RAPL2,MRPL3,WRN,UBR4,RAI2,PBX1,DNAJC12</TD></TR>
<TR><TD>4.142e-05</TD><TD>-10.09</TD><TD>Leu-rich_rpt</TD><TD>interpro domains</TD><TD>IPR001611</TD><TD>255</TD><TD>12</TD><TD>18605</TD><TD>214</TD>
<TD>NTRK2,PXDNL,LRFN5,ASPN,PHLPP1,LRIG3,LRRC70,LRRC3B,LGI1,SLIT2,LRRN2,EPYC</TD></TR>
<TR><TD>4.159e-05</TD><TD>-10.09</TD><TD>axon</TD><TD>cellular component</TD><TD>GO:0030424</TD><TD>650</TD><TD>20</TD><TD>19868</TD><TD>221</TD>
<TD>PCDH9,MAP2,UNC5C,EPS8,SYT1,LGI1,CNTN1,NTRK2,GAP43,UHMK1,NRCAM,UCHL1,DSCAM,CNTNAP2,ROBO2,PRSS12,ADGRL3,EPHA4,SHTN1,NRSN1</TD></TR>
<TR><TD>4.390e-05</TD><TD>-10.03</TD><TD>O-glycosylation of TSR domain-containing proteins</TD><TD>REACTOME pathways</TD><TD>R-HSA-5173214</TD><TD>39</TD><TD>5</TD><TD>10391</TD><TD>106</TD>
<TD>THSD7A,ADAMTS5,ADAMTS3,THSD7B,ADAMTS12</TD></TR>
<TR><TD>4.505e-05</TD><TD>-10.01</TD><TD>stomach-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>stomach-adenocarcinoma</TD><TD>4102</TD><TD>71</TD><TD>16984</TD><TD>192</TD>
<TD>SS18,NOVA1,JMJD1C,CNTNAP2,PARP8,CNTN1,AKAP9,MAP2,CPXM2,IRX1,FAT4,TMEFF2,FIGN,BANK1,MPEG1,DNER,GMDS,EPHA4,CHRM3,DSCAM,SLIT2,LMX1A,KIF6,SPHKAP,EFNA5,EDIL3,FERD3L,TCF20,LRFN5,SEZ6L,ADAMTS3,ACP6,FGF5,MEGF10,BACH2,IQGAP2,ADAMTS12,HNF4G,UHMK1,UTRN,ACVR2A,EPHA3,FGD3,SPATA16,ADAMTS5,IPO8,NAT2,ROBO2,PCDH9,PLEK,ZPLD1,SLC39A10,LRIG3,CALN1,SLC7A8,DAAM1,MRPL13,NRCAM,GHITM,NRG1,ADAM28,GPR83,ATG10,NAV3,NUP35,SPAG9,LMBRD1,TRPS1,COX7B2,FBN2,PTPRK</TD></TR>
<TR><TD>4.676e-05</TD><TD>-9.97</TD><TD>skin-neck-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-neck-malignant_melanoma</TD><TD>1223</TD><TD>30</TD><TD>16984</TD><TD>192</TD>
<TD>PTPRD,SPHKAP,PRSS12,ADAM28,LHCGR,DNAJC12,UBR4,DAAM1,KIF6,FBN2,IL1RAPL2,FERD3L,TCF20,LRFN5,ADAMTS3,PAX6,EPHA3,FAT4,OR52K2,CNTNAP2,AKAP9,CNTN1,DSCAM,CHRM3,SLIT2,LRIG3,SPATA16,EPHA4,DNER,ROBO2</TD></TR>
<TR><TD>4.781e-05</TD><TD>-9.95</TD><TD>Cys-rich_flank_reg_C</TD><TD>interpro domains</TD><TD>IPR000483</TD><TD>83</TD><TD>7</TD><TD>18605</TD><TD>214</TD>
<TD>SLIT2,LRIG3,LRRN2,LRRC70,NTRK2,PXDNL,LGI1</TD></TR>
<TR><TD>5.173e-05</TD><TD>-9.87</TD><TD>large_intestine-adenoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-adenoma</TD><TD>266</TD><TD>12</TD><TD>16984</TD><TD>192</TD>
<TD>ADAMTS12,NAV3,EFR3A,CNTNAP2,COQ2,PAQR3,ZPLD1,SLIT2,PWWP2A,EPHA3,RUNX1T1,MEGF10</TD></TR>
<TR><TD>5.270e-05</TD><TD>-9.85</TD><TD>neck</TD><TD>COSMIC cancer mutations</TD><TD>neck</TD><TD>1231</TD><TD>30</TD><TD>16984</TD><TD>192</TD>
<TD>IL1RAPL2,FBN2,TCF20,FERD3L,ADAMTS3,LRFN5,PTPRD,PRSS12,SPHKAP,DNAJC12,ADAM28,LHCGR,UBR4,KIF6,DAAM1,SLIT2,CHRM3,DSCAM,LRIG3,SPATA16,EPHA4,DNER,ROBO2,PAX6,FAT4,EPHA3,OR52K2,CNTN1,AKAP9,CNTNAP2</TD></TR>
<TR><TD>5.393e-05</TD><TD>-9.83</TD><TD>actin-based cell projection</TD><TD>cellular component</TD><TD>GO:0098858</TD><TD>229</TD><TD>11</TD><TD>19868</TD><TD>221</TD>
<TD>EPS8,UNC5C,SLC7A8,MAP2,SLC10A2,IQGAP2,EPHA4,SHTN1,WWOX,GAP43,UTRN</TD></TR>
<TR><TD>5.552e-05</TD><TD>-9.80</TD><TD>EGF_3</TD><TD>prosite domains</TD><TD>PS50026</TD><TD>196</TD><TD>11</TD><TD>12232</TD><TD>161</TD>
<TD>ADAM28,CNTNAP2,TMEFF2,FBN2,SLIT2,FAT4,EDIL3,EFEMP1,DNER,MEGF10,NRG1</TD></TR>
<TR><TD>5.784e-05</TD><TD>-9.76</TD><TD>upper_leg</TD><TD>COSMIC cancer mutations</TD><TD>upper_leg</TD><TD>880</TD><TD>24</TD><TD>16984</TD><TD>192</TD>
<TD>VAV3,SLIT2,LRRC3B,CHRM3,DSCAM,PCDH9,FUT9,EPHA3,CD96,JMJD1C,OR52K2,PTPRK,MEGF10,FGFR2,GCNT1,ADAMTS3,SEZ6L,EPS8,ADAM28,PWWP2A,PTPRD,SPHKAP,SEMA3C,UBR4</TD></TR>
<TR><TD>6.151e-05</TD><TD>-9.70</TD><TD>LRR_TYP</TD><TD>smart domains</TD><TD>SM00369</TD><TD>175</TD><TD>11</TD><TD>9743</TD><TD>146</TD>
<TD>SLIT2,LRFN5,PXDNL,EPYC,LRRC70,LRRN2,LRIG3,ASPN,LGI1,PHLPP1,LRRC3B</TD></TR>
<TR><TD>6.977e-05</TD><TD>-9.57</TD><TD>prostate-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>prostate-carcinoma-adenocarcinoma</TD><TD>12423</TD><TD>163</TD><TD>16984</TD><TD>192</TD>
<TD>UTRN,PAX6,ACVR2A,ZFPM2,FGD3,RASGEF1B,CELF2,IQGAP2,STXBP6,GAP43,PLEK,SLC39A10,LRIG3,VAV3,REG1B,SPATA16,IPO8,AFM,NRSN1,FUT9,UNC5C,GHITM,PTPRZ1,B3GAT2,SERGEF,GPR83,CD226,OR2AG1,UCHL1,TRPS1,RGS6,DEPTOR,FBN2,EFEMP1,SPAG9,LINC01387,MUC7,MAP2,PHLPP1,SPANXN1,TWIST1,SS18,NOVA1,JMJD1C,PARP8,CNTN1,AKAP9,NAALADL2,LRRC3B,SLIT2,NCKAP5,NOL4,EFR3B,FIGN,FGF20,EPYC,EFNA5,DNAJC12,UBR4,LMX1A,KAZN,PSKH2,SLC10A2,LGI1,MRPL3,LINC00583,WRN,FGFR2,IL1RAPL2,RUNX1T1,AMELX,BCHE,ADAMTS3,RBM20,EPHA3,ARX,ADAMTS12,NTRK2,HNF4G,CD96,THSD7A,PCDH9,ZPLD1,AOAH,PHF14,SGCG,ADAMTS5,REXO2,CDH5,RPH3A,RYR2,ROBO2,PRSS12,PTPRD,NRG1,LHCGR,ADAM28,EPS8,SLC7A8,DAAM1,CRTC3,MRPL13,NRCAM,SEMA3C,KLF12,FMNL2,ZNF521,PTPRK,ATG10,FZD6,EFR3A,NUP35,NAV3,CYTL1,FGF14,THSD7B,LMBRD1,CPXM2,PI15,PRKCE,IRX1,FAT4,CNTNAP2,CHRM3,DSCAM,KCNK9,XPO4,DAOA,SKAP2,DCDC2C,CASK,NBEA,ZNF518B,TMEFF2,BANK1,FANCB,SYT1,SGCD,COQ2,MPEG1,DNER,GMDS,EPHA4,SPHKAP,FNIP2,SLC7A14,EDIL3,AGA,PXDNL,ACVR1C,LRRN2,PAQR3,SLC25A46,KIF6,ZFAND5,FGF5,MEGF10,BACH2,CTSO,TCF20,LRFN5,SEZ6L,PCGF5</TD></TR>
<TR><TD>7.020e-05</TD><TD>-9.56</TD><TD>cell migration</TD><TD>biological process</TD><TD>GO:0016477</TD><TD>922</TD><TD>25</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,PECAM1,ARX,ADGRL3,ZFAND5,PTPRK,EPS8,ADAMTS12,TMEFF2,DNER,MEGF10,EPHA4,SEMA3C,NTRK2,SLIT2,SHTN1,INSM1,VAV3,GCNT1,EPHA3,NRCAM,FMNL2,CXCL13,CDH5,TWIST1</TD></TR>
<TR><TD>7.317e-05</TD><TD>-9.52</TD><TD>Immunoglobulins</TD><TD>gene3d domains</TD><TD>2.60.40.10</TD><TD>726</TD><TD>22</TD><TD>14531</TD><TD>177</TD>
<TD>CD226,LRRN2,PTPRZ1,SEMA3C,IL1RAPL2,UNC5C,NTRK2,LRFN5,FGFR2,CD96,NRCAM,NRG1,CNTN1,DSCAM,PTPRD,LRIG3,EPHA4,PXDNL,EPHA3,PTPRK,PECAM1,ROBO2</TD></TR>
<TR><TD>7.326e-05</TD><TD>-9.52</TD><TD>aortic valve morphogenesis</TD><TD>biological process</TD><TD>GO:0003180</TD><TD>38</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>ADAMTS5,SLIT2,TGFBR2,TWIST1,ROBO2</TD></TR>
<TR><TD>7.821e-05</TD><TD>-9.46</TD><TD>human chr4p15.33</TD><TD>chromosome location</TD><TD>human chr4p15.33</TD><TD>39</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>LINC01182,LINC01085,LINC00504</TD></TR>
<TR><TD>7.874e-05</TD><TD>-9.45</TD><TD>cell differentiation</TD><TD>biological process</TD><TD>GO:0030154</TD><TD>3657</TD><TD>66</TD><TD>18905</TD><TD>219</TD>
<TD>MAP2,THSD7A,PTPRD,SPAG9,NRCAM,DSCAM,ACP6,EPHA3,UCHL1,AFG2A,PBX1,INSM1,LGI1,SLIT2,BCHE,SEMA3C,CNTNAP2,FGFR2,KAZN,AMELX,NOBOX,ADAMTS5,TMEFF2,ADAMTS12,ROBO2,PTPRZ1,WWOX,SGCD,ACVR1C,FUT9,FGF20,SLC25A46,IRX1,ZNF521,CNTN1,ARX,PECAM1,FERD3L,PAX6,PLAAT1,TWIST1,UNC5C,FGF5,SLC39A10,PLEK,NAV3,LMX1A,EFNA5,PHF14,SHTN1,NTRK2,SPATA16,UHMK1,FAT4,ZFPM2,EPHA4,MEGF10,HNF4G,DNER,BRINP3,SYT1,NRG1,ADGRL3,GAP43,CYTL1,TGFBR2</TD></TR>
<TR><TD>8.077e-05</TD><TD>-9.42</TD><TD>cellular developmental process</TD><TD>biological process</TD><TD>GO:0048869</TD><TD>3660</TD><TD>66</TD><TD>18905</TD><TD>219</TD>
<TD>IRX1,ARX,ZNF521,CNTN1,PECAM1,SLC25A46,PLAAT1,PAX6,FERD3L,ADAMTS5,TMEFF2,ADAMTS12,NOBOX,WWOX,SGCD,ACVR1C,FGF20,FUT9,PTPRZ1,ROBO2,LGI1,SLIT2,AFG2A,PBX1,INSM1,AMELX,SEMA3C,BCHE,CNTNAP2,FGFR2,KAZN,PTPRD,SPAG9,MAP2,THSD7A,DSCAM,ACP6,EPHA3,UCHL1,NRCAM,GAP43,ADGRL3,TGFBR2,CYTL1,DNER,MEGF10,HNF4G,NRG1,BRINP3,SYT1,EFNA5,PHF14,SHTN1,UHMK1,FAT4,EPHA4,ZFPM2,NTRK2,SPATA16,FGF5,TWIST1,UNC5C,LMX1A,SLC39A10,PLEK,NAV3</TD></TR>
<TR><TD>8.108e-05</TD><TD>-9.42</TD><TD>EGF-like_dom</TD><TD>interpro domains</TD><TD>IPR000742</TD><TD>232</TD><TD>11</TD><TD>18605</TD><TD>214</TD>
<TD>ADAM28,EFEMP1,CNTNAP2,NRG1,FBN2,TMEFF2,FAT4,EDIL3,MEGF10,SLIT2,DNER</TD></TR>
<TR><TD>8.227e-05</TD><TD>-9.41</TD><TD>olfactory bulb interneuron development</TD><TD>biological process</TD><TD>GO:0021891</TD><TD>8</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>ARX,SLIT2,ROBO2</TD></TR>
<TR><TD>8.495e-05</TD><TD>-9.37</TD><TD>TSP1_rpt_sf</TD><TD>interpro domains</TD><TD>IPR036383</TD><TD>63</TD><TD>6</TD><TD>18605</TD><TD>214</TD>
<TD>UNC5C,ADAMTS3,THSD7A,ADAMTS5,ADAMTS12,THSD7B</TD></TR>
<TR><TD>8.693e-05</TD><TD>-9.35</TD><TD>LRR_dom_sf</TD><TD>interpro domains</TD><TD>IPR032675</TD><TD>319</TD><TD>13</TD><TD>18605</TD><TD>214</TD>
<TD>LRIG3,LRRC70,LRRC3B,PXDNL,NTRK2,LRFN5,ASPN,PHLPP1,SLIT2,LHCGR,LRRN2,EPYC,LGI1</TD></TR>
<TR><TD>8.983e-05</TD><TD>-9.32</TD><TD>retinal ganglion cell axon guidance</TD><TD>biological process</TD><TD>GO:0031290</TD><TD>21</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,EFNA5,ROBO2,NRCAM</TD></TR>
<TR><TD>9.285e-05</TD><TD>-9.28</TD><TD>TSP1_rpt</TD><TD>interpro domains</TD><TD>IPR000884</TD><TD>64</TD><TD>6</TD><TD>18605</TD><TD>214</TD>
<TD>ADAMTS3,THSD7B,UNC5C,THSD7A,ADAMTS12,ADAMTS5</TD></TR>
<TR><TD>9.896e-05</TD><TD>-9.22</TD><TD>growth cone</TD><TD>cellular component</TD><TD>GO:0030426</TD><TD>165</TD><TD>9</TD><TD>19868</TD><TD>221</TD>
<TD>DSCAM,PCDH9,MAP2,UNC5C,EPS8,SHTN1,EPHA4,NRSN1,GAP43</TD></TR>
<TR><TD>1.077e-04</TD><TD>-9.14</TD><TD>skin-scalp-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-scalp-malignant_melanoma</TD><TD>634</TD><TD>19</TD><TD>16984</TD><TD>192</TD>
<TD>LMX1A,ACVR1C,GAP43,UBR4,PTPRZ1,UTRN,PTPRD,SLC7A14,ZNF133,ADAM28,IPO8,AMELX,SEZ6L,ADAMTS3,EPHA4,SLIT2,CHRM3,VAV3,AOAH</TD></TR>
<TR><TD>1.083e-04</TD><TD>-9.13</TD><TD>activin receptor activity</TD><TD>molecular function</TD><TD>GO:0017002</TD><TD>9</TD><TD>3</TD><TD>18530</TD><TD>206</TD>
<TD>TGFBR2,ACVR1C,ACVR2A</TD></TR>
<TR><TD>1.083e-04</TD><TD>-9.13</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.40.1620.60</TD><TD>21</TD><TD>4</TD><TD>14531</TD><TD>177</TD>
<TD>ADAMTS3,ADAMTS5,ADAM28,ADAMTS12</TD></TR>
<TR><TD>1.101e-04</TD><TD>-9.11</TD><TD>lung-carcinoma-undifferentiated_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-undifferentiated_carcinoma</TD><TD>1409</TD><TD>32</TD><TD>16984</TD><TD>192</TD>
<TD>FZD6,SPAG9,FGF14,WRN,FGF5,FGFR2,RUNX1T1,ACVR1C,UCHL1,PTPRD,TGFBR2,NRG1,PBX1,LHCGR,DNAJC12,FANCB,TMEFF2,CDH5,FGF20,EPHA4,DNER,VAV3,SS18,TWIST1,PARP8,NTRK2,CNTN1,AKAP9,ACVR2A,PAX6,PRKCE,EPHA3</TD></TR>
<TR><TD>1.146e-04</TD><TD>-9.07</TD><TD>MARCHF1 (membrane associated ring-CH-type finger 1)</TD><TD>protein interactions</TD><TD>55016</TD><TD>69</TD><TD>6</TD><TD>20077</TD><TD>222</TD>
<TD>TGFBR2,ADGRL3,FGFR2,EPHA3,ACVR2A,SLC25A46</TD></TR>
<TR><TD>1.147e-04</TD><TD>-9.07</TD><TD>Thrombospondin type-1 (TSP1) repeat</TD><TD>gene3d domains</TD><TD>2.20.100.10</TD><TD>63</TD><TD>6</TD><TD>14531</TD><TD>177</TD>
<TD>THSD7A,ADAMTS3,UNC5C,ADAMTS12,ADAMTS5,THSD7B</TD></TR>
<TR><TD>1.171e-04</TD><TD>-9.05</TD><TD>EGF_2</TD><TD>prosite domains</TD><TD>PS01186</TD><TD>213</TD><TD>11</TD><TD>12232</TD><TD>161</TD>
<TD>FBN2,EPHA3,SLIT2,TMEFF2,ADAM28,NRG1,MEGF10,DNER,EFEMP1,EDIL3,FAT4</TD></TR>
<TR><TD>1.174e-04</TD><TD>-9.05</TD><TD>cardiac chamber morphogenesis</TD><TD>biological process</TD><TD>GO:0003206</TD><TD>127</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,RYR2,ZFPM2,NRG1,TGFBR2,FGFR2,ROBO2,SEMA3C</TD></TR>
<TR><TD>1.174e-04</TD><TD>-9.05</TD><TD>cardiac ventricle development</TD><TD>biological process</TD><TD>GO:0003231</TD><TD>127</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,SEMA3C,ROBO2,NRG1,ZFPM2,RYR2,TGFBR2,SLIT2</TD></TR>
<TR><TD>1.223e-04</TD><TD>-9.01</TD><TD>netrin-activated signaling pathway</TD><TD>biological process</TD><TD>GO:0038007</TD><TD>9</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>UNC5C,SHTN1,DSCAM</TD></TR>
<TR><TD>1.243e-04</TD><TD>-8.99</TD><TD>site of polarized growth</TD><TD>cellular component</TD><TD>GO:0030427</TD><TD>170</TD><TD>9</TD><TD>19868</TD><TD>221</TD>
<TD>DSCAM,PCDH9,MAP2,UNC5C,EPS8,EPHA4,SHTN1,NRSN1,GAP43</TD></TR>
<TR><TD>1.243e-04</TD><TD>-8.99</TD><TD>skin-trunk-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-trunk-malignant_melanoma</TD><TD>2649</TD><TD>50</TD><TD>16984</TD><TD>192</TD>
<TD>OR52K2,JMJD1C,NAALADL2,AKAP9,PI15,ZNF133,FAT4,NBEA,BANK1,CHRM3,DSCAM,SLIT2,NCKAP5,SKAP2,DAOA,AGA,UBR4,SPHKAP,EDIL3,LRFN5,ADAMTS3,WRN,CXCL13,ADAMTS12,HNF4G,CD96,UTRN,RBM20,PAX6,ZFPM2,RYR2,RPH3A,ROBO2,PCDH9,THSD7A,TSN,UCHL1,NRCAM,PTPRD,PRSS12,PTPRZ1,ADAM28,EPS8,THSD7B,SPAG9,MUC7,TRPS1,RGS6,FBN2,FMNL2</TD></TR>
<TR><TD>1.250e-04</TD><TD>-8.99</TD><TD>FN3_sf</TD><TD>interpro domains</TD><TD>IPR036116</TD><TD>203</TD><TD>10</TD><TD>18605</TD><TD>214</TD>
<TD>NRCAM,PTPRZ1,PTPRD,PTPRK,ROBO2,LRFN5,DSCAM,EPHA4,CNTN1,EPHA3</TD></TR>
<TR><TD>1.255e-04</TD><TD>-8.98</TD><TD>undifferentiated_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>undifferentiated_carcinoma</TD><TD>1419</TD><TD>32</TD><TD>16984</TD><TD>192</TD>
<TD>FZD6,FGF14,SPAG9,WRN,RUNX1T1,FGF5,FGFR2,ACVR1C,UCHL1,TGFBR2,NRG1,PTPRD,DNAJC12,PBX1,LHCGR,FANCB,TMEFF2,EPHA4,DNER,FGF20,CDH5,VAV3,SS18,TWIST1,CNTN1,AKAP9,NTRK2,PARP8,ACVR2A,PAX6,PRKCE,EPHA3</TD></TR>
<TR><TD>1.285e-04</TD><TD>-8.96</TD><TD>human chr14q31.1</TD><TD>chromosome location</TD><TD>human chr14q31.1</TD><TD>46</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>DIO2-AS1,LINC02311,LINC02301</TD></TR>
<TR><TD>1.285e-04</TD><TD>-8.96</TD><TD>human chr4p13</TD><TD>chromosome location</TD><TD>human chr4p13</TD><TD>46</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>UCHL1,LINC00682,SHISA3</TD></TR>
<TR><TD>1.299e-04</TD><TD>-8.95</TD><TD>MMP26 (matrix metallopeptidase 26)</TD><TD>protein interactions</TD><TD>56547</TD><TD>24</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>EFR3A,EPHA4,ADGRL3,PTPRK</TD></TR>
<TR><TD>1.307e-04</TD><TD>-8.94</TD><TD>kidney-other-neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>kidney-other-neoplasm</TD><TD>10692</TD><TD>145</TD><TD>16984</TD><TD>192</TD>
<TD>KCNK9,DSCAM,CHRM3,XPO4,DAOA,SKAP2,DCDC2C,BANK1,TMEFF2,SGCD,FANCB,SYT1,CASK,DNER,GMDS,EPHA4,COQ2,PI15,CPXM2,FAT4,ZNF133,PRKCE,CNTNAP2,ZFAND5,MEGF10,BACH2,FGF5,ACP6,TCF20,CTSO,SEZ6L,PCGF5,LRFN5,SPHKAP,SLC7A14,EDIL3,ACVR1C,AGA,SLC25A46,KIF6,PAQR3,THSD7A,PCDH9,ZPLD1,AOAH,REXO2,PHF14,SGCG,ADAMTS5,ROBO2,CDH5,RPH3A,RYR2,RBM20,EPHA3,ARX,ADAMTS12,CD96,NTRK2,KLF12,ZNF521,PTPRK,FMNL2,EFR3A,NAV3,NUP35,ATG10,FZD6,LMBRD1,FGF14,THSD7B,NRG1,TGFBR2,PRSS12,EPS8,LHCGR,ADAM28,TSN,SLC7A8,NRCAM,SEMA3C,CRTC3,DAAM1,MRPL13,SLIT2,NOL4,EFR3B,NCKAP5,FIGN,FGF20,MAP2,PHLPP1,SS18,NOVA1,SPANXN1,AKAP9,CNTN1,NAALADL2,JMJD1C,PARP8,CETN3,WRN,MRPL3,IL1RAPL2,BCHE,ADAMTS3,EPYC,DNAJC12,EFNA5,LMX1A,KAZN,UBR4,SLC10A2,LGI1,PSKH2,PLEK,SLC39A10,LRIG3,VAV3,NRSN1,SPATA16,IPO8,AFM,PAX6,ACVR2A,UTRN,ZFPM2,GAP43,RASGEF1B,STXBP6,IQGAP2,TRPS1,FBN2,DEPTOR,LINC01387,MUC7,EFEMP1,GHITM,PTPRZ1,UNC5C,GPR83,SERGEF,B3GAT2,CD226,UCHL1</TD></TR>
<TR><TD>1.317e-04</TD><TD>-8.94</TD><TD>EFR3-like_ARM</TD><TD>interpro domains</TD><TD>IPR049152</TD><TD>2</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>EFR3B,EFR3A</TD></TR>
<TR><TD>1.323e-04</TD><TD>-8.93</TD><TD>EFR3_ARM</TD><TD>pfam domains</TD><TD>PF21052</TD><TD>2</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>EFR3B,EFR3A</TD></TR>
<TR><TD>1.336e-04</TD><TD>-8.92</TD><TD>fasciculation of motor neuron axon</TD><TD>biological process</TD><TD>GO:0097156</TD><TD>2</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.341e-04</TD><TD>-8.92</TD><TD>ventricular septum morphogenesis</TD><TD>biological process</TD><TD>GO:0060412</TD><TD>43</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,TGFBR2,ZFPM2,ROBO2,FGFR2</TD></TR>
<TR><TD>1.341e-04</TD><TD>-8.92</TD><TD>aortic valve development</TD><TD>biological process</TD><TD>GO:0003176</TD><TD>43</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1,ROBO2,TGFBR2,ADAMTS5,SLIT2</TD></TR>
<TR><TD>1.380e-04</TD><TD>-8.89</TD><TD>HER-positive_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>HER-positive_carcinoma</TD><TD>2026</TD><TD>41</TD><TD>16984</TD><TD>192</TD>
<TD>VAV3,XPO4,AFM,FANCB,TMEFF2,CDH5,FGF20,EPHA4,DNER,UTRN,ACVR2A,PAX6,PRKCE,EPHA3,TWIST1,SS18,PARP8,NTRK2,CNTN1,AKAP9,WRN,FGF5,FGFR2,RUNX1T1,MEGF10,FZD6,SPAG9,FGF14,LRFN5,SEZ6L,PTPRD,UNC5C,TGFBR2,GHITM,NRG1,PBX1,LHCGR,DNAJC12,ACVR1C,UCHL1,NRCAM</TD></TR>
<TR><TD>1.380e-04</TD><TD>-8.89</TD><TD>breast-carcinoma-HER-positive_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>breast-carcinoma-HER-positive_carcinoma</TD><TD>2026</TD><TD>41</TD><TD>16984</TD><TD>192</TD>
<TD>NTRK2,PARP8,AKAP9,CNTN1,TWIST1,SS18,PRKCE,EPHA3,UTRN,ACVR2A,PAX6,FGF20,CDH5,EPHA4,DNER,AFM,FANCB,TMEFF2,VAV3,XPO4,UCHL1,NRCAM,ACVR1C,PBX1,LHCGR,DNAJC12,PTPRD,UNC5C,TGFBR2,NRG1,GHITM,SPAG9,FGF14,LRFN5,SEZ6L,FZD6,FGF5,FGFR2,RUNX1T1,MEGF10,WRN</TD></TR>
<TR><TD>1.462e-04</TD><TD>-8.83</TD><TD>signaling receptor binding</TD><TD>molecular function</TD><TD>GO:0005102</TD><TD>1516</TD><TD>33</TD><TD>18530</TD><TD>206</TD>
<TD>FGF5,EDIL3,FGF14,UCHL1,FBN2,ADAMTS5,SLIT2,SEMA3C,BANK1,CXCL13,NRG1,EFNA5,CDH5,TGFBR2,CASK,DNER,UTRN,SYT1,AMELX,DSCAM,VAV3,PTPRD,PTPRZ1,EPHA4,CD226,EFEMP1,CYTL1,MEGF10,FGF20,LGI1,IGFL4,AKAP9,LMBRD1</TD></TR>
<TR><TD>1.466e-04</TD><TD>-8.83</TD><TD>Ribonuclease Inhibitor</TD><TD>gene3d domains</TD><TD>3.80.10.10</TD><TD>319</TD><TD>13</TD><TD>14531</TD><TD>177</TD>
<TD>EPYC,LRRN2,NTRK2,LRFN5,LHCGR,LRRC3B,PHLPP1,LRIG3,LGI1,PXDNL,LRRC70,SLIT2,ASPN</TD></TR>
<TR><TD>1.500e-04</TD><TD>-8.80</TD><TD>skin-head_neck-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-head_neck-carcinoma-squamous_cell_carcinoma</TD><TD>14205</TD><TD>178</TD><TD>16984</TD><TD>192</TD>
<TD>PHLPP1,OR52K2,LRRC70,JMJD1C,LRRC3B,EFR3B,FIGN,RAI2,DNAJC12,UBR4,MRPL3,WRN,CETN3,IL1RAPL2,ADAMTS3,BCHE,PAX6,FGD3,IQGAP2,STXBP6,REG1B,LRIG3,IPO8,NRSN1,FUT9,PWWP2A,UCHL1,RGS6,FBN2,DEPTOR,SPAG9,MUC7,CPXM2,PI15,ZNF133,IRX1,CNTNAP2,DSCAM,SKAP2,XPO4,CASK,SGCD,TMEFF2,COQ2,EPHA4,DNER,SPHKAP,NOBOX,ERCC6L2,LRRN2,ACVR1C,PAQR3,KIF6,CXCL13,MEGF10,TCF20,LRFN5,PCGF5,SEZ6L,EPHA3,ADAMTS12,NTRK2,HNF4G,CD96,ZPLD1,THSD7A,AOAH,ADAMTS5,SGCG,PHF14,RYR2,RPH3A,ROBO2,PTPRD,TGFBR2,ADAM28,CALN1,TSN,DAAM1,SEMA3C,NRCAM,KLF12,FMNL2,PTPRK,ZNF521,ATG10,NUP35,EFR3A,CYTL1,MAP2,SERINC5,SPANXN1,NOVA1,TWIST1,SS18,PARP8,NAALADL2,AKAP9,CNTN1,SLIT2,NCKAP5,NOL4,FGF20,EPYC,PRLHR,EFNA5,LMX1A,KAZN,PSKH2,LGI1,SLC10A2,GCNT1,FGFR2,RUNX1T1,FERD3L,AMELX,UTRN,ACVR2A,ZFPM2,CELF2,RASGEF1B,GAP43,DEFB115,PLEK,VAV3,SLC39A10,AFM,SPATA16,NAT2,UNC5C,PTPRZ1,SERGEF,B3GAT2,GPR83,CD226,OR2AG1,TRPS1,WWOX,EFEMP1,FAT4,CHRM3,KCNK9,DAOA,NBEA,FANCB,SYT1,BANK1,ZNF518B,GMDS,MPEG1,FNIP2,EDIL3,SLC7A14,PXDNL,SLC25A46,FGF5,BACH2,CTSO,IGFL4,ARL14,UHMK1,RBM20,ARX,PCDH9,SHISA3,CDH5,PRSS12,NRG1,LHCGR,EPS8,SLC7A8,CRTC3,COX7B2,FZD6,NAV3,THSD7B,FGF14,LMBRD1</TD></TR>
<TR><TD>1.552e-04</TD><TD>-8.77</TD><TD>human chr4q13.1</TD><TD>chromosome location</TD><TD>human chr4q13.1</TD><TD>49</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>LINC02494,MIR548AG1,ADGRL3</TD></TR>
<TR><TD>1.560e-04</TD><TD>-8.77</TD><TD>mesenchyme development</TD><TD>biological process</TD><TD>GO:0060485</TD><TD>248</TD><TD>11</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,FGFR2,SEMA3C,ZFPM2,AMELX,TGFBR2,SLC39A10,ROBO2,NRG1,TWIST1,ADAMTS5</TD></TR>
<TR><TD>1.574e-04</TD><TD>-8.76</TD><TD>ovary</TD><TD>COSMIC cancer mutations</TD><TD>ovary</TD><TD>14830</TD><TD>183</TD><TD>16984</TD><TD>192</TD>
<TD>BCHE,ADAMTS3,CETN3,WRN,MRPL3,IL1RAPL2,UBR4,DNAJC12,RAI2,PBX1,FIGN,LRRC3B,EFR3B,ASPN,OR52K2,JMJD1C,LRRC70,PHLPP1,LINC01387,MUC7,SPAG9,RGS6,DEPTOR,FBN2,UCHL1,PWWP2A,NRSN1,IPO8,FUT9,REG1B,LRIG3,IQGAP2,STXBP6,PAX6,FGD3,TCF20,SEZ6L,PCGF5,LRFN5,ZFAND5,MEGF10,CXCL13,ACP6,ACVR1C,LRRN2,NOBOX,KIF6,PAQR3,SPHKAP,TMEFF2,SGCD,CASK,DNER,EPHA4,COQ2,DSCAM,XPO4,SKAP2,DCDC2C,CNTNAP2,PI15,CPXM2,IRX1,ZNF133,PRKCE,EFR3A,NUP35,ATG10,CYTL1,KLF12,ZNF521,PTPRK,FMNL2,CALN1,SEMA3C,NRCAM,DAAM1,TGFBR2,PTPRD,ADAM28,REXO2,PHF14,SGCG,ADAMTS5,ROBO2,RPH3A,RYR2,THSD7A,ZPLD1,AOAH,ADAMTS12,NTRK2,HNF4G,CD96,EPHA3,FERD3L,LINC00583,RUNX1T1,FGFR2,KAZN,LMX1A,SLC10A2,LGI1,PSKH2,EPYC,EFNA5,PRLHR,FGF20,SLIT2,NOL4,NCKAP5,TWIST1,SS18,NOVA1,SPANXN1,CNTN1,AKAP9,NAALADL2,PARP8,SERINC5,MAP2,EFEMP1,TRPS1,CD226,OR2AG1,GHITM,PTPRZ1,UNC5C,GPR83,B3GAT2,SERGEF,NAT2,SPATA16,AFM,PLEK,SLC39A10,VAV3,GAP43,RASGEF1B,DEFB115,ACVR2A,UTRN,ZFPM2,CTSO,BACH2,FGF5,PXDNL,AGA,SLC25A46,FABP7,FNIP2,EDIL3,SLC7A14,BANK1,ZNF518B,SYT1,FANCB,NBEA,MPEG1,GMDS,KCNK9,CHRM3,DAOA,FAT4,NAV3,FZD6,LMBRD1,THSD7B,FGF14,SLC7A8,CRTC3,MRPL13,NRG1,PRSS12,EPS8,LHCGR,INSM1,CDH5,SHISA3,PCDH9,RBM20,UHMK1,ARX</TD></TR>
<TR><TD>1.670e-04</TD><TD>-8.70</TD><TD>upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma</TD><TD>9307</TD><TD>130</TD><TD>16984</TD><TD>192</TD>
<TD>LRFN5,SEZ6L,PCGF5,CTSO,TCF20,ACP6,FGF5,MEGF10,CXCL13,BACH2,KIF6,AGA,PXDNL,ACVR1C,LRRN2,SLC7A14,EDIL3,SPHKAP,COQ2,DNER,GMDS,EPHA4,NBEA,CASK,BANK1,FANCB,SYT1,DAOA,XPO4,SKAP2,DSCAM,CHRM3,KCNK9,CNTNAP2,PRKCE,IRX1,FAT4,CPXM2,THSD7B,LMBRD1,FZD6,NUP35,NAV3,FMNL2,COX7B2,ZNF521,PTPRK,DAAM1,MRPL13,SEMA3C,SLC7A8,TSN,LHCGR,ADAM28,EPS8,PTPRD,TGFBR2,CDH5,RYR2,ROBO2,PHF14,ADAMTS5,AOAH,THSD7A,PCDH9,ZPLD1,NTRK2,ADAMTS12,EPHA3,ARX,UHMK1,RBM20,AMELX,ADAMTS3,FERD3L,FGFR2,IL1RAPL2,RUNX1T1,MRPL3,WRN,PSKH2,UBR4,KAZN,LMX1A,PBX1,RAI2,DNAJC12,EFNA5,FGF20,FIGN,NOL4,SLIT2,JMJD1C,PARP8,LRRC70,CNTN1,AKAP9,NAALADL2,SPANXN1,SS18,TWIST1,NOVA1,PHLPP1,MAP2,EFEMP1,SPAG9,MUC7,FBN2,DEPTOR,TRPS1,RGS6,CD226,SERGEF,GPR83,UNC5C,PTPRZ1,AFM,IPO8,SLC39A10,VAV3,LRIG3,DEFB115,RASGEF1B,IQGAP2,GAP43,ZFPM2,FGD3,UTRN,PAX6,ACVR2A</TD></TR>
<TR><TD>1.730e-04</TD><TD>-8.66</TD><TD>large_intestine-colon-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-colon-carcinoma</TD><TD>2612</TD><TD>49</TD><TD>16984</TD><TD>192</TD>
<TD>UBR4,SEZ6L,IGFL4,LRFN5,TCF20,RUNX1T1,MEGF10,FGF5,FGFR2,WRN,AKAP9,CNTNAP2,PARP8,JMJD1C,FAT4,IRX1,PI15,MAP2,FIGN,SKAP2,ASPN,DSCAM,LRRC3B,SEMA3C,CRTC3,CALN1,B3GAT2,PTPRZ1,TGFBR2,GHITM,PTPRD,PRSS12,SPAG9,NAV3,NUP35,FBN2,DEPTOR,KLF12,TRPS1,GAP43,RASGEF1B,ACVR2A,PAX6,UTRN,ROBO2,CDH5,VAV3,SLC39A10,PCDH9</TD></TR>
<TR><TD>1.837e-04</TD><TD>-8.60</TD><TD>astrocytoma_Grade_I</TD><TD>COSMIC cancer mutations</TD><TD>astrocytoma_Grade_I</TD><TD>139</TD><TD>8</TD><TD>16984</TD><TD>192</TD>
<TD>SPATA16,FGF14,CNTNAP2,NAALADL2,NRG1,ZFPM2,FGFR2,NOL4</TD></TR>
<TR><TD>1.838e-04</TD><TD>-8.60</TD><TD>filopodium</TD><TD>cellular component</TD><TD>GO:0030175</TD><TD>106</TD><TD>7</TD><TD>19868</TD><TD>221</TD>
<TD>IQGAP2,SHTN1,EPHA4,GAP43,UTRN,UNC5C,MAP2</TD></TR>
<TR><TD>1.856e-04</TD><TD>-8.59</TD><TD>negative chemotaxis</TD><TD>biological process</TD><TD>GO:0050919</TD><TD>46</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>UNC5C,EFNA5,SEMA3C,SLIT2,NRG1</TD></TR>
<TR><TD>1.865e-04</TD><TD>-8.59</TD><TD>cardiac ventricle morphogenesis</TD><TD>biological process</TD><TD>GO:0003208</TD><TD>72</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,NRG1,ZFPM2,RYR2,SEMA3C,FGFR2</TD></TR>
<TR><TD>1.865e-04</TD><TD>-8.59</TD><TD>cardiac septum morphogenesis</TD><TD>biological process</TD><TD>GO:0060411</TD><TD>72</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,SLIT2,ZFPM2,SEMA3C,ROBO2,FGFR2</TD></TR>
<TR><TD>1.891e-04</TD><TD>-8.57</TD><TD>TSP1</TD><TD>prosite domains</TD><TD>PS50092</TD><TD>64</TD><TD>6</TD><TD>12232</TD><TD>161</TD>
<TD>ADAMTS5,ADAMTS12,UNC5C,THSD7B,THSD7A,ADAMTS3</TD></TR>
<TR><TD>2.057e-04</TD><TD>-8.49</TD><TD>semi-lunar valve development</TD><TD>biological process</TD><TD>GO:1905314</TD><TD>47</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1,ROBO2,TGFBR2,SLIT2,ADAMTS5</TD></TR>
<TR><TD>2.079e-04</TD><TD>-8.48</TD><TD>haematopoietic_neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_neoplasm</TD><TD>11157</TD><TD>149</TD><TD>16984</TD><TD>192</TD>
<TD>AOAH,PCDH9,THSD7A,SHISA3,RYR2,CDH5,RPH3A,ROBO2,ADAMTS5,SGCG,PHF14,EPHA3,UHMK1,RBM20,CD96,NTRK2,HNF4G,ADAMTS12,FMNL2,PTPRK,ZNF521,KLF12,FGF14,THSD7B,LMBRD1,FZD6,ATG10,NUP35,NAV3,EFR3A,ADAM28,LHCGR,EPS8,PTPRD,PRSS12,TGFBR2,NRG1,CRTC3,SEMA3C,SLC7A8,CALN1,DCDC2C,SKAP2,DAOA,XPO4,DSCAM,KCNK9,COQ2,EPHA4,GMDS,DNER,MPEG1,CASK,NBEA,SYT1,FANCB,SGCD,TMEFF2,BANK1,ZNF518B,PRKCE,ZNF133,FAT4,CPXM2,PI15,CNTNAP2,ACP6,BACH2,MEGF10,ZFAND5,LRFN5,SEZ6L,CTSO,TCF20,EDIL3,SLC7A14,SPHKAP,PAQR3,KIF6,FABP7,NOBOX,ERCC6L2,LRRN2,PXDNL,ACVR1C,REG1B,VAV3,LRIG3,SLC39A10,PLEK,FUT9,AFM,SPATA16,ZFPM2,FGD3,UTRN,ACVR2A,PAX6,IQGAP2,STXBP6,RASGEF1B,CELF2,FBN2,DEPTOR,EFEMP1,MUC7,WWOX,B3GAT2,SERGEF,GPR83,UNC5C,PTPRZ1,GHITM,OR2AG1,UCHL1,CD226,NCKAP5,ASPN,EFR3B,NOL4,SLIT2,FIGN,PHLPP1,MAP2,PARP8,JMJD1C,NAALADL2,AKAP9,CNTN1,SPANXN1,NOVA1,FGFR2,RUNX1T1,IL1RAPL2,MRPL3,WRN,CETN3,ADAMTS3,BCHE,AMELX,RAI2,DNAJC12,EFNA5,EPYC,PSKH2,SLC10A2,UBR4,LMX1A,KAZN</TD></TR>
<TR><TD>2.086e-04</TD><TD>-8.48</TD><TD>regulation of axonogenesis</TD><TD>biological process</TD><TD>GO:0050770</TD><TD>138</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4,DSCAM,ROBO2,NTRK2,SLIT2,SHTN1,EFNA5,MAP2</TD></TR>
<TR><TD>2.143e-04</TD><TD>-8.45</TD><TD>regulation of neuron projection development</TD><TD>biological process</TD><TD>GO:0010975</TD><TD>443</TD><TD>15</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,CNTN1,EFNA5,SHTN1,EPHA4,NTRK2,PAX6,PTPRD,MAP2,PAQR3,DSCAM,EPHA3,FUT9,ROBO2,NRCAM</TD></TR>
<TR><TD>2.220e-04</TD><TD>-8.41</TD><TD>EphrinA-EPHA pathway</TD><TD>Pathway Interaction DB</TD><TD>ephrina_ephapathway</TD><TD>8</TD><TD>3</TD><TD>2232</TD><TD>37</TD>
<TD>EFNA5,EPHA3,EPHA4</TD></TR>
<TR><TD>2.261e-04</TD><TD>-8.39</TD><TD>cell-cell adhesion</TD><TD>biological process</TD><TD>GO:0098609</TD><TD>547</TD><TD>17</TD><TD>18905</TD><TD>219</TD>
<TD>PECAM1,CNTN1,ADGRL3,EFNA5,STXBP6,GCNT1,FAT4,TGFBR2,PCDH9,PTPRD,CDH5,MEGF10,DSCAM,LRFN5,NRCAM,ROBO2,PLEK</TD></TR>
<TR><TD>2.357e-04</TD><TD>-8.35</TD><TD>LRRCT</TD><TD>smart domains</TD><TD>SM00082</TD><TD>83</TD><TD>7</TD><TD>9743</TD><TD>146</TD>
<TD>LRRN2,LRIG3,PXDNL,LGI1,NTRK2,LRRC70,SLIT2</TD></TR>
<TR><TD>2.373e-04</TD><TD>-8.35</TD><TD>Diseases of glycosylation</TD><TD>REACTOME pathways</TD><TD>R-HSA-3781865</TD><TD>86</TD><TD>6</TD><TD>10391</TD><TD>106</TD>
<TD>THSD7A,ADAMTS5,MUC7,THSD7B,ADAMTS12,ADAMTS3</TD></TR>
<TR><TD>2.429e-04</TD><TD>-8.32</TD><TD>cell-cell adhesion via plasma-membrane adhesion molecules</TD><TD>biological process</TD><TD>GO:0098742</TD><TD>261</TD><TD>11</TD><TD>18905</TD><TD>219</TD>
<TD>PECAM1,ADGRL3,EFNA5,FAT4,TGFBR2,PCDH9,PTPRD,CDH5,DSCAM,LRFN5,ROBO2</TD></TR>
<TR><TD>2.516e-04</TD><TD>-8.29</TD><TD>skin-upper_leg-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-upper_leg-malignant_melanoma</TD><TD>850</TD><TD>22</TD><TD>16984</TD><TD>192</TD>
<TD>SEMA3C,JMJD1C,CD96,OR52K2,UBR4,EPS8,EPHA3,ADAM28,SPHKAP,PTPRD,SEZ6L,ADAMTS3,FUT9,MEGF10,PTPRK,VAV3,SLIT2,GCNT1,CHRM3,LRRC3B,PCDH9,DSCAM</TD></TR>
<TR><TD>2.536e-04</TD><TD>-8.28</TD><TD>distal axon</TD><TD>cellular component</TD><TD>GO:0150034</TD><TD>273</TD><TD>11</TD><TD>19868</TD><TD>221</TD>
<TD>SHTN1,EPHA4,NRSN1,GAP43,NTRK2,PRSS12,DSCAM,MAP2,UNC5C,EPS8,PCDH9</TD></TR>
<TR><TD>2.593e-04</TD><TD>-8.26</TD><TD>heart morphogenesis</TD><TD>biological process</TD><TD>GO:0003007</TD><TD>263</TD><TD>11</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2,NRG1,ZFPM2,TGFBR2,FGFR2,SEMA3C,ROBO2,SLIT2,ADAMTS5,TWIST1,RBM20</TD></TR>
<TR><TD>2.647e-04</TD><TD>-8.24</TD><TD>LRR</TD><TD>prosite domains</TD><TD>PS51450</TD><TD>196</TD><TD>10</TD><TD>12232</TD><TD>161</TD>
<TD>EPYC,ASPN,PXDNL,SLIT2,PHLPP1,LRRC3B,LRIG3,LRRC70,LRFN5,LRRN2</TD></TR>
<TR><TD>2.697e-04</TD><TD>-8.22</TD><TD>positive regulation of axonogenesis</TD><TD>biological process</TD><TD>GO:0050772</TD><TD>77</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>EFNA5,NTRK2,ROBO2,SHTN1,SLIT2,DSCAM</TD></TR>
<TR><TD>2.740e-04</TD><TD>-8.20</TD><TD>FGFR2c ligand binding and activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-190375</TD><TD>13</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGFR2,FGF20</TD></TR>
<TR><TD>2.743e-04</TD><TD>-8.20</TD><TD>tissue development</TD><TD>biological process</TD><TD>GO:0009888</TD><TD>1762</TD><TD>37</TD><TD>18905</TD><TD>219</TD>
<TD>AMELX,EPHA4,ZFPM2,SEMA3C,KAZN,FGFR2,EPYC,ASPN,SLIT2,GCNT1,INSM1,PBX1,RYR2,SLC39A10,UNC5C,TWIST1,TGFBR2,PLAAT1,FERD3L,CYTL1,PAX6,ACVR2A,IRX1,FZD6,PECAM1,ARX,FGF20,NRG1,ZFAND5,SGCD,ROBO2,SGCG,DNER,ADAMTS5,ADAMTS12,TMEFF2,MEGF10</TD></TR>
<TR><TD>3.058e-04</TD><TD>-8.09</TD><TD>TGFB_receptor</TD><TD>interpro domains</TD><TD>IPR000333</TD><TD>12</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>ACVR1C,ACVR2A,TGFBR2</TD></TR>
<TR><TD>3.239e-04</TD><TD>-8.04</TD><TD>kidney-carcinoma-clear_cell_renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>kidney-carcinoma-clear_cell_renal_cell_carcinoma</TD><TD>13957</TD><TD>175</TD><TD>16984</TD><TD>192</TD>
<TD>TRPS1,EFEMP1,SERGEF,B3GAT2,GPR83,UNC5C,PTPRZ1,OR2AG1,CD226,VAV3,SLC39A10,PLEK,AFM,SPATA16,NAT2,ZFPM2,UTRN,ACVR2A,DEFB115,RASGEF1B,CELF2,GAP43,FGFR2,RUNX1T1,GCNT1,AMELX,PRLHR,EFNA5,EPYC,PSKH2,LGI1,SLC10A2,KAZN,LMX1A,NCKAP5,NOL4,SLIT2,FGF20,MAP2,SERINC5,PARP8,NAALADL2,AKAP9,CNTN1,SPANXN1,NOVA1,TWIST1,SS18,COX7B2,FGF14,THSD7B,LMBRD1,FZD6,NAV3,LHCGR,EPS8,PRSS12,NRG1,MRPL13,CRTC3,SLC7A8,PCDH9,CDH5,ARX,UHMK1,RBM20,FGF5,BACH2,IGFL4,SLC7A14,EDIL3,FNIP2,SLC25A46,AGA,PXDNL,CHRM3,KCNK9,GMDS,MPEG1,NBEA,SYT1,FANCB,BANK1,ZNF518B,FAT4,FBN2,DEPTOR,RGS6,SPAG9,MUC7,PWWP2A,REG1B,LRIG3,FUT9,IPO8,FGD3,PAX6,STXBP6,IQGAP2,IL1RAPL2,MRPL3,WRN,CETN3,ADAMTS3,BCHE,PBX1,RAI2,DNAJC12,UBR4,ASPN,EFR3B,LRRC3B,FIGN,PHLPP1,LRRC70,JMJD1C,OR52K2,FMNL2,PTPRK,ZNF521,KLF12,ATG10,NUP35,EFR3A,ADAM28,PTPRD,TGFBR2,DAAM1,NRCAM,SEMA3C,CALN1,TSN,AOAH,ZPLD1,THSD7A,RYR2,RPH3A,ROBO2,ADAMTS5,PHF14,SGCG,REXO2,EPHA3,HNF4G,NTRK2,CD96,ADAMTS12,ACP6,CXCL13,MEGF10,ZFAND5,LRFN5,PCGF5,SEZ6L,TCF20,SPHKAP,PAQR3,KIF6,NOBOX,ERCC6L2,ACVR1C,SKAP2,XPO4,DSCAM,EPHA4,DNER,CASK,SGCD,TMEFF2,PRKCE,ZNF133,IRX1,CPXM2,PI15,CNTNAP2</TD></TR>
<TR><TD>3.239e-04</TD><TD>-8.04</TD><TD>clear_cell_renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>clear_cell_renal_cell_carcinoma</TD><TD>13957</TD><TD>175</TD><TD>16984</TD><TD>192</TD>
<TD>PAQR3,KIF6,ERCC6L2,NOBOX,ACVR1C,SPHKAP,LRFN5,PCGF5,SEZ6L,TCF20,ACP6,MEGF10,CXCL13,ZFAND5,CNTNAP2,ZNF133,PRKCE,IRX1,CPXM2,PI15,DNER,EPHA4,CASK,TMEFF2,SGCD,XPO4,SKAP2,DSCAM,DAAM1,SEMA3C,NRCAM,CALN1,TSN,ADAM28,PTPRD,TGFBR2,ATG10,EFR3A,NUP35,FMNL2,ZNF521,PTPRK,KLF12,NTRK2,HNF4G,CD96,ADAMTS12,EPHA3,RPH3A,RYR2,ROBO2,PHF14,SGCG,ADAMTS5,REXO2,AOAH,THSD7A,ZPLD1,UBR4,PBX1,RAI2,DNAJC12,BCHE,ADAMTS3,IL1RAPL2,MRPL3,CETN3,WRN,JMJD1C,LRRC70,OR52K2,PHLPP1,FIGN,EFR3B,ASPN,LRRC3B,PWWP2A,SPAG9,MUC7,DEPTOR,FBN2,RGS6,IQGAP2,STXBP6,FGD3,PAX6,FUT9,IPO8,REG1B,LRIG3,SLC25A46,AGA,PXDNL,EDIL3,SLC7A14,FNIP2,IGFL4,FGF5,BACH2,FAT4,MPEG1,GMDS,NBEA,BANK1,ZNF518B,FANCB,SYT1,CHRM3,KCNK9,CRTC3,MRPL13,SLC7A8,LHCGR,EPS8,PRSS12,NRG1,FGF14,THSD7B,LMBRD1,FZD6,NAV3,COX7B2,ARX,UHMK1,RBM20,CDH5,PCDH9,PSKH2,SLC10A2,LGI1,KAZN,LMX1A,EFNA5,PRLHR,EPYC,AMELX,FGFR2,RUNX1T1,GCNT1,PARP8,AKAP9,CNTN1,NAALADL2,SPANXN1,SS18,TWIST1,NOVA1,MAP2,SERINC5,FGF20,NCKAP5,NOL4,SLIT2,OR2AG1,CD226,SERGEF,B3GAT2,GPR83,UNC5C,PTPRZ1,EFEMP1,TRPS1,DEFB115,RASGEF1B,CELF2,GAP43,ZFPM2,UTRN,ACVR2A,SPATA16,AFM,NAT2,SLC39A10,VAV3,PLEK</TD></TR>
<TR><TD>3.381e-04</TD><TD>-7.99</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>751</TD><TD>20</TD><TD>16984</TD><TD>192</TD>
<TD>KIF6,NTRK2,CNTNAP2,ADAMTS12,FAT4,EPS8,B3GAT2,PTPRD,ROBO2,RYR2,FGF20,NAV3,PTPRK,ZNF521,MEGF10,XPO4,FBN2,LRIG3,CHRM3,TRPS1</TD></TR>
<TR><TD>3.413e-04</TD><TD>-7.98</TD><TD>germ_cell_tumour</TD><TD>COSMIC cancer mutations</TD><TD>germ_cell_tumour</TD><TD>869</TD><TD>22</TD><TD>16984</TD><TD>192</TD>
<TD>ACVR2A,TGFBR2,UHMK1,FAT4,PRKCE,EPHA3,ACVR1C,ERCC6L2,NAALADL2,KIF6,CNTN1,NTRK2,PSKH2,JMJD1C,RGS6,TRPS1,FGFR2,CASK,IPO8,EPHA4,LMBRD1,LRFN5</TD></TR>
<TR><TD>3.430e-04</TD><TD>-7.98</TD><TD>human chr4q28.3</TD><TD>chromosome location</TD><TD>human chr4q28.3</TD><TD>64</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>LINC00499,LINC02172,LINC02511</TD></TR>
<TR><TD>3.506e-04</TD><TD>-7.96</TD><TD>GJB7 (gap junction protein beta 7)</TD><TD>protein interactions</TD><TD>375519</TD><TD>55</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>EFNA5,EFR3A,EFR3B,CNTN1,GAP43</TD></TR>
<TR><TD>3.553e-04</TD><TD>-7.94</TD><TD>outflow tract morphogenesis</TD><TD>biological process</TD><TD>GO:0003151</TD><TD>81</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>SEMA3C,TWIST1,ROBO2,FGFR2,TGFBR2,ZFPM2</TD></TR>
<TR><TD>3.570e-04</TD><TD>-7.94</TD><TD>prostate-adenoma</TD><TD>COSMIC cancer mutations</TD><TD>prostate-adenoma</TD><TD>1637</TD><TD>34</TD><TD>16984</TD><TD>192</TD>
<TD>SEZ6L,FGF14,RGS6,GCNT1,KLF12,PTPRK,ZNF521,FBN2,CD226,KAZN,UBR4,LGI1,UCHL1,CRTC3,PAQR3,PTPRZ1,NRG1,PTPRD,SPHKAP,SYT1,ZNF518B,SPATA16,DNER,RPH3A,SLIT2,KCNK9,ZPLD1,LRIG3,AOAH,ADAMTS12,AKAP9,HNF4G,MAP2,EPHA3</TD></TR>
<TR><TD>3.622e-04</TD><TD>-7.92</TD><TD>IL32 (interleukin 32)</TD><TD>protein interactions</TD><TD>9235</TD><TD>31</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>PRKCE,PTPRD,FGFR2,ZFPM2</TD></TR>
<TR><TD>3.668e-04</TD><TD>-7.91</TD><TD>dendritic branch</TD><TD>cellular component</TD><TD>GO:0044307</TD><TD>3</TD><TD>2</TD><TD>19868</TD><TD>221</TD>
<TD>MAP2,AKAP9</TD></TR>
<TR><TD>3.747e-04</TD><TD>-7.89</TD><TD>TSP1</TD><TD>smart domains</TD><TD>SM00209</TD><TD>64</TD><TD>6</TD><TD>9743</TD><TD>146</TD>
<TD>UNC5C,THSD7B,THSD7A,ADAMTS5,ADAMTS3,ADAMTS12</TD></TR>
<TR><TD>3.791e-04</TD><TD>-7.88</TD><TD>enzyme-linked receptor protein signaling pathway</TD><TD>biological process</TD><TD>GO:0007167</TD><TD>626</TD><TD>18</TD><TD>18905</TD><TD>219</TD>
<TD>PTPRK,ZFAND5,ACVR1C,FGF20,NRG1,EPHA3,SS18,CDH5,FGF5,PTPRD,NTRK2,FGFR2,GAREM1,TGFBR2,EPHA4,EFNA5,EFEMP1,ACVR2A</TD></TR>
<TR><TD>3.843e-04</TD><TD>-7.86</TD><TD>LRRNT</TD><TD>interpro domains</TD><TD>IPR000372</TD><TD>54</TD><TD>5</TD><TD>18605</TD><TD>214</TD>
<TD>EPYC,LRRC3B,ASPN,NTRK2,SLIT2</TD></TR>
<TR><TD>3.917e-04</TD><TD>-7.85</TD><TD>FN3</TD><TD>smart domains</TD><TD>SM00060</TD><TD>149</TD><TD>9</TD><TD>9743</TD><TD>146</TD>
<TD>EPHA4,PTPRZ1,PTPRD,CNTN1,ROBO2,PTPRK,EPHA3,NRCAM,DSCAM</TD></TR>
<TR><TD>3.918e-04</TD><TD>-7.84</TD><TD>seminoma</TD><TD>COSMIC cancer mutations</TD><TD>seminoma</TD><TD>702</TD><TD>19</TD><TD>16984</TD><TD>192</TD>
<TD>KIF6,CNTN1,PSKH2,NTRK2,ACVR1C,ERCC6L2,FAT4,PRKCE,EPHA3,ACVR2A,TGFBR2,UHMK1,EPHA4,LMBRD1,IPO8,CASK,FGFR2,RGS6,TRPS1</TD></TR>
<TR><TD>3.921e-04</TD><TD>-7.84</TD><TD>Sarcoglycan_gamma/delta/zeta</TD><TD>interpro domains</TD><TD>IPR039972</TD><TD>3</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>SGCG,SGCD</TD></TR>
<TR><TD>3.977e-04</TD><TD>-7.83</TD><TD>apoptotic process involved in luteolysis</TD><TD>biological process</TD><TD>GO:0061364</TD><TD>3</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>ROBO2,SLIT2</TD></TR>
<TR><TD>3.977e-04</TD><TD>-7.83</TD><TD>fasciculation of sensory neuron axon</TD><TD>biological process</TD><TD>GO:0097155</TD><TD>3</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>3.999e-04</TD><TD>-7.82</TD><TD>human chr1q23.3</TD><TD>chromosome location</TD><TD>human chr1q23.3</TD><TD>162</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>PBX1,LOC127814295,UHMK1,LMX1A</TD></TR>
<TR><TD>4.023e-04</TD><TD>-7.82</TD><TD>plasma membrane bounded cell projection organization</TD><TD>biological process</TD><TD>GO:0120036</TD><TD>1155</TD><TD>27</TD><TD>18905</TD><TD>219</TD>
<TD>ROBO2,PTPRZ1,PAX6,SLC25A46,GAP43,CNTN1,ARX,PLEK,NRCAM,LMX1A,EPHA3,DSCAM,UCHL1,MAP2,UNC5C,FGD3,CNTNAP2,SEMA3C,DAW1,FGFR2,UHMK1,EPHA4,VAV3,EFNA5,SHTN1,SLIT2,LGI1</TD></TR>
<TR><TD>4.025e-04</TD><TD>-7.82</TD><TD>olfactory bulb interneuron differentiation</TD><TD>biological process</TD><TD>GO:0021889</TD><TD>13</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>ARX,SLIT2,ROBO2</TD></TR>
<TR><TD>4.073e-04</TD><TD>-7.81</TD><TD>haematopoietic_and_lymphoid_tissue</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue</TD><TD>14454</TD><TD>179</TD><TD>16984</TD><TD>192</TD>
<TD>NTRK2,CD96,HNF4G,ADAMTS12,EPHA3,ROBO2,RYR2,RPH3A,REXO2,ADAMTS5,PHF14,SGCG,AOAH,ZPLD1,THSD7A,NRCAM,SEMA3C,DAAM1,CALN1,ADAM28,TGFBR2,PTPRD,NUP35,EFR3A,ATG10,PTPRK,ZNF521,FMNL2,KLF12,CNTNAP2,IRX1,PRKCE,ZNF133,PI15,CPXM2,EPHA4,DNER,COQ2,SGCD,TMEFF2,CASK,DCDC2C,SKAP2,XPO4,DSCAM,KIF6,PAQR3,LRRN2,ACVR1C,NOBOX,ERCC6L2,SPHKAP,PCGF5,SEZ6L,LRFN5,TCF20,CXCL13,MEGF10,ACP6,ZFAND5,STXBP6,IQGAP2,FGD3,PAX6,FUT9,NRSN1,IPO8,LRIG3,REG1B,UCHL1,PWWP2A,MUC7,LINC01387,SPAG9,DEPTOR,FBN2,RGS6,JMJD1C,PHLPP1,FIGN,ASPN,EFR3B,LRRC3B,UBR4,DNAJC12,RAI2,ADAMTS3,BCHE,IL1RAPL2,WRN,CETN3,MRPL3,ARX,RBM20,UHMK1,INSM1,CDH5,SHISA3,PCDH9,MRPL13,CRTC3,SLC7A8,EPS8,LHCGR,NRG1,PRSS12,LMBRD1,THSD7B,FGF14,NAV3,FZD6,FAT4,GMDS,MPEG1,SYT1,FANCB,BANK1,ZNF518B,NBEA,DAOA,KCNK9,CHRM3,FABP7,SLC25A46,PXDNL,EDIL3,SLC7A14,FNIP2,CTSO,BACH2,FGF5,DEFB115,GAP43,CELF2,RASGEF1B,ZFPM2,ACVR2A,UTRN,NAT2,AFM,SPATA16,VAV3,SLC39A10,PLEK,OR2AG1,CD226,GPR83,SERGEF,B3GAT2,PTPRZ1,GHITM,UNC5C,EFEMP1,WWOX,TRPS1,NAALADL2,CNTN1,AKAP9,PARP8,NOVA1,SS18,SPANXN1,MAP2,FGF20,NOL4,NCKAP5,SLIT2,LGI1,SLC10A2,PSKH2,LMX1A,KAZN,PRLHR,EFNA5,EPYC,AMELX,RUNX1T1,FGFR2,LINC00583</TD></TR>
<TR><TD>4.128e-04</TD><TD>-7.79</TD><TD>skin-nipple-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-nipple-malignant_melanoma</TD><TD>197</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>FAT4,LRIG3,CHRM3,DSCAM,ADAMTS3,EFEMP1,CD96,TMEFF2,ACVR1C</TD></TR>
<TR><TD>4.128e-04</TD><TD>-7.79</TD><TD>nipple</TD><TD>COSMIC cancer mutations</TD><TD>nipple</TD><TD>197</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>LRIG3,FAT4,CHRM3,DSCAM,CD96,EFEMP1,ADAMTS3,ACVR1C,TMEFF2</TD></TR>
<TR><TD>4.189e-04</TD><TD>-7.78</TD><TD>neuron projection</TD><TD>cellular component</TD><TD>GO:0043005</TD><TD>1335</TD><TD>29</TD><TD>19868</TD><TD>221</TD>
<TD>ROBO2,BRINP3,DNER,NTRK2,UNC5C,EPS8,SYT1,PCDH9,SHTN1,EPHA4,PRLHR,NRSN1,RPH3A,ADGRL3,CNTNAP2,PRSS12,DSCAM,UCHL1,NRCAM,EPHA3,RGS6,UHMK1,AKAP9,GAP43,CETN3,CNTN1,LGI1,MAP2,CHRM3</TD></TR>
<TR><TD>4.369e-04</TD><TD>-7.74</TD><TD>face</TD><TD>COSMIC cancer mutations</TD><TD>face</TD><TD>2139</TD><TD>41</TD><TD>16984</TD><TD>192</TD>
<TD>AKAP9,CNTNAP2,HNF4G,JMJD1C,ADAMTS12,GAP43,IQGAP2,CELF2,FAT4,EPHA3,ZNF518B,ADAMTS5,SPATA16,SGCG,SLC39A10,SLIT2,DSCAM,CHRM3,PCDH9,KIF6,OR2AG1,LMX1A,CALN1,ADAM28,PWWP2A,EPYC,PTPRZ1,PTPRD,ADAMTS3,SEZ6L,LRFN5,NAV3,BACH2,PTPRK,ZNF521,MEGF10,FBN2,DEPTOR,FGFR2,KLF12,TRPS1</TD></TR>
<TR><TD>4.698e-04</TD><TD>-7.66</TD><TD>cell motility</TD><TD>biological process</TD><TD>GO:0048870</TD><TD>1105</TD><TD>26</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,GCNT1,VAV3,INSM1,SHTN1,EPHA4,SEMA3C,NTRK2,CXCL13,TWIST1,CDH5,EPHA3,NRCAM,FMNL2,ARX,PECAM1,ADGRL3,PAX6,DNER,TMEFF2,ADAMTS12,EPS8,MEGF10,LRATD1,ZFAND5,PTPRK</TD></TR>
<TR><TD>4.782e-04</TD><TD>-7.65</TD><TD>skin-scalp-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-scalp-carcinoma-squamous_cell_carcinoma</TD><TD>1596</TD><TD>33</TD><TD>16984</TD><TD>192</TD>
<TD>FAT4,MAP2,CPXM2,CNTN1,DEFB115,NOL4,CHRM3,LRRC3B,DSCAM,RPH3A,ROBO2,ADAMTS5,SYT1,NRSN1,LHCGR,PRLHR,UNC5C,SPHKAP,NRG1,PTPRZ1,DAAM1,SEMA3C,NRCAM,FGFR2,ZNF521,MEGF10,BACH2,TRPS1,WRN,LRFN5,SEZ6L,FERD3L,NAV3</TD></TR>
<TR><TD>4.875e-04</TD><TD>-7.63</TD><TD>cell periphery</TD><TD>cellular component</TD><TD>GO:0071944</TD><TD>6404</TD><TD>95</TD><TD>19868</TD><TD>221</TD>
<TD>PXDNL,RGS6,EPHA3,ADAMTS5,AMELX,PTPRK,PHLPP1,ADGRL3,LRRC70,RPH3A,SGCG,TGFBR2,THSD7B,EFR3B,SEPTIN5,EFR3A,PCDH9,DNER,ADAMTS3,VAV3,EFNA5,SGCD,SLC7A14,LRRN2,KCNK9,SLC7A8,PTPRZ1,EFEMP1,BCHE,AKAP9,CDH5,FBN2,UCHL1,NRCAM,CHRM3,EDIL3,UTRN,EPYC,ADAM28,FGFR2,LRIG3,NRG1,PRSS12,GAREM1,CNTNAP2,SLC39A10,SYT1,EPS8,IL1RAPL2,IQGAP2,MEGF10,CD96,PRKCE,GAP43,OR2AG1,THSD7A,CNTN1,LRRC3B,NUP35,PRLHR,KAZN,CASK,MUC7,SLC10A2,UNC5C,SKAP2,SEMA3C,LMBRD1,LHCGR,GPR83,ROBO2,PLEK,OR52K2,DAAM1,LRFN5,EPHA4,FAT4,CD226,PTPRD,PECAM1,RASGEF1B,ACVR1C,DSCAM,ADAMTS12,TEC,CALN1,NBEA,RYR2,NTRK2,WWOX,UBR4,SERINC5,ASPN,FZD6,ACVR2A</TD></TR>
<TR><TD>4.907e-04</TD><TD>-7.62</TD><TD>central nervous system neuron development</TD><TD>biological process</TD><TD>GO:0021954</TD><TD>86</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4,ARX,SLIT2,FGFR2,MAP2,NTRK2</TD></TR>
<TR><TD>5.050e-04</TD><TD>-7.59</TD><TD>human chr7q31.1</TD><TD>chromosome location</TD><TD>human chr7q31.1</TD><TD>73</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>NRCAM,LINC02903,EIF3IP1</TD></TR>
<TR><TD>5.050e-04</TD><TD>-7.59</TD><TD>human chr9q22.31</TD><TD>chromosome location</TD><TD>human chr9q22.31</TD><TD>73</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>ASPN,FGD3,MIR548AU</TD></TR>
<TR><TD>5.344e-04</TD><TD>-7.53</TD><TD>regulation of cell differentiation</TD><TD>biological process</TD><TD>GO:0045595</TD><TD>1625</TD><TD>34</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4,ZFPM2,FGFR2,NTRK2,SLIT2,EFEMP1,PBX1,SHTN1,INSM1,EFNA5,EPHA3,DSCAM,TRPS1,LMX1A,NRCAM,PTPRD,SPAG9,CDH5,TWIST1,MAP2,TGFBR2,FERD3L,PAX6,ACVR2A,NRG1,FGF20,ROBO2,BRINP3,PTPRZ1,ADAMTS12,RUNX1T1,FBN2,MEGF10,SS18</TD></TR>
<TR><TD>5.471e-04</TD><TD>-7.51</TD><TD>breast-carcinoma-ER-PR-positive_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>breast-carcinoma-ER-PR-positive_carcinoma</TD><TD>1882</TD><TD>37</TD><TD>16984</TD><TD>192</TD>
<TD>UCHL1,ACVR1C,DNAJC12,PBX1,LHCGR,NRG1,TGFBR2,PTPRD,FGF14,SPAG9,FZD6,RUNX1T1,FGFR2,FMNL2,FGF5,WRN,CNTN1,AKAP9,PARP8,NTRK2,SS18,TWIST1,FAT4,EPHA3,PRKCE,PAX6,ACVR2A,DNER,EPHA4,CDH5,FGF20,RPH3A,RYR2,TMEFF2,FANCB,VAV3,ZPLD1</TD></TR>
<TR><TD>5.471e-04</TD><TD>-7.51</TD><TD>ER-PR-positive_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>ER-PR-positive_carcinoma</TD><TD>1882</TD><TD>37</TD><TD>16984</TD><TD>192</TD>
<TD>RUNX1T1,FGFR2,FMNL2,FGF5,WRN,FGF14,SPAG9,FZD6,DNAJC12,PBX1,LHCGR,NRG1,TGFBR2,PTPRD,UCHL1,ACVR1C,VAV3,ZPLD1,DNER,EPHA4,CDH5,FGF20,RPH3A,RYR2,TMEFF2,FANCB,FAT4,EPHA3,PRKCE,PAX6,ACVR2A,AKAP9,CNTN1,NTRK2,PARP8,SS18,TWIST1</TD></TR>
<TR><TD>5.486e-04</TD><TD>-7.51</TD><TD>knee</TD><TD>COSMIC cancer mutations</TD><TD>knee</TD><TD>125</TD><TD>7</TD><TD>16984</TD><TD>192</TD>
<TD>ADAMTS3,CNTN1,RYR2,PTPRD,CHRM3,PWWP2A,ADAM28</TD></TR>
<TR><TD>5.692e-04</TD><TD>-7.47</TD><TD>extracellular matrix</TD><TD>cellular component</TD><TD>GO:0031012</TD><TD>561</TD><TD>16</TD><TD>19868</TD><TD>221</TD>
<TD>LRRN2,EPYC,ASPN,PTPRZ1,CASK,LRIG3,FGFR2,EFEMP1,ADAMTS12,EFNA5,AMELX,EDIL3,LRRC3B,ADAMTS3,ADAMTS5,FBN2</TD></TR>
<TR><TD>5.801e-04</TD><TD>-7.45</TD><TD>external encapsulating structure</TD><TD>cellular component</TD><TD>GO:0030312</TD><TD>562</TD><TD>16</TD><TD>19868</TD><TD>221</TD>
<TD>EFNA5,EPYC,ASPN,LRRN2,CASK,PTPRZ1,FGFR2,LRIG3,ADAMTS12,EFEMP1,FBN2,ADAMTS5,EDIL3,AMELX,LRRC3B,ADAMTS3</TD></TR>
<TR><TD>5.802e-04</TD><TD>-7.45</TD><TD>cell projection</TD><TD>cellular component</TD><TD>GO:0042995</TD><TD>2406</TD><TD>44</TD><TD>19868</TD><TD>221</TD>
<TD>NTRK2,SYT1,EPS8,ASPN,MEGF10,IQGAP2,WWOX,DCDC2C,DAAM1,CHRM3,UHMK1,NRCAM,UCHL1,AKAP9,PLEK,DSCAM,CNTNAP2,PRSS12,SHTN1,EPHA4,UTRN,FGD3,DNER,PCDH9,SLC10A2,UNC5C,ROBO2,GPR83,BRINP3,SLC7A8,CETN3,CNTN1,LGI1,DAW1,THSD7A,MAP2,EPHA3,RGS6,GAP43,CASK,PRLHR,NRSN1,ADGRL3,RPH3A</TD></TR>
<TR><TD>5.870e-04</TD><TD>-7.44</TD><TD>FN3_dom</TD><TD>interpro domains</TD><TD>IPR003961</TD><TD>203</TD><TD>9</TD><TD>18605</TD><TD>214</TD>
<TD>PTPRD,ROBO2,PTPRK,NRCAM,PTPRZ1,EPHA3,CNTN1,EPHA4,DSCAM</TD></TR>
<TR><TD>6.103e-04</TD><TD>-7.40</TD><TD>Regulation of Commissural axon pathfinding by Slit and Robo</TD><TD>REACTOME pathways</TD><TD>R-HSA-428542</TD><TD>4</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>ROBO2,SLIT2</TD></TR>
<TR><TD>6.142e-04</TD><TD>-7.40</TD><TD>positive regulation of neurogenesis</TD><TD>biological process</TD><TD>GO:0050769</TD><TD>246</TD><TD>10</TD><TD>18905</TD><TD>219</TD>
<TD>DSCAM,EPHA4,NTRK2,ROBO2,PTPRZ1,PAX6,SLIT2,PTPRD,EFNA5,SHTN1</TD></TR>
<TR><TD>6.151e-04</TD><TD>-7.39</TD><TD>RSPH1 (radial spoke head component 1)</TD><TD>protein interactions</TD><TD>89765</TD><TD>130</TD><TD>7</TD><TD>20077</TD><TD>222</TD>
<TD>NRCAM,EDIL3,PAX6,PTPRD,SEZ6L,DNER,CASK</TD></TR>
<TR><TD>6.259e-04</TD><TD>-7.38</TD><TD>transmembrane receptor protein tyrosine kinase activity</TD><TD>molecular function</TD><TD>GO:0004714</TD><TD>62</TD><TD>5</TD><TD>18530</TD><TD>206</TD>
<TD>NTRK2,EFEMP1,EPHA4,FGFR2,EPHA3</TD></TR>
<TR><TD>6.323e-04</TD><TD>-7.37</TD><TD>Activated point mutants of FGFR2</TD><TD>REACTOME pathways</TD><TD>R-HSA-2033519</TD><TD>17</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGF5,FGFR2</TD></TR>
<TR><TD>6.351e-04</TD><TD>-7.36</TD><TD>ductolobular_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>ductolobular_carcinoma</TD><TD>1622</TD><TD>33</TD><TD>16984</TD><TD>192</TD>
<TD>AKAP9,CNTN1,JMJD1C,PARP8,EPHA3,ZFPM2,PRKCE,MAP2,ROBO2,EPHA4,RYR2,FIGN,NBEA,XPO4,VAV3,NRCAM,KIF6,TSN,UBR4,LHCGR,PTPRZ1,TGFBR2,PTPRD,FGF14,EFR3A,NAV3,FERD3L,IL1RAPL2,ZNF521,RUNX1T1,FGFR2,FBN2,WRN</TD></TR>
<TR><TD>6.351e-04</TD><TD>-7.36</TD><TD>breast-carcinoma-ductolobular_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>breast-carcinoma-ductolobular_carcinoma</TD><TD>1622</TD><TD>33</TD><TD>16984</TD><TD>192</TD>
<TD>FBN2,FGFR2,RUNX1T1,ZNF521,IL1RAPL2,WRN,FGF14,FERD3L,NAV3,EFR3A,LHCGR,PTPRD,PTPRZ1,TGFBR2,KIF6,NRCAM,UBR4,TSN,VAV3,XPO4,RYR2,EPHA4,ROBO2,NBEA,FIGN,ZFPM2,PRKCE,EPHA3,MAP2,PARP8,JMJD1C,CNTN1,AKAP9</TD></TR>
<TR><TD>6.359e-04</TD><TD>-7.36</TD><TD>bone</TD><TD>COSMIC cancer mutations</TD><TD>bone</TD><TD>8169</TD><TD>115</TD><TD>16984</TD><TD>192</TD>
<TD>KLF12,COX7B2,FMNL2,ZNF521,ATG10,EFR3A,NAV3,FGF14,THSD7B,LMBRD1,PRSS12,PTPRD,NRG1,LHCGR,ADAM28,DAAM1,NRCAM,THSD7A,PCDH9,ZPLD1,AOAH,PHF14,ADAMTS5,CDH5,RYR2,RBM20,EPHA3,ADAMTS12,HNF4G,NTRK2,FGF5,MEGF10,CXCL13,BACH2,TCF20,LRFN5,SEZ6L,SPHKAP,EDIL3,NOBOX,PXDNL,ACVR1C,KIF6,DSCAM,KCNK9,DCDC2C,SKAP2,BANK1,TMEFF2,SYT1,SGCD,FANCB,COQ2,MPEG1,DNER,EPHA4,GMDS,CPXM2,PI15,ZNF133,PRKCE,FAT4,CNTNAP2,TRPS1,RGS6,FBN2,SPAG9,UNC5C,PTPRZ1,B3GAT2,SERGEF,GPR83,OR2AG1,SLC39A10,LRIG3,VAV3,SPATA16,AFM,IPO8,UTRN,PAX6,ACVR2A,ZFPM2,FGD3,CELF2,RASGEF1B,IQGAP2,GAP43,WRN,FGFR2,IL1RAPL2,RUNX1T1,FERD3L,BCHE,ADAMTS3,EPYC,RAI2,PRLHR,UBR4,LMX1A,PSKH2,SLIT2,NCKAP5,NOL4,FIGN,FGF20,MAP2,PHLPP1,SS18,OR52K2,JMJD1C,PARP8,AKAP9,CNTN1,NAALADL2</TD></TR>
<TR><TD>6.710e-04</TD><TD>-7.31</TD><TD>cellular response to growth factor stimulus</TD><TD>biological process</TD><TD>GO:0071363</TD><TD>494</TD><TD>15</TD><TD>18905</TD><TD>219</TD>
<TD>ACVR2A,GAREM1,FGFR2,PAX6,NTRK2,TGFBR2,CDH5,TWIST1,ADAMTS12,CXCL13,FGF5,PTPRK,FGF20,ACVR1C,WWOX</TD></TR>
<TR><TD>6.922e-04</TD><TD>-7.28</TD><TD>embryonic eye morphogenesis</TD><TD>biological process</TD><TD>GO:0048048</TD><TD>35</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>FBN2,TWIST1,PAX6,EFEMP1</TD></TR>
<TR><TD>6.998e-04</TD><TD>-7.26</TD><TD>heart valve morphogenesis</TD><TD>biological process</TD><TD>GO:0003179</TD><TD>61</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,ADAMTS5,TGFBR2,TWIST1,ROBO2</TD></TR>
<TR><TD>7.125e-04</TD><TD>-7.25</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia</TD><TD>10490</TD><TD>140</TD><TD>16984</TD><TD>192</TD>
<TD>EPHA3,RBM20,HNF4G,CD96,NTRK2,ADAMTS12,AOAH,THSD7A,PCDH9,SHISA3,CDH5,RPH3A,RYR2,ROBO2,SGCG,PHF14,ADAMTS5,LHCGR,ADAM28,EPS8,PRSS12,PTPRD,NRG1,CRTC3,SEMA3C,CALN1,SLC7A8,FMNL2,ZNF521,PTPRK,KLF12,THSD7B,FGF14,LMBRD1,ATG10,FZD6,EFR3A,NUP35,NAV3,ZNF133,PRKCE,FAT4,CPXM2,PI15,CNTNAP2,XPO4,DAOA,DCDC2C,SKAP2,DSCAM,KCNK9,COQ2,DNER,MPEG1,GMDS,EPHA4,CASK,NBEA,ZNF518B,TMEFF2,BANK1,SGCD,SYT1,FANCB,SLC7A14,EDIL3,SPHKAP,PAQR3,FABP7,KIF6,ERCC6L2,NOBOX,PXDNL,LRRN2,ACP6,MEGF10,BACH2,ZFAND5,LRFN5,SEZ6L,CTSO,TCF20,ZFPM2,FGD3,UTRN,PAX6,ACVR2A,CELF2,RASGEF1B,STXBP6,IQGAP2,VAV3,LRIG3,REG1B,PLEK,SPATA16,AFM,B3GAT2,GPR83,UNC5C,GHITM,PTPRZ1,OR2AG1,CD226,DEPTOR,FBN2,EFEMP1,MUC7,WWOX,PHLPP1,MAP2,JMJD1C,PARP8,AKAP9,CNTN1,NAALADL2,SPANXN1,NOVA1,NCKAP5,NOL4,EFR3B,ASPN,SLIT2,RAI2,DNAJC12,EFNA5,PSKH2,SLC10A2,UBR4,KAZN,LMX1A,FGFR2,IL1RAPL2,RUNX1T1,MRPL3,CETN3,WRN,BCHE,AMELX,ADAMTS3</TD></TR>
<TR><TD>7.125e-04</TD><TD>-7.25</TD><TD>acute_myeloid_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>acute_myeloid_leukaemia</TD><TD>10490</TD><TD>140</TD><TD>16984</TD><TD>192</TD>
<TD>FZD6,ATG10,NUP35,NAV3,EFR3A,FGF14,THSD7B,LMBRD1,KLF12,FMNL2,PTPRK,ZNF521,SLC7A8,CALN1,CRTC3,SEMA3C,PTPRD,PRSS12,NRG1,ADAM28,LHCGR,EPS8,ADAMTS5,SGCG,PHF14,RYR2,RPH3A,CDH5,ROBO2,PCDH9,THSD7A,SHISA3,AOAH,ADAMTS12,NTRK2,CD96,HNF4G,RBM20,EPHA3,CTSO,TCF20,LRFN5,SEZ6L,ZFAND5,ACP6,BACH2,MEGF10,NOBOX,ERCC6L2,LRRN2,PXDNL,PAQR3,KIF6,FABP7,SPHKAP,EDIL3,SLC7A14,NBEA,CASK,SYT1,FANCB,SGCD,TMEFF2,BANK1,ZNF518B,COQ2,EPHA4,GMDS,MPEG1,DNER,DSCAM,KCNK9,DCDC2C,SKAP2,DAOA,XPO4,CNTNAP2,CPXM2,PI15,PRKCE,ZNF133,FAT4,WWOX,EFEMP1,MUC7,DEPTOR,FBN2,CD226,OR2AG1,UNC5C,PTPRZ1,GHITM,B3GAT2,GPR83,AFM,SPATA16,PLEK,LRIG3,REG1B,VAV3,IQGAP2,STXBP6,RASGEF1B,CELF2,UTRN,ACVR2A,PAX6,ZFPM2,FGD3,ADAMTS3,BCHE,AMELX,MRPL3,WRN,CETN3,FGFR2,RUNX1T1,IL1RAPL2,UBR4,LMX1A,KAZN,PSKH2,SLC10A2,RAI2,DNAJC12,EFNA5,SLIT2,NCKAP5,ASPN,EFR3B,NOL4,SPANXN1,NOVA1,PARP8,JMJD1C,NAALADL2,CNTN1,AKAP9,MAP2,PHLPP1</TD></TR>
<TR><TD>7.218e-04</TD><TD>-7.23</TD><TD>Mta1 (metastasis associated 1)</TD><TD>protein interactions</TD><TD>116870</TD><TD>37</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>TCF20,TRPS1,PHF14,PWWP2A</TD></TR>
<TR><TD>7.271e-04</TD><TD>-7.23</TD><TD>human chr4p15.31</TD><TD>chromosome location</TD><TD>human chr4p15.31</TD><TD>19</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>SLIT2,SLIT2-IT1</TD></TR>
<TR><TD>7.494e-04</TD><TD>-7.20</TD><TD>cell projection organization</TD><TD>biological process</TD><TD>GO:0030030</TD><TD>1203</TD><TD>27</TD><TD>18905</TD><TD>219</TD>
<TD>GAP43,ARX,CNTN1,SLC25A46,PAX6,PTPRZ1,ROBO2,SLIT2,LGI1,SHTN1,EFNA5,VAV3,EPHA4,UHMK1,FGFR2,CNTNAP2,DAW1,SEMA3C,FGD3,MAP2,UNC5C,UCHL1,DSCAM,EPHA3,LMX1A,NRCAM,PLEK</TD></TR>
<TR><TD>7.532e-04</TD><TD>-7.19</TD><TD>Phospholipase C-mediated cascade; FGFR2</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654221</TD><TD>18</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGF5,FGFR2</TD></TR>
<TR><TD>7.777e-04</TD><TD>-7.16</TD><TD>cardiac chamber development</TD><TD>biological process</TD><TD>GO:0003205</TD><TD>168</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,ROBO2,SEMA3C,FGFR2,TGFBR2,RYR2,ZFPM2,NRG1</TD></TR>
<TR><TD>7.782e-04</TD><TD>-7.16</TD><TD>Sarcoglycan</TD><TD>interpro domains</TD><TD>IPR006875</TD><TD>4</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>SGCG,SGCD</TD></TR>
<TR><TD>7.807e-04</TD><TD>-7.16</TD><TD>PK_Tyr_Ser-Thr</TD><TD>pfam domains</TD><TD>PF07714</TD><TD>130</TD><TD>7</TD><TD>17869</TD><TD>206</TD>
<TD>NTRK2,FGFR2,EPHA4,ACVR1C,EPHA3,TGFBR2,TEC</TD></TR>
<TR><TD>7.814e-04</TD><TD>-7.15</TD><TD>large_intestine-colon-adenoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-colon-adenoma</TD><TD>627</TD><TD>17</TD><TD>16984</TD><TD>192</TD>
<TD>ZNF518B,CASK,BCHE,ROBO2,ADAMTS3,THSD7B,SPAG9,RUNX1T1,NCKAP5,LRIG3,PXDNL,ADAMTS12,CALN1,IQGAP2,CNTNAP2,MAP2,FAT4</TD></TR>
<TR><TD>7.816e-04</TD><TD>-7.15</TD><TD>Sarcoglycan_1</TD><TD>pfam domains</TD><TD>PF04790</TD><TD>4</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>SGCG,SGCD</TD></TR>
<TR><TD>7.893e-04</TD><TD>-7.14</TD><TD>regulation of negative chemotaxis</TD><TD>biological process</TD><TD>GO:0050923</TD><TD>4</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>ROBO2,SLIT2</TD></TR>
<TR><TD>7.893e-04</TD><TD>-7.14</TD><TD>embryonic olfactory bulb interneuron precursor migration</TD><TD>biological process</TD><TD>GO:0021831</TD><TD>4</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,ARX</TD></TR>
<TR><TD>7.896e-04</TD><TD>-7.14</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia</TD><TD>1440</TD><TD>30</TD><TD>16984</TD><TD>192</TD>
<TD>PRKCE,EPHA3,FAT4,CNTNAP2,DEFB115,CNTN1,IQGAP2,ADAMTS12,AOAH,NCKAP5,DSCAM,RYR2,DNER,SPATA16,RAI2,LHCGR,EDIL3,PTPRZ1,PAQR3,SLC10A2,UBR4,LRRN2,DEPTOR,FGFR2,PTPRK,MEGF10,WRN,SPAG9,BCHE,NAV3</TD></TR>
<TR><TD>7.896e-04</TD><TD>-7.14</TD><TD>hairy_cell_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>hairy_cell_leukaemia</TD><TD>1440</TD><TD>30</TD><TD>16984</TD><TD>192</TD>
<TD>FAT4,EPHA3,PRKCE,ADAMTS12,IQGAP2,CNTN1,DEFB115,CNTNAP2,DSCAM,NCKAP5,AOAH,SPATA16,DNER,RYR2,PTPRZ1,EDIL3,RAI2,LHCGR,LRRN2,UBR4,SLC10A2,PAQR3,WRN,MEGF10,PTPRK,FGFR2,DEPTOR,NAV3,BCHE,SPAG9</TD></TR>
<TR><TD>7.917e-04</TD><TD>-7.14</TD><TD>FYN (FYN proto-oncogene, Src family tyrosine kinase)</TD><TD>protein interactions</TD><TD>2534</TD><TD>417</TD><TD>13</TD><TD>20077</TD><TD>222</TD>
<TD>PECAM1,SKAP2,PRKCE,PTPRZ1,CNTN1,FGFR2,AKAP9,PTPRD,NTRK2,MAP2,EPHA4,CD226,EPHA3</TD></TR>
<TR><TD>7.997e-04</TD><TD>-7.13</TD><TD>SYCE1L (synaptonemal complex central element protein 1 like)</TD><TD>protein interactions</TD><TD>100130958</TD><TD>38</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>CALN1,SLC7A8,NOL4,SPHKAP</TD></TR>
<TR><TD>8.014e-04</TD><TD>-7.13</TD><TD>EGF-type_Asp/Asn_hydroxyl_site</TD><TD>interpro domains</TD><TD>IPR000152</TD><TD>95</TD><TD>6</TD><TD>18605</TD><TD>214</TD>
<TD>DNER,SLIT2,FBN2,EDIL3,EFEMP1,FAT4</TD></TR>
<TR><TD>8.068e-04</TD><TD>-7.12</TD><TD>human chr4q22.3</TD><TD>chromosome location</TD><TD>human chr4q22.3</TD><TD>20</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>UNC5C,STPG2-AS1</TD></TR>
<TR><TD>8.088e-04</TD><TD>-7.12</TD><TD>CNTN2 (contactin 2)</TD><TD>protein interactions</TD><TD>6900</TD><TD>17</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>NRCAM,CNTNAP2,CNTN1</TD></TR>
<TR><TD>8.207e-04</TD><TD>-7.11</TD><TD>transmembrane receptor protein tyrosine phosphatase activity</TD><TD>molecular function</TD><TD>GO:0005001</TD><TD>17</TD><TD>3</TD><TD>18530</TD><TD>206</TD>
<TD>PTPRK,PTPRD,PTPRZ1</TD></TR>
<TR><TD>8.207e-04</TD><TD>-7.11</TD><TD>transmembrane receptor protein phosphatase activity</TD><TD>molecular function</TD><TD>GO:0019198</TD><TD>17</TD><TD>3</TD><TD>18530</TD><TD>206</TD>
<TD>PTPRZ1,PTPRD,PTPRK</TD></TR>
<TR><TD>8.415e-04</TD><TD>-7.08</TD><TD>KIDINS220 (kinase D interacting substrate 220)</TD><TD>protein interactions</TD><TD>57498</TD><TD>178</TD><TD>8</TD><TD>20077</TD><TD>222</TD>
<TD>CD226,UTRN,SEPTIN5,EPHA3,PHLPP1,NTRK2,CDH5,FGFR2</TD></TR>
<TR><TD>8.468e-04</TD><TD>-7.07</TD><TD>EGF_Ca-bd_CS</TD><TD>interpro domains</TD><TD>IPR018097</TD><TD>96</TD><TD>6</TD><TD>18605</TD><TD>214</TD>
<TD>FBN2,SLIT2,DNER,EDIL3,EFEMP1,FAT4</TD></TR>
<TR><TD>8.525e-04</TD><TD>-7.07</TD><TD>lung-carcinoma-non_small_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-non_small_cell_carcinoma</TD><TD>5226</TD><TD>80</TD><TD>16984</TD><TD>192</TD>
<TD>ADAMTS3,AMELX,SEZ6L,PCGF5,CTSO,FERD3L,FGFR2,RUNX1T1,BACH2,CXCL13,IL1RAPL2,WRN,PSKH2,KIF6,UBR4,NOBOX,ACVR1C,KAZN,RAI2,PBX1,EDIL3,DNAJC12,SPHKAP,EPHA4,CASK,FANCB,SYT1,ZNF518B,XPO4,DSCAM,SLIT2,CNTNAP2,JMJD1C,CNTN1,AKAP9,SPANXN1,NOVA1,TWIST1,SS18,PRKCE,FAT4,IRX1,MAP2,SPAG9,LMBRD1,FZD6,NAV3,NUP35,DEPTOR,FBN2,COX7B2,PTPRK,ZNF521,TRPS1,RGS6,MRPL13,DAAM1,TSN,ADAM28,SERGEF,PTPRD,TGFBR2,PTPRZ1,RYR2,ADAMTS5,IPO8,PHF14,VAV3,LRIG3,THSD7A,NTRK2,IQGAP2,RASGEF1B,ADAMTS12,ARX,EPHA3,FGD3,UHMK1,ACVR2A,PAX6</TD></TR>
<TR><TD>8.525e-04</TD><TD>-7.07</TD><TD>non_small_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>non_small_cell_carcinoma</TD><TD>5226</TD><TD>80</TD><TD>16984</TD><TD>192</TD>
<TD>WRN,IL1RAPL2,BACH2,RUNX1T1,CXCL13,FGFR2,FERD3L,CTSO,PCGF5,AMELX,SEZ6L,ADAMTS3,SPHKAP,DNAJC12,EDIL3,PBX1,RAI2,ACVR1C,KAZN,UBR4,NOBOX,KIF6,PSKH2,SLIT2,DSCAM,XPO4,ZNF518B,FANCB,SYT1,CASK,EPHA4,MAP2,IRX1,FAT4,PRKCE,TWIST1,SS18,NOVA1,SPANXN1,AKAP9,CNTN1,JMJD1C,CNTNAP2,RGS6,TRPS1,ZNF521,PTPRK,COX7B2,DEPTOR,FBN2,NAV3,NUP35,FZD6,LMBRD1,SPAG9,PTPRZ1,TGFBR2,PTPRD,SERGEF,ADAM28,TSN,DAAM1,MRPL13,THSD7A,VAV3,LRIG3,PHF14,IPO8,ADAMTS5,RYR2,PAX6,ACVR2A,UHMK1,FGD3,EPHA3,ARX,ADAMTS12,RASGEF1B,IQGAP2,NTRK2</TD></TR>
<TR><TD>8.574e-04</TD><TD>-7.06</TD><TD>olfactory bulb development</TD><TD>biological process</TD><TD>GO:0021772</TD><TD>37</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>ROBO2,PAX6,SLIT2,ARX</TD></TR>
<TR><TD>8.610e-04</TD><TD>-7.06</TD><TD>urinary_tract-bladder-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>urinary_tract-bladder-carcinoma</TD><TD>14095</TD><TD>175</TD><TD>16984</TD><TD>192</TD>
<TD>IGFL4,CTSO,FGF5,BACH2,SLC25A46,AGA,PXDNL,SLC7A14,EDIL3,MPEG1,GMDS,NBEA,ZNF518B,BANK1,SYT1,FANCB,DAOA,CHRM3,KCNK9,FAT4,FGF14,THSD7B,LMBRD1,FZD6,NAV3,COX7B2,CRTC3,MRPL13,SLC7A8,LHCGR,EPS8,PRSS12,NRG1,CDH5,INSM1,PCDH9,SHISA3,ARX,UHMK1,ARL14,AMELX,FERD3L,FGFR2,RUNX1T1,GCNT1,PSKH2,SLC10A2,LGI1,KAZN,LMX1A,EFNA5,PRLHR,FGF20,NCKAP5,NOL4,PARP8,CNTN1,AKAP9,NAALADL2,SPANXN1,TWIST1,SS18,NOVA1,MAP2,SERINC5,EFEMP1,WWOX,TRPS1,OR2AG1,CD226,B3GAT2,SERGEF,GPR83,UNC5C,GHITM,PTPRZ1,SPATA16,AFM,SLC39A10,VAV3,PLEK,RASGEF1B,CELF2,GAP43,ZFPM2,UTRN,ACVR2A,LRFN5,PCGF5,SEZ6L,TCF20,ACP6,MEGF10,CXCL13,ZFAND5,KIF6,ERCC6L2,NOBOX,ACVR1C,LRRN2,SPHKAP,COQ2,DNER,EPHA4,CASK,TMEFF2,XPO4,SKAP2,DSCAM,CNTNAP2,ZNF133,PRKCE,IRX1,CPXM2,PI15,CYTL1,EFR3A,NUP35,FMNL2,ZNF521,PTPRK,KLF12,DAAM1,SEMA3C,NRCAM,CALN1,TSN,ADAM28,PTPRD,TGFBR2,RPH3A,RYR2,ROBO2,PHF14,ADAMTS5,AOAH,THSD7A,ZPLD1,CD96,NTRK2,HNF4G,ADAMTS12,EPHA3,BCHE,ADAMTS3,IL1RAPL2,MRPL3,CETN3,WRN,UBR4,RAI2,PBX1,DNAJC12,FIGN,ASPN,LRRC3B,JMJD1C,OR52K2,PHLPP1,SPAG9,MUC7,FBN2,DEPTOR,RGS6,UCHL1,PWWP2A,FUT9,IPO8,NRSN1,LRIG3,REG1B,STXBP6,IQGAP2,FGD3,PAX6</TD></TR>
<TR><TD>8.743e-04</TD><TD>-7.04</TD><TD>ARMC1 (armadillo repeat containing 1)</TD><TD>protein interactions</TD><TD>55156</TD><TD>67</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>SLC25A46,CNTN1,SYT1,MAP2,EPS8</TD></TR>
<TR><TD>8.837e-04</TD><TD>-7.03</TD><TD>Ser-Thr/Tyr_kinase_cat_dom</TD><TD>interpro domains</TD><TD>IPR001245</TD><TD>133</TD><TD>7</TD><TD>18605</TD><TD>214</TD>
<TD>TEC,ACVR1C,EPHA4,NTRK2,FGFR2,TGFBR2,EPHA3</TD></TR>
<TR><TD>9.316e-04</TD><TD>-6.98</TD><TD>Reprolysin</TD><TD>pfam domains</TD><TD>PF01421</TD><TD>38</TD><TD>4</TD><TD>17869</TD><TD>206</TD>
<TD>ADAMTS12,ADAMTS5,ADAMTS3,ADAM28</TD></TR>
<TR><TD>9.319e-04</TD><TD>-6.98</TD><TD>behavior</TD><TD>biological process</TD><TD>GO:0007610</TD><TD>620</TD><TD>17</TD><TD>18905</TD><TD>219</TD>
<TD>LMX1A,UCHL1,DSCAM,PTPRZ1,PRKCE,EPS8,GPR83,PRLHR,SEPTIN5,EPHA4,CNTNAP2,NTRK2,BCHE,PAX6,ACVR2A,CNTN1,SLC25A46</TD></TR>
<TR><TD>9.409e-04</TD><TD>-6.97</TD><TD>regulation of cell size</TD><TD>biological process</TD><TD>GO:0008361</TD><TD>173</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>NRCAM,PLEK,DSCAM,DEPTOR,SHTN1,VAV3,EFNA5,MAP2</TD></TR>
<TR><TD>9.491e-04</TD><TD>-6.96</TD><TD>regulation of phosphate metabolic process</TD><TD>biological process</TD><TD>GO:0019220</TD><TD>1159</TD><TD>26</TD><TD>18905</TD><TD>219</TD>
<TD>SPAG9,FGF5,CDH5,UCHL1,DSCAM,DEPTOR,FNIP2,PLEK,AKAP9,SLIT2,INSM1,EFNA5,EPHA4,FGFR2,NTRK2,PRKCE,FGF20,NRG1,BANK1,PAQR3,PECAM1,ACVR2A,LHCGR,PPP1R17,TGFBR2,PAX6</TD></TR>
<TR><TD>9.517e-04</TD><TD>-6.96</TD><TD>TMPRSS13 (transmembrane serine protease 13)</TD><TD>protein interactions</TD><TD>84000</TD><TD>102</TD><TD>6</TD><TD>20077</TD><TD>222</TD>
<TD>CETN3,PTPRK,GCNT1,LRIG3,EFNA5,SKAP2</TD></TR>
<TR><TD>9.602e-04</TD><TD>-6.95</TD><TD>main axon</TD><TD>cellular component</TD><TD>GO:0044304</TD><TD>68</TD><TD>5</TD><TD>19868</TD><TD>221</TD>
<TD>NRCAM,CNTNAP2,ROBO2,LGI1,MAP2</TD></TR>
<TR><TD>9.610e-04</TD><TD>-6.95</TD><TD>regulation of phosphorus metabolic process</TD><TD>biological process</TD><TD>GO:0051174</TD><TD>1160</TD><TD>26</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,PPP1R17,PAX6,PECAM1,ACVR2A,LHCGR,NRG1,FGF20,PAQR3,BANK1,PRKCE,EPHA4,FGFR2,NTRK2,AKAP9,SLIT2,INSM1,EFNA5,UCHL1,DSCAM,DEPTOR,FNIP2,PLEK,SPAG9,FGF5,CDH5</TD></TR>
<TR><TD>9.793e-04</TD><TD>-6.93</TD><TD>dystrophin-associated glycoprotein complex</TD><TD>cellular component</TD><TD>GO:0016010</TD><TD>18</TD><TD>3</TD><TD>19868</TD><TD>221</TD>
<TD>SGCD,UTRN,SGCG</TD></TR>
<TR><TD>9.800e-04</TD><TD>-6.93</TD><TD>EGF</TD><TD>pfam domains</TD><TD>PF00008</TD><TD>66</TD><TD>5</TD><TD>17869</TD><TD>206</TD>
<TD>NRG1,SLIT2,DNER,EDIL3,FAT4</TD></TR>
<TR><TD>9.855e-04</TD><TD>-6.92</TD><TD>FN3</TD><TD>prosite domains</TD><TD>PS50853</TD><TD>192</TD><TD>9</TD><TD>12232</TD><TD>161</TD>
<TD>DSCAM,ROBO2,EPHA3,CNTN1,PTPRD,PTPRK,PTPRZ1,EPHA4,NRCAM</TD></TR>
<TR><TD>1.023e-03</TD><TD>-6.88</TD><TD>plasma_cell_myeloma</TD><TD>COSMIC cancer mutations</TD><TD>plasma_cell_myeloma</TD><TD>1264</TD><TD>27</TD><TD>16984</TD><TD>192</TD>
<TD>TGFBR2,SPHKAP,SLC7A14,ACVR1C,NOBOX,TRPS1,PTPRK,NAV3,PCGF5,LRFN5,THSD7B,FAT4,EPHA3,NAALADL2,NTRK2,HNF4G,CD96,CNTNAP2,SLIT2,THSD7A,DSCAM,BANK1,TMEFF2,FIGN,ADAMTS5,FUT9,RYR2</TD></TR>
<TR><TD>1.023e-03</TD><TD>-6.88</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma</TD><TD>1264</TD><TD>27</TD><TD>16984</TD><TD>192</TD>
<TD>FIGN,BANK1,TMEFF2,ADAMTS5,RYR2,FUT9,SLIT2,DSCAM,THSD7A,NAALADL2,NTRK2,CD96,CNTNAP2,HNF4G,FAT4,EPHA3,NAV3,PCGF5,THSD7B,LRFN5,TRPS1,PTPRK,ACVR1C,NOBOX,TGFBR2,SPHKAP,SLC7A14</TD></TR>
<TR><TD>1.037e-03</TD><TD>-6.87</TD><TD>FGFR2 ligand binding and activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-190241</TD><TD>20</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGF5,FGFR2</TD></TR>
<TR><TD>1.043e-03</TD><TD>-6.87</TD><TD>skin-extremity-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-extremity-malignant_melanoma</TD><TD>1878</TD><TD>36</TD><TD>16984</TD><TD>192</TD>
<TD>FAT4,ZFPM2,EPHA3,ACVR2A,RBM20,NAALADL2,AKAP9,PARP8,CNTNAP2,NTRK2,OR52K2,PCDH9,LRRC3B,ROBO2,COQ2,RYR2,FUT9,SYT1,FANCB,NAT2,SPATA16,PTPRZ1,PTPRD,UNC5C,SPHKAP,KIF6,DAAM1,OR2AG1,FGF5,FBN2,FGFR2,MUC7,SEZ6L,THSD7B,NAV3,TCF20</TD></TR>
<TR><TD>1.048e-03</TD><TD>-6.86</TD><TD>arm</TD><TD>COSMIC cancer mutations</TD><TD>arm</TD><TD>1332</TD><TD>28</TD><TD>16984</TD><TD>192</TD>
<TD>CDH5,SPATA16,SYT1,ZNF518B,SLC39A10,CHRM3,ZPLD1,SHISA3,SLIT2,AKAP9,NOVA1,FAT4,MAP2,ADAMTS3,TCF20,FGFR2,RUNX1T1,BACH2,MEGF10,TRPS1,WRN,RGS6,UCHL1,ADAM28,PWWP2A,PTPRD,SPHKAP,EPYC</TD></TR>
<TR><TD>1.049e-03</TD><TD>-6.86</TD><TD>olfactory lobe development</TD><TD>biological process</TD><TD>GO:0021988</TD><TD>39</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>ROBO2,PAX6,SLIT2,ARX</TD></TR>
<TR><TD>1.053e-03</TD><TD>-6.86</TD><TD>extremity</TD><TD>COSMIC cancer mutations</TD><TD>extremity</TD><TD>1879</TD><TD>36</TD><TD>16984</TD><TD>192</TD>
<TD>KIF6,DAAM1,OR2AG1,PTPRZ1,UNC5C,SPHKAP,PTPRD,TCF20,NAV3,SEZ6L,MUC7,THSD7B,FGFR2,FGF5,FBN2,OR52K2,AKAP9,NAALADL2,NTRK2,CNTNAP2,PARP8,ACVR2A,RBM20,FAT4,EPHA3,ZFPM2,NAT2,SYT1,FANCB,SPATA16,ROBO2,FUT9,RYR2,COQ2,PCDH9,LRRC3B</TD></TR>
<TR><TD>1.067e-03</TD><TD>-6.84</TD><TD>central_nervous_system-brainstem-primitive_neuroectodermal_tumour-medulloblastoma-WNT_subtype</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brainstem-primitive_neuroectodermal_tumour-medulloblastoma-WNT_subtype</TD><TD>181</TD><TD>8</TD><TD>16984</TD><TD>192</TD>
<TD>CNTNAP2,BANK1,NBEA,EPS8,BACH2,NCKAP5,VAV3,THSD7A</TD></TR>
<TR><TD>1.071e-03</TD><TD>-6.84</TD><TD>positive regulation of cell projection organization</TD><TD>biological process</TD><TD>GO:0031346</TD><TD>361</TD><TD>12</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2,EPHA4,EFNA5,SHTN1,SLIT2,CNTN1,ROBO2,EPHA3,FUT9,DSCAM,PTPRD,EPS8</TD></TR>
<TR><TD>1.074e-03</TD><TD>-6.84</TD><TD>cervix-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>cervix-carcinoma-squamous_cell_carcinoma</TD><TD>11825</TD><TD>153</TD><TD>16984</TD><TD>192</TD>
<TD>ASPN,EFR3B,NCKAP5,SLIT2,FGF20,FIGN,PHLPP1,SERINC5,MAP2,NAALADL2,CNTN1,AKAP9,JMJD1C,NOVA1,TWIST1,SPANXN1,RUNX1T1,IL1RAPL2,FGFR2,WRN,MRPL3,ADAMTS3,AMELX,BCHE,FERD3L,PRLHR,DNAJC12,EFNA5,RAI2,EPYC,LGI1,SLC10A2,PSKH2,KAZN,LMX1A,UBR4,REG1B,LRIG3,VAV3,SLC39A10,FUT9,NRSN1,NAT2,AFM,IPO8,SPATA16,FGD3,ZFPM2,ACVR2A,PAX6,UTRN,GAP43,IQGAP2,CELF2,RASGEF1B,FBN2,DEPTOR,RGS6,TRPS1,MUC7,SPAG9,GPR83,PWWP2A,SERGEF,PTPRZ1,UCHL1,OR2AG1,CD226,SKAP2,XPO4,DAOA,KCNK9,CHRM3,DSCAM,EPHA4,GMDS,MPEG1,DNER,SYT1,FANCB,SGCD,TMEFF2,ZNF518B,BANK1,CASK,NBEA,FAT4,IRX1,PRKCE,ZNF133,CPXM2,CNTNAP2,BACH2,MEGF10,ACP6,ZFAND5,SEZ6L,PCGF5,IGFL4,LRFN5,TCF20,CTSO,SLC7A14,EDIL3,FNIP2,SPHKAP,KIF6,SLC25A46,LRRN2,PXDNL,ACVR1C,ERCC6L2,AOAH,PCDH9,ZPLD1,THSD7A,INSM1,ROBO2,RYR2,RPH3A,CDH5,REXO2,ADAMTS5,SGCG,EPHA3,RBM20,ARL14,UHMK1,CD96,NTRK2,ADAMTS12,PTPRK,ZNF521,LMBRD1,FGF14,THSD7B,NAV3,EFR3A,FZD6,ATG10,EPS8,ADAM28,LHCGR,TGFBR2,NRG1,PTPRD,PRSS12,NRCAM,DAAM1,CRTC3,TSN,SLC7A8,CALN1</TD></TR>
<TR><TD>1.090e-03</TD><TD>-6.82</TD><TD>mesenchymal cell differentiation</TD><TD>biological process</TD><TD>GO:0048762</TD><TD>177</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1,SLC39A10,SEMA3C,FGFR2,PAX6,TGFBR2,AMELX,NRG1</TD></TR>
<TR><TD>1.099e-03</TD><TD>-6.81</TD><TD>cervix</TD><TD>COSMIC cancer mutations</TD><TD>cervix</TD><TD>11829</TD><TD>153</TD><TD>16984</TD><TD>192</TD>
<TD>TCF20,CTSO,SEZ6L,PCGF5,IGFL4,LRFN5,ZFAND5,BACH2,MEGF10,ACP6,LRRN2,PXDNL,ACVR1C,ERCC6L2,KIF6,SLC25A46,FNIP2,SPHKAP,SLC7A14,EDIL3,SYT1,FANCB,SGCD,BANK1,TMEFF2,ZNF518B,CASK,NBEA,GMDS,EPHA4,MPEG1,DNER,KCNK9,DSCAM,CHRM3,SKAP2,DAOA,XPO4,CNTNAP2,CPXM2,FAT4,IRX1,PRKCE,ZNF133,NAV3,EFR3A,FZD6,ATG10,LMBRD1,THSD7B,FGF14,PTPRK,ZNF521,TSN,SLC7A8,CALN1,NRCAM,CRTC3,DAAM1,TGFBR2,NRG1,PTPRD,PRSS12,EPS8,ADAM28,LHCGR,REXO2,ADAMTS5,SGCG,INSM1,ROBO2,RYR2,CDH5,RPH3A,PCDH9,ZPLD1,THSD7A,AOAH,ADAMTS12,CD96,NTRK2,RBM20,ARL14,UHMK1,EPHA3,FERD3L,ADAMTS3,BCHE,AMELX,WRN,MRPL3,RUNX1T1,IL1RAPL2,FGFR2,KAZN,LMX1A,UBR4,LGI1,SLC10A2,PSKH2,EPYC,PRLHR,DNAJC12,EFNA5,RAI2,FIGN,FGF20,SLIT2,ASPN,EFR3B,NCKAP5,NOVA1,TWIST1,SPANXN1,NAALADL2,CNTN1,AKAP9,JMJD1C,SERINC5,MAP2,PHLPP1,MUC7,SPAG9,RGS6,TRPS1,FBN2,DEPTOR,CD226,UCHL1,OR2AG1,PTPRZ1,GPR83,PWWP2A,SERGEF,NRSN1,NAT2,AFM,IPO8,SPATA16,FUT9,LRIG3,VAV3,REG1B,SLC39A10,GAP43,IQGAP2,CELF2,RASGEF1B,ACVR2A,PAX6,UTRN,FGD3,ZFPM2</TD></TR>
<TR><TD>1.105e-03</TD><TD>-6.81</TD><TD>FA58C_2</TD><TD>prosite domains</TD><TD>PS01286</TD><TD>16</TD><TD>3</TD><TD>12232</TD><TD>161</TD>
<TD>CPXM2,EDIL3,CNTNAP2</TD></TR>
<TR><TD>1.105e-03</TD><TD>-6.81</TD><TD>pleura</TD><TD>COSMIC cancer mutations</TD><TD>pleura</TD><TD>4941</TD><TD>76</TD><TD>16984</TD><TD>192</TD>
<TD>VAV3,AOAH,LRIG3,PHF14,IPO8,ADAMTS5,AFM,RYR2,PAX6,ACVR2A,UHMK1,FGD3,EPHA3,ARX,ADAMTS12,RASGEF1B,NTRK2,RGS6,TRPS1,ZNF521,PTPRK,COX7B2,DEPTOR,NUP35,NAV3,FZD6,SPAG9,TGFBR2,PTPRZ1,PRSS12,PTPRD,SERGEF,ADAM28,TSN,CALN1,DAAM1,MRPL13,XPO4,NCKAP5,FANCB,SYT1,CASK,EPHA4,MAP2,CPXM2,IRX1,FAT4,PRKCE,SS18,TWIST1,NOVA1,SPANXN1,CNTN1,AKAP9,JMJD1C,CNTNAP2,WRN,IL1RAPL2,RUNX1T1,BACH2,CXCL13,FGFR2,TCF20,AMELX,PCGF5,BCHE,ADAMTS3,SPHKAP,DNAJC12,EDIL3,PBX1,RAI2,ACVR1C,UBR4,KIF6,PSKH2</TD></TR>
<TR><TD>1.106e-03</TD><TD>-6.81</TD><TD>WNT_subtype</TD><TD>COSMIC cancer mutations</TD><TD>WNT_subtype</TD><TD>182</TD><TD>8</TD><TD>16984</TD><TD>192</TD>
<TD>THSD7A,EPS8,BACH2,NCKAP5,VAV3,BANK1,NBEA,CNTNAP2</TD></TR>
<TR><TD>1.107e-03</TD><TD>-6.81</TD><TD>tissue morphogenesis</TD><TD>biological process</TD><TD>GO:0048729</TD><TD>574</TD><TD>16</TD><TD>18905</TD><TD>219</TD>
<TD>PBX1,GCNT1,IRX1,SLIT2,FZD6,FGFR2,SEMA3C,ZFPM2,EPHA4,TGFBR2,TWIST1,TMEFF2,ADAMTS5,ROBO2,NRG1,RYR2</TD></TR>
<TR><TD>1.124e-03</TD><TD>-6.79</TD><TD>Peptidase_M12B</TD><TD>interpro domains</TD><TD>IPR001590</TD><TD>40</TD><TD>4</TD><TD>18605</TD><TD>214</TD>
<TD>ADAMTS5,ADAMTS12,ADAM28,ADAMTS3</TD></TR>
<TR><TD>1.131e-03</TD><TD>-6.78</TD><TD>regulation of developmental growth</TD><TD>biological process</TD><TD>GO:0048638</TD><TD>314</TD><TD>11</TD><TD>18905</TD><TD>219</TD>
<TD>EFNA5,MAP2,SHTN1,SPAG9,ARX,NRCAM,FGFR2,SYT1,DSCAM,FGF20,ZFPM2</TD></TR>
<TR><TD>1.151e-03</TD><TD>-6.77</TD><TD>transmembrane receptor protein serine/threonine kinase activity</TD><TD>molecular function</TD><TD>GO:0004675</TD><TD>19</TD><TD>3</TD><TD>18530</TD><TD>206</TD>
<TD>ACVR2A,ACVR1C,TGFBR2</TD></TR>
<TR><TD>1.166e-03</TD><TD>-6.75</TD><TD>human chr5q22.1</TD><TD>chromosome location</TD><TD>human chr5q22.1</TD><TD>24</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>EPB41L4A-AS1,SLC25A46</TD></TR>
<TR><TD>1.223e-03</TD><TD>-6.71</TD><TD>human chr5q14.3</TD><TD>chromosome location</TD><TD>human chr5q14.3</TD><TD>99</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>MIR9-2HG,EDIL3,CETN3</TD></TR>
<TR><TD>1.223e-03</TD><TD>-6.71</TD><TD>human chr4q26</TD><TD>chromosome location</TD><TD>human chr4q26</TD><TD>99</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>MIR1973,MIR577,PRSS12</TD></TR>
<TR><TD>1.230e-03</TD><TD>-6.70</TD><TD>central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I</TD><TD>105</TD><TD>6</TD><TD>16984</TD><TD>192</TD>
<TD>NRG1,ZFPM2,NOL4,SPATA16,FGF14,NAALADL2</TD></TR>
<TR><TD>1.235e-03</TD><TD>-6.70</TD><TD>somatodendritic compartment</TD><TD>cellular component</TD><TD>GO:0036477</TD><TD>844</TD><TD>20</TD><TD>19868</TD><TD>221</TD>
<TD>RPH3A,SHTN1,EPHA4,NRSN1,SEZ6L,BRINP3,CNTNAP2,PRSS12,DSCAM,AKAP9,GAP43,EPHA3,UCHL1,UHMK1,MAP2,UNC5C,CHRM3,DNER,NTRK2,LGI1</TD></TR>
<TR><TD>1.236e-03</TD><TD>-6.70</TD><TD>LRRNT</TD><TD>smart domains</TD><TD>SM00013</TD><TD>54</TD><TD>5</TD><TD>9743</TD><TD>146</TD>
<TD>EPYC,ASPN,LRRC3B,SLIT2,NTRK2</TD></TR>
<TR><TD>1.260e-03</TD><TD>-6.68</TD><TD>response to growth factor</TD><TD>biological process</TD><TD>GO:0070848</TD><TD>526</TD><TD>15</TD><TD>18905</TD><TD>219</TD>
<TD>ADAMTS12,CXCL13,FGF5,CDH5,TWIST1,ACVR1C,FGF20,WWOX,PTPRK,ACVR2A,TGFBR2,PAX6,FGFR2,GAREM1,NTRK2</TD></TR>
<TR><TD>1.268e-03</TD><TD>-6.67</TD><TD>endocardial cushion morphogenesis</TD><TD>biological process</TD><TD>GO:0003203</TD><TD>41</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,ADAMTS5,TWIST1,ROBO2</TD></TR>
<TR><TD>1.269e-03</TD><TD>-6.67</TD><TD>ADAMTS_CR_2</TD><TD>interpro domains</TD><TD>IPR041645</TD><TD>19</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>ADAMTS5,ADAMTS12,ADAMTS3</TD></TR>
<TR><TD>1.277e-03</TD><TD>-6.66</TD><TD>ADAMTS_CR_2</TD><TD>pfam domains</TD><TD>PF17771</TD><TD>19</TD><TD>3</TD><TD>17869</TD><TD>206</TD>
<TD>ADAMTS3,ADAMTS5,ADAMTS12</TD></TR>
<TR><TD>1.282e-03</TD><TD>-6.66</TD><TD>circulatory system development</TD><TD>biological process</TD><TD>GO:0072359</TD><TD>934</TD><TD>22</TD><TD>18905</TD><TD>219</TD>
<TD>ZFPM2,TGFBR2,PAX6,FGFR2,DAW1,SEMA3C,NTRK2,PECAM1,SLIT2,RBM20,VAV3,RYR2,ZFAND5,SGCD,NRG1,NRCAM,SGCG,ROBO2,ADAMTS5,CDH5,THSD7A,TWIST1</TD></TR>
<TR><TD>1.292e-03</TD><TD>-6.65</TD><TD>regulation of phosphorylation</TD><TD>biological process</TD><TD>GO:0042325</TD><TD>996</TD><TD>23</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,TGFBR2,ACVR2A,PECAM1,BANK1,PAQR3,NRG1,FGF20,PRKCE,NTRK2,FGFR2,EPHA4,EFNA5,INSM1,AKAP9,SLIT2,FNIP2,DEPTOR,UCHL1,DSCAM,CDH5,FGF5,SPAG9</TD></TR>
<TR><TD>1.296e-03</TD><TD>-6.65</TD><TD>pulmonary valve morphogenesis</TD><TD>biological process</TD><TD>GO:0003184</TD><TD>19</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>ROBO2,SLIT2,ADAMTS5</TD></TR>
<TR><TD>1.296e-03</TD><TD>-6.65</TD><TD>kidney epithelium development</TD><TD>biological process</TD><TD>GO:0072073</TD><TD>141</TD><TD>7</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,IRX1,EPHA4,PECAM1,ROBO2,PBX1,FGFR2</TD></TR>
<TR><TD>1.305e-03</TD><TD>-6.64</TD><TD>mesenchymal cell proliferation involved in lung development</TD><TD>biological process</TD><TD>GO:0060916</TD><TD>5</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,PHF14</TD></TR>
<TR><TD>1.326e-03</TD><TD>-6.63</TD><TD>positive regulation of phosphorus metabolic process</TD><TD>biological process</TD><TD>GO:0010562</TD><TD>698</TD><TD>18</TD><TD>18905</TD><TD>219</TD>
<TD>BANK1,UCHL1,NRG1,FGF20,DSCAM,PLEK,FNIP2,FGF5,CDH5,TGFBR2,EPHA4,NTRK2,FGFR2,ACVR2A,AKAP9,PECAM1,EFNA5,LHCGR</TD></TR>
<TR><TD>1.326e-03</TD><TD>-6.63</TD><TD>positive regulation of phosphate metabolic process</TD><TD>biological process</TD><TD>GO:0045937</TD><TD>698</TD><TD>18</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,NTRK2,EPHA4,TGFBR2,LHCGR,EFNA5,PECAM1,ACVR2A,AKAP9,FNIP2,PLEK,NRG1,FGF20,DSCAM,UCHL1,BANK1,CDH5,FGF5</TD></TR>
<TR><TD>1.332e-03</TD><TD>-6.62</TD><TD>urinary_tract</TD><TD>COSMIC cancer mutations</TD><TD>urinary_tract</TD><TD>14159</TD><TD>175</TD><TD>16984</TD><TD>192</TD>
<TD>CASK,TMEFF2,COQ2,EPHA4,DNER,DSCAM,SKAP2,XPO4,CNTNAP2,CPXM2,PI15,PRKCE,ZNF133,IRX1,TCF20,LRFN5,SEZ6L,PCGF5,ZFAND5,ACP6,CXCL13,MEGF10,NOBOX,ERCC6L2,LRRN2,ACVR1C,KIF6,SPHKAP,ADAMTS5,PHF14,RYR2,RPH3A,ROBO2,ZPLD1,THSD7A,AOAH,ADAMTS12,NTRK2,HNF4G,CD96,EPHA3,NUP35,EFR3A,CYTL1,KLF12,FMNL2,PTPRK,ZNF521,CALN1,TSN,DAAM1,SEMA3C,NRCAM,PTPRD,TGFBR2,ADAM28,FIGN,LRRC3B,ASPN,OR52K2,JMJD1C,PHLPP1,ADAMTS3,BCHE,MRPL3,WRN,CETN3,IL1RAPL2,UBR4,RAI2,PBX1,DNAJC12,IPO8,NRSN1,FUT9,REG1B,LRIG3,IQGAP2,STXBP6,PAX6,FGD3,SPAG9,MUC7,RGS6,FBN2,DEPTOR,UCHL1,PWWP2A,NBEA,SYT1,FANCB,ZNF518B,BANK1,GMDS,MPEG1,CHRM3,KCNK9,DAOA,FAT4,CTSO,IGFL4,FGF5,BACH2,AGA,PXDNL,SLC25A46,EDIL3,SLC7A14,CDH5,INSM1,PCDH9,SHISA3,ARL14,UHMK1,ARX,FZD6,NAV3,FGF14,THSD7B,LMBRD1,COX7B2,SLC7A8,MRPL13,CRTC3,PRSS12,NRG1,LHCGR,EPS8,FGF20,NCKAP5,NOL4,SPANXN1,NOVA1,SS18,TWIST1,PARP8,NAALADL2,CNTN1,AKAP9,MAP2,SERINC5,FERD3L,AMELX,GCNT1,FGFR2,RUNX1T1,KAZN,LMX1A,PSKH2,LGI1,SLC10A2,PRLHR,EFNA5,AFM,SPATA16,PLEK,VAV3,SLC39A10,RASGEF1B,CELF2,GAP43,UTRN,ACVR2A,ZFPM2,WWOX,EFEMP1,TRPS1,CD226,OR2AG1,UNC5C,PTPRZ1,GHITM,SERGEF,B3GAT2,GPR83</TD></TR>
<TR><TD>1.332e-03</TD><TD>-6.62</TD><TD>bladder</TD><TD>COSMIC cancer mutations</TD><TD>bladder</TD><TD>14159</TD><TD>175</TD><TD>16984</TD><TD>192</TD>
<TD>WWOX,EFEMP1,TRPS1,CD226,OR2AG1,GHITM,PTPRZ1,UNC5C,GPR83,B3GAT2,SERGEF,SPATA16,AFM,PLEK,SLC39A10,VAV3,GAP43,CELF2,RASGEF1B,ACVR2A,UTRN,ZFPM2,FERD3L,AMELX,GCNT1,RUNX1T1,FGFR2,LMX1A,KAZN,SLC10A2,LGI1,PSKH2,EFNA5,PRLHR,FGF20,NOL4,NCKAP5,SS18,TWIST1,NOVA1,SPANXN1,CNTN1,AKAP9,NAALADL2,PARP8,SERINC5,MAP2,NAV3,FZD6,LMBRD1,THSD7B,FGF14,COX7B2,SLC7A8,CRTC3,MRPL13,NRG1,PRSS12,EPS8,LHCGR,INSM1,CDH5,SHISA3,PCDH9,UHMK1,ARL14,ARX,CTSO,IGFL4,BACH2,FGF5,PXDNL,AGA,SLC25A46,EDIL3,SLC7A14,ZNF518B,BANK1,SYT1,FANCB,NBEA,MPEG1,GMDS,KCNK9,CHRM3,DAOA,FAT4,MUC7,SPAG9,RGS6,DEPTOR,FBN2,UCHL1,PWWP2A,NRSN1,IPO8,FUT9,REG1B,LRIG3,IQGAP2,STXBP6,PAX6,FGD3,BCHE,ADAMTS3,CETN3,WRN,MRPL3,IL1RAPL2,UBR4,DNAJC12,PBX1,RAI2,FIGN,LRRC3B,ASPN,OR52K2,JMJD1C,PHLPP1,EFR3A,NUP35,CYTL1,KLF12,ZNF521,PTPRK,FMNL2,TSN,CALN1,NRCAM,SEMA3C,DAAM1,TGFBR2,PTPRD,ADAM28,PHF14,ADAMTS5,ROBO2,RPH3A,RYR2,THSD7A,ZPLD1,AOAH,ADAMTS12,NTRK2,CD96,HNF4G,EPHA3,TCF20,SEZ6L,PCGF5,LRFN5,ZFAND5,MEGF10,CXCL13,ACP6,ACVR1C,LRRN2,ERCC6L2,NOBOX,KIF6,SPHKAP,TMEFF2,CASK,DNER,EPHA4,COQ2,DSCAM,XPO4,SKAP2,CNTNAP2,PI15,CPXM2,IRX1,ZNF133,PRKCE</TD></TR>
<TR><TD>1.336e-03</TD><TD>-6.62</TD><TD>regulation of protein-containing complex assembly</TD><TD>biological process</TD><TD>GO:0043254</TD><TD>422</TD><TD>13</TD><TD>18905</TD><TD>219</TD>
<TD>STXBP6,INSM1,AKAP9,SLIT2,MAP2,CDH5,PRKCE,CXCL13,EPS8,NAV3,PLEK,FNIP2,NRG1</TD></TR>
<TR><TD>1.339e-03</TD><TD>-6.62</TD><TD>autonomic_ganglia</TD><TD>COSMIC cancer mutations</TD><TD>autonomic_ganglia</TD><TD>4009</TD><TD>64</TD><TD>16984</TD><TD>192</TD>
<TD>ZNF133,FAT4,MAP2,CPXM2,CNTNAP2,AKAP9,NAALADL2,OR52K2,SS18,NCKAP5,SLIT2,GMDS,FANCB,SPHKAP,LGI1,AGA,ACVR1C,PXDNL,FGFR2,CXCL13,AMELX,TCF20,EPHA3,UTRN,PAX6,RBM20,NTRK2,DEFB115,IQGAP2,ADAMTS12,SLC39A10,AOAH,LRIG3,VAV3,THSD7A,PLEK,PCDH9,RPH3A,CDH5,FUT9,RYR2,SPATA16,SGCG,ADAMTS5,AFM,NAT2,SERGEF,ADAM28,PRSS12,PTPRD,PTPRZ1,DAAM1,OR2AG1,CALN1,SLC7A8,TSN,DEPTOR,FBN2,ZNF521,PTPRK,TRPS1,SPAG9,FZD6,NAV3</TD></TR>
<TR><TD>1.350e-03</TD><TD>-6.61</TD><TD>neuron migration</TD><TD>biological process</TD><TD>GO:0001764</TD><TD>142</TD><TD>7</TD><TD>18905</TD><TD>219</TD>
<TD>NRCAM,PAX6,NTRK2,ADGRL3,TWIST1,ARX,DNER</TD></TR>
<TR><TD>1.369e-03</TD><TD>-6.59</TD><TD>human chr9p24.2</TD><TD>chromosome location</TD><TD>human chr9p24.2</TD><TD>26</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>GLIS3-AS1,PUM3</TD></TR>
<TR><TD>1.369e-03</TD><TD>-6.59</TD><TD>human chr13q22.1</TD><TD>chromosome location</TD><TD>human chr13q22.1</TD><TD>26</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC00392,KLF12</TD></TR>
<TR><TD>1.410e-03</TD><TD>-6.56</TD><TD>EPH-ephrin mediated repulsion of cells</TD><TD>REACTOME pathways</TD><TD>R-HSA-3928665</TD><TD>48</TD><TD>4</TD><TD>10391</TD><TD>106</TD>
<TD>VAV3,EPHA4,EFNA5,EPHA3</TD></TR>
<TR><TD>1.412e-03</TD><TD>-6.56</TD><TD>upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma</TD><TD>1426</TD><TD>29</TD><TD>16984</TD><TD>192</TD>
<TD>FGF5,FMNL2,FGFR2,ZNF521,TCF20,ADAMTS3,BCHE,LMBRD1,SPHKAP,UNC5C,B3GAT2,UBR4,CALN1,CRTC3,DSCAM,THSD7A,REG1B,NCKAP5,NBEA,ADAMTS5,TMEFF2,RYR2,MPEG1,MAP2,ZFPM2,PRKCE,STXBP6,NTRK2,AKAP9</TD></TR>
<TR><TD>1.412e-03</TD><TD>-6.56</TD><TD>nasopharyngeal_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>nasopharyngeal_carcinoma</TD><TD>1426</TD><TD>29</TD><TD>16984</TD><TD>192</TD>
<TD>ZNF521,FGF5,FMNL2,FGFR2,ADAMTS3,BCHE,LMBRD1,TCF20,B3GAT2,UNC5C,SPHKAP,CRTC3,UBR4,CALN1,REG1B,NCKAP5,DSCAM,THSD7A,MPEG1,RYR2,TMEFF2,ADAMTS5,NBEA,PRKCE,ZFPM2,MAP2,AKAP9,NTRK2,STXBP6</TD></TR>
<TR><TD>1.426e-03</TD><TD>-6.55</TD><TD>plasma membrane bounded cell projection</TD><TD>cellular component</TD><TD>GO:0120025</TD><TD>2293</TD><TD>41</TD><TD>19868</TD><TD>221</TD>
<TD>PLEK,AKAP9,GAP43,EPHA3,UCHL1,NRCAM,RGS6,UHMK1,MAP2,CHRM3,DAW1,DAAM1,CETN3,DCDC2C,LGI1,CNTN1,FGD3,RPH3A,ADGRL3,UTRN,PRLHR,EPHA4,SHTN1,NRSN1,CASK,CNTNAP2,PRSS12,DSCAM,EPS8,SYT1,UNC5C,PCDH9,SLC10A2,DNER,NTRK2,WWOX,IQGAP2,SLC7A8,GPR83,BRINP3,ROBO2</TD></TR>
<TR><TD>1.428e-03</TD><TD>-6.55</TD><TD>hepatocellular_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>hepatocellular_carcinoma</TD><TD>14860</TD><TD>181</TD><TD>16984</TD><TD>192</TD>
<TD>CNTNAP2,IRX1,ZNF133,PRKCE,PI15,CPXM2,DNER,EPHA4,COQ2,TMEFF2,SGCD,CASK,XPO4,DCDC2C,SKAP2,DSCAM,KIF6,PAQR3,ACVR1C,LRRN2,NOBOX,SPHKAP,SEZ6L,LRFN5,TCF20,MEGF10,ZFAND5,HNF4G,CD96,NTRK2,ADAMTS12,EPHA3,ROBO2,RPH3A,RYR2,PHF14,SGCG,ADAMTS5,AOAH,THSD7A,ZPLD1,NRCAM,SEMA3C,DAAM1,TSN,CALN1,ADAM28,TGFBR2,PTPRD,CYTL1,EFR3A,NUP35,ATG10,ZNF521,PTPRK,FMNL2,KLF12,JMJD1C,LRRC70,OR52K2,PHLPP1,FIGN,EFR3B,ASPN,LRRC3B,UBR4,DNAJC12,RAI2,BCHE,ADAMTS3,IL1RAPL2,WRN,MRPL3,IQGAP2,STXBP6,FGD3,PAX6,FUT9,NRSN1,IPO8,REG1B,LRIG3,UCHL1,PWWP2A,MUC7,SPAG9,DEPTOR,FBN2,RGS6,FAT4,MPEG1,GMDS,ZNF518B,BANK1,FANCB,SYT1,NBEA,DAOA,KCNK9,CHRM3,SLC25A46,FABP7,PXDNL,SLC7A14,EDIL3,FNIP2,IGFL4,CTSO,BACH2,FGF5,ARX,RBM20,UHMK1,ARL14,INSM1,CDH5,SHISA3,PCDH9,CRTC3,MRPL13,SLC7A8,EPS8,LHCGR,NRG1,PRSS12,LMBRD1,THSD7B,FGF14,NAV3,FZD6,COX7B2,CNTN1,AKAP9,NAALADL2,PARP8,SS18,TWIST1,NOVA1,SPANXN1,SERINC5,MAP2,FGF20,NOL4,NCKAP5,SLIT2,SLC10A2,LGI1,PSKH2,LMX1A,KAZN,EFNA5,PRLHR,EPYC,FERD3L,RUNX1T1,FGFR2,GCNT1,LINC00583,DEFB115,GAP43,RASGEF1B,CELF2,ZFPM2,ACVR2A,UTRN,NAT2,SPATA16,AFM,SLC39A10,VAV3,PLEK,OR2AG1,CD226,GPR83,SERGEF,B3GAT2,GHITM,PTPRZ1,UNC5C,EFEMP1,TRPS1</TD></TR>
<TR><TD>1.428e-03</TD><TD>-6.55</TD><TD>liver-carcinoma-hepatocellular_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>liver-carcinoma-hepatocellular_carcinoma</TD><TD>14860</TD><TD>181</TD><TD>16984</TD><TD>192</TD>
<TD>CDH5,INSM1,PCDH9,SHISA3,ARX,ARL14,UHMK1,RBM20,FGF14,THSD7B,LMBRD1,FZD6,NAV3,COX7B2,MRPL13,CRTC3,SLC7A8,LHCGR,EPS8,PRSS12,NRG1,GMDS,MPEG1,NBEA,SYT1,FANCB,ZNF518B,BANK1,DAOA,CHRM3,KCNK9,FAT4,IGFL4,CTSO,FGF5,BACH2,FABP7,SLC25A46,PXDNL,EDIL3,SLC7A14,FNIP2,AFM,SPATA16,NAT2,VAV3,SLC39A10,PLEK,DEFB115,CELF2,RASGEF1B,GAP43,ZFPM2,UTRN,ACVR2A,EFEMP1,TRPS1,OR2AG1,CD226,B3GAT2,SERGEF,GPR83,UNC5C,PTPRZ1,GHITM,FGF20,NCKAP5,NOL4,SLIT2,PARP8,NAALADL2,AKAP9,CNTN1,SPANXN1,NOVA1,SS18,TWIST1,MAP2,SERINC5,FERD3L,FGFR2,RUNX1T1,LINC00583,GCNT1,PSKH2,LGI1,SLC10A2,LMX1A,KAZN,PRLHR,EFNA5,EPYC,RYR2,RPH3A,ROBO2,ADAMTS5,SGCG,PHF14,AOAH,ZPLD1,THSD7A,HNF4G,CD96,NTRK2,ADAMTS12,EPHA3,CYTL1,ATG10,NUP35,EFR3A,FMNL2,PTPRK,ZNF521,KLF12,DAAM1,SEMA3C,NRCAM,CALN1,TSN,ADAM28,PTPRD,TGFBR2,COQ2,EPHA4,DNER,CASK,SGCD,TMEFF2,SKAP2,DCDC2C,XPO4,DSCAM,CNTNAP2,PRKCE,ZNF133,IRX1,CPXM2,PI15,LRFN5,SEZ6L,TCF20,MEGF10,ZFAND5,PAQR3,KIF6,NOBOX,LRRN2,ACVR1C,SPHKAP,FUT9,IPO8,NRSN1,REG1B,LRIG3,IQGAP2,STXBP6,FGD3,PAX6,SPAG9,MUC7,DEPTOR,FBN2,RGS6,UCHL1,PWWP2A,FIGN,ASPN,EFR3B,LRRC3B,LRRC70,JMJD1C,OR52K2,PHLPP1,ADAMTS3,BCHE,IL1RAPL2,MRPL3,WRN,UBR4,RAI2,DNAJC12</TD></TR>
<TR><TD>1.439e-03</TD><TD>-6.54</TD><TD>neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>neoplasm</TD><TD>14861</TD><TD>181</TD><TD>16984</TD><TD>192</TD>
<TD>CTSO,IGFL4,FGF5,BACH2,AGA,PXDNL,FABP7,SLC25A46,FNIP2,EDIL3,SLC7A14,NBEA,SYT1,FANCB,BANK1,GMDS,MPEG1,CHRM3,KCNK9,DAOA,FAT4,FZD6,NAV3,FGF14,THSD7B,LMBRD1,SLC7A8,MRPL13,CRTC3,PRSS12,NRG1,LHCGR,EPS8,CDH5,INSM1,PCDH9,SHISA3,RBM20,ARX,FERD3L,AMELX,LINC00583,GCNT1,FGFR2,RUNX1T1,LMX1A,KAZN,PSKH2,LGI1,SLC10A2,EPYC,EFNA5,FGF20,SLIT2,NCKAP5,NOL4,SPANXN1,NOVA1,SS18,TWIST1,PARP8,NAALADL2,CNTN1,AKAP9,MAP2,EFEMP1,TRPS1,CD226,OR2AG1,UNC5C,PTPRZ1,GHITM,SERGEF,B3GAT2,GPR83,AFM,SPATA16,NAT2,PLEK,VAV3,SLC39A10,RASGEF1B,CELF2,GAP43,DEFB115,UTRN,ACVR2A,ZFPM2,TCF20,LRFN5,PCGF5,SEZ6L,ZFAND5,ACP6,CXCL13,MEGF10,NOBOX,LRRN2,ACVR1C,PAQR3,KIF6,SPHKAP,CASK,SGCD,TMEFF2,COQ2,EPHA4,DNER,DSCAM,SKAP2,DCDC2C,XPO4,CNTNAP2,CPXM2,PI15,PRKCE,ZNF133,IRX1,ATG10,NUP35,EFR3A,CYTL1,KLF12,FMNL2,PTPRK,ZNF521,TSN,DAAM1,SEMA3C,NRCAM,PTPRD,TGFBR2,ADAM28,ADAMTS5,PHF14,SGCG,REXO2,RYR2,RPH3A,ROBO2,ZPLD1,THSD7A,AOAH,ADAMTS12,CD96,NTRK2,HNF4G,EPHA3,ADAMTS3,BCHE,MRPL3,WRN,CETN3,IL1RAPL2,UBR4,RAI2,PBX1,DNAJC12,FIGN,LRRC3B,ASPN,EFR3B,LRRC70,JMJD1C,PHLPP1,SPAG9,MUC7,LINC01387,DEPTOR,FBN2,UCHL1,PWWP2A,IPO8,NRSN1,FUT9,REG1B,LRIG3,IQGAP2,STXBP6,PAX6,FGD3</TD></TR>
<TR><TD>1.461e-03</TD><TD>-6.53</TD><TD>EPHA forward signaling</TD><TD>Pathway Interaction DB</TD><TD>epha_fwdpathway</TD><TD>31</TD><TD>4</TD><TD>2232</TD><TD>37</TD>
<TD>EPHA4,EPHA3,EFNA5,VAV3</TD></TR>
<TR><TD>1.494e-03</TD><TD>-6.51</TD><TD>mesothelioma</TD><TD>COSMIC cancer mutations</TD><TD>mesothelioma</TD><TD>4504</TD><TD>70</TD><TD>16984</TD><TD>192</TD>
<TD>SPHKAP,EDIL3,DNAJC12,PBX1,RAI2,ACVR1C,UBR4,KIF6,PSKH2,WRN,CXCL13,BACH2,RUNX1T1,IL1RAPL2,FGFR2,TCF20,ADAMTS3,PCGF5,AMELX,CPXM2,IRX1,PRKCE,NOVA1,SS18,TWIST1,SPANXN1,CNTN1,AKAP9,CNTNAP2,JMJD1C,XPO4,FANCB,SYT1,CASK,EPHA4,PTPRZ1,TGFBR2,PTPRD,ADAM28,SERGEF,TSN,MRPL13,DAAM1,RGS6,TRPS1,PTPRK,ZNF521,DEPTOR,COX7B2,NAV3,NUP35,FZD6,SPAG9,ACVR2A,PAX6,UHMK1,FGD3,ARX,EPHA3,ADAMTS12,RASGEF1B,NTRK2,VAV3,AOAH,LRIG3,IPO8,ADAMTS5,AFM,PHF14,RYR2</TD></TR>
<TR><TD>1.511e-03</TD><TD>-6.49</TD><TD>axonal fasciculation</TD><TD>biological process</TD><TD>GO:0007413</TD><TD>20</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4,EPHA3,NRCAM</TD></TR>
<TR><TD>1.511e-03</TD><TD>-6.49</TD><TD>neuron projection fasciculation</TD><TD>biological process</TD><TD>GO:0106030</TD><TD>20</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4,EPHA3,NRCAM</TD></TR>
<TR><TD>1.517e-03</TD><TD>-6.49</TD><TD>cell surface receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0007166</TD><TD>2070</TD><TD>39</TD><TD>18905</TD><TD>219</TD>
<TD>CNTN1,PECAM1,FZD6,ACVR2A,IL1RAPL2,ADGRL3,TGFBR2,PAX6,GAREM1,PRKCE,DNER,SS18,ACVR1C,ZFAND5,FGF20,NRG1,BANK1,WWOX,PTPRK,SLIT2,GMDS,EFEMP1,SHTN1,DAAM1,EFNA5,VAV3,EPHA4,FGFR2,SEMA3C,NTRK2,PTPRD,CXCL13,FGF5,CDH5,UNC5C,DSCAM,EPHA3,TEC,PLEK</TD></TR>
<TR><TD>1.529e-03</TD><TD>-6.48</TD><TD>human chr1q43</TD><TD>chromosome location</TD><TD>human chr1q43</TD><TD>107</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>LINC01139,CHRM3,RYR2</TD></TR>
<TR><TD>1.531e-03</TD><TD>-6.48</TD><TD>SHC4 (SHC adaptor protein 4)</TD><TD>protein interactions</TD><TD>399694</TD><TD>21</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>GAREM1,NTRK2,NBEA</TD></TR>
<TR><TD>1.531e-03</TD><TD>-6.48</TD><TD>SGSM3 (small G protein signaling modulator 3)</TD><TD>protein interactions</TD><TD>27352</TD><TD>21</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>DSCAM,CD226,CHRM3</TD></TR>
<TR><TD>1.547e-03</TD><TD>-6.47</TD><TD>regulation of neurogenesis</TD><TD>biological process</TD><TD>GO:0050767</TD><TD>377</TD><TD>12</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,SHTN1,EFNA5,EPHA4,PAX6,FERD3L,NTRK2,PTPRD,MAP2,DSCAM,ROBO2,PTPRZ1</TD></TR>
<TR><TD>1.557e-03</TD><TD>-6.46</TD><TD>axon initial segment</TD><TD>cellular component</TD><TD>GO:0043194</TD><TD>21</TD><TD>3</TD><TD>19868</TD><TD>221</TD>
<TD>NRCAM,LGI1,MAP2</TD></TR>
<TR><TD>1.572e-03</TD><TD>-6.46</TD><TD>Bile Acid Indirect Signalling Pathway</TD><TD>SMPDB pathways</TD><TD>SMP0086851</TD><TD>8</TD><TD>2</TD><TD>1382</TD><TD>11</TD>
<TD>FGFR2,SLC10A2</TD></TR>
<TR><TD>1.575e-03</TD><TD>-6.45</TD><TD>SHC-mediated cascade:FGFR2</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654699</TD><TD>23</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGFR2,FGF20</TD></TR>
<TR><TD>1.575e-03</TD><TD>-6.45</TD><TD>PI-3K cascade:FGFR2</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654695</TD><TD>23</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGFR2,FGF20</TD></TR>
<TR><TD>1.579e-03</TD><TD>-6.45</TD><TD>FA58C_1</TD><TD>prosite domains</TD><TD>PS01285</TD><TD>18</TD><TD>3</TD><TD>12232</TD><TD>161</TD>
<TD>CPXM2,EDIL3,CNTNAP2</TD></TR>
<TR><TD>1.580e-03</TD><TD>-6.45</TD><TD>heart valve development</TD><TD>biological process</TD><TD>GO:0003170</TD><TD>73</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,ADAMTS5,SLIT2,ROBO2,TWIST1</TD></TR>
<TR><TD>1.588e-03</TD><TD>-6.45</TD><TD>human chr5p14.1</TD><TD>chromosome location</TD><TD>human chr5p14.1</TD><TD>28</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC02103,PURPL</TD></TR>
<TR><TD>1.611e-03</TD><TD>-6.43</TD><TD>PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha)</TD><TD>protein interactions</TD><TD>5576</TD><TD>197</TD><TD>8</TD><TD>20077</TD><TD>222</TD>
<TD>AKAP9,SPAG9,RYR2,RUNX1T1,MAP2,SLC25A46,NBEA,DEPTOR</TD></TR>
<TR><TD>1.617e-03</TD><TD>-6.43</TD><TD>cell communication</TD><TD>biological process</TD><TD>GO:0007154</TD><TD>5154</TD><TD>80</TD><TD>18905</TD><TD>219</TD>
<TD>CHRM3,FGFR2,CNTNAP2,SEMA3C,AMELX,OR2AG1,EFEMP1,VAV3,FGF14,SLIT2,AKAP9,GMDS,NRCAM,TEC,PHLPP1,UCHL1,EPHA3,DSCAM,RYR2,CDH5,PRLHR,SPAG9,CD226,PTPRD,IPO8,PAX6,LHCGR,PECAM1,CNTN1,IL1RAPL2,FGF20,ACVR1C,SGCD,ZFAND5,WWOX,SERGEF,SS18,EPS8,OR52K2,UTRN,NTRK2,EPHA4,FAT4,SHTN1,IQGAP2,EFNA5,DAAM1,DCDC2C,FNIP2,PLEK,DEPTOR,UNC5C,CXCL13,GPR83,FGF5,LRRN2,GAREM1,CYTL1,TGFBR2,PPP1R17,PARP8,RPH3A,ATG10,ADGRL3,GAP43,ACVR2A,FZD6,SKAP2,RGS6,SYT1,PTPRK,NRG1,BANK1,SEPTIN5,MAST4,HNF4G,DNER,FBN2,PRKCE,RASGEF1B</TD></TR>
<TR><TD>1.619e-03</TD><TD>-6.43</TD><TD>cardiac septum development</TD><TD>biological process</TD><TD>GO:0003279</TD><TD>108</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>SEMA3C,ROBO2,FGFR2,TGFBR2,ZFPM2,SLIT2</TD></TR>
<TR><TD>1.626e-03</TD><TD>-6.42</TD><TD>Galactose-bd-like_sf</TD><TD>interpro domains</TD><TD>IPR008979</TD><TD>74</TD><TD>5</TD><TD>18605</TD><TD>214</TD>
<TD>EDIL3,CNTNAP2,EPHA3,CPXM2,EPHA4</TD></TR>
<TR><TD>1.645e-03</TD><TD>-6.41</TD><TD>dendrite</TD><TD>cellular component</TD><TD>GO:0030425</TD><TD>621</TD><TD>16</TD><TD>19868</TD><TD>221</TD>
<TD>RPH3A,EPHA4,BRINP3,DSCAM,PRSS12,CNTNAP2,GAP43,AKAP9,UHMK1,EPHA3,UNC5C,CHRM3,MAP2,LGI1,DNER,NTRK2</TD></TR>
<TR><TD>1.656e-03</TD><TD>-6.40</TD><TD>EGF_CA</TD><TD>prosite domains</TD><TD>PS01187</TD><TD>96</TD><TD>6</TD><TD>12232</TD><TD>161</TD>
<TD>DNER,FBN2,SLIT2,FAT4,EDIL3,EFEMP1</TD></TR>
<TR><TD>1.665e-03</TD><TD>-6.40</TD><TD>HBGFFGF</TD><TD>prints domains</TD><TD>PR00263</TD><TD>18</TD><TD>3</TD><TD>5258</TD><TD>71</TD>
<TD>FGF20,FGF14,FGF5</TD></TR>
<TR><TD>1.678e-03</TD><TD>-6.39</TD><TD>ventricular septum development</TD><TD>biological process</TD><TD>GO:0003281</TD><TD>74</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>ZFPM2,SLIT2,TGFBR2,FGFR2,ROBO2</TD></TR>
<TR><TD>1.690e-03</TD><TD>-6.38</TD><TD>endometrium-carcinoma-serous_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>endometrium-carcinoma-serous_carcinoma</TD><TD>1443</TD><TD>29</TD><TD>16984</TD><TD>192</TD>
<TD>FGFR2,TRPS1,ADAMTS3,LMBRD1,SEZ6L,NUP35,WWOX,DNAJC12,LHCGR,B3GAT2,SPHKAP,ACVR1C,NCKAP5,PLEK,EPHA4,RYR2,FAT4,IRX1,EPHA3,ACVR2A,UTRN,CNTN1,AKAP9,CNTNAP2,PARP8,JMJD1C,ADAMTS12,GAP43,RASGEF1B</TD></TR>
<TR><TD>1.698e-03</TD><TD>-6.38</TD><TD>human chr4q13.3</TD><TD>chromosome location</TD><TD>human chr4q13.3</TD><TD>111</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>MUC7,AFM,ADAMTS3</TD></TR>
<TR><TD>1.700e-03</TD><TD>-6.38</TD><TD>dendritic tree</TD><TD>cellular component</TD><TD>GO:0097447</TD><TD>623</TD><TD>16</TD><TD>19868</TD><TD>221</TD>
<TD>LGI1,DNER,NTRK2,MAP2,UNC5C,CHRM3,UHMK1,EPHA3,AKAP9,GAP43,DSCAM,CNTNAP2,PRSS12,BRINP3,EPHA4,RPH3A</TD></TR>
<TR><TD>1.703e-03</TD><TD>-6.38</TD><TD>human chr7q21.2</TD><TD>chromosome location</TD><TD>human chr7q21.2</TD><TD>29</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>AKAP9,MTERF1</TD></TR>
<TR><TD>1.723e-03</TD><TD>-6.36</TD><TD>DEP</TD><TD>pfam domains</TD><TD>PF00610</TD><TD>21</TD><TD>3</TD><TD>17869</TD><TD>206</TD>
<TD>DEPTOR,PLEK,RGS6</TD></TR>
<TR><TD>1.764e-03</TD><TD>-6.34</TD><TD>EGF</TD><TD>smart domains</TD><TD>SM00181</TD><TD>184</TD><TD>9</TD><TD>9743</TD><TD>146</TD>
<TD>NRG1,CNTNAP2,FAT4,MEGF10,FBN2,DNER,SLIT2,EFEMP1,EDIL3</TD></TR>
<TR><TD>1.786e-03</TD><TD>-6.33</TD><TD>autonomic_ganglia-neuroblastoma</TD><TD>COSMIC cancer mutations</TD><TD>autonomic_ganglia-neuroblastoma</TD><TD>3974</TD><TD>63</TD><TD>16984</TD><TD>192</TD>
<TD>THSD7A,PCDH9,PLEK,SLC39A10,VAV3,LRIG3,AOAH,NAT2,SGCG,SPATA16,ADAMTS5,AFM,RPH3A,CDH5,FUT9,RYR2,PAX6,RBM20,UTRN,EPHA3,ADAMTS12,IQGAP2,DEFB115,NTRK2,TRPS1,ZNF521,PTPRK,FBN2,DEPTOR,NAV3,FZD6,SPAG9,PTPRZ1,PRSS12,SERGEF,ADAM28,TSN,CALN1,SLC7A8,DAAM1,OR2AG1,SLIT2,NCKAP5,FANCB,GMDS,MAP2,CPXM2,FAT4,ZNF133,OR52K2,SS18,AKAP9,NAALADL2,CNTNAP2,CXCL13,FGFR2,TCF20,AMELX,SPHKAP,PXDNL,ACVR1C,AGA,LGI1</TD></TR>
<TR><TD>1.787e-03</TD><TD>-6.33</TD><TD>human chr8p12</TD><TD>chromosome location</TD><TD>human chr8p12</TD><TD>113</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>SMIM18,WRN,NRG1</TD></TR>
<TR><TD>1.791e-03</TD><TD>-6.32</TD><TD>GPI-linked ephrin receptor activity</TD><TD>molecular function</TD><TD>GO:0005004</TD><TD>6</TD><TD>2</TD><TD>18530</TD><TD>206</TD>
<TD>EPHA4,EPHA3</TD></TR>
<TR><TD>1.791e-03</TD><TD>-6.32</TD><TD>splicing factor binding</TD><TD>molecular function</TD><TD>GO:1990935</TD><TD>6</TD><TD>2</TD><TD>18530</TD><TD>206</TD>
<TD>UHMK1,RBM20</TD></TR>
<TR><TD>1.794e-03</TD><TD>-6.32</TD><TD>activin receptor complex</TD><TD>cellular component</TD><TD>GO:0048179</TD><TD>6</TD><TD>2</TD><TD>19868</TD><TD>221</TD>
<TD>ACVR2A,ACVR1C</TD></TR>
<TR><TD>1.794e-03</TD><TD>-6.32</TD><TD>sarcoglycan complex</TD><TD>cellular component</TD><TD>GO:0016012</TD><TD>6</TD><TD>2</TD><TD>19868</TD><TD>221</TD>
<TD>SGCD,SGCG</TD></TR>
<TR><TD>1.797e-03</TD><TD>-6.32</TD><TD>neuroblastoma</TD><TD>COSMIC cancer mutations</TD><TD>neuroblastoma</TD><TD>3975</TD><TD>63</TD><TD>16984</TD><TD>192</TD>
<TD>SLC39A10,LRIG3,VAV3,AOAH,THSD7A,PCDH9,PLEK,RPH3A,FUT9,CDH5,RYR2,NAT2,SPATA16,SGCG,ADAMTS5,AFM,EPHA3,PAX6,RBM20,UTRN,DEFB115,NTRK2,ADAMTS12,IQGAP2,ZNF521,PTPRK,DEPTOR,FBN2,TRPS1,SPAG9,NAV3,FZD6,SERGEF,ADAM28,PTPRZ1,PRSS12,OR2AG1,DAAM1,TSN,CALN1,SLC7A8,NCKAP5,SLIT2,GMDS,FANCB,FAT4,ZNF133,MAP2,CPXM2,AKAP9,NAALADL2,CNTNAP2,SS18,OR52K2,CXCL13,FGFR2,AMELX,TCF20,SPHKAP,LGI1,PXDNL,ACVR1C,AGA</TD></TR>
<TR><TD>1.803e-03</TD><TD>-6.32</TD><TD>synapse organization</TD><TD>biological process</TD><TD>GO:0050808</TD><TD>333</TD><TD>11</TD><TD>18905</TD><TD>219</TD>
<TD>DNER,PTPRD,SEZ6L,EFNA5,ADGRL3,SLC25A46,LRFN5,LMX1A,EPHA4,DSCAM,NRCAM</TD></TR>
<TR><TD>1.803e-03</TD><TD>-6.32</TD><TD>regulation of cellular component biogenesis</TD><TD>biological process</TD><TD>GO:0044087</TD><TD>1022</TD><TD>23</TD><TD>18905</TD><TD>219</TD>
<TD>CDH5,MAP2,PTPRD,CXCL13,FNIP2,PLEK,NAV3,EPHA3,LRFN5,INSM1,EFNA5,SLIT2,AKAP9,NTRK2,CNTNAP2,TMEFF2,EPS8,PRKCE,ROBO2,NRG1,STXBP6,GAP43,IL1RAPL2</TD></TR>
<TR><TD>1.815e-03</TD><TD>-6.31</TD><TD>synaptic membrane</TD><TD>cellular component</TD><TD>GO:0097060</TD><TD>400</TD><TD>12</TD><TD>19868</TD><TD>221</TD>
<TD>AKAP9,NRCAM,CHRM3,SYT1,LRFN5,CNTN1,RPH3A,UTRN,PTPRD,EPHA4,CASK,CNTNAP2</TD></TR>
<TR><TD>1.818e-03</TD><TD>-6.31</TD><TD>Laminin</TD><TD>gene3d domains</TD><TD>2.10.25.10</TD><TD>226</TD><TD>9</TD><TD>14531</TD><TD>177</TD>
<TD>SLIT2,TMEFF2,FBN2,EFEMP1,DNER,NRG1,CNTNAP2,EDIL3,FAT4</TD></TR>
<TR><TD>1.827e-03</TD><TD>-6.31</TD><TD>ADAM_MEPRO</TD><TD>prosite domains</TD><TD>PS50215</TD><TD>40</TD><TD>4</TD><TD>12232</TD><TD>161</TD>
<TD>ADAMTS5,ADAMTS12,ADAM28,ADAMTS3</TD></TR>
<TR><TD>1.827e-03</TD><TD>-6.30</TD><TD>regulation of neuron differentiation</TD><TD>biological process</TD><TD>GO:0045664</TD><TD>192</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>SPAG9,PBX1,FGF20,LMX1A,NRCAM,FERD3L,PAX6,BRINP3</TD></TR>
<TR><TD>1.864e-03</TD><TD>-6.28</TD><TD>regulation of growth</TD><TD>biological process</TD><TD>GO:0040008</TD><TD>604</TD><TD>16</TD><TD>18905</TD><TD>219</TD>
<TD>ZFPM2,FGFR2,WRN,ARX,GAP43,LGI1,SLIT2,SHTN1,EFNA5,DSCAM,FGF20,LMX1A,SYT1,NRCAM,SPAG9,MAP2</TD></TR>
<TR><TD>1.879e-03</TD><TD>-6.28</TD><TD>human chr8q22.3</TD><TD>chromosome location</TD><TD>human chr8q22.3</TD><TD>115</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>FZD6,MIR548A3,LOC105375690</TD></TR>
<TR><TD>1.909e-03</TD><TD>-6.26</TD><TD>head development</TD><TD>biological process</TD><TD>GO:0060322</TD><TD>781</TD><TD>19</TD><TD>18905</TD><TD>219</TD>
<TD>CNTNAP2,NTRK2,PAX6,FGFR2,TGFBR2,FAT4,SLC25A46,PBX1,AFG2A,SLIT2,FZD6,CNTN1,ARX,ROBO2,NRCAM,LMX1A,ZFAND5,UNC5C,PCDH9</TD></TR>
<TR><TD>1.916e-03</TD><TD>-6.26</TD><TD>LRR_5</TD><TD>interpro domains</TD><TD>IPR026906</TD><TD>6</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>LHCGR,LRRC70</TD></TR>
<TR><TD>1.916e-03</TD><TD>-6.26</TD><TD>TSP1_spondin_dom</TD><TD>interpro domains</TD><TD>IPR044004</TD><TD>6</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>THSD7B,THSD7A</TD></TR>
<TR><TD>1.917e-03</TD><TD>-6.26</TD><TD>LRR_1</TD><TD>pfam domains</TD><TD>PF00560</TD><TD>46</TD><TD>4</TD><TD>17869</TD><TD>206</TD>
<TD>LRRC3B,LRIG3,EPYC,SLIT2</TD></TR>
<TR><TD>1.924e-03</TD><TD>-6.25</TD><TD>LRR_5</TD><TD>pfam domains</TD><TD>PF13306</TD><TD>6</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>LRRC70,LHCGR</TD></TR>
<TR><TD>1.924e-03</TD><TD>-6.25</TD><TD>TSP1_spondin</TD><TD>pfam domains</TD><TD>PF19028</TD><TD>6</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>THSD7A,THSD7B</TD></TR>
<TR><TD>1.931e-03</TD><TD>-6.25</TD><TD>adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning</TD><TD>COSMIC cancer mutations</TD><TD>adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning</TD><TD>1803</TD><TD>34</TD><TD>16984</TD><TD>192</TD>
<TD>RYR2,EPHA4,MPEG1,ADAMTS5,IPO8,NBEA,FIGN,NCKAP5,CHRM3,PCDH9,KCNK9,HNF4G,NTRK2,CNTN1,RASGEF1B,SS18,UTRN,RBM20,EFEMP1,BCHE,RUNX1T1,IL1RAPL2,MEGF10,WRN,SEMA3C,UCHL1,NRCAM,UBR4,RAI2,SERGEF,PTPRD,UNC5C,PTPRZ1,TGFBR2</TD></TR>
<TR><TD>1.931e-03</TD><TD>-6.25</TD><TD>functioning</TD><TD>COSMIC cancer mutations</TD><TD>functioning</TD><TD>1803</TD><TD>34</TD><TD>16984</TD><TD>192</TD>
<TD>BCHE,EFEMP1,RUNX1T1,IL1RAPL2,MEGF10,WRN,NRCAM,UCHL1,SEMA3C,UBR4,RAI2,SERGEF,TGFBR2,PTPRZ1,PTPRD,UNC5C,EPHA4,MPEG1,RYR2,FIGN,NBEA,IPO8,ADAMTS5,NCKAP5,KCNK9,PCDH9,CHRM3,CNTN1,HNF4G,NTRK2,SS18,RASGEF1B,RBM20,UTRN</TD></TR>
<TR><TD>1.939e-03</TD><TD>-6.25</TD><TD>LTBP1 (latent transforming growth factor beta binding protein 1)</TD><TD>protein interactions</TD><TD>4052</TD><TD>80</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>NRSN1,CDH5,BCHE,FBN2,EFEMP1</TD></TR>
<TR><TD>1.939e-03</TD><TD>-6.25</TD><TD>CEACAM21 (CEA cell adhesion molecule 21)</TD><TD>protein interactions</TD><TD>90273</TD><TD>80</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>EPHA4,FAT4,PCDH9,CNTN1,EPHA3</TD></TR>
<TR><TD>1.943e-03</TD><TD>-6.24</TD><TD>cerebral cortex tangential migration</TD><TD>biological process</TD><TD>GO:0021800</TD><TD>6</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,ARX</TD></TR>
<TR><TD>1.943e-03</TD><TD>-6.24</TD><TD>luteolysis</TD><TD>biological process</TD><TD>GO:0001554</TD><TD>6</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,ROBO2</TD></TR>
<TR><TD>1.947e-03</TD><TD>-6.24</TD><TD>vasculature development</TD><TD>biological process</TD><TD>GO:0001944</TD><TD>550</TD><TD>15</TD><TD>18905</TD><TD>219</TD>
<TD>VAV3,PECAM1,SLIT2,PAX6,FGFR2,NTRK2,SEMA3C,ZFPM2,TGFBR2,THSD7A,CDH5,NRCAM,ROBO2,ZFAND5,SGCD</TD></TR>
<TR><TD>1.952e-03</TD><TD>-6.24</TD><TD>tube development</TD><TD>biological process</TD><TD>GO:0035295</TD><TD>904</TD><TD>21</TD><TD>18905</TD><TD>219</TD>
<TD>FERD3L,PAX6,FGFR2,SEMA3C,NTRK2,EPHA4,ZFPM2,TGFBR2,PHF14,PBX1,LHCGR,VAV3,FZD6,SLIT2,IRX1,NRCAM,ROBO2,SGCD,RYR2,THSD7A,TWIST1</TD></TR>
<TR><TD>1.966e-03</TD><TD>-6.23</TD><TD>FA58C</TD><TD>interpro domains</TD><TD>IPR000421</TD><TD>22</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>CPXM2,CNTNAP2,EDIL3</TD></TR>
<TR><TD>1.966e-03</TD><TD>-6.23</TD><TD>Fibroblast_GF_fam</TD><TD>interpro domains</TD><TD>IPR002209</TD><TD>22</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>FGF20,FGF5,FGF14</TD></TR>
<TR><TD>1.966e-03</TD><TD>-6.23</TD><TD>DEP_dom</TD><TD>interpro domains</TD><TD>IPR000591</TD><TD>22</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>DEPTOR,PLEK,RGS6</TD></TR>
<TR><TD>1.978e-03</TD><TD>-6.23</TD><TD>F5_F8_type_C</TD><TD>pfam domains</TD><TD>PF00754</TD><TD>22</TD><TD>3</TD><TD>17869</TD><TD>206</TD>
<TD>EDIL3,CNTNAP2,CPXM2</TD></TR>
<TR><TD>1.978e-03</TD><TD>-6.23</TD><TD>FGF</TD><TD>pfam domains</TD><TD>PF00167</TD><TD>22</TD><TD>3</TD><TD>17869</TD><TD>206</TD>
<TD>FGF20,FGF5,FGF14</TD></TR>
<TR><TD>2.005e-03</TD><TD>-6.21</TD><TD>CASK (calcium/calmodulin dependent serine protein kinase)</TD><TD>protein interactions</TD><TD>8573</TD><TD>204</TD><TD>8</TD><TD>20077</TD><TD>222</TD>
<TD>EPS8,CASK,EPHA4,CNTNAP2,UTRN,RPH3A,ARL14,AKAP9</TD></TR>
<TR><TD>2.016e-03</TD><TD>-6.21</TD><TD>FRS-mediated FGFR2 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654700</TD><TD>25</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGFR2,FGF20</TD></TR>
<TR><TD>2.022e-03</TD><TD>-6.20</TD><TD>human chr8q21.13</TD><TD>chromosome location</TD><TD>human chr8q21.13</TD><TD>118</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>LOC101927141,PI15,HNF4G</TD></TR>
<TR><TD>2.032e-03</TD><TD>-6.20</TD><TD>positive regulation of cell differentiation</TD><TD>biological process</TD><TD>GO:0045597</TD><TD>907</TD><TD>21</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2,PAX6,TGFBR2,EPHA4,EFNA5,SHTN1,INSM1,SLIT2,ACVR2A,BRINP3,PTPRZ1,ROBO2,NRCAM,DSCAM,NRG1,FGF20,TWIST1,CDH5,FBN2,PTPRD,SPAG9</TD></TR>
<TR><TD>2.033e-03</TD><TD>-6.20</TD><TD>regulation of plasma membrane bounded cell projection organization</TD><TD>biological process</TD><TD>GO:0120035</TD><TD>667</TD><TD>17</TD><TD>18905</TD><TD>219</TD>
<TD>MAP2,PTPRD,EPS8,ROBO2,NRCAM,PAQR3,EPHA3,FUT9,DSCAM,EFNA5,SHTN1,SLIT2,CNTN1,GAP43,NTRK2,PAX6,EPHA4</TD></TR>
<TR><TD>2.039e-03</TD><TD>-6.20</TD><TD>ASX_HYDROXYL</TD><TD>prosite domains</TD><TD>PS00010</TD><TD>100</TD><TD>6</TD><TD>12232</TD><TD>161</TD>
<TD>EFEMP1,EDIL3,FAT4,SLIT2,FBN2,DNER</TD></TR>
<TR><TD>2.040e-03</TD><TD>-6.19</TD><TD>glycoprotein complex</TD><TD>cellular component</TD><TD>GO:0090665</TD><TD>23</TD><TD>3</TD><TD>19868</TD><TD>221</TD>
<TD>UTRN,SGCG,SGCD</TD></TR>
<TR><TD>2.071e-03</TD><TD>-6.18</TD><TD>human chr18q11.2</TD><TD>chromosome location</TD><TD>human chr18q11.2</TD><TD>119</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>ZNF521,LINC01894,SS18</TD></TR>
<TR><TD>2.087e-03</TD><TD>-6.17</TD><TD>mast_cell_neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>mast_cell_neoplasm</TD><TD>248</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>DSCAM,PCDH9,NOL4,IL1RAPL2,SYT1,KAZN,DNER,CNTNAP2,PARP8</TD></TR>
<TR><TD>2.087e-03</TD><TD>-6.17</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm</TD><TD>248</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>DSCAM,PCDH9,IL1RAPL2,NOL4,KAZN,SYT1,CNTNAP2,PARP8,DNER</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr4p12-p11</TD><TD>chromosome location</TD><TD>human chr4p12-p11</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>TEC</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr2q22.3-q23.1</TD><TD>chromosome location</TD><TD>human chr2q22.3-q23.1</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>ACVR2A</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr16q23.1-q23.2</TD><TD>chromosome location</TD><TD>human chr16q23.1-q23.2</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>WWOX</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr7q35-q36.1</TD><TD>chromosome location</TD><TD>human chr7q35-q36.1</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr9p24.1-p23</TD><TD>chromosome location</TD><TD>human chr9p24.1-p23</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>PTPRD</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr5q14.1-q14.2</TD><TD>chromosome location</TD><TD>human chr5q14.1-q14.2</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>ATG10</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr22q13.2|22q13.3</TD><TD>chromosome location</TD><TD>human chr22q13.2|22q13.3</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>TCF20</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr1q21.1-q21.2</TD><TD>chromosome location</TD><TD>human chr1q21.1-q21.2</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LINC00624</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr7p21.1-p15.3</TD><TD>chromosome location</TD><TD>human chr7p21.1-p15.3</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LINC01162</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr3q13.13-q13.2</TD><TD>chromosome location</TD><TD>human chr3q13.13-q13.2</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>CD96</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr8q11.22-q11.23</TD><TD>chromosome location</TD><TD>human chr8q11.22-q11.23</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>PXDNL</TD></TR>
<TR><TD>2.094e-03</TD><TD>-6.17</TD><TD>Neurofascin interactions</TD><TD>REACTOME pathways</TD><TD>R-HSA-447043</TD><TD>7</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>CNTN1,NRCAM</TD></TR>
<TR><TD>2.097e-03</TD><TD>-6.17</TD><TD>negative regulation of cellular process</TD><TD>biological process</TD><TD>GO:0048523</TD><TD>5358</TD><TD>82</TD><TD>18905</TD><TD>219</TD>
<TD>MIR569,PHLPP1,RYR2,EPHA3,C8orf88,DSCAM,UCHL1,TSN,LRFN5,CASK,CDH5,GHITM,MAP2,SHISA3,PTPRD,SPAG9,CRTC3,FGFR2,BCHE,EFEMP1,PBX1,INSM1,RBM20,SLIT2,ROBO2,PTPRZ1,MIR551B,ACVR1C,FGF20,WWOX,PAQR3,MIR9-2HG,SERGEF,FANCB,SS18,TMEFF2,RUNX1T1,ADAMTS12,EPS8,PAX6,FERD3L,FABP7,CD96,KLF12,ARX,IRX1,FNIP2,MIR577,MIR548AA2,PLEK,SLC39A10,NAV3,DEPTOR,TRPS1,LMX1A,TWIST1,CXCL13,BACH2,PCGF5,NTRK2,MIR147A,ZFPM2,EPHA4,PHF14,MIR548A3,EFNA5,ASPN,MIR891A,RGS6,SKAP2,BRINP3,PTPRK,NRG1,BANK1,ZNF133,PRKCE,FBN2,MIR1260B,MRPL13,STXBP6,UBR4,FZD6</TD></TR>
<TR><TD>2.116e-03</TD><TD>-6.16</TD><TD>ventricular cardiac muscle tissue morphogenesis</TD><TD>biological process</TD><TD>GO:0055010</TD><TD>47</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>NRG1,ZFPM2,RYR2,FGFR2</TD></TR>
<TR><TD>2.118e-03</TD><TD>-6.16</TD><TD>EGF_1</TD><TD>prosite domains</TD><TD>PS00022</TD><TD>174</TD><TD>8</TD><TD>12232</TD><TD>161</TD>
<TD>EDIL3,FAT4,MEGF10,NRG1,DNER,TMEFF2,SLIT2,FBN2</TD></TR>
<TR><TD>2.146e-03</TD><TD>-6.14</TD><TD>locomotory behavior</TD><TD>biological process</TD><TD>GO:0007626</TD><TD>197</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>UCHL1,EPHA4,DSCAM,LMX1A,EPS8,CNTN1,PRKCE,SLC25A46</TD></TR>
<TR><TD>2.164e-03</TD><TD>-6.14</TD><TD>FA58C_3</TD><TD>prosite domains</TD><TD>PS50022</TD><TD>20</TD><TD>3</TD><TD>12232</TD><TD>161</TD>
<TD>CPXM2,EDIL3,CNTNAP2</TD></TR>
<TR><TD>2.164e-03</TD><TD>-6.14</TD><TD>HBGF_FGF</TD><TD>prosite domains</TD><TD>PS00247</TD><TD>20</TD><TD>3</TD><TD>12232</TD><TD>161</TD>
<TD>FGF14,FGF5,FGF20</TD></TR>
<TR><TD>2.182e-03</TD><TD>-6.13</TD><TD>other</TD><TD>COSMIC cancer mutations</TD><TD>other</TD><TD>14918</TD><TD>181</TD><TD>16984</TD><TD>192</TD>
<TD>CETN3,WRN,MRPL3,IL1RAPL2,BCHE,ADAMTS3,DNAJC12,PBX1,RAI2,UBR4,LRRC3B,EFR3B,ASPN,FIGN,PHLPP1,JMJD1C,LRRC70,FBN2,DEPTOR,LINC01387,MUC7,SPAG9,PWWP2A,UCHL1,LRIG3,REG1B,NRSN1,IPO8,FUT9,PAX6,FGD3,STXBP6,IQGAP2,ZFAND5,MEGF10,CXCL13,ACP6,TCF20,PCGF5,SEZ6L,LRFN5,SPHKAP,ACVR1C,LRRN2,NOBOX,KIF6,PAQR3,DSCAM,XPO4,SKAP2,DCDC2C,TMEFF2,SGCD,CASK,DNER,EPHA4,COQ2,PI15,CPXM2,IRX1,ZNF133,PRKCE,CNTNAP2,KLF12,ZNF521,PTPRK,FMNL2,EFR3A,NUP35,ATG10,CYTL1,TGFBR2,PTPRD,ADAM28,TSN,SEMA3C,NRCAM,DAAM1,THSD7A,ZPLD1,AOAH,REXO2,SGCG,PHF14,ADAMTS5,ROBO2,RPH3A,RYR2,EPHA3,ADAMTS12,HNF4G,CD96,NTRK2,GCNT1,LINC00583,RUNX1T1,FGFR2,FERD3L,AMELX,EPYC,EFNA5,KAZN,LMX1A,SLC10A2,LGI1,PSKH2,SLIT2,NOL4,NCKAP5,FGF20,MAP2,SS18,TWIST1,NOVA1,SPANXN1,AKAP9,CNTN1,NAALADL2,PARP8,TRPS1,EFEMP1,GHITM,PTPRZ1,UNC5C,GPR83,B3GAT2,SERGEF,CD226,OR2AG1,PLEK,SLC39A10,VAV3,NAT2,SPATA16,AFM,ACVR2A,UTRN,ZFPM2,GAP43,RASGEF1B,CELF2,DEFB115,BACH2,FGF5,CTSO,IGFL4,FNIP2,EDIL3,SLC7A14,PXDNL,AGA,SLC25A46,FABP7,KCNK9,CHRM3,DAOA,BANK1,FANCB,SYT1,NBEA,MPEG1,GMDS,FAT4,NAV3,FZD6,LMBRD1,THSD7B,FGF14,NRG1,PRSS12,EPS8,LHCGR,SLC7A8,CRTC3,MRPL13,SHISA3,PCDH9,INSM1,CDH5,RBM20,ARX</TD></TR>
<TR><TD>2.198e-03</TD><TD>-6.12</TD><TD>brain development</TD><TD>biological process</TD><TD>GO:0007420</TD><TD>731</TD><TD>18</TD><TD>18905</TD><TD>219</TD>
<TD>FAT4,TGFBR2,PAX6,FGFR2,NTRK2,CNTNAP2,ARX,CNTN1,FZD6,SLIT2,AFG2A,PBX1,SLC25A46,LMX1A,NRCAM,ROBO2,PCDH9,UNC5C</TD></TR>
<TR><TD>2.284e-03</TD><TD>-6.08</TD><TD>MTA3 (metastasis associated 1 family member 3)</TD><TD>protein interactions</TD><TD>57504</TD><TD>163</TD><TD>7</TD><TD>20077</TD><TD>222</TD>
<TD>TRPS1,KLF12,DSCAM,FGFR2,ZFPM2,PWWP2A,TCF20</TD></TR>
<TR><TD>2.285e-03</TD><TD>-6.08</TD><TD>positive regulation of protein-containing complex assembly</TD><TD>biological process</TD><TD>GO:0031334</TD><TD>199</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>FNIP2,NAV3,PLEK,NRG1,CDH5,CXCL13,AKAP9,PRKCE</TD></TR>
<TR><TD>2.286e-03</TD><TD>-6.08</TD><TD>skin-face-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-face-carcinoma-squamous_cell_carcinoma</TD><TD>2036</TD><TD>37</TD><TD>16984</TD><TD>192</TD>
<TD>ADAMTS12,GAP43,IQGAP2,CELF2,AKAP9,HNF4G,CNTNAP2,JMJD1C,FAT4,EPHA3,ZNF518B,ADAMTS5,SPATA16,SGCG,SLIT2,PCDH9,DSCAM,SLC39A10,LMX1A,CALN1,KIF6,OR2AG1,PTPRZ1,EPYC,ADAM28,NAV3,SEZ6L,LRFN5,KLF12,TRPS1,BACH2,PTPRK,MEGF10,ZNF521,FBN2,DEPTOR,FGFR2</TD></TR>
<TR><TD>2.288e-03</TD><TD>-6.08</TD><TD>pulmonary valve development</TD><TD>biological process</TD><TD>GO:0003177</TD><TD>23</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>ADAMTS5,SLIT2,ROBO2</TD></TR>
<TR><TD>2.296e-03</TD><TD>-6.08</TD><TD>Tyr_kinase_cat_dom</TD><TD>interpro domains</TD><TD>IPR020635</TD><TD>80</TD><TD>5</TD><TD>18605</TD><TD>214</TD>
<TD>EPHA4,EPHA3,FGFR2,NTRK2,TEC</TD></TR>
<TR><TD>2.330e-03</TD><TD>-6.06</TD><TD>RYK (receptor like tyrosine kinase)</TD><TD>protein interactions</TD><TD>6259</TD><TD>209</TD><TD>8</TD><TD>20077</TD><TD>222</TD>
<TD>CDH5,FGFR2,PTPRD,FAT4,PCDH9,EPHA4,PTPRK,CNTN1</TD></TR>
<TR><TD>2.337e-03</TD><TD>-6.06</TD><TD>human chr5q21.3</TD><TD>chromosome location</TD><TD>human chr5q21.3</TD><TD>34</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>EFNA5,LINC01950</TD></TR>
<TR><TD>2.376e-03</TD><TD>-6.04</TD><TD>regulation of protein phosphorylation</TD><TD>biological process</TD><TD>GO:0001932</TD><TD>919</TD><TD>21</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,NTRK2,EPHA4,TGFBR2,INSM1,EFNA5,PECAM1,AKAP9,SLIT2,ACVR2A,FNIP2,FGF20,UCHL1,NRG1,BANK1,DEPTOR,PAQR3,CDH5,SPAG9,PRKCE,FGF5</TD></TR>
<TR><TD>2.421e-03</TD><TD>-6.02</TD><TD>NRP2 (neuropilin 2)</TD><TD>protein interactions</TD><TD>8828</TD><TD>51</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>BRINP3,SEMA3C,NRSN1,TGFBR2</TD></TR>
<TR><TD>2.428e-03</TD><TD>-6.02</TD><TD>regulation of synapse assembly</TD><TD>biological process</TD><TD>GO:0051963</TD><TD>117</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2,ROBO2,EFNA5,LRFN5,IL1RAPL2,PTPRD</TD></TR>
<TR><TD>2.452e-03</TD><TD>-6.01</TD><TD>positive regulation of nervous system development</TD><TD>biological process</TD><TD>GO:0051962</TD><TD>296</TD><TD>10</TD><TD>18905</TD><TD>219</TD>
<TD>DSCAM,EPHA4,NTRK2,ROBO2,PTPRZ1,PAX6,SLIT2,PTPRD,EFNA5,SHTN1</TD></TR>
<TR><TD>2.464e-03</TD><TD>-6.01</TD><TD>LRRN1 (leucine rich repeat neuronal 1)</TD><TD>protein interactions</TD><TD>57633</TD><TD>7</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>GHITM,PTPRD</TD></TR>
<TR><TD>2.469e-03</TD><TD>-6.00</TD><TD>ephrin receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0048013</TD><TD>49</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>EFNA5,SS18,EPHA4,EPHA3</TD></TR>
<TR><TD>2.473e-03</TD><TD>-6.00</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-peripheral_T_cell_lymphoma_unspecified</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-peripheral_T_cell_lymphoma_unspecified</TD><TD>162</TD><TD>7</TD><TD>16984</TD><TD>192</TD>
<TD>NRSN1,ADAMTS12,IQGAP2,NOL4,EPS8,FMNL2,NCKAP5</TD></TR>
<TR><TD>2.493e-03</TD><TD>-5.99</TD><TD>dystroglycan complex</TD><TD>cellular component</TD><TD>GO:0016011</TD><TD>7</TD><TD>2</TD><TD>19868</TD><TD>221</TD>
<TD>SGCD,SGCG</TD></TR>
<TR><TD>2.501e-03</TD><TD>-5.99</TD><TD>DEP</TD><TD>prosite domains</TD><TD>PS50186</TD><TD>21</TD><TD>3</TD><TD>12232</TD><TD>161</TD>
<TD>RGS6,PLEK,DEPTOR</TD></TR>
<TR><TD>2.534e-03</TD><TD>-5.98</TD><TD>synapse assembly</TD><TD>biological process</TD><TD>GO:0007416</TD><TD>118</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>SLC25A46,NRCAM,ADGRL3,DSCAM,PTPRD,DNER</TD></TR>
<TR><TD>2.541e-03</TD><TD>-5.98</TD><TD>ADAMTS/ADAMTS-like</TD><TD>interpro domains</TD><TD>IPR013273</TD><TD>24</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>ADAMTS5,ADAMTS12,ADAMTS3</TD></TR>
<TR><TD>2.593e-03</TD><TD>-5.95</TD><TD>synaptic membrane adhesion</TD><TD>biological process</TD><TD>GO:0099560</TD><TD>24</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>PTPRD,LRFN5,EFNA5</TD></TR>
<TR><TD>2.593e-03</TD><TD>-5.95</TD><TD>negative regulation of keratinocyte proliferation</TD><TD>biological process</TD><TD>GO:0010839</TD><TD>24</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>CASK,PTPRK,FGFR2</TD></TR>
<TR><TD>2.596e-03</TD><TD>-5.95</TD><TD>lung-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-adenocarcinoma</TD><TD>15181</TD><TD>183</TD><TD>16984</TD><TD>192</TD>
<TD>TSN,CALN1,SEMA3C,NRCAM,DAAM1,TGFBR2,PTPRD,ADAM28,EFR3A,NUP35,ATG10,KLF12,ZNF521,PTPRK,FMNL2,ADAMTS12,NTRK2,HNF4G,CD96,EPHA3,PHF14,SGCG,ADAMTS5,ROBO2,RPH3A,RYR2,THSD7A,ZPLD1,AOAH,ACVR1C,LRRN2,NOBOX,KIF6,PAQR3,SPHKAP,TCF20,PCGF5,SEZ6L,LRFN5,ZFAND5,MEGF10,CXCL13,ACP6,CNTNAP2,PI15,CPXM2,IRX1,ZNF133,PRKCE,TMEFF2,SGCD,CASK,DNER,EPHA4,COQ2,DSCAM,XPO4,SKAP2,UCHL1,PWWP2A,MUC7,SPAG9,RGS6,DEPTOR,FBN2,IQGAP2,STXBP6,PAX6,FGD3,NRSN1,IPO8,FUT9,REG1B,LRIG3,UBR4,DNAJC12,RAI2,PBX1,BCHE,ADAMTS3,CETN3,WRN,MRPL3,IL1RAPL2,OR52K2,JMJD1C,LRRC70,PHLPP1,FIGN,LRRC3B,ASPN,SLC7A8,CRTC3,MRPL13,NRG1,PRSS12,EPS8,LHCGR,NAV3,FZD6,LMBRD1,FGF14,THSD7B,COX7B2,RBM20,UHMK1,ARL14,ARX,INSM1,CDH5,PCDH9,PXDNL,AGA,SLC25A46,FNIP2,SLC7A14,EDIL3,CTSO,IGFL4,BACH2,FGF5,FAT4,ZNF518B,BANK1,SYT1,FANCB,NBEA,MPEG1,GMDS,KCNK9,CHRM3,DAOA,CD226,OR2AG1,GHITM,PTPRZ1,UNC5C,GPR83,B3GAT2,SERGEF,WWOX,EFEMP1,TRPS1,GAP43,CELF2,RASGEF1B,DEFB115,ACVR2A,UTRN,ZFPM2,NAT2,SPATA16,AFM,PLEK,SLC39A10,VAV3,KAZN,LMX1A,SLC10A2,LGI1,PSKH2,EPYC,EFNA5,PRLHR,FERD3L,AMELX,GCNT1,RUNX1T1,FGFR2,TWIST1,SS18,NOVA1,SPANXN1,AKAP9,CNTN1,NAALADL2,PARP8,SERINC5,MAP2,FGF20,SLIT2,NOL4,NCKAP5</TD></TR>
<TR><TD>2.604e-03</TD><TD>-5.95</TD><TD>ACTIVIN2R</TD><TD>prints domains</TD><TD>PR00653</TD><TD>6</TD><TD>2</TD><TD>5258</TD><TD>71</TD>
<TD>TGFBR2,ACVR2A</TD></TR>
<TR><TD>2.617e-03</TD><TD>-5.95</TD><TD>human chr13q33.1</TD><TD>chromosome location</TD><TD>human chr13q33.1</TD><TD>36</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>SLC10A2,FGF14</TD></TR>
<TR><TD>2.637e-03</TD><TD>-5.94</TD><TD>regulation of cell projection organization</TD><TD>biological process</TD><TD>GO:0031344</TD><TD>684</TD><TD>17</TD><TD>18905</TD><TD>219</TD>
<TD>PTPRD,EPS8,MAP2,DSCAM,EPHA3,FUT9,PAQR3,NRCAM,ROBO2,CNTN1,GAP43,SLIT2,SHTN1,EFNA5,EPHA4,PAX6,NTRK2</TD></TR>
<TR><TD>2.647e-03</TD><TD>-5.93</TD><TD>cell-cell adhesion mediator activity</TD><TD>molecular function</TD><TD>GO:0098632</TD><TD>52</TD><TD>4</TD><TD>18530</TD><TD>206</TD>
<TD>NRCAM,STXBP6,DSCAM,CNTN1</TD></TR>
<TR><TD>2.688e-03</TD><TD>-5.92</TD><TD>Negative regulation of the PI3K/AKT network</TD><TD>REACTOME pathways</TD><TD>R-HSA-199418</TD><TD>94</TD><TD>5</TD><TD>10391</TD><TD>106</TD>
<TD>FGFR2,FGF5,PHLPP1,NRG1,FGF20</TD></TR>
<TR><TD>2.700e-03</TD><TD>-5.91</TD><TD>lacrimal gland development</TD><TD>biological process</TD><TD>GO:0032808</TD><TD>7</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,PAX6</TD></TR>
<TR><TD>2.700e-03</TD><TD>-5.91</TD><TD>spontaneous neurotransmitter secretion</TD><TD>biological process</TD><TD>GO:0061669</TD><TD>7</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>SYT1,RPH3A</TD></TR>
<TR><TD>2.700e-03</TD><TD>-5.91</TD><TD>lung lobe morphogenesis</TD><TD>biological process</TD><TD>GO:0060463</TD><TD>7</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,FGFR2</TD></TR>
<TR><TD>2.700e-03</TD><TD>-5.91</TD><TD>lung lobe development</TD><TD>biological process</TD><TD>GO:0060462</TD><TD>7</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,FGFR2</TD></TR>
<TR><TD>2.700e-03</TD><TD>-5.91</TD><TD>axon choice point recognition</TD><TD>biological process</TD><TD>GO:0016198</TD><TD>7</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>ROBO2,GAP43</TD></TR>
<TR><TD>2.760e-03</TD><TD>-5.89</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.80.10.50</TD><TD>79</TD><TD>5</TD><TD>14531</TD><TD>177</TD>
<TD>GALNT15,FGF5,FGF20,FGF14,RYR2</TD></TR>
<TR><TD>2.771e-03</TD><TD>-5.89</TD><TD>EGF-like_Ca-bd_dom</TD><TD>interpro domains</TD><TD>IPR001881</TD><TD>121</TD><TD>6</TD><TD>18605</TD><TD>214</TD>
<TD>EDIL3,SLIT2,DNER,FAT4,FBN2,EFEMP1</TD></TR>
<TR><TD>2.803e-03</TD><TD>-5.88</TD><TD>peritoneum-appendix-other-pseudomyxoma_peritonei</TD><TD>COSMIC cancer mutations</TD><TD>peritoneum-appendix-other-pseudomyxoma_peritonei</TD><TD>587</TD><TD>15</TD><TD>16984</TD><TD>192</TD>
<TD>WRN,TRPS1,ZPLD1,FGFR2,NCKAP5,DNER,ROBO2,NRG1,TGFBR2,MAP2,IRX1,FAT4,EDIL3,AKAP9,CNTNAP2</TD></TR>
<TR><TD>2.803e-03</TD><TD>-5.88</TD><TD>pseudomyxoma_peritonei</TD><TD>COSMIC cancer mutations</TD><TD>pseudomyxoma_peritonei</TD><TD>587</TD><TD>15</TD><TD>16984</TD><TD>192</TD>
<TD>FGFR2,NCKAP5,WRN,ZPLD1,TRPS1,ROBO2,DNER,FAT4,EDIL3,IRX1,TGFBR2,NRG1,MAP2,AKAP9,CNTNAP2</TD></TR>
<TR><TD>2.821e-03</TD><TD>-5.87</TD><TD>Regulation of actin cytoskeleton</TD><TD>KEGG pathways</TD><TD>ko04810</TD><TD>212</TD><TD>8</TD><TD>7246</TD><TD>83</TD>
<TD>FGF14,FGFR2,IQGAP2,FGF20,CHRM3,FGF5,VAV3,FGD3</TD></TR>
<TR><TD>2.821e-03</TD><TD>-5.87</TD><TD>Regulation of actin cytoskeleton</TD><TD>KEGG pathways</TD><TD>hsa04810</TD><TD>212</TD><TD>8</TD><TD>7246</TD><TD>83</TD>
<TD>IQGAP2,FGF20,FGF14,FGFR2,CHRM3,FGF5,FGD3,VAV3</TD></TR>
<TR><TD>2.832e-03</TD><TD>-5.87</TD><TD>regulation of cellular component size</TD><TD>biological process</TD><TD>GO:0032535</TD><TD>353</TD><TD>11</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,SHTN1,VAV3,EFNA5,EPS8,PRKCE,MAP2,DSCAM,DEPTOR,NRCAM,PLEK</TD></TR>
<TR><TD>2.849e-03</TD><TD>-5.86</TD><TD>appendix</TD><TD>COSMIC cancer mutations</TD><TD>appendix</TD><TD>588</TD><TD>15</TD><TD>16984</TD><TD>192</TD>
<TD>DNER,ROBO2,FGFR2,NCKAP5,ZPLD1,TRPS1,WRN,CNTNAP2,AKAP9,FAT4,EDIL3,IRX1,MAP2,TGFBR2,NRG1</TD></TR>
<TR><TD>2.860e-03</TD><TD>-5.86</TD><TD>endocardial cushion development</TD><TD>biological process</TD><TD>GO:0003197</TD><TD>51</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1,ROBO2,ADAMTS5,TGFBR2</TD></TR>
<TR><TD>2.863e-03</TD><TD>-5.86</TD><TD>ADAMTS_CR_3</TD><TD>interpro domains</TD><TD>IPR045371</TD><TD>25</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>ADAMTS12,ADAMTS5,ADAMTS3</TD></TR>
<TR><TD>2.863e-03</TD><TD>-5.86</TD><TD>ADAMTS_spacer1</TD><TD>interpro domains</TD><TD>IPR010294</TD><TD>25</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>ADAMTS3,ADAMTS12,ADAMTS5</TD></TR>
<TR><TD>2.874e-03</TD><TD>-5.85</TD><TD>LYVE1 (lymphatic vessel endothelial hyaluronan receptor 1)</TD><TD>protein interactions</TD><TD>10894</TD><TD>26</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>NRSN1,THSD7A,THSD7B</TD></TR>
<TR><TD>2.880e-03</TD><TD>-5.85</TD><TD>ADAMTS_CR_3</TD><TD>pfam domains</TD><TD>PF19236</TD><TD>25</TD><TD>3</TD><TD>17869</TD><TD>206</TD>
<TD>ADAMTS12,ADAMTS5,ADAMTS3</TD></TR>
<TR><TD>2.880e-03</TD><TD>-5.85</TD><TD>ADAMTS_spacer1</TD><TD>pfam domains</TD><TD>PF05986</TD><TD>25</TD><TD>3</TD><TD>17869</TD><TD>206</TD>
<TD>ADAMTS5,ADAMTS12,ADAMTS3</TD></TR>
<TR><TD>2.895e-03</TD><TD>-5.84</TD><TD>peritoneum</TD><TD>COSMIC cancer mutations</TD><TD>peritoneum</TD><TD>589</TD><TD>15</TD><TD>16984</TD><TD>192</TD>
<TD>NCKAP5,FGFR2,TRPS1,ZPLD1,WRN,DNER,ROBO2,IRX1,FAT4,EDIL3,MAP2,NRG1,TGFBR2,CNTNAP2,AKAP9</TD></TR>
<TR><TD>2.902e-03</TD><TD>-5.84</TD><TD>positive regulation of developmental process</TD><TD>biological process</TD><TD>GO:0051094</TD><TD>1388</TD><TD>28</TD><TD>18905</TD><TD>219</TD>
<TD>ACVR2A,ARX,PAX6,TGFBR2,SS18,FBN2,BRINP3,PTPRZ1,ROBO2,SYT1,NRG1,FGF20,EFNA5,SHTN1,INSM1,SLIT2,NTRK2,FGFR2,AMELX,EPHA4,ZFPM2,UNC5C,TWIST1,CDH5,SPAG9,PTPRD,NRCAM,DSCAM</TD></TR>
<TR><TD>2.912e-03</TD><TD>-5.84</TD><TD>human chr1q31.1</TD><TD>chromosome location</TD><TD>human chr1q31.1</TD><TD>38</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC01037,BRINP3</TD></TR>
<TR><TD>2.931e-03</TD><TD>-5.83</TD><TD>peripheral_T_cell_lymphoma_unspecified</TD><TD>COSMIC cancer mutations</TD><TD>peripheral_T_cell_lymphoma_unspecified</TD><TD>167</TD><TD>7</TD><TD>16984</TD><TD>192</TD>
<TD>IQGAP2,ADAMTS12,NRSN1,FMNL2,NCKAP5,NOL4,EPS8</TD></TR>
<TR><TD>2.942e-03</TD><TD>-5.83</TD><TD>PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta)</TD><TD>protein interactions</TD><TD>5291</TD><TD>88</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>CDH5,TGFBR2,PRKCE,CHRM3,NTRK2</TD></TR>
<TR><TD>2.942e-03</TD><TD>-5.83</TD><TD>ROBO1 (roundabout guidance receptor 1)</TD><TD>protein interactions</TD><TD>6091</TD><TD>88</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>PHLPP1,SLIT2,ROBO2,DSCAM,ARL14</TD></TR>
<TR><TD>3.026e-03</TD><TD>-5.80</TD><TD>PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta)</TD><TD>protein interactions</TD><TD>5577</TD><TD>128</TD><TD>6</TD><TD>20077</TD><TD>222</TD>
<TD>AKAP9,NBEA,SLC25A46,RYR2,MATCAP2,MAP2</TD></TR>
<TR><TD>3.117e-03</TD><TD>-5.77</TD><TD>FA58C</TD><TD>smart domains</TD><TD>SM00231</TD><TD>20</TD><TD>3</TD><TD>9743</TD><TD>146</TD>
<TD>CNTNAP2,EDIL3,CPXM2</TD></TR>
<TR><TD>3.176e-03</TD><TD>-5.75</TD><TD>oesophagus-lower_third-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-lower_third-carcinoma-squamous_cell_carcinoma</TD><TD>3513</TD><TD>56</TD><TD>16984</TD><TD>192</TD>
<TD>KAZN,PXDNL,UBR4,SLC25A46,GCNT1,WRN,RUNX1T1,ACP6,TCF20,SEZ6L,ADAMTS3,LRFN5,MAP2,PHLPP1,FAT4,PRKCE,SS18,NOVA1,CNTN1,NAALADL2,JMJD1C,CNTNAP2,PARP8,SLIT2,DSCAM,CHRM3,EFR3B,XPO4,NCKAP5,CASK,NBEA,MPEG1,DNER,NRG1,PTPRZ1,TGFBR2,UNC5C,PTPRD,B3GAT2,ADAM28,ZNF521,DEPTOR,FBN2,NAV3,THSD7B,ARL14,UTRN,EPHA3,ADAMTS12,RASGEF1B,IQGAP2,THSD7A,PCDH9,RPH3A,CDH5,RYR2</TD></TR>
<TR><TD>3.324e-03</TD><TD>-5.71</TD><TD>sensory organ development</TD><TD>biological process</TD><TD>GO:0007423</TD><TD>582</TD><TD>15</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1,LRIG3,FBN2,DSCAM,FGF20,EFEMP1,PBX1,FZD6,NTRK2,PAX6,FGFR2,CYTL1,PLAAT1,TGFBR2,EPHA4</TD></TR>
<TR><TD>3.383e-03</TD><TD>-5.69</TD><TD>human chr8q24.12</TD><TD>chromosome location</TD><TD>human chr8q24.12</TD><TD>41</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>MRPL13,DEPTOR</TD></TR>
<TR><TD>3.383e-03</TD><TD>-5.69</TD><TD>human chr7p14.2</TD><TD>chromosome location</TD><TD>human chr7p14.2</TD><TD>41</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>AOAH,MATCAP2</TD></TR>
<TR><TD>3.404e-03</TD><TD>-5.68</TD><TD>synovial</TD><TD>COSMIC cancer mutations</TD><TD>synovial</TD><TD>8</TD><TD>2</TD><TD>16984</TD><TD>192</TD>
<TD>CNTN1,RYR2</TD></TR>
<TR><TD>3.404e-03</TD><TD>-5.68</TD><TD>bone-knee-chondrosarcoma-synovial</TD><TD>COSMIC cancer mutations</TD><TD>bone-knee-chondrosarcoma-synovial</TD><TD>8</TD><TD>2</TD><TD>16984</TD><TD>192</TD>
<TD>RYR2,CNTN1</TD></TR>
<TR><TD>3.409e-03</TD><TD>-5.68</TD><TD>HTR6 (5-hydroxytryptamine receptor 6)</TD><TD>protein interactions</TD><TD>3362</TD><TD>56</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>PARP8,NOVA1,XPO4,IPO8</TD></TR>
<TR><TD>3.411e-03</TD><TD>-5.68</TD><TD>cellular response to fibroblast growth factor stimulus</TD><TD>biological process</TD><TD>GO:0044344</TD><TD>87</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>FGF20,CXCL13,FGF5,FGFR2,PAX6</TD></TR>
<TR><TD>3.429e-03</TD><TD>-5.68</TD><TD>Downstream signaling of activated FGFR2</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654696</TD><TD>30</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>FGFR2,FGF5,FGF20</TD></TR>
<TR><TD>3.437e-03</TD><TD>-5.67</TD><TD>renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>renal_cell_carcinoma</TD><TD>4562</TD><TD>69</TD><TD>16984</TD><TD>192</TD>
<TD>TRPS1,RGS6,COX7B2,DEPTOR,PTPRK,ZNF521,FZD6,NAV3,NUP35,SPAG9,PTPRD,PTPRZ1,TGFBR2,ADAM28,SERGEF,TSN,MRPL13,DAAM1,PCDH9,LRIG3,VAV3,IPO8,ADAMTS5,PHF14,SGCG,UHMK1,ACVR2A,PAX6,ARX,EPHA3,FGD3,RASGEF1B,ADAMTS12,NTRK2,WRN,FGFR2,RUNX1T1,CXCL13,BACH2,IL1RAPL2,ADAMTS3,AMELX,PCGF5,SPHKAP,RAI2,PBX1,EDIL3,DNAJC12,UBR4,ACVR1C,PSKH2,KIF6,CHRM3,XPO4,CASK,SYT1,FANCB,EPHA4,PRKCE,FAT4,IRX1,SPANXN1,NOVA1,TWIST1,SS18,CNTNAP2,JMJD1C,AKAP9,CNTN1</TD></TR>
<TR><TD>3.437e-03</TD><TD>-5.67</TD><TD>kidney-carcinoma-renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>kidney-carcinoma-renal_cell_carcinoma</TD><TD>4562</TD><TD>69</TD><TD>16984</TD><TD>192</TD>
<TD>EPHA3,ARX,FGD3,UHMK1,PAX6,ACVR2A,NTRK2,RASGEF1B,ADAMTS12,LRIG3,VAV3,PCDH9,SGCG,PHF14,ADAMTS5,IPO8,SERGEF,ADAM28,PTPRD,TGFBR2,PTPRZ1,DAAM1,MRPL13,TSN,COX7B2,DEPTOR,ZNF521,PTPRK,TRPS1,RGS6,SPAG9,FZD6,NUP35,NAV3,PRKCE,IRX1,FAT4,JMJD1C,CNTNAP2,AKAP9,CNTN1,SPANXN1,SS18,TWIST1,NOVA1,XPO4,CHRM3,EPHA4,CASK,SYT1,FANCB,PBX1,RAI2,DNAJC12,EDIL3,SPHKAP,PSKH2,KIF6,UBR4,ACVR1C,FGFR2,IL1RAPL2,CXCL13,BACH2,RUNX1T1,WRN,PCGF5,AMELX,ADAMTS3</TD></TR>
<TR><TD>3.443e-03</TD><TD>-5.67</TD><TD>IL1HBGF</TD><TD>prints domains</TD><TD>PR00262</TD><TD>23</TD><TD>3</TD><TD>5258</TD><TD>71</TD>
<TD>FGF20,FGF14,FGF5</TD></TR>
<TR><TD>3.472e-03</TD><TD>-5.66</TD><TD>cell development</TD><TD>biological process</TD><TD>GO:0048468</TD><TD>2240</TD><TD>40</TD><TD>18905</TD><TD>219</TD>
<TD>NRCAM,PLEK,UCHL1,DSCAM,EPHA3,ACP6,LMX1A,TWIST1,UNC5C,MAP2,FGFR2,SPATA16,NTRK2,SEMA3C,CNTNAP2,EPHA4,UHMK1,PBX1,PHF14,INSM1,SHTN1,EFNA5,SLIT2,LGI1,PTPRZ1,ROBO2,SGCD,NRG1,MEGF10,NOBOX,DNER,FERD3L,PAX6,TGFBR2,SLC25A46,CNTN1,ARX,PECAM1,GAP43,IRX1</TD></TR>
<TR><TD>3.478e-03</TD><TD>-5.66</TD><TD>skin-arm-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-arm-malignant_melanoma</TD><TD>1309</TD><TD>26</TD><TD>16984</TD><TD>192</TD>
<TD>CDH5,ZNF518B,SYT1,SPATA16,SLC39A10,SLIT2,SHISA3,CHRM3,ZPLD1,AKAP9,NOVA1,FAT4,MAP2,ADAMTS3,TCF20,MEGF10,RUNX1T1,BACH2,RGS6,WRN,TRPS1,UCHL1,ADAM28,EPYC,SPHKAP,PTPRD</TD></TR>
<TR><TD>3.481e-03</TD><TD>-5.66</TD><TD>DNA-binding transcription repressor activity</TD><TD>molecular function</TD><TD>GO:0001217</TD><TD>272</TD><TD>9</TD><TD>18530</TD><TD>206</TD>
<TD>ARX,PAX6,INSM1,BACH2,FERD3L,KLF12,TRPS1,TWIST1,IRX1</TD></TR>
<TR><TD>3.488e-03</TD><TD>-5.66</TD><TD>positive regulation of developmental growth</TD><TD>biological process</TD><TD>GO:0048639</TD><TD>168</TD><TD>7</TD><TD>18905</TD><TD>219</TD>
<TD>SYT1,FGFR2,ZFPM2,DSCAM,EFNA5,SHTN1,ARX</TD></TR>
<TR><TD>3.511e-03</TD><TD>-5.65</TD><TD>neuronal cell body</TD><TD>cellular component</TD><TD>GO:0043025</TD><TD>491</TD><TD>13</TD><TD>19868</TD><TD>221</TD>
<TD>GAP43,AKAP9,UCHL1,UNC5C,MAP2,DNER,NRSN1,EPHA4,SHTN1,BRINP3,SEZ6L,DSCAM,CNTNAP2</TD></TR>
<TR><TD>3.523e-03</TD><TD>-5.65</TD><TD>LRAT_dom</TD><TD>interpro domains</TD><TD>IPR007053</TD><TD>8</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>LRATD1,PLAAT1</TD></TR>
<TR><TD>3.523e-03</TD><TD>-5.65</TD><TD>DAD_dom</TD><TD>interpro domains</TD><TD>IPR014767</TD><TD>8</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>3.538e-03</TD><TD>-5.64</TD><TD>LRAT</TD><TD>pfam domains</TD><TD>PF04970</TD><TD>8</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>LRATD1,PLAAT1</TD></TR>
<TR><TD>3.563e-03</TD><TD>-5.64</TD><TD>KCNK18 (potassium two pore domain channel subfamily K member 18)</TD><TD>protein interactions</TD><TD>338567</TD><TD>28</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>ACVR2A,PTPRD,TGFBR2</TD></TR>
<TR><TD>3.572e-03</TD><TD>-5.63</TD><TD>corticospinal tract morphogenesis</TD><TD>biological process</TD><TD>GO:0021957</TD><TD>8</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,EPHA4</TD></TR>
<TR><TD>3.572e-03</TD><TD>-5.63</TD><TD>membranous septum morphogenesis</TD><TD>biological process</TD><TD>GO:0003149</TD><TD>8</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,TGFBR2</TD></TR>
<TR><TD>3.572e-03</TD><TD>-5.63</TD><TD>tangential migration from the subventricular zone to the olfactory bulb</TD><TD>biological process</TD><TD>GO:0022028</TD><TD>8</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,ARX</TD></TR>
<TR><TD>3.573e-03</TD><TD>-5.63</TD><TD>negative regulation of biological process</TD><TD>biological process</TD><TD>GO:0048519</TD><TD>5777</TD><TD>86</TD><TD>18905</TD><TD>219</TD>
<TD>FERD3L,PAX6,CD96,FABP7,KLF12,IRX1,ARX,MIR551B,PTPRZ1,ROBO2,PAQR3,WWOX,FGF20,ACVR1C,SS18,FANCB,MIR9-2HG,SERGEF,ADAMTS5,ADAMTS12,RUNX1T1,EPS8,TMEFF2,CNTNAP2,BCHE,AOAH,FGFR2,RBM20,INSM1,PBX1,EFEMP1,SLIT2,PHLPP1,MIR569,CASK,TSN,LRFN5,C8orf88,UCHL1,DSCAM,EPHA3,RYR2,MAP2,GHITM,CDH5,CRTC3,SPAG9,SHISA3,PTPRD,MIR1260B,STXBP6,MRPL13,FZD6,UBR4,PTPRK,BRINP3,SKAP2,RGS6,BANK1,NRG1,ZNF133,NOVA1,PRKCE,FBN2,NTRK2,ZFPM2,EPHA4,MIR147A,EFNA5,MIR548A3,PHF14,MIR891A,ASPN,NAV3,SLC39A10,PLEK,MIR548AA2,FNIP2,MIR577,DEPTOR,TRPS1,LMX1A,TWIST1,PCGF5,BACH2,CXCL13</TD></TR>
<TR><TD>3.579e-03</TD><TD>-5.63</TD><TD>OCLN (occludin)</TD><TD>protein interactions</TD><TD>100506658</TD><TD>495</TD><TD>13</TD><TD>20077</TD><TD>222</TD>
<TD>CASK,NBEA,EFEMP1,NTRK2,SLC39A10,TGFBR2,EPHA4,UTRN,ROBO2,ARL14,IQGAP2,EFR3A,EFR3B</TD></TR>
<TR><TD>3.597e-03</TD><TD>-5.63</TD><TD>DEP</TD><TD>smart domains</TD><TD>SM00049</TD><TD>21</TD><TD>3</TD><TD>9743</TD><TD>146</TD>
<TD>RGS6,PLEK,DEPTOR</TD></TR>
<TR><TD>3.614e-03</TD><TD>-5.62</TD><TD>chemorepellent activity</TD><TD>molecular function</TD><TD>GO:0045499</TD><TD>28</TD><TD>3</TD><TD>18530</TD><TD>206</TD>
<TD>SEMA3C,NRG1,EFNA5</TD></TR>
<TR><TD>3.632e-03</TD><TD>-5.62</TD><TD>blood vessel development</TD><TD>biological process</TD><TD>GO:0001568</TD><TD>530</TD><TD>14</TD><TD>18905</TD><TD>219</TD>
<TD>NRCAM,ROBO2,SGCD,CDH5,THSD7A,FGFR2,PAX6,NTRK2,SEMA3C,ZFPM2,TGFBR2,VAV3,PECAM1,SLIT2</TD></TR>
<TR><TD>3.650e-03</TD><TD>-5.61</TD><TD>cerebral cortex development</TD><TD>biological process</TD><TD>GO:0021987</TD><TD>127</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,FAT4,ARX,NTRK2,CNTNAP2,PAX6</TD></TR>
<TR><TD>3.653e-03</TD><TD>-5.61</TD><TD>cell proliferation in forebrain</TD><TD>biological process</TD><TD>GO:0021846</TD><TD>27</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>ARX,PAX6,FGFR2</TD></TR>
<TR><TD>3.678e-03</TD><TD>-5.61</TD><TD>lower_leg</TD><TD>COSMIC cancer mutations</TD><TD>lower_leg</TD><TD>174</TD><TD>7</TD><TD>16984</TD><TD>192</TD>
<TD>PXDNL,ADAMTS3,CHRM3,PTPRD,PWWP2A,ADAM28,FGFR2</TD></TR>
<TR><TD>3.684e-03</TD><TD>-5.60</TD><TD>striated_muscle</TD><TD>COSMIC cancer mutations</TD><TD>striated_muscle</TD><TD>4251</TD><TD>65</TD><TD>16984</TD><TD>192</TD>
<TD>FBN2,FMNL2,TRPS1,RGS6,SPAG9,THSD7B,FZD6,SERGEF,LHCGR,PRSS12,NRG1,PTPRZ1,UCHL1,CD226,SLC39A10,AOAH,VAV3,THSD7A,SHISA3,RPH3A,RYR2,INSM1,ROBO2,AFM,ADAMTS5,ARX,ZFPM2,FGD3,UHMK1,RBM20,RASGEF1B,IQGAP2,GAP43,FGFR2,MRPL3,GCNT1,WRN,BCHE,SEZ6L,ADAMTS3,TCF20,SLC10A2,KIF6,NOBOX,UBR4,ACVR1C,PXDNL,NCKAP5,ASPN,DSCAM,KCNK9,COQ2,MPEG1,DNER,NBEA,ZNF518B,FANCB,IRX1,FAT4,PHLPP1,MAP2,JMJD1C,CNTNAP2,AKAP9,SS18</TD></TR>
<TR><TD>3.715e-03</TD><TD>-5.60</TD><TD>human chr8q23.1</TD><TD>chromosome location</TD><TD>human chr8q23.1</TD><TD>43</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>EMC2,ZFPM2</TD></TR>
<TR><TD>3.733e-03</TD><TD>-5.59</TD><TD>rhabdomyosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>rhabdomyosarcoma</TD><TD>4173</TD><TD>64</TD><TD>16984</TD><TD>192</TD>
<TD>PRSS12,PTPRZ1,NRG1,SERGEF,LHCGR,CD226,UCHL1,TRPS1,RGS6,FMNL2,FBN2,FZD6,SPAG9,THSD7B,UHMK1,RBM20,ARX,ZFPM2,FGD3,IQGAP2,RASGEF1B,GAP43,THSD7A,SHISA3,AOAH,VAV3,SLC39A10,ADAMTS5,AFM,RYR2,RPH3A,INSM1,ROBO2,NOBOX,UBR4,PXDNL,ACVR1C,KIF6,SLC10A2,MRPL3,WRN,GCNT1,FGFR2,TCF20,ADAMTS3,BCHE,SEZ6L,MAP2,FAT4,PHLPP1,SS18,CNTNAP2,JMJD1C,AKAP9,DSCAM,KCNK9,NCKAP5,ASPN,NBEA,FANCB,ZNF518B,COQ2,DNER,MPEG1</TD></TR>
<TR><TD>3.755e-03</TD><TD>-5.58</TD><TD>cell junction organization</TD><TD>biological process</TD><TD>GO:0034330</TD><TD>532</TD><TD>14</TD><TD>18905</TD><TD>219</TD>
<TD>CDH5,PTPRD,DNER,NRCAM,PTPRK,DSCAM,LRFN5,LMX1A,SLC25A46,ADGRL3,EFNA5,PECAM1,SEZ6L,EPHA4</TD></TR>
<TR><TD>3.759e-03</TD><TD>-5.58</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.60.120.830</TD><TD>26</TD><TD>3</TD><TD>14531</TD><TD>177</TD>
<TD>ADAMTS3,ADAMTS5,ADAMTS12</TD></TR>
<TR><TD>3.770e-03</TD><TD>-5.58</TD><TD>Axon guidance</TD><TD>KEGG pathways</TD><TD>ko04360</TD><TD>175</TD><TD>7</TD><TD>7246</TD><TD>83</TD>
<TD>EPHA4,EFNA5,EPHA3,SLIT2,UNC5C,SEMA3C,ROBO2</TD></TR>
<TR><TD>3.770e-03</TD><TD>-5.58</TD><TD>Axon guidance</TD><TD>KEGG pathways</TD><TD>hsa04360</TD><TD>175</TD><TD>7</TD><TD>7246</TD><TD>83</TD>
<TD>ROBO2,EFNA5,SLIT2,EPHA3,SEMA3C,UNC5C,EPHA4</TD></TR>
<TR><TD>3.804e-03</TD><TD>-5.57</TD><TD>Growth_fac_rcpt_cys_sf</TD><TD>interpro domains</TD><TD>IPR009030</TD><TD>129</TD><TD>6</TD><TD>18605</TD><TD>214</TD>
<TD>DNER,FAT4,EPHA3,FBN2,BRINP3,EFEMP1</TD></TR>
<TR><TD>3.813e-03</TD><TD>-5.57</TD><TD>regulation of anatomical structure morphogenesis</TD><TD>biological process</TD><TD>GO:0022603</TD><TD>894</TD><TD>20</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,SHTN1,EFNA5,EPHA4,TGFBR2,FGFR2,NTRK2,PTPRD,ADAMTS12,CXCL13,FGD3,EPS8,SPAG9,CDH5,TWIST1,MAP2,DSCAM,SYT1,FMNL2,ROBO2</TD></TR>
<TR><TD>3.877e-03</TD><TD>-5.55</TD><TD>regulation of cell junction assembly</TD><TD>biological process</TD><TD>GO:1901888</TD><TD>217</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2,ROBO2,CNTNAP2,LRFN5,EPHA3,EFNA5,IL1RAPL2,PTPRD</TD></TR>
<TR><TD>3.886e-03</TD><TD>-5.55</TD><TD>human chr4q34.3</TD><TD>chromosome location</TD><TD>human chr4q34.3</TD><TD>44</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>AGA,LINC01098</TD></TR>
<TR><TD>3.886e-03</TD><TD>-5.55</TD><TD>human chr11q23.2</TD><TD>chromosome location</TD><TD>human chr11q23.2</TD><TD>44</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>REXO2,LOC101928847</TD></TR>
<TR><TD>3.889e-03</TD><TD>-5.55</TD><TD>Prot_kinase_dom</TD><TD>interpro domains</TD><TD>IPR000719</TD><TD>481</TD><TD>13</TD><TD>18605</TD><TD>214</TD>
<TD>FGFR2,EPHA3,PSKH2,PRKCE,UHMK1,CASK,TGFBR2,MAST4,NTRK2,EPHA4,ACVR1C,TEC,ACVR2A</TD></TR>
<TR><TD>3.897e-03</TD><TD>-5.55</TD><TD>ADAMTSFAMILY</TD><TD>prints domains</TD><TD>PR01857</TD><TD>24</TD><TD>3</TD><TD>5258</TD><TD>71</TD>
<TD>ADAMTS12,ADAMTS5,ADAMTS3</TD></TR>
<TR><TD>3.904e-03</TD><TD>-5.55</TD><TD>muscle organ development</TD><TD>biological process</TD><TD>GO:0007517</TD><TD>316</TD><TD>10</TD><TD>18905</TD><TD>219</TD>
<TD>SGCD,RYR2,ZFPM2,NRG1,FGFR2,SGCG,UTRN,DNER,MEGF10,TWIST1</TD></TR>
<TR><TD>3.912e-03</TD><TD>-5.54</TD><TD>regulation of developmental process</TD><TD>biological process</TD><TD>GO:0050793</TD><TD>2545</TD><TD>44</TD><TD>18905</TD><TD>219</TD>
<TD>ASPN,PHF14,SHTN1,EFNA5,EPHA4,ZFPM2,NTRK2,FGD3,CXCL13,TWIST1,UNC5C,LMX1A,TRPS1,ACVR2A,TGFBR2,FBN2,MEGF10,NRG1,SYT1,BRINP3,SLIT2,EFEMP1,PBX1,INSM1,AMELX,FGFR2,PTPRD,SPAG9,CDH5,MAP2,DSCAM,EPHA3,NRCAM,FMNL2,ARX,PAX6,FERD3L,RUNX1T1,EPS8,ADAMTS12,SS18,FGF20,PTPRZ1,ROBO2</TD></TR>
<TR><TD>3.937e-03</TD><TD>-5.54</TD><TD>endopeptidase domain like (from Nostoc punctiforme)</TD><TD>gene3d domains</TD><TD>3.90.1720.10</TD><TD>8</TD><TD>2</TD><TD>14531</TD><TD>177</TD>
<TD>LRATD1,PLAAT1</TD></TR>
<TR><TD>3.964e-03</TD><TD>-5.53</TD><TD>pelvis</TD><TD>COSMIC cancer mutations</TD><TD>pelvis</TD><TD>987</TD><TD>21</TD><TD>16984</TD><TD>192</TD>
<TD>UTRN,PTPRD,ACVR2A,SERGEF,EPHA3,ZFPM2,FGD3,IQGAP2,NOBOX,DAAM1,TRPS1,MEGF10,SPATA16,FIGN,TCF20,BANK1,NAV3,SGCD,THSD7B,RYR2,BCHE</TD></TR>
<TR><TD>4.019e-03</TD><TD>-5.52</TD><TD>mesenchyme morphogenesis</TD><TD>biological process</TD><TD>GO:0072132</TD><TD>56</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,ADAMTS5,ROBO2,TWIST1</TD></TR>
<TR><TD>4.061e-03</TD><TD>-5.51</TD><TD>human chr5p12</TD><TD>chromosome location</TD><TD>human chr5p12</TD><TD>45</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>NNT-AS1,FGF10-AS1</TD></TR>
<TR><TD>4.061e-03</TD><TD>-5.51</TD><TD>human chr6q16.1</TD><TD>chromosome location</TD><TD>human chr6q16.1</TD><TD>45</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>TSG1,FUT9</TD></TR>
<TR><TD>4.090e-03</TD><TD>-5.50</TD><TD>GRIN1 (glutamate ionotropic receptor NMDA type subunit 1)</TD><TD>protein interactions</TD><TD>2902</TD><TD>95</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>MAP2,PTPRK,AKAP9,PRKCE,NTRK2</TD></TR>
<TR><TD>4.097e-03</TD><TD>-5.50</TD><TD>glial cell differentiation</TD><TD>biological process</TD><TD>GO:0010001</TD><TD>219</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2,PTPRZ1,PAX6,SLC25A46,FGF5,DNER,GAP43,CNTN1</TD></TR>
<TR><TD>4.120e-03</TD><TD>-5.49</TD><TD>FGF</TD><TD>smart domains</TD><TD>SM00442</TD><TD>22</TD><TD>3</TD><TD>9743</TD><TD>146</TD>
<TD>FGF20,FGF5,FGF14</TD></TR>
<TR><TD>4.141e-03</TD><TD>-5.49</TD><TD>cell adhesion molecule binding</TD><TD>molecular function</TD><TD>GO:0050839</TD><TD>561</TD><TD>14</TD><TD>18530</TD><TD>206</TD>
<TD>NRG1,PTPRZ1,CDH5,CD226,UTRN,FMNL2,CNTN1,EDIL3,SHTN1,NRCAM,DSCAM,ADAMTS5,STXBP6,PTPRD</TD></TR>
<TR><TD>4.173e-03</TD><TD>-5.48</TD><TD>growth factor binding</TD><TD>molecular function</TD><TD>GO:0019838</TD><TD>136</TD><TD>6</TD><TD>18530</TD><TD>206</TD>
<TD>TGFBR2,FGFR2,CXCL13,NTRK2,ACVR1C,ACVR2A</TD></TR>
<TR><TD>4.174e-03</TD><TD>-5.48</TD><TD>human chr5p13.3-p13.2</TD><TD>chromosome location</TD><TD>human chr5p13.3-p13.2</TD><TD>2</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>ADAMTS12</TD></TR>
<TR><TD>4.174e-03</TD><TD>-5.48</TD><TD>human chr5q33.2-q33.3</TD><TD>chromosome location</TD><TD>human chr5q33.2-q33.3</TD><TD>2</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>SGCD</TD></TR>
<TR><TD>4.174e-03</TD><TD>-5.48</TD><TD>human chr13q33.2|13q34</TD><TD>chromosome location</TD><TD>human chr13q33.2|13q34</TD><TD>2</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>DAOA</TD></TR>
<TR><TD>4.269e-03</TD><TD>-5.46</TD><TD>adenoid_cystic_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>adenoid_cystic_carcinoma</TD><TD>1126</TD><TD>23</TD><TD>16984</TD><TD>192</TD>
<TD>CASK,RYR2,THSD7A,IQGAP2,NTRK2,PARP8,JMJD1C,AKAP9,UTRN,MAP2,UHMK1,RBM20,ACVR2A,FAT4,SEZ6L,FBN2,FGFR2,PTPRK,CD226,CRTC3,NRCAM,TGFBR2,DNAJC12</TD></TR>
<TR><TD>4.299e-03</TD><TD>-5.45</TD><TD>Constitutive Signaling by Aberrant PI3K in Cancer</TD><TD>REACTOME pathways</TD><TD>R-HSA-2219530</TD><TD>65</TD><TD>4</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGFR2,FGF20,NRG1</TD></TR>
<TR><TD>4.343e-03</TD><TD>-5.44</TD><TD>cell surface receptor protein tyrosine kinase signaling pathway</TD><TD>biological process</TD><TD>GO:0007169</TD><TD>428</TD><TD>12</TD><TD>18905</TD><TD>219</TD>
<TD>FGF5,SS18,ZFAND5,FGF20,NRG1,EPHA3,EFEMP1,EFNA5,EPHA4,FGFR2,GAREM1,NTRK2</TD></TR>
<TR><TD>4.373e-03</TD><TD>-5.43</TD><TD>EOGT (EGF domain specific O-linked N-acetylglucosamine transferase)</TD><TD>protein interactions</TD><TD>285203</TD><TD>60</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>LGI1,PTPRK,PI15,SLC7A14</TD></TR>
<TR><TD>4.423e-03</TD><TD>-5.42</TD><TD>human chr3p24.1</TD><TD>chromosome location</TD><TD>human chr3p24.1</TD><TD>47</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>TGFBR2,LRRC3B</TD></TR>
<TR><TD>4.437e-03</TD><TD>-5.42</TD><TD>kidney-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>kidney-carcinoma</TD><TD>3724</TD><TD>58</TD><TD>16984</TD><TD>192</TD>
<TD>TWIST1,SS18,NOVA1,JMJD1C,AKAP9,CNTN1,PRKCE,IRX1,CASK,SYT1,EPHA4,XPO4,UBR4,ACVR1C,PSKH2,KIF6,SPHKAP,PBX1,DNAJC12,PCGF5,ADAMTS3,WRN,FGFR2,CXCL13,RUNX1T1,BACH2,RASGEF1B,ADAMTS12,NTRK2,HNF4G,UHMK1,PAX6,ACVR2A,EPHA3,FGD3,PHF14,IPO8,ADAMTS5,LRIG3,VAV3,TSN,DAAM1,MRPL13,PTPRD,PTPRZ1,TGFBR2,SERGEF,ADAM28,FZD6,NUP35,NAV3,SPAG9,TRPS1,RGS6,COX7B2,DEPTOR,ZNF521,PTPRK</TD></TR>
<TR><TD>4.441e-03</TD><TD>-5.42</TD><TD>acute_lymphoblastic_T_cell_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>acute_lymphoblastic_T_cell_leukaemia</TD><TD>740</TD><TD>17</TD><TD>16984</TD><TD>192</TD>
<TD>NBEA,PHF14,RYR2,RPH3A,ROBO2,DSCAM,TRPS1,FGFR2,NOL4,NOBOX,ADAMTS12,PXDNL,CRTC3,PTPRD,TGFBR2,NRG1,DNAJC12</TD></TR>
<TR><TD>4.441e-03</TD><TD>-5.42</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_T_cell_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_T_cell_leukaemia</TD><TD>740</TD><TD>17</TD><TD>16984</TD><TD>192</TD>
<TD>CRTC3,ADAMTS12,PXDNL,NOBOX,DNAJC12,TGFBR2,NRG1,PTPRD,ROBO2,RYR2,RPH3A,NBEA,PHF14,NOL4,FGFR2,DSCAM,TRPS1</TD></TR>
<TR><TD>4.469e-03</TD><TD>-5.41</TD><TD>PCK2 (phosphoenolpyruvate carboxykinase 2, mitochondrial)</TD><TD>protein interactions</TD><TD>5106</TD><TD>97</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>EMC2,NUP35,PRKCE,COQ2,GAP43</TD></TR>
<TR><TD>4.487e-03</TD><TD>-5.41</TD><TD>salivary gland morphogenesis</TD><TD>biological process</TD><TD>GO:0007435</TD><TD>29</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>SEMA3C,FGFR2,PAX6</TD></TR>
<TR><TD>4.495e-03</TD><TD>-5.40</TD><TD>Activin_recp</TD><TD>interpro domains</TD><TD>IPR000472</TD><TD>9</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>ACVR1C,ACVR2A</TD></TR>
<TR><TD>4.495e-03</TD><TD>-5.40</TD><TD>GTPase-bd</TD><TD>interpro domains</TD><TD>IPR010473</TD><TD>9</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>DAAM1,FMNL2</TD></TR>
<TR><TD>4.495e-03</TD><TD>-5.40</TD><TD>FH3_dom</TD><TD>interpro domains</TD><TD>IPR010472</TD><TD>9</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>4.498e-03</TD><TD>-5.40</TD><TD>signal transduction</TD><TD>biological process</TD><TD>GO:0007165</TD><TD>4780</TD><TD>73</TD><TD>18905</TD><TD>219</TD>
<TD>FAT4,EPHA4,NTRK2,DCDC2C,DAAM1,EFNA5,SHTN1,IQGAP2,DEPTOR,PLEK,FNIP2,FGF5,LRRN2,GPR83,CXCL13,UNC5C,PPP1R17,TGFBR2,CYTL1,GAREM1,FZD6,ACVR2A,GAP43,ADGRL3,ATG10,PARP8,BANK1,NRG1,PTPRK,RGS6,SKAP2,PRKCE,FBN2,RASGEF1B,DNER,HNF4G,MAST4,OR2AG1,AMELX,SEMA3C,FGFR2,CHRM3,SLIT2,AKAP9,GMDS,FGF14,VAV3,EFEMP1,RYR2,DSCAM,EPHA3,PHLPP1,TEC,PTPRD,CD226,SPAG9,PRLHR,CDH5,PAX6,IPO8,IL1RAPL2,CNTN1,PECAM1,LHCGR,WWOX,SGCD,ZFAND5,ACVR1C,FGF20,OR52K2,EPS8,SS18,SERGEF</TD></TR>
<TR><TD>4.507e-03</TD><TD>-5.40</TD><TD>FGFR2 mutant receptor activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-1839126</TD><TD>33</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGFR2,FGF5</TD></TR>
<TR><TD>4.507e-03</TD><TD>-5.40</TD><TD>Regulation of beta-cell development</TD><TD>REACTOME pathways</TD><TD>R-HSA-186712</TD><TD>33</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>HNF4G,INSM1,PAX6</TD></TR>
<TR><TD>4.514e-03</TD><TD>-5.40</TD><TD>Drf_FH3</TD><TD>pfam domains</TD><TD>PF06367</TD><TD>9</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>4.514e-03</TD><TD>-5.40</TD><TD>Activin_recp</TD><TD>pfam domains</TD><TD>PF01064</TD><TD>9</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>ACVR2A,ACVR1C</TD></TR>
<TR><TD>4.514e-03</TD><TD>-5.40</TD><TD>Drf_GBD</TD><TD>pfam domains</TD><TD>PF06371</TD><TD>9</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>DAAM1,FMNL2</TD></TR>
<TR><TD>4.538e-03</TD><TD>-5.40</TD><TD>regulation of extent of cell growth</TD><TD>biological process</TD><TD>GO:0061387</TD><TD>93</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>DSCAM,EFNA5,MAP2,SHTN1,NRCAM</TD></TR>
<TR><TD>4.558e-03</TD><TD>-5.39</TD><TD>positive regulation of cardiac epithelial to mesenchymal transition</TD><TD>biological process</TD><TD>GO:0062043</TD><TD>9</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,TWIST1</TD></TR>
<TR><TD>4.558e-03</TD><TD>-5.39</TD><TD>spontaneous synaptic transmission</TD><TD>biological process</TD><TD>GO:0098814</TD><TD>9</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>RPH3A,SYT1</TD></TR>
<TR><TD>4.558e-03</TD><TD>-5.39</TD><TD>limb bud formation</TD><TD>biological process</TD><TD>GO:0060174</TD><TD>9</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>SEMA3C,FGFR2</TD></TR>
<TR><TD>4.567e-03</TD><TD>-5.39</TD><TD>regulation of locomotion</TD><TD>biological process</TD><TD>GO:0040012</TD><TD>1167</TD><TD>24</TD><TD>18905</TD><TD>219</TD>
<TD>TMEFF2,PRKCE,ACVR1C,FGF20,FUT9,ROBO2,PTPRK,PECAM1,TGFBR2,PAX6,CXCL13,SPAG9,FGF5,CDH5,TWIST1,UNC5C,DSCAM,NAV3,SLIT2,INSM1,SHTN1,GCNT1,EPHA4,SEMA3C</TD></TR>
<TR><TD>4.576e-03</TD><TD>-5.39</TD><TD>DAD</TD><TD>prosite domains</TD><TD>PS51231</TD><TD>8</TD><TD>2</TD><TD>12232</TD><TD>161</TD>
<TD>DAAM1,FMNL2</TD></TR>
<TR><TD>4.576e-03</TD><TD>-5.39</TD><TD>LRAT</TD><TD>prosite domains</TD><TD>PS51934</TD><TD>8</TD><TD>2</TD><TD>12232</TD><TD>161</TD>
<TD>PLAAT1,LRATD1</TD></TR>
<TR><TD>4.731e-03</TD><TD>-5.35</TD><TD>GJA1 (gap junction protein alpha 1)</TD><TD>protein interactions</TD><TD>2697</TD><TD>572</TD><TD>14</TD><TD>20077</TD><TD>222</TD>
<TD>UNC5C,NBEA,PRKCE,CASK,WWOX,PCDH9,ROBO2,UTRN,SLC39A10,LRIG3,EPHA4,EPHA3,EFR3B,EFR3A</TD></TR>
<TR><TD>4.734e-03</TD><TD>-5.35</TD><TD>fibula</TD><TD>COSMIC cancer mutations</TD><TD>fibula</TD><TD>388</TD><TD>11</TD><TD>16984</TD><TD>192</TD>
<TD>SS18,ZFPM2,SERGEF,BANK1,SPATA16,PHF14,MPEG1,DSCAM,SKAP2,FBN2,NCKAP5</TD></TR>
<TR><TD>4.743e-03</TD><TD>-5.35</TD><TD>alveolar</TD><TD>COSMIC cancer mutations</TD><TD>alveolar</TD><TD>2423</TD><TD>41</TD><TD>16984</TD><TD>192</TD>
<TD>AKAP9,JMJD1C,CNTNAP2,IQGAP2,PHLPP1,ZFPM2,ARX,RBM20,MAP2,INSM1,ROBO2,MPEG1,DNER,RYR2,ZNF518B,FANCB,NCKAP5,VAV3,AOAH,KCNK9,SHISA3,THSD7A,UCHL1,SLC10A2,KIF6,CD226,ACVR1C,NOBOX,LHCGR,SERGEF,PRSS12,BCHE,SEZ6L,THSD7B,SPAG9,FZD6,FGFR2,FMNL2,FBN2,WRN,TRPS1</TD></TR>
<TR><TD>4.743e-03</TD><TD>-5.35</TD><TD>soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar</TD><TD>2423</TD><TD>41</TD><TD>16984</TD><TD>192</TD>
<TD>FGFR2,FMNL2,FBN2,TRPS1,WRN,THSD7B,SPAG9,BCHE,SEZ6L,FZD6,LHCGR,SERGEF,PRSS12,SLC10A2,UCHL1,KIF6,NOBOX,CD226,ACVR1C,NCKAP5,VAV3,AOAH,THSD7A,KCNK9,SHISA3,RYR2,INSM1,MPEG1,ROBO2,DNER,ZNF518B,FANCB,ARX,ZFPM2,PHLPP1,MAP2,RBM20,JMJD1C,CNTNAP2,AKAP9,IQGAP2</TD></TR>
<TR><TD>4.749e-03</TD><TD>-5.35</TD><TD>positive regulation of neuron differentiation</TD><TD>biological process</TD><TD>GO:0045666</TD><TD>94</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>SPAG9,FGF20,BRINP3,NRCAM,PAX6</TD></TR>
<TR><TD>4.791e-03</TD><TD>-5.34</TD><TD>pleura-mesothelioma</TD><TD>COSMIC cancer mutations</TD><TD>pleura-mesothelioma</TD><TD>4216</TD><TD>64</TD><TD>16984</TD><TD>192</TD>
<TD>CASK,SYT1,FANCB,EPHA4,XPO4,SPANXN1,TWIST1,SS18,NOVA1,JMJD1C,CNTN1,AKAP9,PRKCE,IRX1,AMELX,PCGF5,ADAMTS3,WRN,FGFR2,IL1RAPL2,CXCL13,BACH2,RUNX1T1,UBR4,ACVR1C,PSKH2,KIF6,SPHKAP,RAI2,PBX1,DNAJC12,EDIL3,PHF14,ADAMTS5,IPO8,VAV3,LRIG3,RASGEF1B,ADAMTS12,NTRK2,UHMK1,PAX6,ACVR2A,EPHA3,ARX,FGD3,FZD6,NUP35,NAV3,SPAG9,TRPS1,RGS6,DEPTOR,COX7B2,ZNF521,PTPRK,TSN,DAAM1,MRPL13,PTPRD,PTPRZ1,TGFBR2,SERGEF,ADAM28</TD></TR>
<TR><TD>4.819e-03</TD><TD>-5.34</TD><TD>Tyr_kinase_AS</TD><TD>interpro domains</TD><TD>IPR008266</TD><TD>95</TD><TD>5</TD><TD>18605</TD><TD>214</TD>
<TD>EPHA4,FGFR2,EPHA3,NTRK2,TEC</TD></TR>
<TR><TD>4.854e-03</TD><TD>-5.33</TD><TD>signaling</TD><TD>biological process</TD><TD>GO:0023052</TD><TD>5112</TD><TD>77</TD><TD>18905</TD><TD>219</TD>
<TD>ADGRL3,ATG10,PARP8,RPH3A,ACVR2A,FZD6,GAP43,GAREM1,CYTL1,TGFBR2,PPP1R17,HNF4G,SEPTIN5,MAST4,DNER,RASGEF1B,PRKCE,FBN2,PTPRK,SKAP2,RGS6,SYT1,BANK1,NRG1,EFNA5,DAAM1,IQGAP2,SHTN1,DCDC2C,UTRN,NTRK2,FAT4,EPHA4,UNC5C,FGF5,LRRN2,CXCL13,GPR83,PLEK,FNIP2,DEPTOR,LHCGR,IL1RAPL2,PECAM1,CNTN1,IPO8,PAX6,SS18,SERGEF,EPS8,OR52K2,WWOX,FGF20,SGCD,ZFAND5,ACVR1C,VAV3,EFEMP1,GMDS,SLIT2,AKAP9,FGF14,SEMA3C,CHRM3,FGFR2,OR2AG1,AMELX,PRLHR,CDH5,SPAG9,PTPRD,CD226,PHLPP1,TEC,EPHA3,DSCAM,RYR2</TD></TR>
<TR><TD>4.896e-03</TD><TD>-5.32</TD><TD>gliogenesis</TD><TD>biological process</TD><TD>GO:0042063</TD><TD>275</TD><TD>9</TD><TD>18905</TD><TD>219</TD>
<TD>SLC25A46,DNER,FGF5,CNTN1,GAP43,NTRK2,PTPRZ1,PAX6,EPHA4</TD></TR>
<TR><TD>4.907e-03</TD><TD>-5.32</TD><TD>EPHA-mediated growth cone collapse</TD><TD>REACTOME pathways</TD><TD>R-HSA-3928663</TD><TD>34</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>EPHA3,EFNA5,EPHA4</TD></TR>
<TR><TD>4.907e-03</TD><TD>-5.32</TD><TD>Negative regulation of FGFR2 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654727</TD><TD>34</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGFR2,FGF5</TD></TR>
<TR><TD>4.918e-03</TD><TD>-5.31</TD><TD>CETN1 (centrin 1)</TD><TD>protein interactions</TD><TD>1068</TD><TD>62</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>CETN3,TWIST1,CALN1,ZFAND5</TD></TR>
<TR><TD>4.967e-03</TD><TD>-5.30</TD><TD>response to fibroblast growth factor</TD><TD>biological process</TD><TD>GO:0071774</TD><TD>95</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>FGF20,CXCL13,FGF5,FGFR2,PAX6</TD></TR>
<TR><TD>4.974e-03</TD><TD>-5.30</TD><TD>FGFR4 (fibroblast growth factor receptor 4)</TD><TD>protein interactions</TD><TD>2264</TD><TD>456</TD><TD>12</TD><TD>20077</TD><TD>222</TD>
<TD>FGF5,UTRN,SLC39A10,TGFBR2,EPHA4,EFR3B,PI15,SEPTIN5,NBEA,ADAMTS12,NRSN1,UBR4</TD></TR>
<TR><TD>4.991e-03</TD><TD>-5.30</TD><TD>human chr2q32.3</TD><TD>chromosome location</TD><TD>human chr2q32.3</TD><TD>50</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>SLC39A10,TMEFF2</TD></TR>
<TR><TD>5.012e-03</TD><TD>-5.30</TD><TD>sensory organ morphogenesis</TD><TD>biological process</TD><TD>GO:0090596</TD><TD>276</TD><TD>9</TD><TD>18905</TD><TD>219</TD>
<TD>EFEMP1,LRIG3,TWIST1,FBN2,FZD6,FGFR2,PAX6,NTRK2,DSCAM</TD></TR>
<TR><TD>5.029e-03</TD><TD>-5.29</TD><TD>GOLM1 (golgi membrane protein 1)</TD><TD>protein interactions</TD><TD>51280</TD><TD>142</TD><TD>6</TD><TD>20077</TD><TD>222</TD>
<TD>GALNT15,FUT9,NRSN1,THSD7A,SLC7A14,SYT1</TD></TR>
<TR><TD>5.035e-03</TD><TD>-5.29</TD><TD>Signaling pathways regulating pluripotency of stem cells</TD><TD>KEGG pathways</TD><TD>ko04550</TD><TD>139</TD><TD>6</TD><TD>7246</TD><TD>83</TD>
<TD>ACVR1C,PCGF5,FGFR2,FZD6,ACVR2A,PAX6</TD></TR>
<TR><TD>5.035e-03</TD><TD>-5.29</TD><TD>Signaling pathways regulating pluripotency of stem cells</TD><TD>KEGG pathways</TD><TD>hsa04550</TD><TD>139</TD><TD>6</TD><TD>7246</TD><TD>83</TD>
<TD>PAX6,ACVR2A,FZD6,ACVR1C,PCGF5,FGFR2</TD></TR>
<TR><TD>5.058e-03</TD><TD>-5.29</TD><TD>salivary_gland</TD><TD>COSMIC cancer mutations</TD><TD>salivary_gland</TD><TD>1142</TD><TD>23</TD><TD>16984</TD><TD>192</TD>
<TD>RBM20,ACVR2A,UHMK1,UTRN,MAP2,FAT4,IQGAP2,AKAP9,JMJD1C,PARP8,NTRK2,THSD7A,CASK,RYR2,TGFBR2,DNAJC12,CD226,NRCAM,CRTC3,PTPRK,FGFR2,FBN2,SEZ6L</TD></TR>
<TR><TD>5.140e-03</TD><TD>-5.27</TD><TD>metallopeptidase activity</TD><TD>molecular function</TD><TD>GO:0008237</TD><TD>188</TD><TD>7</TD><TD>18530</TD><TD>206</TD>
<TD>ADAMTS5,CPXM2,ADAMTS12,CPQ,ADAM28,ADAMTS3,MATCAP2</TD></TR>
<TR><TD>5.144e-03</TD><TD>-5.27</TD><TD>protein tyrosine kinase activity</TD><TD>molecular function</TD><TD>GO:0004713</TD><TD>142</TD><TD>6</TD><TD>18530</TD><TD>206</TD>
<TD>NTRK2,TEC,EFEMP1,FGFR2,EPHA4,EPHA3</TD></TR>
<TR><TD>5.200e-03</TD><TD>-5.26</TD><TD>plasma membrane</TD><TD>cellular component</TD><TD>GO:0005886</TD><TD>5920</TD><TD>84</TD><TD>19868</TD><TD>221</TD>
<TD>PCDH9,SLC10A2,UNC5C,SEMA3C,SKAP2,DNER,EFR3B,SEPTIN5,EFR3A,KCNK9,GPR83,LHCGR,PTPRZ1,SLC7A8,ROBO2,VAV3,SGCD,EFNA5,SLC7A14,LMBRD1,OR2AG1,THSD7A,PTPRK,CNTN1,PHLPP1,NUP35,PXDNL,GAP43,EPHA3,RGS6,KAZN,THSD7B,MUC7,CASK,ADGRL3,LRRC70,SGCG,RPH3A,TGFBR2,PRLHR,CALN1,RYR2,IL1RAPL2,EPS8,NBEA,SYT1,NTRK2,TEC,SLC39A10,FZD6,CD96,ACVR2A,PRKCE,WWOX,UBR4,MEGF10,IQGAP2,SERINC5,DAAM1,CHRM3,LRFN5,AKAP9,PLEK,BCHE,CDH5,UCHL1,OR52K2,NRCAM,ACVR1C,ADAM28,RASGEF1B,PECAM1,LRIG3,NRG1,DSCAM,FGFR2,CNTNAP2,GAREM1,PRSS12,UTRN,EPHA4,CD226,PTPRD,FAT4</TD></TR>
<TR><TD>5.302e-03</TD><TD>-5.24</TD><TD>FAM171A2 (family with sequence similarity 171 member A2)</TD><TD>protein interactions</TD><TD>284069</TD><TD>101</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>EPHA3,NTRK2,EPHA4,NRSN1,TGFBR2</TD></TR>
<TR><TD>5.339e-03</TD><TD>-5.23</TD><TD>Signaling by activated point mutants of FGFR1</TD><TD>REACTOME pathways</TD><TD>R-HSA-1839122</TD><TD>11</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>5.364e-03</TD><TD>-5.23</TD><TD>protein kinase activity</TD><TD>molecular function</TD><TD>GO:0004672</TD><TD>578</TD><TD>14</TD><TD>18530</TD><TD>206</TD>
<TD>ACVR1C,PSKH2,EPHA3,MAST4,UHMK1,NTRK2,CASK,ACVR2A,FGFR2,EPHA4,TGFBR2,TEC,PRKCE,EFEMP1</TD></TR>
<TR><TD>5.427e-03</TD><TD>-5.22</TD><TD>activin receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0032924</TD><TD>31</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>ACVR2A,TGFBR2,ACVR1C</TD></TR>
<TR><TD>5.459e-03</TD><TD>-5.21</TD><TD>regulation of microtubule polymerization</TD><TD>biological process</TD><TD>GO:0031113</TD><TD>61</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>CDH5,NAV3,MAP2,AKAP9</TD></TR>
<TR><TD>5.459e-03</TD><TD>-5.21</TD><TD>cardiac muscle tissue morphogenesis</TD><TD>biological process</TD><TD>GO:0055008</TD><TD>61</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,NRG1,ZFPM2,RYR2</TD></TR>
<TR><TD>5.506e-03</TD><TD>-5.20</TD><TD>CD83 (CD83 molecule)</TD><TD>protein interactions</TD><TD>9308</TD><TD>64</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRD,ACVR2A,SPAG9,FGFR2</TD></TR>
<TR><TD>5.506e-03</TD><TD>-5.20</TD><TD>RELT (RELT TNF receptor)</TD><TD>protein interactions</TD><TD>84957</TD><TD>64</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>TGFBR2,NRSN1,PTPRD,ACVR2A</TD></TR>
<TR><TD>5.591e-03</TD><TD>-5.19</TD><TD>human chr14q21.1</TD><TD>chromosome location</TD><TD>human chr14q21.1</TD><TD>53</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC02315,LRFN5</TD></TR>
<TR><TD>5.603e-03</TD><TD>-5.18</TD><TD>FBXO2 (F-box protein 2)</TD><TD>protein interactions</TD><TD>26232</TD><TD>405</TD><TD>11</TD><TD>20077</TD><TD>222</TD>
<TD>FGFR2,PCDH9,BCHE,PTPRK,CNTN1,AGA,SLIT2,EDIL3,SEMA3C,LRIG3,FBN2</TD></TR>
<TR><TD>5.654e-03</TD><TD>-5.18</TD><TD>thrombin-activated receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0070493</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>IQGAP2,PLEK</TD></TR>
<TR><TD>5.654e-03</TD><TD>-5.18</TD><TD>regulation of dopaminergic neuron differentiation</TD><TD>biological process</TD><TD>GO:1904338</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>FERD3L,FGF20</TD></TR>
<TR><TD>5.654e-03</TD><TD>-5.18</TD><TD>substrate-independent telencephalic tangential migration</TD><TD>biological process</TD><TD>GO:0021826</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,ARX</TD></TR>
<TR><TD>5.654e-03</TD><TD>-5.18</TD><TD>learned vocalization behavior or vocal learning</TD><TD>biological process</TD><TD>GO:0098598</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>CNTNAP2,PAX6</TD></TR>
<TR><TD>5.654e-03</TD><TD>-5.18</TD><TD>substrate-independent telencephalic tangential interneuron migration</TD><TD>biological process</TD><TD>GO:0021843</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>ARX,SLIT2</TD></TR>
<TR><TD>5.654e-03</TD><TD>-5.18</TD><TD>pancreatic A cell differentiation</TD><TD>biological process</TD><TD>GO:0003310</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,INSM1</TD></TR>
<TR><TD>5.654e-03</TD><TD>-5.18</TD><TD>neuronal action potential propagation</TD><TD>biological process</TD><TD>GO:0019227</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2,NRCAM</TD></TR>
<TR><TD>5.654e-03</TD><TD>-5.18</TD><TD>action potential propagation</TD><TD>biological process</TD><TD>GO:0098870</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2,NRCAM</TD></TR>
<TR><TD>5.658e-03</TD><TD>-5.17</TD><TD>stomach-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>stomach-carcinoma-adenocarcinoma</TD><TD>15170</TD><TD>182</TD><TD>16984</TD><TD>192</TD>
<TD>NRG1,PRSS12,EPS8,LHCGR,SLC7A8,MRPL13,CRTC3,COX7B2,NAV3,FZD6,LMBRD1,FGF14,THSD7B,UHMK1,ARX,SHISA3,PCDH9,INSM1,CDH5,FNIP2,SLC7A14,EDIL3,PXDNL,AGA,FABP7,SLC25A46,BACH2,FGF5,CTSO,IGFL4,FAT4,KCNK9,CHRM3,DAOA,SYT1,FANCB,ZNF518B,BANK1,NBEA,GMDS,MPEG1,PTPRZ1,GHITM,UNC5C,GPR83,SERGEF,B3GAT2,CD226,OR2AG1,TRPS1,WWOX,EFEMP1,ACVR2A,UTRN,ZFPM2,GAP43,RASGEF1B,CELF2,PLEK,VAV3,SLC39A10,NAT2,AFM,SPATA16,EPYC,PRLHR,EFNA5,KAZN,LMX1A,LGI1,SLC10A2,PSKH2,GCNT1,RUNX1T1,FGFR2,FERD3L,AMELX,SERINC5,MAP2,NOVA1,SS18,TWIST1,SPANXN1,NAALADL2,AKAP9,CNTN1,PARP8,SLIT2,NOL4,NCKAP5,FGF20,TGFBR2,PTPRD,ADAM28,TSN,CALN1,SEMA3C,NRCAM,DAAM1,KLF12,PTPRK,ZNF521,FMNL2,NUP35,EFR3A,ATG10,CYTL1,EPHA3,ADAMTS12,HNF4G,NTRK2,CD96,ZPLD1,THSD7A,AOAH,REXO2,ADAMTS5,PHF14,SGCG,ROBO2,RYR2,RPH3A,SPHKAP,LRRN2,ACVR1C,NOBOX,ERCC6L2,KIF6,PAQR3,ZFAND5,MEGF10,ACP6,TCF20,PCGF5,SEZ6L,LRFN5,PI15,CPXM2,IRX1,PRKCE,ZNF133,CNTNAP2,DSCAM,SKAP2,XPO4,SGCD,TMEFF2,CASK,EPHA4,DNER,COQ2,PWWP2A,UCHL1,RGS6,FBN2,DEPTOR,MUC7,SPAG9,PAX6,FGD3,IQGAP2,STXBP6,REG1B,LRIG3,NRSN1,IPO8,FUT9,DNAJC12,RAI2,UBR4,WRN,CETN3,MRPL3,IL1RAPL2,ADAMTS3,BCHE,PHLPP1,OR52K2,JMJD1C,LRRC3B,ASPN,FIGN</TD></TR>
<TR><TD>5.699e-03</TD><TD>-5.17</TD><TD>HS6ST1 (heparan sulfate 6-O-sulfotransferase 1)</TD><TD>protein interactions</TD><TD>9394</TD><TD>33</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>NRG1,CPQ,NRSN1</TD></TR>
<TR><TD>5.785e-03</TD><TD>-5.15</TD><TD>skeletal system development</TD><TD>biological process</TD><TD>GO:0001501</TD><TD>501</TD><TD>13</TD><TD>18905</TD><TD>219</TD>
<TD>AMELX,TGFBR2,CYTL1,FGFR2,EPYC,ACVR2A,PBX1,ZFAND5,WWOX,TRPS1,ADAMTS12,FBN2,TWIST1</TD></TR>
<TR><TD>5.798e-03</TD><TD>-5.15</TD><TD>human chr4p15.1</TD><TD>chromosome location</TD><TD>human chr4p15.1</TD><TD>54</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC02484,LINC02497</TD></TR>
<TR><TD>5.938e-03</TD><TD>-5.13</TD><TD>salivary gland development</TD><TD>biological process</TD><TD>GO:0007431</TD><TD>32</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,PAX6,SEMA3C</TD></TR>
<TR><TD>5.943e-03</TD><TD>-5.13</TD><TD>head_neck</TD><TD>COSMIC cancer mutations</TD><TD>head_neck</TD><TD>15414</TD><TD>184</TD><TD>16984</TD><TD>192</TD>
<TD>ADAM28,TGFBR2,PTPRD,SEMA3C,NRCAM,DAAM1,TSN,CALN1,PTPRK,ZNF521,FMNL2,KLF12,CYTL1,NUP35,EFR3A,ATG10,EPHA3,NTRK2,CD96,HNF4G,ADAMTS12,AOAH,ZPLD1,THSD7A,ROBO2,RYR2,RPH3A,ADAMTS5,SGCG,PHF14,SPHKAP,KIF6,PAQR3,LRRN2,ACVR1C,NOBOX,ERCC6L2,CXCL13,MEGF10,ACP6,SEZ6L,PCGF5,LRFN5,TCF20,IRX1,PRKCE,ZNF133,PI15,CPXM2,CNTNAP2,SKAP2,XPO4,DSCAM,EPHA4,DNER,COQ2,SGCD,TMEFF2,CASK,PWWP2A,UCHL1,FBN2,DEPTOR,RGS6,MUC7,SPAG9,FGD3,PAX6,IQGAP2,STXBP6,REG1B,LRIG3,FUT9,NRSN1,IPO8,DNAJC12,RAI2,PBX1,UBR4,IL1RAPL2,WRN,CETN3,MRPL3,ADAMTS3,BCHE,PHLPP1,LRRC70,JMJD1C,OR52K2,ASPN,EFR3B,LRRC3B,FIGN,EPS8,LHCGR,NRG1,PRSS12,MRPL13,CRTC3,SLC7A8,COX7B2,LMBRD1,FGF14,THSD7B,NAV3,FZD6,ARX,RBM20,ARL14,UHMK1,SHISA3,PCDH9,CDH5,EDIL3,SLC7A14,FNIP2,SLC25A46,PXDNL,AGA,BACH2,FGF5,IGFL4,CTSO,FAT4,DAOA,KCNK9,CHRM3,GMDS,MPEG1,SYT1,FANCB,ZNF518B,BANK1,NBEA,GPR83,SERGEF,B3GAT2,PTPRZ1,UNC5C,OR2AG1,CD226,TRPS1,EFEMP1,WWOX,ZFPM2,ACVR2A,UTRN,DEFB115,GAP43,RASGEF1B,CELF2,VAV3,SLC39A10,PLEK,NAT2,AFM,SPATA16,PRLHR,EFNA5,EPYC,LGI1,SLC10A2,PSKH2,LMX1A,KAZN,RUNX1T1,FGFR2,GCNT1,AMELX,FERD3L,SERINC5,MAP2,NAALADL2,CNTN1,AKAP9,PARP8,NOVA1,SS18,TWIST1,SPANXN1,NOL4,NCKAP5,SLIT2,FGF20</TD></TR>
<TR><TD>5.972e-03</TD><TD>-5.12</TD><TD>Cell adhesion molecules (CAMs)</TD><TD>KEGG pathways</TD><TD>ko04514</TD><TD>144</TD><TD>6</TD><TD>7246</TD><TD>83</TD>
<TD>CD226,CNTN1,NRCAM,PECAM1,CDH5,CNTNAP2</TD></TR>
<TR><TD>5.972e-03</TD><TD>-5.12</TD><TD>Cell adhesion molecules (CAMs)</TD><TD>KEGG pathways</TD><TD>hsa04514</TD><TD>144</TD><TD>6</TD><TD>7246</TD><TD>83</TD>
<TD>PECAM1,CDH5,CNTNAP2,CNTN1,CD226,NRCAM</TD></TR>
<TR><TD>6.072e-03</TD><TD>-5.10</TD><TD>protein phosphorylation</TD><TD>biological process</TD><TD>GO:0006468</TD><TD>504</TD><TD>13</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,UHMK1,EPHA4,NTRK2,FGFR2,ACVR2A,EFEMP1,EPHA3,ACVR1C,FNIP2,TEC,PRKCE,MAST4</TD></TR>
<TR><TD>6.080e-03</TD><TD>-5.10</TD><TD>glycosaminoglycan binding</TD><TD>molecular function</TD><TD>GO:0005539</TD><TD>244</TD><TD>8</TD><TD>18530</TD><TD>206</TD>
<TD>ADAMTS3,CXCL13,FGFR2,TGFBR2,SLIT2,ADAMTS5,EPYC,REG1B</TD></TR>
<TR><TD>6.099e-03</TD><TD>-5.10</TD><TD>regulation of cell migration</TD><TD>biological process</TD><TD>GO:0030334</TD><TD>1063</TD><TD>22</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4,TGFBR2,PAX6,SEMA3C,PECAM1,SLIT2,SHTN1,INSM1,GCNT1,ACVR1C,FUT9,FGF20,PTPRK,NAV3,TMEFF2,SPAG9,CXCL13,PRKCE,FGF5,CDH5,TWIST1,UNC5C</TD></TR>
<TR><TD>6.121e-03</TD><TD>-5.10</TD><TD>ventricular cardiac muscle tissue development</TD><TD>biological process</TD><TD>GO:0003229</TD><TD>63</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2,ZFPM2,NRG1,FGFR2</TD></TR>
<TR><TD>6.149e-03</TD><TD>-5.09</TD><TD>cell junction assembly</TD><TD>biological process</TD><TD>GO:0034329</TD><TD>285</TD><TD>9</TD><TD>18905</TD><TD>219</TD>
<TD>NRCAM,PTPRK,DSCAM,SLC25A46,CDH5,ADGRL3,PECAM1,PTPRD,DNER</TD></TR>
<TR><TD>6.223e-03</TD><TD>-5.08</TD><TD>human chr3p12.3</TD><TD>chromosome location</TD><TD>human chr3p12.3</TD><TD>56</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>ROBO2,LINC02077</TD></TR>
<TR><TD>6.254e-03</TD><TD>-5.07</TD><TD>human chr9q11</TD><TD>chromosome location</TD><TD>human chr9q11</TD><TD>3</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LOC102724904</TD></TR>
<TR><TD>6.254e-03</TD><TD>-5.07</TD><TD>human chr6q22.2</TD><TD>chromosome location</TD><TD>human chr6q22.2</TD><TD>3</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LOC105377967</TD></TR>
<TR><TD>6.264e-03</TD><TD>-5.07</TD><TD>genital_tract-extragonadal-germ_cell_tumour-seminoma</TD><TD>COSMIC cancer mutations</TD><TD>genital_tract-extragonadal-germ_cell_tumour-seminoma</TD><TD>65</TD><TD>4</TD><TD>16984</TD><TD>192</TD>
<TD>ERCC6L2,IPO8,CNTN1,FAT4</TD></TR>
<TR><TD>6.269e-03</TD><TD>-5.07</TD><TD>CACNA1D (calcium voltage-gated channel subunit alpha1 D)</TD><TD>protein interactions</TD><TD>776</TD><TD>11</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>RYR2,FGFR2</TD></TR>
<TR><TD>6.269e-03</TD><TD>-5.07</TD><TD>SCN3A (sodium voltage-gated channel alpha subunit 3)</TD><TD>protein interactions</TD><TD>6328</TD><TD>11</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>CNTN1,UCHL1</TD></TR>
<TR><TD>6.269e-03</TD><TD>-5.07</TD><TD>Caskin1 (CASK interacting protein 1)</TD><TD>protein interactions</TD><TD>140722</TD><TD>11</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>SYT1,CASK</TD></TR>
<TR><TD>6.288e-03</TD><TD>-5.07</TD><TD>lung-middle_lobe-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-middle_lobe-carcinoma-adenocarcinoma</TD><TD>1370</TD><TD>26</TD><TD>16984</TD><TD>192</TD>
<TD>REG1B,NCKAP5,NOL4,PCDH9,SLIT2,RYR2,ZFPM2,FAT4,IRX1,PAX6,CNTNAP2,STXBP6,ADAMTS12,DEPTOR,FBN2,FGFR2,ZNF521,WRN,ADAMTS3,SEZ6L,BCHE,RAI2,SLC7A14,PTPRD,TGFBR2,ACVR1C</TD></TR>
<TR><TD>6.332e-03</TD><TD>-5.06</TD><TD>activin binding</TD><TD>molecular function</TD><TD>GO:0048185</TD><TD>11</TD><TD>2</TD><TD>18530</TD><TD>206</TD>
<TD>TGFBR2,ACVR2A</TD></TR>
<TR><TD>6.332e-03</TD><TD>-5.06</TD><TD>neuropeptide Y receptor activity</TD><TD>molecular function</TD><TD>GO:0004983</TD><TD>11</TD><TD>2</TD><TD>18530</TD><TD>206</TD>
<TD>GPR83,PRLHR</TD></TR>
<TR><TD>6.341e-03</TD><TD>-5.06</TD><TD>nuclear envelope lumen</TD><TD>cellular component</TD><TD>GO:0005641</TD><TD>11</TD><TD>2</TD><TD>19868</TD><TD>221</TD>
<TD>PLAAT1,BCHE</TD></TR>
<TR><TD>6.350e-03</TD><TD>-5.06</TD><TD>IL1/FGF</TD><TD>interpro domains</TD><TD>IPR008996</TD><TD>33</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>FGF14,FGF5,FGF20</TD></TR>
<TR><TD>6.365e-03</TD><TD>-5.06</TD><TD>Regulation of signaling by NODAL</TD><TD>REACTOME pathways</TD><TD>R-HSA-1433617</TD><TD>12</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>ACVR2A,ACVR1C</TD></TR>
<TR><TD>6.365e-03</TD><TD>-5.06</TD><TD>FGFR1c ligand binding and activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-190373</TD><TD>12</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>6.365e-03</TD><TD>-5.06</TD><TD>Signaling by activated point mutants of FGFR3</TD><TD>REACTOME pathways</TD><TD>R-HSA-1839130</TD><TD>12</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>6.365e-03</TD><TD>-5.06</TD><TD>FGFR3 mutant receptor activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-2033514</TD><TD>12</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>6.440e-03</TD><TD>-5.05</TD><TD>human chr21q22.2</TD><TD>chromosome location</TD><TD>human chr21q22.2</TD><TD>57</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>DSCAM,DSCAM-AS1</TD></TR>
<TR><TD>6.475e-03</TD><TD>-5.04</TD><TD>EVA1B (eva-1 homolog B)</TD><TD>protein interactions</TD><TD>55194</TD><TD>67</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>NUP35,ACVR2A,GHITM,PTPRK</TD></TR>
<TR><TD>6.476e-03</TD><TD>-5.04</TD><TD>skin-abdomen-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-abdomen-malignant_melanoma</TD><TD>405</TD><TD>11</TD><TD>16984</TD><TD>192</TD>
<TD>CHRM3,REG1B,NAV3,ADAMTS5,ROBO2,MPEG1,FUT9,RPH3A,PTPRD,ADAMTS12,CALN1</TD></TR>
<TR><TD>6.476e-03</TD><TD>-5.04</TD><TD>regulation of mesenchymal cell proliferation</TD><TD>biological process</TD><TD>GO:0010464</TD><TD>33</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,FGFR2,PHF14</TD></TR>
<TR><TD>6.491e-03</TD><TD>-5.04</TD><TD>USP6NL (USP6 N-terminal like)</TD><TD>protein interactions</TD><TD>9712</TD><TD>106</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>NTRK2,WWOX,EPHA4,FGFR2,EPS8</TD></TR>
<TR><TD>6.521e-03</TD><TD>-5.03</TD><TD>molecular transducer activity</TD><TD>molecular function</TD><TD>GO:0060089</TD><TD>1537</TD><TD>28</TD><TD>18530</TD><TD>206</TD>
<TD>ROBO2,HNF4G,EPHA4,PTPRZ1,GPR83,EFEMP1,REG1B,ACVR2A,FZD6,OR52K2,EPHA3,PAQR3,ACVR1C,OR2AG1,ADGRL3,PTPRD,PRLHR,LHCGR,TGFBR2,CHRM3,FGFR2,PECAM1,PTPRK,UNC5C,DNER,NTRK2,IL1RAPL2,LRRN2</TD></TR>
<TR><TD>6.521e-03</TD><TD>-5.03</TD><TD>signaling receptor activity</TD><TD>molecular function</TD><TD>GO:0038023</TD><TD>1537</TD><TD>28</TD><TD>18530</TD><TD>206</TD>
<TD>REG1B,OR52K2,ACVR2A,FZD6,PTPRZ1,ROBO2,HNF4G,EPHA4,GPR83,EFEMP1,ACVR1C,OR2AG1,PTPRD,ADGRL3,PRLHR,PAQR3,EPHA3,DNER,TGFBR2,LHCGR,CHRM3,FGFR2,UNC5C,PECAM1,PTPRK,LRRN2,IL1RAPL2,NTRK2</TD></TR>
<TR><TD>6.552e-03</TD><TD>-5.03</TD><TD>chest</TD><TD>COSMIC cancer mutations</TD><TD>chest</TD><TD>147</TD><TD>6</TD><TD>16984</TD><TD>192</TD>
<TD>PTPRD,CHRM3,ACVR2A,PWWP2A,FGFR2,ADAMTS3</TD></TR>
<TR><TD>6.587e-03</TD><TD>-5.02</TD><TD>cell adhesion mediator activity</TD><TD>molecular function</TD><TD>GO:0098631</TD><TD>67</TD><TD>4</TD><TD>18530</TD><TD>206</TD>
<TD>STXBP6,NRCAM,CNTN1,DSCAM</TD></TR>
<TR><TD>6.620e-03</TD><TD>-5.02</TD><TD>response to endogenous stimulus</TD><TD>biological process</TD><TD>GO:0009719</TD><TD>1406</TD><TD>27</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,GAREM1,TGFBR2,LHCGR,ACVR2A,ROBO2,PTPRK,ACVR1C,FGF20,WWOX,REG1B,ADAMTS12,PRKCE,FGFR2,NTRK2,BCHE,EPHA4,GCNT1,EFNA5,SLIT2,AKAP9,RYR2,CDH5,TWIST1,GPR83,CXCL13,FGF5</TD></TR>
<TR><TD>6.628e-03</TD><TD>-5.02</TD><TD>Galactose-binding domain-like</TD><TD>gene3d domains</TD><TD>2.60.120.260</TD><TD>97</TD><TD>5</TD><TD>14531</TD><TD>177</TD>
<TD>EPHA4,CPXM2,EPHA3,EDIL3,CNTNAP2</TD></TR>
<TR><TD>6.640e-03</TD><TD>-5.01</TD><TD>cellular response to endogenous stimulus</TD><TD>biological process</TD><TD>GO:0071495</TD><TD>1137</TD><TD>23</TD><TD>18905</TD><TD>219</TD>
<TD>EFNA5,SLIT2,AKAP9,NTRK2,FGFR2,EPHA4,TWIST1,CDH5,FGF5,CXCL13,RYR2,LHCGR,ACVR2A,GAREM1,PAX6,TGFBR2,PRKCE,ADAMTS12,PTPRK,ROBO2,WWOX,FGF20,ACVR1C</TD></TR>
<TR><TD>6.727e-03</TD><TD>-5.00</TD><TD>NRXN1 (neurexin 1)</TD><TD>protein interactions</TD><TD>9378</TD><TD>35</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>RPH3A,SYT1,CASK</TD></TR>
<TR><TD>6.749e-03</TD><TD>-5.00</TD><TD>BMPR2 (bone morphogenetic protein receptor type 2)</TD><TD>protein interactions</TD><TD>659</TD><TD>107</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>CDH5,NRSN1,ACVR2A,LMX1A,NBEA</TD></TR>
<TR><TD>6.764e-03</TD><TD>-5.00</TD><TD>GBD/FH3_dom</TD><TD>interpro domains</TD><TD>IPR014768</TD><TD>11</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>6.764e-03</TD><TD>-5.00</TD><TD>Peptidase_M28</TD><TD>interpro domains</TD><TD>IPR007484</TD><TD>11</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>CPQ,NAALADL2</TD></TR>
<TR><TD>6.766e-03</TD><TD>-5.00</TD><TD>foot</TD><TD>COSMIC cancer mutations</TD><TD>foot</TD><TD>148</TD><TD>6</TD><TD>16984</TD><TD>192</TD>
<TD>ADAMTS3,PTPRD,CHRM3,FAT4,PWWP2A,ADAM28</TD></TR>
<TR><TD>6.793e-03</TD><TD>-4.99</TD><TD>RINGv</TD><TD>pfam domains</TD><TD>PF12906</TD><TD>11</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>MARCHF3,MARCHF11</TD></TR>
<TR><TD>6.793e-03</TD><TD>-4.99</TD><TD>MACPF</TD><TD>pfam domains</TD><TD>PF01823</TD><TD>11</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>MPEG1,BRINP3</TD></TR>
<TR><TD>6.793e-03</TD><TD>-4.99</TD><TD>Peptidase_M28</TD><TD>pfam domains</TD><TD>PF04389</TD><TD>11</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>NAALADL2,CPQ</TD></TR>
<TR><TD>6.858e-03</TD><TD>-4.98</TD><TD>positive regulation of integrin activation</TD><TD>biological process</TD><TD>GO:0033625</TD><TD>11</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PLEK,CXCL13</TD></TR>
<TR><TD>6.885e-03</TD><TD>-4.98</TD><TD>leg</TD><TD>COSMIC cancer mutations</TD><TD>leg</TD><TD>970</TD><TD>20</TD><TD>16984</TD><TD>192</TD>
<TD>OR52K2,ACVR1C,CNTNAP2,HNF4G,CNTN1,PTPRD,PTPRZ1,TGFBR2,PWWP2A,FAT4,FGF20,CDH5,RPH3A,DNER,ADAMTS3,CHRM3,FGFR2,MEGF10,NOL4,RUNX1T1</TD></TR>
<TR><TD>6.893e-03</TD><TD>-4.98</TD><TD>TyrKc</TD><TD>smart domains</TD><TD>SM00219</TD><TD>80</TD><TD>5</TD><TD>9743</TD><TD>146</TD>
<TD>EPHA3,FGFR2,TEC,EPHA4,NTRK2</TD></TR>
<TR><TD>6.900e-03</TD><TD>-4.98</TD><TD>adrenal_gland</TD><TD>COSMIC cancer mutations</TD><TD>adrenal_gland</TD><TD>2628</TD><TD>43</TD><TD>16984</TD><TD>192</TD>
<TD>LRFN5,BCHE,WRN,FGFR2,MEGF10,IL1RAPL2,RUNX1T1,UBR4,RAI2,NBEA,BANK1,FIGN,MPEG1,EPHA4,CHRM3,KCNK9,NCKAP5,SS18,CNTN1,FAT4,EFEMP1,THSD7B,FBN2,PTPRK,CD226,NRCAM,SEMA3C,UCHL1,UNC5C,PTPRD,TGFBR2,PTPRZ1,SERGEF,LHCGR,ADAMTS5,IPO8,RYR2,PCDH9,RASGEF1B,HNF4G,NTRK2,UTRN,RBM20</TD></TR>
<TR><TD>6.906e-03</TD><TD>-4.98</TD><TD>Peptidase_M12B_N</TD><TD>interpro domains</TD><TD>IPR002870</TD><TD>34</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>ADAMTS3,ADAM28,ADAMTS12</TD></TR>
<TR><TD>6.922e-03</TD><TD>-4.97</TD><TD>lung-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma</TD><TD>4282</TD><TD>64</TD><TD>16984</TD><TD>192</TD>
<TD>PCGF5,AMELX,ADAMTS3,FGFR2,IL1RAPL2,RUNX1T1,CXCL13,BACH2,WRN,PSKH2,KIF6,UBR4,ACVR1C,RAI2,PBX1,DNAJC12,EDIL3,SPHKAP,EPHA4,CASK,SYT1,FANCB,XPO4,JMJD1C,AKAP9,CNTN1,SPANXN1,TWIST1,SS18,NOVA1,PRKCE,IRX1,SPAG9,FZD6,NAV3,NUP35,COX7B2,DEPTOR,ZNF521,PTPRK,TRPS1,RGS6,DAAM1,MRPL13,TSN,SERGEF,ADAM28,PTPRD,TGFBR2,PTPRZ1,PHF14,ADAMTS5,IPO8,LRIG3,VAV3,NTRK2,RASGEF1B,ADAMTS12,EPHA3,ARX,FGD3,UHMK1,PAX6,ACVR2A</TD></TR>
<TR><TD>6.937e-03</TD><TD>-4.97</TD><TD>mucin core 1 and core 2 O-glycosylation</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY-7433</TD><TD>25</TD><TD>2</TD><TD>907</TD><TD>5</TD>
<TD>GALNT15,GCNT1</TD></TR>
<TR><TD>6.946e-03</TD><TD>-4.97</TD><TD>Pep_M12B_propep</TD><TD>pfam domains</TD><TD>PF01562</TD><TD>34</TD><TD>3</TD><TD>17869</TD><TD>206</TD>
<TD>ADAMTS3,ADAM28,ADAMTS12</TD></TR>
<TR><TD>6.969e-03</TD><TD>-4.97</TD><TD>regulation of biomineral tissue development</TD><TD>biological process</TD><TD>GO:0070167</TD><TD>103</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>ACVR2A,FBN2,ASPN,AMELX,TWIST1</TD></TR>
<TR><TD>7.008e-03</TD><TD>-4.96</TD><TD>heart development</TD><TD>biological process</TD><TD>GO:0007507</TD><TD>572</TD><TD>14</TD><TD>18905</TD><TD>219</TD>
<TD>ADAMTS5,TWIST1,RYR2,SGCD,NRG1,SGCG,ROBO2,SLIT2,RBM20,ZFPM2,TGFBR2,FGFR2,SEMA3C,DAW1</TD></TR>
<TR><TD>7.088e-03</TD><TD>-4.95</TD><TD>regulation of nervous system development</TD><TD>biological process</TD><TD>GO:0051960</TD><TD>456</TD><TD>12</TD><TD>18905</TD><TD>219</TD>
<TD>MAP2,PTPRD,PTPRZ1,ROBO2,DSCAM,EFNA5,SHTN1,SLIT2,NTRK2,PAX6,FERD3L,EPHA4</TD></TR>
<TR><TD>7.098e-03</TD><TD>-4.95</TD><TD>testis-germ_cell_tumour-seminoma</TD><TD>COSMIC cancer mutations</TD><TD>testis-germ_cell_tumour-seminoma</TD><TD>650</TD><TD>15</TD><TD>16984</TD><TD>192</TD>
<TD>TRPS1,RGS6,FGFR2,CASK,EPHA4,LMBRD1,UHMK1,ACVR2A,TGFBR2,PRKCE,EPHA3,ACVR1C,NTRK2,PSKH2,KIF6</TD></TR>
<TR><TD>7.140e-03</TD><TD>-4.94</TD><TD>EFNB1 (ephrin B1)</TD><TD>protein interactions</TD><TD>1947</TD><TD>252</TD><TD>8</TD><TD>20077</TD><TD>222</TD>
<TD>GHITM,XPO4,NRSN1,IPO8,ARL14,PHLPP1,ACVR2A,EPHA3</TD></TR>
<TR><TD>7.148e-03</TD><TD>-4.94</TD><TD>middle_lobe</TD><TD>COSMIC cancer mutations</TD><TD>middle_lobe</TD><TD>1384</TD><TD>26</TD><TD>16984</TD><TD>192</TD>
<TD>RYR2,NOL4,NCKAP5,REG1B,SLIT2,PCDH9,CNTNAP2,ADAMTS12,STXBP6,IRX1,FAT4,ZFPM2,PAX6,SEZ6L,BCHE,ADAMTS3,ZNF521,FGFR2,DEPTOR,FBN2,WRN,ACVR1C,SLC7A14,RAI2,TGFBR2,PTPRD</TD></TR>
<TR><TD>7.152e-03</TD><TD>-4.94</TD><TD>Transferase(Phosphotransferase) domain 1</TD><TD>gene3d domains</TD><TD>1.10.510.10</TD><TD>491</TD><TD>13</TD><TD>14531</TD><TD>177</TD>
<TD>CASK,PSKH2,ACVR1C,NTRK2,UHMK1,FGFR2,EPHA3,MAST4,ACVR2A,EPHA4,PRKCE,TGFBR2,TEC</TD></TR>
<TR><TD>7.164e-03</TD><TD>-4.94</TD><TD>pallium development</TD><TD>biological process</TD><TD>GO:0021543</TD><TD>192</TD><TD>7</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,ARX,FAT4,LMX1A,CNTNAP2,NTRK2,PAX6</TD></TR>
<TR><TD>7.179e-03</TD><TD>-4.94</TD><TD>TIGD5 (tigger transposable element derived 5)</TD><TD>protein interactions</TD><TD>84948</TD><TD>69</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>GAP43,EFR3B,EFR3A,CDH5</TD></TR>
<TR><TD>7.209e-03</TD><TD>-4.93</TD><TD>large_intestine-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-carcinoma-adenocarcinoma</TD><TD>16221</TD><TD>190</TD><TD>16984</TD><TD>192</TD>
<TD>REG1B,LRIG3,FUT9,NRSN1,IPO8,FGD3,PAX6,IQGAP2,STXBP6,FBN2,DEPTOR,RGS6,MUC7,SPAG9,PWWP2A,UCHL1,ASPN,EFR3B,LRRC3B,FIGN,PHLPP1,LRRC70,JMJD1C,OR52K2,IL1RAPL2,WRN,CETN3,MRPL3,ADAMTS3,BCHE,DNAJC12,PBX1,RAI2,UBR4,AOAH,ZPLD1,THSD7A,ROBO2,RYR2,RPH3A,REXO2,ADAMTS5,SGCG,PHF14,EPHA3,CD96,HNF4G,NTRK2,ADAMTS12,PTPRK,ZNF521,FMNL2,KLF12,CYTL1,NUP35,EFR3A,ATG10,ADAM28,TGFBR2,PTPRD,SEMA3C,NRCAM,DAAM1,TSN,CALN1,SKAP2,DCDC2C,XPO4,DSCAM,EPHA4,DNER,COQ2,SGCD,TMEFF2,CASK,IRX1,PRKCE,ZNF133,PI15,CPXM2,CNTNAP2,CXCL13,MEGF10,ACP6,ZFAND5,PCGF5,SEZ6L,LRFN5,TCF20,SPHKAP,KIF6,PAQR3,LRRN2,ACVR1C,NOBOX,ERCC6L2,VAV3,SLC39A10,PLEK,NAT2,AFM,SPATA16,ZFPM2,ACVR2A,UTRN,DEFB115,GAP43,RASGEF1B,CELF2,TRPS1,EFEMP1,WWOX,GPR83,B3GAT2,SERGEF,PTPRZ1,GHITM,UNC5C,OR2AG1,CD226,NOL4,NCKAP5,SLIT2,FGF20,SERINC5,MAP2,NAALADL2,AKAP9,CNTN1,PARP8,NOVA1,SS18,TWIST1,SPANXN1,RUNX1T1,FGFR2,GCNT1,AMELX,FERD3L,PRLHR,EFNA5,EPYC,LGI1,SLC10A2,PSKH2,LMX1A,KAZN,SHISA3,PCDH9,INSM1,CDH5,ARX,RBM20,ARL14,UHMK1,COX7B2,LMBRD1,FGF14,THSD7B,NAV3,FZD6,EPS8,LHCGR,NRG1,PRSS12,MRPL13,CRTC3,SLC7A8,DAOA,KCNK9,CHRM3,GMDS,MPEG1,FANCB,SYT1,ZNF518B,BANK1,NBEA,FAT4,BACH2,FGF5,IGFL4,CTSO,EDIL3,SLC7A14,FNIP2,FABP7,SLC25A46,PXDNL,AGA</TD></TR>
<TR><TD>7.210e-03</TD><TD>-4.93</TD><TD>peptidyl-tyrosine phosphorylation</TD><TD>biological process</TD><TD>GO:0018108</TD><TD>66</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,EFEMP1,EPHA3,EPHA4</TD></TR>
<TR><TD>7.216e-03</TD><TD>-4.93</TD><TD>thyroid-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>thyroid-carcinoma</TD><TD>4128</TD><TD>62</TD><TD>16984</TD><TD>192</TD>
<TD>SKAP2,NOL4,XPO4,SLIT2,DSCAM,CHRM3,GMDS,EPHA4,FGF20,SYT1,MAP2,NAALADL2,AKAP9,PARP8,JMJD1C,TWIST1,SPANXN1,RUNX1T1,CXCL13,FGF5,FGFR2,WRN,ZFAND5,ADAMTS3,SEZ6L,IGFL4,TCF20,LGI1,KAZN,LMX1A,UBR4,AGA,VAV3,PLEK,PCDH9,ROBO2,RYR2,FUT9,AFM,ZFPM2,ARX,ACVR2A,UTRN,CELF2,RASGEF1B,PTPRK,ZNF521,FBN2,RGS6,TRPS1,MUC7,SPAG9,THSD7B,NAV3,EFR3A,GPR83,PWWP2A,PTPRZ1,TGFBR2,PTPRD,PRSS12,DAAM1</TD></TR>
<TR><TD>7.224e-03</TD><TD>-4.93</TD><TD>positive regulation of cellular component biogenesis</TD><TD>biological process</TD><TD>GO:0044089</TD><TD>515</TD><TD>13</TD><TD>18905</TD><TD>219</TD>
<TD>CDH5,CXCL13,EPS8,PTPRD,PRKCE,FNIP2,NAV3,PLEK,NRG1,EFNA5,AKAP9,CNTNAP2,NTRK2</TD></TR>
<TR><TD>7.241e-03</TD><TD>-4.93</TD><TD>synapse</TD><TD>cellular component</TD><TD>GO:0045202</TD><TD>1474</TD><TD>27</TD><TD>19868</TD><TD>221</TD>
<TD>EPHA4,PTPRD,ADGRL3,UTRN,RPH3A,DSCAM,FGFR2,CNTNAP2,PRSS12,CASK,NRCAM,AKAP9,GAP43,CNTN1,LGI1,LRFN5,CHRM3,EFNA5,PRKCE,KCNK9,PTPRZ1,SEPTIN5,NTRK2,IL1RAPL2,EPS8,UNC5C,SYT1</TD></TR>
<TR><TD>7.279e-03</TD><TD>-4.92</TD><TD>PTPRB (protein tyrosine phosphatase receptor type B)</TD><TD>protein interactions</TD><TD>5787</TD><TD>36</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>CNTN1,NRCAM,CDH5</TD></TR>
<TR><TD>7.279e-03</TD><TD>-4.92</TD><TD>ARSG (arylsulfatase G)</TD><TD>protein interactions</TD><TD>22901</TD><TD>36</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>B3GAT2,PTPRK,ADAMTS12</TD></TR>
<TR><TD>7.327e-03</TD><TD>-4.92</TD><TD>positive regulation of cell development</TD><TD>biological process</TD><TD>GO:0010720</TD><TD>458</TD><TD>12</TD><TD>18905</TD><TD>219</TD>
<TD>DSCAM,EPHA4,TGFBR2,PAX6,ROBO2,PTPRZ1,NTRK2,PTPRD,SLIT2,CDH5,SHTN1,EFNA5</TD></TR>
<TR><TD>7.344e-03</TD><TD>-4.91</TD><TD>human chr12q21.2</TD><TD>chromosome location</TD><TD>human chr12q21.2</TD><TD>61</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>SYT1,NAV3</TD></TR>
<TR><TD>7.406e-03</TD><TD>-4.91</TD><TD>pancreas-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>pancreas-carcinoma</TD><TD>14868</TD><TD>179</TD><TD>16984</TD><TD>192</TD>
<TD>LMX1A,KAZN,PSKH2,LGI1,SLC10A2,EPYC,PRLHR,EFNA5,LINC00583,GCNT1,FGFR2,RUNX1T1,SPANXN1,NOVA1,TWIST1,SS18,PARP8,NAALADL2,AKAP9,CNTN1,MAP2,FGF20,SLIT2,NCKAP5,NOL4,CD226,OR2AG1,UNC5C,PTPRZ1,GHITM,B3GAT2,SERGEF,GPR83,EFEMP1,TRPS1,CELF2,RASGEF1B,GAP43,DEFB115,UTRN,ACVR2A,ZFPM2,AFM,SPATA16,PLEK,VAV3,SLC39A10,AGA,PXDNL,FABP7,SLC25A46,EDIL3,SLC7A14,CTSO,FGF5,BACH2,FAT4,NBEA,SYT1,FANCB,ZNF518B,BANK1,GMDS,MPEG1,CHRM3,KCNK9,DAOA,SLC7A8,MRPL13,CRTC3,PRSS12,NRG1,LHCGR,EPS8,FZD6,NAV3,THSD7B,FGF14,LMBRD1,COX7B2,RBM20,ARX,CDH5,INSM1,PCDH9,SHISA3,UBR4,PBX1,RAI2,DNAJC12,ADAMTS3,BCHE,MRPL3,WRN,CETN3,IL1RAPL2,OR52K2,LRRC70,JMJD1C,PHLPP1,FIGN,LRRC3B,ASPN,EFR3B,UCHL1,PWWP2A,SPAG9,MUC7,LINC01387,RGS6,DEPTOR,FBN2,STXBP6,IQGAP2,PAX6,FGD3,IPO8,NRSN1,REG1B,LRIG3,NOBOX,ERCC6L2,LRRN2,ACVR1C,PAQR3,KIF6,SPHKAP,TCF20,LRFN5,SEZ6L,PCGF5,ACP6,CXCL13,MEGF10,CNTNAP2,CPXM2,PI15,PRKCE,ZNF133,IRX1,CASK,SGCD,TMEFF2,COQ2,EPHA4,DNER,DSCAM,DCDC2C,SKAP2,XPO4,TSN,DAAM1,SEMA3C,NRCAM,PTPRD,TGFBR2,ADAM28,ATG10,NUP35,EFR3A,CYTL1,KLF12,FMNL2,PTPRK,ZNF521,ADAMTS12,NTRK2,CD96,EPHA3,ADAMTS5,PHF14,SGCG,REXO2,RYR2,RPH3A,ROBO2,ZPLD1,THSD7A,AOAH</TD></TR>
<TR><TD>7.413e-03</TD><TD>-4.90</TD><TD>CD59</TD><TD>gene3d domains</TD><TD>2.10.60.10</TD><TD>33</TD><TD>3</TD><TD>14531</TD><TD>177</TD>
<TD>ACVR1C,ACVR2A,TGFBR2</TD></TR>
<TR><TD>7.416e-03</TD><TD>-4.90</TD><TD>human chr2q35</TD><TD>chromosome location</TD><TD>human chr2q35</TD><TD>188</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>LINC01614,LINC00607,MIR4268</TD></TR>
<TR><TD>7.468e-03</TD><TD>-4.90</TD><TD>ORF17.5 (ORF17.5)</TD><TD>protein interactions</TD><TD>4961482</TD><TD>12</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>WWOX,GMDS</TD></TR>
<TR><TD>7.472e-03</TD><TD>-4.90</TD><TD>Phospholipase C-mediated cascade; FGFR3</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654227</TD><TD>13</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>7.472e-03</TD><TD>-4.90</TD><TD>Signaling by Activin</TD><TD>REACTOME pathways</TD><TD>R-HSA-1502540</TD><TD>13</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>ACVR2A,ACVR1C</TD></TR>
<TR><TD>7.472e-03</TD><TD>-4.90</TD><TD>FGFR3 ligand binding and activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-190239</TD><TD>13</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>7.472e-03</TD><TD>-4.90</TD><TD>FGFR3c ligand binding and activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-190372</TD><TD>13</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>7.493e-03</TD><TD>-4.89</TD><TD>Drf_FH3</TD><TD>smart domains</TD><TD>SM01139</TD><TD>9</TD><TD>2</TD><TD>9743</TD><TD>146</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>7.493e-03</TD><TD>-4.89</TD><TD>Drf_GBD</TD><TD>smart domains</TD><TD>SM01140</TD><TD>9</TD><TD>2</TD><TD>9743</TD><TD>146</TD>
<TD>DAAM1,FMNL2</TD></TR>
<TR><TD>7.505e-03</TD><TD>-4.89</TD><TD>LRR_SD22</TD><TD>smart domains</TD><TD>SM00365</TD><TD>52</TD><TD>4</TD><TD>9743</TD><TD>146</TD>
<TD>LRRC70,SLIT2,LRIG3,LRRN2</TD></TR>
<TR><TD>7.543e-03</TD><TD>-4.89</TD><TD>GTPase inhibitor activity</TD><TD>molecular function</TD><TD>GO:0005095</TD><TD>12</TD><TD>2</TD><TD>18530</TD><TD>206</TD>
<TD>SLIT2,IQGAP2</TD></TR>
<TR><TD>7.554e-03</TD><TD>-4.89</TD><TD>nuclear pore nuclear basket</TD><TD>cellular component</TD><TD>GO:0044615</TD><TD>12</TD><TD>2</TD><TD>19868</TD><TD>221</TD>
<TD>CETN3,NUP35</TD></TR>
<TR><TD>7.567e-03</TD><TD>-4.88</TD><TD>HOXB5 (homeobox B5)</TD><TD>protein interactions</TD><TD>3215</TD><TD>110</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>CNTN1,EFR3B,PBX1,NUP35,EFR3A</TD></TR>
<TR><TD>7.579e-03</TD><TD>-4.88</TD><TD>human chrXq27.3</TD><TD>chromosome location</TD><TD>human chrXq27.3</TD><TD>62</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>MIR891A,SPANXN1</TD></TR>
<TR><TD>7.579e-03</TD><TD>-4.88</TD><TD>human chr7p21.1</TD><TD>chromosome location</TD><TD>human chr7p21.1</TD><TD>62</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>FERD3L,TWIST1</TD></TR>
<TR><TD>7.637e-03</TD><TD>-4.87</TD><TD>embryonic organ morphogenesis</TD><TD>biological process</TD><TD>GO:0048562</TD><TD>295</TD><TD>9</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2,TGFBR2,PAX6,FGFR2,FZD6,FBN2,LRIG3,EFEMP1,TWIST1</TD></TR>
<TR><TD>7.638e-03</TD><TD>-4.87</TD><TD>apoptotic process involved in development</TD><TD>biological process</TD><TD>GO:1902742</TD><TD>35</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>ROBO2,MEGF10,SLIT2</TD></TR>
<TR><TD>7.725e-03</TD><TD>-4.86</TD><TD>skin-ankle-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-ankle-malignant_melanoma</TD><TD>69</TD><TD>4</TD><TD>16984</TD><TD>192</TD>
<TD>PTPRD,CHRM3,ADAM28,ADAMTS3</TD></TR>
<TR><TD>7.816e-03</TD><TD>-4.85</TD><TD>human chr3q26.31</TD><TD>chromosome location</TD><TD>human chr3q26.31</TD><TD>63</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>SPATA16,NAALADL2</TD></TR>
<TR><TD>7.818e-03</TD><TD>-4.85</TD><TD>Kinase-like_dom_sf</TD><TD>interpro domains</TD><TD>IPR011009</TD><TD>524</TD><TD>13</TD><TD>18605</TD><TD>214</TD>
<TD>EPHA4,ACVR1C,TGFBR2,MAST4,NTRK2,ACVR2A,TEC,FGFR2,EPHA3,CASK,PSKH2,PRKCE,UHMK1</TD></TR>
<TR><TD>7.855e-03</TD><TD>-4.85</TD><TD>P2RY2 (purinergic receptor P2Y2)</TD><TD>protein interactions</TD><TD>5029</TD><TD>111</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>GHITM,CDH5,XPO4,IPO8,SLC39A10</TD></TR>
<TR><TD>7.858e-03</TD><TD>-4.85</TD><TD>HCRTR2 (hypocretin receptor 2)</TD><TD>protein interactions</TD><TD>3062</TD><TD>37</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRD,SLC25A46,ACTR3C</TD></TR>
<TR><TD>7.924e-03</TD><TD>-4.84</TD><TD>soft_tissue-striated_muscle-rhabdomyosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-striated_muscle-rhabdomyosarcoma</TD><TD>596</TD><TD>14</TD><TD>16984</TD><TD>192</TD>
<TD>FAT4,ZFPM2,NRG1,SS18,IQGAP2,RASGEF1B,ASPN,SLC39A10,TRPS1,ADAMTS3,SPAG9,COQ2,RYR2,NBEA</TD></TR>
<TR><TD>7.932e-03</TD><TD>-4.84</TD><TD>FTSJ1 (FtsJ RNA 2'-O-methyltransferase 1)</TD><TD>protein interactions</TD><TD>24140</TD><TD>71</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>EPHA4,NTRK2,CHRM3,EPHA3</TD></TR>
<TR><TD>7.937e-03</TD><TD>-4.84</TD><TD>ST14 (ST14 transmembrane serine protease matriptase)</TD><TD>protein interactions</TD><TD>6768</TD><TD>205</TD><TD>7</TD><TD>20077</TD><TD>222</TD>
<TD>SEMA3C,FBN2,BCHE,AGA,SLIT2,EFNA5,GCNT1</TD></TR>
<TR><TD>7.938e-03</TD><TD>-4.84</TD><TD>kidney</TD><TD>COSMIC cancer mutations</TD><TD>kidney</TD><TD>15454</TD><TD>184</TD><TD>16984</TD><TD>192</TD>
<TD>OR52K2,JMJD1C,LRRC70,PHLPP1,FIGN,LRRC3B,EFR3B,ASPN,UBR4,RAI2,PBX1,DNAJC12,BCHE,ADAMTS3,MRPL3,CETN3,WRN,IL1RAPL2,IQGAP2,STXBP6,PAX6,FGD3,IPO8,NRSN1,FUT9,REG1B,LRIG3,UCHL1,PWWP2A,SPAG9,LINC01387,MUC7,RGS6,FBN2,DEPTOR,CNTNAP2,CPXM2,PI15,ZNF133,PRKCE,IRX1,CASK,TMEFF2,SGCD,COQ2,DNER,EPHA4,DSCAM,XPO4,DCDC2C,SKAP2,ERCC6L2,NOBOX,ACVR1C,LRRN2,PAQR3,KIF6,SPHKAP,TCF20,LRFN5,SEZ6L,PCGF5,ZFAND5,ACP6,MEGF10,CXCL13,ADAMTS12,NTRK2,HNF4G,CD96,EPHA3,SGCG,PHF14,ADAMTS5,REXO2,RPH3A,RYR2,ROBO2,THSD7A,ZPLD1,AOAH,CALN1,TSN,DAAM1,SEMA3C,NRCAM,PTPRD,TGFBR2,ADAM28,ATG10,EFR3A,NUP35,KLF12,FMNL2,ZNF521,PTPRK,SPANXN1,TWIST1,SS18,NOVA1,PARP8,CNTN1,AKAP9,NAALADL2,MAP2,SERINC5,FGF20,SLIT2,NCKAP5,NOL4,KAZN,LMX1A,PSKH2,SLC10A2,LGI1,EPYC,EFNA5,PRLHR,AMELX,GCNT1,FGFR2,RUNX1T1,RASGEF1B,CELF2,GAP43,DEFB115,UTRN,ACVR2A,ZFPM2,SPATA16,AFM,NAT2,PLEK,SLC39A10,VAV3,CD226,OR2AG1,UNC5C,GHITM,PTPRZ1,SERGEF,B3GAT2,GPR83,EFEMP1,TRPS1,FAT4,NBEA,ZNF518B,BANK1,SYT1,FANCB,MPEG1,GMDS,CHRM3,KCNK9,DAOA,AGA,PXDNL,SLC25A46,FNIP2,SLC7A14,EDIL3,CTSO,IGFL4,FGF5,BACH2,UHMK1,RBM20,ARX,CDH5,PCDH9,SLC7A8,CRTC3,MRPL13,PRSS12,NRG1,LHCGR,EPS8,FZD6,NAV3,FGF14,THSD7B,LMBRD1,COX7B2</TD></TR>
<TR><TD>7.959e-03</TD><TD>-4.83</TD><TD>PROTEIN_KINASE_TYR</TD><TD>prosite domains</TD><TD>PS00109</TD><TD>94</TD><TD>5</TD><TD>12232</TD><TD>161</TD>
<TD>TEC,EPHA4,FGFR2,NTRK2,EPHA3</TD></TR>
<TR><TD>8.003e-03</TD><TD>-4.83</TD><TD>peptidyl-tyrosine modification</TD><TD>biological process</TD><TD>GO:0018212</TD><TD>68</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,EFEMP1,EPHA4,EPHA3</TD></TR>
<TR><TD>8.031e-03</TD><TD>-4.82</TD><TD>stomach</TD><TD>COSMIC cancer mutations</TD><TD>stomach</TD><TD>15576</TD><TD>185</TD><TD>16984</TD><TD>192</TD>
<TD>PSKH2,SLC10A2,LGI1,KAZN,LMX1A,EFNA5,PRLHR,EPYC,AMELX,FERD3L,FGFR2,RUNX1T1,GCNT1,PARP8,AKAP9,CNTN1,NAALADL2,SPANXN1,SS18,TWIST1,NOVA1,MAP2,SERINC5,FGF20,NCKAP5,NOL4,SLIT2,OR2AG1,CD226,SERGEF,B3GAT2,GPR83,UNC5C,GHITM,PTPRZ1,EFEMP1,WWOX,TRPS1,DEFB115,CELF2,RASGEF1B,GAP43,ZFPM2,UTRN,ACVR2A,SPATA16,AFM,NAT2,SLC39A10,VAV3,PLEK,SLC25A46,FABP7,AGA,PXDNL,SLC7A14,EDIL3,FNIP2,IGFL4,CTSO,FGF5,BACH2,FAT4,MPEG1,GMDS,NBEA,ZNF518B,BANK1,FANCB,SYT1,DAOA,CHRM3,KCNK9,CRTC3,MRPL13,SLC7A8,LHCGR,EPS8,PRSS12,NRG1,FGF14,THSD7B,LMBRD1,FZD6,NAV3,COX7B2,ARX,UHMK1,RBM20,CDH5,INSM1,PCDH9,SHISA3,UBR4,RAI2,DNAJC12,BCHE,ADAMTS3,IL1RAPL2,MRPL3,CETN3,WRN,JMJD1C,OR52K2,PHLPP1,FIGN,EFR3B,ASPN,LRRC3B,UCHL1,PWWP2A,SPAG9,MUC7,DEPTOR,FBN2,RGS6,STXBP6,IQGAP2,FGD3,PAX6,FUT9,IPO8,NRSN1,REG1B,LRIG3,PAQR3,KIF6,ERCC6L2,NOBOX,ACVR1C,LRRN2,SPHKAP,LRFN5,PCGF5,SEZ6L,TCF20,ACP6,MEGF10,ZFAND5,CNTNAP2,ZNF133,PRKCE,IRX1,CPXM2,PI15,COQ2,DNER,EPHA4,CASK,TMEFF2,SGCD,XPO4,SKAP2,DSCAM,DAAM1,NRCAM,SEMA3C,CALN1,TSN,ADAM28,PTPRD,TGFBR2,CYTL1,ATG10,EFR3A,NUP35,FMNL2,ZNF521,PTPRK,KLF12,CD96,HNF4G,NTRK2,ADAMTS12,EPHA3,RPH3A,RYR2,ROBO2,SGCG,PHF14,ADAMTS5,REXO2,AOAH,THSD7A,ZPLD1</TD></TR>
<TR><TD>8.056e-03</TD><TD>-4.82</TD><TD>MACPF</TD><TD>interpro domains</TD><TD>IPR020864</TD><TD>12</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>BRINP3,MPEG1</TD></TR>
<TR><TD>8.099e-03</TD><TD>-4.82</TD><TD>regulation of synapse organization</TD><TD>biological process</TD><TD>GO:0050807</TD><TD>246</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>IL1RAPL2,LRFN5,EPHA4,PTPRD,EFNA5,NTRK2,ROBO2,NRCAM</TD></TR>
<TR><TD>8.099e-03</TD><TD>-4.82</TD><TD>regulation of cell morphogenesis</TD><TD>biological process</TD><TD>GO:0022604</TD><TD>246</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>PTPRD,SPAG9,EPS8,FGD3,EFNA5,EPHA4,SYT1,FMNL2</TD></TR>
<TR><TD>8.118e-03</TD><TD>-4.81</TD><TD>appendage morphogenesis</TD><TD>biological process</TD><TD>GO:0035107</TD><TD>150</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>SEMA3C,FGFR2,TWIST1,PBX1,FBN2,FZD6</TD></TR>
<TR><TD>8.118e-03</TD><TD>-4.81</TD><TD>limb morphogenesis</TD><TD>biological process</TD><TD>GO:0035108</TD><TD>150</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>FBN2,FZD6,TWIST1,PBX1,SEMA3C,FGFR2</TD></TR>
<TR><TD>8.150e-03</TD><TD>-4.81</TD><TD>SIGLECL1 (SIGLEC family like 1)</TD><TD>protein interactions</TD><TD>284369</TD><TD>112</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>CNTN1,XPO4,FGFR2,IPO8,SLC39A10</TD></TR>
<TR><TD>8.165e-03</TD><TD>-4.81</TD><TD>muscle structure development</TD><TD>biological process</TD><TD>GO:0061061</TD><TD>523</TD><TD>13</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,UTRN,ZFPM2,MEGF10,TWIST1,SPAG9,ADAMTS5,DNER,SGCG,SGCD,RYR2,NRG1,UCHL1</TD></TR>
<TR><TD>8.168e-03</TD><TD>-4.81</TD><TD>neuronal ion channel clustering</TD><TD>biological process</TD><TD>GO:0045161</TD><TD>12</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>NRCAM,CNTNAP2</TD></TR>
<TR><TD>8.316e-03</TD><TD>-4.79</TD><TD>muscle tissue development</TD><TD>biological process</TD><TD>GO:0060537</TD><TD>353</TD><TD>10</TD><TD>18905</TD><TD>219</TD>
<TD>MEGF10,DNER,SEMA3C,SGCG,FGFR2,NRG1,ZFPM2,SGCD,RYR2,ZFAND5</TD></TR>
<TR><TD>8.342e-03</TD><TD>-4.79</TD><TD>calmodulin binding</TD><TD>molecular function</TD><TD>GO:0005516</TD><TD>206</TD><TD>7</TD><TD>18530</TD><TD>206</TD>
<TD>GAP43,MAP2,RYR2,SYT1,UBR4,IQGAP2,CASK</TD></TR>
<TR><TD>8.388e-03</TD><TD>-4.78</TD><TD>Glypican 1 network</TD><TD>Pathway Interaction DB</TD><TD>glypican_1pathway</TD><TD>26</TD><TD>3</TD><TD>2232</TD><TD>37</TD>
<TD>SLIT2,TGFBR2,NRG1</TD></TR>
<TR><TD>8.463e-03</TD><TD>-4.77</TD><TD>LRRIQ1 (leucine rich repeats and IQ motif containing 1)</TD><TD>protein interactions</TD><TD>84125</TD><TD>38</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>EPHA3,ACVR2A,FGFR2</TD></TR>
<TR><TD>8.538e-03</TD><TD>-4.76</TD><TD>integrin binding</TD><TD>molecular function</TD><TD>GO:0005178</TD><TD>158</TD><TD>6</TD><TD>18530</TD><TD>206</TD>
<TD>UTRN,ADAMTS5,EDIL3,NRG1,PTPRZ1,CD226</TD></TR>
<TR><TD>8.641e-03</TD><TD>-4.75</TD><TD>ameboidal-type cell migration</TD><TD>biological process</TD><TD>GO:0001667</TD><TD>199</TD><TD>7</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,ZFAND5,CXCL13,TWIST1,SEMA3C,PAX6,CDH5</TD></TR>
<TR><TD>8.721e-03</TD><TD>-4.74</TD><TD>pancreas</TD><TD>COSMIC cancer mutations</TD><TD>pancreas</TD><TD>16572</TD><TD>192</TD><TD>16984</TD><TD>192</TD>
<TD>FIGN,LRRC3B,EFR3B,ASPN,OR52K2,JMJD1C,LRRC70,PHLPP1,BCHE,ADAMTS3,CETN3,WRN,MRPL3,IL1RAPL2,UBR4,DNAJC12,RAI2,PBX1,NRSN1,IPO8,FUT9,LRIG3,REG1B,STXBP6,IQGAP2,PAX6,FGD3,LINC01387,MUC7,SPAG9,RGS6,FBN2,DEPTOR,UCHL1,PWWP2A,TMEFF2,SGCD,CASK,DNER,EPHA4,COQ2,DSCAM,XPO4,DCDC2C,SKAP2,CNTNAP2,PI15,CPXM2,IRX1,ZNF133,PRKCE,TCF20,SEZ6L,PCGF5,LRFN5,ZFAND5,MEGF10,CXCL13,ACP6,ACVR1C,LRRN2,ERCC6L2,NOBOX,KIF6,PAQR3,SPHKAP,REXO2,SGCG,PHF14,ADAMTS5,ROBO2,RPH3A,RYR2,THSD7A,ZPLD1,AOAH,ADAMTS12,NTRK2,HNF4G,CD96,EPHA3,EFR3A,NUP35,ATG10,CYTL1,KLF12,ZNF521,PTPRK,FMNL2,TSN,CALN1,NRCAM,SEMA3C,DAAM1,TGFBR2,PTPRD,ADAM28,FGF20,SLIT2,NOL4,NCKAP5,SS18,TWIST1,NOVA1,SPANXN1,CNTN1,AKAP9,NAALADL2,PARP8,SERINC5,MAP2,FERD3L,AMELX,GCNT1,LINC00583,RUNX1T1,FGFR2,LMX1A,KAZN,SLC10A2,LGI1,PSKH2,EPYC,EFNA5,PRLHR,NAT2,SPATA16,AFM,PLEK,SLC39A10,VAV3,GAP43,RASGEF1B,CELF2,DEFB115,ACVR2A,UTRN,ZFPM2,WWOX,EFEMP1,TRPS1,CD226,OR2AG1,GHITM,PTPRZ1,UNC5C,GPR83,B3GAT2,SERGEF,ZNF518B,BANK1,FANCB,SYT1,NBEA,MPEG1,GMDS,KCNK9,CHRM3,DAOA,FAT4,CTSO,IGFL4,BACH2,FGF5,PXDNL,AGA,SLC25A46,FABP7,FNIP2,EDIL3,SLC7A14,INSM1,CDH5,SHISA3,PCDH9,RBM20,UHMK1,ARL14,ARX,NAV3,FZD6,LMBRD1,THSD7B,FGF14,COX7B2,SLC7A8,CRTC3,MRPL13,NRG1,PRSS12,EPS8,LHCGR</TD></TR>
<TR><TD>8.736e-03</TD><TD>-4.74</TD><TD>PCDHGB1 (protocadherin gamma subfamily B, 1)</TD><TD>protein interactions</TD><TD>56104</TD><TD>73</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRK,FAT4,CNTN1,PCDH9</TD></TR>
<TR><TD>8.759e-03</TD><TD>-4.74</TD><TD>ZF_RING_CH</TD><TD>prosite domains</TD><TD>PS51292</TD><TD>11</TD><TD>2</TD><TD>12232</TD><TD>161</TD>
<TD>MARCHF11,MARCHF3</TD></TR>
<TR><TD>8.759e-03</TD><TD>-4.74</TD><TD>GBD_FH3</TD><TD>prosite domains</TD><TD>PS51232</TD><TD>11</TD><TD>2</TD><TD>12232</TD><TD>161</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>8.794e-03</TD><TD>-4.73</TD><TD>SAM_2</TD><TD>pfam domains</TD><TD>PF07647</TD><TD>37</TD><TD>3</TD><TD>17869</TD><TD>206</TD>
<TD>EPHA4,EPHA3,KAZN</TD></TR>
<TR><TD>8.825e-03</TD><TD>-4.73</TD><TD>collagen-containing extracellular matrix</TD><TD>cellular component</TD><TD>GO:0062023</TD><TD>429</TD><TD>11</TD><TD>19868</TD><TD>221</TD>
<TD>ADAMTS3,EDIL3,AMELX,FBN2,ADAMTS5,EFEMP1,FGFR2,CASK,PTPRZ1,ASPN,EFNA5</TD></TR>
<TR><TD>8.854e-03</TD><TD>-4.73</TD><TD>back</TD><TD>COSMIC cancer mutations</TD><TD>back</TD><TD>310</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>ADAMTS3,LGI1,LRIG3,PWWP2A,ADAM28,FGFR2,CHRM3,PTPRD,GHITM</TD></TR>
<TR><TD>8.917e-03</TD><TD>-4.72</TD><TD>large_intestine-caecum-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-caecum-carcinoma-adenocarcinoma</TD><TD>14247</TD><TD>173</TD><TD>16984</TD><TD>192</TD>
<TD>CYTL1,ATG10,EFR3A,NUP35,FMNL2,ZNF521,PTPRK,KLF12,DAAM1,SEMA3C,NRCAM,TSN,ADAM28,PTPRD,TGFBR2,RPH3A,RYR2,ROBO2,SGCG,PHF14,ADAMTS5,REXO2,AOAH,THSD7A,ZPLD1,HNF4G,NTRK2,CD96,ADAMTS12,EPHA3,LRFN5,SEZ6L,TCF20,ACP6,MEGF10,CXCL13,PAQR3,KIF6,ERCC6L2,NOBOX,ACVR1C,LRRN2,SPHKAP,DNER,EPHA4,CASK,TMEFF2,XPO4,SKAP2,DSCAM,CNTNAP2,ZNF133,PRKCE,IRX1,CPXM2,PI15,SPAG9,MUC7,FBN2,RGS6,UCHL1,PWWP2A,FUT9,IPO8,NRSN1,REG1B,LRIG3,IQGAP2,STXBP6,FGD3,PAX6,BCHE,ADAMTS3,IL1RAPL2,MRPL3,CETN3,WRN,UBR4,RAI2,DNAJC12,FIGN,ASPN,LRRC3B,JMJD1C,LRRC70,OR52K2,PHLPP1,FGF14,THSD7B,LMBRD1,FZD6,NAV3,CRTC3,MRPL13,SLC7A8,LHCGR,EPS8,PRSS12,NRG1,CDH5,INSM1,PCDH9,SHISA3,ARX,UHMK1,RBM20,CTSO,FGF5,BACH2,SLC25A46,AGA,PXDNL,EDIL3,SLC7A14,MPEG1,GMDS,NBEA,BANK1,ZNF518B,FANCB,SYT1,CHRM3,KCNK9,FAT4,EFEMP1,WWOX,TRPS1,OR2AG1,CD226,SERGEF,B3GAT2,GPR83,UNC5C,GHITM,PTPRZ1,SPATA16,AFM,NAT2,SLC39A10,VAV3,PLEK,DEFB115,RASGEF1B,CELF2,GAP43,ZFPM2,UTRN,ACVR2A,AMELX,FERD3L,FGFR2,RUNX1T1,GCNT1,PSKH2,SLC10A2,LGI1,KAZN,LMX1A,PRLHR,EPYC,FGF20,NCKAP5,NOL4,SLIT2,PARP8,AKAP9,CNTN1,NAALADL2,TWIST1,SS18,NOVA1,MAP2,SERINC5</TD></TR>
<TR><TD>8.963e-03</TD><TD>-4.71</TD><TD>LGALS1 (galectin 1)</TD><TD>protein interactions</TD><TD>3956</TD><TD>317</TD><TD>9</TD><TD>20077</TD><TD>222</TD>
<TD>ADGRL3,PTPRD,FAT4,PCDH9,SLC39A10,PTPRK,PECAM1,PTPRZ1,NRCAM</TD></TR>
<TR><TD>8.965e-03</TD><TD>-4.71</TD><TD>PIP3 activates AKT signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-1257604</TD><TD>125</TD><TD>5</TD><TD>10391</TD><TD>106</TD>
<TD>NRG1,FGF20,FGFR2,FGF5,PHLPP1</TD></TR>
<TR><TD>9.055e-03</TD><TD>-4.70</TD><TD>human chr22q12.1</TD><TD>chromosome location</TD><TD>human chr22q12.1</TD><TD>68</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>SEZ6L,MIR5739</TD></TR>
<TR><TD>9.055e-03</TD><TD>-4.70</TD><TD>human chr3q13.33</TD><TD>chromosome location</TD><TD>human chr3q13.33</TD><TD>68</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>ARHGAP31-AS1,LINC02049</TD></TR>
<TR><TD>9.255e-03</TD><TD>-4.68</TD><TD>medullomyoblastoma</TD><TD>COSMIC cancer mutations</TD><TD>medullomyoblastoma</TD><TD>485</TD><TD>12</TD><TD>16984</TD><TD>192</TD>
<TD>SPHKAP,PCDH9,UTRN,LHCGR,IL1RAPL2,BACH2,NOVA1,PAQR3,FGF14,RYR2,AKAP9,CNTN1</TD></TR>
<TR><TD>9.255e-03</TD><TD>-4.68</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-medullomyoblastoma</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-medullomyoblastoma</TD><TD>485</TD><TD>12</TD><TD>16984</TD><TD>192</TD>
<TD>UTRN,PCDH9,SPHKAP,LHCGR,BACH2,IL1RAPL2,NOVA1,FGF14,RYR2,PAQR3,CNTN1,AKAP9</TD></TR>
<TR><TD>9.291e-03</TD><TD>-4.68</TD><TD>regulation of synapse structure or activity</TD><TD>biological process</TD><TD>GO:0050803</TD><TD>252</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>EFNA5,PTPRD,IL1RAPL2,NRCAM,ROBO2,NTRK2,EPHA4,LRFN5</TD></TR>
<TR><TD>9.312e-03</TD><TD>-4.68</TD><TD>human chr7p21.3</TD><TD>chromosome location</TD><TD>human chr7p21.3</TD><TD>69</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>PHF14,THSD7A</TD></TR>
<TR><TD>9.360e-03</TD><TD>-4.67</TD><TD>DNA-binding transcription repressor activity, RNA polymerase II-specific</TD><TD>molecular function</TD><TD>GO:0001227</TD><TD>263</TD><TD>8</TD><TD>18530</TD><TD>206</TD>
<TD>KLF12,TRPS1,IRX1,ARX,PAX6,INSM1,BACH2,FERD3L</TD></TR>
<TR><TD>9.372e-03</TD><TD>-4.67</TD><TD>testis</TD><TD>COSMIC cancer mutations</TD><TD>testis</TD><TD>735</TD><TD>16</TD><TD>16984</TD><TD>192</TD>
<TD>PSKH2,NTRK2,NAALADL2,KIF6,ACVR1C,EPHA3,PRKCE,UHMK1,ACVR2A,TGFBR2,LMBRD1,EPHA4,CASK,FGFR2,TRPS1,RGS6</TD></TR>
<TR><TD>9.378e-03</TD><TD>-4.67</TD><TD>Signalling by NGF</TD><TD>REACTOME pathways</TD><TD>R-HSA-166520</TD><TD>478</TD><TD>11</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,NRG1,FGFR2,FGF5,PHLPP1,AKAP9,PAQR3,PRKCE,VAV3,FGD3,NTRK2</TD></TR>
<TR><TD>9.395e-03</TD><TD>-4.67</TD><TD>enzyme binding</TD><TD>molecular function</TD><TD>GO:0019899</TD><TD>2100</TD><TD>35</TD><TD>18530</TD><TD>206</TD>
<TD>UNC5C,PRKCE,PTPRK,NRG1,IPO8,LHCGR,CDH5,UTRN,NTRK2,XPO4,UHMK1,SPAG9,FMNL2,PLEK,EPS8,UCHL1,BANK1,CNTNAP2,RPH3A,ERCC6L2,CD226,RYR2,EPHA4,FZD6,FGD3,IQGAP2,INSM1,TWIST1,DAAM1,WWOX,NBEA,PARP8,BCHE,DSCAM,PAX6</TD></TR>
<TR><TD>9.449e-03</TD><TD>-4.66</TD><TD>AA/rel_permease1</TD><TD>interpro domains</TD><TD>IPR002293</TD><TD>13</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>SLC7A8,SLC7A14</TD></TR>
<TR><TD>9.473e-03</TD><TD>-4.66</TD><TD>Signaling by FGFR2 in disease</TD><TD>REACTOME pathways</TD><TD>R-HSA-5655253</TD><TD>43</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>FGFR2,FGF5,FGF20</TD></TR>
<TR><TD>9.489e-03</TD><TD>-4.66</TD><TD>AA_permease_2</TD><TD>pfam domains</TD><TD>PF13520</TD><TD>13</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>SLC7A14,SLC7A8</TD></TR>
<TR><TD>9.539e-03</TD><TD>-4.65</TD><TD>anatomical structure formation involved in morphogenesis</TD><TD>biological process</TD><TD>GO:0048646</TD><TD>974</TD><TD>20</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,AMELX,SEMA3C,FGFR2,PAX6,SLIT2,FZD6,IRX1,CNTN1,RBM20,VAV3,SLC25A46,DSCAM,ROBO2,NRCAM,FBN2,ADAMTS5,CXCL13,TWIST1,THSD7A</TD></TR>
<TR><TD>9.546e-03</TD><TD>-4.65</TD><TD>caecum</TD><TD>COSMIC cancer mutations</TD><TD>caecum</TD><TD>14259</TD><TD>173</TD><TD>16984</TD><TD>192</TD>
<TD>LRIG3,REG1B,FUT9,IPO8,NRSN1,FGD3,PAX6,STXBP6,IQGAP2,FBN2,RGS6,SPAG9,MUC7,PWWP2A,UCHL1,ASPN,LRRC3B,FIGN,PHLPP1,JMJD1C,LRRC70,OR52K2,IL1RAPL2,MRPL3,CETN3,WRN,BCHE,ADAMTS3,RAI2,DNAJC12,UBR4,AOAH,THSD7A,ZPLD1,RPH3A,RYR2,ROBO2,SGCG,PHF14,ADAMTS5,REXO2,EPHA3,CD96,HNF4G,NTRK2,ADAMTS12,FMNL2,ZNF521,PTPRK,KLF12,CYTL1,ATG10,EFR3A,NUP35,ADAM28,PTPRD,TGFBR2,DAAM1,NRCAM,SEMA3C,TSN,XPO4,SKAP2,DSCAM,DNER,EPHA4,CASK,TMEFF2,ZNF133,PRKCE,IRX1,CPXM2,PI15,CNTNAP2,ACP6,MEGF10,CXCL13,LRFN5,SEZ6L,TCF20,SPHKAP,PAQR3,KIF6,ERCC6L2,NOBOX,ACVR1C,LRRN2,SLC39A10,VAV3,PLEK,SPATA16,AFM,NAT2,ZFPM2,UTRN,ACVR2A,DEFB115,RASGEF1B,CELF2,GAP43,TRPS1,EFEMP1,WWOX,B3GAT2,SERGEF,GPR83,UNC5C,GHITM,PTPRZ1,OR2AG1,CD226,NCKAP5,NOL4,SLIT2,FGF20,MAP2,SERINC5,PARP8,AKAP9,CNTN1,NAALADL2,TWIST1,SS18,NOVA1,FGFR2,RUNX1T1,GCNT1,AMELX,FERD3L,PRLHR,EPYC,PSKH2,SLC10A2,LGI1,LMX1A,KAZN,PCDH9,SHISA3,CDH5,INSM1,ARX,UHMK1,RBM20,FGF14,THSD7B,LMBRD1,FZD6,NAV3,LHCGR,EPS8,PRSS12,NRG1,CRTC3,MRPL13,SLC7A8,CHRM3,KCNK9,MPEG1,GMDS,NBEA,BANK1,ZNF518B,SYT1,FANCB,FAT4,FGF5,BACH2,CTSO,EDIL3,SLC7A14,SLC25A46,AGA,PXDNL</TD></TR>
<TR><TD>9.579e-03</TD><TD>-4.65</TD><TD>regulation of protein polymerization</TD><TD>biological process</TD><TD>GO:0032271</TD><TD>203</TD><TD>7</TD><TD>18905</TD><TD>219</TD>
<TD>PRKCE,AKAP9,SLIT2,EPS8,MAP2,CDH5,NAV3</TD></TR>
<TR><TD>9.579e-03</TD><TD>-4.65</TD><TD>regulation of T cell tolerance induction</TD><TD>biological process</TD><TD>GO:0002664</TD><TD>13</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PHLPP1,TGFBR2</TD></TR>
<TR><TD>9.579e-03</TD><TD>-4.65</TD><TD>negative regulation of microtubule polymerization</TD><TD>biological process</TD><TD>GO:0031115</TD><TD>13</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>CDH5,MAP2</TD></TR>
<TR><TD>9.579e-03</TD><TD>-4.65</TD><TD>detection of calcium ion</TD><TD>biological process</TD><TD>GO:0005513</TD><TD>13</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2,SYT1</TD></TR>
<TR><TD>9.579e-03</TD><TD>-4.65</TD><TD>regulation of tooth mineralization</TD><TD>biological process</TD><TD>GO:0070170</TD><TD>13</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>ASPN,AMELX</TD></TR>
<TR><TD>9.580e-03</TD><TD>-4.65</TD><TD>bone-pelvis-chondrosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-pelvis-chondrosarcoma</TD><TD>314</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>FGD3,MEGF10,DAAM1,RYR2,SPATA16,NOBOX,FIGN,SGCD,NAV3</TD></TR>
<TR><TD>9.590e-03</TD><TD>-4.65</TD><TD>growth factor activity</TD><TD>molecular function</TD><TD>GO:0008083</TD><TD>162</TD><TD>6</TD><TD>18530</TD><TD>206</TD>
<TD>FGF20,FGF14,EFEMP1,AMELX,FGF5,NRG1</TD></TR>
<TR><TD>9.591e-03</TD><TD>-4.65</TD><TD>EGF_CA</TD><TD>smart domains</TD><TD>SM00179</TD><TD>121</TD><TD>6</TD><TD>9743</TD><TD>146</TD>
<TD>EFEMP1,EDIL3,SLIT2,FBN2,DNER,FAT4</TD></TR>
<TR><TD>9.740e-03</TD><TD>-4.63</TD><TD>ARL14 (ADP ribosylation factor like GTPase 14)</TD><TD>protein interactions</TD><TD>80117</TD><TD>117</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>FAT4,NBEA,PCDH9,SLC39A10,CASK</TD></TR>
<TR><TD>9.753e-03</TD><TD>-4.63</TD><TD>CPNE5 (copine 5)</TD><TD>protein interactions</TD><TD>57699</TD><TD>40</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>UBR4,DSCAM,UTRN</TD></TR>
<TR><TD>9.755e-03</TD><TD>-4.63</TD><TD>negative regulation of neuron differentiation</TD><TD>biological process</TD><TD>GO:0045665</TD><TD>72</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>PBX1,PAX6,LMX1A,SPAG9</TD></TR>
<TR><TD>9.861e-03</TD><TD>-4.62</TD><TD>protein binding</TD><TD>molecular function</TD><TD>GO:0005515</TD><TD>14097</TD><TD>171</TD><TD>18530</TD><TD>206</TD>
<TD>UBR4,INSM1,LMBRD1,ACVR2A,FIGN,SLC7A14,ADAM28,CYTL1,PTPRD,DAAM1,EFR3B,DAOA,RAI2,C8orf88,PECAM1,SLC39A10,AFM,CNTNAP2,BANK1,CTSO,DNAJC12,LRATD1,MTERF1,LGI1,NRSN1,DEFB115,PARP8,FUT9,DSCAM,PAX6,WWOX,PRLHR,NAALADL2,FHIP1A,GAP43,RUNX1T1,CASK,DNER,NRG1,TGFBR2,FNIP2,TSN,SGCG,EDIL3,THSD7B,ATG10,TRPS1,MEGF10,UTRN,LHCGR,SLC10A2,PHLPP1,PUM3,FBN2,SLIT2,SEMA3C,FGF5,FANCB,FGF14,NAT2,SPHKAP,CALN1,TMEFF2,MARCHF3,RYR2,EPHA4,CRTC3,GAREM1,VAV3,JMJD1C,AMELX,KAZN,EPHA3,SYT1,PLAAT1,DAW1,TWIST1,NOVA1,ACTR3C,DEPTOR,SERGEF,CETN3,ADAMTS12,MRPL13,CDH5,MUC7,UNC5C,ADAMTS3,PRKCE,ZNF133,ERCC6L2,ZFAND5,ZFPM2,AGA,GMDS,PTPRZ1,TEC,WRN,EMC2,NRCAM,LRIG3,THSD7A,AOAH,PHF14,FERD3L,CXCL13,SLC25A46,STXBP6,NTRK2,FGD3,IQGAP2,FZD6,ROBO2,EFEMP1,ACVR1C,ADGRL3,KIF6,FAT4,RGS6,GCNT1,ZNF521,LRFN5,TCF20,UHMK1,FMNL2,ARL14,SHISA3,LMX1A,SHTN1,BACH2,GHITM,NAV3,PCGF5,CD226,FABP7,NBEA,LRRC3B,SEPTIN5,IPO8,EFNA5,CHRM3,PTPRK,RPH3A,ARX,PSKH2,ADAMTS5,UCHL1,SS18,KLF12,SPAG9,MAP2,XPO4,FGF20,IGFL4,AKAP9,NUP35,OR2AG1,BCHE,SKAP2,PAQR3,CNTN1,CPQ,PWWP2A,RBM20,PBX1,AFG2A,FGFR2,PLEK,EPS8,GALNT15,SLC7A8</TD></TR>
<TR><TD>9.875e-03</TD><TD>-4.62</TD><TD>PI3K/AKT activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-198203</TD><TD>128</TD><TD>5</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,NRG1,PHLPP1,FGFR2,FGF5</TD></TR>
<TR><TD>9.875e-03</TD><TD>-4.62</TD><TD>GAB1 signalosome</TD><TD>REACTOME pathways</TD><TD>R-HSA-180292</TD><TD>128</TD><TD>5</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,NRG1,FGF5,FGFR2,PHLPP1</TD></TR>
<TR><TD>9.897e-03</TD><TD>-4.62</TD><TD>cell body</TD><TD>cellular component</TD><TD>GO:0044297</TD><TD>558</TD><TD>13</TD><TD>19868</TD><TD>221</TD>
<TD>EPHA4,SHTN1,NRSN1,BRINP3,SEZ6L,DSCAM,CNTNAP2,AKAP9,GAP43,UCHL1,MAP2,UNC5C,DNER</TD></TR>
<TR><TD>1.001e-02</TD><TD>-4.60</TD><TD>TYRKINASE</TD><TD>prints domains</TD><TD>PR00109</TD><TD>98</TD><TD>5</TD><TD>5258</TD><TD>71</TD>
<TD>TEC,NTRK2,EPHA3,FGFR2,EPHA4</TD></TR>
<TR><TD>1.007e-02</TD><TD>-4.60</TD><TD>kidney-carcinoma-chromophobe_renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>kidney-carcinoma-chromophobe_renal_cell_carcinoma</TD><TD>431</TD><TD>11</TD><TD>16984</TD><TD>192</TD>
<TD>ACVR2A,TGFBR2,UHMK1,PRKCE,EPHA3,FGFR2,ACVR1C,CASK,EPHA4,PSKH2,NTRK2</TD></TR>
<TR><TD>1.007e-02</TD><TD>-4.60</TD><TD>chromophobe_renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>chromophobe_renal_cell_carcinoma</TD><TD>431</TD><TD>11</TD><TD>16984</TD><TD>192</TD>
<TD>FGFR2,EPHA4,CASK,EPHA3,PRKCE,ACVR2A,TGFBR2,UHMK1,NTRK2,PSKH2,ACVR1C</TD></TR>
<TR><TD>1.007e-02</TD><TD>-4.60</TD><TD>striated muscle tissue development</TD><TD>biological process</TD><TD>GO:0014706</TD><TD>205</TD><TD>7</TD><TD>18905</TD><TD>219</TD>
<TD>SGCD,RYR2,NRG1,ZFPM2,FGFR2,SEMA3C,SGCG</TD></TR>
<TR><TD>1.008e-02</TD><TD>-4.60</TD><TD>SHTN1 (shootin 1)</TD><TD>protein interactions</TD><TD>57698</TD><TD>118</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>BCHE,PHLPP1,SHTN1,MEGF10,DSCAM</TD></TR>
<TR><TD>1.011e-02</TD><TD>-4.59</TD><TD>Snake_toxin-like_sf</TD><TD>interpro domains</TD><TD>IPR045860</TD><TD>39</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>TGFBR2,ACVR2A,ACVR1C</TD></TR>
<TR><TD>1.015e-02</TD><TD>-4.59</TD><TD>SYNPR (synaptoporin)</TD><TD>protein interactions</TD><TD>132204</TD><TD>14</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>SPAG9,GALNT15</TD></TR>
<TR><TD>1.020e-02</TD><TD>-4.59</TD><TD>Mitochondrial transcription termination</TD><TD>REACTOME pathways</TD><TD>R-HSA-163316</TD><TD>1</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>MTERF1</TD></TR>
<TR><TD>1.020e-02</TD><TD>-4.59</TD><TD>Signaling by FGFR2 amplification mutants</TD><TD>REACTOME pathways</TD><TD>R-HSA-2023837</TD><TD>1</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>FGFR2</TD></TR>
<TR><TD>1.020e-02</TD><TD>-4.59</TD><TD>Signaling by FGFR2 fusions</TD><TD>REACTOME pathways</TD><TD>R-HSA-8853333</TD><TD>1</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>FGFR2</TD></TR>
<TR><TD>1.026e-02</TD><TD>-4.58</TD><TD>catalytic activity, acting on a protein</TD><TD>molecular function</TD><TD>GO:0140096</TD><TD>2341</TD><TD>38</TD><TD>18530</TD><TD>206</TD>
<TD>TGFBR2,FGFR2,PRSS12,ADAMTS3,PRKCE,PTPRK,GCNT1,CASK,ADAMTS12,UHMK1,MAST4,GALNT15,CTSO,NTRK2,PHLPP1,MARCHF11,PSKH2,UCHL1,ADAMTS5,PTPRZ1,EPHA4,PCGF5,ADAM28,EFEMP1,TEC,UBR4,MARCHF3,FIGN,ATG10,ACVR2A,CPQ,EPHA3,MATCAP2,PARP8,JMJD1C,ACVR1C,PTPRD,CPXM2</TD></TR>
<TR><TD>1.031e-02</TD><TD>-4.57</TD><TD>negative regulation of microtubule polymerization or depolymerization</TD><TD>biological process</TD><TD>GO:0031111</TD><TD>39</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>CDH5,MAP2,NAV3</TD></TR>
<TR><TD>1.031e-02</TD><TD>-4.57</TD><TD>animal organ formation</TD><TD>biological process</TD><TD>GO:0048645</TD><TD>39</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,FGFR2,RBM20</TD></TR>
<TR><TD>1.037e-02</TD><TD>-4.57</TD><TD>human chr9q21.13</TD><TD>chromosome location</TD><TD>human chr9q21.13</TD><TD>73</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>ZFAND5,GCNT1</TD></TR>
<TR><TD>1.038e-02</TD><TD>-4.57</TD><TD>positive regulation of growth</TD><TD>biological process</TD><TD>GO:0045927</TD><TD>257</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,SYT1,DSCAM,ZFPM2,EFNA5,SHTN1,LGI1,ARX</TD></TR>
<TR><TD>1.042e-02</TD><TD>-4.56</TD><TD>DAP12 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-2424491</TD><TD>356</TD><TD>9</TD><TD>10391</TD><TD>106</TD>
<TD>PRKCE,VAV3,FGF20,NRG1,PHLPP1,PAQR3,AKAP9,FGF5,FGFR2</TD></TR>
<TR><TD>1.046e-02</TD><TD>-4.56</TD><TD>FNTYPEIII</TD><TD>prints domains</TD><TD>PR00014</TD><TD>34</TD><TD>3</TD><TD>5258</TD><TD>71</TD>
<TD>EPHA3,PTPRD,EPHA4</TD></TR>
<TR><TD>1.054e-02</TD><TD>-4.55</TD><TD>calcium ion binding</TD><TD>molecular function</TD><TD>GO:0005509</TD><TD>691</TD><TD>15</TD><TD>18530</TD><TD>206</TD>
<TD>EFEMP1,ASPN,FAT4,RYR2,CETN3,DNER,CALN1,AOAH,SYT1,EDIL3,FBN2,ADGRL3,SLIT2,PCDH9,RPH3A</TD></TR>
<TR><TD>1.064e-02</TD><TD>-4.54</TD><TD>negative regulation of cytoskeleton organization</TD><TD>biological process</TD><TD>GO:0051494</TD><TD>159</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>CDH5,NAV3,MAP2,TMEFF2,EPS8,SLIT2</TD></TR>
<TR><TD>1.072e-02</TD><TD>-4.54</TD><TD>negative regulation of protein polymerization</TD><TD>biological process</TD><TD>GO:0032272</TD><TD>74</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>EPS8,SLIT2,CDH5,MAP2</TD></TR>
<TR><TD>1.076e-02</TD><TD>-4.53</TD><TD>LAM_G_DOMAIN</TD><TD>prosite domains</TD><TD>PS50025</TD><TD>35</TD><TD>3</TD><TD>12232</TD><TD>161</TD>
<TD>SLIT2,FAT4,CNTNAP2</TD></TR>
<TR><TD>1.092e-02</TD><TD>-4.52</TD><TD>human chr13q31.1</TD><TD>chromosome location</TD><TD>human chr13q31.1</TD><TD>75</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC00377,LINC00430</TD></TR>
<TR><TD>1.092e-02</TD><TD>-4.52</TD><TD>human chr18q12.1</TD><TD>chromosome location</TD><TD>human chr18q12.1</TD><TD>75</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>GAREM1,NOL4</TD></TR>
<TR><TD>1.092e-02</TD><TD>-4.52</TD><TD>human chr21q21.3</TD><TD>chromosome location</TD><TD>human chr21q21.3</TD><TD>75</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>ADAMTS5,LINC01697</TD></TR>
<TR><TD>1.094e-02</TD><TD>-4.52</TD><TD>Eph_TM</TD><TD>interpro domains</TD><TD>IPR027936</TD><TD>14</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>EPHA4,EPHA3</TD></TR>
<TR><TD>1.094e-02</TD><TD>-4.52</TD><TD>Tyr_kinase_ephrin_rcpt</TD><TD>interpro domains</TD><TD>IPR016257</TD><TD>14</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.094e-02</TD><TD>-4.52</TD><TD>Tyr-kin_ephrin_A/B_rcpt-like</TD><TD>interpro domains</TD><TD>IPR011641</TD><TD>14</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.094e-02</TD><TD>-4.52</TD><TD>Tyr_kinase_rcpt_V_CS</TD><TD>interpro domains</TD><TD>IPR001426</TD><TD>14</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.094e-02</TD><TD>-4.52</TD><TD>Ephrin_rcpt_lig-bd_dom</TD><TD>interpro domains</TD><TD>IPR001090</TD><TD>14</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.096e-02</TD><TD>-4.51</TD><TD>lung-carcinoid-endocrine_tumour-typical</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoid-endocrine_tumour-typical</TD><TD>321</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>JMJD1C,CNTNAP2,TRPS1,PTPRZ1,WRN,FGFR2,FMNL2,FAT4,PRLHR</TD></TR>
<TR><TD>1.096e-02</TD><TD>-4.51</TD><TD>typical</TD><TD>COSMIC cancer mutations</TD><TD>typical</TD><TD>321</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>TRPS1,WRN,PTPRZ1,FGFR2,FMNL2,PRLHR,FAT4,JMJD1C,CNTNAP2</TD></TR>
<TR><TD>1.098e-02</TD><TD>-4.51</TD><TD>transmembrane signaling receptor activity</TD><TD>molecular function</TD><TD>GO:0004888</TD><TD>1311</TD><TD>24</TD><TD>18530</TD><TD>206</TD>
<TD>IL1RAPL2,NTRK2,LHCGR,CHRM3,FGFR2,TGFBR2,UNC5C,PTPRK,PECAM1,DNER,EPHA3,ACVR1C,OR2AG1,ADGRL3,PRLHR,PTPRD,PTPRZ1,ROBO2,EPHA4,GPR83,EFEMP1,OR52K2,ACVR2A,FZD6</TD></TR>
<TR><TD>1.099e-02</TD><TD>-4.51</TD><TD>EphA2_TM</TD><TD>pfam domains</TD><TD>PF14575</TD><TD>14</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>EPHA4,EPHA3</TD></TR>
<TR><TD>1.099e-02</TD><TD>-4.51</TD><TD>Ephrin_rec_like</TD><TD>pfam domains</TD><TD>PF07699</TD><TD>14</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.099e-02</TD><TD>-4.51</TD><TD>Ephrin_lbd</TD><TD>pfam domains</TD><TD>PF01404</TD><TD>14</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.099e-02</TD><TD>-4.51</TD><TD>epithelial tube morphogenesis</TD><TD>biological process</TD><TD>GO:0060562</TD><TD>313</TD><TD>9</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,TGFBR2,RYR2,EPHA4,TWIST1,PBX1,SLIT2,FZD6,IRX1</TD></TR>
<TR><TD>1.100e-02</TD><TD>-4.51</TD><TD>bone-fibula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>COSMIC cancer mutations</TD><TD>bone-fibula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>378</TD><TD>10</TD><TD>16984</TD><TD>192</TD>
<TD>ZFPM2,FBN2,NCKAP5,SERGEF,SKAP2,DSCAM,MPEG1,PHF14,SPATA16,BANK1</TD></TR>
<TR><TD>1.101e-02</TD><TD>-4.51</TD><TD>PROTEIN_KINASE_DOM</TD><TD>prosite domains</TD><TD>PS50011</TD><TD>481</TD><TD>13</TD><TD>12232</TD><TD>161</TD>
<TD>MAST4,EPHA3,ACVR1C,NTRK2,FGFR2,TEC,CASK,TGFBR2,UHMK1,ACVR2A,PSKH2,EPHA4,PRKCE</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>DAO (D-amino acid oxidase)</TD><TD>protein interactions</TD><TD>397134</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>DAOA</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>Erbb4 (erb-b2 receptor tyrosine kinase 4)</TD><TD>protein interactions</TD><TD>13869</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>NRG1</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>SMARCA2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2)</TD><TD>protein interactions</TD><TD>396040</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>SS18</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>AMELX (amelogenin X-linked)</TD><TD>protein interactions</TD><TD>265</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>AMELX</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>Apob (apolipoprotein B)</TD><TD>protein interactions</TD><TD>54225</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>CELF2</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>PRLH (prolactin releasing hormone)</TD><TD>protein interactions</TD><TD>51052</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>PRLHR</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta)</TD><TD>protein interactions</TD><TD>282463</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>MAP2</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>Dynlt1 (dynein light chain Tctex-type 1)</TD><TD>protein interactions</TD><TD>83462</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>NTRK2</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>RPS15AP21 (ribosomal protein S15a pseudogene 21)</TD><TD>protein interactions</TD><TD>100271357</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>WWOX</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>Csnk1e (casein kinase 1, epsilon)</TD><TD>protein interactions</TD><TD>58822</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>AKAP9</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>USP17L24 (ubiquitin specific peptidase 17 like family member 24)</TD><TD>protein interactions</TD><TD>728369</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>UCHL1</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>Robo1 (roundabout guidance receptor 1)</TD><TD>protein interactions</TD><TD>58946</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>SLIT2</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>Cntnap2 (contactin associated protein-like 2)</TD><TD>protein interactions</TD><TD>66797</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>CNTN1</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>Bdnf (brain derived neurotrophic factor)</TD><TD>protein interactions</TD><TD>12064</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>NTRK2</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>F11r (F11 receptor)</TD><TD>protein interactions</TD><TD>16456</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>CASK</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>GIS1 (histone demethylase GIS1)</TD><TD>protein interactions</TD><TD>851670</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>WRN</TD></TR>
<TR><TD>1.106e-02</TD><TD>-4.50</TD><TD>CSNK1E (casein kinase 1 epsilon)</TD><TD>protein interactions</TD><TD>700565</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>AKAP9</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>regulation of cardiac epithelial to mesenchymal transition</TD><TD>biological process</TD><TD>GO:0062042</TD><TD>14</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1,TGFBR2</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>Atg12 conjugating enzyme activity</TD><TD>molecular function</TD><TD>GO:0061651</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>ATG10</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>luteinizing hormone receptor activity</TD><TD>molecular function</TD><TD>GO:0004964</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>LHCGR</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>acyloxyacyl hydrolase activity</TD><TD>molecular function</TD><TD>GO:0050528</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>AOAH</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>choriogonadotropin hormone binding</TD><TD>molecular function</TD><TD>GO:0038106</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>LHCGR</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>neurotrophin TRKB receptor binding</TD><TD>molecular function</TD><TD>GO:0005169</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>EFNA5</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>3'-flap-structured DNA binding</TD><TD>molecular function</TD><TD>GO:0070337</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>WRN</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>CXCR5 chemokine receptor binding</TD><TD>molecular function</TD><TD>GO:0031724</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>CXCL13</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>4-hydroxybenzoate octaprenyltransferase activity</TD><TD>molecular function</TD><TD>GO:0008412</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>COQ2</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>choriogonadotropin hormone receptor activity</TD><TD>molecular function</TD><TD>GO:0035472</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>LHCGR</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>4-hydroxybenzoate nonaprenyltransferase activity</TD><TD>molecular function</TD><TD>GO:0047293</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>COQ2</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>GDP-mannose 4,6-dehydratase activity</TD><TD>molecular function</TD><TD>GO:0008446</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>GMDS</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>DH domain binding</TD><TD>molecular function</TD><TD>GO:0097161</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>EPHA4</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>brain-derived neurotrophic factor receptor activity</TD><TD>molecular function</TD><TD>GO:0060175</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>NTRK2</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>netrin receptor activity involved in chemorepulsion</TD><TD>molecular function</TD><TD>GO:0005043</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>UNC5C</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>neurotrophin TRKC receptor binding</TD><TD>molecular function</TD><TD>GO:0005170</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>EFNA5</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>apical distal dendrite</TD><TD>cellular component</TD><TD>GO:0150014</TD><TD>1</TD><TD>1</TD><TD>19868</TD><TD>221</TD>
<TD>MAP2</TD></TR>
<TR><TD>1.112e-02</TD><TD>-4.50</TD><TD>extrinsic component of endoplasmic reticulum membrane</TD><TD>cellular component</TD><TD>GO:0042406</TD><TD>1</TD><TD>1</TD><TD>19868</TD><TD>221</TD>
<TD>EMC2</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>LOC254896 (uncharacterized LOC254896)</TD><TD>protein interactions</TD><TD>254896</TD><TD>42</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>BCHE,FAT4,NBEA</TD></TR>
<TR><TD>1.120e-02</TD><TD>-4.49</TD><TD>positive regulation of cellular component organization</TD><TD>biological process</TD><TD>GO:0051130</TD><TD>1123</TD><TD>22</TD><TD>18905</TD><TD>219</TD>
<TD>FNIP2,PLEK,NAV3,EPHA3,DSCAM,CDH5,PTPRD,CXCL13,NTRK2,CNTNAP2,EPHA4,SHTN1,EFNA5,AKAP9,SLIT2,SYT1,ROBO2,NRG1,FUT9,EPS8,PRKCE,CNTN1</TD></TR>
<TR><TD>1.120e-02</TD><TD>-4.49</TD><TD>human chr10q26.13</TD><TD>chromosome location</TD><TD>human chr10q26.13</TD><TD>76</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>CPXM2,FGFR2</TD></TR>
<TR><TD>1.122e-02</TD><TD>-4.49</TD><TD>muscle tissue morphogenesis</TD><TD>biological process</TD><TD>GO:0060415</TD><TD>75</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2,NRG1,ZFPM2,FGFR2</TD></TR>
<TR><TD>1.123e-02</TD><TD>-4.49</TD><TD>extragonadal</TD><TD>COSMIC cancer mutations</TD><TD>extragonadal</TD><TD>165</TD><TD>6</TD><TD>16984</TD><TD>192</TD>
<TD>CNTN1,FAT4,JMJD1C,LRFN5,ERCC6L2,IPO8</TD></TR>
<TR><TD>1.127e-02</TD><TD>-4.49</TD><TD>eye morphogenesis</TD><TD>biological process</TD><TD>GO:0048592</TD><TD>161</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>DSCAM,NTRK2,PAX6,FBN2,TWIST1,EFEMP1</TD></TR>
<TR><TD>1.127e-02</TD><TD>-4.49</TD><TD>regulation of microtubule cytoskeleton organization</TD><TD>biological process</TD><TD>GO:0070507</TD><TD>161</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>EFNA5,MAP2,CDH5,AKAP9,NAV3,EPHA3</TD></TR>
<TR><TD>1.127e-02</TD><TD>-4.49</TD><TD>FGFR1 ligand binding and activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-190242</TD><TD>16</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>1.127e-02</TD><TD>-4.49</TD><TD>Phospholipase C-mediated cascade: FGFR1</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654219</TD><TD>16</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>1.141e-02</TD><TD>-4.47</TD><TD>regulation of cell motility</TD><TD>biological process</TD><TD>GO:2000145</TD><TD>1125</TD><TD>22</TD><TD>18905</TD><TD>219</TD>
<TD>CDH5,UNC5C,TWIST1,SPAG9,CXCL13,TMEFF2,FGF5,PRKCE,PTPRK,NAV3,FUT9,FGF20,ACVR1C,INSM1,SHTN1,GCNT1,PECAM1,SLIT2,PAX6,SEMA3C,EPHA4,TGFBR2</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>VAV3_SH3_2</TD><TD>interpro domains</TD><TD>IPR035734</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>VAV3</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>CPL_dom</TD><TD>interpro domains</TD><TD>IPR012959</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PUM3</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>EMC2-like</TD><TD>interpro domains</TD><TD>IPR039856</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>EMC2</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>VAV3_SH2</TD><TD>interpro domains</TD><TD>IPR035881</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>VAV3</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Musac_Ach_M3_rcpt</TD><TD>interpro domains</TD><TD>IPR001183</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CHRM3</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>UBR4-like</TD><TD>interpro domains</TD><TD>IPR045189</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>UBR4</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>GHITM</TD><TD>interpro domains</TD><TD>IPR035871</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>GHITM</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Oligoribonuclease</TD><TD>interpro domains</TD><TD>IPR022894</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>REXO2</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>CD96</TD><TD>interpro domains</TD><TD>IPR042381</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CD96</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>UBR4-like_UBR-box</TD><TD>interpro domains</TD><TD>IPR047509</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>UBR4</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>PI15_CAP</TD><TD>interpro domains</TD><TD>IPR047832</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PI15</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Helicase_HTH</TD><TD>interpro domains</TD><TD>IPR029491</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>WRN</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>FANCB</TD><TD>interpro domains</TD><TD>IPR033333</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FANCB</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>TCF-20_ePHD</TD><TD>interpro domains</TD><TD>IPR041972</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>TCF20</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>EphA3_rcpt_lig-bd</TD><TD>interpro domains</TD><TD>IPR034266</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>EPHA3</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>DEPTOR_DEP_2</TD><TD>interpro domains</TD><TD>IPR037336</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>DEPTOR</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>MAP2_projctn</TD><TD>interpro domains</TD><TD>IPR013588</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MAP2</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>TRPS1</TD><TD>interpro domains</TD><TD>IPR028440</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>TRPS1</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>DNER_C</TD><TD>interpro domains</TD><TD>IPR045769</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>DNER</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Tec_SH3</TD><TD>interpro domains</TD><TD>IPR035572</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>TEC</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>PUM3</TD><TD>interpro domains</TD><TD>IPR040059</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PUM3</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Kazrin</TD><TD>interpro domains</TD><TD>IPR037614</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>KAZN</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>PLEK_DEP</TD><TD>interpro domains</TD><TD>IPR037371</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PLEK</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Neuromodulin_palmitoyl_site</TD><TD>interpro domains</TD><TD>IPR018243</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>MUC7</TD><TD>interpro domains</TD><TD>IPR033529</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MUC7</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Nucleoporin_NUP53</TD><TD>interpro domains</TD><TD>IPR017389</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NUP35</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Lmx1a_LIM1</TD><TD>interpro domains</TD><TD>IPR042688</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>LMX1A</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>SPATA16</TD><TD>interpro domains</TD><TD>IPR029161</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>SPATA16</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>NOBOX</TD><TD>interpro domains</TD><TD>IPR042988</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NOBOX</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>AOAH_Saposin_N</TD><TD>interpro domains</TD><TD>IPR048593</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>AOAH</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>NRG1</TD><TD>interpro domains</TD><TD>IPR018250</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NRG1</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>nPKC_epsilon</TD><TD>interpro domains</TD><TD>IPR034669</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PRKCE</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>STXBP6_SNARE</TD><TD>interpro domains</TD><TD>IPR037822</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>STXBP6</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>CPQ</TD><TD>interpro domains</TD><TD>IPR039866</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CPQ</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>RRM_NUP35_dom</TD><TD>interpro domains</TD><TD>IPR007846</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NUP35</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>EphA4_rcpt_lig-bd</TD><TD>interpro domains</TD><TD>IPR034270</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>EPHA4</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>RBM20_RRM</TD><TD>interpro domains</TD><TD>IPR034790</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RBM20</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>SLC25A46</TD><TD>interpro domains</TD><TD>IPR039158</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>SLC25A46</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>LSH_rcpt</TD><TD>interpro domains</TD><TD>IPR002273</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>LHCGR</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>E3_UBR4_N</TD><TD>interpro domains</TD><TD>IPR045841</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>UBR4</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Neuromodulin_P_site</TD><TD>interpro domains</TD><TD>IPR033137</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>AOAH</TD><TD>interpro domains</TD><TD>IPR039676</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>AOAH</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>DEPTOR_DEP_1</TD><TD>interpro domains</TD><TD>IPR037335</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>DEPTOR</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Kazrin_SAM_rpt_2</TD><TD>interpro domains</TD><TD>IPR037615</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>KAZN</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>FYVE_RPH3A</TD><TD>interpro domains</TD><TD>IPR028698</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RPH3A</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>KCNK9</TD><TD>interpro domains</TD><TD>IPR005407</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>KCNK9</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>CD226</TD><TD>interpro domains</TD><TD>IPR042842</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CD226</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>MPEG1</TD><TD>interpro domains</TD><TD>IPR039707</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MPEG1</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Ribosomal_uL13_bac-type</TD><TD>interpro domains</TD><TD>IPR005823</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MRPL13</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>EphA4_SAM</TD><TD>interpro domains</TD><TD>IPR030602</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>EPHA4</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Shootin-1</TD><TD>interpro domains</TD><TD>IPR024849</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>SHTN1</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Transforming_GF_b_rcpt_2_ecto</TD><TD>interpro domains</TD><TD>IPR015013</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>TWIST1_bHLH</TD><TD>interpro domains</TD><TD>IPR047093</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>TWIST1</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>FZ6_CRD</TD><TD>interpro domains</TD><TD>IPR041770</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FZD6</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Prenyltransferase</TD><TD>interpro domains</TD><TD>IPR039653</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>COQ2</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>RGS6_RGS</TD><TD>interpro domains</TD><TD>IPR037956</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RGS6</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>GDP_Man_deHydtase</TD><TD>interpro domains</TD><TD>IPR006368</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>GMDS</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>ELK_dom</TD><TD>interpro domains</TD><TD>IPR005539</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>AKAP9</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Death_UNC5C</TD><TD>interpro domains</TD><TD>IPR042154</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>UNC5C</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>STXBP6_PH</TD><TD>interpro domains</TD><TD>IPR037821</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>STXBP6</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>R-PTP-delta_cat</TD><TD>interpro domains</TD><TD>IPR045905</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PTPRD</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Translin</TD><TD>interpro domains</TD><TD>IPR033956</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>TSN</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>NTRK2</TD><TD>interpro domains</TD><TD>IPR020455</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NTRK2</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Pept_M12B_ADAM-TS5</TD><TD>interpro domains</TD><TD>IPR013276</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>ADAMTS5</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Transform_growth_fac-b_typ-2</TD><TD>interpro domains</TD><TD>IPR017194</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Contactin-1_Ig3</TD><TD>interpro domains</TD><TD>IPR047100</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CNTN1</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Kazrin_SAM_rpt_1</TD><TD>interpro domains</TD><TD>IPR037613</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>KAZN</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>FZD6_7TM</TD><TD>interpro domains</TD><TD>IPR026543</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FZD6</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>CASK_SH3</TD><TD>interpro domains</TD><TD>IPR035473</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CASK</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Neuromodulin_C</TD><TD>interpro domains</TD><TD>IPR017454</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>DAOA</TD><TD>interpro domains</TD><TD>IPR027929</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>DAOA</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Heliccase-ass-bd</TD><TD>interpro domains</TD><TD>IPR029256</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>ERCC6L2</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Neuromodulin_gap-junction_N</TD><TD>interpro domains</TD><TD>IPR018947</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>UHMK1</TD><TD>interpro domains</TD><TD>IPR034372</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>UHMK1</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>CYTL1</TD><TD>interpro domains</TD><TD>IPR029253</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CYTL1</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Kazrin_SAM_rpt_3</TD><TD>interpro domains</TD><TD>IPR037616</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>KAZN</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Contactin-1_Ig1</TD><TD>interpro domains</TD><TD>IPR036992</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CNTN1</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>CBFA2T1</TD><TD>interpro domains</TD><TD>IPR013290</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>WWOX_SDR_c-like</TD><TD>interpro domains</TD><TD>IPR042732</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>WWOX</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>PKC_epsilon</TD><TD>interpro domains</TD><TD>IPR027274</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PRKCE</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Prolrel_pep_rcpt</TD><TD>interpro domains</TD><TD>IPR001402</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PRLHR</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>PPP1R17</TD><TD>interpro domains</TD><TD>IPR033242</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PPP1R17</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>E3_Ub_ligase_UBR4_C</TD><TD>interpro domains</TD><TD>IPR025704</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>UBR4</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>HB_polyprenyltransferase-like</TD><TD>interpro domains</TD><TD>IPR006370</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>COQ2</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Ribosomal_uL3_bac/org-type</TD><TD>interpro domains</TD><TD>IPR019927</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MRPL3</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>MARCHF11_RING_CH-C4HC3</TD><TD>interpro domains</TD><TD>IPR047906</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MARCHF11</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>VAV3_SH3_1</TD><TD>interpro domains</TD><TD>IPR047015</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>VAV3</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>JDP1-like</TD><TD>interpro domains</TD><TD>IPR029827</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>DNAJC12</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Contactin-1_Ig6</TD><TD>interpro domains</TD><TD>IPR047101</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CNTN1</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>Neuromodulin</TD><TD>interpro domains</TD><TD>IPR001422</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.153e-02</TD><TD>-4.46</TD><TD>Neuromodulin</TD><TD>pfam domains</TD><TD>PF06614</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.153e-02</TD><TD>-4.46</TD><TD>Neuromodulin_N</TD><TD>pfam domains</TD><TD>PF10580</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.153e-02</TD><TD>-4.46</TD><TD>E3_UBR4_N</TD><TD>pfam domains</TD><TD>PF19423</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>UBR4</TD></TR>
<TR><TD>1.153e-02</TD><TD>-4.46</TD><TD>MAP2_projctn</TD><TD>pfam domains</TD><TD>PF08377</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>MAP2</TD></TR>
<TR><TD>1.153e-02</TD><TD>-4.46</TD><TD>ecTbetaR2</TD><TD>pfam domains</TD><TD>PF08917</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.153e-02</TD><TD>-4.46</TD><TD>DAOA</TD><TD>pfam domains</TD><TD>PF15199</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>DAOA</TD></TR>
<TR><TD>1.153e-02</TD><TD>-4.46</TD><TD>E3_UbLigase_R4</TD><TD>pfam domains</TD><TD>PF13764</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>UBR4</TD></TR>
<TR><TD>1.153e-02</TD><TD>-4.46</TD><TD>CPL</TD><TD>pfam domains</TD><TD>PF08144</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>PUM3</TD></TR>
<TR><TD>1.153e-02</TD><TD>-4.46</TD><TD>NYD-SP12_N</TD><TD>pfam domains</TD><TD>PF15015</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>SPATA16</TD></TR>
<TR><TD>1.153e-02</TD><TD>-4.46</TD><TD>Saposin</TD><TD>pfam domains</TD><TD>PF20825</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>AOAH</TD></TR>
<TR><TD>1.153e-02</TD><TD>-4.46</TD><TD>VIGSSK</TD><TD>pfam domains</TD><TD>PF14773</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>ERCC6L2</TD></TR>
<TR><TD>1.153e-02</TD><TD>-4.46</TD><TD>DNER_C</TD><TD>pfam domains</TD><TD>PF19330</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>DNER</TD></TR>
<TR><TD>1.153e-02</TD><TD>-4.46</TD><TD>HTH_40</TD><TD>pfam domains</TD><TD>PF14493</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>WRN</TD></TR>
<TR><TD>1.153e-02</TD><TD>-4.46</TD><TD>Nup35_RRM</TD><TD>pfam domains</TD><TD>PF05172</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>NUP35</TD></TR>
<TR><TD>1.153e-02</TD><TD>-4.46</TD><TD>CYTL1</TD><TD>pfam domains</TD><TD>PF15153</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>CYTL1</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>fibroblast growth factor receptor signaling pathway involved in mammary gland specification</TD><TD>biological process</TD><TD>GO:0060595</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>lymphocyte chemotaxis across high endothelial venule</TD><TD>biological process</TD><TD>GO:0002518</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>CXCL13</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>induction of negative chemotaxis</TD><TD>biological process</TD><TD>GO:0050929</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>regulation of endocardial cushion to mesenchymal transition involved in heart valve formation</TD><TD>biological process</TD><TD>GO:2000800</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>regulation of tolerance induction to self antigen</TD><TD>biological process</TD><TD>GO:0002649</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>regulation of endocardial cushion to mesenchymal transition</TD><TD>biological process</TD><TD>GO:0140049</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>positive regulation of guanyl-nucleotide exchange factor activity</TD><TD>biological process</TD><TD>GO:1905099</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>negative regulation of TORC2 signaling</TD><TD>biological process</TD><TD>GO:1903940</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>DEPTOR</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>primary adaptive immune response</TD><TD>biological process</TD><TD>GO:0090720</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>BACH2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>tropane alkaloid metabolic process</TD><TD>biological process</TD><TD>GO:0046448</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>BCHE</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>positive regulation of strand invasion</TD><TD>biological process</TD><TD>GO:0098530</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>WRN</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>positive regulation of glutamatergic neuron differentiation</TD><TD>biological process</TD><TD>GO:0120008</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>protein transport within extracellular region</TD><TD>biological process</TD><TD>GO:0071693</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>AFM</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow</TD><TD>biological process</TD><TD>GO:0035604</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>trans-synaptic signaling by neuropeptide</TD><TD>biological process</TD><TD>GO:0099540</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>regulation of cell diameter</TD><TD>biological process</TD><TD>GO:0060305</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PLEK</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>cardiac endothelial to mesenchymal transition</TD><TD>biological process</TD><TD>GO:0140074</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SEMA3C</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>regulation of cellular glucuronidation</TD><TD>biological process</TD><TD>GO:2001029</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PRKCE</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>positive regulation of tolerance induction to self antigen</TD><TD>biological process</TD><TD>GO:0002651</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>positive regulation of endocardial cushion to mesenchymal transition</TD><TD>biological process</TD><TD>GO:0140051</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>O-glycan processing, core 2</TD><TD>biological process</TD><TD>GO:0016268</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>GCNT1</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>lipopolysaccharide catabolic process</TD><TD>biological process</TD><TD>GO:0009104</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>AOAH</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>superior endocardial cushion morphogenesis</TD><TD>biological process</TD><TD>GO:1905316</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>primary adaptive immune response involving T cells and B cells</TD><TD>biological process</TD><TD>GO:0090721</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>BACH2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>positive regulation of negative chemotaxis</TD><TD>biological process</TD><TD>GO:0050924</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>corticospinal neuron axon guidance through spinal cord</TD><TD>biological process</TD><TD>GO:0021972</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>forebrain-midbrain boundary formation</TD><TD>biological process</TD><TD>GO:0021905</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>cell proliferation involved in heart valve development</TD><TD>biological process</TD><TD>GO:2000793</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>lipopolysaccharide metabolic process</TD><TD>biological process</TD><TD>GO:0008653</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>AOAH</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>positive regulation of inositol-polyphosphate 5-phosphatase activity</TD><TD>biological process</TD><TD>GO:0010925</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PLEK</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>fibroblast growth factor receptor signaling pathway involved in hemopoiesis</TD><TD>biological process</TD><TD>GO:0035603</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>positive regulation of calcium ion-dependent exocytosis of neurotransmitter</TD><TD>biological process</TD><TD>GO:1903235</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SYT1</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>regulation of transcriptional start site selection at RNA polymerase II promoter</TD><TD>biological process</TD><TD>GO:0001178</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PWWP2A</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>regulation of strand invasion</TD><TD>biological process</TD><TD>GO:0060542</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>WRN</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>trans-synaptic signaling by neuropeptide, modulating synaptic transmission</TD><TD>biological process</TD><TD>GO:0099551</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>sensory neuron migration</TD><TD>biological process</TD><TD>GO:1904937</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>positive regulation of cellular glucuronidation</TD><TD>biological process</TD><TD>GO:2001031</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PRKCE</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>negative regulation of hepatocyte growth factor receptor signaling pathway</TD><TD>biological process</TD><TD>GO:1902203</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ADAMTS12</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>actin filament bundle retrograde transport</TD><TD>biological process</TD><TD>GO:0061573</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SHTN1</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>phospholipase C-inhibiting G protein-coupled receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0030845</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PLEK</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation</TD><TD>biological process</TD><TD>GO:2000802</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>regulation of cellular response to hepatocyte growth factor stimulus</TD><TD>biological process</TD><TD>GO:2001112</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ADAMTS12</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>synchronous neurotransmitter secretion</TD><TD>biological process</TD><TD>GO:0071911</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SYT1</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>protein secretion by platelet</TD><TD>biological process</TD><TD>GO:0070560</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PLEK</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell</TD><TD>biological process</TD><TD>GO:0035602</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>regulation of inositol-polyphosphate 5-phosphatase activity</TD><TD>biological process</TD><TD>GO:0010924</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PLEK</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>endoplasmic reticulum polarization</TD><TD>biological process</TD><TD>GO:0061163</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SHTN1</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>cell proliferation involved in endocardial cushion morphogenesis</TD><TD>biological process</TD><TD>GO:1905315</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>cell chemotaxis to fibroblast growth factor</TD><TD>biological process</TD><TD>GO:0035766</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>CXCL13</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>positive regulation of Rho guanyl-nucleotide exchange factor activity</TD><TD>biological process</TD><TD>GO:2001108</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>endothelial cell chemotaxis to fibroblast growth factor</TD><TD>biological process</TD><TD>GO:0035768</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>CXCL13</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>pancreatic A cell development</TD><TD>biological process</TD><TD>GO:0003322</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>cocaine metabolic process</TD><TD>biological process</TD><TD>GO:0050783</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>BCHE</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>inferior endocardial cushion morphogenesis</TD><TD>biological process</TD><TD>GO:1905317</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>Lewis x epitope biosynthetic process</TD><TD>biological process</TD><TD>GO:0106402</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FUT9</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>negative regulation of cellular response to hepatocyte growth factor stimulus</TD><TD>biological process</TD><TD>GO:2001113</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ADAMTS12</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>fast, calcium ion-dependent exocytosis of neurotransmitter</TD><TD>biological process</TD><TD>GO:0098746</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SYT1</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>actin filament bundle distribution</TD><TD>biological process</TD><TD>GO:0070650</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SHTN1</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>positive regulation of protein localization to cell-cell junction</TD><TD>biological process</TD><TD>GO:0150107</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PECAM1</TD></TR>
<TR><TD>1.160e-02</TD><TD>-4.46</TD><TD>Laminin_G</TD><TD>interpro domains</TD><TD>IPR001791</TD><TD>41</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>CNTNAP2,SLIT2,FAT4</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>stomach-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>stomach-carcinoma</TD><TD>440</TD><TD>11</TD><TD>16984</TD><TD>192</TD>
<TD>FGFR2,CASK,EPHA4,ACVR2A,TGFBR2,UHMK1,EPHA3,PRKCE,ACVR1C,PSKH2,NTRK2</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>PIANP (PILR alpha associated neural protein)</TD><TD>protein interactions</TD><TD>196500</TD><TD>15</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>GHITM,PTPRD</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>FGF9 (fibroblast growth factor 9)</TD><TD>protein interactions</TD><TD>2254</TD><TD>15</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>FGF20,FGFR2</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>INHBB (inhibin subunit beta B)</TD><TD>protein interactions</TD><TD>3625</TD><TD>15</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>ACVR1C,ACVR2A</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>EFCAB11 (EF-hand calcium binding domain 11)</TD><TD>protein interactions</TD><TD>90141</TD><TD>15</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>CETN3,CASK</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>CCDC127 (coiled-coil domain containing 127)</TD><TD>protein interactions</TD><TD>133957</TD><TD>15</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>CETN3,GHITM</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>ACOT12 (acyl-CoA thioesterase 12)</TD><TD>protein interactions</TD><TD>134526</TD><TD>15</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>SPAG9,PAX6</TD></TR>
<TR><TD>1.174e-02</TD><TD>-4.44</TD><TD>regulation of axon extension</TD><TD>biological process</TD><TD>GO:0030516</TD><TD>76</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>DSCAM,NRCAM,SHTN1,MAP2</TD></TR>
<TR><TD>1.174e-02</TD><TD>-4.44</TD><TD>transmembrane-ephrin receptor activity</TD><TD>molecular function</TD><TD>GO:0005005</TD><TD>15</TD><TD>2</TD><TD>18530</TD><TD>206</TD>
<TD>EPHA4,EPHA3</TD></TR>
<TR><TD>1.176e-02</TD><TD>-4.44</TD><TD>axolemma</TD><TD>cellular component</TD><TD>GO:0030673</TD><TD>15</TD><TD>2</TD><TD>19868</TD><TD>221</TD>
<TD>CNTNAP2,ROBO2</TD></TR>
<TR><TD>1.183e-02</TD><TD>-4.44</TD><TD>cortical actin cytoskeleton organization</TD><TD>biological process</TD><TD>GO:0030866</TD><TD>41</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>IQGAP2,FMNL2,PLEK</TD></TR>
<TR><TD>1.188e-02</TD><TD>-4.43</TD><TD>Cell-Cell communication</TD><TD>REACTOME pathways</TD><TD>R-HSA-1500931</TD><TD>134</TD><TD>5</TD><TD>10391</TD><TD>106</TD>
<TD>DSCAM,SLC7A14-AS1,CASK,CDH5,SKAP2</TD></TR>
<TR><TD>1.192e-02</TD><TD>-4.43</TD><TD>AVPR2 (arginine vasopressin receptor 2)</TD><TD>protein interactions</TD><TD>554</TD><TD>123</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>IPO8,PAQR3,SLC39A10,XPO4,SLC25A46</TD></TR>
<TR><TD>1.192e-02</TD><TD>-4.43</TD><TD>PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-6811558</TD><TD>87</TD><TD>4</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,NRG1,FGF5,FGFR2</TD></TR>
<TR><TD>1.192e-02</TD><TD>-4.43</TD><TD>negative regulation of supramolecular fiber organization</TD><TD>biological process</TD><TD>GO:1902904</TD><TD>163</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>EPS8,TMEFF2,SLIT2,CDH5,MAP2,NAV3</TD></TR>
<TR><TD>1.193e-02</TD><TD>-4.43</TD><TD>Signaling by EGFR</TD><TD>REACTOME pathways</TD><TD>R-HSA-177929</TD><TD>364</TD><TD>9</TD><TD>10391</TD><TD>106</TD>
<TD>PRKCE,FGF20,NRG1,PTPRK,FGF5,FGFR2,PHLPP1,PAQR3,AKAP9</TD></TR>
<TR><TD>1.205e-02</TD><TD>-4.42</TD><TD>adrenal_cortical_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>adrenal_cortical_carcinoma</TD><TD>2256</TD><TD>37</TD><TD>16984</TD><TD>192</TD>
<TD>NRCAM,SEMA3C,UCHL1,UBR4,LHCGR,SERGEF,RAI2,PTPRZ1,TGFBR2,UNC5C,PTPRD,BCHE,EFEMP1,MEGF10,IL1RAPL2,RUNX1T1,FBN2,WRN,CNTN1,HNF4G,NTRK2,SS18,RASGEF1B,RBM20,UTRN,MPEG1,EPHA4,RYR2,BANK1,FIGN,ADAMTS5,IPO8,NBEA,NCKAP5,KCNK9,PCDH9,CHRM3</TD></TR>
<TR><TD>1.210e-02</TD><TD>-4.41</TD><TD>lung-carcinoid-endocrine_tumour</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoid-endocrine_tumour</TD><TD>503</TD><TD>12</TD><TD>16984</TD><TD>192</TD>
<TD>FGFR2,EPHA4,CASK,EPHA3,PRKCE,ACVR2A,TGFBR2,SPHKAP,UHMK1,PSKH2,NTRK2,ACVR1C</TD></TR>
<TR><TD>1.218e-02</TD><TD>-4.41</TD><TD>ppGaNTase-T1 linker domain-like</TD><TD>gene3d domains</TD><TD>1.10.8.460</TD><TD>1</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>GALNT15</TD></TR>
<TR><TD>1.219e-02</TD><TD>-4.41</TD><TD>ephrin a2 ectodomain</TD><TD>gene3d domains</TD><TD>2.60.40.1770</TD><TD>14</TD><TD>2</TD><TD>14531</TD><TD>177</TD>
<TD>EPHA4,EPHA3</TD></TR>
<TR><TD>1.220e-02</TD><TD>-4.41</TD><TD>genital_tract</TD><TD>COSMIC cancer mutations</TD><TD>genital_tract</TD><TD>168</TD><TD>6</TD><TD>16984</TD><TD>192</TD>
<TD>FAT4,CNTN1,JMJD1C,LRFN5,IPO8,ERCC6L2</TD></TR>
<TR><TD>1.239e-02</TD><TD>-4.39</TD><TD>PTP_cat</TD><TD>interpro domains</TD><TD>IPR000242</TD><TD>42</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>PTPRD,PTPRK,PTPRZ1</TD></TR>
<TR><TD>1.246e-02</TD><TD>-4.39</TD><TD>Y_phosphatase</TD><TD>pfam domains</TD><TD>PF00102</TD><TD>42</TD><TD>3</TD><TD>17869</TD><TD>206</TD>
<TD>PTPRD,PTPRK,PTPRZ1</TD></TR>
<TR><TD>1.253e-02</TD><TD>-4.38</TD><TD>FH2_Formin</TD><TD>interpro domains</TD><TD>IPR015425</TD><TD>15</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>DAAM1,FMNL2</TD></TR>
<TR><TD>1.253e-02</TD><TD>-4.38</TD><TD>FH2_Formin_sf</TD><TD>interpro domains</TD><TD>IPR042201</TD><TD>15</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>DAAM1,FMNL2</TD></TR>
<TR><TD>1.253e-02</TD><TD>-4.38</TD><TD>TYR_PHOSPHATASE_PTP</TD><TD>prosite domains</TD><TD>PS50055</TD><TD>37</TD><TD>3</TD><TD>12232</TD><TD>161</TD>
<TD>PTPRZ1,PTPRD,PTPRK</TD></TR>
<TR><TD>1.258e-02</TD><TD>-4.38</TD><TD>FH2</TD><TD>pfam domains</TD><TD>PF02181</TD><TD>15</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>1.260e-02</TD><TD>-4.37</TD><TD>homophilic cell adhesion via plasma membrane adhesion molecules</TD><TD>biological process</TD><TD>GO:0007156</TD><TD>165</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>CDH5,ROBO2,DSCAM,PECAM1,PCDH9,FAT4</TD></TR>
<TR><TD>1.261e-02</TD><TD>-4.37</TD><TD>SAM/pointed_sf</TD><TD>interpro domains</TD><TD>IPR013761</TD><TD>120</TD><TD>5</TD><TD>18605</TD><TD>214</TD>
<TD>EPHA4,GAREM1,KAZN,EPHA3,EPS8</TD></TR>
<TR><TD>1.268e-02</TD><TD>-4.37</TD><TD>LSR (lipolysis stimulated lipoprotein receptor)</TD><TD>protein interactions</TD><TD>51599</TD><TD>173</TD><TD>6</TD><TD>20077</TD><TD>222</TD>
<TD>TGFBR2,EPHA4,ARL14,MARCHF3,NRG1,NTRK2</TD></TR>
<TR><TD>1.270e-02</TD><TD>-4.37</TD><TD>peripheral nervous system neuron development</TD><TD>biological process</TD><TD>GO:0048935</TD><TD>15</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2,SLC25A46</TD></TR>
<TR><TD>1.270e-02</TD><TD>-4.37</TD><TD>peripheral nervous system neuron differentiation</TD><TD>biological process</TD><TD>GO:0048934</TD><TD>15</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>SLC25A46,NTRK2</TD></TR>
<TR><TD>1.270e-02</TD><TD>-4.37</TD><TD>regulation of inositol phosphate biosynthetic process</TD><TD>biological process</TD><TD>GO:0010919</TD><TD>15</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PLEK,LHCGR</TD></TR>
<TR><TD>1.281e-02</TD><TD>-4.36</TD><TD>large_intestine-rectum</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-rectum</TD><TD>569</TD><TD>13</TD><TD>16984</TD><TD>192</TD>
<TD>AKAP9,CNTN1,GAP43,IQGAP2,FAT4,EPS8,ZNF133,PTPRD,RYR2,ASPN,RUNX1T1,FGFR2,TRPS1</TD></TR>
<TR><TD>1.282e-02</TD><TD>-4.36</TD><TD>neural crest cell development</TD><TD>biological process</TD><TD>GO:0014032</TD><TD>78</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>NRG1,SEMA3C,TWIST1,PAX6</TD></TR>
<TR><TD>1.295e-02</TD><TD>-4.35</TD><TD>human chr8p22</TD><TD>chromosome location</TD><TD>human chr8p22</TD><TD>82</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>NAT2,FGF20</TD></TR>
<TR><TD>1.296e-02</TD><TD>-4.35</TD><TD>protein tyrosine kinase binding</TD><TD>molecular function</TD><TD>GO:1990782</TD><TD>125</TD><TD>5</TD><TD>18530</TD><TD>206</TD>
<TD>DSCAM,EPHA4,CDH5,NRG1,BANK1</TD></TR>
<TR><TD>1.298e-02</TD><TD>-4.34</TD><TD>Role of LAT2/NTAL/LAB on calcium mobilization</TD><TD>REACTOME pathways</TD><TD>R-HSA-2730905</TD><TD>137</TD><TD>5</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,NRG1,PHLPP1,FGF5,FGFR2</TD></TR>
<TR><TD>1.300e-02</TD><TD>-4.34</TD><TD>HYAL2 (hyaluronidase 2)</TD><TD>protein interactions</TD><TD>8692</TD><TD>82</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>ADAMTS12,PTPRK,WWOX,LGI1</TD></TR>
<TR><TD>1.314e-02</TD><TD>-4.33</TD><TD>cell surface</TD><TD>cellular component</TD><TD>GO:0009986</TD><TD>909</TD><TD>18</TD><TD>19868</TD><TD>221</TD>
<TD>CD226,IQGAP2,EFNA5,EPHA4,TGFBR2,PECAM1,FZD6,ZPLD1,ROBO2,CNTNAP2,FGFR2,ACVR2A,CDH5,NRCAM,UNC5C,AMELX,LRFN5,PTPRK</TD></TR>
<TR><TD>1.316e-02</TD><TD>-4.33</TD><TD>RRM_NUP35</TD><TD>prosite domains</TD><TD>PS51472</TD><TD>1</TD><TD>1</TD><TD>12232</TD><TD>161</TD>
<TD>NUP35</TD></TR>
<TR><TD>1.316e-02</TD><TD>-4.33</TD><TD>NEUROMODULIN_1</TD><TD>prosite domains</TD><TD>PS00412</TD><TD>1</TD><TD>1</TD><TD>12232</TD><TD>161</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.316e-02</TD><TD>-4.33</TD><TD>NEUROMODULIN_2</TD><TD>prosite domains</TD><TD>PS00413</TD><TD>1</TD><TD>1</TD><TD>12232</TD><TD>161</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.318e-02</TD><TD>-4.33</TD><TD>breast-carcinoma-lobular_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>breast-carcinoma-lobular_carcinoma</TD><TD>764</TD><TD>16</TD><TD>16984</TD><TD>192</TD>
<TD>NTRK2,PSKH2,ACVR1C,ADAMTS12,EPHA3,LHCGR,PRKCE,IRX1,UHMK1,PTPRD,ACVR2A,TGFBR2,CDH5,EPHA4,CASK,FGFR2</TD></TR>
<TR><TD>1.318e-02</TD><TD>-4.33</TD><TD>lobular_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lobular_carcinoma</TD><TD>764</TD><TD>16</TD><TD>16984</TD><TD>192</TD>
<TD>FGFR2,CASK,CDH5,EPHA4,UHMK1,PTPRD,ACVR2A,TGFBR2,LHCGR,EPHA3,PRKCE,IRX1,ACVR1C,ADAMTS12,NTRK2,PSKH2</TD></TR>
<TR><TD>1.319e-02</TD><TD>-4.33</TD><TD>RBM18 (RNA binding motif protein 18)</TD><TD>protein interactions</TD><TD>92400</TD><TD>16</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>SYT1,EPHA3</TD></TR>
<TR><TD>1.319e-02</TD><TD>-4.33</TD><TD>TWIST2 (twist family bHLH transcription factor 2)</TD><TD>protein interactions</TD><TD>117581</TD><TD>16</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>FERD3L,TWIST1</TD></TR>
<TR><TD>1.320e-02</TD><TD>-4.33</TD><TD>PRTYPHPHTASE</TD><TD>prints domains</TD><TD>PR00700</TD><TD>37</TD><TD>3</TD><TD>5258</TD><TD>71</TD>
<TD>PTPRZ1,PTPRD,PTPRK</TD></TR>
<TR><TD>1.327e-02</TD><TD>-4.32</TD><TD>Transcription Factor, Ets-1</TD><TD>gene3d domains</TD><TD>1.10.150.50</TD><TD>115</TD><TD>5</TD><TD>14531</TD><TD>177</TD>
<TD>EPHA3,GAREM1,KAZN,EPHA4,EPS8</TD></TR>
<TR><TD>1.334e-02</TD><TD>-4.32</TD><TD>MACPF</TD><TD>smart domains</TD><TD>SM00457</TD><TD>12</TD><TD>2</TD><TD>9743</TD><TD>146</TD>
<TD>MPEG1,BRINP3</TD></TR>
<TR><TD>1.336e-02</TD><TD>-4.32</TD><TD>positive regulation of phosphorylation</TD><TD>biological process</TD><TD>GO:0042327</TD><TD>619</TD><TD>14</TD><TD>18905</TD><TD>219</TD>
<TD>PECAM1,ACVR2A,AKAP9,EFNA5,EPHA4,TGFBR2,FGFR2,NTRK2,FGF5,NRG1,DSCAM,FGF20,BANK1,FNIP2</TD></TR>
<TR><TD>1.337e-02</TD><TD>-4.31</TD><TD>postsynaptic membrane</TD><TD>cellular component</TD><TD>GO:0045211</TD><TD>280</TD><TD>8</TD><TD>19868</TD><TD>221</TD>
<TD>CHRM3,LRFN5,CNTN1,RPH3A,UTRN,AKAP9,NRCAM,EPHA4</TD></TR>
<TR><TD>1.337e-02</TD><TD>-4.31</TD><TD>PI3K/AKT Signaling in Cancer</TD><TD>REACTOME pathways</TD><TD>R-HSA-2219528</TD><TD>90</TD><TD>4</TD><TD>10391</TD><TD>106</TD>
<TD>FGFR2,FGF5,FGF20,NRG1</TD></TR>
<TR><TD>1.338e-02</TD><TD>-4.31</TD><TD>DAP12 interactions</TD><TD>REACTOME pathways</TD><TD>R-HSA-2172127</TD><TD>371</TD><TD>9</TD><TD>10391</TD><TD>106</TD>
<TD>VAV3,PRKCE,FGFR2,FGF5,PHLPP1,PAQR3,AKAP9,FGF20,NRG1</TD></TR>
<TR><TD>1.339e-02</TD><TD>-4.31</TD><TD>protein kinase binding</TD><TD>molecular function</TD><TD>GO:0019901</TD><TD>711</TD><TD>15</TD><TD>18530</TD><TD>206</TD>
<TD>PLEK,SPAG9,NBEA,BANK1,ERCC6L2,PAX6,DSCAM,CD226,UNC5C,PTPRK,RYR2,NRG1,CDH5,EPHA4,UTRN</TD></TR>
<TR><TD>1.341e-02</TD><TD>-4.31</TD><TD>bone-vertebrae-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>COSMIC cancer mutations</TD><TD>bone-vertebrae-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>44</TD><TD>3</TD><TD>16984</TD><TD>192</TD>
<TD>THSD7B,FBN2,ADAMTS5</TD></TR>
<TR><TD>1.350e-02</TD><TD>-4.30</TD><TD>NTKRECEPTOR2</TD><TD>prints domains</TD><TD>PR01941</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>NTRK2</TD></TR>
<TR><TD>1.350e-02</TD><TD>-4.30</TD><TD>LSHRECEPTOR</TD><TD>prints domains</TD><TD>PR01144</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>LHCGR</TD></TR>
<TR><TD>1.350e-02</TD><TD>-4.30</TD><TD>MTG8PROTEIN</TD><TD>prints domains</TD><TD>PR01876</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>1.350e-02</TD><TD>-4.30</TD><TD>TASK3CHANNEL</TD><TD>prints domains</TD><TD>PR01585</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>KCNK9</TD></TR>
<TR><TD>1.350e-02</TD><TD>-4.30</TD><TD>ADAMTS5</TD><TD>prints domains</TD><TD>PR01860</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>ADAMTS5</TD></TR>
<TR><TD>1.350e-02</TD><TD>-4.30</TD><TD>NEUROMODULIN</TD><TD>prints domains</TD><TD>PR00215</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.350e-02</TD><TD>-4.30</TD><TD>PRPRECEPTOR</TD><TD>prints domains</TD><TD>PR01018</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>PRLHR</TD></TR>
<TR><TD>1.350e-02</TD><TD>-4.30</TD><TD>NEUREGULIN</TD><TD>prints domains</TD><TD>PR01089</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>NRG1</TD></TR>
<TR><TD>1.350e-02</TD><TD>-4.30</TD><TD>MUSCRINICM3R</TD><TD>prints domains</TD><TD>PR00540</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>CHRM3</TD></TR>
<TR><TD>1.354e-02</TD><TD>-4.30</TD><TD>PAX9 (paired box 9)</TD><TD>protein interactions</TD><TD>5083</TD><TD>127</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>TCF20,TRPS1,PCGF5,FIGN,WWOX</TD></TR>
<TR><TD>1.354e-02</TD><TD>-4.30</TD><TD>LYN (LYN proto-oncogene, Src family tyrosine kinase)</TD><TD>protein interactions</TD><TD>4067</TD><TD>715</TD><TD>15</TD><TD>20077</TD><TD>222</TD>
<TD>SLC39A10,FMNL2,EPHA4,ROBO2,UTRN,EFR3B,TEC,EPHA3,EFR3A,IQGAP2,PECAM1,CASK,SKAP2,BANK1,FGFR2</TD></TR>
<TR><TD>1.369e-02</TD><TD>-4.29</TD><TD>central_nervous_system-brain-glioma-astrocytoma_Grade_IV</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brain-glioma-astrocytoma_Grade_IV</TD><TD>15893</TD><TD>187</TD><TD>16984</TD><TD>192</TD>
<TD>ZNF521,PTPRK,FMNL2,KLF12,CYTL1,EFR3A,NUP35,ATG10,ADAM28,TGFBR2,PTPRD,SEMA3C,NRCAM,DAAM1,TSN,CALN1,AOAH,THSD7A,ZPLD1,ROBO2,RPH3A,RYR2,REXO2,PHF14,SGCG,ADAMTS5,EPHA3,HNF4G,NTRK2,CD96,ADAMTS12,MEGF10,CXCL13,ACP6,ZFAND5,PCGF5,SEZ6L,LRFN5,TCF20,SPHKAP,KIF6,PAQR3,ACVR1C,LRRN2,NOBOX,XPO4,SKAP2,DCDC2C,DSCAM,DNER,EPHA4,COQ2,TMEFF2,SGCD,CASK,IRX1,ZNF133,PRKCE,PI15,CPXM2,CNTNAP2,DEPTOR,FBN2,RGS6,MUC7,SPAG9,PWWP2A,UCHL1,LRIG3,REG1B,FUT9,NRSN1,IPO8,FGD3,PAX6,IQGAP2,STXBP6,IL1RAPL2,CETN3,WRN,MRPL3,BCHE,ADAMTS3,DNAJC12,RAI2,PBX1,UBR4,ASPN,LRRC3B,FIGN,PHLPP1,JMJD1C,LRRC70,OR52K2,COX7B2,LMBRD1,THSD7B,FGF14,NAV3,FZD6,EPS8,LHCGR,NRG1,PRSS12,CRTC3,MRPL13,SLC7A8,SHISA3,PCDH9,INSM1,CDH5,ARX,RBM20,UHMK1,ARL14,BACH2,FGF5,IGFL4,CTSO,EDIL3,SLC7A14,FNIP2,SLC25A46,FABP7,PXDNL,AGA,DAOA,KCNK9,CHRM3,MPEG1,GMDS,ZNF518B,BANK1,SYT1,FANCB,NBEA,FAT4,TRPS1,EFEMP1,WWOX,GPR83,B3GAT2,SERGEF,GHITM,PTPRZ1,UNC5C,OR2AG1,CD226,SLC39A10,VAV3,PLEK,NAT2,SPATA16,AFM,ZFPM2,ACVR2A,UTRN,DEFB115,GAP43,RASGEF1B,CELF2,RUNX1T1,FGFR2,GCNT1,AMELX,FERD3L,EFNA5,PRLHR,EPYC,SLC10A2,LGI1,PSKH2,LMX1A,KAZN,NOL4,NCKAP5,SLIT2,FGF20,SERINC5,MAP2,AKAP9,CNTN1,NAALADL2,PARP8,SS18,TWIST1,NOVA1</TD></TR>
<TR><TD>1.382e-02</TD><TD>-4.28</TD><TD>primitive_neuroectodermal_tumour-medulloblastoma</TD><TD>COSMIC cancer mutations</TD><TD>primitive_neuroectodermal_tumour-medulloblastoma</TD><TD>15417</TD><TD>183</TD><TD>16984</TD><TD>192</TD>
<TD>EPS8,LHCGR,NRG1,PRSS12,MRPL13,CRTC3,SLC7A8,LMBRD1,THSD7B,FGF14,NAV3,FZD6,ARX,RBM20,ARL14,UHMK1,SHISA3,PCDH9,INSM1,CDH5,SLC7A14,EDIL3,FNIP2,FABP7,SLC25A46,PXDNL,AGA,BACH2,FGF5,IGFL4,CTSO,FAT4,DAOA,KCNK9,CHRM3,GMDS,MPEG1,SYT1,FANCB,BANK1,ZNF518B,NBEA,GPR83,B3GAT2,SERGEF,PTPRZ1,GHITM,UNC5C,CD226,TRPS1,EFEMP1,WWOX,ZFPM2,ACVR2A,UTRN,DEFB115,GAP43,RASGEF1B,CELF2,VAV3,SLC39A10,PLEK,NAT2,AFM,SPATA16,PRLHR,EFNA5,EPYC,LGI1,SLC10A2,PSKH2,LMX1A,KAZN,RUNX1T1,FGFR2,GCNT1,AMELX,FERD3L,MAP2,NAALADL2,CNTN1,AKAP9,PARP8,NOVA1,TWIST1,SS18,SPANXN1,NOL4,NCKAP5,SLIT2,FGF20,ADAM28,TGFBR2,PTPRD,NRCAM,SEMA3C,DAAM1,TSN,CALN1,PTPRK,ZNF521,FMNL2,KLF12,CYTL1,EFR3A,ATG10,EPHA3,HNF4G,CD96,NTRK2,ADAMTS12,AOAH,ZPLD1,THSD7A,ROBO2,RYR2,RPH3A,REXO2,ADAMTS5,SGCG,PHF14,SPHKAP,KIF6,PAQR3,LRRN2,ACVR1C,NOBOX,CXCL13,MEGF10,ACP6,ZFAND5,PCGF5,SEZ6L,LRFN5,TCF20,IRX1,PRKCE,ZNF133,PI15,CPXM2,CNTNAP2,SKAP2,DCDC2C,XPO4,DSCAM,EPHA4,DNER,COQ2,SGCD,TMEFF2,CASK,PWWP2A,UCHL1,DEPTOR,FBN2,RGS6,MUC7,SPAG9,FGD3,PAX6,STXBP6,IQGAP2,LRIG3,REG1B,FUT9,NRSN1,IPO8,DNAJC12,PBX1,RAI2,UBR4,IL1RAPL2,WRN,CETN3,MRPL3,ADAMTS3,BCHE,PHLPP1,JMJD1C,ASPN,EFR3B,LRRC3B,FIGN</TD></TR>
<TR><TD>1.386e-02</TD><TD>-4.28</TD><TD>human chr11q21</TD><TD>chromosome location</TD><TD>human chr11q21</TD><TD>85</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>GPR83,MIR1260B</TD></TR>
<TR><TD>1.396e-02</TD><TD>-4.27</TD><TD>Formin, FH2 domain</TD><TD>gene3d domains</TD><TD>1.20.58.2220</TD><TD>15</TD><TD>2</TD><TD>14531</TD><TD>177</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>1.396e-02</TD><TD>-4.27</TD><TD>EPB41L4A (erythrocyte membrane protein band 4.1 like 4A)</TD><TD>protein interactions</TD><TD>64097</TD><TD>128</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>EFR3A,EFR3B,UTRN,CASK,SLC39A10</TD></TR>
<TR><TD>1.408e-02</TD><TD>-4.26</TD><TD>tube morphogenesis</TD><TD>biological process</TD><TD>GO:0035239</TD><TD>686</TD><TD>15</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2,SGCD,NRCAM,THSD7A,TWIST1,ZFPM2,EPHA4,TGFBR2,FGFR2,NTRK2,IRX1,SLIT2,FZD6,PBX1,VAV3</TD></TR>
<TR><TD>1.410e-02</TD><TD>-4.26</TD><TD>TMEM185A (transmembrane protein 185A)</TD><TD>protein interactions</TD><TD>84548</TD><TD>84</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>GAP43,DAAM1,EFR3A,EFR3B</TD></TR>
<TR><TD>1.410e-02</TD><TD>-4.26</TD><TD>P3H3 (prolyl 3-hydroxylase 3)</TD><TD>protein interactions</TD><TD>10536</TD><TD>84</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRK,ADAMTS12,PI15,LGI1</TD></TR>
<TR><TD>1.412e-02</TD><TD>-4.26</TD><TD>EPH_LBD</TD><TD>prosite domains</TD><TD>PS51550</TD><TD>14</TD><TD>2</TD><TD>12232</TD><TD>161</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.412e-02</TD><TD>-4.26</TD><TD>RECEPTOR_TYR_KIN_V_1</TD><TD>prosite domains</TD><TD>PS00790</TD><TD>14</TD><TD>2</TD><TD>12232</TD><TD>161</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.412e-02</TD><TD>-4.26</TD><TD>RECEPTOR_TYR_KIN_V_2</TD><TD>prosite domains</TD><TD>PS00791</TD><TD>14</TD><TD>2</TD><TD>12232</TD><TD>161</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.413e-02</TD><TD>-4.26</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-essential_thrombocythaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-essential_thrombocythaemia</TD><TD>393</TD><TD>10</TD><TD>16984</TD><TD>192</TD>
<TD>THSD7B,COQ2,UCHL1,PHF14,CASK,PXDNL,NCKAP5,LRIG3,FAT4,EPYC</TD></TR>
<TR><TD>1.413e-02</TD><TD>-4.26</TD><TD>essential_thrombocythaemia</TD><TD>COSMIC cancer mutations</TD><TD>essential_thrombocythaemia</TD><TD>393</TD><TD>10</TD><TD>16984</TD><TD>192</TD>
<TD>CASK,PHF14,EPYC,PXDNL,COQ2,LRIG3,THSD7B,NCKAP5,FAT4,UCHL1</TD></TR>
<TR><TD>1.418e-02</TD><TD>-4.26</TD><TD>PI-3K cascade:FGFR3</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654710</TD><TD>18</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>1.418e-02</TD><TD>-4.26</TD><TD>SHC-mediated cascade:FGFR3</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654704</TD><TD>18</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>1.422e-02</TD><TD>-4.25</TD><TD>CH_dom</TD><TD>interpro domains</TD><TD>IPR001715</TD><TD>81</TD><TD>4</TD><TD>18605</TD><TD>214</TD>
<TD>UTRN,NAV3,VAV3,IQGAP2</TD></TR>
<TR><TD>1.429e-02</TD><TD>-4.25</TD><TD>neuron projection terminus</TD><TD>cellular component</TD><TD>GO:0044306</TD><TD>128</TD><TD>5</TD><TD>19868</TD><TD>221</TD>
<TD>EPHA4,UCHL1,NTRK2,PRSS12,SYT1</TD></TR>
<TR><TD>1.433e-02</TD><TD>-4.25</TD><TD>exocrine system development</TD><TD>biological process</TD><TD>GO:0035272</TD><TD>44</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,FGFR2,SEMA3C</TD></TR>
<TR><TD>1.433e-02</TD><TD>-4.25</TD><TD>regulation of synaptic vesicle exocytosis</TD><TD>biological process</TD><TD>GO:2000300</TD><TD>44</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>CASK,SEPTIN5,SYT1</TD></TR>
<TR><TD>1.435e-02</TD><TD>-4.24</TD><TD>small GTPase binding</TD><TD>molecular function</TD><TD>GO:0031267</TD><TD>284</TD><TD>8</TD><TD>18530</TD><TD>206</TD>
<TD>FGD3,RPH3A,IQGAP2,EPS8,DAAM1,FMNL2,IPO8,XPO4</TD></TR>
<TR><TD>1.441e-02</TD><TD>-4.24</TD><TD>cellular response to prostaglandin E stimulus</TD><TD>biological process</TD><TD>GO:0071380</TD><TD>16</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PRKCE,PAX6</TD></TR>
<TR><TD>1.441e-02</TD><TD>-4.24</TD><TD>regulation of postsynaptic specialization assembly</TD><TD>biological process</TD><TD>GO:0099150</TD><TD>16</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>GAP43,PTPRD</TD></TR>
<TR><TD>1.441e-02</TD><TD>-4.24</TD><TD>cardiac left ventricle morphogenesis</TD><TD>biological process</TD><TD>GO:0003214</TD><TD>16</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2,TGFBR2</TD></TR>
<TR><TD>1.441e-02</TD><TD>-4.24</TD><TD>branching involved in salivary gland morphogenesis</TD><TD>biological process</TD><TD>GO:0060445</TD><TD>16</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>SEMA3C,FGFR2</TD></TR>
<TR><TD>1.442e-02</TD><TD>-4.24</TD><TD>ERBB4 (erb-b2 receptor tyrosine kinase 4)</TD><TD>protein interactions</TD><TD>2066</TD><TD>178</TD><TD>6</TD><TD>20077</TD><TD>222</TD>
<TD>NTRK2,NRG1,TEC,VAV3,LRIG3,WWOX</TD></TR>
<TR><TD>1.449e-02</TD><TD>-4.23</TD><TD>human chr10q21.3</TD><TD>chromosome location</TD><TD>human chr10q21.3</TD><TD>87</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>JMJD1C,DNAJC12</TD></TR>
<TR><TD>1.449e-02</TD><TD>-4.23</TD><TD>human chr4q32.1</TD><TD>chromosome location</TD><TD>human chr4q32.1</TD><TD>87</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>CTSO,FNIP2</TD></TR>
<TR><TD>1.468e-02</TD><TD>-4.22</TD><TD>CFAP298 (cilia and flagella associated protein 298)</TD><TD>protein interactions</TD><TD>56683</TD><TD>85</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>TRPS1,PAX6,RPH3A,ZNF521</TD></TR>
<TR><TD>1.469e-02</TD><TD>-4.22</TD><TD>biliary_tract-gallbladder-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>biliary_tract-gallbladder-carcinoma-adenocarcinoma</TD><TD>2826</TD><TD>44</TD><TD>16984</TD><TD>192</TD>
<TD>AKAP9,CNTNAP2,NOVA1,FAT4,FANCB,NBEA,EFR3B,SLIT2,KCNK9,DSCAM,PRLHR,SPHKAP,ADAMTS3,MEGF10,FGFR2,GCNT1,WRN,CD96,ADAMTS12,ACVR2A,INSM1,ROBO2,SPATA16,AFM,IPO8,SLC39A10,LRIG3,AOAH,THSD7A,PCDH9,ZPLD1,NRCAM,CD226,GPR83,NRG1,PTPRZ1,TGFBR2,UNC5C,FGF14,NUP35,ZNF521,FBN2,COX7B2,TRPS1</TD></TR>
<TR><TD>1.469e-02</TD><TD>-4.22</TD><TD>gallbladder</TD><TD>COSMIC cancer mutations</TD><TD>gallbladder</TD><TD>2826</TD><TD>44</TD><TD>16984</TD><TD>192</TD>
<TD>COX7B2,FBN2,ZNF521,TRPS1,FGF14,NUP35,GPR83,UNC5C,TGFBR2,PTPRZ1,NRG1,NRCAM,CD226,AOAH,LRIG3,SLC39A10,ZPLD1,PCDH9,THSD7A,ROBO2,INSM1,AFM,IPO8,SPATA16,ACVR2A,CD96,ADAMTS12,FGFR2,MEGF10,WRN,GCNT1,ADAMTS3,PRLHR,SPHKAP,EFR3B,DSCAM,KCNK9,SLIT2,NBEA,FANCB,FAT4,CNTNAP2,AKAP9,NOVA1</TD></TR>
<TR><TD>1.481e-02</TD><TD>-4.21</TD><TD>parotid</TD><TD>COSMIC cancer mutations</TD><TD>parotid</TD><TD>580</TD><TD>13</TD><TD>16984</TD><TD>192</TD>
<TD>TGFBR2,ACVR2A,UHMK1,IQGAP2,NRCAM,AKAP9,CRTC3,PARP8,NTRK2,THSD7A,FGFR2,CASK,SEZ6L</TD></TR>
<TR><TD>1.482e-02</TD><TD>-4.21</TD><TD>CH_dom_sf</TD><TD>interpro domains</TD><TD>IPR036872</TD><TD>82</TD><TD>4</TD><TD>18605</TD><TD>214</TD>
<TD>UTRN,IQGAP2,VAV3,NAV3</TD></TR>
<TR><TD>1.484e-02</TD><TD>-4.21</TD><TD>Tnks (tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase)</TD><TD>protein interactions</TD><TD>21951</TD><TD>17</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>GMDS,SLC39A10</TD></TR>
<TR><TD>1.484e-02</TD><TD>-4.21</TD><TD>GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C)</TD><TD>protein interactions</TD><TD>2905</TD><TD>17</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>BCHE,PTPRK</TD></TR>
<TR><TD>1.496e-02</TD><TD>-4.20</TD><TD>Fc epsilon receptor (FCERI) signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-2454202</TD><TD>378</TD><TD>9</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,NRG1,FGF5,FGFR2,PHLPP1,AKAP9,PAQR3,VAV3,TEC</TD></TR>
<TR><TD>1.499e-02</TD><TD>-4.20</TD><TD>ELK</TD><TD>smart domains</TD><TD>SM01188</TD><TD>1</TD><TD>1</TD><TD>9743</TD><TD>146</TD>
<TD>AKAP9</TD></TR>
<TR><TD>1.499e-02</TD><TD>-4.20</TD><TD>ephrin receptor activity</TD><TD>molecular function</TD><TD>GO:0005003</TD><TD>17</TD><TD>2</TD><TD>18530</TD><TD>206</TD>
<TD>EPHA4,EPHA3</TD></TR>
<TR><TD>1.505e-02</TD><TD>-4.20</TD><TD>ovary-carcinoma-mucinous_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>ovary-carcinoma-mucinous_carcinoma</TD><TD>457</TD><TD>11</TD><TD>16984</TD><TD>192</TD>
<TD>FGFR2,EPHA4,CASK,PRKCE,EPHA3,TGFBR2,ACVR2A,UHMK1,PSKH2,NTRK2,ACVR1C</TD></TR>
<TR><TD>1.508e-02</TD><TD>-4.19</TD><TD>ear development</TD><TD>biological process</TD><TD>GO:0043583</TD><TD>222</TD><TD>7</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,CYTL1,LRIG3,TWIST1,FGF20,EPHA4,FZD6</TD></TR>
<TR><TD>1.509e-02</TD><TD>-4.19</TD><TD>regulation of actin filament-based process</TD><TD>biological process</TD><TD>GO:0032970</TD><TD>387</TD><TD>10</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA3,RYR2,PLEK,PRKCE,SLIT2,AKAP9,EPS8,TMEFF2,EFNA5,IQGAP2</TD></TR>
<TR><TD>1.512e-02</TD><TD>-4.19</TD><TD>human chr6q13</TD><TD>chromosome location</TD><TD>human chr6q13</TD><TD>89</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>B3GAT2,LMBRD1</TD></TR>
<TR><TD>1.513e-02</TD><TD>-4.19</TD><TD>LRIG3 (leucine rich repeats and immunoglobulin like domains 3)</TD><TD>protein interactions</TD><TD>121227</TD><TD>47</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>NRSN1,PTPRK,LRRN2</TD></TR>
<TR><TD>1.514e-02</TD><TD>-4.19</TD><TD>skin-foot-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-foot-malignant_melanoma</TD><TD>84</TD><TD>4</TD><TD>16984</TD><TD>192</TD>
<TD>PTPRD,CHRM3,ADAM28,ADAMTS3</TD></TR>
<TR><TD>1.517e-02</TD><TD>-4.19</TD><TD>muscle organ morphogenesis</TD><TD>biological process</TD><TD>GO:0048644</TD><TD>82</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,ZFPM2,NRG1,RYR2</TD></TR>
<TR><TD>1.522e-02</TD><TD>-4.19</TD><TD>embryonic cranial skeleton morphogenesis</TD><TD>biological process</TD><TD>GO:0048701</TD><TD>45</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,TWIST1,FGFR2</TD></TR>
<TR><TD>1.526e-02</TD><TD>-4.18</TD><TD>FAM171A1 (family with sequence similarity 171 member A1)</TD><TD>protein interactions</TD><TD>221061</TD><TD>86</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>EPHA4,NRSN1,EPHA3,NTRK2</TD></TR>
<TR><TD>1.534e-02</TD><TD>-4.18</TD><TD>carboxypeptidase activity</TD><TD>molecular function</TD><TD>GO:0004180</TD><TD>47</TD><TD>3</TD><TD>18530</TD><TD>206</TD>
<TD>CPQ,CPXM2,MATCAP2</TD></TR>
<TR><TD>1.539e-02</TD><TD>-4.17</TD><TD>kinase binding</TD><TD>molecular function</TD><TD>GO:0019900</TD><TD>790</TD><TD>16</TD><TD>18530</TD><TD>206</TD>
<TD>UNC5C,CD226,PTPRK,NRG1,RYR2,CDH5,EPHA4,UTRN,SPAG9,PLEK,NBEA,BANK1,PARP8,ERCC6L2,DSCAM,PAX6</TD></TR>
<TR><TD>1.543e-02</TD><TD>-4.17</TD><TD>HDAC1 (histone deacetylase 1)</TD><TD>protein interactions</TD><TD>3065</TD><TD>1070</TD><TD>20</TD><TD>20077</TD><TD>222</TD>
<TD>INSM1,UTRN,RBM20,ZNF521,WRN,TCF20,PBX1,PHF14,PWWP2A,ZFPM2,TRPS1,SS18,SPAG9,WWOX,JMJD1C,RUNX1T1,PHLPP1,AKAP9,SHTN1,UBR4</TD></TR>
<TR><TD>1.543e-02</TD><TD>-4.17</TD><TD>MetalloPept_cat_dom_sf</TD><TD>interpro domains</TD><TD>IPR024079</TD><TD>83</TD><TD>4</TD><TD>18605</TD><TD>214</TD>
<TD>ADAMTS3,ADAMTS5,ADAMTS12,ADAM28</TD></TR>
<TR><TD>1.549e-02</TD><TD>-4.17</TD><TD>mucinous_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>mucinous_carcinoma</TD><TD>459</TD><TD>11</TD><TD>16984</TD><TD>192</TD>
<TD>ACVR2A,TGFBR2,UHMK1,PRKCE,EPHA3,FGFR2,ACVR1C,CASK,EPHA4,PSKH2,NTRK2</TD></TR>
<TR><TD>1.551e-02</TD><TD>-4.17</TD><TD>large_intestine-caecum-adenoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-caecum-adenoma</TD><TD>229</TD><TD>7</TD><TD>16984</TD><TD>192</TD>
<TD>UNC5C,UBR4,SLIT2,RPH3A,LHCGR,FGD3,EDIL3</TD></TR>
<TR><TD>1.558e-02</TD><TD>-4.16</TD><TD>pulmonary_blastoma</TD><TD>COSMIC cancer mutations</TD><TD>pulmonary_blastoma</TD><TD>648</TD><TD>14</TD><TD>16984</TD><TD>192</TD>
<TD>CNTNAP2,CALN1,FAT4,TGFBR2,PRSS12,SPHKAP,MAP2,PTPRD,BCHE,CASK,XPO4,RUNX1T1,NCKAP5,TRPS1</TD></TR>
<TR><TD>1.558e-02</TD><TD>-4.16</TD><TD>pleura-pulmonary_blastoma</TD><TD>COSMIC cancer mutations</TD><TD>pleura-pulmonary_blastoma</TD><TD>648</TD><TD>14</TD><TD>16984</TD><TD>192</TD>
<TD>CALN1,CNTNAP2,SPHKAP,PRSS12,PTPRD,MAP2,TGFBR2,FAT4,CASK,BCHE,TRPS1,NCKAP5,XPO4,RUNX1T1</TD></TR>
<TR><TD>1.575e-02</TD><TD>-4.15</TD><TD>Calponin-like domain</TD><TD>gene3d domains</TD><TD>1.10.418.10</TD><TD>79</TD><TD>4</TD><TD>14531</TD><TD>177</TD>
<TD>VAV3,UTRN,NAV3,IQGAP2</TD></TR>
<TR><TD>1.575e-02</TD><TD>-4.15</TD><TD>bronchioloalveolar_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>bronchioloalveolar_adenocarcinoma</TD><TD>780</TD><TD>16</TD><TD>16984</TD><TD>192</TD>
<TD>SYT1,CASK,EPHA4,BCHE,LRIG3,FGFR2,ADAMTS12,ACVR1C,NTRK2,PSKH2,TGFBR2,ACVR2A,CPXM2,UHMK1,PRKCE,EPHA3</TD></TR>
<TR><TD>1.575e-02</TD><TD>-4.15</TD><TD>lung-carcinoma-bronchioloalveolar_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-bronchioloalveolar_adenocarcinoma</TD><TD>780</TD><TD>16</TD><TD>16984</TD><TD>192</TD>
<TD>EPHA3,PRKCE,TGFBR2,ACVR2A,UHMK1,CPXM2,PSKH2,NTRK2,ACVR1C,ADAMTS12,FGFR2,LRIG3,BCHE,EPHA4,SYT1,CASK</TD></TR>
<TR><TD>1.599e-02</TD><TD>-4.14</TD><TD>Synaptotagmin</TD><TD>interpro domains</TD><TD>IPR001565</TD><TD>17</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>RPH3A,SYT1</TD></TR>
<TR><TD>1.599e-02</TD><TD>-4.14</TD><TD>Znf_RING-CH</TD><TD>interpro domains</TD><TD>IPR011016</TD><TD>17</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>MARCHF11,MARCHF3</TD></TR>
<TR><TD>1.601e-02</TD><TD>-4.13</TD><TD>IL3RA (interleukin 3 receptor subunit alpha)</TD><TD>protein interactions</TD><TD>3563</TD><TD>48</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>MARCHF3,PTPRD,FGFR2</TD></TR>
<TR><TD>1.601e-02</TD><TD>-4.13</TD><TD>telencephalon development</TD><TD>biological process</TD><TD>GO:0021537</TD><TD>278</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>ARX,SLIT2,PAX6,CNTNAP2,ROBO2,NTRK2,FAT4,LMX1A</TD></TR>
<TR><TD>1.603e-02</TD><TD>-4.13</TD><TD>EPH-Ephrin signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-2682334</TD><TD>95</TD><TD>4</TD><TD>10391</TD><TD>106</TD>
<TD>EPHA3,EPHA4,EFNA5,VAV3</TD></TR>
<TR><TD>1.616e-02</TD><TD>-4.13</TD><TD>FH2</TD><TD>prosite domains</TD><TD>PS51444</TD><TD>15</TD><TD>2</TD><TD>12232</TD><TD>161</TD>
<TD>DAAM1,FMNL2</TD></TR>
<TR><TD>1.620e-02</TD><TD>-4.12</TD><TD>ganglion development</TD><TD>biological process</TD><TD>GO:0061548</TD><TD>17</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>INSM1,UNC5C</TD></TR>
<TR><TD>1.620e-02</TD><TD>-4.12</TD><TD>regulation of integrin activation</TD><TD>biological process</TD><TD>GO:0033623</TD><TD>17</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>CXCL13,PLEK</TD></TR>
<TR><TD>1.622e-02</TD><TD>-4.12</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.60.120.200</TD><TD>121</TD><TD>5</TD><TD>14531</TD><TD>177</TD>
<TD>SLIT2,PTPRK,FAT4,CNTNAP2,NBEA</TD></TR>
<TR><TD>1.633e-02</TD><TD>-4.11</TD><TD>regulation of GTPase activity</TD><TD>biological process</TD><TD>GO:0043087</TD><TD>279</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>VAV3,EFNA5,FGD3,CXCL13,NTRK2,RGS6,EPHA3,EPHA4</TD></TR>
<TR><TD>1.640e-02</TD><TD>-4.11</TD><TD>epithelium development</TD><TD>biological process</TD><TD>GO:0060429</TD><TD>1096</TD><TD>21</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1,TMEFF2,ROBO2,FGF20,NRG1,RYR2,INSM1,PBX1,PECAM1,ARX,IRX1,SLIT2,FZD6,KAZN,PAX6,FGFR2,FERD3L,SEMA3C,EPHA4,TGFBR2,PLAAT1</TD></TR>
<TR><TD>1.644e-02</TD><TD>-4.11</TD><TD>stem cell development</TD><TD>biological process</TD><TD>GO:0048864</TD><TD>84</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>NRG1,TWIST1,SEMA3C,PAX6</TD></TR>
<TR><TD>1.647e-02</TD><TD>-4.11</TD><TD>L-asparagine degradation III (mammalian)</TD><TD>BIOCYC pathways</TD><TD>META_ASPARAGINE-DEG1-PWY-1</TD><TD>3</TD><TD>1</TD><TD>907</TD><TD>5</TD>
<TD>AGA</TD></TR>
<TR><TD>1.653e-02</TD><TD>-4.10</TD><TD>positive regulation of locomotion</TD><TD>biological process</TD><TD>GO:0040017</TD><TD>636</TD><TD>14</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4,TGFBR2,PAX6,SEMA3C,PECAM1,SLIT2,SHTN1,INSM1,DSCAM,SPAG9,CXCL13,PRKCE,CDH5,TWIST1</TD></TR>
<TR><TD>1.655e-02</TD><TD>-4.10</TD><TD>WW_DOMAIN_1</TD><TD>prosite domains</TD><TD>PS01159</TD><TD>41</TD><TD>3</TD><TD>12232</TD><TD>161</TD>
<TD>IQGAP2,UTRN,WWOX</TD></TR>
<TR><TD>1.662e-02</TD><TD>-4.10</TD><TD>ARM-type_fold</TD><TD>interpro domains</TD><TD>IPR016024</TD><TD>338</TD><TD>9</TD><TD>18605</TD><TD>214</TD>
<TD>XPO4,DAAM1,FMNL2,IPO8,UBR4,PUM3,NBEA,EFR3A,EFR3B</TD></TR>
<TR><TD>1.672e-02</TD><TD>-4.09</TD><TD>ARL4C (ADP ribosylation factor like GTPase 4C)</TD><TD>protein interactions</TD><TD>10123</TD><TD>134</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>DNAJC12,SLC39A10,PTPRK,PCDH9,UNC5C</TD></TR>
<TR><TD>1.673e-02</TD><TD>-4.09</TD><TD>embryonic skeletal system development</TD><TD>biological process</TD><TD>GO:0048706</TD><TD>128</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,PBX1,TWIST1,TGFBR2,ACVR2A</TD></TR>
<TR><TD>1.674e-02</TD><TD>-4.09</TD><TD>transmembrane receptor protein tyrosine kinase activator activity</TD><TD>molecular function</TD><TD>GO:0030297</TD><TD>18</TD><TD>2</TD><TD>18530</TD><TD>206</TD>
<TD>EFNA5,NRG1</TD></TR>
<TR><TD>1.676e-02</TD><TD>-4.09</TD><TD>filopodium membrane</TD><TD>cellular component</TD><TD>GO:0031527</TD><TD>18</TD><TD>2</TD><TD>19868</TD><TD>221</TD>
<TD>UTRN,GAP43</TD></TR>
<TR><TD>1.688e-02</TD><TD>-4.08</TD><TD>AAA</TD><TD>pfam domains</TD><TD>PF00004</TD><TD>47</TD><TD>3</TD><TD>17869</TD><TD>206</TD>
<TD>NAV3,FIGN,AFG2A</TD></TR>
<TR><TD>1.690e-02</TD><TD>-4.08</TD><TD>ovary-carcinoma-endometrioid_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>ovary-carcinoma-endometrioid_carcinoma</TD><TD>465</TD><TD>11</TD><TD>16984</TD><TD>192</TD>
<TD>PSKH2,NTRK2,ACVR1C,EPHA3,PRKCE,UHMK1,ACVR2A,TGFBR2,EPHA4,CASK,FGFR2</TD></TR>
<TR><TD>1.702e-02</TD><TD>-4.07</TD><TD>CH</TD><TD>smart domains</TD><TD>SM00033</TD><TD>66</TD><TD>4</TD><TD>9743</TD><TD>146</TD>
<TD>UTRN,VAV3,NAV3,IQGAP2</TD></TR>
<TR><TD>1.710e-02</TD><TD>-4.07</TD><TD>regulation of neuron migration</TD><TD>biological process</TD><TD>GO:2001222</TD><TD>47</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>UNC5C,SHTN1,PAX6</TD></TR>
<TR><TD>1.710e-02</TD><TD>-4.07</TD><TD>ovulation cycle process</TD><TD>biological process</TD><TD>GO:0022602</TD><TD>47</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>ROBO2,LHCGR,SLIT2</TD></TR>
<TR><TD>1.710e-02</TD><TD>-4.07</TD><TD>oligodendrocyte differentiation</TD><TD>biological process</TD><TD>GO:0048709</TD><TD>85</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>PTPRZ1,NTRK2,PAX6,CNTN1</TD></TR>
<TR><TD>1.710e-02</TD><TD>-4.07</TD><TD>regulation of sodium ion transport</TD><TD>biological process</TD><TD>GO:0002028</TD><TD>85</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>UTRN,PRKCE,FGF14,CNTN1</TD></TR>
<TR><TD>1.710e-02</TD><TD>-4.07</TD><TD>chondrocyte differentiation</TD><TD>biological process</TD><TD>GO:0002062</TD><TD>85</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,AMELX,ADAMTS12,CYTL1</TD></TR>
<TR><TD>1.712e-02</TD><TD>-4.07</TD><TD>embryonic organ development</TD><TD>biological process</TD><TD>GO:0048568</TD><TD>454</TD><TD>11</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2,LRIG3,TWIST1,FBN2,FGFR2,PAX6,ZFPM2,TGFBR2,EFEMP1,PBX1,FZD6</TD></TR>
<TR><TD>1.715e-02</TD><TD>-4.07</TD><TD>skin-head_neck-malignant_melanoma-superficial_spreading</TD><TD>COSMIC cancer mutations</TD><TD>skin-head_neck-malignant_melanoma-superficial_spreading</TD><TD>923</TD><TD>18</TD><TD>16984</TD><TD>192</TD>
<TD>UTRN,SPHKAP,EPHA3,FAT4,RASGEF1B,ADAMTS12,NOVA1,HNF4G,CNTNAP2,SLC25A46,SLIT2,FBN2,ASPN,PTPRK,RUNX1T1,SYT1,EFR3A,FUT9</TD></TR>
<TR><TD>1.719e-02</TD><TD>-4.06</TD><TD>NGF signalling via TRKA from the plasma membrane</TD><TD>REACTOME pathways</TD><TD>R-HSA-187037</TD><TD>387</TD><TD>9</TD><TD>10391</TD><TD>106</TD>
<TD>PRKCE,NTRK2,FGF20,NRG1,PHLPP1,PAQR3,AKAP9,FGFR2,FGF5</TD></TR>
<TR><TD>1.735e-02</TD><TD>-4.05</TD><TD>glutamatergic synapse</TD><TD>cellular component</TD><TD>GO:0098978</TD><TD>412</TD><TD>10</TD><TD>19868</TD><TD>221</TD>
<TD>PTPRD,NRCAM,EPHA4,AKAP9,ADGRL3,LRFN5,LGI1,IL1RAPL2,EPS8,SYT1</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>FRS-mediated FGFR3 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654706</TD><TD>20</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>1.765e-02</TD><TD>-4.04</TD><TD>ACBD3 (acyl-CoA binding domain containing 3)</TD><TD>protein interactions</TD><TD>64746</TD><TD>240</TD><TD>7</TD><TD>20077</TD><TD>222</TD>
<TD>EPHA4,SPAG9,SLC25A46,FGFR2,EPHA3,NUP35,NTRK2</TD></TR>
<TR><TD>1.766e-02</TD><TD>-4.04</TD><TD>PTPc</TD><TD>smart domains</TD><TD>SM00194</TD><TD>37</TD><TD>3</TD><TD>9743</TD><TD>146</TD>
<TD>PTPRK,PTPRZ1,PTPRD</TD></TR>
<TR><TD>1.785e-02</TD><TD>-4.03</TD><TD>PLAC</TD><TD>interpro domains</TD><TD>IPR010909</TD><TD>18</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>ADAMTS3,ADAMTS12</TD></TR>
<TR><TD>1.785e-02</TD><TD>-4.03</TD><TD>ZNF516 (zinc finger protein 516)</TD><TD>protein interactions</TD><TD>9658</TD><TD>50</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>NOL4,PAX6,KLF12</TD></TR>
<TR><TD>1.785e-02</TD><TD>-4.03</TD><TD>TGFBR3 (transforming growth factor beta receptor 3)</TD><TD>protein interactions</TD><TD>7049</TD><TD>50</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>TGFBR2,ACVR2A,SHISA3</TD></TR>
<TR><TD>1.788e-02</TD><TD>-4.02</TD><TD>spleen</TD><TD>COSMIC cancer mutations</TD><TD>spleen</TD><TD>408</TD><TD>10</TD><TD>16984</TD><TD>192</TD>
<TD>NAT2,ROBO2,PTPRD,LRRC3B,UTRN,PTPRZ1,FBN2,PTPRK,EDIL3,FAT4</TD></TR>
<TR><TD>1.801e-02</TD><TD>-4.02</TD><TD>ERBIN (erbb2 interacting protein)</TD><TD>protein interactions</TD><TD>55914</TD><TD>241</TD><TD>7</TD><TD>20077</TD><TD>222</TD>
<TD>EPHA3,ACVR2A,NTRK2,ARL14,FGFR2,EPHA4,CASK</TD></TR>
<TR><TD>1.804e-02</TD><TD>-4.02</TD><TD>EPH_lbd</TD><TD>smart domains</TD><TD>SM00615</TD><TD>14</TD><TD>2</TD><TD>9743</TD><TD>146</TD>
<TD>EPHA4,EPHA3</TD></TR>
<TR><TD>1.809e-02</TD><TD>-4.01</TD><TD>cellular response to gonadotropin stimulus</TD><TD>biological process</TD><TD>GO:0071371</TD><TD>18</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>EFNA5,LHCGR</TD></TR>
<TR><TD>1.809e-02</TD><TD>-4.01</TD><TD>regulation of leukocyte tethering or rolling</TD><TD>biological process</TD><TD>GO:1903236</TD><TD>18</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>FUT9,GCNT1</TD></TR>
<TR><TD>1.809e-02</TD><TD>-4.01</TD><TD>positive regulation of neuron migration</TD><TD>biological process</TD><TD>GO:2001224</TD><TD>18</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,SHTN1</TD></TR>
<TR><TD>1.809e-02</TD><TD>-4.01</TD><TD>regulation of keratinocyte proliferation</TD><TD>biological process</TD><TD>GO:0010837</TD><TD>48</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>PTPRK,FGFR2,CASK</TD></TR>
<TR><TD>1.809e-02</TD><TD>-4.01</TD><TD>regulation of cardiac muscle cell proliferation</TD><TD>biological process</TD><TD>GO:0060043</TD><TD>48</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>ZFPM2,FGF20,FGFR2</TD></TR>
<TR><TD>1.822e-02</TD><TD>-4.01</TD><TD>GNA13 (G protein subunit alpha 13)</TD><TD>protein interactions</TD><TD>10672</TD><TD>137</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>TEC,PRKCE,UTRN,EPHA4,EFNA5</TD></TR>
<TR><TD>1.839e-02</TD><TD>-4.00</TD><TD>CCL19 (C-C motif chemokine ligand 19)</TD><TD>protein interactions</TD><TD>6363</TD><TD>19</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>FAT4,CXCL13</TD></TR>
<TR><TD>1.839e-02</TD><TD>-4.00</TD><TD>HTR4 (5-hydroxytryptamine receptor 4)</TD><TD>protein interactions</TD><TD>3360</TD><TD>19</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>GHITM,TMEFF2</TD></TR>
<TR><TD>1.839e-02</TD><TD>-4.00</TD><TD>DYNLT4 (dynein light chain Tctex-type 4)</TD><TD>protein interactions</TD><TD>343521</TD><TD>19</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>TGFBR2,ACVR2A</TD></TR>
<TR><TD>1.839e-02</TD><TD>-4.00</TD><TD>TNR (tenascin R)</TD><TD>protein interactions</TD><TD>7143</TD><TD>19</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRZ1,CNTN1</TD></TR>
<TR><TD>1.839e-02</TD><TD>-4.00</TD><TD>DEFB125 (defensin beta 125)</TD><TD>protein interactions</TD><TD>245938</TD><TD>19</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>UBR4,FBN2</TD></TR>
<TR><TD>1.841e-02</TD><TD>-3.99</TD><TD>IPO13 (importin 13)</TD><TD>protein interactions</TD><TD>9670</TD><TD>91</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>PAX6,CHRM3,XPO4,ARX</TD></TR>
<TR><TD>1.841e-02</TD><TD>-3.99</TD><TD>DGUOK (deoxyguanosine kinase)</TD><TD>protein interactions</TD><TD>1716</TD><TD>91</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>MAP2,SYT1,CNTN1,EDIL3</TD></TR>
<TR><TD>1.841e-02</TD><TD>-3.99</TD><TD>ACVR1B (activin A receptor type 1B)</TD><TD>protein interactions</TD><TD>91</TD><TD>91</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>TGFBR2,ACVR2A,GPR83,ACVR1C</TD></TR>
<TR><TD>1.848e-02</TD><TD>-3.99</TD><TD>human chr17p12</TD><TD>chromosome location</TD><TD>human chr17p12</TD><TD>99</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LOC101928475,LINC00670</TD></TR>
<TR><TD>1.856e-02</TD><TD>-3.99</TD><TD>Collagenase (Catalytic Domain)</TD><TD>gene3d domains</TD><TD>3.40.390.10</TD><TD>83</TD><TD>4</TD><TD>14531</TD><TD>177</TD>
<TD>ADAMTS3,ADAMTS12,ADAM28,ADAMTS5</TD></TR>
<TR><TD>1.867e-02</TD><TD>-3.98</TD><TD>morphogenesis of an epithelium</TD><TD>biological process</TD><TD>GO:0002009</TD><TD>460</TD><TD>11</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,SEMA3C,RYR2,EPHA4,TGFBR2,PBX1,TWIST1,TMEFF2,SLIT2,FZD6,IRX1</TD></TR>
<TR><TD>1.876e-02</TD><TD>-3.98</TD><TD>ATPase_AAA_core</TD><TD>interpro domains</TD><TD>IPR003959</TD><TD>49</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>NAV3,FIGN,AFG2A</TD></TR>
<TR><TD>1.882e-02</TD><TD>-3.97</TD><TD>CHST10 (carbohydrate sulfotransferase 10)</TD><TD>protein interactions</TD><TD>9486</TD><TD>51</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>CDH5,PTPRK,NRG1</TD></TR>
<TR><TD>1.908e-02</TD><TD>-3.96</TD><TD>SHC-mediated cascade:FGFR1</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654688</TD><TD>21</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>1.908e-02</TD><TD>-3.96</TD><TD>Signaling by NODAL</TD><TD>REACTOME pathways</TD><TD>R-HSA-1181150</TD><TD>21</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>ACVR1C,ACVR2A</TD></TR>
<TR><TD>1.908e-02</TD><TD>-3.96</TD><TD>Regulation of gene expression in beta cells</TD><TD>REACTOME pathways</TD><TD>R-HSA-210745</TD><TD>21</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>HNF4G,PAX6</TD></TR>
<TR><TD>1.908e-02</TD><TD>-3.96</TD><TD>PI-3K cascade:FGFR1</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654689</TD><TD>21</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>1.910e-02</TD><TD>-3.96</TD><TD>growth factor receptor binding</TD><TD>molecular function</TD><TD>GO:0070851</TD><TD>138</TD><TD>5</TD><TD>18530</TD><TD>206</TD>
<TD>EFEMP1,FGF20,FGF5,VAV3,CDH5</TD></TR>
<TR><TD>1.911e-02</TD><TD>-3.96</TD><TD>regulation of sodium ion transmembrane transporter activity</TD><TD>biological process</TD><TD>GO:2000649</TD><TD>49</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>UTRN,FGF14,PRKCE</TD></TR>
<TR><TD>1.913e-02</TD><TD>-3.96</TD><TD>regulation of cell growth</TD><TD>biological process</TD><TD>GO:0001558</TD><TD>402</TD><TD>10</TD><TD>18905</TD><TD>219</TD>
<TD>EFNA5,MAP2,SHTN1,SLIT2,LGI1,SPAG9,NRCAM,SYT1,LMX1A,DSCAM</TD></TR>
<TR><TD>1.918e-02</TD><TD>-3.95</TD><TD>ureteric bud development</TD><TD>biological process</TD><TD>GO:0001657</TD><TD>88</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>PBX1,FGFR2,ROBO2,SLIT2</TD></TR>
<TR><TD>1.926e-02</TD><TD>-3.95</TD><TD>ovary-carcinoma-clear_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>ovary-carcinoma-clear_cell_carcinoma</TD><TD>666</TD><TD>14</TD><TD>16984</TD><TD>192</TD>
<TD>FGFR2,EPHA4,CASK,PRKCE,RAI2,EPHA3,FAT4,UTRN,UHMK1,TGFBR2,ACVR2A,NTRK2,PSKH2,ACVR1C</TD></TR>
<TR><TD>1.936e-02</TD><TD>-3.94</TD><TD>embryo development</TD><TD>biological process</TD><TD>GO:0009790</TD><TD>1046</TD><TD>20</TD><TD>18905</TD><TD>219</TD>
<TD>PBX1,EFEMP1,LMBRD1,IRX1,ACVR2A,FZD6,SEMA3C,ADAMTS3,PAX6,FGFR2,FERD3L,TGFBR2,ZFPM2,TWIST1,LRIG3,FBN2,RAI2,RYR2,ACVR1C,ZFAND5</TD></TR>
<TR><TD>1.941e-02</TD><TD>-3.94</TD><TD>VEGFA-VEGFR2 Pathway</TD><TD>REACTOME pathways</TD><TD>R-HSA-4420097</TD><TD>330</TD><TD>8</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGFR2,PAQR3,AKAP9,CDH5,NRG1,FGF20,VAV3</TD></TR>
<TR><TD>1.947e-02</TD><TD>-3.94</TD><TD>Zn peptidases</TD><TD>gene3d domains</TD><TD>3.40.630.10</TD><TD>47</TD><TD>3</TD><TD>14531</TD><TD>177</TD>
<TD>CPXM2,NAALADL2,CPQ</TD></TR>
<TR><TD>1.971e-02</TD><TD>-3.93</TD><TD>regulation of cytoskeleton organization</TD><TD>biological process</TD><TD>GO:0051493</TD><TD>525</TD><TD>12</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA3,NAV3,PLEK,EPS8,TMEFF2,SLIT2,AKAP9,PRKCE,IQGAP2,CDH5,EFNA5,MAP2</TD></TR>
<TR><TD>1.978e-02</TD><TD>-3.92</TD><TD>MYADM (myeloid associated differentiation marker)</TD><TD>protein interactions</TD><TD>91663</TD><TD>93</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>SHISA3,TGFBR2,NRSN1,SEZ6L</TD></TR>
<TR><TD>1.981e-02</TD><TD>-3.92</TD><TD>FBXO34 (F-box protein 34)</TD><TD>protein interactions</TD><TD>55030</TD><TD>52</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>FGF14,TGFBR2,GAP43</TD></TR>
<TR><TD>1.981e-02</TD><TD>-3.92</TD><TD>EFNB2 (ephrin B2)</TD><TD>protein interactions</TD><TD>1948</TD><TD>140</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>ARL14,EPHA4,PECAM1,EPHA3,PHLPP1</TD></TR>
<TR><TD>1.985e-02</TD><TD>-3.92</TD><TD>adamantinomatous</TD><TD>COSMIC cancer mutations</TD><TD>adamantinomatous</TD><TD>355</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>CRTC3,NRCAM,UBR4,PXDNL,VAV3,ADAM28,UTRN,EPYC,PTPRZ1</TD></TR>
<TR><TD>1.985e-02</TD><TD>-3.92</TD><TD>pituitary-craniopharyngeal_duct-craniopharyngioma-adamantinomatous</TD><TD>COSMIC cancer mutations</TD><TD>pituitary-craniopharyngeal_duct-craniopharyngioma-adamantinomatous</TD><TD>355</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>PXDNL,UBR4,NRCAM,CRTC3,EPYC,PTPRZ1,UTRN,ADAM28,VAV3</TD></TR>
<TR><TD>1.991e-02</TD><TD>-3.92</TD><TD>mesonephric tubule development</TD><TD>biological process</TD><TD>GO:0072164</TD><TD>89</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,PBX1,FGFR2,ROBO2</TD></TR>
<TR><TD>1.991e-02</TD><TD>-3.92</TD><TD>mesonephric epithelium development</TD><TD>biological process</TD><TD>GO:0072163</TD><TD>89</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,FGFR2,PBX1,ROBO2</TD></TR>
<TR><TD>1.998e-02</TD><TD>-3.91</TD><TD>abdomen</TD><TD>COSMIC cancer mutations</TD><TD>abdomen</TD><TD>604</TD><TD>13</TD><TD>16984</TD><TD>192</TD>
<TD>CALN1,ADAMTS12,PTPRD,FAT4,ADAMTS5,NAV3,RPH3A,FUT9,ROBO2,MPEG1,CHRM3,FGFR2,REG1B</TD></TR>
<TR><TD>2.011e-02</TD><TD>-3.91</TD><TD>embryonic morphogenesis</TD><TD>biological process</TD><TD>GO:0048598</TD><TD>589</TD><TD>13</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2,FBN2,LRIG3,TWIST1,TGFBR2,FGFR2,PAX6,ACVR2A,IRX1,FZD6,PBX1,EFEMP1,LMBRD1</TD></TR>
<TR><TD>2.014e-02</TD><TD>-3.91</TD><TD>skin-trunk-malignant_melanoma-nodular</TD><TD>COSMIC cancer mutations</TD><TD>skin-trunk-malignant_melanoma-nodular</TD><TD>1292</TD><TD>23</TD><TD>16984</TD><TD>192</TD>
<TD>IQGAP2,PARP8,NTRK2,UTRN,CPXM2,FAT4,EPHA3,AFM,KCNK9,CHRM3,PLEK,LMX1A,KIF6,PTPRZ1,SPHKAP,LHCGR,SEZ6L,LRFN5,RGS6,PTPRK,FBN2,FGF5,FGFR2</TD></TR>
<TR><TD>2.016e-02</TD><TD>-3.90</TD><TD>cortical cytoskeleton organization</TD><TD>biological process</TD><TD>GO:0030865</TD><TD>50</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>FMNL2,IQGAP2,PLEK</TD></TR>
<TR><TD>2.016e-02</TD><TD>-3.90</TD><TD>eye photoreceptor cell differentiation</TD><TD>biological process</TD><TD>GO:0001754</TD><TD>50</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,NTRK2,DSCAM</TD></TR>
<TR><TD>2.017e-02</TD><TD>-3.90</TD><TD>clear_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>clear_cell_carcinoma</TD><TD>670</TD><TD>14</TD><TD>16984</TD><TD>192</TD>
<TD>ACVR2A,TGFBR2,UHMK1,UTRN,FAT4,EPHA3,FGFR2,RAI2,PRKCE,ACVR1C,CASK,EPHA4,NTRK2,PSKH2</TD></TR>
<TR><TD>2.028e-02</TD><TD>-3.90</TD><TD>L1CAM interactions</TD><TD>REACTOME pathways</TD><TD>R-HSA-373760</TD><TD>102</TD><TD>4</TD><TD>10391</TD><TD>106</TD>
<TD>GAP43,CNTN1,SHTN1,NRCAM</TD></TR>
<TR><TD>2.029e-02</TD><TD>-3.90</TD><TD>CCDC197 (coiled-coil domain containing 197)</TD><TD>protein interactions</TD><TD>256369</TD><TD>20</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>RUNX1T1,FMNL2</TD></TR>
<TR><TD>2.029e-02</TD><TD>-3.90</TD><TD>DOK5 (docking protein 5)</TD><TD>protein interactions</TD><TD>55816</TD><TD>20</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>RAI2,NTRK2</TD></TR>
<TR><TD>2.029e-02</TD><TD>-3.90</TD><TD>TTC38 (tetratricopeptide repeat domain 38)</TD><TD>protein interactions</TD><TD>55020</TD><TD>20</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>GMDS,SEMA3C</TD></TR>
<TR><TD>2.029e-02</TD><TD>-3.90</TD><TD>ADRA2C (adrenoceptor alpha 2C)</TD><TD>protein interactions</TD><TD>152</TD><TD>20</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>WWOX,UCHL1</TD></TR>
<TR><TD>2.029e-02</TD><TD>-3.90</TD><TD>C1orf87 (chromosome 1 open reading frame 87)</TD><TD>protein interactions</TD><TD>127795</TD><TD>20</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>UBR4,AKAP9</TD></TR>
<TR><TD>2.029e-02</TD><TD>-3.90</TD><TD>CPQ (carboxypeptidase Q)</TD><TD>protein interactions</TD><TD>10404</TD><TD>20</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>DAAM1,SLC25A46</TD></TR>
<TR><TD>2.030e-02</TD><TD>-3.90</TD><TD>TGFBR2 MSI Frameshift Mutants in Cancer</TD><TD>REACTOME pathways</TD><TD>R-HSA-3642279</TD><TD>2</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>2.030e-02</TD><TD>-3.90</TD><TD>TWIK-releated acid-sensitive K+ channel (TASK)</TD><TD>REACTOME pathways</TD><TD>R-HSA-1299316</TD><TD>2</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>KCNK9</TD></TR>
<TR><TD>2.030e-02</TD><TD>-3.90</TD><TD>Acetylation</TD><TD>REACTOME pathways</TD><TD>R-HSA-156582</TD><TD>2</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>NAT2</TD></TR>
<TR><TD>2.048e-02</TD><TD>-3.89</TD><TD>EIF1AD (eukaryotic translation initiation factor 1A domain containing)</TD><TD>protein interactions</TD><TD>84285</TD><TD>94</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>ZNF521,CASK,MTERF1,PAX6</TD></TR>
<TR><TD>2.061e-02</TD><TD>-3.88</TD><TD>FH2</TD><TD>smart domains</TD><TD>SM00498</TD><TD>15</TD><TD>2</TD><TD>9743</TD><TD>146</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>2.065e-02</TD><TD>-3.88</TD><TD>epithelial to mesenchymal transition</TD><TD>biological process</TD><TD>GO:0001837</TD><TD>90</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,SLC39A10,AMELX,TGFBR2</TD></TR>
<TR><TD>2.070e-02</TD><TD>-3.88</TD><TD>human chr5q21.2</TD><TD>chromosome location</TD><TD>human chr5q21.2</TD><TD>10</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LINC02115</TD></TR>
<TR><TD>2.073e-02</TD><TD>-3.88</TD><TD>Interleukin-3, 5 and GM-CSF signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-512988</TD><TD>271</TD><TD>7</TD><TD>10391</TD><TD>106</TD>
<TD>TEC,NRG1,FGF20,FGFR2,FGF5,AKAP9,PAQR3</TD></TR>
<TR><TD>2.073e-02</TD><TD>-3.88</TD><TD>FCERI mediated MAPK activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-2871796</TD><TD>271</TD><TD>7</TD><TD>10391</TD><TD>106</TD>
<TD>VAV3,NRG1,FGF20,AKAP9,PAQR3,FGFR2,FGF5</TD></TR>
<TR><TD>2.085e-02</TD><TD>-3.87</TD><TD>WW_dom</TD><TD>interpro domains</TD><TD>IPR001202</TD><TD>51</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>WWOX,UTRN,IQGAP2</TD></TR>
<TR><TD>2.085e-02</TD><TD>-3.87</TD><TD>Signaling by FGFR3 point mutants in cancer</TD><TD>REACTOME pathways</TD><TD>R-HSA-8853338</TD><TD>22</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>2.085e-02</TD><TD>-3.87</TD><TD>Signaling by FGFR3 in disease</TD><TD>REACTOME pathways</TD><TD>R-HSA-5655332</TD><TD>22</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>2.085e-02</TD><TD>-3.87</TD><TD>SHC1 events in ERBB2 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-1250196</TD><TD>22</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>PRKCE,NRG1</TD></TR>
<TR><TD>2.086e-02</TD><TD>-3.87</TD><TD>pancreatic_intraepithelial_neoplasia_(PanIN)</TD><TD>COSMIC cancer mutations</TD><TD>pancreatic_intraepithelial_neoplasia_(PanIN)</TD><TD>673</TD><TD>14</TD><TD>16984</TD><TD>192</TD>
<TD>REG1B,VAV3,ZNF521,XPO4,ASPN,LRFN5,RYR2,FANCB,NRSN1,NAV3,RAI2,EPS8,UBR4,KAZN</TD></TR>
<TR><TD>2.086e-02</TD><TD>-3.87</TD><TD>pancreas-pancreatic_intraepithelial_neoplasia_(PanIN)</TD><TD>COSMIC cancer mutations</TD><TD>pancreas-pancreatic_intraepithelial_neoplasia_(PanIN)</TD><TD>673</TD><TD>14</TD><TD>16984</TD><TD>192</TD>
<TD>NAV3,FANCB,NRSN1,RYR2,LRFN5,ASPN,XPO4,ZNF521,VAV3,REG1B,KAZN,UBR4,EPS8,RAI2</TD></TR>
<TR><TD>2.090e-02</TD><TD>-3.87</TD><TD>skin-lower_leg-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-lower_leg-malignant_melanoma</TD><TD>139</TD><TD>5</TD><TD>16984</TD><TD>192</TD>
<TD>PTPRD,CHRM3,PXDNL,ADAM28,ADAMTS3</TD></TR>
<TR><TD>2.111e-02</TD><TD>-3.86</TD><TD>protein kinase A binding</TD><TD>molecular function</TD><TD>GO:0051018</TD><TD>53</TD><TD>3</TD><TD>18530</TD><TD>206</TD>
<TD>AKAP9,SPHKAP,RYR2</TD></TR>
<TR><TD>2.120e-02</TD><TD>-3.85</TD><TD>POM121C (POM121 transmembrane nucleoporin C)</TD><TD>protein interactions</TD><TD>100101267</TD><TD>95</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>PI15,CHRM3,NUP35,SHISA3</TD></TR>
<TR><TD>2.124e-02</TD><TD>-3.85</TD><TD>negative regulation of chemotaxis</TD><TD>biological process</TD><TD>GO:0050922</TD><TD>51</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>ROBO2,SLIT2,CXCL13</TD></TR>
<TR><TD>2.127e-02</TD><TD>-3.85</TD><TD>nodular</TD><TD>COSMIC cancer mutations</TD><TD>nodular</TD><TD>1517</TD><TD>26</TD><TD>16984</TD><TD>192</TD>
<TD>KIF6,LMX1A,LHCGR,SPHKAP,PTPRZ1,LRFN5,SEZ6L,FGFR2,FGF5,FBN2,PTPRK,RGS6,PARP8,NTRK2,CNTN1,IQGAP2,EPHA3,FAT4,CPXM2,UTRN,RPH3A,FGF20,AFM,CHRM3,PLEK,KCNK9</TD></TR>
<TR><TD>2.139e-02</TD><TD>-3.84</TD><TD>neuron to neuron synapse</TD><TD>cellular component</TD><TD>GO:0098984</TD><TD>365</TD><TD>9</TD><TD>19868</TD><TD>221</TD>
<TD>AKAP9,GAP43,NRCAM,PTPRD,EPHA4,SYT1,EPS8,NTRK2,LRFN5</TD></TR>
<TR><TD>2.141e-02</TD><TD>-3.84</TD><TD>feeding behavior</TD><TD>biological process</TD><TD>GO:0007631</TD><TD>91</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2,PRLHR,GPR83,UCHL1</TD></TR>
<TR><TD>2.141e-02</TD><TD>-3.84</TD><TD>neural crest cell differentiation</TD><TD>biological process</TD><TD>GO:0014033</TD><TD>91</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>NRG1,PAX6,SEMA3C,TWIST1</TD></TR>
<TR><TD>2.142e-02</TD><TD>-3.84</TD><TD>astrocytoma_Grade_IV</TD><TD>COSMIC cancer mutations</TD><TD>astrocytoma_Grade_IV</TD><TD>15952</TD><TD>187</TD><TD>16984</TD><TD>192</TD>
<TD>DNAJC12,PBX1,RAI2,UBR4,CETN3,WRN,MRPL3,IL1RAPL2,BCHE,ADAMTS3,PHLPP1,OR52K2,JMJD1C,LRRC70,LRRC3B,ASPN,FIGN,PWWP2A,UCHL1,RGS6,DEPTOR,FBN2,MUC7,SPAG9,PAX6,FGD3,IQGAP2,STXBP6,REG1B,LRIG3,NRSN1,IPO8,FUT9,SPHKAP,ACVR1C,LRRN2,NOBOX,KIF6,PAQR3,ZFAND5,MEGF10,CXCL13,ACP6,TCF20,PCGF5,SEZ6L,LRFN5,PI15,CPXM2,IRX1,ZNF133,PRKCE,CNTNAP2,DSCAM,XPO4,DCDC2C,SKAP2,TMEFF2,SGCD,CASK,DNER,EPHA4,COQ2,TGFBR2,PTPRD,ADAM28,TSN,CALN1,SEMA3C,NRCAM,DAAM1,KLF12,ZNF521,PTPRK,FMNL2,EFR3A,NUP35,ATG10,CYTL1,EPHA3,ADAMTS12,NTRK2,HNF4G,CD96,THSD7A,ZPLD1,AOAH,REXO2,PHF14,SGCG,ADAMTS5,ROBO2,RPH3A,RYR2,EPYC,EFNA5,PRLHR,LMX1A,KAZN,SLC10A2,LGI1,PSKH2,GCNT1,RUNX1T1,FGFR2,FERD3L,AMELX,SERINC5,MAP2,SS18,TWIST1,NOVA1,CNTN1,AKAP9,NAALADL2,PARP8,SLIT2,NOL4,NCKAP5,FGF20,GHITM,PTPRZ1,UNC5C,GPR83,SERGEF,B3GAT2,CD226,OR2AG1,TRPS1,WWOX,EFEMP1,ACVR2A,UTRN,ZFPM2,GAP43,CELF2,RASGEF1B,DEFB115,PLEK,SLC39A10,VAV3,NAT2,SPATA16,AFM,FNIP2,SLC7A14,EDIL3,PXDNL,AGA,SLC25A46,FABP7,BACH2,FGF5,CTSO,IGFL4,FAT4,KCNK9,CHRM3,DAOA,BANK1,ZNF518B,SYT1,FANCB,NBEA,MPEG1,GMDS,NRG1,PRSS12,EPS8,LHCGR,SLC7A8,CRTC3,MRPL13,COX7B2,NAV3,FZD6,LMBRD1,FGF14,THSD7B,RBM20,UHMK1,ARL14,ARX,SHISA3,PCDH9,INSM1,CDH5</TD></TR>
<TR><TD>2.145e-02</TD><TD>-3.84</TD><TD>SYNAPTOTAGMN</TD><TD>prints domains</TD><TD>PR00399</TD><TD>17</TD><TD>2</TD><TD>5258</TD><TD>71</TD>
<TD>RPH3A,SYT1</TD></TR>
<TR><TD>2.146e-02</TD><TD>-3.84</TD><TD>appendage development</TD><TD>biological process</TD><TD>GO:0048736</TD><TD>186</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>SEMA3C,FGFR2,TWIST1,PBX1,FZD6,FBN2</TD></TR>
<TR><TD>2.146e-02</TD><TD>-3.84</TD><TD>limb development</TD><TD>biological process</TD><TD>GO:0060173</TD><TD>186</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>FBN2,FZD6,PBX1,TWIST1,FGFR2,SEMA3C</TD></TR>
<TR><TD>2.147e-02</TD><TD>-3.84</TD><TD>PH</TD><TD>pfam domains</TD><TD>PF00169</TD><TD>187</TD><TD>6</TD><TD>17869</TD><TD>206</TD>
<TD>SKAP2,PHLPP1,FGD3,PLEK,VAV3,TEC</TD></TR>
<TR><TD>2.149e-02</TD><TD>-3.84</TD><TD>GPM6A (glycoprotein M6A)</TD><TD>protein interactions</TD><TD>2823</TD><TD>143</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>MAP2,SYT1,SEPTIN5,CNTN1,EDIL3</TD></TR>
<TR><TD>2.157e-02</TD><TD>-3.84</TD><TD>regulation of multicellular organismal process</TD><TD>biological process</TD><TD>GO:0051239</TD><TD>3120</TD><TD>48</TD><TD>18905</TD><TD>219</TD>
<TD>PRKCE,FBN2,NOVA1,BANK1,CELF2,ACVR2A,TGFBR2,CXCL13,TWIST1,TRPS1,PLEK,SLC39A10,NAV3,ASPN,PHF14,SHTN1,EFNA5,ZFPM2,EPHA4,MIR147A,NTRK2,ADAMTS12,ADAMTS5,SS18,ACVR1C,FGF20,PTPRZ1,ROBO2,ARX,CD96,FERD3L,PAX6,PTPRD,CD226,CDH5,MAP2,RYR2,DSCAM,LRFN5,TEC,AKAP9,SLIT2,PBX1,EFEMP1,VAV3,AMELX,FGFR2,CHRM3</TD></TR>
<TR><TD>2.158e-02</TD><TD>-3.84</TD><TD>forebrain development</TD><TD>biological process</TD><TD>GO:0030900</TD><TD>410</TD><TD>10</TD><TD>18905</TD><TD>219</TD>
<TD>PCDH9,ARX,SLIT2,PAX6,FGFR2,CNTNAP2,ROBO2,NTRK2,FAT4,LMX1A</TD></TR>
<TR><TD>2.159e-02</TD><TD>-3.84</TD><TD>kidney-Wilms_tumour</TD><TD>COSMIC cancer mutations</TD><TD>kidney-Wilms_tumour</TD><TD>546</TD><TD>12</TD><TD>16984</TD><TD>192</TD>
<TD>EPHA3,PRKCE,ACVR2A,TGFBR2,UHMK1,NTRK2,PSKH2,SS18,ACVR1C,FGFR2,EPHA4,CASK</TD></TR>
<TR><TD>2.166e-02</TD><TD>-3.83</TD><TD>phosphotransferase activity, alcohol group as acceptor</TD><TD>molecular function</TD><TD>GO:0016773</TD><TD>687</TD><TD>14</TD><TD>18530</TD><TD>206</TD>
<TD>NTRK2,UHMK1,EPHA3,MAST4,ACVR1C,PSKH2,PRKCE,EFEMP1,TEC,EPHA4,TGFBR2,FGFR2,ACVR2A,CASK</TD></TR>
<TR><TD>2.170e-02</TD><TD>-3.83</TD><TD>Signaling by SCF-KIT</TD><TD>REACTOME pathways</TD><TD>R-HSA-1433557</TD><TD>337</TD><TD>8</TD><TD>10391</TD><TD>106</TD>
<TD>TEC,PHLPP1,PAQR3,AKAP9,FGF5,FGFR2,FGF20,NRG1</TD></TR>
<TR><TD>2.174e-02</TD><TD>-3.83</TD><TD>LamG</TD><TD>smart domains</TD><TD>SM00282</TD><TD>40</TD><TD>3</TD><TD>9743</TD><TD>146</TD>
<TD>SLIT2,FAT4,CNTNAP2</TD></TR>
<TR><TD>2.186e-02</TD><TD>-3.82</TD><TD>Wilms_tumour</TD><TD>COSMIC cancer mutations</TD><TD>Wilms_tumour</TD><TD>547</TD><TD>12</TD><TD>16984</TD><TD>192</TD>
<TD>FGFR2,EPHA4,CASK,PRKCE,EPHA3,UHMK1,TGFBR2,ACVR2A,NTRK2,PSKH2,ACVR1C,SS18</TD></TR>
<TR><TD>2.188e-02</TD><TD>-3.82</TD><TD>GALNT10 (polypeptide N-acetylgalactosaminyltransferase 10)</TD><TD>protein interactions</TD><TD>55568</TD><TD>54</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>PI15,GCNT1,MUC7</TD></TR>
<TR><TD>2.188e-02</TD><TD>-3.82</TD><TD>PKLR (pyruvate kinase L/R)</TD><TD>protein interactions</TD><TD>5313</TD><TD>54</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>LRRC3B,PI15,WWOX</TD></TR>
<TR><TD>2.191e-02</TD><TD>-3.82</TD><TD>terminal O-glycans residues modification</TD><TD>BIOCYC pathways</TD><TD>META_PWY-7434</TD><TD>4</TD><TD>1</TD><TD>907</TD><TD>5</TD>
<TD>FUT9</TD></TR>
<TR><TD>2.191e-02</TD><TD>-3.82</TD><TD>asparagine degradation</TD><TD>BIOCYC pathways</TD><TD>HUMAN_ASPARAGINE-DEG1-PWY-1</TD><TD>4</TD><TD>1</TD><TD>907</TD><TD>5</TD>
<TD>AGA</TD></TR>
<TR><TD>2.199e-02</TD><TD>-3.82</TD><TD>CH</TD><TD>prosite domains</TD><TD>PS50021</TD><TD>81</TD><TD>4</TD><TD>12232</TD><TD>161</TD>
<TD>NAV3,IQGAP2,VAV3,UTRN</TD></TR>
<TR><TD>2.199e-02</TD><TD>-3.82</TD><TD>MDH1B (malate dehydrogenase 1B)</TD><TD>protein interactions</TD><TD>130752</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>EPHA3</TD></TR>
<TR><TD>2.199e-02</TD><TD>-3.82</TD><TD>Diaph1 (diaphanous related formin 1)</TD><TD>protein interactions</TD><TD>13367</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>PAX6</TD></TR>
<TR><TD>2.199e-02</TD><TD>-3.82</TD><TD>EXO1 (Rad2 family nuclease EXO1)</TD><TD>protein interactions</TD><TD>854198</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>WRN</TD></TR>
<TR><TD>2.199e-02</TD><TD>-3.82</TD><TD>FCRL6 (Fc receptor like 6)</TD><TD>protein interactions</TD><TD>343413</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>GALNT15</TD></TR>
<TR><TD>2.199e-02</TD><TD>-3.82</TD><TD>Prkcz (protein kinase C, zeta)</TD><TD>protein interactions</TD><TD>25522</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>PRKCE</TD></TR>
<TR><TD>2.199e-02</TD><TD>-3.82</TD><TD>RAX (retina and anterior neural fold homeobox)</TD><TD>protein interactions</TD><TD>30062</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>PAX6</TD></TR>
<TR><TD>2.199e-02</TD><TD>-3.82</TD><TD>Flcn (folliculin)</TD><TD>protein interactions</TD><TD>303185</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.199e-02</TD><TD>-3.82</TD><TD>Cdon (cell adhesion associated, oncogene regulated)</TD><TD>protein interactions</TD><TD>50938</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>SPAG9</TD></TR>
<TR><TD>2.199e-02</TD><TD>-3.82</TD><TD>SLC3A1 (solute carrier family 3 member 1)</TD><TD>protein interactions</TD><TD>6519</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>SLC7A8</TD></TR>
<TR><TD>2.199e-02</TD><TD>-3.82</TD><TD>OR4E2 (olfactory receptor family 4 subfamily E member 2)</TD><TD>protein interactions</TD><TD>26686</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>SHTN1</TD></TR>
<TR><TD>2.199e-02</TD><TD>-3.82</TD><TD>TEX30 (testis expressed 30)</TD><TD>protein interactions</TD><TD>93081</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>SHTN1</TD></TR>
<TR><TD>2.199e-02</TD><TD>-3.82</TD><TD>Cacnb3 (calcium voltage-gated channel auxiliary subunit beta 3)</TD><TD>protein interactions</TD><TD>25297</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>PAX6</TD></TR>
<TR><TD>2.203e-02</TD><TD>-3.82</TD><TD>haematopoietic_and_lymphoid_tissue-skin-lymphoid_neoplasm-mycosis_fungoides-Sezary_syndrome</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-skin-lymphoid_neoplasm-mycosis_fungoides-Sezary_syndrome</TD><TD>53</TD><TD>3</TD><TD>16984</TD><TD>192</TD>
<TD>FGFR2,PTPRD,NBEA</TD></TR>
<TR><TD>2.203e-02</TD><TD>-3.82</TD><TD>mycosis_fungoides-Sezary_syndrome</TD><TD>COSMIC cancer mutations</TD><TD>mycosis_fungoides-Sezary_syndrome</TD><TD>53</TD><TD>3</TD><TD>16984</TD><TD>192</TD>
<TD>PTPRD,NBEA,FGFR2</TD></TR>
<TR><TD>2.205e-02</TD><TD>-3.81</TD><TD>Signaling by VEGF</TD><TD>REACTOME pathways</TD><TD>R-HSA-194138</TD><TD>338</TD><TD>8</TD><TD>10391</TD><TD>106</TD>
<TD>VAV3,NRG1,FGF20,PAQR3,AKAP9,CDH5,FGF5,FGFR2</TD></TR>
<TR><TD>2.211e-02</TD><TD>-3.81</TD><TD>N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity</TD><TD>molecular function</TD><TD>GO:0003948</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>AGA</TD></TR>
<TR><TD>2.211e-02</TD><TD>-3.81</TD><TD>transforming growth factor beta receptor activity, type II</TD><TD>molecular function</TD><TD>GO:0005026</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>2.211e-02</TD><TD>-3.81</TD><TD>calcium:proton antiporter activity</TD><TD>molecular function</TD><TD>GO:0015369</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>GHITM</TD></TR>
<TR><TD>2.211e-02</TD><TD>-3.81</TD><TD>flap-structured DNA binding</TD><TD>molecular function</TD><TD>GO:0070336</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>WRN</TD></TR>
<TR><TD>2.211e-02</TD><TD>-3.81</TD><TD>netrin receptor binding</TD><TD>molecular function</TD><TD>GO:1990890</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>DSCAM</TD></TR>
<TR><TD>2.211e-02</TD><TD>-3.81</TD><TD>suramin binding</TD><TD>molecular function</TD><TD>GO:0043924</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>RYR2</TD></TR>
<TR><TD>2.211e-02</TD><TD>-3.81</TD><TD>ethanol binding</TD><TD>molecular function</TD><TD>GO:0035276</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>PRKCE</TD></TR>
<TR><TD>2.211e-02</TD><TD>-3.81</TD><TD>Atg12 transferase activity</TD><TD>molecular function</TD><TD>GO:0019777</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>ATG10</TD></TR>
<TR><TD>2.211e-02</TD><TD>-3.81</TD><TD>4-hydroxybenzoate decaprenyltransferase activity</TD><TD>molecular function</TD><TD>GO:0002083</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>COQ2</TD></TR>
<TR><TD>2.211e-02</TD><TD>-3.81</TD><TD>acetylcholinesterase activity</TD><TD>molecular function</TD><TD>GO:0003990</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>BCHE</TD></TR>
<TR><TD>2.211e-02</TD><TD>-3.81</TD><TD>interleukin-1, type II, blocking receptor activity</TD><TD>molecular function</TD><TD>GO:0004910</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>IL1RAPL2</TD></TR>
<TR><TD>2.211e-02</TD><TD>-3.81</TD><TD>forked DNA-dependent helicase activity</TD><TD>molecular function</TD><TD>GO:0061749</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>WRN</TD></TR>
<TR><TD>2.211e-02</TD><TD>-3.81</TD><TD>syntaxin-3 binding</TD><TD>molecular function</TD><TD>GO:0030348</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>SYT1</TD></TR>
<TR><TD>2.212e-02</TD><TD>-3.81</TD><TD>human chr13q14.11</TD><TD>chromosome location</TD><TD>human chr13q14.11</TD><TD>109</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC00332,MIR4305</TD></TR>
<TR><TD>2.212e-02</TD><TD>-3.81</TD><TD>distal dendrite</TD><TD>cellular component</TD><TD>GO:0150002</TD><TD>2</TD><TD>1</TD><TD>19868</TD><TD>221</TD>
<TD>MAP2</TD></TR>
<TR><TD>2.212e-02</TD><TD>-3.81</TD><TD>primary dendrite</TD><TD>cellular component</TD><TD>GO:0150001</TD><TD>2</TD><TD>1</TD><TD>19868</TD><TD>221</TD>
<TD>MAP2</TD></TR>
<TR><TD>2.213e-02</TD><TD>-3.81</TD><TD>Fc-gamma receptor signaling pathway involved in phagocytosis</TD><TD>biological process</TD><TD>GO:0038096</TD><TD>20</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>VAV3,PRKCE</TD></TR>
<TR><TD>2.213e-02</TD><TD>-3.81</TD><TD>regulation of tolerance induction</TD><TD>biological process</TD><TD>GO:0002643</TD><TD>20</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,PHLPP1</TD></TR>
<TR><TD>2.213e-02</TD><TD>-3.81</TD><TD>immune response-regulating cell surface receptor signaling pathway involved in phagocytosis</TD><TD>biological process</TD><TD>GO:0002433</TD><TD>20</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PRKCE,VAV3</TD></TR>
<TR><TD>2.213e-02</TD><TD>-3.81</TD><TD>positive regulation of transcription regulatory region DNA binding</TD><TD>biological process</TD><TD>GO:2000679</TD><TD>20</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1,PAX6</TD></TR>
<TR><TD>2.223e-02</TD><TD>-3.81</TD><TD>cell population proliferation</TD><TD>biological process</TD><TD>GO:0008283</TD><TD>726</TD><TD>15</TD><TD>18905</TD><TD>219</TD>
<TD>UCHL1,ACVR1C,TWIST1,MEGF10,CNTNAP2,PAX6,FGFR2,TGFBR2,FABP7,INSM1,PBX1,PHF14,ACVR2A,FZD6,ARX</TD></TR>
<TR><TD>2.226e-02</TD><TD>-3.80</TD><TD>LINC01588 (long intergenic non-protein coding RNA 1588)</TD><TD>protein interactions</TD><TD>283551</TD><TD>21</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>FAT4,SKAP2</TD></TR>
<TR><TD>2.226e-02</TD><TD>-3.80</TD><TD>PDX1 (pancreatic and duodenal homeobox 1)</TD><TD>protein interactions</TD><TD>3651</TD><TD>21</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>NAV3,PBX1</TD></TR>
<TR><TD>2.238e-02</TD><TD>-3.80</TD><TD>C11orf52 (chromosome 11 open reading frame 52)</TD><TD>protein interactions</TD><TD>91894</TD><TD>310</TD><TD>8</TD><TD>20077</TD><TD>222</TD>
<TD>CASK,EPS8,SLC39A10,UTRN,IQGAP2,EFR3A,EFR3B,EPHA3</TD></TR>
<TR><TD>2.241e-02</TD><TD>-3.80</TD><TD>skin-leg-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-leg-malignant_melanoma</TD><TD>549</TD><TD>12</TD><TD>16984</TD><TD>192</TD>
<TD>ADAMTS3,DNER,HNF4G,CDH5,ACVR1C,OR52K2,FAT4,MEGF10,NOL4,PTPRZ1,CHRM3,PTPRD</TD></TR>
<TR><TD>2.264e-02</TD><TD>-3.79</TD><TD>bone-femur-chondrosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-femur-chondrosarcoma</TD><TD>424</TD><TD>10</TD><TD>16984</TD><TD>192</TD>
<TD>FMNL2,LRIG3,PHLPP1,CXCL13,SPHKAP,UNC5C,PI15,THSD7B,UBR4,IQGAP2</TD></TR>
<TR><TD>2.269e-02</TD><TD>-3.79</TD><TD>FRS-mediated FGFR1 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654693</TD><TD>23</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>2.269e-02</TD><TD>-3.79</TD><TD>Dopamine Neurotransmitter Release Cycle</TD><TD>REACTOME pathways</TD><TD>R-HSA-212676</TD><TD>23</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>SYT1,CASK</TD></TR>
<TR><TD>2.270e-02</TD><TD>-3.79</TD><TD>regulation of multicellular organismal development</TD><TD>biological process</TD><TD>GO:2000026</TD><TD>1485</TD><TD>26</TD><TD>18905</TD><TD>219</TD>
<TD>FBN2,ADAMTS12,ROBO2,PTPRZ1,FGF20,ACVR2A,FERD3L,PAX6,TGFBR2,MAP2,TWIST1,CDH5,CXCL13,PTPRD,TRPS1,DSCAM,EFNA5,SHTN1,EFEMP1,SLIT2,ASPN,NTRK2,FGFR2,ZFPM2,EPHA4,AMELX</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>RHOB (ras homolog family member B)</TD><TD>protein interactions</TD><TD>388</TD><TD>832</TD><TD>16</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRK,EPS8,CASK,UNC5C,NBEA,EMC2,FAT4,SLC39A10,FZD6,FMNL2,ROBO2,UTRN,DAAM1,EFR3A,EFR3B,IQGAP2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>AChE_tetra</TD><TD>interpro domains</TD><TD>IPR014788</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>BCHE</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>DENN_FNIP1/2</TD><TD>interpro domains</TD><TD>IPR037545</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>CELF1/2_RRM1</TD><TD>interpro domains</TD><TD>IPR034196</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CELF2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Sec3-PIP2_bind</TD><TD>interpro domains</TD><TD>IPR028258</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>STXBP6</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Pleckstrin</TD><TD>interpro domains</TD><TD>IPR037370</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PLEK</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>CELF1/2_RRM2</TD><TD>interpro domains</TD><TD>IPR034198</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CELF2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Contactin-1_2_Ig1</TD><TD>interpro domains</TD><TD>IPR047102</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CNTN1</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>JIP3/JIP4</TD><TD>interpro domains</TD><TD>IPR039911</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>SPAG9</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>NCKAP5_C</TD><TD>interpro domains</TD><TD>IPR032769</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NCKAP5</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Dystrophin/utrophin</TD><TD>interpro domains</TD><TD>IPR035436</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>UTRN</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>NOL4/NOL4L</TD><TD>interpro domains</TD><TD>IPR039788</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NOL4</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Ribosomal_uL13_CS</TD><TD>interpro domains</TD><TD>IPR023563</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MRPL13</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Translin_C</TD><TD>interpro domains</TD><TD>IPR016069</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>TSN</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>ZF_CCHC_FOG</TD><TD>interpro domains</TD><TD>IPR034731</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>FNIP_mid_dom</TD><TD>interpro domains</TD><TD>IPR028085</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>PIK3AP1_TIR</TD><TD>interpro domains</TD><TD>IPR041340</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>BANK1</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>RAI2/SOBP</TD><TD>interpro domains</TD><TD>IPR026092</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RAI2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Arylamine_N-AcTrfase</TD><TD>interpro domains</TD><TD>IPR001447</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NAT2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Cyt_c_oxidase_suVIIB_dom_sf</TD><TD>interpro domains</TD><TD>IPR023272</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>COX7B2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Cyt_c_oxidase_suVIIB</TD><TD>interpro domains</TD><TD>IPR008433</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>COX7B2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>UbiA_prenylTrfase_CS</TD><TD>interpro domains</TD><TD>IPR030470</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>COQ2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>DBB_domain</TD><TD>interpro domains</TD><TD>IPR017893</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>BANK1</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>KH-I_NOVA_rpt3</TD><TD>interpro domains</TD><TD>IPR047274</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NOVA1</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Neurensin</TD><TD>interpro domains</TD><TD>IPR024883</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NRSN1</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Cholinesterase</TD><TD>interpro domains</TD><TD>IPR000997</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>BCHE</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Fidgetin_ATPase</TD><TD>interpro domains</TD><TD>IPR047828</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FIGN</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Neuregulin_C</TD><TD>interpro domains</TD><TD>IPR002154</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NRG1</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>MATCAP</TD><TD>interpro domains</TD><TD>IPR012548</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MATCAP2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>FOG</TD><TD>interpro domains</TD><TD>IPR039746</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>AKAP9/Pericentrin</TD><TD>interpro domains</TD><TD>IPR028745</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>AKAP9</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>INSM1/2</TD><TD>interpro domains</TD><TD>IPR042972</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>INSM1</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>FNIP_C_dom</TD><TD>interpro domains</TD><TD>IPR028086</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Translin_fam</TD><TD>interpro domains</TD><TD>IPR002848</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>TSN</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Peroxidasin_peroxidase</TD><TD>interpro domains</TD><TD>IPR034824</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PXDNL</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>LRATD1_LRATD2</TD><TD>interpro domains</TD><TD>IPR043299</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>LRATD1</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Nckap5l</TD><TD>interpro domains</TD><TD>IPR026163</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NCKAP5</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>CELF1/2_RRM3</TD><TD>interpro domains</TD><TD>IPR034199</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CELF2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>FNIP_N_dom</TD><TD>interpro domains</TD><TD>IPR028084</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>SS18</TD><TD>interpro domains</TD><TD>IPR044779</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>SS18</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>PACT_domain</TD><TD>interpro domains</TD><TD>IPR019528</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>AKAP9</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>HNF4-like_DBD</TD><TD>interpro domains</TD><TD>IPR049636</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>HNF4G</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>KH-I_NOVA_rpt2</TD><TD>interpro domains</TD><TD>IPR047276</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NOVA1</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Alpha_CARP_receptor-type</TD><TD>interpro domains</TD><TD>IPR041887</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PTPRZ1</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>RQC_domain</TD><TD>interpro domains</TD><TD>IPR018982</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>WRN</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>bZIP_BACH</TD><TD>interpro domains</TD><TD>IPR043321</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>BACH2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>ZFPM1/2_PR</TD><TD>interpro domains</TD><TD>IPR049361</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Ribosomal_uL13</TD><TD>interpro domains</TD><TD>IPR005822</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MRPL13</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Translin_N</TD><TD>interpro domains</TD><TD>IPR016068</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>TSN</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>HNF4_LBD</TD><TD>interpro domains</TD><TD>IPR049635</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>HNF4G</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>JIP_LZII</TD><TD>interpro domains</TD><TD>IPR032486</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>SPAG9</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>IL-1_rcpt_II-typ</TD><TD>interpro domains</TD><TD>IPR004077</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>IL1RAPL2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Atg3/Atg10</TD><TD>interpro domains</TD><TD>IPR007135</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>ATG10</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Amelogenin</TD><TD>interpro domains</TD><TD>IPR004116</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>AMELX</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>NBEA-like_DUF1088</TD><TD>interpro domains</TD><TD>IPR010508</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NBEA</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>SKAP_fam</TD><TD>interpro domains</TD><TD>IPR037781</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>SKAP2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>FNIP_fam</TD><TD>interpro domains</TD><TD>IPR026156</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Ribosomal_uL13_sf</TD><TD>interpro domains</TD><TD>IPR036899</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MRPL13</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>XPO1_C_dom</TD><TD>interpro domains</TD><TD>IPR014877</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>XPO4</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>Translin_sf</TD><TD>interpro domains</TD><TD>IPR036081</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>TSN</TD></TR>
<TR><TD>2.287e-02</TD><TD>-3.78</TD><TD>KH-I_NOVA_rpt1</TD><TD>interpro domains</TD><TD>IPR047275</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NOVA1</TD></TR>
<TR><TD>2.289e-02</TD><TD>-3.78</TD><TD>eye-uveal_tract-malignant_melanoma-spindle</TD><TD>COSMIC cancer mutations</TD><TD>eye-uveal_tract-malignant_melanoma-spindle</TD><TD>364</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>CASK,SPATA16,NRSN1,THSD7B,SPAG9,SLC10A2,PCDH9,FAT4,SLC7A14</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>DUF1088</TD><TD>pfam domains</TD><TD>PF06469</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>NBEA</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>MATCAP</TD><TD>pfam domains</TD><TD>PF08014</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>MATCAP2</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>Ribosomal_L13</TD><TD>pfam domains</TD><TD>PF00572</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>MRPL13</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>FNIP_C</TD><TD>pfam domains</TD><TD>PF14638</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>DBB</TD><TD>pfam domains</TD><TD>PF14545</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>BANK1</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>FOG1-like_PR</TD><TD>pfam domains</TD><TD>PF21182</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>TIR_3</TD><TD>pfam domains</TD><TD>PF18567</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>BANK1</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>Autophagy_act_C</TD><TD>pfam domains</TD><TD>PF03987</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>ATG10</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>CRM1_C</TD><TD>pfam domains</TD><TD>PF08767</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>XPO4</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>AChE_tetra</TD><TD>pfam domains</TD><TD>PF08674</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>BCHE</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>Acetyltransf_2</TD><TD>pfam domains</TD><TD>PF00797</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>NAT2</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>Translin</TD><TD>pfam domains</TD><TD>PF01997</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>TSN</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>Sec3-PIP2_bind</TD><TD>pfam domains</TD><TD>PF15277</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>STXBP6</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>Amelogenin</TD><TD>pfam domains</TD><TD>PF02948</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>AMELX</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>FNIP_N</TD><TD>pfam domains</TD><TD>PF14636</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>JIP_LZII</TD><TD>pfam domains</TD><TD>PF16471</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>SPAG9</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>SOBP</TD><TD>pfam domains</TD><TD>PF15279</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>RAI2</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>PACT_coil_coil</TD><TD>pfam domains</TD><TD>PF10495</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>AKAP9</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>COX7B</TD><TD>pfam domains</TD><TD>PF05392</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>COX7B2</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>RQC</TD><TD>pfam domains</TD><TD>PF09382</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>WRN</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>NCKAP5</TD><TD>pfam domains</TD><TD>PF15246</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>NCKAP5</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>FNIP_M</TD><TD>pfam domains</TD><TD>PF14637</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>Neuregulin</TD><TD>pfam domains</TD><TD>PF02158</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>NRG1</TD></TR>
<TR><TD>2.294e-02</TD><TD>-3.77</TD><TD>PLAC</TD><TD>prosite domains</TD><TD>PS50900</TD><TD>18</TD><TD>2</TD><TD>12232</TD><TD>161</TD>
<TD>ADAMTS3,ADAMTS12</TD></TR>
<TR><TD>2.296e-02</TD><TD>-3.77</TD><TD>SCAF8 (SR-related CTD associated factor 8)</TD><TD>protein interactions</TD><TD>22828</TD><TD>55</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>NUP35,WWOX,EMC2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>mesonephros development</TD><TD>biological process</TD><TD>GO:0001823</TD><TD>93</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>PBX1,FGFR2,ROBO2,SLIT2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>biliary_tract</TD><TD>COSMIC cancer mutations</TD><TD>biliary_tract</TD><TD>15383</TD><TD>182</TD><TD>16984</TD><TD>192</TD>
<TD>MEGF10,CXCL13,ACP6,ZFAND5,SEZ6L,PCGF5,LRFN5,TCF20,SPHKAP,KIF6,PAQR3,ACVR1C,LRRN2,NOBOX,XPO4,SKAP2,DSCAM,DNER,EPHA4,COQ2,TMEFF2,CASK,IRX1,ZNF133,PRKCE,PI15,CPXM2,CNTNAP2,ZNF521,PTPRK,FMNL2,KLF12,CYTL1,EFR3A,NUP35,ATG10,ADAM28,TGFBR2,PTPRD,NRCAM,SEMA3C,DAAM1,TSN,CALN1,AOAH,THSD7A,ZPLD1,ROBO2,RPH3A,RYR2,REXO2,SGCG,PHF14,ADAMTS5,EPHA3,NTRK2,HNF4G,CD96,ADAMTS12,IL1RAPL2,CETN3,WRN,MRPL3,BCHE,ADAMTS3,DNAJC12,RAI2,PBX1,UBR4,EFR3B,ASPN,LRRC3B,FIGN,PHLPP1,JMJD1C,OR52K2,FBN2,DEPTOR,RGS6,MUC7,SPAG9,PWWP2A,UCHL1,REG1B,LRIG3,FUT9,NRSN1,IPO8,FGD3,PAX6,IQGAP2,STXBP6,BACH2,FGF5,IGFL4,CTSO,SLC7A14,EDIL3,FNIP2,SLC25A46,FABP7,PXDNL,AGA,DAOA,KCNK9,CHRM3,MPEG1,GMDS,BANK1,ZNF518B,FANCB,SYT1,NBEA,FAT4,COX7B2,LMBRD1,FGF14,THSD7B,NAV3,FZD6,EPS8,LHCGR,NRG1,PRSS12,CRTC3,MRPL13,SLC7A8,SHISA3,PCDH9,INSM1,CDH5,ARX,UHMK1,ARL14,RUNX1T1,FGFR2,GCNT1,AMELX,FERD3L,EFNA5,PRLHR,EPYC,SLC10A2,LGI1,PSKH2,KAZN,LMX1A,NOL4,SLIT2,FGF20,MAP2,CNTN1,AKAP9,NAALADL2,PARP8,TWIST1,SS18,NOVA1,TRPS1,EFEMP1,WWOX,GPR83,B3GAT2,SERGEF,GHITM,PTPRZ1,UNC5C,OR2AG1,CD226,SLC39A10,VAV3,PLEK,NAT2,SPATA16,AFM,ZFPM2,ACVR2A,UTRN,DEFB115,GAP43,RASGEF1B,CELF2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development</TD><TD>biological process</TD><TD>GO:0035607</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>negative regulation of chorionic trophoblast cell proliferation</TD><TD>biological process</TD><TD>GO:1901383</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ACVR1C</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>negative regulation of integrin biosynthetic process</TD><TD>biological process</TD><TD>GO:0045720</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TMEFF2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>negative regulation of natural killer cell cytokine production</TD><TD>biological process</TD><TD>GO:0002728</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>CD96</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>negative regulation of mesenchymal cell proliferation involved in lung development</TD><TD>biological process</TD><TD>GO:2000791</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PHF14</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>lysobisphosphatidic acid metabolic process</TD><TD>biological process</TD><TD>GO:2001311</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ACP6</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>negative regulation of platelet-derived growth factor receptor-alpha signaling pathway</TD><TD>biological process</TD><TD>GO:2000584</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PHF14</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>mesenchymal cell differentiation involved in lung development</TD><TD>biological process</TD><TD>GO:0060915</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>regulation of B cell tolerance induction</TD><TD>biological process</TD><TD>GO:0002661</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>mammary gland bud formation</TD><TD>biological process</TD><TD>GO:0060615</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>pulmonary myocardium development</TD><TD>biological process</TD><TD>GO:0003350</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SEMA3C</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>regulation of anterograde synaptic vesicle transport</TD><TD>biological process</TD><TD>GO:1903742</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>MAP2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>luteinizing hormone signaling pathway</TD><TD>biological process</TD><TD>GO:0042700</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>LHCGR</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>cerebral cortex tangential migration using cell-cell interactions</TD><TD>biological process</TD><TD>GO:0021823</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity</TD><TD>biological process</TD><TD>GO:1904217</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SERINC5</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>superior temporal gyrus development</TD><TD>biological process</TD><TD>GO:0071109</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>bronchus morphogenesis</TD><TD>biological process</TD><TD>GO:0060434</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>mammary gland specification</TD><TD>biological process</TD><TD>GO:0060594</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>positive regulation of serine C-palmitoyltransferase activity</TD><TD>biological process</TD><TD>GO:1904222</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SERINC5</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>development of secondary male sexual characteristics</TD><TD>biological process</TD><TD>GO:0046544</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>LHCGR</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>regulation of mesenchymal cell proliferation involved in lung development</TD><TD>biological process</TD><TD>GO:2000790</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PHF14</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>regulation of glutamatergic neuron differentiation</TD><TD>biological process</TD><TD>GO:0120006</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>chemorepulsion involved in postnatal olfactory bulb interneuron migration</TD><TD>biological process</TD><TD>GO:0021836</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>squamous basal epithelial stem cell differentiation involved in prostate gland acinus development</TD><TD>biological process</TD><TD>GO:0060529</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>negative regulation of axon guidance</TD><TD>biological process</TD><TD>GO:1902668</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>'de novo' GDP-L-fucose biosynthetic process</TD><TD>biological process</TD><TD>GO:0042351</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>GMDS</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>penile erection</TD><TD>biological process</TD><TD>GO:0043084</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ACVR2A</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>positive regulation of B cell tolerance induction</TD><TD>biological process</TD><TD>GO:0002663</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>termination of mitochondrial transcription</TD><TD>biological process</TD><TD>GO:0006393</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>MTERF1</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>positive regulation of anterograde synaptic vesicle transport</TD><TD>biological process</TD><TD>GO:1903744</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>MAP2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>positive regulation of synaptic vesicle transport</TD><TD>biological process</TD><TD>GO:1902805</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>MAP2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>negative regulation of retinal ganglion cell axon guidance</TD><TD>biological process</TD><TD>GO:0090260</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>proximal/distal pattern formation involved in metanephric nephron development</TD><TD>biological process</TD><TD>GO:0072272</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>IRX1</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity</TD><TD>biological process</TD><TD>GO:1904219</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SERINC5</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>neuronal stem cell division</TD><TD>biological process</TD><TD>GO:0036445</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FUT9</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>post-embryonic retina morphogenesis in camera-type eye</TD><TD>biological process</TD><TD>GO:0060060</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>DSCAM</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>positive regulation of GTP binding</TD><TD>biological process</TD><TD>GO:1904426</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>negative regulation of microtubule binding</TD><TD>biological process</TD><TD>GO:1904527</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>MAP2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>adrenal chromaffin cell differentiation</TD><TD>biological process</TD><TD>GO:0061104</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>INSM1</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>corticospinal neuron axon guidance</TD><TD>biological process</TD><TD>GO:0021966</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>branch elongation involved in salivary gland morphogenesis</TD><TD>biological process</TD><TD>GO:0060667</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>mitochondrial membrane fission</TD><TD>biological process</TD><TD>GO:0090149</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLC25A46</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>postnatal olfactory bulb interneuron migration</TD><TD>biological process</TD><TD>GO:0021827</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>negative regulation of inositol phosphate biosynthetic process</TD><TD>biological process</TD><TD>GO:0010920</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PLEK</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>negative regulation of negative chemotaxis</TD><TD>biological process</TD><TD>GO:0050925</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ROBO2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>substrate-dependent cerebral cortex tangential migration</TD><TD>biological process</TD><TD>GO:0021825</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2</TD></TR>
<TR><TD>2.303e-02</TD><TD>-3.77</TD><TD>negative regulation of tooth mineralization</TD><TD>biological process</TD><TD>GO:0070171</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ASPN</TD></TR>
<TR><TD>2.317e-02</TD><TD>-3.76</TD><TD>testis-germ_cell_tumour-non_seminoma</TD><TD>COSMIC cancer mutations</TD><TD>testis-germ_cell_tumour-non_seminoma</TD><TD>488</TD><TD>11</TD><TD>16984</TD><TD>192</TD>
<TD>TGFBR2,ACVR2A,UHMK1,EPHA3,PRKCE,ACVR1C,PSKH2,NTRK2,FGFR2,CASK,EPHA4</TD></TR>
<TR><TD>2.332e-02</TD><TD>-3.76</TD><TD>haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma</TD><TD>683</TD><TD>14</TD><TD>16984</TD><TD>192</TD>
<TD>LGI1,CNTNAP2,UBR4,PRLHR,PRKCE,EPHA3,ACVR2A,MAP2,MPEG1,RYR2,FZD6,ADAMTS5,XPO4,LRIG3</TD></TR>
<TR><TD>2.332e-02</TD><TD>-3.76</TD><TD>primary_central_nervous_system_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>primary_central_nervous_system_lymphoma</TD><TD>683</TD><TD>14</TD><TD>16984</TD><TD>192</TD>
<TD>UBR4,LGI1,CNTNAP2,ACVR2A,MAP2,PRLHR,PRKCE,EPHA3,FZD6,ADAMTS5,MPEG1,RYR2,XPO4,LRIG3</TD></TR>
<TR><TD>2.346e-02</TD><TD>-3.75</TD><TD>FBRS (fibrosin)</TD><TD>protein interactions</TD><TD>64319</TD><TD>98</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>WWOX,PCGF5,NUP35,PAX6</TD></TR>
<TR><TD>2.350e-02</TD><TD>-3.75</TD><TD>regulation of chondrocyte differentiation</TD><TD>biological process</TD><TD>GO:0032330</TD><TD>53</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>ADAMTS12,TRPS1,EFEMP1</TD></TR>
<TR><TD>2.350e-02</TD><TD>-3.75</TD><TD>positive regulation of organ growth</TD><TD>biological process</TD><TD>GO:0046622</TD><TD>53</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>ARX,ZFPM2,FGFR2</TD></TR>
<TR><TD>2.355e-02</TD><TD>-3.75</TD><TD>biliary_tract-bile_duct-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>biliary_tract-bile_duct-carcinoma-adenocarcinoma</TD><TD>15167</TD><TD>180</TD><TD>16984</TD><TD>192</TD>
<TD>TRPS1,EFEMP1,WWOX,GPR83,SERGEF,B3GAT2,PTPRZ1,GHITM,UNC5C,OR2AG1,CD226,VAV3,SLC39A10,PLEK,NAT2,AFM,SPATA16,ZFPM2,ACVR2A,UTRN,DEFB115,GAP43,CELF2,RASGEF1B,RUNX1T1,FGFR2,GCNT1,AMELX,FERD3L,PRLHR,EFNA5,EPYC,LGI1,SLC10A2,PSKH2,KAZN,LMX1A,NOL4,SLIT2,FGF20,MAP2,NAALADL2,AKAP9,CNTN1,PARP8,NOVA1,TWIST1,SS18,COX7B2,LMBRD1,FGF14,THSD7B,NAV3,FZD6,EPS8,LHCGR,NRG1,PRSS12,MRPL13,CRTC3,SLC7A8,SHISA3,PCDH9,INSM1,CDH5,ARX,ARL14,UHMK1,BACH2,FGF5,IGFL4,CTSO,EDIL3,SLC7A14,FNIP2,FABP7,SLC25A46,PXDNL,AGA,DAOA,KCNK9,CHRM3,GMDS,MPEG1,FANCB,SYT1,BANK1,ZNF518B,NBEA,FAT4,DEPTOR,FBN2,RGS6,MUC7,SPAG9,PWWP2A,UCHL1,REG1B,LRIG3,FUT9,NRSN1,IPO8,FGD3,PAX6,IQGAP2,STXBP6,IL1RAPL2,WRN,CETN3,MRPL3,ADAMTS3,BCHE,DNAJC12,RAI2,PBX1,UBR4,ASPN,LRRC3B,FIGN,PHLPP1,JMJD1C,OR52K2,PTPRK,ZNF521,FMNL2,KLF12,CYTL1,NUP35,EFR3A,ATG10,ADAM28,TGFBR2,PTPRD,SEMA3C,NRCAM,DAAM1,TSN,CALN1,AOAH,ZPLD1,THSD7A,ROBO2,RYR2,RPH3A,REXO2,ADAMTS5,SGCG,PHF14,EPHA3,HNF4G,NTRK2,CD96,ADAMTS12,CXCL13,MEGF10,ACP6,ZFAND5,PCGF5,SEZ6L,LRFN5,TCF20,KIF6,PAQR3,LRRN2,ACVR1C,NOBOX,SKAP2,XPO4,DSCAM,EPHA4,DNER,COQ2,TMEFF2,CASK,IRX1,PRKCE,ZNF133,PI15,CPXM2,CNTNAP2</TD></TR>
<TR><TD>2.355e-02</TD><TD>-3.75</TD><TD>bile_duct</TD><TD>COSMIC cancer mutations</TD><TD>bile_duct</TD><TD>15167</TD><TD>180</TD><TD>16984</TD><TD>192</TD>
<TD>SPATA16,AFM,NAT2,SLC39A10,VAV3,PLEK,DEFB115,RASGEF1B,CELF2,GAP43,ZFPM2,UTRN,ACVR2A,EFEMP1,WWOX,TRPS1,OR2AG1,CD226,B3GAT2,SERGEF,GPR83,UNC5C,GHITM,PTPRZ1,FGF20,NOL4,SLIT2,PARP8,AKAP9,CNTN1,NAALADL2,TWIST1,SS18,NOVA1,MAP2,AMELX,FERD3L,FGFR2,RUNX1T1,GCNT1,PSKH2,SLC10A2,LGI1,KAZN,LMX1A,EFNA5,PRLHR,EPYC,CDH5,INSM1,PCDH9,SHISA3,ARX,UHMK1,ARL14,THSD7B,FGF14,LMBRD1,FZD6,NAV3,COX7B2,CRTC3,MRPL13,SLC7A8,LHCGR,EPS8,PRSS12,NRG1,MPEG1,GMDS,NBEA,BANK1,ZNF518B,FANCB,SYT1,DAOA,CHRM3,KCNK9,FAT4,IGFL4,CTSO,FGF5,BACH2,SLC25A46,FABP7,AGA,PXDNL,SLC7A14,EDIL3,FNIP2,FUT9,IPO8,NRSN1,LRIG3,REG1B,IQGAP2,STXBP6,FGD3,PAX6,SPAG9,MUC7,DEPTOR,FBN2,RGS6,UCHL1,PWWP2A,FIGN,ASPN,LRRC3B,JMJD1C,OR52K2,PHLPP1,BCHE,ADAMTS3,IL1RAPL2,MRPL3,CETN3,WRN,UBR4,RAI2,PBX1,DNAJC12,RPH3A,RYR2,ROBO2,SGCG,PHF14,ADAMTS5,REXO2,AOAH,THSD7A,ZPLD1,NTRK2,HNF4G,CD96,ADAMTS12,EPHA3,CYTL1,ATG10,EFR3A,NUP35,FMNL2,ZNF521,PTPRK,KLF12,DAAM1,SEMA3C,NRCAM,CALN1,TSN,ADAM28,PTPRD,TGFBR2,COQ2,DNER,EPHA4,CASK,TMEFF2,XPO4,SKAP2,DSCAM,CNTNAP2,ZNF133,PRKCE,IRX1,CPXM2,PI15,LRFN5,SEZ6L,PCGF5,TCF20,ACP6,MEGF10,CXCL13,ZFAND5,PAQR3,KIF6,NOBOX,ACVR1C,LRRN2</TD></TR>
<TR><TD>2.370e-02</TD><TD>-3.74</TD><TD>phosphorylation</TD><TD>biological process</TD><TD>GO:0016310</TD><TD>732</TD><TD>15</TD><TD>18905</TD><TD>219</TD>
<TD>EFEMP1,ACVR2A,NTRK2,FGFR2,UHMK1,TGFBR2,EPHA4,PSKH2,MAST4,PRKCE,TEC,FNIP2,CASK,ACVR1C,EPHA3</TD></TR>
<TR><TD>2.371e-02</TD><TD>-3.74</TD><TD>Bile Acid Direct Signalling Pathway (2) </TD><TD>SMPDB pathways</TD><TD>SMP0089751</TD><TD>3</TD><TD>1</TD><TD>1382</TD><TD>11</TD>
<TD>SLC10A2</TD></TR>
<TR><TD>2.389e-02</TD><TD>-3.73</TD><TD>soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal</TD><TD>2677</TD><TD>41</TD><TD>16984</TD><TD>192</TD>
<TD>LHCGR,NRG1,PTPRZ1,PRSS12,SLC10A2,KIF6,ACVR1C,PXDNL,CD226,NOBOX,UBR4,FGFR2,FMNL2,FBN2,GCNT1,RGS6,WRN,MRPL3,SEZ6L,ADAMTS3,THSD7B,SPAG9,TCF20,FGD3,FAT4,ZFPM2,UHMK1,CNTNAP2,GAP43,RASGEF1B,IQGAP2,ASPN,SLC39A10,VAV3,THSD7A,DSCAM,ROBO2,RPH3A,RYR2,ADAMTS5,AFM</TD></TR>
<TR><TD>2.389e-02</TD><TD>-3.73</TD><TD>embryonal</TD><TD>COSMIC cancer mutations</TD><TD>embryonal</TD><TD>2677</TD><TD>41</TD><TD>16984</TD><TD>192</TD>
<TD>RASGEF1B,IQGAP2,GAP43,CNTNAP2,UHMK1,ZFPM2,FGD3,FAT4,AFM,ADAMTS5,RPH3A,RYR2,ROBO2,THSD7A,DSCAM,SLC39A10,VAV3,ASPN,UBR4,NOBOX,PXDNL,CD226,ACVR1C,SLC10A2,KIF6,PRSS12,NRG1,PTPRZ1,LHCGR,TCF20,SPAG9,THSD7B,SEZ6L,ADAMTS3,MRPL3,GCNT1,RGS6,WRN,FGFR2,FMNL2,FBN2</TD></TR>
<TR><TD>2.407e-02</TD><TD>-3.73</TD><TD>ECI1 (enoyl-CoA delta isomerase 1)</TD><TD>protein interactions</TD><TD>1632</TD><TD>56</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>REXO2,AGA,ACP6</TD></TR>
<TR><TD>2.412e-02</TD><TD>-3.72</TD><TD>endometrium-carcinoma-endometrioid_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>endometrium-carcinoma-endometrioid_carcinoma</TD><TD>15731</TD><TD>185</TD><TD>16984</TD><TD>192</TD>
<TD>SLIT2,NOL4,NCKAP5,NOVA1,TWIST1,SS18,SPANXN1,NAALADL2,CNTN1,AKAP9,PARP8,SERINC5,MAP2,FERD3L,AMELX,GCNT1,RUNX1T1,FGFR2,KAZN,LMX1A,LGI1,SLC10A2,PSKH2,EPYC,PRLHR,EFNA5,NAT2,AFM,SPATA16,PLEK,VAV3,SLC39A10,GAP43,CELF2,RASGEF1B,DEFB115,ACVR2A,UTRN,ZFPM2,WWOX,EFEMP1,TRPS1,CD226,OR2AG1,PTPRZ1,GHITM,UNC5C,GPR83,SERGEF,B3GAT2,FANCB,SYT1,BANK1,ZNF518B,NBEA,GMDS,MPEG1,KCNK9,CHRM3,DAOA,FAT4,CTSO,IGFL4,BACH2,FGF5,PXDNL,AGA,FABP7,SLC25A46,FNIP2,SLC7A14,EDIL3,CDH5,SHISA3,PCDH9,RBM20,ARL14,UHMK1,ARX,NAV3,FZD6,LMBRD1,FGF14,THSD7B,COX7B2,SLC7A8,MRPL13,CRTC3,NRG1,PRSS12,EPS8,LHCGR,FIGN,LRRC3B,ASPN,EFR3B,OR52K2,LRRC70,JMJD1C,PHLPP1,ADAMTS3,BCHE,WRN,CETN3,MRPL3,IL1RAPL2,UBR4,DNAJC12,RAI2,NRSN1,IPO8,FUT9,LRIG3,REG1B,STXBP6,IQGAP2,PAX6,FGD3,MUC7,SPAG9,RGS6,DEPTOR,FBN2,UCHL1,PWWP2A,SGCD,TMEFF2,CASK,EPHA4,DNER,COQ2,DSCAM,SKAP2,XPO4,CNTNAP2,PI15,CPXM2,IRX1,PRKCE,ZNF133,TCF20,PCGF5,SEZ6L,LRFN5,ZFAND5,CXCL13,MEGF10,ACP6,LRRN2,ACVR1C,NOBOX,KIF6,PAQR3,SPHKAP,REXO2,ADAMTS5,SGCG,PHF14,ROBO2,RYR2,RPH3A,ZPLD1,THSD7A,AOAH,ADAMTS12,NTRK2,CD96,HNF4G,EPHA3,NUP35,EFR3A,ATG10,CYTL1,KLF12,PTPRK,ZNF521,FMNL2,TSN,CALN1,SEMA3C,NRCAM,DAAM1,TGFBR2,PTPRD,ADAM28</TD></TR>
<TR><TD>2.421e-02</TD><TD>-3.72</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.30.1460.50</TD><TD>2</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>ATG10</TD></TR>
<TR><TD>2.421e-02</TD><TD>-3.72</TD><TD>-</TD><TD>gene3d domains</TD><TD>6.10.250.220</TD><TD>2</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>SKAP2</TD></TR>
<TR><TD>2.421e-02</TD><TD>-3.72</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.30.29.90</TD><TD>2</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>STXBP6</TD></TR>
<TR><TD>2.421e-02</TD><TD>-3.72</TD><TD>arf6 gtpase in complex with a specific effector, jip4</TD><TD>gene3d domains</TD><TD>1.20.5.1000</TD><TD>2</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>SPAG9</TD></TR>
<TR><TD>2.421e-02</TD><TD>-3.72</TD><TD>Ribosomal protein L13</TD><TD>gene3d domains</TD><TD>3.90.1180.10</TD><TD>2</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>MRPL13</TD></TR>
<TR><TD>2.421e-02</TD><TD>-3.72</TD><TD>Cytochrome C Oxidase, chain K</TD><TD>gene3d domains</TD><TD>4.10.51.10</TD><TD>2</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>COX7B2</TD></TR>
<TR><TD>2.421e-02</TD><TD>-3.72</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.30.2140.20</TD><TD>2</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>NAT2</TD></TR>
<TR><TD>2.424e-02</TD><TD>-3.72</TD><TD>PRKACG (protein kinase cAMP-activated catalytic subunit gamma)</TD><TD>protein interactions</TD><TD>5568</TD><TD>99</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>AKAP9,MAP2,RYR2,SPAG9</TD></TR>
<TR><TD>2.427e-02</TD><TD>-3.72</TD><TD>protein localization to extracellular region</TD><TD>biological process</TD><TD>GO:0071692</TD><TD>141</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>AFM,ACVR1C,FBN2,PRKCE,PLEK</TD></TR>
<TR><TD>2.427e-02</TD><TD>-3.72</TD><TD>cardiac right ventricle morphogenesis</TD><TD>biological process</TD><TD>GO:0003215</TD><TD>21</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>ZFPM2,SEMA3C</TD></TR>
<TR><TD>2.427e-02</TD><TD>-3.72</TD><TD>cellular response to prostaglandin stimulus</TD><TD>biological process</TD><TD>GO:0071379</TD><TD>21</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,PRKCE</TD></TR>
<TR><TD>2.430e-02</TD><TD>-3.72</TD><TD>skin-knee-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-knee-malignant_melanoma</TD><TD>97</TD><TD>4</TD><TD>16984</TD><TD>192</TD>
<TD>ADAM28,ADAMTS3,CHRM3,PTPRD</TD></TR>
<TR><TD>2.431e-02</TD><TD>-3.72</TD><TD>TTC7B (tetratricopeptide repeat domain 7B)</TD><TD>protein interactions</TD><TD>145567</TD><TD>22</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>DSCAM,CD226</TD></TR>
<TR><TD>2.431e-02</TD><TD>-3.72</TD><TD>RFXAP (regulatory factor X associated protein)</TD><TD>protein interactions</TD><TD>5994</TD><TD>22</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>EPS8,PAX6</TD></TR>
<TR><TD>2.431e-02</TD><TD>-3.72</TD><TD>TRHR (thyrotropin releasing hormone receptor)</TD><TD>protein interactions</TD><TD>7201</TD><TD>22</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>EFNA5,TMEFF2</TD></TR>
<TR><TD>2.431e-02</TD><TD>-3.72</TD><TD>ENC1 (ectodermal-neural cortex 1)</TD><TD>protein interactions</TD><TD>8507</TD><TD>22</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>DSCAM,BACH2</TD></TR>
<TR><TD>2.444e-02</TD><TD>-3.71</TD><TD>human chr1p13.3</TD><TD>chromosome location</TD><TD>human chr1p13.3</TD><TD>115</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>VAV3,LINC01661</TD></TR>
<TR><TD>2.455e-02</TD><TD>-3.71</TD><TD>extracellular matrix structural constituent conferring compression resistance</TD><TD>molecular function</TD><TD>GO:0030021</TD><TD>22</TD><TD>2</TD><TD>18530</TD><TD>206</TD>
<TD>AMELX,ASPN</TD></TR>
<TR><TD>2.458e-02</TD><TD>-3.71</TD><TD>synaptic cleft</TD><TD>cellular component</TD><TD>GO:0043083</TD><TD>22</TD><TD>2</TD><TD>19868</TD><TD>221</TD>
<TD>PRSS12,LGI1</TD></TR>
<TR><TD>2.467e-02</TD><TD>-3.70</TD><TD>positive regulation of biomineral tissue development</TD><TD>biological process</TD><TD>GO:0070169</TD><TD>54</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>FBN2,ACVR2A,AMELX</TD></TR>
<TR><TD>2.470e-02</TD><TD>-3.70</TD><TD>microvillus</TD><TD>cellular component</TD><TD>GO:0005902</TD><TD>99</TD><TD>4</TD><TD>19868</TD><TD>221</TD>
<TD>IQGAP2,SLC10A2,WWOX,SLC7A8</TD></TR>
<TR><TD>2.474e-02</TD><TD>-3.70</TD><TD>non_seminoma</TD><TD>COSMIC cancer mutations</TD><TD>non_seminoma</TD><TD>493</TD><TD>11</TD><TD>16984</TD><TD>192</TD>
<TD>EPHA4,PSKH2,NTRK2,ACVR1C,CASK,PRKCE,FGFR2,EPHA3,TGFBR2,ACVR2A,UHMK1</TD></TR>
<TR><TD>2.478e-02</TD><TD>-3.70</TD><TD>human chr5q11.1</TD><TD>chromosome location</TD><TD>human chr5q11.1</TD><TD>12</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>PARP8</TD></TR>
<TR><TD>2.478e-02</TD><TD>-3.70</TD><TD>human chr4q21.3</TD><TD>chromosome location</TD><TD>human chr4q21.3</TD><TD>12</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>MAPK10-AS1</TD></TR>
<TR><TD>2.483e-02</TD><TD>-3.70</TD><TD>human chrXp22.2</TD><TD>chromosome location</TD><TD>human chrXp22.2</TD><TD>116</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>AMELX,FANCB</TD></TR>
<TR><TD>2.501e-02</TD><TD>-3.69</TD><TD>PLCG1 (phospholipase C gamma 1)</TD><TD>protein interactions</TD><TD>5335</TD><TD>258</TD><TD>7</TD><TD>20077</TD><TD>222</TD>
<TD>FGFR2,NTRK2,GAREM1,TEC,VAV3,PECAM1,PRKCE</TD></TR>
<TR><TD>2.504e-02</TD><TD>-3.69</TD><TD>FATE1 (fetal and adult testis expressed 1)</TD><TD>protein interactions</TD><TD>89885</TD><TD>100</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>MARCHF3,CALN1,NRSN1,SLC7A14</TD></TR>
<TR><TD>2.504e-02</TD><TD>-3.69</TD><TD>NDFIP1 (Nedd4 family interacting protein 1)</TD><TD>protein interactions</TD><TD>80762</TD><TD>100</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>LRRN2,TGFBR2,NRSN1,NTRK2</TD></TR>
<TR><TD>2.521e-02</TD><TD>-3.68</TD><TD>regulation of cellular process</TD><TD>biological process</TD><TD>GO:0050794</TD><TD>11710</TD><TD>150</TD><TD>18905</TD><TD>219</TD>
<TD>PARP8,ATG10,ADGRL3,GAP43,CELF2,FZD6,PPP1R17,MAST4,PUM3,FBN2,RGS6,PTPRK,MTERF1,BRINP3,NRG1,PHF14,EFNA5,DAAM1,DCDC2C,SEZ6L,ASPN,UTRN,EPHA4,UHMK1,FGD3,FNIP2,NAV3,SLC39A10,EDIL3,LMX1A,DEPTOR,PECAM1,ARX,IL1RAPL2,IPO8,CD96,FABP7,SERGEF,SS18,NOBOX,FANCB,EPS8,REG1B,TMEFF2,JMJD1C,ZFAND5,WWOX,EFEMP1,VAV3,RBM20,FGF14,AKAP9,LGI1,CNTNAP2,BCHE,SEMA3C,AMELX,OR2AG1,CDH5,SPAG9,CD226,SHISA3,CRTC3,NRCAM,TEC,UCHL1,RYR2,TSN,RPH3A,MRPL13,STXBP6,UBR4,ACVR2A,GAREM1,CYTL1,PWWP2A,MIR1260B,TGFBR2,ZNF133,NOVA1,SEPTIN5,HNF4G,ZNF518B,MEGF10,DNER,PRKCE,RASGEF1B,SKAP2,SYT1,BANK1,IQGAP2,SHTN1,MIR548A3,MIR891A,NTRK2,MIR147A,ZFPM2,FAT4,UNC5C,TWIST1,CXCL13,GPR83,PCGF5,LRRN2,FGF5,BACH2,MIR577,PLEK,MIR548AA2,TRPS1,LHCGR,KLF12,CNTN1,ZNF521,IRX1,ADAMTS3,FERD3L,PAX6,MIR9-2HG,RUNX1T1,ADAMTS12,TCF20,OR52K2,MIR551B,ROBO2,PTPRZ1,FGF20,FUT9,SGCD,ACVR1C,PAQR3,INSM1,PBX1,GCNT1,GMDS,SLIT2,CHRM3,FGFR2,XPO4,MAP2,GHITM,PRLHR,PTPRD,PHLPP1,MIR569,C8orf88,EPHA3,DSCAM,CASK,LRFN5</TD></TR>
<TR><TD>2.534e-02</TD><TD>-3.68</TD><TD>GTPase binding</TD><TD>molecular function</TD><TD>GO:0051020</TD><TD>316</TD><TD>8</TD><TD>18530</TD><TD>206</TD>
<TD>EPS8,DAAM1,FMNL2,IPO8,XPO4,FGD3,RPH3A,IQGAP2</TD></TR>
<TR><TD>2.538e-02</TD><TD>-3.67</TD><TD>embryo development ending in birth or egg hatching</TD><TD>biological process</TD><TD>GO:0009792</TD><TD>673</TD><TD>14</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1,ZFAND5,ACVR1C,RAI2,ACVR2A,FZD6,PBX1,TGFBR2,ZFPM2,SEMA3C,ADAMTS3,FGFR2,PAX6,FERD3L</TD></TR>
<TR><TD>2.546e-02</TD><TD>-3.67</TD><TD>regulation of microtubule polymerization or depolymerization</TD><TD>biological process</TD><TD>GO:0031110</TD><TD>96</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>AKAP9,CDH5,MAP2,NAV3</TD></TR>
<TR><TD>2.553e-02</TD><TD>-3.67</TD><TD>ear</TD><TD>COSMIC cancer mutations</TD><TD>ear</TD><TD>625</TD><TD>13</TD><TD>16984</TD><TD>192</TD>
<TD>SPATA16,FGFR2,PTPRK,CHRM3,CNTNAP2,SLC7A8,AGA,UBR4,LRRN2,EDIL3,FAT4,PTPRD,UTRN</TD></TR>
<TR><TD>2.554e-02</TD><TD>-3.67</TD><TD>clathrin binding</TD><TD>molecular function</TD><TD>GO:0030276</TD><TD>57</TD><TD>3</TD><TD>18530</TD><TD>206</TD>
<TD>DNER,LMBRD1,SYT1</TD></TR>
<TR><TD>2.581e-02</TD><TD>-3.66</TD><TD>endometrioid_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>endometrioid_carcinoma</TD><TD>15741</TD><TD>185</TD><TD>16984</TD><TD>192</TD>
<TD>FGD3,PAX6,STXBP6,IQGAP2,REG1B,LRIG3,FUT9,IPO8,NRSN1,PWWP2A,UCHL1,DEPTOR,FBN2,RGS6,SPAG9,MUC7,PHLPP1,LRRC70,JMJD1C,OR52K2,ASPN,EFR3B,LRRC3B,FIGN,RAI2,DNAJC12,UBR4,IL1RAPL2,MRPL3,WRN,CETN3,ADAMTS3,BCHE,EPHA3,HNF4G,CD96,NTRK2,ADAMTS12,AOAH,ZPLD1,THSD7A,RYR2,RPH3A,ROBO2,ADAMTS5,SGCG,PHF14,REXO2,ADAM28,PTPRD,TGFBR2,DAAM1,SEMA3C,NRCAM,CALN1,TSN,FMNL2,PTPRK,ZNF521,KLF12,CYTL1,ATG10,NUP35,EFR3A,PRKCE,ZNF133,IRX1,CPXM2,PI15,CNTNAP2,SKAP2,XPO4,DSCAM,COQ2,EPHA4,DNER,CASK,SGCD,TMEFF2,SPHKAP,PAQR3,KIF6,NOBOX,LRRN2,ACVR1C,ACP6,CXCL13,MEGF10,ZFAND5,LRFN5,SEZ6L,PCGF5,TCF20,ZFPM2,UTRN,ACVR2A,DEFB115,RASGEF1B,CELF2,GAP43,VAV3,SLC39A10,PLEK,AFM,SPATA16,NAT2,B3GAT2,SERGEF,GPR83,UNC5C,PTPRZ1,GHITM,OR2AG1,CD226,TRPS1,EFEMP1,WWOX,MAP2,SERINC5,PARP8,NAALADL2,AKAP9,CNTN1,SPANXN1,NOVA1,SS18,TWIST1,NCKAP5,NOL4,SLIT2,PRLHR,EFNA5,EPYC,PSKH2,LGI1,SLC10A2,LMX1A,KAZN,FGFR2,RUNX1T1,GCNT1,AMELX,FERD3L,ARX,ARL14,UHMK1,RBM20,PCDH9,SHISA3,CDH5,LHCGR,EPS8,PRSS12,NRG1,MRPL13,CRTC3,SLC7A8,COX7B2,THSD7B,FGF14,LMBRD1,FZD6,NAV3,FAT4,DAOA,CHRM3,KCNK9,GMDS,MPEG1,NBEA,SYT1,FANCB,ZNF518B,BANK1,SLC7A14,EDIL3,FNIP2,FABP7,SLC25A46,AGA,PXDNL,FGF5,BACH2,IGFL4,CTSO</TD></TR>
<TR><TD>2.585e-02</TD><TD>-3.66</TD><TD>LDB1 (LIM domain binding 1)</TD><TD>protein interactions</TD><TD>8861</TD><TD>101</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>PAX6,LMX1A,DSCAM,ATG10</TD></TR>
<TR><TD>2.585e-02</TD><TD>-3.66</TD><TD>EFNA1 (ephrin A1)</TD><TD>protein interactions</TD><TD>1942</TD><TD>101</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>EPHA3,GAREM1,KAZN,EPHA4</TD></TR>
<TR><TD>2.585e-02</TD><TD>-3.66</TD><TD>LRP5 (LDL receptor related protein 5)</TD><TD>protein interactions</TD><TD>4041</TD><TD>101</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>BRINP3,LGI1,NRSN1,PI15</TD></TR>
<TR><TD>2.588e-02</TD><TD>-3.65</TD><TD>neural crest cell migration</TD><TD>biological process</TD><TD>GO:0001755</TD><TD>55</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,TWIST1,SEMA3C</TD></TR>
<TR><TD>2.588e-02</TD><TD>-3.65</TD><TD>regulation of alternative mRNA splicing, via spliceosome</TD><TD>biological process</TD><TD>GO:0000381</TD><TD>55</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>CELF2,RBM20,NOVA1</TD></TR>
<TR><TD>2.595e-02</TD><TD>-3.65</TD><TD>large_intestine-rectum-adenoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-rectum-adenoma</TD><TD>99</TD><TD>4</TD><TD>16984</TD><TD>192</TD>
<TD>PTPRK,FAT4,UCHL1,NTRK2</TD></TR>
<TR><TD>2.595e-02</TD><TD>-3.65</TD><TD>bone-tibia-other-chondroblastoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-tibia-other-chondroblastoma</TD><TD>99</TD><TD>4</TD><TD>16984</TD><TD>192</TD>
<TD>VAV3,NCKAP5,NAALADL2,NOL4</TD></TR>
<TR><TD>2.603e-02</TD><TD>-3.65</TD><TD>human chr16q21</TD><TD>chromosome location</TD><TD>human chr16q21</TD><TD>119</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>APOOP5,CDH5</TD></TR>
<TR><TD>2.615e-02</TD><TD>-3.64</TD><TD>UCH_1</TD><TD>prosite domains</TD><TD>PS00140</TD><TD>2</TD><TD>1</TD><TD>12232</TD><TD>161</TD>
<TD>UCHL1</TD></TR>
<TR><TD>2.615e-02</TD><TD>-3.64</TD><TD>RIBOSOMAL_L13</TD><TD>prosite domains</TD><TD>PS00783</TD><TD>2</TD><TD>1</TD><TD>12232</TD><TD>161</TD>
<TD>MRPL13</TD></TR>
<TR><TD>2.615e-02</TD><TD>-3.64</TD><TD>DBB</TD><TD>prosite domains</TD><TD>PS51376</TD><TD>2</TD><TD>1</TD><TD>12232</TD><TD>161</TD>
<TD>BANK1</TD></TR>
<TR><TD>2.615e-02</TD><TD>-3.64</TD><TD>UBIA</TD><TD>prosite domains</TD><TD>PS00943</TD><TD>2</TD><TD>1</TD><TD>12232</TD><TD>161</TD>
<TD>COQ2</TD></TR>
<TR><TD>2.615e-02</TD><TD>-3.64</TD><TD>DENN_FNIP12</TD><TD>prosite domains</TD><TD>PS51836</TD><TD>2</TD><TD>1</TD><TD>12232</TD><TD>161</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.615e-02</TD><TD>-3.64</TD><TD>ZF_CCHC_FOG</TD><TD>prosite domains</TD><TD>PS51810</TD><TD>2</TD><TD>1</TD><TD>12232</TD><TD>161</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>2.615e-02</TD><TD>-3.64</TD><TD>EPHD</TD><TD>interpro domains</TD><TD>IPR034732</TD><TD>22</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>PHF14,TCF20</TD></TR>
<TR><TD>2.616e-02</TD><TD>-3.64</TD><TD>endometrium</TD><TD>COSMIC cancer mutations</TD><TD>endometrium</TD><TD>15743</TD><TD>185</TD><TD>16984</TD><TD>192</TD>
<TD>FUT9,NRSN1,IPO8,REG1B,LRIG3,IQGAP2,STXBP6,FGD3,PAX6,MUC7,SPAG9,DEPTOR,FBN2,RGS6,UCHL1,PWWP2A,FIGN,ASPN,EFR3B,LRRC3B,LRRC70,JMJD1C,OR52K2,PHLPP1,ADAMTS3,BCHE,IL1RAPL2,WRN,CETN3,MRPL3,UBR4,DNAJC12,RAI2,ROBO2,RYR2,RPH3A,REXO2,ADAMTS5,SGCG,PHF14,AOAH,ZPLD1,THSD7A,HNF4G,CD96,NTRK2,ADAMTS12,EPHA3,CYTL1,NUP35,EFR3A,ATG10,PTPRK,ZNF521,FMNL2,KLF12,NRCAM,SEMA3C,DAAM1,TSN,CALN1,ADAM28,TGFBR2,PTPRD,EPHA4,DNER,COQ2,SGCD,TMEFF2,CASK,SKAP2,XPO4,DSCAM,CNTNAP2,IRX1,PRKCE,ZNF133,PI15,CPXM2,PCGF5,SEZ6L,LRFN5,TCF20,CXCL13,MEGF10,ACP6,ZFAND5,KIF6,PAQR3,LRRN2,ACVR1C,NOBOX,SPHKAP,NAT2,AFM,SPATA16,VAV3,SLC39A10,PLEK,DEFB115,GAP43,RASGEF1B,CELF2,ZFPM2,ACVR2A,UTRN,EFEMP1,WWOX,TRPS1,OR2AG1,CD226,GPR83,B3GAT2,SERGEF,PTPRZ1,GHITM,UNC5C,NOL4,NCKAP5,SLIT2,NAALADL2,AKAP9,CNTN1,PARP8,NOVA1,SS18,TWIST1,SPANXN1,SERINC5,MAP2,AMELX,FERD3L,RUNX1T1,FGFR2,GCNT1,LGI1,SLC10A2,PSKH2,KAZN,LMX1A,PRLHR,EFNA5,EPYC,CDH5,SHISA3,PCDH9,ARX,RBM20,ARL14,UHMK1,LMBRD1,THSD7B,FGF14,NAV3,FZD6,COX7B2,MRPL13,CRTC3,SLC7A8,EPS8,LHCGR,NRG1,PRSS12,GMDS,MPEG1,SYT1,FANCB,ZNF518B,BANK1,NBEA,DAOA,KCNK9,CHRM3,FAT4,IGFL4,CTSO,BACH2,FGF5,FABP7,SLC25A46,PXDNL,AGA,SLC7A14,EDIL3,FNIP2</TD></TR>
<TR><TD>2.618e-02</TD><TD>-3.64</TD><TD>RINGv</TD><TD>smart domains</TD><TD>SM00744</TD><TD>17</TD><TD>2</TD><TD>9743</TD><TD>146</TD>
<TD>MARCHF3,MARCHF11</TD></TR>
<TR><TD>2.622e-02</TD><TD>-3.64</TD><TD>extracellular region</TD><TD>cellular component</TD><TD>GO:0005576</TD><TD>4518</TD><TD>63</TD><TD>19868</TD><TD>221</TD>
<TD>BCHE,PLEK,NRCAM,FBN2,EDIL3,AGA,AOAH,UTRN,FGF5,MIR1973,PTPRD,SPAG9,FAT4,SLIT2,EDDM13,ADAM28,PECAM1,IGFL4,NRG1,LRIG3,DSCAM,FGFR2,ADAMTS12,ZPLD1,GCNT1,PRSS12,CXCL13,EPS8,CTSO,CPQ,GMDS,IQGAP2,SERINC5,DEFB115,ASPN,PXDNL,EPHA3,ADAMTS5,DAW1,ACTR3C,AFM,THSD7A,FGF20,AMELX,LRRC3B,LGI1,CNTN1,TGFBR2,GHITM,MUC7,CYTL1,SEMA3C,PI15,ADAMTS3,MPEG1,TMEFF2,LRRN2,LHCGR,BRINP3,PTPRZ1,REG1B,EFEMP1,ROBO2</TD></TR>
<TR><TD>2.629e-02</TD><TD>-3.64</TD><TD>inner ear development</TD><TD>biological process</TD><TD>GO:0048839</TD><TD>195</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4,FGF20,FZD6,FGFR2,CYTL1,LRIG3</TD></TR>
<TR><TD>2.632e-02</TD><TD>-3.64</TD><TD>superficial_spreading</TD><TD>COSMIC cancer mutations</TD><TD>superficial_spreading</TD><TD>1110</TD><TD>20</TD><TD>16984</TD><TD>192</TD>
<TD>FUT9,EFR3A,SYT1,FGFR2,FBN2,PTPRK,ASPN,RUNX1T1,SLIT2,CNTNAP2,HNF4G,SLC25A46,RASGEF1B,ADAMTS12,NOVA1,EPHA3,FAT4,SPHKAP,UTRN,TGFBR2</TD></TR>
<TR><TD>2.634e-02</TD><TD>-3.64</TD><TD>Signaling by FGFR in disease</TD><TD>REACTOME pathways</TD><TD>R-HSA-1226099</TD><TD>63</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGFR2,FGF20</TD></TR>
<TR><TD>2.634e-02</TD><TD>-3.64</TD><TD>postsynaptic density membrane</TD><TD>cellular component</TD><TD>GO:0098839</TD><TD>101</TD><TD>4</TD><TD>19868</TD><TD>221</TD>
<TD>LRFN5,NRCAM,EPHA4,AKAP9</TD></TR>
<TR><TD>2.637e-02</TD><TD>-3.64</TD><TD>SNAP25 (synaptosome associated protein 25)</TD><TD>protein interactions</TD><TD>6616</TD><TD>58</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>STXBP6,RPH3A,SYT1</TD></TR>
<TR><TD>2.644e-02</TD><TD>-3.63</TD><TD>TGFB2 (transforming growth factor beta 2)</TD><TD>protein interactions</TD><TD>7042</TD><TD>23</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>TGFBR2,EFEMP1</TD></TR>
<TR><TD>2.644e-02</TD><TD>-3.63</TD><TD>LRRN2 (leucine rich repeat neuronal 2)</TD><TD>protein interactions</TD><TD>10446</TD><TD>23</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>LRIG3,PTPRD</TD></TR>
<TR><TD>2.650e-02</TD><TD>-3.63</TD><TD>negative regulation of translational initiation</TD><TD>biological process</TD><TD>GO:0045947</TD><TD>22</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>C8orf88,BANK1</TD></TR>
<TR><TD>2.650e-02</TD><TD>-3.63</TD><TD>type B pancreatic cell differentiation</TD><TD>biological process</TD><TD>GO:0003309</TD><TD>22</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>INSM1,PAX6</TD></TR>
<TR><TD>2.650e-02</TD><TD>-3.63</TD><TD>Fc receptor mediated stimulatory signaling pathway</TD><TD>biological process</TD><TD>GO:0002431</TD><TD>22</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>VAV3,PRKCE</TD></TR>
<TR><TD>2.651e-02</TD><TD>-3.63</TD><TD>EGFBLOOD</TD><TD>prints domains</TD><TD>PR00010</TD><TD>19</TD><TD>2</TD><TD>5258</TD><TD>71</TD>
<TD>DNER,FBN2</TD></TR>
<TR><TD>2.655e-02</TD><TD>-3.63</TD><TD>Nuclear signaling by ERBB4</TD><TD>REACTOME pathways</TD><TD>R-HSA-1251985</TD><TD>25</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>NRG1,WWOX</TD></TR>
<TR><TD>2.655e-02</TD><TD>-3.63</TD><TD>Downstream signaling of activated FGFR3</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654708</TD><TD>25</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>2.657e-02</TD><TD>-3.63</TD><TD>salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma</TD><TD>563</TD><TD>12</TD><TD>16984</TD><TD>192</TD>
<TD>TGFBR2,ACVR2A,UHMK1,IQGAP2,AKAP9,NRCAM,NTRK2,PARP8,THSD7A,FGFR2,CASK,SEZ6L</TD></TR>
<TR><TD>2.659e-02</TD><TD>-3.63</TD><TD>kidney development</TD><TD>biological process</TD><TD>GO:0001822</TD><TD>306</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4,FGFR2,ROBO2,PECAM1,IRX1,SLIT2,PBX1,GCNT1</TD></TR>
<TR><TD>2.668e-02</TD><TD>-3.62</TD><TD>CLEC4A (C-type lectin domain family 4 member A)</TD><TD>protein interactions</TD><TD>50856</TD><TD>102</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRK,LRRN2,FGFR2,LRIG3</TD></TR>
<TR><TD>2.669e-02</TD><TD>-3.62</TD><TD>fibroblast growth factor binding</TD><TD>molecular function</TD><TD>GO:0017134</TD><TD>23</TD><TD>2</TD><TD>18530</TD><TD>206</TD>
<TD>CXCL13,FGFR2</TD></TR>
<TR><TD>2.682e-02</TD><TD>-3.62</TD><TD>human chr8q23.2</TD><TD>chromosome location</TD><TD>human chr8q23.2</TD><TD>13</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LINC01608</TD></TR>
<TR><TD>2.683e-02</TD><TD>-3.62</TD><TD>ANATRNSFRASE</TD><TD>prints domains</TD><TD>PR01543</TD><TD>2</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>NAT2</TD></TR>
<TR><TD>2.683e-02</TD><TD>-3.62</TD><TD>FOLLICULNIP1</TD><TD>prints domains</TD><TD>PR02073</TD><TD>2</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.683e-02</TD><TD>-3.62</TD><TD>WILMSTUMOUR</TD><TD>prints domains</TD><TD>PR00049</TD><TD>2</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>FMNL2</TD></TR>
<TR><TD>2.683e-02</TD><TD>-3.62</TD><TD>AFETOPROTEIN</TD><TD>prints domains</TD><TD>PR00803</TD><TD>2</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>AFM</TD></TR>
<TR><TD>2.683e-02</TD><TD>-3.62</TD><TD>INTRLEUKN1R2</TD><TD>prints domains</TD><TD>PR01539</TD><TD>2</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>IL1RAPL2</TD></TR>
<TR><TD>2.683e-02</TD><TD>-3.62</TD><TD>CHOLNESTRASE</TD><TD>prints domains</TD><TD>PR00878</TD><TD>2</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>BCHE</TD></TR>
<TR><TD>2.683e-02</TD><TD>-3.62</TD><TD>AMELOGENIN</TD><TD>prints domains</TD><TD>PR01757</TD><TD>2</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>AMELX</TD></TR>
<TR><TD>2.701e-02</TD><TD>-3.61</TD><TD>upper_third</TD><TD>COSMIC cancer mutations</TD><TD>upper_third</TD><TD>630</TD><TD>13</TD><TD>16984</TD><TD>192</TD>
<TD>NOL4,SGCG,ROBO2,EPHA4,EFEMP1,FUT9,IGFL4,RYR2,PAX6,UTRN,EPHA3,PXDNL,SLC7A8</TD></TR>
<TR><TD>2.701e-02</TD><TD>-3.61</TD><TD>oesophagus-upper_third-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-upper_third-carcinoma-squamous_cell_carcinoma</TD><TD>630</TD><TD>13</TD><TD>16984</TD><TD>192</TD>
<TD>NOL4,SGCG,EPHA4,ROBO2,RYR2,IGFL4,EFEMP1,FUT9,PAX6,UTRN,EPHA3,PXDNL,SLC7A8</TD></TR>
<TR><TD>2.707e-02</TD><TD>-3.61</TD><TD>TRIP11 (thyroid hormone receptor interactor 11)</TD><TD>protein interactions</TD><TD>9321</TD><TD>152</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>NUP35,NTRK2,SLC25A46,DSCAM,FGFR2</TD></TR>
<TR><TD>2.720e-02</TD><TD>-3.60</TD><TD>positive regulation of cell division</TD><TD>biological process</TD><TD>GO:0051781</TD><TD>98</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>FGF5,PRKCE,GAREM1,FGFR2</TD></TR>
<TR><TD>2.726e-02</TD><TD>-3.60</TD><TD>Downstream signal transduction</TD><TD>REACTOME pathways</TD><TD>R-HSA-186763</TD><TD>352</TD><TD>8</TD><TD>10391</TD><TD>106</TD>
<TD>PHLPP1,AKAP9,PAQR3,FGF5,FGFR2,FGF20,NRG1,PRKCE</TD></TR>
<TR><TD>2.732e-02</TD><TD>-3.60</TD><TD>mucin core 1 and core 2 O-glycosylation</TD><TD>BIOCYC pathways</TD><TD>META_PWY-7433</TD><TD>5</TD><TD>1</TD><TD>907</TD><TD>5</TD>
<TD>GCNT1</TD></TR>
<TR><TD>2.747e-02</TD><TD>-3.59</TD><TD>Disease</TD><TD>REACTOME pathways</TD><TD>R-HSA-1643685</TD><TD>859</TD><TD>15</TD><TD>10391</TD><TD>106</TD>
<TD>ADAMTS5,SYT1,AKAP9,ADAMTS12,FGF20,NRG1,NUP35,THSD7B,MUC7,THSD7A,FZD6,TGFBR2,ADAMTS3,FGF5,FGFR2</TD></TR>
<TR><TD>2.753e-02</TD><TD>-3.59</TD><TD>ZFYVE9 (zinc finger FYVE-type containing 9)</TD><TD>protein interactions</TD><TD>9372</TD><TD>103</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>TGFBR2,FGFR2,EPHA4,NTRK2</TD></TR>
<TR><TD>2.762e-02</TD><TD>-3.59</TD><TD>HGS (hepatocyte growth factor-regulated tyrosine kinase substrate)</TD><TD>protein interactions</TD><TD>9146</TD><TD>512</TD><TD>11</TD><TD>20077</TD><TD>222</TD>
<TD>NRSN1,FGFR2,EPHA3,PAX6,NTRK2,SERGEF,BRINP3,FIGN,EPHA4,CASK,PLAAT1</TD></TR>
<TR><TD>2.767e-02</TD><TD>-3.59</TD><TD>adult behavior</TD><TD>biological process</TD><TD>GO:0030534</TD><TD>146</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4,UCHL1,EPS8,SEPTIN5,CNTNAP2</TD></TR>
<TR><TD>2.793e-02</TD><TD>-3.58</TD><TD>negative regulation of response to external stimulus</TD><TD>biological process</TD><TD>GO:0032102</TD><TD>428</TD><TD>10</TD><TD>18905</TD><TD>219</TD>
<TD>AOAH,CNTNAP2,ROBO2,EPHA4,CASK,CD96,LRFN5,CDH5,CXCL13,SLIT2</TD></TR>
<TR><TD>2.794e-02</TD><TD>-3.58</TD><TD>WW_DOMAIN_2</TD><TD>prosite domains</TD><TD>PS50020</TD><TD>50</TD><TD>3</TD><TD>12232</TD><TD>161</TD>
<TD>WWOX,UTRN,IQGAP2</TD></TR>
<TR><TD>2.804e-02</TD><TD>-3.57</TD><TD>plasma membrane region</TD><TD>cellular component</TD><TD>GO:0098590</TD><TD>1279</TD><TD>22</TD><TD>19868</TD><TD>221</TD>
<TD>CNTNAP2,CASK,EPHA4,TGFBR2,PTPRD,UTRN,RPH3A,CNTN1,LRFN5,CHRM3,NRCAM,PLEK,AKAP9,GAP43,ROBO2,FZD6,SLC7A8,EFNA5,SLC10A2,SYT1,EPS8,SLC39A10</TD></TR>
<TR><TD>2.807e-02</TD><TD>-3.57</TD><TD>Mannose type O-glycan biosynthesis</TD><TD>KEGG pathways</TD><TD>ko00515</TD><TD>23</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>B3GAT2,FUT9</TD></TR>
<TR><TD>2.807e-02</TD><TD>-3.57</TD><TD>Mannose type O-glycan biosynthesis</TD><TD>KEGG pathways</TD><TD>hsa00515</TD><TD>23</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>FUT9,B3GAT2</TD></TR>
<TR><TD>2.808e-02</TD><TD>-3.57</TD><TD>locomotion</TD><TD>biological process</TD><TD>GO:0040011</TD><TD>368</TD><TD>9</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,CXCL13,VAV3,EFNA5,UNC5C,SLC25A46,NRG1,SEMA3C,ROBO2</TD></TR>
<TR><TD>2.839e-02</TD><TD>-3.56</TD><TD>fibroblast growth factor receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0008543</TD><TD>57</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>FGF20,FGF5,FGFR2</TD></TR>
<TR><TD>2.839e-02</TD><TD>-3.56</TD><TD>mesenchymal cell migration</TD><TD>biological process</TD><TD>GO:0090497</TD><TD>57</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,TWIST1,SEMA3C</TD></TR>
<TR><TD>2.843e-02</TD><TD>-3.56</TD><TD>OPALIN (oligodendrocytic myelin paranodal and inner loop protein)</TD><TD>protein interactions</TD><TD>93377</TD><TD>208</TD><TD>6</TD><TD>20077</TD><TD>222</TD>
<TD>IPO8,XPO4,GHITM,ACVR2A,EFR3A,PTPRD</TD></TR>
<TR><TD>2.843e-02</TD><TD>-3.56</TD><TD>Homeobox_KN_domain</TD><TD>interpro domains</TD><TD>IPR008422</TD><TD>23</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>IRX1,PBX1</TD></TR>
<TR><TD>2.854e-02</TD><TD>-3.56</TD><TD>Homeobox_KN</TD><TD>pfam domains</TD><TD>PF05920</TD><TD>23</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>IRX1,PBX1</TD></TR>
<TR><TD>2.863e-02</TD><TD>-3.55</TD><TD>RNF133 (ring finger protein 133)</TD><TD>protein interactions</TD><TD>168433</TD><TD>24</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>NUP35,PTPRD</TD></TR>
<TR><TD>2.863e-02</TD><TD>-3.55</TD><TD>ADAM22 (ADAM metallopeptidase domain 22)</TD><TD>protein interactions</TD><TD>53616</TD><TD>24</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>EPS8,LGI1</TD></TR>
<TR><TD>2.863e-02</TD><TD>-3.55</TD><TD>SLC37A3 (solute carrier family 37 member 3)</TD><TD>protein interactions</TD><TD>84255</TD><TD>24</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>DAAM1,SLC25A46</TD></TR>
<TR><TD>2.863e-02</TD><TD>-3.55</TD><TD>CYS1 (cystin 1)</TD><TD>protein interactions</TD><TD>192668</TD><TD>24</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>SPAG9,UCHL1</TD></TR>
<TR><TD>2.866e-02</TD><TD>-3.55</TD><TD>cardiac muscle tissue development</TD><TD>biological process</TD><TD>GO:0048738</TD><TD>199</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>ZFPM2,NRG1,RYR2,SGCD,SGCG,FGFR2</TD></TR>
<TR><TD>2.877e-02</TD><TD>-3.55</TD><TD>signaling receptor activator activity</TD><TD>molecular function</TD><TD>GO:0030546</TD><TD>513</TD><TD>11</TD><TD>18530</TD><TD>206</TD>
<TD>FGF5,NRG1,CXCL13,AMELX,EFNA5,EFEMP1,PRKCE,FGF14,FGF20,FBN2,SEMA3C</TD></TR>
<TR><TD>2.878e-02</TD><TD>-3.55</TD><TD>GALNT18 (polypeptide N-acetylgalactosaminyltransferase 18)</TD><TD>protein interactions</TD><TD>374378</TD><TD>60</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>ADAMTS12,PTPRK,PI15</TD></TR>
<TR><TD>2.878e-02</TD><TD>-3.55</TD><TD>CRLF2 (cytokine receptor like factor 2)</TD><TD>protein interactions</TD><TD>64109</TD><TD>60</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>FGFR2,SLC25A46,ACVR2A</TD></TR>
<TR><TD>2.878e-02</TD><TD>-3.55</TD><TD>PTPRE (protein tyrosine phosphatase receptor type E)</TD><TD>protein interactions</TD><TD>5791</TD><TD>60</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>XPO4,PTPRD,EFR3A</TD></TR>
<TR><TD>2.881e-02</TD><TD>-3.55</TD><TD>embryonic hemopoiesis</TD><TD>biological process</TD><TD>GO:0035162</TD><TD>23</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,PBX1</TD></TR>
<TR><TD>2.881e-02</TD><TD>-3.55</TD><TD>substrate-dependent cell migration</TD><TD>biological process</TD><TD>GO:0006929</TD><TD>23</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>SHTN1,SLIT2</TD></TR>
<TR><TD>2.881e-02</TD><TD>-3.55</TD><TD>signal transduction involved in regulation of gene expression</TD><TD>biological process</TD><TD>GO:0023019</TD><TD>23</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,FGF5</TD></TR>
<TR><TD>2.881e-02</TD><TD>-3.55</TD><TD>regulation of establishment of cell polarity</TD><TD>biological process</TD><TD>GO:2000114</TD><TD>23</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>CDH5,SHTN1</TD></TR>
<TR><TD>2.885e-02</TD><TD>-3.55</TD><TD>human chr6q16.2</TD><TD>chromosome location</TD><TD>human chr6q16.2</TD><TD>14</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>MIR548AI</TD></TR>
<TR><TD>2.889e-02</TD><TD>-3.54</TD><TD>skin-upper_back-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-upper_back-malignant_melanoma</TD><TD>319</TD><TD>8</TD><TD>16984</TD><TD>192</TD>
<TD>FBN2,FAT4,SPHKAP,PTPRD,CHRM3,FUT9,CNTN1,MUC7</TD></TR>
<TR><TD>2.950e-02</TD><TD>-3.52</TD><TD>response to xenobiotic stimulus</TD><TD>biological process</TD><TD>GO:0009410</TD><TD>432</TD><TD>10</TD><TD>18905</TD><TD>219</TD>
<TD>UCHL1,AMELX,NAT2,TGFBR2,PAX6,SEMA3C,BCHE,LHCGR,VAV3,SS18</TD></TR>
<TR><TD>2.957e-02</TD><TD>-3.52</TD><TD>lung</TD><TD>COSMIC cancer mutations</TD><TD>lung</TD><TD>16375</TD><TD>190</TD><TD>16984</TD><TD>192</TD>
<TD>ROBO2,RYR2,RPH3A,REXO2,ADAMTS5,PHF14,SGCG,AOAH,ZPLD1,THSD7A,CD96,HNF4G,NTRK2,ADAMTS12,EPHA3,CYTL1,NUP35,EFR3A,ATG10,PTPRK,ZNF521,FMNL2,KLF12,SEMA3C,NRCAM,DAAM1,TSN,CALN1,ADAM28,TGFBR2,PTPRD,EPHA4,DNER,COQ2,SGCD,TMEFF2,CASK,SKAP2,DCDC2C,XPO4,DSCAM,CNTNAP2,IRX1,PRKCE,ZNF133,PI15,CPXM2,SEZ6L,PCGF5,LRFN5,TCF20,CXCL13,MEGF10,ACP6,ZFAND5,KIF6,PAQR3,LRRN2,ACVR1C,NOBOX,ERCC6L2,SPHKAP,FUT9,NRSN1,IPO8,REG1B,LRIG3,IQGAP2,STXBP6,FGD3,PAX6,MUC7,SPAG9,FBN2,DEPTOR,RGS6,UCHL1,PWWP2A,FIGN,ASPN,EFR3B,LRRC3B,LRRC70,JMJD1C,OR52K2,PHLPP1,ADAMTS3,BCHE,IL1RAPL2,WRN,CETN3,MRPL3,UBR4,DNAJC12,RAI2,PBX1,INSM1,CDH5,SHISA3,PCDH9,ARX,RBM20,ARL14,UHMK1,LMBRD1,THSD7B,FGF14,NAV3,FZD6,COX7B2,MRPL13,CRTC3,SLC7A8,EPS8,LHCGR,NRG1,PRSS12,GMDS,MPEG1,SYT1,FANCB,ZNF518B,BANK1,NBEA,DAOA,KCNK9,CHRM3,FAT4,IGFL4,CTSO,BACH2,FGF5,FABP7,SLC25A46,PXDNL,AGA,SLC7A14,EDIL3,FNIP2,NAT2,AFM,SPATA16,VAV3,SLC39A10,PLEK,DEFB115,GAP43,CELF2,RASGEF1B,ZFPM2,ACVR2A,UTRN,EFEMP1,WWOX,TRPS1,OR2AG1,CD226,GPR83,SERGEF,B3GAT2,PTPRZ1,GHITM,UNC5C,FGF20,NOL4,NCKAP5,SLIT2,NAALADL2,CNTN1,AKAP9,PARP8,NOVA1,TWIST1,SS18,SPANXN1,SERINC5,MAP2,AMELX,FERD3L,RUNX1T1,FGFR2,GCNT1,LGI1,SLC10A2,PSKH2,KAZN,LMX1A,PRLHR,EFNA5,EPYC</TD></TR>
<TR><TD>2.960e-02</TD><TD>-3.52</TD><TD>breast-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>breast-carcinoma</TD><TD>15099</TD><TD>179</TD><TD>16984</TD><TD>192</TD>
<TD>LRIG3,REG1B,FUT9,IPO8,NRSN1,FGD3,PAX6,STXBP6,IQGAP2,FBN2,DEPTOR,RGS6,SPAG9,MUC7,PWWP2A,UCHL1,EFR3B,ASPN,LRRC3B,FIGN,PHLPP1,JMJD1C,LRRC70,OR52K2,IL1RAPL2,MRPL3,WRN,BCHE,ADAMTS3,RAI2,DNAJC12,UBR4,AOAH,THSD7A,ZPLD1,RPH3A,RYR2,ROBO2,SGCG,PHF14,ADAMTS5,REXO2,EPHA3,CD96,HNF4G,NTRK2,ADAMTS12,FMNL2,ZNF521,PTPRK,KLF12,ATG10,EFR3A,NUP35,ADAM28,PTPRD,TGFBR2,DAAM1,SEMA3C,NRCAM,CALN1,TSN,XPO4,DCDC2C,SKAP2,DSCAM,DNER,EPHA4,CASK,TMEFF2,SGCD,ZNF133,PRKCE,CPXM2,PI15,CNTNAP2,ACP6,MEGF10,ZFAND5,LRFN5,SEZ6L,PCGF5,TCF20,SPHKAP,PAQR3,KIF6,NOBOX,ACVR1C,LRRN2,SLC39A10,VAV3,PLEK,SPATA16,AFM,ZFPM2,UTRN,ACVR2A,DEFB115,RASGEF1B,CELF2,GAP43,TRPS1,EFEMP1,WWOX,B3GAT2,SERGEF,GPR83,UNC5C,GHITM,PTPRZ1,OR2AG1,CD226,NCKAP5,NOL4,SLIT2,FGF20,MAP2,SERINC5,PARP8,CNTN1,AKAP9,NAALADL2,SS18,TWIST1,NOVA1,FGFR2,RUNX1T1,GCNT1,AMELX,FERD3L,EFNA5,PRLHR,EPYC,PSKH2,SLC10A2,LGI1,LMX1A,KAZN,PCDH9,SHISA3,CDH5,ARX,UHMK1,RBM20,COX7B2,THSD7B,FGF14,LMBRD1,FZD6,NAV3,LHCGR,EPS8,PRSS12,NRG1,CRTC3,MRPL13,SLC7A8,DAOA,CHRM3,KCNK9,MPEG1,GMDS,NBEA,ZNF518B,BANK1,SYT1,FANCB,FAT4,FGF5,BACH2,IGFL4,CTSO,EDIL3,SLC7A14,FNIP2,SLC25A46,FABP7,AGA,PXDNL</TD></TR>
<TR><TD>2.961e-02</TD><TD>-3.52</TD><TD>ERBB2 (erb-b2 receptor tyrosine kinase 2)</TD><TD>protein interactions</TD><TD>2064</TD><TD>584</TD><TD>12</TD><TD>20077</TD><TD>222</TD>
<TD>NAALADL2,TEC,EPHA3,NAT2,EPHA4,LRIG3,TGFBR2,DEPTOR,FGFR2,NTRK2,VAV3,NRG1</TD></TR>
<TR><TD>2.969e-02</TD><TD>-3.52</TD><TD>B cell receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0050853</TD><TD>58</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>BANK1,TEC,VAV3</TD></TR>
<TR><TD>2.972e-02</TD><TD>-3.52</TD><TD>cell-cell junction</TD><TD>cellular component</TD><TD>GO:0005911</TD><TD>515</TD><TD>11</TD><TD>19868</TD><TD>221</TD>
<TD>KAZN,PCDH9,PECAM1,CASK,PTPRK,CNTNAP2,ADGRL3,STXBP6,CDH5,EFNA5,EPHA4</TD></TR>
<TR><TD>2.975e-02</TD><TD>-3.52</TD><TD>DBB</TD><TD>smart domains</TD><TD>SM01282</TD><TD>2</TD><TD>1</TD><TD>9743</TD><TD>146</TD>
<TD>BANK1</TD></TR>
<TR><TD>2.975e-02</TD><TD>-3.52</TD><TD>DUF1704</TD><TD>smart domains</TD><TD>SM01154</TD><TD>2</TD><TD>1</TD><TD>9743</TD><TD>146</TD>
<TD>MATCAP2</TD></TR>
<TR><TD>2.975e-02</TD><TD>-3.52</TD><TD>Sec3-PIP2_bind</TD><TD>smart domains</TD><TD>SM01313</TD><TD>2</TD><TD>1</TD><TD>9743</TD><TD>146</TD>
<TD>STXBP6</TD></TR>
<TR><TD>2.975e-02</TD><TD>-3.52</TD><TD>RQC</TD><TD>smart domains</TD><TD>SM00956</TD><TD>2</TD><TD>1</TD><TD>9743</TD><TD>146</TD>
<TD>WRN</TD></TR>
<TR><TD>2.975e-02</TD><TD>-3.52</TD><TD>Amelogenin</TD><TD>smart domains</TD><TD>SM00818</TD><TD>2</TD><TD>1</TD><TD>9743</TD><TD>146</TD>
<TD>AMELX</TD></TR>
<TR><TD>2.981e-02</TD><TD>-3.51</TD><TD>soft_tissue-fibrous_tissue_and_uncertain_origin-endometrial_stromal_sarcoma</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-fibrous_tissue_and_uncertain_origin-endometrial_stromal_sarcoma</TD><TD>24</TD><TD>2</TD><TD>16984</TD><TD>192</TD>
<TD>SS18,FGFR2</TD></TR>
<TR><TD>2.981e-02</TD><TD>-3.51</TD><TD>endometrial_stromal_sarcoma</TD><TD>COSMIC cancer mutations</TD><TD>endometrial_stromal_sarcoma</TD><TD>24</TD><TD>2</TD><TD>16984</TD><TD>192</TD>
<TD>SS18,FGFR2</TD></TR>
<TR><TD>2.981e-02</TD><TD>-3.51</TD><TD>mouth_roof</TD><TD>COSMIC cancer mutations</TD><TD>mouth_roof</TD><TD>24</TD><TD>2</TD><TD>16984</TD><TD>192</TD>
<TD>CRTC3,MAP2</TD></TR>
<TR><TD>3.003e-02</TD><TD>-3.51</TD><TD>MAPK8IP3 (mitogen-activated protein kinase 8 interacting protein 3)</TD><TD>protein interactions</TD><TD>23162</TD><TD>61</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>FGF14,SPAG9,SHTN1</TD></TR>
<TR><TD>3.025e-02</TD><TD>-3.50</TD><TD>liver-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>liver-carcinoma</TD><TD>15428</TD><TD>182</TD><TD>16984</TD><TD>192</TD>
<TD>SPHKAP,KIF6,PAQR3,LRRN2,ACVR1C,CXCL13,MEGF10,ACP6,ZFAND5,SEZ6L,PCGF5,LRFN5,TCF20,IRX1,PRKCE,ZNF133,PI15,CPXM2,CNTNAP2,DCDC2C,SKAP2,XPO4,DSCAM,EPHA4,DNER,COQ2,SGCD,TMEFF2,CASK,ADAM28,PTPRD,SEMA3C,NRCAM,DAAM1,TSN,CALN1,PTPRK,ZNF521,FMNL2,KLF12,CYTL1,NUP35,EFR3A,ATG10,EPHA3,NTRK2,HNF4G,CD96,ADAMTS12,AOAH,ZPLD1,THSD7A,ROBO2,RYR2,RPH3A,REXO2,ADAMTS5,PHF14,SGCG,DNAJC12,RAI2,UBR4,IL1RAPL2,WRN,CETN3,MRPL3,ADAMTS3,BCHE,PHLPP1,LRRC70,JMJD1C,OR52K2,ASPN,EFR3B,FIGN,PWWP2A,UCHL1,DEPTOR,FBN2,RGS6,MUC7,LINC01387,SPAG9,FGD3,PAX6,IQGAP2,STXBP6,REG1B,LRIG3,FUT9,NRSN1,IPO8,EDIL3,SLC7A14,FNIP2,FABP7,SLC25A46,PXDNL,AGA,BACH2,FGF5,IGFL4,CTSO,FAT4,DAOA,KCNK9,CHRM3,GMDS,MPEG1,FANCB,SYT1,ZNF518B,BANK1,NBEA,EPS8,LHCGR,NRG1,PRSS12,MRPL13,CRTC3,SLC7A8,COX7B2,LMBRD1,FGF14,THSD7B,NAV3,FZD6,ARX,RBM20,UHMK1,SHISA3,PCDH9,INSM1,CDH5,PRLHR,EFNA5,EPYC,LGI1,SLC10A2,PSKH2,LMX1A,KAZN,RUNX1T1,FGFR2,LINC00583,GCNT1,FERD3L,SERINC5,MAP2,NAALADL2,AKAP9,CNTN1,PARP8,NOVA1,SS18,SPANXN1,NOL4,NCKAP5,SLIT2,FGF20,GPR83,SERGEF,B3GAT2,PTPRZ1,GHITM,UNC5C,OR2AG1,CD226,TRPS1,EFEMP1,ZFPM2,ACVR2A,UTRN,DEFB115,GAP43,CELF2,RASGEF1B,VAV3,SLC39A10,PLEK,AFM,SPATA16</TD></TR>
<TR><TD>3.026e-02</TD><TD>-3.50</TD><TD>lung-carcinoid-endocrine_tumour-atypical</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoid-endocrine_tumour-atypical</TD><TD>509</TD><TD>11</TD><TD>16984</TD><TD>192</TD>
<TD>PRKCE,EPHA3,FGFR2,UHMK1,TGFBR2,ACVR2A,NTRK2,PSKH2,EPHA4,CASK,ACVR1C</TD></TR>
<TR><TD>3.029e-02</TD><TD>-3.50</TD><TD>Globo Sphingolipid Metabolism</TD><TD>WikiPathways</TD><TD>WP1424</TD><TD>22</TD><TD>2</TD><TD>5358</TD><TD>67</TD>
<TD>GCNT1,FUT9</TD></TR>
<TR><TD>3.030e-02</TD><TD>-3.50</TD><TD>Toxicity of botulinum toxin type B (BoNT/B)</TD><TD>REACTOME pathways</TD><TD>R-HSA-5250958</TD><TD>3</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>SYT1</TD></TR>
<TR><TD>3.030e-02</TD><TD>-3.50</TD><TD>Toxicity of botulinum toxin type G (BoNT/G)</TD><TD>REACTOME pathways</TD><TD>R-HSA-5250989</TD><TD>3</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>SYT1</TD></TR>
<TR><TD>3.052e-02</TD><TD>-3.49</TD><TD>biological regulation</TD><TD>biological process</TD><TD>GO:0065007</TD><TD>12754</TD><TD>161</TD><TD>18905</TD><TD>219</TD>
<TD>TMEFF2,REG1B,EPS8,FANCB,NOBOX,SS18,SERGEF,WWOX,ZFAND5,JMJD1C,IL1RAPL2,ARX,PECAM1,LRRC70,FABP7,CD96,IPO8,CRTC3,SHISA3,CD226,SPAG9,CDH5,TSN,RYR2,UCHL1,TEC,NRCAM,LGI1,AKAP9,FGF14,RBM20,VAV3,EFEMP1,OR2AG1,AMELX,SEMA3C,BCHE,CNTNAP2,AOAH,FBN2,MAST4,PUM3,NRG1,BRINP3,MTERF1,PTPRK,RGS6,FZD6,CELF2,GAP43,ADGRL3,ATG10,PARP8,PPP1R17,FGD3,KCNK9,DEPTOR,LMX1A,SLC39A10,EDIL3,NAV3,FNIP2,ASPN,SEZ6L,DCDC2C,DAAM1,EFNA5,PHF14,UHMK1,SERINC5,EPHA4,UTRN,WRN,ADAMTS5,OR52K2,TCF20,ADAMTS12,RUNX1T1,DAOA,MIR9-2HG,PAQR3,SGCD,ACVR1C,FUT9,FGF20,PTPRZ1,ROBO2,MIR551B,IRX1,ZNF521,CNTN1,KLF12,CPQ,LHCGR,PAX6,FERD3L,ADAMTS3,PTPRD,PRLHR,GHITM,MAP2,LRFN5,CASK,EPHA3,DSCAM,C8orf88,MIR569,PHLPP1,FMNL2,GMDS,SLIT2,GCNT1,PBX1,INSM1,XPO4,FGFR2,CHRM3,RASGEF1B,PRKCE,DNER,AFM,ZNF518B,MEGF10,HNF4G,SEPTIN5,NOVA1,ZNF133,BANK1,SYT1,SKAP2,ACVR2A,UBR4,MRPL13,STXBP6,RPH3A,TGFBR2,MIR1260B,PWWP2A,CYTL1,GAREM1,BACH2,PCGF5,FGF5,LRRN2,GPR83,CXCL13,TWIST1,UNC5C,TRPS1,PLEK,MIR548AA2,MIR577,MIR891A,MIR548A3,SHTN1,IQGAP2,FAT4,ZFPM2,MIR147A,NTRK2,SLC7A8</TD></TR>
<TR><TD>3.064e-02</TD><TD>-3.49</TD><TD>cell-cell signaling</TD><TD>biological process</TD><TD>GO:0007267</TD><TD>824</TD><TD>16</TD><TD>18905</TD><TD>219</TD>
<TD>PTPRD,CXCL13,PRKCE,FGF5,SEPTIN5,RYR2,ACVR1C,FGF20,SYT1,FGF14,AKAP9,RPH3A,FGFR2,CHRM3,NTRK2,UTRN</TD></TR>
<TR><TD>3.078e-02</TD><TD>-3.48</TD><TD>haematopoietic_and_lymphoid_tissue-spleen-lymphoid_neoplasm-marginal_zone_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-spleen-lymphoid_neoplasm-marginal_zone_lymphoma</TD><TD>323</TD><TD>8</TD><TD>16984</TD><TD>192</TD>
<TD>EDIL3,PTPRK,FAT4,LRRC3B,PTPRD,PTPRZ1,ROBO2,NAT2</TD></TR>
<TR><TD>3.087e-02</TD><TD>-3.48</TD><TD>O-linked glycosylation of mucins</TD><TD>REACTOME pathways</TD><TD>R-HSA-913709</TD><TD>67</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>MUC7,GALNT15,GCNT1</TD></TR>
<TR><TD>3.088e-02</TD><TD>-3.48</TD><TD>human chr20p11.1</TD><TD>chromosome location</TD><TD>human chr20p11.1</TD><TD>15</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>MIR663AHG</TD></TR>
<TR><TD>3.089e-02</TD><TD>-3.48</TD><TD>regulation of organ growth</TD><TD>biological process</TD><TD>GO:0046620</TD><TD>102</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>ARX,ZFPM2,FGF20,FGFR2</TD></TR>
<TR><TD>3.090e-02</TD><TD>-3.48</TD><TD>PAQR3 (progestin and adipoQ receptor family member 3)</TD><TD>protein interactions</TD><TD>152559</TD><TD>25</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>NRSN1,TWIST1</TD></TR>
<TR><TD>3.090e-02</TD><TD>-3.48</TD><TD>LCTL (lactase like)</TD><TD>protein interactions</TD><TD>197021</TD><TD>25</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>SLC25A46,GHITM</TD></TR>
<TR><TD>3.090e-02</TD><TD>-3.48</TD><TD>TIGIT (T cell immunoreceptor with Ig and ITIM domains)</TD><TD>protein interactions</TD><TD>201633</TD><TD>25</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>ACVR2A,PTPRD</TD></TR>
<TR><TD>3.102e-02</TD><TD>-3.47</TD><TD>regulation of sodium ion transmembrane transport</TD><TD>biological process</TD><TD>GO:1902305</TD><TD>59</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>UTRN,FGF14,PRKCE</TD></TR>
<TR><TD>3.105e-02</TD><TD>-3.47</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-follicular_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-follicular_lymphoma</TD><TD>208</TD><TD>6</TD><TD>16984</TD><TD>192</TD>
<TD>FBN2,ZNF521,PCDH9,CNTNAP2,KIF6,AMELX</TD></TR>
<TR><TD>3.119e-02</TD><TD>-3.47</TD><TD>regulation of dopamine secretion</TD><TD>biological process</TD><TD>GO:0014059</TD><TD>24</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>SYT1,FGF20</TD></TR>
<TR><TD>3.119e-02</TD><TD>-3.47</TD><TD>chondroitin sulfate proteoglycan biosynthetic process</TD><TD>biological process</TD><TD>GO:0050650</TD><TD>24</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>CYTL1,B3GAT2</TD></TR>
<TR><TD>3.120e-02</TD><TD>-3.47</TD><TD>fibroblast growth factor receptor binding</TD><TD>molecular function</TD><TD>GO:0005104</TD><TD>25</TD><TD>2</TD><TD>18530</TD><TD>206</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>3.120e-02</TD><TD>-3.47</TD><TD>protein kinase A regulatory subunit binding</TD><TD>molecular function</TD><TD>GO:0034237</TD><TD>25</TD><TD>2</TD><TD>18530</TD><TD>206</TD>
<TD>RYR2,AKAP9</TD></TR>
<TR><TD>3.124e-02</TD><TD>-3.47</TD><TD>extrinsic component of organelle membrane</TD><TD>cellular component</TD><TD>GO:0031312</TD><TD>25</TD><TD>2</TD><TD>19868</TD><TD>221</TD>
<TD>EMC2,RPH3A</TD></TR>
<TR><TD>3.126e-02</TD><TD>-3.47</TD><TD>Protein_kinase_ATP_BS</TD><TD>interpro domains</TD><TD>IPR017441</TD><TD>378</TD><TD>9</TD><TD>18605</TD><TD>214</TD>
<TD>TEC,PRKCE,PSKH2,ACVR1C,EPHA4,NTRK2,EPHA3,FGFR2,TGFBR2</TD></TR>
<TR><TD>3.130e-02</TD><TD>-3.46</TD><TD>MYH4 (myosin heavy chain 4)</TD><TD>protein interactions</TD><TD>4622</TD><TD>62</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>WWOX,CNTN1,GAP43</TD></TR>
<TR><TD>3.133e-02</TD><TD>-3.46</TD><TD>renal system development</TD><TD>biological process</TD><TD>GO:0072001</TD><TD>316</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>IRX1,SLIT2,PECAM1,GCNT1,PBX1,EPHA4,ROBO2,FGFR2</TD></TR>
<TR><TD>3.146e-02</TD><TD>-3.46</TD><TD>pancreas-carcinoma-ductal_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>pancreas-carcinoma-ductal_carcinoma</TD><TD>15657</TD><TD>184</TD><TD>16984</TD><TD>192</TD>
<TD>UNC5C,GHITM,PTPRZ1,SERGEF,B3GAT2,GPR83,CD226,OR2AG1,TRPS1,WWOX,EFEMP1,UTRN,ACVR2A,ZFPM2,CELF2,RASGEF1B,GAP43,DEFB115,PLEK,SLC39A10,VAV3,SPATA16,AFM,NAT2,EPYC,EFNA5,PRLHR,KAZN,LMX1A,PSKH2,SLC10A2,LGI1,GCNT1,FGFR2,RUNX1T1,FERD3L,AMELX,MAP2,SPANXN1,SS18,TWIST1,NOVA1,PARP8,AKAP9,CNTN1,NAALADL2,SLIT2,NCKAP5,NOL4,FGF20,PRSS12,NRG1,LHCGR,EPS8,SLC7A8,CRTC3,MRPL13,COX7B2,FZD6,NAV3,THSD7B,FGF14,LMBRD1,UHMK1,ARL14,ARX,PCDH9,SHISA3,CDH5,INSM1,FNIP2,EDIL3,SLC7A14,AGA,PXDNL,SLC25A46,FABP7,FGF5,BACH2,CTSO,IGFL4,FAT4,CHRM3,KCNK9,DAOA,NBEA,BANK1,ZNF518B,SYT1,FANCB,MPEG1,GMDS,PWWP2A,UCHL1,RGS6,DEPTOR,FBN2,SPAG9,MUC7,PAX6,FGD3,IQGAP2,STXBP6,LRIG3,REG1B,IPO8,NRSN1,FUT9,RAI2,PBX1,DNAJC12,UBR4,MRPL3,CETN3,WRN,IL1RAPL2,BCHE,ADAMTS3,OR52K2,JMJD1C,LRRC3B,EFR3B,ASPN,FIGN,PTPRD,TGFBR2,ADAM28,CALN1,TSN,DAAM1,NRCAM,SEMA3C,KLF12,FMNL2,ZNF521,PTPRK,ATG10,EFR3A,NUP35,CYTL1,EPHA3,ADAMTS12,HNF4G,NTRK2,CD96,THSD7A,ZPLD1,AOAH,SGCG,PHF14,ADAMTS5,REXO2,RPH3A,RYR2,ROBO2,SPHKAP,NOBOX,ACVR1C,LRRN2,PAQR3,KIF6,ZFAND5,ACP6,MEGF10,CXCL13,TCF20,LRFN5,PCGF5,SEZ6L,CPXM2,PI15,ZNF133,PRKCE,IRX1,CNTNAP2,DSCAM,XPO4,SKAP2,CASK,TMEFF2,SGCD,COQ2,DNER,EPHA4</TD></TR>
<TR><TD>3.149e-02</TD><TD>-3.46</TD><TD>Heroin Metabolism Pathway</TD><TD>SMPDB pathways</TD><TD>SMP0000623</TD><TD>4</TD><TD>1</TD><TD>1382</TD><TD>11</TD>
<TD>BCHE</TD></TR>
<TR><TD>3.169e-02</TD><TD>-3.45</TD><TD>PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1)</TD><TD>protein interactions</TD><TD>5295</TD><TD>394</TD><TD>9</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRK,PECAM1,VAV3,TGFBR2,EPHA4,NTRK2,EPHA3,TEC,FGFR2</TD></TR>
<TR><TD>3.178e-02</TD><TD>-3.45</TD><TD>regulation of anatomical structure size</TD><TD>biological process</TD><TD>GO:0090066</TD><TD>500</TD><TD>11</TD><TD>18905</TD><TD>219</TD>
<TD>MAP2,EPS8,PRKCE,NRCAM,PLEK,DSCAM,DEPTOR,SHTN1,VAV3,EFNA5,SLIT2</TD></TR>
<TR><TD>3.193e-02</TD><TD>-3.44</TD><TD>large_cell</TD><TD>COSMIC cancer mutations</TD><TD>large_cell</TD><TD>14901</TD><TD>177</TD><TD>16984</TD><TD>192</TD>
<TD>WWOX,EFEMP1,TRPS1,CD226,GHITM,PTPRZ1,UNC5C,GPR83,B3GAT2,SERGEF,NAT2,SPATA16,AFM,PLEK,SLC39A10,VAV3,GAP43,RASGEF1B,CELF2,DEFB115,ACVR2A,UTRN,ZFPM2,FERD3L,AMELX,GCNT1,RUNX1T1,FGFR2,LMX1A,KAZN,SLC10A2,LGI1,PSKH2,EPYC,EFNA5,PRLHR,FGF20,SLIT2,NOL4,NCKAP5,SS18,TWIST1,NOVA1,SPANXN1,AKAP9,CNTN1,NAALADL2,PARP8,MAP2,NAV3,FZD6,LMBRD1,THSD7B,FGF14,SLC7A8,CRTC3,MRPL13,NRG1,PRSS12,EPS8,LHCGR,INSM1,CDH5,SHISA3,PCDH9,RBM20,UHMK1,ARL14,ARX,CTSO,IGFL4,BACH2,FGF5,AGA,SLC25A46,FABP7,FNIP2,SLC7A14,EDIL3,BANK1,ZNF518B,FANCB,SYT1,NBEA,MPEG1,GMDS,KCNK9,CHRM3,DAOA,FAT4,MUC7,SPAG9,RGS6,DEPTOR,FBN2,UCHL1,PWWP2A,NRSN1,IPO8,FUT9,LRIG3,REG1B,STXBP6,IQGAP2,PAX6,FGD3,BCHE,ADAMTS3,CETN3,WRN,MRPL3,IL1RAPL2,UBR4,DNAJC12,PBX1,RAI2,FIGN,LRRC3B,ASPN,JMJD1C,EFR3A,ATG10,CYTL1,KLF12,ZNF521,PTPRK,FMNL2,TSN,CALN1,SEMA3C,NRCAM,DAAM1,TGFBR2,PTPRD,ADAM28,REXO2,PHF14,SGCG,ADAMTS5,ROBO2,RPH3A,RYR2,THSD7A,ZPLD1,AOAH,ADAMTS12,NTRK2,CD96,HNF4G,EPHA3,TCF20,PCGF5,SEZ6L,LRFN5,ZFAND5,MEGF10,CXCL13,ACP6,ACVR1C,LRRN2,NOBOX,KIF6,SPHKAP,TMEFF2,CASK,DNER,EPHA4,COQ2,DSCAM,XPO4,SKAP2,CNTNAP2,PI15,CPXM2,IRX1,ZNF133,PRKCE</TD></TR>
<TR><TD>3.199e-02</TD><TD>-3.44</TD><TD>POGLUT1 (protein O-glucosyltransferase 1)</TD><TD>protein interactions</TD><TD>56983</TD><TD>108</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRK,UBR4,PI15,LGI1</TD></TR>
<TR><TD>3.203e-02</TD><TD>-3.44</TD><TD>DLG1 (discs large MAGUK scaffold protein 1)</TD><TD>protein interactions</TD><TD>1739</TD><TD>214</TD><TD>6</TD><TD>20077</TD><TD>222</TD>
<TD>PHLPP1,PAX6,ARL14,DSCAM,EPHA4,CASK</TD></TR>
<TR><TD>3.205e-02</TD><TD>-3.44</TD><TD>Extracellular matrix organization</TD><TD>REACTOME pathways</TD><TD>R-HSA-1474244</TD><TD>297</TD><TD>7</TD><TD>10391</TD><TD>106</TD>
<TD>ASPN,CASK,ADAMTS5,FBN2,PECAM1,EFEMP1,ADAMTS3</TD></TR>
<TR><TD>3.217e-02</TD><TD>-3.44</TD><TD>spindle</TD><TD>COSMIC cancer mutations</TD><TD>spindle</TD><TD>387</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>SLC7A14,FAT4,PCDH9,SLC10A2,SPAG9,THSD7B,NRSN1,CASK,SPATA16</TD></TR>
<TR><TD>3.238e-02</TD><TD>-3.43</TD><TD>transmission of nerve impulse</TD><TD>biological process</TD><TD>GO:0019226</TD><TD>60</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>NRCAM,NTRK2,CNTNAP2</TD></TR>
<TR><TD>3.238e-02</TD><TD>-3.43</TD><TD>regulation of protein modification process</TD><TD>biological process</TD><TD>GO:0031399</TD><TD>1247</TD><TD>22</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2,EPHA4,EFNA5,INSM1,AKAP9,SLIT2,FNIP2,DEPTOR,UCHL1,CDH5,FGF5,SPAG9,PAX6,TGFBR2,ATG10,ACVR2A,PECAM1,BANK1,PAQR3,NRG1,FGF20,PRKCE</TD></TR>
<TR><TD>3.261e-02</TD><TD>-3.42</TD><TD>GP5 (glycoprotein V platelet)</TD><TD>protein interactions</TD><TD>2814</TD><TD>63</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>SLC39A10,ADGRL3,GHITM</TD></TR>
<TR><TD>3.261e-02</TD><TD>-3.42</TD><TD>PTX3 (pentraxin 3)</TD><TD>protein interactions</TD><TD>5806</TD><TD>63</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>FGF20,UBR4,FGF5</TD></TR>
<TR><TD>3.261e-02</TD><TD>-3.42</TD><TD>PPP1R16B (protein phosphatase 1 regulatory subunit 16B)</TD><TD>protein interactions</TD><TD>26051</TD><TD>63</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>DSCAM,PXDNL,TGFBR2</TD></TR>
<TR><TD>3.261e-02</TD><TD>-3.42</TD><TD>BCHE (butyrylcholinesterase)</TD><TD>protein interactions</TD><TD>590</TD><TD>63</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRK,SHTN1,BCHE</TD></TR>
<TR><TD>3.271e-02</TD><TD>-3.42</TD><TD>glycoaminoglycan-protein linkage region biosynthesis</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY-6557</TD><TD>6</TD><TD>1</TD><TD>907</TD><TD>5</TD>
<TD>B3GAT2</TD></TR>
<TR><TD>3.271e-02</TD><TD>-3.42</TD><TD>glycoaminoglycan-protein linkage region biosynthesis</TD><TD>BIOCYC pathways</TD><TD>META_PWY-6557</TD><TD>6</TD><TD>1</TD><TD>907</TD><TD>5</TD>
<TD>B3GAT2</TD></TR>
<TR><TD>3.275e-02</TD><TD>-3.42</TD><TD>sulfur compound binding</TD><TD>molecular function</TD><TD>GO:1901681</TD><TD>272</TD><TD>7</TD><TD>18530</TD><TD>206</TD>
<TD>FGFR2,CXCL13,RYR2,ADAMTS3,FGF20,ADAMTS5,SLIT2</TD></TR>
<TR><TD>3.281e-02</TD><TD>-3.42</TD><TD>CYP7B1 (cytochrome P450 family 7 subfamily B member 1)</TD><TD>protein interactions</TD><TD>9420</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>GHITM</TD></TR>
<TR><TD>3.281e-02</TD><TD>-3.42</TD><TD>KLHL4 (kelch like family member 4)</TD><TD>protein interactions</TD><TD>56062</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>DSCAM</TD></TR>
<TR><TD>3.281e-02</TD><TD>-3.42</TD><TD>LYSET (lysosomal enzyme trafficking factor)</TD><TD>protein interactions</TD><TD>26175</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>ATG10</TD></TR>
<TR><TD>3.281e-02</TD><TD>-3.42</TD><TD>TPH2 (tryptophan hydroxylase 2)</TD><TD>protein interactions</TD><TD>121278</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>DNAJC12</TD></TR>
<TR><TD>3.281e-02</TD><TD>-3.42</TD><TD>Cdk5 (cyclin-dependent kinase 5)</TD><TD>protein interactions</TD><TD>140908</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>SEPTIN5</TD></TR>
<TR><TD>3.281e-02</TD><TD>-3.42</TD><TD>Hsp90aa1 (heat shock protein 90 alpha family class A member 1)</TD><TD>protein interactions</TD><TD>299331</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>3.281e-02</TD><TD>-3.42</TD><TD>IL34 (interleukin 34)</TD><TD>protein interactions</TD><TD>146433</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRZ1</TD></TR>
<TR><TD>3.281e-02</TD><TD>-3.42</TD><TD>PRDM12 (PR/SET domain 12)</TD><TD>protein interactions</TD><TD>59335</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>3.281e-02</TD><TD>-3.42</TD><TD>PRRT3 (proline rich transmembrane protein 3)</TD><TD>protein interactions</TD><TD>285368</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRD</TD></TR>
<TR><TD>3.281e-02</TD><TD>-3.42</TD><TD>NRN1L (neuritin 1 like)</TD><TD>protein interactions</TD><TD>123904</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>SLC39A10</TD></TR>
<TR><TD>3.281e-02</TD><TD>-3.42</TD><TD>LRRC74A (leucine rich repeat containing 74A)</TD><TD>protein interactions</TD><TD>145497</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>EPHA4</TD></TR>
<TR><TD>3.281e-02</TD><TD>-3.42</TD><TD>SSPN (sarcospan)</TD><TD>protein interactions</TD><TD>8082</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>SGCG</TD></TR>
<TR><TD>3.281e-02</TD><TD>-3.42</TD><TD>Daxx (Fas death domain-associated protein)</TD><TD>protein interactions</TD><TD>13163</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>3.281e-02</TD><TD>-3.42</TD><TD>FRMD7 (FERM domain containing 7)</TD><TD>protein interactions</TD><TD>90167</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>CASK</TD></TR>
<TR><TD>3.282e-02</TD><TD>-3.42</TD><TD>CALM3 (calmodulin 3)</TD><TD>protein interactions</TD><TD>808</TD><TD>334</TD><TD>8</TD><TD>20077</TD><TD>222</TD>
<TD>EPHA4,CETN3,UBR4,FGFR2,EPHA3,AKAP9,CHRM3,NTRK2</TD></TR>
<TR><TD>3.293e-02</TD><TD>-3.41</TD><TD>XPR1 (xenotropic and polytropic retrovirus receptor 1)</TD><TD>protein interactions</TD><TD>9213</TD><TD>109</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>NTRK2,CD226,UTRN,FGFR2</TD></TR>
<TR><TD>3.293e-02</TD><TD>-3.41</TD><TD>atypical</TD><TD>COSMIC cancer mutations</TD><TD>atypical</TD><TD>516</TD><TD>11</TD><TD>16984</TD><TD>192</TD>
<TD>NTRK2,PSKH2,EPHA4,CASK,ACVR1C,FGFR2,EPHA3,PRKCE,UHMK1,ACVR2A,TGFBR2</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity</TD><TD>molecular function</TD><TD>GO:0003829</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>GCNT1</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>arylamine N-acetyltransferase activity</TD><TD>molecular function</TD><TD>GO:0004060</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>NAT2</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>diacylglycerol-dependent, calcium-independent serine/threonine kinase activity</TD><TD>molecular function</TD><TD>GO:0004699</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>PRKCE</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>NuRD complex binding</TD><TD>molecular function</TD><TD>GO:0120325</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>PWWP2A</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>8-hydroxy-2'-deoxyguanosine DNA binding</TD><TD>molecular function</TD><TD>GO:1905773</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>WRN</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity</TD><TD>molecular function</TD><TD>GO:0015018</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>B3GAT2</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>CCR10 chemokine receptor binding</TD><TD>molecular function</TD><TD>GO:0031735</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>CXCL13</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>cholinesterase activity</TD><TD>molecular function</TD><TD>GO:0004104</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>BCHE</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>telomeric G-quadruplex DNA binding</TD><TD>molecular function</TD><TD>GO:0061849</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>WRN</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>polyprenyltransferase activity</TD><TD>molecular function</TD><TD>GO:0002094</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>COQ2</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>epidermal growth factor receptor activity</TD><TD>molecular function</TD><TD>GO:0005006</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>EFEMP1</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>NADP+ binding</TD><TD>molecular function</TD><TD>GO:0070401</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>GMDS</TD></TR>
<TR><TD>3.300e-02</TD><TD>-3.41</TD><TD>clathrin-sculpted acetylcholine transport vesicle membrane</TD><TD>cellular component</TD><TD>GO:0060201</TD><TD>3</TD><TD>1</TD><TD>19868</TD><TD>221</TD>
<TD>SYT1</TD></TR>
<TR><TD>3.300e-02</TD><TD>-3.41</TD><TD>clathrin-sculpted acetylcholine transport vesicle</TD><TD>cellular component</TD><TD>GO:0060200</TD><TD>3</TD><TD>1</TD><TD>19868</TD><TD>221</TD>
<TD>SYT1</TD></TR>
<TR><TD>3.300e-02</TD><TD>-3.41</TD><TD>dendritic filopodium</TD><TD>cellular component</TD><TD>GO:1902737</TD><TD>3</TD><TD>1</TD><TD>19868</TD><TD>221</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.300e-02</TD><TD>-3.41</TD><TD>inhibin-betaglycan-ActRII complex</TD><TD>cellular component</TD><TD>GO:0034673</TD><TD>3</TD><TD>1</TD><TD>19868</TD><TD>221</TD>
<TD>ACVR2A</TD></TR>
<TR><TD>3.300e-02</TD><TD>-3.41</TD><TD>transforming growth factor beta ligand-receptor complex</TD><TD>cellular component</TD><TD>GO:0070021</TD><TD>3</TD><TD>1</TD><TD>19868</TD><TD>221</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>3.300e-02</TD><TD>-3.41</TD><TD>phagolysosome membrane</TD><TD>cellular component</TD><TD>GO:0061474</TD><TD>3</TD><TD>1</TD><TD>19868</TD><TD>221</TD>
<TD>MPEG1</TD></TR>
<TR><TD>3.317e-02</TD><TD>-3.41</TD><TD>Tyr_Pase_cat</TD><TD>interpro domains</TD><TD>IPR003595</TD><TD>61</TD><TD>3</TD><TD>18605</TD><TD>214</TD>
<TD>PTPRD,PTPRK,PTPRZ1</TD></TR>
<TR><TD>3.324e-02</TD><TD>-3.40</TD><TD>CRTAC1 (cartilage acidic protein 1)</TD><TD>protein interactions</TD><TD>55118</TD><TD>26</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>DSCAM,EFEMP1</TD></TR>
<TR><TD>3.324e-02</TD><TD>-3.40</TD><TD>Fbxo21 (F-box protein 21)</TD><TD>protein interactions</TD><TD>231670</TD><TD>26</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>PHF14,TCF20</TD></TR>
<TR><TD>3.324e-02</TD><TD>-3.40</TD><TD>Csk (c-src tyrosine kinase)</TD><TD>protein interactions</TD><TD>12988</TD><TD>26</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>CELF2,PCGF5</TD></TR>
<TR><TD>3.326e-02</TD><TD>-3.40</TD><TD>upper_back</TD><TD>COSMIC cancer mutations</TD><TD>upper_back</TD><TD>328</TD><TD>8</TD><TD>16984</TD><TD>192</TD>
<TD>MUC7,CNTN1,FUT9,FAT4,FBN2,CHRM3,PTPRD,SPHKAP</TD></TR>
<TR><TD>3.331e-02</TD><TD>-3.40</TD><TD>regulation of biological process</TD><TD>biological process</TD><TD>GO:0050789</TD><TD>12325</TD><TD>156</TD><TD>18905</TD><TD>219</TD>
<TD>PWWP2A,MIR1260B,GAREM1,CYTL1,TGFBR2,STXBP6,MRPL13,RPH3A,ACVR2A,UBR4,SKAP2,SYT1,BANK1,HNF4G,MEGF10,ZNF518B,ZNF133,NOVA1,SEPTIN5,DNER,PRKCE,RASGEF1B,NTRK2,FAT4,MIR147A,ZFPM2,MIR548A3,SHTN1,IQGAP2,MIR891A,PLEK,MIR548AA2,MIR577,TRPS1,UNC5C,TWIST1,FGF5,LRRN2,PCGF5,BACH2,CXCL13,GPR83,ADAMTS3,PAX6,FERD3L,KLF12,LHCGR,IRX1,ZNF521,CNTN1,MIR551B,PTPRZ1,ROBO2,PAQR3,FGF20,FUT9,SGCD,ACVR1C,MIR9-2HG,DAOA,ADAMTS5,ADAMTS12,RUNX1T1,OR52K2,TCF20,CHRM3,FGFR2,XPO4,GCNT1,INSM1,PBX1,GMDS,SLIT2,PHLPP1,MIR569,FMNL2,CASK,LRFN5,C8orf88,DSCAM,EPHA3,MAP2,GHITM,PRLHR,PTPRD,PPP1R17,ADGRL3,PARP8,ATG10,FZD6,CELF2,GAP43,PTPRK,BRINP3,MTERF1,RGS6,NRG1,PUM3,MAST4,FBN2,UTRN,WRN,UHMK1,EPHA4,EFNA5,DAAM1,PHF14,ASPN,DCDC2C,SEZ6L,NAV3,EDIL3,SLC39A10,FNIP2,DEPTOR,LMX1A,FGD3,IPO8,CD96,FABP7,LRRC70,IL1RAPL2,PECAM1,ARX,JMJD1C,WWOX,ZFAND5,NOBOX,SS18,FANCB,SERGEF,EPS8,REG1B,TMEFF2,CNTNAP2,SEMA3C,BCHE,AOAH,OR2AG1,AMELX,VAV3,RBM20,EFEMP1,LGI1,AKAP9,FGF14,NRCAM,TEC,TSN,UCHL1,RYR2,CDH5,CRTC3,SPAG9,SHISA3,CD226</TD></TR>
<TR><TD>3.346e-02</TD><TD>-3.40</TD><TD>upper_arm</TD><TD>COSMIC cancer mutations</TD><TD>upper_arm</TD><TD>583</TD><TD>12</TD><TD>16984</TD><TD>192</TD>
<TD>FIGN,ADAMTS3,ROBO2,FUT9,AOAH,FGFR2,SLC10A2,PTPRD,SPHKAP,PWWP2A,ADAM28,PBX1</TD></TR>
<TR><TD>3.348e-02</TD><TD>-3.40</TD><TD>EPHD</TD><TD>prosite domains</TD><TD>PS51805</TD><TD>22</TD><TD>2</TD><TD>12232</TD><TD>161</TD>
<TD>PHF14,TCF20</TD></TR>
<TR><TD>3.353e-02</TD><TD>-3.40</TD><TD>salivary_gland-mouth_roof-carcinoma-mucoepidermoid_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>salivary_gland-mouth_roof-carcinoma-mucoepidermoid_carcinoma</TD><TD>3</TD><TD>1</TD><TD>16984</TD><TD>192</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.353e-02</TD><TD>-3.40</TD><TD>soft_tissue-nerve_sheath-malignant_peripheral_nerve_sheath_tumour-with_rhabdomyosarcomatous_differentiation</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-nerve_sheath-malignant_peripheral_nerve_sheath_tumour-with_rhabdomyosarcomatous_differentiation</TD><TD>3</TD><TD>1</TD><TD>16984</TD><TD>192</TD>
<TD>SS18</TD></TR>
<TR><TD>3.353e-02</TD><TD>-3.40</TD><TD>salivary_gland-mouth_floor-carcinoma-mucoepidermoid_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>salivary_gland-mouth_floor-carcinoma-mucoepidermoid_carcinoma</TD><TD>3</TD><TD>1</TD><TD>16984</TD><TD>192</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.353e-02</TD><TD>-3.40</TD><TD>with_rhabdomyosarcomatous_differentiation</TD><TD>COSMIC cancer mutations</TD><TD>with_rhabdomyosarcomatous_differentiation</TD><TD>3</TD><TD>1</TD><TD>16984</TD><TD>192</TD>
<TD>SS18</TD></TR>
<TR><TD>3.356e-02</TD><TD>-3.39</TD><TD>Notch binding</TD><TD>molecular function</TD><TD>GO:0005112</TD><TD>26</TD><TD>2</TD><TD>18530</TD><TD>206</TD>
<TD>DNER,MEGF10</TD></TR>
<TR><TD>3.365e-02</TD><TD>-3.39</TD><TD>negative regulation of chondrocyte differentiation</TD><TD>biological process</TD><TD>GO:0032331</TD><TD>25</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>EFEMP1,ADAMTS12</TD></TR>
<TR><TD>3.365e-02</TD><TD>-3.39</TD><TD>response to prostaglandin E</TD><TD>biological process</TD><TD>GO:0034695</TD><TD>25</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PRKCE,PAX6</TD></TR>
<TR><TD>3.377e-02</TD><TD>-3.39</TD><TD>exocytic process</TD><TD>biological process</TD><TD>GO:0140029</TD><TD>61</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>SEPTIN5,RPH3A,PLEK</TD></TR>
<TR><TD>3.377e-02</TD><TD>-3.39</TD><TD>negative regulation of G protein-coupled receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0045744</TD><TD>61</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>PLEK,CRTC3,SLIT2</TD></TR>
<TR><TD>3.385e-02</TD><TD>-3.39</TD><TD>neural precursor cell proliferation</TD><TD>biological process</TD><TD>GO:0061351</TD><TD>105</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>FZD6,ARX,FGFR2,PAX6</TD></TR>
<TR><TD>3.385e-02</TD><TD>-3.39</TD><TD>gland morphogenesis</TD><TD>biological process</TD><TD>GO:0022612</TD><TD>105</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,PAX6,FGFR2,SEMA3C</TD></TR>
<TR><TD>3.388e-02</TD><TD>-3.39</TD><TD>brain</TD><TD>COSMIC cancer mutations</TD><TD>brain</TD><TD>16260</TD><TD>189</TD><TD>16984</TD><TD>192</TD>
<TD>MEGF10,CXCL13,ACP6,ZFAND5,PCGF5,SEZ6L,LRFN5,TCF20,SPHKAP,KIF6,PAQR3,ACVR1C,LRRN2,NOBOX,XPO4,DCDC2C,SKAP2,DSCAM,DNER,EPHA4,COQ2,TMEFF2,SGCD,CASK,IRX1,ZNF133,PRKCE,PI15,CPXM2,CNTNAP2,ZNF521,PTPRK,FMNL2,KLF12,CYTL1,EFR3A,NUP35,ATG10,ADAM28,TGFBR2,PTPRD,NRCAM,SEMA3C,DAAM1,TSN,CALN1,AOAH,THSD7A,ZPLD1,ROBO2,RPH3A,RYR2,REXO2,SGCG,PHF14,ADAMTS5,EPHA3,HNF4G,CD96,NTRK2,ADAMTS12,IL1RAPL2,CETN3,WRN,MRPL3,BCHE,ADAMTS3,DNAJC12,RAI2,PBX1,UBR4,EFR3B,ASPN,LRRC3B,FIGN,PHLPP1,JMJD1C,LRRC70,OR52K2,FBN2,DEPTOR,RGS6,MUC7,SPAG9,PWWP2A,UCHL1,REG1B,LRIG3,FUT9,NRSN1,IPO8,FGD3,PAX6,STXBP6,IQGAP2,BACH2,FGF5,IGFL4,CTSO,SLC7A14,EDIL3,FNIP2,SLC25A46,FABP7,PXDNL,AGA,DAOA,KCNK9,CHRM3,MPEG1,GMDS,BANK1,ZNF518B,SYT1,FANCB,NBEA,FAT4,COX7B2,LMBRD1,FGF14,THSD7B,NAV3,FZD6,EPS8,LHCGR,NRG1,PRSS12,CRTC3,MRPL13,SLC7A8,SHISA3,PCDH9,INSM1,CDH5,ARX,RBM20,UHMK1,ARL14,RUNX1T1,FGFR2,GCNT1,AMELX,FERD3L,EFNA5,PRLHR,EPYC,SLC10A2,LGI1,PSKH2,KAZN,LMX1A,NOL4,NCKAP5,SLIT2,FGF20,SERINC5,MAP2,AKAP9,CNTN1,NAALADL2,PARP8,TWIST1,SS18,NOVA1,SPANXN1,TRPS1,EFEMP1,WWOX,GPR83,B3GAT2,SERGEF,GHITM,PTPRZ1,UNC5C,OR2AG1,CD226,SLC39A10,VAV3,PLEK,NAT2,SPATA16,AFM,ZFPM2,ACVR2A,UTRN,DEFB115,GAP43,RASGEF1B,CELF2</TD></TR>
<TR><TD>3.389e-02</TD><TD>-3.38</TD><TD>UBIAD1 (UbiA prenyltransferase domain containing 1)</TD><TD>protein interactions</TD><TD>29914</TD><TD>110</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>NTRK2,TMEFF2,SLC7A14,SYT1</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>MARCHF4/9/11</TD><TD>interpro domains</TD><TD>IPR046356</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MARCHF11</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>Ryan_recept</TD><TD>interpro domains</TD><TD>IPR013333</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>Neurobeachin_a-sol</TD><TD>interpro domains</TD><TD>IPR046852</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NBEA</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>XPO4/7-like</TD><TD>interpro domains</TD><TD>IPR044189</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>XPO4</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>Neuregulin</TD><TD>interpro domains</TD><TD>IPR040180</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NRG1</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>RYDR_Jsol</TD><TD>interpro domains</TD><TD>IPR048581</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>GPCR_2_latrophilin_rcpt_C</TD><TD>interpro domains</TD><TD>IPR003334</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>ADGRL3</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>MAP2/MAP4/Tau</TD><TD>interpro domains</TD><TD>IPR027324</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>RasGAP_C</TD><TD>interpro domains</TD><TD>IPR000593</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>IQGAP2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>SLRP_I_decor/aspor/byglycan</TD><TD>interpro domains</TD><TD>IPR016352</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>ASPN</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>CBFA2T1/2/3</TD><TD>interpro domains</TD><TD>IPR013289</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>Ribosomal_uL3</TD><TD>interpro domains</TD><TD>IPR000597</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MRPL3</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>Ryanodine_rcpt</TD><TD>interpro domains</TD><TD>IPR003032</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>HRDC_dom</TD><TD>interpro domains</TD><TD>IPR002121</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>WRN</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>PH_Vav</TD><TD>interpro domains</TD><TD>IPR037832</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>VAV3</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>BRINP</TD><TD>interpro domains</TD><TD>IPR033237</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>BRINP3</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>Peptidase_T2</TD><TD>interpro domains</TD><TD>IPR000246</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>AGA</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>UbiA_prenyltransferase</TD><TD>interpro domains</TD><TD>IPR000537</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>COQ2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>NHR2</TD><TD>interpro domains</TD><TD>IPR014896</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>SPRY1_RyR</TD><TD>interpro domains</TD><TD>IPR035761</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>TORC_M</TD><TD>interpro domains</TD><TD>IPR024784</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>SPRY2_RyR</TD><TD>interpro domains</TD><TD>IPR035764</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>MAP_tubulin-bd_rpt</TD><TD>interpro domains</TD><TD>IPR001084</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>SS18_N</TD><TD>interpro domains</TD><TD>IPR007726</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>SS18</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>Ryanrecept_TM4-6</TD><TD>interpro domains</TD><TD>IPR009460</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>Serum_albumin/AFP/Afamin</TD><TD>interpro domains</TD><TD>IPR021177</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>AFM</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>Mimecan/Epiphycan/Opticin</TD><TD>interpro domains</TD><TD>IPR043547</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>EPYC</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>PUM-HD</TD><TD>interpro domains</TD><TD>IPR033133</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PUM3</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>Glyco_trans_43</TD><TD>interpro domains</TD><TD>IPR005027</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>B3GAT2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>L_AA_transporter</TD><TD>interpro domains</TD><TD>IPR004760</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>SLC7A8</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>GDSL</TD><TD>interpro domains</TD><TD>IPR001087</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>AOAH</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>Rabphilin_Doc2_C2A</TD><TD>interpro domains</TD><TD>IPR047022</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RPH3A</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>IL-40-like_Ig</TD><TD>interpro domains</TD><TD>IPR040878</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PECAM1</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>Nav/unc-53</TD><TD>interpro domains</TD><TD>IPR039041</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NAV3</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>TORC_N</TD><TD>interpro domains</TD><TD>IPR024783</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>TORC</TD><TD>interpro domains</TD><TD>IPR024786</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>SPRY3_RyR</TD><TD>interpro domains</TD><TD>IPR035762</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>NTRK_LRRCT</TD><TD>interpro domains</TD><TD>IPR031635</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NTRK2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>XPO2_central</TD><TD>interpro domains</TD><TD>IPR013713</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>IPO8</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>FMNL_animal</TD><TD>interpro domains</TD><TD>IPR043592</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FMNL2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>Fibrillin_U_N</TD><TD>interpro domains</TD><TD>IPR040872</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FBN2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>GPCR_2_latrophilin</TD><TD>interpro domains</TD><TD>IPR003924</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>ADGRL3</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>NTRK</TD><TD>interpro domains</TD><TD>IPR020777</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NTRK2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>CDC4_N-term_subdom</TD><TD>interpro domains</TD><TD>IPR003338</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>AFG2A</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>FBN_EGF_N</TD><TD>interpro domains</TD><TD>IPR049388</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FBN2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>Ribosomal_uL3_CS</TD><TD>interpro domains</TD><TD>IPR019926</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MRPL3</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>HRDC_dom_sf</TD><TD>interpro domains</TD><TD>IPR044876</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>WRN</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>TORC_C</TD><TD>interpro domains</TD><TD>IPR024785</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>SMIM5/18/22</TD><TD>interpro domains</TD><TD>IPR031671</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>SMIM18</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>UbiA_sf</TD><TD>interpro domains</TD><TD>IPR044878</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>COQ2</TD></TR>
<TR><TD>3.411e-02</TD><TD>-3.38</TD><TD>AKAP_110_C</TD><TD>interpro domains</TD><TD>IPR018292</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>SPHKAP</TD></TR>
<TR><TD>3.417e-02</TD><TD>-3.38</TD><TD>Amino acid/polyamine transporter I</TD><TD>gene3d domains</TD><TD>1.20.1740.10</TD><TD>24</TD><TD>2</TD><TD>14531</TD><TD>177</TD>
<TD>SLC7A8,SLC7A14</TD></TR>
<TR><TD>3.417e-02</TD><TD>-3.38</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.50.30.30</TD><TD>24</TD><TD>2</TD><TD>14531</TD><TD>177</TD>
<TD>NAALADL2,CPQ</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>SMIM5_18_22</TD><TD>pfam domains</TD><TD>PF15831</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>SMIM18</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>Asparaginase_2</TD><TD>pfam domains</TD><TD>PF01112</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>AGA</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>RasGAP_C</TD><TD>pfam domains</TD><TD>PF03836</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>IQGAP2</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>RR_TM4-6</TD><TD>pfam domains</TD><TD>PF06459</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>Neurobeachin</TD><TD>pfam domains</TD><TD>PF20425</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>NBEA</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>TORC_M</TD><TD>pfam domains</TD><TD>PF12885</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>UbiA</TD><TD>pfam domains</TD><TD>PF01040</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>COQ2</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>Tubulin-binding</TD><TD>pfam domains</TD><TD>PF00418</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>Ribosomal_L3</TD><TD>pfam domains</TD><TD>PF00297</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>MRPL3</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>NHR2</TD><TD>pfam domains</TD><TD>PF08788</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>RYDR_Jsol</TD><TD>pfam domains</TD><TD>PF21119</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>TORC_C</TD><TD>pfam domains</TD><TD>PF12886</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>LRRCT_2</TD><TD>pfam domains</TD><TD>PF16920</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>NTRK2</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>AKAP_110</TD><TD>pfam domains</TD><TD>PF05716</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>SPHKAP</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>Lipase_GDSL</TD><TD>pfam domains</TD><TD>PF00657</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>AOAH</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>Neurensin</TD><TD>pfam domains</TD><TD>PF14927</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>NRSN1</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>Cse1</TD><TD>pfam domains</TD><TD>PF08506</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>IPO8</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>RyR</TD><TD>pfam domains</TD><TD>PF02026</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>SSXT</TD><TD>pfam domains</TD><TD>PF05030</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>SS18</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>BRINP</TD><TD>pfam domains</TD><TD>PF19052</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>BRINP3</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>FBN_EGF_st1</TD><TD>pfam domains</TD><TD>PF21364</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>FBN2</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>HRDC</TD><TD>pfam domains</TD><TD>PF00570</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>WRN</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>Ig_C17orf99</TD><TD>pfam domains</TD><TD>PF17736</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>PECAM1</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>Fibrillin_U_N</TD><TD>pfam domains</TD><TD>PF18193</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>FBN2</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>Glyco_transf_43</TD><TD>pfam domains</TD><TD>PF03360</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>B3GAT2</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>Latrophilin</TD><TD>pfam domains</TD><TD>PF02354</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>ADGRL3</TD></TR>
<TR><TD>3.419e-02</TD><TD>-3.38</TD><TD>TORC_N</TD><TD>pfam domains</TD><TD>PF12884</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>TRAM-dependent toll-like receptor 4 signaling pathway</TD><TD>biological process</TD><TD>GO:0035669</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PRKCE</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>positive regulation of cell fate specification</TD><TD>biological process</TD><TD>GO:0042660</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>ventricular zone neuroblast division</TD><TD>biological process</TD><TD>GO:0021847</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>export from the mitochondrion</TD><TD>biological process</TD><TD>GO:0170037</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>GHITM</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>orbitofrontal cortex development</TD><TD>biological process</TD><TD>GO:0021769</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>trans-synaptic signaling by BDNF, modulating synaptic transmission</TD><TD>biological process</TD><TD>GO:0099183</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>prostate epithelial cord elongation</TD><TD>biological process</TD><TD>GO:0060523</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis</TD><TD>biological process</TD><TD>GO:1905312</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SEMA3C</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>olfactory bulb mitral cell layer development</TD><TD>biological process</TD><TD>GO:0061034</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>cell adhesion molecule production</TD><TD>biological process</TD><TD>GO:0060352</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>GCNT1</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>regulation of dense core granule transport</TD><TD>biological process</TD><TD>GO:1904809</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>positive regulation of anterograde dense core granule transport</TD><TD>biological process</TD><TD>GO:1901953</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>rhombomere morphogenesis</TD><TD>biological process</TD><TD>GO:0021593</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>GDP-L-fucose biosynthetic process</TD><TD>biological process</TD><TD>GO:0042350</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>GMDS</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>TRAM-dependent toll-like receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0035668</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PRKCE</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>axon target recognition</TD><TD>biological process</TD><TD>GO:0007412</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>UCHL1</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>positive regulation of ATPase-coupled calcium transmembrane transporter activity</TD><TD>biological process</TD><TD>GO:1901896</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>mitotic actomyosin contractile ring assembly</TD><TD>biological process</TD><TD>GO:1903475</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>IQGAP2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>regulation of protein localization to cell-cell junction</TD><TD>biological process</TD><TD>GO:0150106</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PECAM1</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>positive regulation of dopaminergic neuron differentiation</TD><TD>biological process</TD><TD>GO:1904340</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGF20</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>right ventricular cardiac muscle tissue morphogenesis</TD><TD>biological process</TD><TD>GO:0003221</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>positive regulation of synaptic vesicle exocytosis</TD><TD>biological process</TD><TD>GO:2000302</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SYT1</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>insulin receptor internalization</TD><TD>biological process</TD><TD>GO:0038016</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>LMBRD1</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>miRNA transport</TD><TD>biological process</TD><TD>GO:1990428</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>midbrain morphogenesis</TD><TD>biological process</TD><TD>GO:1904693</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FZD6</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>cell proliferation involved in heart morphogenesis</TD><TD>biological process</TD><TD>GO:0061323</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>negative regulation of female gonad development</TD><TD>biological process</TD><TD>GO:2000195</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>cytoplasmic actin-based contraction involved in cell motility</TD><TD>biological process</TD><TD>GO:0060327</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SHTN1</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration</TD><TD>biological process</TD><TD>GO:0021834</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>male germ cell proliferation</TD><TD>biological process</TD><TD>GO:0002176</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>UCHL1</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>epithalamus development</TD><TD>biological process</TD><TD>GO:0021538</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>mammary gland bud morphogenesis</TD><TD>biological process</TD><TD>GO:0060648</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>germ cell proliferation</TD><TD>biological process</TD><TD>GO:0036093</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>UCHL1</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>regulation of anterograde dense core granule transport</TD><TD>biological process</TD><TD>GO:1901951</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>calcium export from the mitochondrion</TD><TD>biological process</TD><TD>GO:0099093</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>GHITM</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>acetylcholine catabolic process</TD><TD>biological process</TD><TD>GO:0006581</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>BCHE</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>establishment of body hair or bristle planar orientation</TD><TD>biological process</TD><TD>GO:0048104</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FZD6</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>mitotic actomyosin contractile ring assembly actin filament organization</TD><TD>biological process</TD><TD>GO:1903479</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>IQGAP2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>assembly of actomyosin apparatus involved in mitotic cytokinesis</TD><TD>biological process</TD><TD>GO:1902407</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>IQGAP2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>L-leucine import across plasma membrane</TD><TD>biological process</TD><TD>GO:1903801</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLC7A8</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>regulation of SA node cell action potential</TD><TD>biological process</TD><TD>GO:0098907</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>habenula development</TD><TD>biological process</TD><TD>GO:0021986</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>regulation of serine C-palmitoyltransferase activity</TD><TD>biological process</TD><TD>GO:1904220</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SERINC5</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>positive regulation of dense core granule transport</TD><TD>biological process</TD><TD>GO:1904811</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>growth plate cartilage chondrocyte growth</TD><TD>biological process</TD><TD>GO:0003430</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>establishment of body hair planar orientation</TD><TD>biological process</TD><TD>GO:0048105</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FZD6</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>type B pancreatic cell apoptotic process</TD><TD>biological process</TD><TD>GO:0097050</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>trophectodermal cell proliferation</TD><TD>biological process</TD><TD>GO:0001834</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ACVR1C</TD></TR>
<TR><TD>3.442e-02</TD><TD>-3.37</TD><TD>eye development</TD><TD>biological process</TD><TD>GO:0001654</TD><TD>382</TD><TD>9</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2,PAX6,TGFBR2,PLAAT1,DSCAM,TWIST1,PBX1,EFEMP1,FBN2</TD></TR>
<TR><TD>3.453e-02</TD><TD>-3.37</TD><TD>response to alcohol</TD><TD>biological process</TD><TD>GO:0097305</TD><TD>264</TD><TD>7</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,FGFR2,TGFBR2,EFNA5,PRKCE,SLIT2,EPS8</TD></TR>
<TR><TD>3.459e-02</TD><TD>-3.36</TD><TD>lung-carcinoma-acinar_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-acinar_adenocarcinoma</TD><TD>26</TD><TD>2</TD><TD>16984</TD><TD>192</TD>
<TD>FGFR2,LRIG3</TD></TR>
<TR><TD>3.481e-02</TD><TD>-3.36</TD><TD>marginal_zone_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>marginal_zone_lymphoma</TD><TD>331</TD><TD>8</TD><TD>16984</TD><TD>192</TD>
<TD>FAT4,EDIL3,PTPRK,PTPRZ1,PTPRD,LRRC3B,ROBO2,NAT2</TD></TR>
<TR><TD>3.482e-02</TD><TD>-3.36</TD><TD>cell junction</TD><TD>cellular component</TD><TD>GO:0030054</TD><TD>2227</TD><TD>34</TD><TD>19868</TD><TD>221</TD>
<TD>ADGRL3,UTRN,RPH3A,EPHA4,PTPRD,KAZN,CASK,PECAM1,FGFR2,DSCAM,CNTNAP2,PRSS12,AKAP9,GAP43,CDH5,STXBP6,NRCAM,CHRM3,CNTN1,PTPRK,LGI1,LRFN5,REXO2,EFNA5,KCNK9,PTPRZ1,PRKCE,SEPTIN5,PCDH9,IL1RAPL2,SYT1,UNC5C,EPS8,NTRK2</TD></TR>
<TR><TD>3.483e-02</TD><TD>-3.36</TD><TD>PHF21A (PHD finger protein 21A)</TD><TD>protein interactions</TD><TD>51317</TD><TD>338</TD><TD>8</TD><TD>20077</TD><TD>222</TD>
<TD>UBR4,NOL4,PAX6,WWOX,JMJD1C,RBM20,UTRN,TRPS1</TD></TR>
<TR><TD>3.486e-02</TD><TD>-3.36</TD><TD>DLG3 (discs large MAGUK scaffold protein 3)</TD><TD>protein interactions</TD><TD>1741</TD><TD>111</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>AOAH,CASK,ARL14,NBEA</TD></TR>
<TR><TD>3.486e-02</TD><TD>-3.36</TD><TD>CTNNA3 (catenin alpha 3)</TD><TD>protein interactions</TD><TD>29119</TD><TD>111</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>EPS8,PAX6,AKAP9,FERD3L</TD></TR>
<TR><TD>3.486e-02</TD><TD>-3.36</TD><TD>cerebellum development</TD><TD>biological process</TD><TD>GO:0021549</TD><TD>106</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>SLC25A46,PAX6,LMX1A,CNTN1</TD></TR>
<TR><TD>3.489e-02</TD><TD>-3.36</TD><TD>negative regulation of response to stimulus</TD><TD>biological process</TD><TD>GO:0048585</TD><TD>1766</TD><TD>29</TD><TD>18905</TD><TD>219</TD>
<TD>CD96,FZD6,BANK1,WWOX,PAQR3,ROBO2,RGS6,FBN2,ADAMTS12,FANCB,EPHA4,CNTNAP2,AOAH,SLIT2,ASPN,PHF14,LRFN5,DEPTOR,CASK,UCHL1,PLEK,PHLPP1,CRTC3,PTPRD,SHISA3,CXCL13,TWIST1,GHITM,CDH5</TD></TR>
<TR><TD>3.500e-02</TD><TD>-3.35</TD><TD>Negative regulation of FGFR3 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654732</TD><TD>29</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>3.500e-02</TD><TD>-3.35</TD><TD>VEGFR2 mediated vascular permeability</TD><TD>REACTOME pathways</TD><TD>R-HSA-5218920</TD><TD>29</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>CDH5,VAV3</TD></TR>
<TR><TD>3.504e-02</TD><TD>-3.35</TD><TD>MCAM (melanoma cell adhesion molecule)</TD><TD>protein interactions</TD><TD>4162</TD><TD>466</TD><TD>10</TD><TD>20077</TD><TD>222</TD>
<TD>ARL14,PHLPP1,EPHA3,EFR3A,EFR3B,PTPRK,SLC39A10,CASK,CNTN1,UTRN</TD></TR>
<TR><TD>3.527e-02</TD><TD>-3.34</TD><TD>Maturity onset diabetes of the young</TD><TD>KEGG pathways</TD><TD>hsa04950</TD><TD>26</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>HNF4G,PAX6</TD></TR>
<TR><TD>3.527e-02</TD><TD>-3.34</TD><TD>Maturity onset diabetes of the young</TD><TD>KEGG pathways</TD><TD>ko04950</TD><TD>26</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>HNF4G,PAX6</TD></TR>
<TR><TD>3.542e-02</TD><TD>-3.34</TD><TD>metalloendopeptidase activity</TD><TD>molecular function</TD><TD>GO:0004222</TD><TD>111</TD><TD>4</TD><TD>18530</TD><TD>206</TD>
<TD>ADAMTS5,ADAM28,ADAMTS3,ADAMTS12</TD></TR>
<TR><TD>3.564e-02</TD><TD>-3.33</TD><TD>ZNF354C (zinc finger protein 354C)</TD><TD>protein interactions</TD><TD>30832</TD><TD>27</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>IPO8,LINC00624</TD></TR>
<TR><TD>3.564e-02</TD><TD>-3.33</TD><TD>NPPB (natriuretic peptide B)</TD><TD>protein interactions</TD><TD>4879</TD><TD>27</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>FAT4,CASK</TD></TR>
<TR><TD>3.571e-02</TD><TD>-3.33</TD><TD>TIR_dom</TD><TD>interpro domains</TD><TD>IPR000157</TD><TD>26</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>IL1RAPL2,BANK1</TD></TR>
<TR><TD>3.575e-02</TD><TD>-3.33</TD><TD>positive regulation of protein phosphorylation</TD><TD>biological process</TD><TD>GO:0001934</TD><TD>574</TD><TD>12</TD><TD>18905</TD><TD>219</TD>
<TD>FNIP2,BANK1,NRG1,FGF20,FGF5,NTRK2,TGFBR2,EPHA4,EFNA5,AKAP9,ACVR2A,PECAM1</TD></TR>
<TR><TD>3.584e-02</TD><TD>-3.33</TD><TD>DLG4 (discs large MAGUK scaffold protein 4)</TD><TD>protein interactions</TD><TD>1742</TD><TD>164</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>LGI1,CNTNAP2,NRG1,CASK,DSCAM</TD></TR>
<TR><TD>3.585e-02</TD><TD>-3.33</TD><TD>PTPRU (protein tyrosine phosphatase receptor type U)</TD><TD>protein interactions</TD><TD>10076</TD><TD>112</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRK,NRSN1,CDH5,PI15</TD></TR>
<TR><TD>3.591e-02</TD><TD>-3.33</TD><TD>ERG (ETS transcription factor ERG)</TD><TD>protein interactions</TD><TD>2078</TD><TD>220</TD><TD>6</TD><TD>20077</TD><TD>222</TD>
<TD>SS18,ZNF521,TRPS1,UBR4,TCF20,PTPRD</TD></TR>
<TR><TD>3.598e-02</TD><TD>-3.32</TD><TD>ephrin receptor binding</TD><TD>molecular function</TD><TD>GO:0046875</TD><TD>27</TD><TD>2</TD><TD>18530</TD><TD>206</TD>
<TD>EPHA4,EFNA5</TD></TR>
<TR><TD>3.600e-02</TD><TD>-3.32</TD><TD>ovary-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>ovary-carcinoma</TD><TD>934</TD><TD>17</TD><TD>16984</TD><TD>192</TD>
<TD>UHMK1,PAX6,ACVR2A,TGFBR2,LHCGR,EPHA3,PRKCE,FAT4,EDIL3,ACVR1C,NTRK2,PSKH2,FGFR2,ZNF521,CASK,SYT1,EPHA4</TD></TR>
<TR><TD>3.603e-02</TD><TD>-3.32</TD><TD>dendrite cytoplasm</TD><TD>cellular component</TD><TD>GO:0032839</TD><TD>27</TD><TD>2</TD><TD>19868</TD><TD>221</TD>
<TD>UHMK1,MAP2</TD></TR>
<TR><TD>3.603e-02</TD><TD>-3.32</TD><TD>axonal growth cone</TD><TD>cellular component</TD><TD>GO:0044295</TD><TD>27</TD><TD>2</TD><TD>19868</TD><TD>221</TD>
<TD>SHTN1,EPHA4</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.30.30.1150</TD><TD>3</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>PHF14</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>UbiA prenyltransferase</TD><TD>gene3d domains</TD><TD>1.10.357.140</TD><TD>3</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>COQ2</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>(Glycosyl)asparaginase</TD><TD>gene3d domains</TD><TD>3.60.20.30</TD><TD>3</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>AGA</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>HRDC domain</TD><TD>gene3d domains</TD><TD>1.10.150.80</TD><TD>3</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>WRN</TD></TR>
<TR><TD>3.610e-02</TD><TD>-3.32</TD><TD>-</TD><TD>gene3d domains</TD><TD>1.10.490.160</TD><TD>3</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.617e-02</TD><TD>-3.32</TD><TD>neural tube development</TD><TD>biological process</TD><TD>GO:0021915</TD><TD>157</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,FERD3L,TWIST1,SEMA3C,FZD6</TD></TR>
<TR><TD>3.618e-02</TD><TD>-3.32</TD><TD>embryonic camera-type eye morphogenesis</TD><TD>biological process</TD><TD>GO:0048596</TD><TD>26</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,TWIST1</TD></TR>
<TR><TD>3.618e-02</TD><TD>-3.32</TD><TD>atrioventricular valve morphogenesis</TD><TD>biological process</TD><TD>GO:0003181</TD><TD>26</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,TWIST1</TD></TR>
<TR><TD>3.618e-02</TD><TD>-3.32</TD><TD>regulation of establishment or maintenance of cell polarity</TD><TD>biological process</TD><TD>GO:0032878</TD><TD>26</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>SHTN1,CDH5</TD></TR>
<TR><TD>3.618e-02</TD><TD>-3.32</TD><TD>motor neuron axon guidance</TD><TD>biological process</TD><TD>GO:0008045</TD><TD>26</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,EPHA4</TD></TR>
<TR><TD>3.618e-02</TD><TD>-3.32</TD><TD>positive regulation of mesenchymal cell proliferation</TD><TD>biological process</TD><TD>GO:0002053</TD><TD>26</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,FGFR2</TD></TR>
<TR><TD>3.618e-02</TD><TD>-3.32</TD><TD>regulation of skeletal muscle tissue development</TD><TD>biological process</TD><TD>GO:0048641</TD><TD>26</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>MEGF10,TWIST1</TD></TR>
<TR><TD>3.641e-02</TD><TD>-3.31</TD><TD>visual system development</TD><TD>biological process</TD><TD>GO:0150063</TD><TD>386</TD><TD>9</TD><TD>18905</TD><TD>219</TD>
<TD>EFEMP1,PBX1,TWIST1,FBN2,PAX6,NTRK2,DSCAM,PLAAT1,TGFBR2</TD></TR>
<TR><TD>3.643e-02</TD><TD>-3.31</TD><TD>skin-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-malignant_melanoma</TD><TD>15793</TD><TD>185</TD><TD>16984</TD><TD>192</TD>
<TD>PWWP2A,UCHL1,RGS6,FBN2,DEPTOR,MUC7,SPAG9,PAX6,FGD3,IQGAP2,STXBP6,LRIG3,REG1B,NRSN1,IPO8,FUT9,DNAJC12,RAI2,PBX1,UBR4,WRN,CETN3,MRPL3,IL1RAPL2,ADAMTS3,BCHE,PHLPP1,OR52K2,JMJD1C,LRRC3B,ASPN,FIGN,TGFBR2,PTPRD,ADAM28,TSN,CALN1,NRCAM,SEMA3C,DAAM1,KLF12,PTPRK,ZNF521,FMNL2,NUP35,EFR3A,ATG10,CYTL1,EPHA3,ADAMTS12,CD96,NTRK2,HNF4G,ZPLD1,THSD7A,AOAH,ADAMTS5,PHF14,SGCG,ROBO2,RYR2,RPH3A,SPHKAP,LRRN2,ACVR1C,NOBOX,ERCC6L2,KIF6,PAQR3,ZFAND5,CXCL13,MEGF10,ACP6,TCF20,PCGF5,SEZ6L,LRFN5,PI15,CPXM2,IRX1,PRKCE,ZNF133,CNTNAP2,DSCAM,SKAP2,XPO4,SGCD,TMEFF2,CASK,EPHA4,DNER,COQ2,PTPRZ1,GHITM,UNC5C,GPR83,SERGEF,B3GAT2,CD226,OR2AG1,TRPS1,EFEMP1,ACVR2A,UTRN,ZFPM2,GAP43,CELF2,RASGEF1B,DEFB115,PLEK,VAV3,SLC39A10,NAT2,AFM,SPATA16,EPYC,PRLHR,EFNA5,LMX1A,KAZN,LGI1,SLC10A2,PSKH2,GCNT1,RUNX1T1,FGFR2,FERD3L,AMELX,SERINC5,MAP2,NOVA1,TWIST1,SS18,SPANXN1,NAALADL2,CNTN1,AKAP9,PARP8,SLIT2,NOL4,NCKAP5,FGF20,NRG1,PRSS12,EPS8,LHCGR,SLC7A8,MRPL13,CRTC3,COX7B2,NAV3,FZD6,LMBRD1,FGF14,THSD7B,RBM20,ARL14,UHMK1,ARX,SHISA3,PCDH9,INSM1,CDH5,FNIP2,SLC7A14,EDIL3,PXDNL,AGA,FABP7,SLC25A46,BACH2,FGF5,CTSO,IGFL4,FAT4,KCNK9,CHRM3,DAOA,FANCB,SYT1,ZNF518B,BANK1,NBEA,GMDS,MPEG1</TD></TR>
<TR><TD>3.644e-02</TD><TD>-3.31</TD><TD>human chr14q12</TD><TD>chromosome location</TD><TD>human chr14q12</TD><TD>143</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>STXBP6,NOVA1</TD></TR>
<TR><TD>3.659e-02</TD><TD>-3.31</TD><TD>SCGB2A2 (secretoglobin family 2A member 2)</TD><TD>protein interactions</TD><TD>4250</TD><TD>221</TD><TD>6</TD><TD>20077</TD><TD>222</TD>
<TD>PRSS12,SEMA3C,BCHE,BRINP3,SLIT2,GCNT1</TD></TR>
<TR><TD>3.665e-02</TD><TD>-3.31</TD><TD>synaptic vesicle exocytosis</TD><TD>biological process</TD><TD>GO:0016079</TD><TD>63</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>SYT1,RPH3A,SEPTIN5</TD></TR>
<TR><TD>3.669e-02</TD><TD>-3.31</TD><TD>CLSTN3 (calsyntenin 3)</TD><TD>protein interactions</TD><TD>9746</TD><TD>66</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>ADAMTS12,NRSN1,B3GAT2</TD></TR>
<TR><TD>3.686e-02</TD><TD>-3.30</TD><TD>CEP170P1 (centrosomal protein 170 pseudogene 1)</TD><TD>protein interactions</TD><TD>645455</TD><TD>113</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>RUNX1T1,TRPS1,PHF14,AKAP9</TD></TR>
<TR><TD>3.693e-02</TD><TD>-3.30</TD><TD>SPPL3 (signal peptide peptidase like 3)</TD><TD>protein interactions</TD><TD>121665</TD><TD>884</TD><TD>16</TD><TD>20077</TD><TD>222</TD>
<TD>RASGEF1B,BCHE,KIF6,PXDNL,ADGRL3,EDIL3,NBEA,SPAG9,IL1RAPL2,SLC7A14,UHMK1,EPHA3,LRRC3B,ADAM28,PRLHR,RBM20</TD></TR>
<TR><TD>3.706e-02</TD><TD>-3.30</TD><TD>Protein-protein interactions at synapses</TD><TD>REACTOME pathways</TD><TD>R-HSA-6794362</TD><TD>72</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>PTPRD,SYT1,CASK</TD></TR>
<TR><TD>3.708e-02</TD><TD>-3.29</TD><TD>acinar_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>acinar_adenocarcinoma</TD><TD>27</TD><TD>2</TD><TD>16984</TD><TD>192</TD>
<TD>FGFR2,LRIG3</TD></TR>
<TR><TD>3.727e-02</TD><TD>-3.29</TD><TD>vertebrae</TD><TD>COSMIC cancer mutations</TD><TD>vertebrae</TD><TD>65</TD><TD>3</TD><TD>16984</TD><TD>192</TD>
<TD>FBN2,THSD7B,ADAMTS5</TD></TR>
<TR><TD>3.742e-02</TD><TD>-3.29</TD><TD>ankle</TD><TD>COSMIC cancer mutations</TD><TD>ankle</TD><TD>398</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>ADAM28,GPR83,MAP2,PTPRD,CHRM3,CNTNAP2,AKAP9,ADAMTS3,SPATA16</TD></TR>
<TR><TD>3.781e-02</TD><TD>-3.28</TD><TD>O-glycan biosynthesis, mucin type core</TD><TD>KEGG pathways</TD><TD>hsa_M00056</TD><TD>27</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>GALNT15,GCNT1</TD></TR>
<TR><TD>3.781e-02</TD><TD>-3.28</TD><TD>O-glycan biosynthesis, mucin type core</TD><TD>KEGG pathways</TD><TD>M00056</TD><TD>27</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>GALNT15,GCNT1</TD></TR>
<TR><TD>3.788e-02</TD><TD>-3.27</TD><TD>ORF3b (ORF3b protein)</TD><TD>protein interactions</TD><TD>1489670</TD><TD>114</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>NOVA1,NRG1,PCDH9,TGFBR2</TD></TR>
<TR><TD>3.788e-02</TD><TD>-3.27</TD><TD>ACVR1 (activin A receptor type 1)</TD><TD>protein interactions</TD><TD>90</TD><TD>114</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>PLEK,TGFBR2,NRSN1,ACVR2A</TD></TR>
<TR><TD>3.789e-02</TD><TD>-3.27</TD><TD>C2DOMAIN</TD><TD>prints domains</TD><TD>PR00360</TD><TD>23</TD><TD>2</TD><TD>5258</TD><TD>71</TD>
<TD>SYT1,RPH3A</TD></TR>
<TR><TD>3.797e-02</TD><TD>-3.27</TD><TD>kinase activity</TD><TD>molecular function</TD><TD>GO:0016301</TD><TD>742</TD><TD>14</TD><TD>18530</TD><TD>206</TD>
<TD>NTRK2,UHMK1,EPHA3,MAST4,ACVR1C,PSKH2,PRKCE,EFEMP1,TEC,FGFR2,EPHA4,TGFBR2,ACVR2A,CASK</TD></TR>
<TR><TD>3.810e-02</TD><TD>-3.27</TD><TD>Signaling by PDGF</TD><TD>REACTOME pathways</TD><TD>R-HSA-186797</TD><TD>376</TD><TD>8</TD><TD>10391</TD><TD>106</TD>
<TD>PRKCE,FGF5,FGFR2,PHLPP1,PAQR3,AKAP9,FGF20,NRG1</TD></TR>
<TR><TD>3.811e-02</TD><TD>-3.27</TD><TD>EGF (epidermal growth factor)</TD><TD>protein interactions</TD><TD>1950</TD><TD>28</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>NRG1,FGF5</TD></TR>
<TR><TD>3.811e-02</TD><TD>-3.27</TD><TD>B3GALNT2 (beta-1,3-N-acetylgalactosaminyltransferase 2)</TD><TD>protein interactions</TD><TD>148789</TD><TD>28</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>NRG1,KLF12</TD></TR>
<TR><TD>3.811e-02</TD><TD>-3.27</TD><TD>IZUMO1 (izumo sperm-oocyte fusion 1)</TD><TD>protein interactions</TD><TD>284359</TD><TD>28</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRD,GHITM</TD></TR>
<TR><TD>3.811e-02</TD><TD>-3.27</TD><TD>KCNC3 (potassium voltage-gated channel subfamily C member 3)</TD><TD>protein interactions</TD><TD>3748</TD><TD>28</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>PAX6,PTPRD</TD></TR>
<TR><TD>3.811e-02</TD><TD>-3.27</TD><TD>ZNF696 (zinc finger protein 696)</TD><TD>protein interactions</TD><TD>79943</TD><TD>67</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>SHISA3,EFEMP1,IPO8</TD></TR>
<TR><TD>3.811e-02</TD><TD>-3.27</TD><TD>EFNA5 (ephrin A5)</TD><TD>protein interactions</TD><TD>1946</TD><TD>67</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>SLC10A2,EPHA3,EPHA4</TD></TR>
<TR><TD>3.811e-02</TD><TD>-3.27</TD><TD>CRIPTO (cripto, EGF-CFC family member)</TD><TD>protein interactions</TD><TD>6997</TD><TD>67</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>ACVR1C,ACVR2A,TGFBR2</TD></TR>
<TR><TD>3.813e-02</TD><TD>-3.27</TD><TD>glandular epithelial cell differentiation</TD><TD>biological process</TD><TD>GO:0002067</TD><TD>64</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>INSM1,FGFR2,PAX6</TD></TR>
<TR><TD>3.813e-02</TD><TD>-3.27</TD><TD>photoreceptor cell differentiation</TD><TD>biological process</TD><TD>GO:0046530</TD><TD>64</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,NTRK2,DSCAM</TD></TR>
<TR><TD>3.813e-02</TD><TD>-3.27</TD><TD>extracellular matrix structural constituent</TD><TD>molecular function</TD><TD>GO:0005201</TD><TD>166</TD><TD>5</TD><TD>18530</TD><TD>206</TD>
<TD>AMELX,EDIL3,ASPN,EFEMP1,FBN2</TD></TR>
<TR><TD>3.824e-02</TD><TD>-3.26</TD><TD>pancreas-carcinoma-acinar_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>pancreas-carcinoma-acinar_carcinoma</TD><TD>1983</TD><TD>31</TD><TD>16984</TD><TD>192</TD>
<TD>PTPRD,PTPRZ1,UBR4,SEMA3C,FMNL2,FGF5,FGFR2,RUNX1T1,FERD3L,NAV3,EFR3A,BCHE,ARL14,UTRN,ACVR2A,SERINC5,ZFPM2,PHLPP1,FAT4,NOVA1,CNTNAP2,CD96,ZPLD1,DSCAM,THSD7A,XPO4,NBEA,SPATA16,REXO2,CDH5,FUT9</TD></TR>
<TR><TD>3.824e-02</TD><TD>-3.26</TD><TD>acinar_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>acinar_carcinoma</TD><TD>1983</TD><TD>31</TD><TD>16984</TD><TD>192</TD>
<TD>THSD7A,DSCAM,ZPLD1,XPO4,REXO2,SPATA16,NBEA,CDH5,FUT9,SERINC5,ACVR2A,UTRN,ARL14,PHLPP1,FAT4,ZFPM2,NOVA1,CD96,CNTNAP2,RUNX1T1,FGFR2,FGF5,FMNL2,EFR3A,NAV3,FERD3L,BCHE,PTPRZ1,PTPRD,UBR4,SEMA3C</TD></TR>
<TR><TD>3.828e-02</TD><TD>-3.26</TD><TD>ATP13A1 (ATPase 13A1)</TD><TD>protein interactions</TD><TD>57130</TD><TD>167</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>EMC2,SLC7A14,CDH5,NUP35,CD226</TD></TR>
<TR><TD>3.828e-02</TD><TD>-3.26</TD><TD>Toll_tir_struct_dom_sf</TD><TD>interpro domains</TD><TD>IPR035897</TD><TD>27</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>IL1RAPL2,BANK1</TD></TR>
<TR><TD>3.828e-02</TD><TD>-3.26</TD><TD>ATPase_AAA_CS</TD><TD>interpro domains</TD><TD>IPR003960</TD><TD>27</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>FIGN,AFG2A</TD></TR>
<TR><TD>3.828e-02</TD><TD>-3.26</TD><TD>ADAM_Cys-rich</TD><TD>interpro domains</TD><TD>IPR006586</TD><TD>27</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>ADAMTS5,ADAM28</TD></TR>
<TR><TD>3.830e-02</TD><TD>-3.26</TD><TD>human chr4p16.1</TD><TD>chromosome location</TD><TD>human chr4p16.1</TD><TD>147</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>ZNF518B,MIR548I2</TD></TR>
<TR><TD>3.841e-02</TD><TD>-3.26</TD><TD>Hypothesized Pathways in Pathogenesis of Cardiovascular Disease</TD><TD>WikiPathways</TD><TD>WP3668</TD><TD>25</TD><TD>2</TD><TD>5358</TD><TD>67</TD>
<TD>FBN2,TGFBR2</TD></TR>
<TR><TD>3.863e-02</TD><TD>-3.25</TD><TD>central_nervous_system-brainstem-glioma</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brainstem-glioma</TD><TD>338</TD><TD>8</TD><TD>16984</TD><TD>192</TD>
<TD>CNTNAP2,IGFL4,RPH3A,GMDS,NAALADL2,IL1RAPL2,PTPRD,THSD7A</TD></TR>
<TR><TD>3.878e-02</TD><TD>-3.25</TD><TD>adrenal gland development</TD><TD>biological process</TD><TD>GO:0030325</TD><TD>27</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>INSM1,PBX1</TD></TR>
<TR><TD>3.878e-02</TD><TD>-3.25</TD><TD>regulation of dendrite extension</TD><TD>biological process</TD><TD>GO:1903859</TD><TD>27</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>SPAG9,SYT1</TD></TR>
<TR><TD>3.878e-02</TD><TD>-3.25</TD><TD>positive regulation of lipid catabolic process</TD><TD>biological process</TD><TD>GO:0050996</TD><TD>27</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PRKCE,TWIST1</TD></TR>
<TR><TD>3.878e-02</TD><TD>-3.25</TD><TD>cytokine production</TD><TD>biological process</TD><TD>GO:0001816</TD><TD>27</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>CD226,ADAMTS3</TD></TR>
<TR><TD>3.878e-02</TD><TD>-3.25</TD><TD>mesenchymal cell proliferation</TD><TD>biological process</TD><TD>GO:0010463</TD><TD>27</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PHF14,FGFR2</TD></TR>
<TR><TD>3.892e-02</TD><TD>-3.25</TD><TD>YIPF6 (Yip1 domain family member 6)</TD><TD>protein interactions</TD><TD>286451</TD><TD>115</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>EFNA5,SLC7A14,SLC7A8,LRRC3B</TD></TR>
<TR><TD>3.895e-02</TD><TD>-3.25</TD><TD>craniopharyngioma</TD><TD>COSMIC cancer mutations</TD><TD>craniopharyngioma</TD><TD>401</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>PXDNL,UBR4,NRCAM,CRTC3,PTPRZ1,EPYC,UTRN,ADAM28,VAV3</TD></TR>
<TR><TD>3.895e-02</TD><TD>-3.25</TD><TD>craniopharyngeal_duct</TD><TD>COSMIC cancer mutations</TD><TD>craniopharyngeal_duct</TD><TD>401</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>ADAM28,VAV3,PTPRZ1,EPYC,UTRN,NRCAM,CRTC3,PXDNL,UBR4</TD></TR>
<TR><TD>3.896e-02</TD><TD>-3.25</TD><TD>human chr8q24.23</TD><TD>chromosome location</TD><TD>human chr8q24.23</TD><TD>19</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LINC02055</TD></TR>
<TR><TD>3.897e-02</TD><TD>-3.24</TD><TD>HRDC</TD><TD>prosite domains</TD><TD>PS50967</TD><TD>3</TD><TD>1</TD><TD>12232</TD><TD>161</TD>
<TD>WRN</TD></TR>
<TR><TD>3.897e-02</TD><TD>-3.24</TD><TD>PUM</TD><TD>prosite domains</TD><TD>PS50302</TD><TD>3</TD><TD>1</TD><TD>12232</TD><TD>161</TD>
<TD>PUM3</TD></TR>
<TR><TD>3.897e-02</TD><TD>-3.24</TD><TD>TAU_MAP_2</TD><TD>prosite domains</TD><TD>PS51491</TD><TD>3</TD><TD>1</TD><TD>12232</TD><TD>161</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.897e-02</TD><TD>-3.24</TD><TD>RIBOSOMAL_L3</TD><TD>prosite domains</TD><TD>PS00474</TD><TD>3</TD><TD>1</TD><TD>12232</TD><TD>161</TD>
<TD>MRPL3</TD></TR>
<TR><TD>3.897e-02</TD><TD>-3.24</TD><TD>TAU_MAP_1</TD><TD>prosite domains</TD><TD>PS00229</TD><TD>3</TD><TD>1</TD><TD>12232</TD><TD>161</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.897e-02</TD><TD>-3.24</TD><TD>PUM_HD</TD><TD>prosite domains</TD><TD>PS50303</TD><TD>3</TD><TD>1</TD><TD>12232</TD><TD>161</TD>
<TD>PUM3</TD></TR>
<TR><TD>3.899e-02</TD><TD>-3.24</TD><TD>regulation of supramolecular fiber organization</TD><TD>biological process</TD><TD>GO:1902903</TD><TD>391</TD><TD>9</TD><TD>18905</TD><TD>219</TD>
<TD>PLEK,NAV3,TMEFF2,EPS8,SLIT2,AKAP9,PRKCE,CDH5,MAP2</TD></TR>
<TR><TD>3.904e-02</TD><TD>-3.24</TD><TD>Integrins in angiogenesis</TD><TD>Pathway Interaction DB</TD><TD>avb3_integrin_pathway</TD><TD>46</TD><TD>3</TD><TD>2232</TD><TD>37</TD>
<TD>VAV3,EDIL3,TGFBR2</TD></TR>
<TR><TD>3.912e-02</TD><TD>-3.24</TD><TD>positive regulation of cell junction assembly</TD><TD>biological process</TD><TD>GO:1901890</TD><TD>110</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>EFNA5,CNTNAP2,NTRK2,PTPRD</TD></TR>
<TR><TD>3.915e-02</TD><TD>-3.24</TD><TD>GRB2 events in EGFR signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-179812</TD><TD>245</TD><TD>6</TD><TD>10391</TD><TD>106</TD>
<TD>AKAP9,PAQR3,FGF5,FGFR2,FGF20,NRG1</TD></TR>
<TR><TD>3.915e-02</TD><TD>-3.24</TD><TD>RAF/MAP kinase cascade</TD><TD>REACTOME pathways</TD><TD>R-HSA-5673001</TD><TD>245</TD><TD>6</TD><TD>10391</TD><TD>106</TD>
<TD>NRG1,FGF20,FGFR2,FGF5,PAQR3,AKAP9</TD></TR>
<TR><TD>3.915e-02</TD><TD>-3.24</TD><TD>SHC1 events in EGFR signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-180336</TD><TD>245</TD><TD>6</TD><TD>10391</TD><TD>106</TD>
<TD>NRG1,FGF20,PAQR3,AKAP9,FGF5,FGFR2</TD></TR>
<TR><TD>3.915e-02</TD><TD>-3.24</TD><TD>SOS-mediated signalling</TD><TD>REACTOME pathways</TD><TD>R-HSA-112412</TD><TD>245</TD><TD>6</TD><TD>10391</TD><TD>106</TD>
<TD>FGFR2,FGF5,PAQR3,AKAP9,NRG1,FGF20</TD></TR>
<TR><TD>3.922e-02</TD><TD>-3.24</TD><TD>Ubiquinone Biosynthesis</TD><TD>SMPDB pathways</TD><TD>SMP0000065</TD><TD>5</TD><TD>1</TD><TD>1382</TD><TD>11</TD>
<TD>COQ2</TD></TR>
<TR><TD>3.922e-02</TD><TD>-3.24</TD><TD>Bile Acid Direct Signalling Pathway (1)</TD><TD>SMPDB pathways</TD><TD>SMP0086608</TD><TD>5</TD><TD>1</TD><TD>1382</TD><TD>11</TD>
<TD>SLC10A2</TD></TR>
<TR><TD>3.938e-02</TD><TD>-3.23</TD><TD>KLF3 (KLF transcription factor 3)</TD><TD>protein interactions</TD><TD>51274</TD><TD>225</TD><TD>6</TD><TD>20077</TD><TD>222</TD>
<TD>NOL4,UCHL1,PCGF5,SS18,JMJD1C,TRPS1</TD></TR>
<TR><TD>3.952e-02</TD><TD>-3.23</TD><TD>sensory system development</TD><TD>biological process</TD><TD>GO:0048880</TD><TD>392</TD><TD>9</TD><TD>18905</TD><TD>219</TD>
<TD>PBX1,EFEMP1,TWIST1,FBN2,PAX6,NTRK2,DSCAM,TGFBR2,PLAAT1</TD></TR>
<TR><TD>3.955e-02</TD><TD>-3.23</TD><TD>C1QTNF7 (C1q and TNF related 7)</TD><TD>protein interactions</TD><TD>114905</TD><TD>68</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>BCHE,SLIT2,SEMA3C</TD></TR>
<TR><TD>3.956e-02</TD><TD>-3.23</TD><TD>FGFR1 mutant receptor activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-1839124</TD><TD>31</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>3.956e-02</TD><TD>-3.23</TD><TD>Downstream signaling of activated FGFR1</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654687</TD><TD>31</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>3.956e-02</TD><TD>-3.23</TD><TD>Activated NOTCH1 Transmits Signal to the Nucleus</TD><TD>REACTOME pathways</TD><TD>R-HSA-2122948</TD><TD>31</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>CNTN1,DNER</TD></TR>
<TR><TD>3.960e-02</TD><TD>-3.23</TD><TD>Toll/interleukin-1 receptor homology (TIR) domain</TD><TD>gene3d domains</TD><TD>3.40.50.10140</TD><TD>26</TD><TD>2</TD><TD>14531</TD><TD>177</TD>
<TD>IL1RAPL2,BANK1</TD></TR>
<TR><TD>3.964e-02</TD><TD>-3.23</TD><TD>positive regulation of synapse assembly</TD><TD>biological process</TD><TD>GO:0051965</TD><TD>65</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2,EFNA5,PTPRD</TD></TR>
<TR><TD>3.965e-02</TD><TD>-3.23</TD><TD>lip</TD><TD>COSMIC cancer mutations</TD><TD>lip</TD><TD>28</TD><TD>2</TD><TD>16984</TD><TD>192</TD>
<TD>CRTC3,FGFR2</TD></TR>
<TR><TD>3.995e-02</TD><TD>-3.22</TD><TD>presynaptic membrane</TD><TD>cellular component</TD><TD>GO:0042734</TD><TD>168</TD><TD>5</TD><TD>19868</TD><TD>221</TD>
<TD>PTPRD,EPHA4,CNTN1,SYT1,CASK</TD></TR>
<TR><TD>3.997e-02</TD><TD>-3.22</TD><TD>CDK2AP1 (cyclin dependent kinase 2 associated protein 1)</TD><TD>protein interactions</TD><TD>8099</TD><TD>116</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>TCF20,TRPS1,PWWP2A,PHF14</TD></TR>
<TR><TD>3.997e-02</TD><TD>-3.22</TD><TD>LATROPHILIN</TD><TD>prints domains</TD><TD>PR01444</TD><TD>3</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>ADGRL3</TD></TR>
<TR><TD>3.997e-02</TD><TD>-3.22</TD><TD>ETOFAMILY</TD><TD>prints domains</TD><TD>PR01875</TD><TD>3</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>3.997e-02</TD><TD>-3.22</TD><TD>RYANODINER</TD><TD>prints domains</TD><TD>PR00795</TD><TD>3</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.997e-02</TD><TD>-3.22</TD><TD>NTKRECEPTOR</TD><TD>prints domains</TD><TD>PR01939</TD><TD>3</TD><TD>1</TD><TD>5258</TD><TD>71</TD>
<TD>NTRK2</TD></TR>
<TR><TD>4.009e-02</TD><TD>-3.22</TD><TD>PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2)</TD><TD>protein interactions</TD><TD>5296</TD><TD>226</TD><TD>6</TD><TD>20077</TD><TD>222</TD>
<TD>EPHA4,TGFBR2,EPHA3,TEC,NTRK2,FGFR2</TD></TR>
<TR><TD>4.018e-02</TD><TD>-3.21</TD><TD>glioma</TD><TD>COSMIC cancer mutations</TD><TD>glioma</TD><TD>16158</TD><TD>188</TD><TD>16984</TD><TD>192</TD>
<TD>KAZN,LMX1A,SLC10A2,LGI1,PSKH2,EPYC,EFNA5,PRLHR,FERD3L,AMELX,GCNT1,RUNX1T1,FGFR2,TWIST1,SS18,NOVA1,SPANXN1,CNTN1,AKAP9,NAALADL2,PARP8,SERINC5,MAP2,FGF20,SLIT2,NOL4,NCKAP5,CD226,OR2AG1,GHITM,PTPRZ1,UNC5C,GPR83,SERGEF,B3GAT2,WWOX,EFEMP1,TRPS1,GAP43,RASGEF1B,CELF2,DEFB115,ACVR2A,UTRN,ZFPM2,NAT2,SPATA16,AFM,PLEK,SLC39A10,VAV3,PXDNL,AGA,SLC25A46,FABP7,FNIP2,SLC7A14,EDIL3,CTSO,IGFL4,BACH2,FGF5,FAT4,BANK1,ZNF518B,SYT1,FANCB,NBEA,MPEG1,GMDS,KCNK9,CHRM3,DAOA,SLC7A8,CRTC3,MRPL13,NRG1,PRSS12,EPS8,LHCGR,NAV3,FZD6,LMBRD1,FGF14,THSD7B,COX7B2,RBM20,UHMK1,ARL14,ARX,INSM1,CDH5,SHISA3,PCDH9,UBR4,DNAJC12,PBX1,RAI2,BCHE,ADAMTS3,CETN3,WRN,MRPL3,IL1RAPL2,OR52K2,JMJD1C,LRRC70,PHLPP1,FIGN,LRRC3B,ASPN,UCHL1,PWWP2A,MUC7,SPAG9,RGS6,DEPTOR,FBN2,STXBP6,IQGAP2,PAX6,FGD3,NRSN1,IPO8,FUT9,REG1B,LRIG3,ACVR1C,LRRN2,NOBOX,KIF6,PAQR3,SPHKAP,TCF20,SEZ6L,PCGF5,LRFN5,ZFAND5,MEGF10,CXCL13,ACP6,CNTNAP2,PI15,CPXM2,IRX1,ZNF133,PRKCE,TMEFF2,SGCD,CASK,DNER,EPHA4,COQ2,DSCAM,XPO4,DCDC2C,SKAP2,TSN,CALN1,NRCAM,SEMA3C,DAAM1,TGFBR2,PTPRD,ADAM28,EFR3A,NUP35,ATG10,CYTL1,KLF12,ZNF521,PTPRK,FMNL2,ADAMTS12,NTRK2,CD96,HNF4G,EPHA3,REXO2,PHF14,SGCG,ADAMTS5,ROBO2,RPH3A,RYR2,THSD7A,ZPLD1,AOAH</TD></TR>
<TR><TD>4.019e-02</TD><TD>-3.21</TD><TD>Transcription from mitochondrial promoters</TD><TD>REACTOME pathways</TD><TD>R-HSA-75944</TD><TD>4</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>MTERF1</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>skin-back-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-back-malignant_melanoma</TD><TD>280</TD><TD>7</TD><TD>16984</TD><TD>192</TD>
<TD>ADAMTS3,LGI1,ADAM28,LRIG3,CHRM3,PTPRD,GHITM</TD></TR>
<TR><TD>4.023e-02</TD><TD>-3.21</TD><TD>positive regulation of cellular process</TD><TD>biological process</TD><TD>GO:0048522</TD><TD>5745</TD><TD>79</TD><TD>18905</TD><TD>219</TD>
<TD>HNF4G,MEGF10,FBN2,PRKCE,BRINP3,SYT1,BANK1,NRG1,ACVR2A,PWWP2A,MIR1260B,GAREM1,CYTL1,TGFBR2,UNC5C,TWIST1,FGF5,PCGF5,CXCL13,NAV3,SLC39A10,PLEK,EDIL3,FNIP2,DEPTOR,LMX1A,EFNA5,SHTN1,UTRN,NTRK2,UHMK1,EPHA4,ZFPM2,SS18,FANCB,EPS8,TCF20,REG1B,PTPRZ1,ROBO2,WWOX,FGF20,FUT9,ACVR1C,KLF12,LHCGR,IRX1,PECAM1,ZNF521,CNTN1,ARX,ADAMTS3,PAX6,MAP2,GHITM,CDH5,CRTC3,SPAG9,CD226,PTPRD,NRCAM,CASK,EPHA3,DSCAM,UCHL1,RYR2,VAV3,RBM20,GCNT1,INSM1,PBX1,AKAP9,SLIT2,LGI1,CNTNAP2,SEMA3C,CHRM3,FGFR2,XPO4</TD></TR>
<TR><TD>4.025e-02</TD><TD>-3.21</TD><TD>regulation of monoatomic ion transmembrane transporter activity</TD><TD>biological process</TD><TD>GO:0032412</TD><TD>216</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>CHRM3,UTRN,RYR2,FGF14,PRKCE,AKAP9</TD></TR>
<TR><TD>4.046e-02</TD><TD>-3.21</TD><TD>skin-chest-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-chest-malignant_melanoma</TD><TD>114</TD><TD>4</TD><TD>16984</TD><TD>192</TD>
<TD>ADAMTS3,PTPRD,CHRM3,ACVR2A</TD></TR>
<TR><TD>4.049e-02</TD><TD>-3.21</TD><TD>FGFR1 (fibroblast growth factor receptor 1)</TD><TD>protein interactions</TD><TD>2260</TD><TD>613</TD><TD>12</TD><TD>20077</TD><TD>222</TD>
<TD>SEPTIN5,NBEA,CASK,LRRN2,FGFR2,NRSN1,FGF5,UTRN,TGFBR2,EPHA4,EFR3A,EFR3B</TD></TR>
<TR><TD>4.052e-02</TD><TD>-3.21</TD><TD>positive regulation of cell growth</TD><TD>biological process</TD><TD>GO:0030307</TD><TD>162</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>EFNA5,SYT1,SHTN1,LGI1,DSCAM</TD></TR>
<TR><TD>4.064e-02</TD><TD>-3.20</TD><TD>CAPN15 (calpain 15)</TD><TD>protein interactions</TD><TD>6650</TD><TD>29</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>NRSN1,CDH5</TD></TR>
<TR><TD>4.064e-02</TD><TD>-3.20</TD><TD>Regulation of Actin Cytoskeleton</TD><TD>WikiPathways</TD><TD>WP51</TD><TD>152</TD><TD>5</TD><TD>5358</TD><TD>67</TD>
<TD>FGFR2,CHRM3,FGF5,FGF20,FGF14</TD></TR>
<TR><TD>4.078e-02</TD><TD>-3.20</TD><TD>chordate embryonic development</TD><TD>biological process</TD><TD>GO:0043009</TD><TD>652</TD><TD>13</TD><TD>18905</TD><TD>219</TD>
<TD>ACVR1C,ZFAND5,TWIST1,SEMA3C,ADAMTS3,FGFR2,PAX6,FERD3L,TGFBR2,ZFPM2,PBX1,ACVR2A,FZD6</TD></TR>
<TR><TD>4.082e-02</TD><TD>-3.20</TD><TD>BCL6 (BCL6 transcription repressor)</TD><TD>protein interactions</TD><TD>604</TD><TD>227</TD><TD>6</TD><TD>20077</TD><TD>222</TD>
<TD>BACH2,PRKCE,TWIST1,RUNX1T1,PCDH9,UCHL1</TD></TR>
<TR><TD>4.090e-02</TD><TD>-3.20</TD><TD>HSPA1B (heat shock protein family A (Hsp70) member 1B)</TD><TD>protein interactions</TD><TD>3304</TD><TD>287</TD><TD>7</TD><TD>20077</TD><TD>222</TD>
<TD>EPHA3,SGCG,NTRK2,GMDS,EPHA4,FGFR2,FNIP2</TD></TR>
<TR><TD>4.097e-02</TD><TD>-3.20</TD><TD>human chr5q14.2</TD><TD>chromosome location</TD><TD>human chr5q14.2</TD><TD>20</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>MIR3977</TD></TR>
<TR><TD>4.104e-02</TD><TD>-3.19</TD><TD>PTGER3 (prostaglandin E receptor 3)</TD><TD>protein interactions</TD><TD>5733</TD><TD>117</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>ACVR2A,IPO8,XPO4,LRIG3</TD></TR>
<TR><TD>4.106e-02</TD><TD>-3.19</TD><TD>Signaling by FGFR2</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654738</TD><TD>75</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGFR2,FGF20</TD></TR>
<TR><TD>4.106e-02</TD><TD>-3.19</TD><TD>regulation of molecular function</TD><TD>biological process</TD><TD>GO:0065009</TD><TD>2017</TD><TD>32</TD><TD>18905</TD><TD>219</TD>
<TD>PUM3,PRKCE,RGS6,NRG1,ACVR1C,PAQR3,LHCGR,FZD6,PAX6,TGFBR2,PPP1R17,MAP2,TWIST1,FGD3,CXCL13,CRTC3,PLEK,EPHA3,UCHL1,RYR2,DEPTOR,VAV3,EFNA5,FGF14,AKAP9,CHRM3,WRN,FGFR2,UTRN,NTRK2,EPHA4,SERINC5</TD></TR>
<TR><TD>4.111e-02</TD><TD>-3.19</TD><TD>positive regulation of cell population proliferation</TD><TD>biological process</TD><TD>GO:0008284</TD><TD>995</TD><TD>18</TD><TD>18905</TD><TD>219</TD>
<TD>GAREM1,PAX6,FGFR2,NTRK2,ZFPM2,EPHA4,TGFBR2,INSM1,PBX1,VAV3,SLC39A10,FGF20,NRG1,SS18,MEGF10,TWIST1,REG1B,FGF5</TD></TR>
<TR><TD>4.117e-02</TD><TD>-3.19</TD><TD>human chr1q41</TD><TD>chromosome location</TD><TD>human chr1q41</TD><TD>153</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC02817,LYPLAL1-AS1</TD></TR>
<TR><TD>4.119e-02</TD><TD>-3.19</TD><TD>ERBB signaling pathway</TD><TD>biological process</TD><TD>GO:0038127</TD><TD>66</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>NRG1,GAREM1,EFEMP1</TD></TR>
<TR><TD>4.119e-02</TD><TD>-3.19</TD><TD>regulation of lipid catabolic process</TD><TD>biological process</TD><TD>GO:0050994</TD><TD>66</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1,PRKCE,CRTC3</TD></TR>
<TR><TD>4.133e-02</TD><TD>-3.19</TD><TD>RAC3 (Rac family small GTPase 3)</TD><TD>protein interactions</TD><TD>5881</TD><TD>615</TD><TD>12</TD><TD>20077</TD><TD>222</TD>
<TD>EMC2,SHTN1,FAT4,PTPRK,EPS8,DAAM1,EFR3A,EPHA3,IQGAP2,FZD6,SLC39A10,UTRN</TD></TR>
<TR><TD>4.134e-02</TD><TD>-3.19</TD><TD>ConA-like_dom_sf</TD><TD>interpro domains</TD><TD>IPR013320</TD><TD>219</TD><TD>6</TD><TD>18605</TD><TD>214</TD>
<TD>FAT4,RYR2,SLIT2,PTPRK,NBEA,CNTNAP2</TD></TR>
<TR><TD>4.138e-02</TD><TD>-3.18</TD><TD>EPHA2 (EPH receptor A2)</TD><TD>protein interactions</TD><TD>1969</TD><TD>350</TD><TD>8</TD><TD>20077</TD><TD>222</TD>
<TD>CDH5,FGFR2,EFR3B,EPHA3,PHLPP1,NTRK2,EPHA4,EFNA5</TD></TR>
<TR><TD>4.145e-02</TD><TD>-3.18</TD><TD>response to gonadotropin</TD><TD>biological process</TD><TD>GO:0034698</TD><TD>28</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>LHCGR,EFNA5</TD></TR>
<TR><TD>4.145e-02</TD><TD>-3.18</TD><TD>positive regulation of antigen receptor-mediated signaling pathway</TD><TD>biological process</TD><TD>GO:0050857</TD><TD>28</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>CD226,SLC39A10</TD></TR>
<TR><TD>4.145e-02</TD><TD>-3.18</TD><TD>regulation of calcium ion-dependent exocytosis</TD><TD>biological process</TD><TD>GO:0017158</TD><TD>28</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>RPH3A,SYT1</TD></TR>
<TR><TD>4.145e-02</TD><TD>-3.18</TD><TD>endochondral bone growth</TD><TD>biological process</TD><TD>GO:0003416</TD><TD>28</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,TGFBR2</TD></TR>
<TR><TD>4.149e-02</TD><TD>-3.18</TD><TD>regulation of cell population proliferation</TD><TD>biological process</TD><TD>GO:0042127</TD><TD>1794</TD><TD>29</TD><TD>18905</TD><TD>219</TD>
<TD>ARX,PAX6,GAREM1,FABP7,TGFBR2,MEGF10,SS18,REG1B,PTPRZ1,PTPRK,SKAP2,ACVR1C,NRG1,FGF20,VAV3,PBX1,PHF14,INSM1,NTRK2,BCHE,FGFR2,AMELX,EPHA4,ZFPM2,TWIST1,CDH5,FGF5,SLC39A10,CASK</TD></TR>
<TR><TD>4.183e-02</TD><TD>-3.17</TD><TD>Signalling to p38 via RIT and RIN</TD><TD>REACTOME pathways</TD><TD>R-HSA-187706</TD><TD>249</TD><TD>6</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGFR2,AKAP9,PAQR3,NRG1,FGF20</TD></TR>
<TR><TD>4.183e-02</TD><TD>-3.17</TD><TD>ARMS-mediated activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-170984</TD><TD>249</TD><TD>6</TD><TD>10391</TD><TD>106</TD>
<TD>FGFR2,FGF5,AKAP9,PAQR3,FGF20,NRG1</TD></TR>
<TR><TD>4.213e-02</TD><TD>-3.17</TD><TD>ALDH7A1 (aldehyde dehydrogenase 7 family member A1)</TD><TD>protein interactions</TD><TD>501</TD><TD>118</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>WWOX,EMC2,EPS8,NUP35</TD></TR>
<TR><TD>4.213e-02</TD><TD>-3.17</TD><TD>DDR1 (discoidin domain receptor tyrosine kinase 1)</TD><TD>protein interactions</TD><TD>780</TD><TD>118</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>SHISA3,GPR83,WWOX,TGFBR2</TD></TR>
<TR><TD>4.224e-02</TD><TD>-3.16</TD><TD>CH</TD><TD>pfam domains</TD><TD>PF00307</TD><TD>67</TD><TD>3</TD><TD>17869</TD><TD>206</TD>
<TD>IQGAP2,NAV3,UTRN</TD></TR>
<TR><TD>4.229e-02</TD><TD>-3.16</TD><TD>VANGL1 (VANGL planar cell polarity protein 1)</TD><TD>protein interactions</TD><TD>81839</TD><TD>229</TD><TD>6</TD><TD>20077</TD><TD>222</TD>
<TD>EPHA3,NTRK2,PHLPP1,FGFR2,SLC25A46,EPHA4</TD></TR>
<TR><TD>4.248e-02</TD><TD>-3.16</TD><TD>small molecule binding</TD><TD>molecular function</TD><TD>GO:0036094</TD><TD>6276</TD><TD>82</TD><TD>18530</TD><TD>206</TD>
<TD>BCHE,ACVR1C,JMJD1C,VAV3,ADGRL3,RBM20,EPHA3,SYT1,RUNX1T1,CPQ,AMELX,GAP43,MATCAP2,IQGAP2,FGD3,MARCHF3,CALN1,HNF4G,ASPN,EPHA4,RYR2,EFEMP1,ERCC6L2,MARCHF11,ZNF133,TCF20,ZFAND5,GALNT15,EDIL3,ZFPM2,PLEK,ARL14,UHMK1,GMDS,LMX1A,CASK,AFG2A,DEPTOR,KIF6,ACTR3C,ADAMTS12,CETN3,DNER,REXO2,FAT4,FGFR2,TGFBR2,ZNF521,PRKCE,ADAMTS3,WRN,FABP7,CPXM2,PCDH9,INSM1,UBR4,ACVR2A,FIGN,NAV3,LMBRD1,PCGF5,TEC,B3GAT2,TRPS1,ADAM28,AFM,PSKH2,RPH3A,PHLPP1,FBN2,ADAMTS5,SLIT2,MAST4,KLF12,ZNF518B,NTRK2,SEPTIN5,UTRN,PHF14,AOAH,PXDNL,CHRM3</TD></TR>
<TR><TD>4.248e-02</TD><TD>-3.16</TD><TD>camera-type eye development</TD><TD>biological process</TD><TD>GO:0043010</TD><TD>336</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>PLAAT1,TGFBR2,DSCAM,NTRK2,PAX6,FBN2,TWIST1,EFEMP1</TD></TR>
<TR><TD>4.252e-02</TD><TD>-3.16</TD><TD>Frs2-mediated activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-170968</TD><TD>250</TD><TD>6</TD><TD>10391</TD><TD>106</TD>
<TD>NRG1,FGF20,PAQR3,AKAP9,FGF5,FGFR2</TD></TR>
<TR><TD>4.252e-02</TD><TD>-3.16</TD><TD>ITGB3 (integrin subunit beta 3)</TD><TD>protein interactions</TD><TD>3690</TD><TD>70</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRZ1,EPS8,PECAM1</TD></TR>
<TR><TD>4.252e-02</TD><TD>-3.16</TD><TD>DUSP10 (dual specificity phosphatase 10)</TD><TD>protein interactions</TD><TD>11221</TD><TD>70</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>FBN2,UTRN,CASK</TD></TR>
<TR><TD>4.252e-02</TD><TD>-3.16</TD><TD>NCAM1 (neural cell adhesion molecule 1)</TD><TD>protein interactions</TD><TD>4684</TD><TD>70</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>UCHL1,ARL14,EPHA3</TD></TR>
<TR><TD>4.254e-02</TD><TD>-3.16</TD><TD>SHC1 (SHC adaptor protein 1)</TD><TD>protein interactions</TD><TD>6464</TD><TD>352</TD><TD>8</TD><TD>20077</TD><TD>222</TD>
<TD>GAREM1,TEC,NTRK2,CDH5,FGFR2,EPHA4,EPS8,VAV3</TD></TR>
<TR><TD>4.276e-02</TD><TD>-3.15</TD><TD>neutrophil migration</TD><TD>biological process</TD><TD>GO:1990266</TD><TD>67</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>PECAM1,CXCL13,VAV3</TD></TR>
<TR><TD>4.276e-02</TD><TD>-3.15</TD><TD>regulation of cardiac muscle tissue growth</TD><TD>biological process</TD><TD>GO:0055021</TD><TD>67</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>FGF20,ZFPM2,FGFR2</TD></TR>
<TR><TD>4.321e-02</TD><TD>-3.14</TD><TD>MAPK1/MAPK3 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-5684996</TD><TD>251</TD><TD>6</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,NRG1,FGF5,FGFR2,AKAP9,PAQR3</TD></TR>
<TR><TD>4.323e-02</TD><TD>-3.14</TD><TD>PARD6G (par-6 family cell polarity regulator gamma)</TD><TD>protein interactions</TD><TD>84552</TD><TD>30</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>AKAP9,CASK</TD></TR>
<TR><TD>4.323e-02</TD><TD>-3.14</TD><TD>PECAM1 (platelet and endothelial cell adhesion molecule 1)</TD><TD>protein interactions</TD><TD>5175</TD><TD>30</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>PECAM1,PRKCE</TD></TR>
<TR><TD>4.323e-02</TD><TD>-3.14</TD><TD>ACVRL1 (activin A receptor like type 1)</TD><TD>protein interactions</TD><TD>94</TD><TD>30</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>ACVR2A,TGFBR2</TD></TR>
<TR><TD>4.327e-02</TD><TD>-3.14</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia</TD><TD>2082</TD><TD>32</TD><TD>16984</TD><TD>192</TD>
<TD>PRLHR,TGFBR2,PTPRZ1,DAAM1,PSKH2,KIF6,SLC7A8,UBR4,ACVR1C,FGFR2,FBN2,PTPRK,RUNX1T1,TRPS1,RGS6,TCF20,ZNF133,EPHA3,PRKCE,FGD3,FAT4,UHMK1,MAP2,ACVR2A,NTRK2,HNF4G,ADAMTS12,MPEG1,EPHA4,SPATA16,CASK,SYT1</TD></TR>
<TR><TD>4.327e-02</TD><TD>-3.14</TD><TD>cellular response to transforming growth factor beta stimulus</TD><TD>biological process</TD><TD>GO:0071560</TD><TD>165</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>CDH5,FGFR2,PTPRK,TGFBR2,WWOX</TD></TR>
<TR><TD>4.342e-02</TD><TD>-3.14</TD><TD>terminal O-glycans residues modification</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY-7434</TD><TD>8</TD><TD>1</TD><TD>907</TD><TD>5</TD>
<TD>FUT9</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>CALY (calcyon neuron specific vesicular protein)</TD><TD>protein interactions</TD><TD>50632</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>NRG1</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>ERI2 (ERI1 exoribonuclease family member 2)</TD><TD>protein interactions</TD><TD>112479</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>DNAJC12</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>MAMLD1 (mastermind like domain containing 1)</TD><TD>protein interactions</TD><TD>10046</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>NUP35</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>CASD1 (CAS1 domain containing 1)</TD><TD>protein interactions</TD><TD>64921</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>PCAT1</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>IFNL2 (interferon lambda 2)</TD><TD>protein interactions</TD><TD>282616</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>ATG10</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>SPATA31G1 (SPATA31 subfamily G member 1)</TD><TD>protein interactions</TD><TD>138724</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>UCHL1</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>Fancc (Fanconi anemia, complementation group C)</TD><TD>protein interactions</TD><TD>14088</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>FANCB</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>RAD50 (MRX complex DNA-binding subunit)</TD><TD>protein interactions</TD><TD>855471</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>WRN</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>MYH16 (myosin heavy chain 16 (pseudogene))</TD><TD>protein interactions</TD><TD>84176</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>WWOX</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>DAOA (D-amino acid oxidase activator)</TD><TD>protein interactions</TD><TD>267012</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>DAOA</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>Pax6 (paired box 6)</TD><TD>protein interactions</TD><TD>18508</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>PAX6</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>GJA10 (gap junction protein alpha 10)</TD><TD>protein interactions</TD><TD>84694</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>PCAT1</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>mug82 (putative translation release factor)</TD><TD>protein interactions</TD><TD>2541472</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>MRPL3</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>ORF52 (ORF52)</TD><TD>protein interactions</TD><TD>4961496</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>PUM3</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>CPT1B (carnitine palmitoyltransferase 1B)</TD><TD>protein interactions</TD><TD>1375</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>UCHL1</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>IGL (immunoglobulin lambda locus)</TD><TD>protein interactions</TD><TD>3535</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>SHTN1</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>CALHM2 (calcium homeostasis modulator family member 2)</TD><TD>protein interactions</TD><TD>51063</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>Adar (adenosine deaminase, RNA-specific)</TD><TD>protein interactions</TD><TD>56417</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>LINC00624</TD></TR>
<TR><TD>4.350e-02</TD><TD>-3.13</TD><TD>OR52N5 (olfactory receptor family 52 subfamily N member 5)</TD><TD>protein interactions</TD><TD>390075</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>222</TD>
<TD>CD226</TD></TR>
<TR><TD>4.362e-02</TD><TD>-3.13</TD><TD>human chr6p22.3</TD><TD>chromosome location</TD><TD>human chr6p22.3</TD><TD>158</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>NRSN1,CASC15</TD></TR>
<TR><TD>4.366e-02</TD><TD>-3.13</TD><TD>regulation of regulated secretory pathway</TD><TD>biological process</TD><TD>GO:1903305</TD><TD>114</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>SEPTIN5,SYT1,RPH3A,CASK</TD></TR>
<TR><TD>4.374e-02</TD><TD>-3.13</TD><TD>Y-form DNA binding</TD><TD>molecular function</TD><TD>GO:0000403</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>WRN</TD></TR>
<TR><TD>4.374e-02</TD><TD>-3.13</TD><TD>choline binding</TD><TD>molecular function</TD><TD>GO:0033265</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>BCHE</TD></TR>
<TR><TD>4.374e-02</TD><TD>-3.13</TD><TD>calcium ion sensor activity</TD><TD>molecular function</TD><TD>GO:0061891</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>SYT1</TD></TR>
<TR><TD>4.374e-02</TD><TD>-3.13</TD><TD>hydroxyapatite binding</TD><TD>molecular function</TD><TD>GO:0046848</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>AMELX</TD></TR>
<TR><TD>4.374e-02</TD><TD>-3.13</TD><TD>histone H2AK119 ubiquitin ligase activity</TD><TD>molecular function</TD><TD>GO:0140862</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>PCGF5</TD></TR>
<TR><TD>4.374e-02</TD><TD>-3.13</TD><TD>inhibin binding</TD><TD>molecular function</TD><TD>GO:0034711</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>ACVR2A</TD></TR>
<TR><TD>4.374e-02</TD><TD>-3.13</TD><TD>receptor-receptor interaction</TD><TD>molecular function</TD><TD>GO:0090722</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>FGF20</TD></TR>
<TR><TD>4.374e-02</TD><TD>-3.13</TD><TD>vitamin E binding</TD><TD>molecular function</TD><TD>GO:0008431</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>AFM</TD></TR>
<TR><TD>4.374e-02</TD><TD>-3.13</TD><TD>lactoperoxidase activity</TD><TD>molecular function</TD><TD>GO:0140825</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>PXDNL</TD></TR>
<TR><TD>4.374e-02</TD><TD>-3.13</TD><TD>ryanodine-sensitive calcium-release channel activity</TD><TD>molecular function</TD><TD>GO:0005219</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>RYR2</TD></TR>
<TR><TD>4.374e-02</TD><TD>-3.13</TD><TD>brain-derived neurotrophic factor binding</TD><TD>molecular function</TD><TD>GO:0048403</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>NTRK2</TD></TR>
<TR><TD>4.374e-02</TD><TD>-3.13</TD><TD>telomeric D-loop binding</TD><TD>molecular function</TD><TD>GO:0061821</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>206</TD>
<TD>WRN</TD></TR>
<TR><TD>4.376e-02</TD><TD>-3.13</TD><TD>proximal neuron projection</TD><TD>cellular component</TD><TD>GO:1990769</TD><TD>4</TD><TD>1</TD><TD>19868</TD><TD>221</TD>
<TD>MAP2</TD></TR>
<TR><TD>4.376e-02</TD><TD>-3.13</TD><TD>clathrin-sculpted glutamate transport vesicle membrane</TD><TD>cellular component</TD><TD>GO:0060203</TD><TD>4</TD><TD>1</TD><TD>19868</TD><TD>221</TD>
<TD>SYT1</TD></TR>
<TR><TD>4.376e-02</TD><TD>-3.13</TD><TD>clathrin-sculpted glutamate transport vesicle</TD><TD>cellular component</TD><TD>GO:0060199</TD><TD>4</TD><TD>1</TD><TD>19868</TD><TD>221</TD>
<TD>SYT1</TD></TR>
<TR><TD>4.391e-02</TD><TD>-3.13</TD><TD>Prolonged ERK activation events</TD><TD>REACTOME pathways</TD><TD>R-HSA-169893</TD><TD>252</TD><TD>6</TD><TD>10391</TD><TD>106</TD>
<TD>FGF20,NRG1,FGF5,FGFR2,PAQR3,AKAP9</TD></TR>
<TR><TD>4.415e-02</TD><TD>-3.12</TD><TD>regulation of cell-substrate adhesion</TD><TD>biological process</TD><TD>GO:0010810</TD><TD>221</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>EDIL3,UTRN,EPHA3,CASK,EFNA5,PRKCE</TD></TR>
<TR><TD>4.419e-02</TD><TD>-3.12</TD><TD>peripheral nervous system axon ensheathment</TD><TD>biological process</TD><TD>GO:0032292</TD><TD>29</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2,SLC25A46</TD></TR>
<TR><TD>4.419e-02</TD><TD>-3.12</TD><TD>atrioventricular valve development</TD><TD>biological process</TD><TD>GO:0003171</TD><TD>29</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2,TWIST1</TD></TR>
<TR><TD>4.419e-02</TD><TD>-3.12</TD><TD>myelination in peripheral nervous system</TD><TD>biological process</TD><TD>GO:0022011</TD><TD>29</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2,SLC25A46</TD></TR>
<TR><TD>4.419e-02</TD><TD>-3.12</TD><TD>glandular epithelial cell development</TD><TD>biological process</TD><TD>GO:0002068</TD><TD>29</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,INSM1</TD></TR>
<TR><TD>4.419e-02</TD><TD>-3.12</TD><TD>enteroendocrine cell differentiation</TD><TD>biological process</TD><TD>GO:0035883</TD><TD>29</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6,INSM1</TD></TR>
<TR><TD>4.419e-02</TD><TD>-3.12</TD><TD>central nervous system projection neuron axonogenesis</TD><TD>biological process</TD><TD>GO:0021952</TD><TD>29</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA4,SLIT2</TD></TR>
<TR><TD>4.419e-02</TD><TD>-3.12</TD><TD>regulation of cardiac muscle cell action potential</TD><TD>biological process</TD><TD>GO:0098901</TD><TD>29</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2,AKAP9</TD></TR>
<TR><TD>4.421e-02</TD><TD>-3.12</TD><TD>morphogenesis of a branching epithelium</TD><TD>biological process</TD><TD>GO:0061138</TD><TD>166</TD><TD>5</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,TGFBR2,FGFR2,PBX1,SEMA3C</TD></TR>
<TR><TD>4.424e-02</TD><TD>-3.12</TD><TD>Melanoma</TD><TD>KEGG pathways</TD><TD>ko05218</TD><TD>69</TD><TD>3</TD><TD>7246</TD><TD>83</TD>
<TD>FGF20,FGF5,FGF14</TD></TR>
<TR><TD>4.424e-02</TD><TD>-3.12</TD><TD>Melanoma</TD><TD>KEGG pathways</TD><TD>hsa05218</TD><TD>69</TD><TD>3</TD><TD>7246</TD><TD>83</TD>
<TD>FGF5,FGF14,FGF20</TD></TR>
<TR><TD>4.429e-02</TD><TD>-3.12</TD><TD>HRDC</TD><TD>smart domains</TD><TD>SM00341</TD><TD>3</TD><TD>1</TD><TD>9743</TD><TD>146</TD>
<TD>WRN</TD></TR>
<TR><TD>4.429e-02</TD><TD>-3.12</TD><TD>CDC48_N</TD><TD>smart domains</TD><TD>SM01073</TD><TD>3</TD><TD>1</TD><TD>9743</TD><TD>146</TD>
<TD>AFG2A</TD></TR>
<TR><TD>4.434e-02</TD><TD>-3.12</TD><TD>Signaling by Robo receptor</TD><TD>REACTOME pathways</TD><TD>R-HSA-376176</TD><TD>33</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>ROBO2,SLIT2</TD></TR>
<TR><TD>4.434e-02</TD><TD>-3.12</TD><TD>Negative regulation of FGFR1 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654726</TD><TD>33</TD><TD>2</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>4.437e-02</TD><TD>-3.12</TD><TD>cellular response to retinoic acid</TD><TD>biological process</TD><TD>GO:0071300</TD><TD>68</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>EPHA3,FGFR2,BRINP3</TD></TR>
<TR><TD>4.443e-02</TD><TD>-3.11</TD><TD>positive regulation of cell migration</TD><TD>biological process</TD><TD>GO:0030335</TD><TD>594</TD><TD>12</TD><TD>18905</TD><TD>219</TD>
<TD>SEMA3C,PAX6,TGFBR2,EPHA4,INSM1,SHTN1,PECAM1,TWIST1,CDH5,PRKCE,CXCL13,SPAG9</TD></TR>
<TR><TD>4.446e-02</TD><TD>-3.11</TD><TD>bone-fibula-osteosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-fibula-osteosarcoma</TD><TD>4</TD><TD>1</TD><TD>16984</TD><TD>192</TD>
<TD>SS18</TD></TR>
<TR><TD>4.446e-02</TD><TD>-3.11</TD><TD>soft_tissue-fibrous_tissue_and_uncertain_origin-synovial_sarcoma-poorly_differentiated</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-fibrous_tissue_and_uncertain_origin-synovial_sarcoma-poorly_differentiated</TD><TD>4</TD><TD>1</TD><TD>16984</TD><TD>192</TD>
<TD>SS18</TD></TR>
<TR><TD>4.446e-02</TD><TD>-3.11</TD><TD>bone-frontal-other-ameloblastoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-frontal-other-ameloblastoma</TD><TD>4</TD><TD>1</TD><TD>16984</TD><TD>192</TD>
<TD>FGFR2</TD></TR>
<TR><TD>4.446e-02</TD><TD>-3.11</TD><TD>poorly_differentiated</TD><TD>COSMIC cancer mutations</TD><TD>poorly_differentiated</TD><TD>4</TD><TD>1</TD><TD>16984</TD><TD>192</TD>
<TD>SS18</TD></TR>
<TR><TD>4.447e-02</TD><TD>-3.11</TD><TD>microtubule cytoskeleton</TD><TD>cellular component</TD><TD>GO:0015630</TD><TD>1419</TD><TD>23</TD><TD>19868</TD><TD>221</TD>
<TD>KIF6,FNIP2,SEPTIN5,LHCGR,NAV3,UBR4,ERCC6L2,NCKAP5,SERINC5,MAP2,DAW1,DAAM1,PCGF5,SS18,AFG2A,CETN3,DCDC2C,AKAP9,HNF4G,WRN,FIGN,SPAG9,SHTN1</TD></TR>
<TR><TD>4.462e-02</TD><TD>-3.11</TD><TD>Signaling by Leptin</TD><TD>REACTOME pathways</TD><TD>R-HSA-2586552</TD><TD>253</TD><TD>6</TD><TD>10391</TD><TD>106</TD>
<TD>NRG1,FGF20,FGFR2,FGF5,AKAP9,PAQR3</TD></TR>
<TR><TD>4.464e-02</TD><TD>-3.11</TD><TD>Mesodermal Commitment Pathway</TD><TD>WikiPathways</TD><TD>WP2857</TD><TD>156</TD><TD>5</TD><TD>5358</TD><TD>67</TD>
<TD>PAX6,PARP8,VAV3,ACVR2A,PBX1</TD></TR>
<TR><TD>4.514e-02</TD><TD>-3.10</TD><TD>heparin binding</TD><TD>molecular function</TD><TD>GO:0008201</TD><TD>174</TD><TD>5</TD><TD>18530</TD><TD>206</TD>
<TD>FGFR2,CXCL13,ADAMTS3,SLIT2,ADAMTS5</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>MTERF_sf</TD><TD>interpro domains</TD><TD>IPR038538</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MTERF1</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>Peptidase_C12_UCH_sf</TD><TD>interpro domains</TD><TD>IPR036959</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>UCHL1</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>FHIP</TD><TD>interpro domains</TD><TD>IPR019384</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FHIP1A</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>RGS_DHEX</TD><TD>interpro domains</TD><TD>IPR040759</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RGS6</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>LMBR1-like_membr_prot</TD><TD>interpro domains</TD><TD>IPR006876</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>LMBRD1</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>Eps8_SH3</TD><TD>interpro domains</TD><TD>IPR035462</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>EPS8</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>MAST_pre-PK_dom_sf</TD><TD>interpro domains</TD><TD>IPR023142</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MAST4</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>Neurofascin/L1/NrCAM_C</TD><TD>interpro domains</TD><TD>IPR026966</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NRCAM</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>MAST</TD><TD>interpro domains</TD><TD>IPR037711</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MAST4</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>Serum_albumin_N</TD><TD>interpro domains</TD><TD>IPR014760</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>AFM</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>ALB/AFP/VDB</TD><TD>interpro domains</TD><TD>IPR000264</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>AFM</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>RecQ_Zn-bd</TD><TD>interpro domains</TD><TD>IPR032284</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>WRN</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>FHIP_C</TD><TD>interpro domains</TD><TD>IPR045669</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FHIP1A</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>MAST_pre-PK_dom</TD><TD>interpro domains</TD><TD>IPR015022</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MAST4</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>IGFL</TD><TD>interpro domains</TD><TD>IPR032744</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>IGFL4</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>PBX_PBC_dom</TD><TD>interpro domains</TD><TD>IPR005542</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PBX1</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>Asp_de-COase-like_dom_sf</TD><TD>interpro domains</TD><TD>IPR009010</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>AFG2A</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>Rabphilin/DOC2/Noc2</TD><TD>interpro domains</TD><TD>IPR043566</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RPH3A</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>RGS6/7/9/11</TD><TD>interpro domains</TD><TD>IPR047016</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RGS6</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>CABIT_dom</TD><TD>interpro domains</TD><TD>IPR025946</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>GAREM1</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>NBEA/BDCP_DUF4704</TD><TD>interpro domains</TD><TD>IPR031570</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NBEA</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>Peptidase_C12_UCH</TD><TD>interpro domains</TD><TD>IPR001578</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>UCHL1</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>JHDM2-like</TD><TD>interpro domains</TD><TD>IPR045109</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>JMJD1C</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>RGS6/7/9/11_DHEX_sf</TD><TD>interpro domains</TD><TD>IPR047017</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>RGS6</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>EPS8_PTB</TD><TD>interpro domains</TD><TD>IPR033928</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>EPS8</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>Prot_kin_PKC_delta</TD><TD>interpro domains</TD><TD>IPR014376</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PRKCE</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>MTERF</TD><TD>interpro domains</TD><TD>IPR003690</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>MTERF1</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>JNK/Rab-associated_protein-1_N</TD><TD>interpro domains</TD><TD>IPR019143</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>SPAG9</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>FGF_rcpt_fam</TD><TD>interpro domains</TD><TD>IPR016248</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FGFR2</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>FHIP_KELAA_motif</TD><TD>interpro domains</TD><TD>IPR045668</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FHIP1A</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>Serum_albumin_CS</TD><TD>interpro domains</TD><TD>IPR020857</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>AFM</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>Pumilio_RNA-bd_rpt</TD><TD>interpro domains</TD><TD>IPR001313</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>PUM3</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>SPHK1-interactor_AKAP_110</TD><TD>interpro domains</TD><TD>IPR008382</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>SPHKAP</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>NBCH_WD40</TD><TD>interpro domains</TD><TD>IPR046851</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>NBEA</TD></TR>
<TR><TD>4.522e-02</TD><TD>-3.10</TD><TD>FGD1-4_PH2</TD><TD>interpro domains</TD><TD>IPR035941</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>214</TD>
<TD>FGD3</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>KELAA</TD><TD>pfam domains</TD><TD>PF19311</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>FHIP1A</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>Peptidase_C12</TD><TD>pfam domains</TD><TD>PF01088</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>UCHL1</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>CABIT</TD><TD>pfam domains</TD><TD>PF12736</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>GAREM1</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>IGFL</TD><TD>pfam domains</TD><TD>PF14653</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>IGFL4</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>RAI16-like</TD><TD>pfam domains</TD><TD>PF10257</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>FHIP1A</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>DUF1908</TD><TD>pfam domains</TD><TD>PF08926</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>MAST4</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>Bravo_FIGEY</TD><TD>pfam domains</TD><TD>PF13882</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>NRCAM</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>PBC</TD><TD>pfam domains</TD><TD>PF03792</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>PBX1</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>mTERF</TD><TD>pfam domains</TD><TD>PF02536</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>MTERF1</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>NBCH_WD40</TD><TD>pfam domains</TD><TD>PF20426</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>NBEA</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>DUF5917</TD><TD>pfam domains</TD><TD>PF19314</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>FHIP1A</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>Jnk-SapK_ap_N</TD><TD>pfam domains</TD><TD>PF09744</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>SPAG9</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>GDP_Man_Dehyd</TD><TD>pfam domains</TD><TD>PF16363</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>GMDS</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>RecQ_Zn_bind</TD><TD>pfam domains</TD><TD>PF16124</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>WRN</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>RGS_DHEX</TD><TD>pfam domains</TD><TD>PF18148</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>RGS6</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>Serum_albumin</TD><TD>pfam domains</TD><TD>PF00273</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>AFM</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>LMBR1</TD><TD>pfam domains</TD><TD>PF04791</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>LMBRD1</TD></TR>
<TR><TD>4.533e-02</TD><TD>-3.09</TD><TD>DUF4704</TD><TD>pfam domains</TD><TD>PF15787</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>206</TD>
<TD>NBEA</TD></TR>
<TR><TD>4.544e-02</TD><TD>-3.09</TD><TD>EGF_CA</TD><TD>pfam domains</TD><TD>PF07645</TD><TD>69</TD><TD>3</TD><TD>17869</TD><TD>206</TD>
<TD>FAT4,EFEMP1,FBN2</TD></TR>
<TR><TD>4.548e-02</TD><TD>-3.09</TD><TD>RCOR1 (REST corepressor 1)</TD><TD>protein interactions</TD><TD>23186</TD><TD>488</TD><TD>10</TD><TD>20077</TD><TD>222</TD>
<TD>RBM20,SPAG9,WWOX,JMJD1C,KLF12,TRPS1,UTRN,NOL4,SHTN1,UBR4</TD></TR>
<TR><TD>4.552e-02</TD><TD>-3.09</TD><TD>TIR</TD><TD>prosite domains</TD><TD>PS50104</TD><TD>26</TD><TD>2</TD><TD>12232</TD><TD>161</TD>
<TD>IL1RAPL2,BANK1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>regulation of inositol trisphosphate biosynthetic process</TD><TD>biological process</TD><TD>GO:0032960</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>LHCGR</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>sequestering of TGFbeta in extracellular matrix</TD><TD>biological process</TD><TD>GO:0035583</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FBN2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>response to fluoride</TD><TD>biological process</TD><TD>GO:1902617</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ASPN</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>myoblast development</TD><TD>biological process</TD><TD>GO:0048627</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>MEGF10</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>oligodendrocyte cell fate commitment</TD><TD>biological process</TD><TD>GO:0021779</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>positive regulation of core promoter binding</TD><TD>biological process</TD><TD>GO:1904798</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>L-alanine import across plasma membrane</TD><TD>biological process</TD><TD>GO:1904273</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLC7A8</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>negative regulation of skeletal muscle tissue development</TD><TD>biological process</TD><TD>GO:0048642</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>vestibular reflex</TD><TD>biological process</TD><TD>GO:0060005</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ZPLD1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>trans-synaptic signaling by BDNF</TD><TD>biological process</TD><TD>GO:0099191</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>embryonic nail plate morphogenesis</TD><TD>biological process</TD><TD>GO:0035880</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FZD6</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>left ventricular cardiac muscle tissue morphogenesis</TD><TD>biological process</TD><TD>GO:0003220</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>regulation of calcium ion-dependent exocytosis of neurotransmitter</TD><TD>biological process</TD><TD>GO:1903233</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SYT1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>D-amino acid metabolic process</TD><TD>biological process</TD><TD>GO:0046416</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>DAOA</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>negative regulation of peroxisome proliferator activated receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0035359</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>GDP-L-fucose metabolic process</TD><TD>biological process</TD><TD>GO:0046368</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>GMDS</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>dichotomous subdivision of terminal units involved in salivary gland branching</TD><TD>biological process</TD><TD>GO:0060666</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SEMA3C</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>globus pallidus development</TD><TD>biological process</TD><TD>GO:0021759</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ARX</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>oligodendrocyte cell fate specification</TD><TD>biological process</TD><TD>GO:0021778</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PAX6</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>prostate gland morphogenetic growth</TD><TD>biological process</TD><TD>GO:0060737</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>clustering of voltage-gated potassium channels</TD><TD>biological process</TD><TD>GO:0045163</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>regulation of retinal ganglion cell axon guidance</TD><TD>biological process</TD><TD>GO:0090259</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>negative regulation of dendrite extension</TD><TD>biological process</TD><TD>GO:1903860</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SPAG9</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>Langerhans cell differentiation</TD><TD>biological process</TD><TD>GO:0061520</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>negative regulation of apoptotic process in bone marrow cell</TD><TD>biological process</TD><TD>GO:0071866</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>lens fiber cell apoptotic process</TD><TD>biological process</TD><TD>GO:1990086</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>negative regulation of endothelial cell chemotaxis to fibroblast growth factor</TD><TD>biological process</TD><TD>GO:2000545</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>CXCL13</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>positive regulation of synaptic vesicle fusion to presynaptic active zone membrane</TD><TD>biological process</TD><TD>GO:0031632</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SYT1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>regulation of atrial cardiac muscle cell action potential</TD><TD>biological process</TD><TD>GO:0098910</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis</TD><TD>biological process</TD><TD>GO:1905310</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SEMA3C</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>positive regulation of synaptic vesicle membrane organization</TD><TD>biological process</TD><TD>GO:1901634</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SYT1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>negative regulation of smooth muscle cell chemotaxis</TD><TD>biological process</TD><TD>GO:0071672</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>protein localization to juxtaparanode region of axon</TD><TD>biological process</TD><TD>GO:0071205</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation</TD><TD>biological process</TD><TD>GO:1905007</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>cellular response to heparin</TD><TD>biological process</TD><TD>GO:0071504</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>regulation of AV node cell action potential</TD><TD>biological process</TD><TD>GO:0098904</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>RYR2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>peripheral nervous system neuron axonogenesis</TD><TD>biological process</TD><TD>GO:0048936</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLC25A46</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>N-glycan fucosylation</TD><TD>biological process</TD><TD>GO:0036071</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>FUT9</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>synaptic vesicle targeting</TD><TD>biological process</TD><TD>GO:0016080</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SEPTIN5</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>positive regulation of inositol trisphosphate biosynthetic process</TD><TD>biological process</TD><TD>GO:0032962</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>LHCGR</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>actomyosin contractile ring assembly actin filament organization</TD><TD>biological process</TD><TD>GO:2000689</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>IQGAP2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>negative regulation of gonad development</TD><TD>biological process</TD><TD>GO:1905940</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>valine transport</TD><TD>biological process</TD><TD>GO:0015829</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SLC7A8</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>mitochondrial potassium ion transmembrane transport</TD><TD>biological process</TD><TD>GO:0140141</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>GHITM</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>brain-derived neurotrophic factor receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0031547</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>NTRK2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>pattern specification involved in metanephros development</TD><TD>biological process</TD><TD>GO:0072268</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>IRX1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>calcium-dependent activation of synaptic vesicle fusion</TD><TD>biological process</TD><TD>GO:0099502</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>SYT1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>positive regulation of NK T cell differentiation</TD><TD>biological process</TD><TD>GO:0051138</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>specification of loop of Henle identity</TD><TD>biological process</TD><TD>GO:0072086</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>IRX1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>positive regulation of mitochondrial ATP synthesis coupled electron transport</TD><TD>biological process</TD><TD>GO:1905448</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>GHITM</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>monocyte extravasation</TD><TD>biological process</TD><TD>GO:0035696</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>PECAM1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>regulation of hepatocyte growth factor receptor signaling pathway</TD><TD>biological process</TD><TD>GO:1902202</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>ADAMTS12</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>cartilage homeostasis</TD><TD>biological process</TD><TD>GO:1990079</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>219</TD>
<TD>CYTL1</TD></TR>
<TR><TD>4.588e-02</TD><TD>-3.08</TD><TD>DSE (dermatan sulfate epimerase)</TD><TD>protein interactions</TD><TD>29940</TD><TD>31</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>SLC7A14,NRG1</TD></TR>
<TR><TD>4.588e-02</TD><TD>-3.08</TD><TD>GNPTG (N-acetylglucosamine-1-phosphate transferase subunit gamma)</TD><TD>protein interactions</TD><TD>84572</TD><TD>31</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRK,ZPLD1</TD></TR>
<TR><TD>4.588e-02</TD><TD>-3.08</TD><TD>MMP15 (matrix metallopeptidase 15)</TD><TD>protein interactions</TD><TD>4324</TD><TD>31</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>PI15,EMC2</TD></TR>
<TR><TD>4.604e-02</TD><TD>-3.08</TD><TD>metencephalon development</TD><TD>biological process</TD><TD>GO:0022037</TD><TD>116</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>CNTN1,LMX1A,PAX6,SLC25A46</TD></TR>
<TR><TD>4.604e-02</TD><TD>-3.08</TD><TD>Notch signaling pathway</TD><TD>biological process</TD><TD>GO:0007219</TD><TD>116</TD><TD>4</TD><TD>18905</TD><TD>219</TD>
<TD>DNER,TGFBR2,GMDS,CNTN1</TD></TR>
<TR><TD>4.605e-02</TD><TD>-3.08</TD><TD>Interleukin receptor SHC signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-912526</TD><TD>255</TD><TD>6</TD><TD>10391</TD><TD>106</TD>
<TD>PAQR3,AKAP9,FGFR2,FGF5,FGF20,NRG1</TD></TR>
<TR><TD>4.623e-02</TD><TD>-3.07</TD><TD>cell projection membrane</TD><TD>cellular component</TD><TD>GO:0031253</TD><TD>356</TD><TD>8</TD><TD>19868</TD><TD>221</TD>
<TD>CNTNAP2,ROBO2,SLC7A8,CASK,EPS8,PLEK,GAP43,UTRN</TD></TR>
<TR><TD>4.640e-02</TD><TD>-3.07</TD><TD>cEGF</TD><TD>interpro domains</TD><TD>IPR026823</TD><TD>30</TD><TD>2</TD><TD>18605</TD><TD>214</TD>
<TD>FBN2,EFEMP1</TD></TR>
<TR><TD>4.646e-02</TD><TD>-3.07</TD><TD>upper_aerodigestive_tract-sinonasal_and_nasal_cavity-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-sinonasal_and_nasal_cavity-carcinoma-squamous_cell_carcinoma</TD><TD>71</TD><TD>3</TD><TD>16984</TD><TD>192</TD>
<TD>UNC5C,THSD7B,MPEG1</TD></TR>
<TR><TD>4.658e-02</TD><TD>-3.07</TD><TD>cEGF</TD><TD>pfam domains</TD><TD>PF12662</TD><TD>30</TD><TD>2</TD><TD>17869</TD><TD>206</TD>
<TD>FBN2,EFEMP1</TD></TR>
<TR><TD>4.660e-02</TD><TD>-3.07</TD><TD>regulation of transmembrane transporter activity</TD><TD>biological process</TD><TD>GO:0022898</TD><TD>224</TD><TD>6</TD><TD>18905</TD><TD>219</TD>
<TD>UTRN,CHRM3,PRKCE,AKAP9,FGF14,RYR2</TD></TR>
<TR><TD>4.664e-02</TD><TD>-3.07</TD><TD>SRC (SRC proto-oncogene, non-receptor tyrosine kinase)</TD><TD>protein interactions</TD><TD>6714</TD><TD>627</TD><TD>12</TD><TD>20077</TD><TD>222</TD>
<TD>PRKCE,SKAP2,WWOX,PECAM1,EPS8,CDH5,FGFR2,EFNA5,EPHA4,MAP2,EPHA3,ARL14</TD></TR>
<TR><TD>4.672e-02</TD><TD>-3.06</TD><TD>PI3K Cascade</TD><TD>REACTOME pathways</TD><TD>R-HSA-109704</TD><TD>79</TD><TD>3</TD><TD>10391</TD><TD>106</TD>
<TD>FGF5,FGFR2,FGF20</TD></TR>
<TR><TD>4.678e-02</TD><TD>-3.06</TD><TD>Signalling to RAS</TD><TD>REACTOME pathways</TD><TD>R-HSA-167044</TD><TD>256</TD><TD>6</TD><TD>10391</TD><TD>106</TD>
<TD>NRG1,FGF20,AKAP9,PAQR3,FGF5,FGFR2</TD></TR>
<TR><TD>4.696e-02</TD><TD>-3.06</TD><TD>human chr3p11.1</TD><TD>chromosome location</TD><TD>human chr3p11.1</TD><TD>23</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>EPHA3</TD></TR>
<TR><TD>4.696e-02</TD><TD>-3.06</TD><TD>human chr18q22.2</TD><TD>chromosome location</TD><TD>human chr18q22.2</TD><TD>23</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>CD226</TD></TR>
<TR><TD>4.696e-02</TD><TD>-3.06</TD><TD>human chr4p16.2</TD><TD>chromosome location</TD><TD>human chr4p16.2</TD><TD>23</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>CYTL1</TD></TR>
<TR><TD>4.696e-02</TD><TD>-3.06</TD><TD>human chr13q22.2</TD><TD>chromosome location</TD><TD>human chr13q22.2</TD><TD>23</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LINC00561</TD></TR>
<TR><TD>4.714e-02</TD><TD>-3.05</TD><TD>human chr7q36.1</TD><TD>chromosome location</TD><TD>human chr7q36.1</TD><TD>165</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LOC100134040,ACTR3C</TD></TR>
<TR><TD>4.718e-02</TD><TD>-3.05</TD><TD>PKNOX1 (PBX/knotted 1 homeobox 1)</TD><TD>protein interactions</TD><TD>5316</TD><TD>73</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>FMNL2,PAX6,PBX1</TD></TR>
<TR><TD>4.718e-02</TD><TD>-3.05</TD><TD>TMED4 (transmembrane p24 trafficking protein 4)</TD><TD>protein interactions</TD><TD>222068</TD><TD>73</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>LGI1,SLC7A14,EMC2</TD></TR>
<TR><TD>4.723e-02</TD><TD>-3.05</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelofibrosis</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelofibrosis</TD><TD>416</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>FBN2,FAT4,ZNF521,PRSS12,PARP8,FUT9,CDH5,SLC7A8,ADAMTS12</TD></TR>
<TR><TD>4.723e-02</TD><TD>-3.05</TD><TD>myelofibrosis</TD><TD>COSMIC cancer mutations</TD><TD>myelofibrosis</TD><TD>416</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>FBN2,FAT4,ZNF521,PRSS12,PARP8,CDH5,FUT9,SLC7A8,ADAMTS12</TD></TR>
<TR><TD>4.758e-02</TD><TD>-3.05</TD><TD>HADHA (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha)</TD><TD>protein interactions</TD><TD>3030</TD><TD>492</TD><TD>10</TD><TD>20077</TD><TD>222</TD>
<TD>CETN3,CASK,EPHA4,WWOX,PTPRD,FGFR2,EMC2,PSKH2,CDH5,UBR4</TD></TR>
<TR><TD>4.762e-02</TD><TD>-3.04</TD><TD>SP7 (Sp7 transcription factor)</TD><TD>protein interactions</TD><TD>121340</TD><TD>297</TD><TD>7</TD><TD>20077</TD><TD>222</TD>
<TD>TRPS1,FBN2,PCGF5,SS18,RBM20,TCF20,PBX1</TD></TR>
<TR><TD>4.767e-02</TD><TD>-3.04</TD><TD>ovulation cycle</TD><TD>biological process</TD><TD>GO:0042698</TD><TD>70</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>SLIT2,ROBO2,LHCGR</TD></TR>
<TR><TD>4.780e-02</TD><TD>-3.04</TD><TD>EIF2B3 (eukaryotic translation initiation factor 2B subunit gamma)</TD><TD>protein interactions</TD><TD>8891</TD><TD>123</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>CD226,DEPTOR,SYT1,FGF14</TD></TR>
<TR><TD>4.780e-02</TD><TD>-3.04</TD><TD>TPST2 (tyrosylprotein sulfotransferase 2)</TD><TD>protein interactions</TD><TD>8459</TD><TD>123</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>NRSN1,XPO4,IPO8,SPAG9</TD></TR>
<TR><TD>4.785e-02</TD><TD>-3.04</TD><TD>-</TD><TD>gene3d domains</TD><TD>6.10.250.230</TD><TD>4</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>4.785e-02</TD><TD>-3.04</TD><TD>Transcription termination factor 3, mitochondrial</TD><TD>gene3d domains</TD><TD>1.25.70.10</TD><TD>4</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>MTERF1</TD></TR>
<TR><TD>4.785e-02</TD><TD>-3.04</TD><TD>-</TD><TD>gene3d domains</TD><TD>1.10.1240.60</TD><TD>4</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>RGS6</TD></TR>
<TR><TD>4.785e-02</TD><TD>-3.04</TD><TD>MAST3 pre-PK domain-like</TD><TD>gene3d domains</TD><TD>1.20.1480.20</TD><TD>4</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>MAST4</TD></TR>
<TR><TD>4.785e-02</TD><TD>-3.04</TD><TD>Peptidase C12, ubiquitin carboxyl-terminal hydrolase</TD><TD>gene3d domains</TD><TD>3.40.532.10</TD><TD>4</TD><TD>1</TD><TD>14531</TD><TD>177</TD>
<TD>UCHL1</TD></TR>
<TR><TD>4.786e-02</TD><TD>-3.04</TD><TD>Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>COSMIC cancer mutations</TD><TD>Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>7438</TD><TD>96</TD><TD>16984</TD><TD>192</TD>
<TD>MAP2,PHLPP1,SS18,OR52K2,CNTN1,AKAP9,NAALADL2,JMJD1C,PARP8,NOL4,NCKAP5,FGF20,EPYC,PRLHR,RAI2,LMX1A,UBR4,PSKH2,WRN,RUNX1T1,FGFR2,FERD3L,BCHE,PAX6,ACVR2A,UTRN,FGD3,ZFPM2,GAP43,RASGEF1B,CELF2,IQGAP2,SLC39A10,VAV3,SPATA16,IPO8,AFM,PTPRZ1,UNC5C,GPR83,B3GAT2,SERGEF,OR2AG1,RGS6,TRPS1,FBN2,SPAG9,CPXM2,FAT4,ZNF133,PRKCE,KCNK9,DSCAM,SKAP2,BANK1,TMEFF2,FANCB,MPEG1,DNER,EPHA4,COQ2,SPHKAP,EDIL3,ACVR1C,PXDNL,KIF6,BACH2,FGF5,TCF20,SEZ6L,LRFN5,RBM20,EPHA3,ADAMTS12,HNF4G,NTRK2,THSD7A,ZPLD1,AOAH,PHF14,ADAMTS5,CDH5,RYR2,NRG1,PRSS12,PTPRD,LHCGR,ADAM28,NRCAM,KLF12,ZNF521,FMNL2,NAV3,LMBRD1,THSD7B,FGF14</TD></TR>
<TR><TD>4.806e-02</TD><TD>-3.04</TD><TD>CCL3 (C-C motif chemokine ligand 3)</TD><TD>protein interactions</TD><TD>6348</TD><TD>178</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>SEMA3C,EDIL3,PRSS12,SLIT2,BCHE</TD></TR>
<TR><TD>4.809e-02</TD><TD>-3.03</TD><TD>adrenal_gland-adrenal_gland-adrenal_cortical_adenoma-cortisol_producing</TD><TD>COSMIC cancer mutations</TD><TD>adrenal_gland-adrenal_gland-adrenal_cortical_adenoma-cortisol_producing</TD><TD>72</TD><TD>3</TD><TD>16984</TD><TD>192</TD>
<TD>FAT4,LRFN5,RYR2</TD></TR>
<TR><TD>4.809e-02</TD><TD>-3.03</TD><TD>cortisol_producing</TD><TD>COSMIC cancer mutations</TD><TD>cortisol_producing</TD><TD>72</TD><TD>3</TD><TD>16984</TD><TD>192</TD>
<TD>FAT4,RYR2,LRFN5</TD></TR>
<TR><TD>4.826e-02</TD><TD>-3.03</TD><TD>VEGFR2 mediated cell proliferation</TD><TD>REACTOME pathways</TD><TD>R-HSA-5218921</TD><TD>258</TD><TD>6</TD><TD>10391</TD><TD>106</TD>
<TD>AKAP9,PAQR3,FGFR2,FGF5,FGF20,NRG1</TD></TR>
<TR><TD>4.827e-02</TD><TD>-3.03</TD><TD>regulation of actin cytoskeleton organization</TD><TD>biological process</TD><TD>GO:0032956</TD><TD>345</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>PLEK,EPHA3,EFNA5,IQGAP2,PRKCE,SLIT2,EPS8,TMEFF2</TD></TR>
<TR><TD>4.828e-02</TD><TD>-3.03</TD><TD>regulation of MAPK cascade</TD><TD>biological process</TD><TD>GO:0043408</TD><TD>669</TD><TD>13</TD><TD>18905</TD><TD>219</TD>
<TD>FGF5,PRKCE,SPAG9,PHLPP1,NTRK2,GAREM1,FGFR2,PAQR3,BANK1,FGF20,NRG1,EPHA4,UCHL1</TD></TR>
<TR><TD>4.859e-02</TD><TD>-3.02</TD><TD>SLC2A9 (solute carrier family 2 member 9)</TD><TD>protein interactions</TD><TD>56606</TD><TD>32</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>RAI2,SLC25A46</TD></TR>
<TR><TD>4.859e-02</TD><TD>-3.02</TD><TD>NXPH2 (neurexophilin 2)</TD><TD>protein interactions</TD><TD>11249</TD><TD>32</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>PCDH9,FAT4</TD></TR>
<TR><TD>4.859e-02</TD><TD>-3.02</TD><TD>SERINC5 (serine incorporator 5)</TD><TD>protein interactions</TD><TD>256987</TD><TD>32</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>SERINC5,UBR4</TD></TR>
<TR><TD>4.859e-02</TD><TD>-3.02</TD><TD>ELL2 (elongation factor for RNA polymerase II 2)</TD><TD>protein interactions</TD><TD>22936</TD><TD>32</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>EFR3A,CASK</TD></TR>
<TR><TD>4.859e-02</TD><TD>-3.02</TD><TD>DSG3 (desmoglein 3)</TD><TD>protein interactions</TD><TD>1830</TD><TD>32</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>NRSN1,WWOX</TD></TR>
<TR><TD>4.859e-02</TD><TD>-3.02</TD><TD>MCOLN2 (mucolipin TRP cation channel 2)</TD><TD>protein interactions</TD><TD>255231</TD><TD>32</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRD,UTRN</TD></TR>
<TR><TD>4.859e-02</TD><TD>-3.02</TD><TD>RUFY2 (RUN and FYVE domain containing 2)</TD><TD>protein interactions</TD><TD>55680</TD><TD>32</TD><TD>2</TD><TD>20077</TD><TD>222</TD>
<TD>DSCAM,EPHA3</TD></TR>
<TR><TD>4.865e-02</TD><TD>-3.02</TD><TD>Mucin type O-glycan biosynthesis</TD><TD>KEGG pathways</TD><TD>ko00512</TD><TD>31</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>GCNT1,GALNT15</TD></TR>
<TR><TD>4.865e-02</TD><TD>-3.02</TD><TD>Mucin type O-glycan biosynthesis</TD><TD>KEGG pathways</TD><TD>hsa00512</TD><TD>31</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>GALNT15,GCNT1</TD></TR>
<TR><TD>4.875e-02</TD><TD>-3.02</TD><TD>AAA</TD><TD>prosite domains</TD><TD>PS00674</TD><TD>27</TD><TD>2</TD><TD>12232</TD><TD>161</TD>
<TD>AFG2A,FIGN</TD></TR>
<TR><TD>4.879e-02</TD><TD>-3.02</TD><TD>BNIP3L (BCL2 interacting protein 3 like)</TD><TD>protein interactions</TD><TD>665</TD><TD>74</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>CASK,ROBO2,SLC25A46</TD></TR>
<TR><TD>4.879e-02</TD><TD>-3.02</TD><TD>CBARP (CACN subunit beta associated regulatory protein)</TD><TD>protein interactions</TD><TD>255057</TD><TD>74</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>NTRK2,PHLPP1,ARL14</TD></TR>
<TR><TD>4.879e-02</TD><TD>-3.02</TD><TD>FUT11 (fucosyltransferase 11)</TD><TD>protein interactions</TD><TD>170384</TD><TD>74</TD><TD>3</TD><TD>20077</TD><TD>222</TD>
<TD>PTPRK,PI15,LGI1</TD></TR>
<TR><TD>4.883e-02</TD><TD>-3.02</TD><TD>GRB2 (growth factor receptor bound protein 2)</TD><TD>protein interactions</TD><TD>2885</TD><TD>773</TD><TD>14</TD><TD>20077</TD><TD>222</TD>
<TD>UBR4,ATG10,FGFR2,GAREM1,NTRK2,VAV3,SS18,EPS8,SKAP2,LMX1A,EPHA3,TEC,EPHA4,MAP2</TD></TR>
<TR><TD>4.893e-02</TD><TD>-3.02</TD><TD>Ephrin A  reverse signaling</TD><TD>Pathway Interaction DB</TD><TD>ephrinarevpathway</TD><TD>3</TD><TD>1</TD><TD>2232</TD><TD>37</TD>
<TD>EFNA5</TD></TR>
<TR><TD>4.894e-02</TD><TD>-3.02</TD><TD>chemotaxis</TD><TD>biological process</TD><TD>GO:0006935</TD><TD>346</TD><TD>8</TD><TD>18905</TD><TD>219</TD>
<TD>NRG1,ROBO2,SEMA3C,CXCL13,SLIT2,EFNA5,VAV3,UNC5C</TD></TR>
<TR><TD>4.899e-02</TD><TD>-3.02</TD><TD>BRMS1L (BRMS1 like transcriptional repressor)</TD><TD>protein interactions</TD><TD>84312</TD><TD>124</TD><TD>4</TD><TD>20077</TD><TD>222</TD>
<TD>PWWP2A,PBX1,PAX6,KLF12</TD></TR>
<TR><TD>4.905e-02</TD><TD>-3.01</TD><TD>protein tyrosine kinase activator activity</TD><TD>molecular function</TD><TD>GO:0030296</TD><TD>32</TD><TD>2</TD><TD>18530</TD><TD>206</TD>
<TD>EFNA5,NRG1</TD></TR>
<TR><TD>4.910e-02</TD><TD>-3.01</TD><TD>eIF5A regulation in response to inhibition of the nuclear export system</TD><TD>WikiPathways</TD><TD>WP3302</TD><TD>4</TD><TD>1</TD><TD>5358</TD><TD>67</TD>
<TD>XPO4</TD></TR>
<TR><TD>4.910e-02</TD><TD>-3.01</TD><TD>Caffeine and Theobromine metabolism</TD><TD>WikiPathways</TD><TD>WP3633</TD><TD>4</TD><TD>1</TD><TD>5358</TD><TD>67</TD>
<TD>NAT2</TD></TR>
<TR><TD>4.916e-02</TD><TD>-3.01</TD><TD>Arrhythmogenic right ventricular cardiomyopathy (ARVC)</TD><TD>KEGG pathways</TD><TD>hsa05412</TD><TD>72</TD><TD>3</TD><TD>7246</TD><TD>83</TD>
<TD>SGCD,RYR2,SGCG</TD></TR>
<TR><TD>4.916e-02</TD><TD>-3.01</TD><TD>Arrhythmogenic right ventricular cardiomyopathy (ARVC)</TD><TD>KEGG pathways</TD><TD>ko05412</TD><TD>72</TD><TD>3</TD><TD>7246</TD><TD>83</TD>
<TD>SGCG,RYR2,SGCD</TD></TR>
<TR><TD>4.934e-02</TD><TD>-3.01</TD><TD>LCOR (ligand dependent nuclear receptor corepressor)</TD><TD>protein interactions</TD><TD>84458</TD><TD>238</TD><TD>6</TD><TD>20077</TD><TD>222</TD>
<TD>NAV3,LRRN2,PWWP2A,SERGEF,FMNL2,NRCAM</TD></TR>
<TR><TD>4.936e-02</TD><TD>-3.01</TD><TD>negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction</TD><TD>biological process</TD><TD>GO:0051898</TD><TD>71</TD><TD>3</TD><TD>18905</TD><TD>219</TD>
<TD>TWIST1,PHLPP1,BANK1</TD></TR>
<TR><TD>4.962e-02</TD><TD>-3.00</TD><TD>pituitary</TD><TD>COSMIC cancer mutations</TD><TD>pituitary</TD><TD>420</TD><TD>9</TD><TD>16984</TD><TD>192</TD>
<TD>ADAM28,VAV3,UTRN,PTPRZ1,EPYC,CRTC3,NRCAM,UBR4,PXDNL</TD></TR>
<TR><TD>4.974e-02</TD><TD>-3.00</TD><TD>lung-left_lower_lobe-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-left_lower_lobe-carcinoma-adenocarcinoma</TD><TD>73</TD><TD>3</TD><TD>16984</TD><TD>192</TD>
<TD>NAV3,UBR4,AKAP9</TD></TR>
<TR><TD>4.986e-02</TD><TD>-3.00</TD><TD>positive regulation of cardiac muscle cell proliferation</TD><TD>biological process</TD><TD>GO:0060045</TD><TD>31</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,ZFPM2</TD></TR>
<TR><TD>4.986e-02</TD><TD>-3.00</TD><TD>bone growth</TD><TD>biological process</TD><TD>GO:0098868</TD><TD>31</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>FGFR2,TGFBR2</TD></TR>
<TR><TD>4.986e-02</TD><TD>-3.00</TD><TD>regulation of cellular response to vascular endothelial growth factor stimulus</TD><TD>biological process</TD><TD>GO:1902547</TD><TD>31</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>ADAMTS3,ADAMTS12</TD></TR>
<TR><TD>4.986e-02</TD><TD>-3.00</TD><TD>secretion by tissue</TD><TD>biological process</TD><TD>GO:0032941</TD><TD>31</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>PRKCE,CHRM3</TD></TR>
<TR><TD>4.986e-02</TD><TD>-3.00</TD><TD>chondroitin sulfate proteoglycan metabolic process</TD><TD>biological process</TD><TD>GO:0050654</TD><TD>31</TD><TD>2</TD><TD>18905</TD><TD>219</TD>
<TD>B3GAT2,CYTL1</TD></TR>
<TR><TD>4.995e-02</TD><TD>-3.00</TD><TD>signaling receptor regulator activity</TD><TD>molecular function</TD><TD>GO:0030545</TD><TD>562</TD><TD>11</TD><TD>18530</TD><TD>206</TD>
<TD>PRKCE,EFEMP1,EFNA5,CXCL13,NRG1,FGF20,FGF14,AMELX,FGF5,SEMA3C,FBN2</TD></TR>
<TR><TD>4.998e-02</TD><TD>-3.00</TD><TD>EPHA4 (EPH receptor A4)</TD><TD>protein interactions</TD><TD>2043</TD><TD>180</TD><TD>5</TD><TD>20077</TD><TD>222</TD>
<TD>EPHA3,FGFR2,EPHA4,CASK,EFNA5</TD></TR>
<TR><TD>4.999e-02</TD><TD>-3.00</TD><TD>GRB7 events in ERBB2 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-1306955</TD><TD>5</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>NRG1</TD></TR>
<TR><TD>4.999e-02</TD><TD>-3.00</TD><TD>TGFBR1 LBD Mutants in Cancer</TD><TD>REACTOME pathways</TD><TD>R-HSA-3656535</TD><TD>5</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>4.999e-02</TD><TD>-3.00</TD><TD>TGFBR2 Kinase Domain Mutants in Cancer</TD><TD>REACTOME pathways</TD><TD>R-HSA-3645790</TD><TD>5</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>4.999e-02</TD><TD>-3.00</TD><TD>Muscarinic acetylcholine receptors</TD><TD>REACTOME pathways</TD><TD>R-HSA-390648</TD><TD>5</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>CHRM3</TD></TR>
<TR><TD>4.999e-02</TD><TD>-3.00</TD><TD>Loss of Function of TGFBR2 in Cancer</TD><TD>REACTOME pathways</TD><TD>R-HSA-3642278</TD><TD>5</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>4.999e-02</TD><TD>-3.00</TD><TD>NGF-independant TRKA activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-187024</TD><TD>5</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>NTRK2</TD></TR>
<TR><TD>4.999e-02</TD><TD>-3.00</TD><TD>Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells</TD><TD>REACTOME pathways</TD><TD>R-HSA-210746</TD><TD>5</TD><TD>1</TD><TD>10391</TD><TD>106</TD>
<TD>INSM1</TD></TR>
</TABLE>
</BODY></HTML>
